cluster	Patient ID	Name	Alternative Name	Binds to	Doesn't Bind to	Neutralising Vs	Not Neutralising Vs	Protein + Epitope	Bait	Origin	VH_nuc	VH	VL_nuc	VL	Heavy V Gene	Heavy J Gene	Heavy D Gene	Light V Gene	Light J Gene	CDRH3	CDRL3	Structures	Sources	VH Genbank ID	VL Genbank ID
1	Xie_mix	BD-503	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASGLIVSSNYMSWVRQAPGKGLEWVSVLYAGGSTDYAGSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDAAVYGIDVWGQGTTVTVSS	nan	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYTTPLFTFGPGTKVDIK	IGHV3-53*01	IGHJ6	nan	IGKV1-39*01	IGKJ3	ARDAAVYGIDV	QQSYTTPLFT	nan	Cao et al. Cell 182:73-84.e16 (2020)	nan	nan
1	TAU-2	TAU-2303	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGGAGCAACTATATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCATCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTATATTACTGTGCGAGAGATCTGGCAGTCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGFTVRSNYMSWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFIISRDNSKNTLYLQMNSLRAEDTAVYYCARDLAVYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGGTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCAAACTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAATTACCCTCCGGTCACCTTCGGCCAAGGGACACGACTGGAGATTAAA	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYGASTLQSGVPSRFSGSGSGTEFKLTISSLQPEDFATYYCQQLNNYPPVTFGQGTRLEIK	IGHV3-66*01	IGHJ6*02	IGHD6-19*01	IGKV1-9*01	IGKJ5*01	ARDLAVYGMDV	QQLNNYPPVT	nan	Mor et al. PLoS Pathog. 17:e1009165 (2021)	MW367329.1	MW367330.1
1	COV057	COVD57_P1_HC_F9-1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAAAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATCACTGTGCGAGAGATTTGGCCGTCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYHCARDLAVYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCCGGTCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPVTFGQGTRLEIK	IGHV3-66*01	IGHJ6*02	IGHD3-16*01,IGHD3-16*02,IGHD3-3*01	IGKV1-9*01	IGKJ5*01	ARDLAVYGMDV	QQLNSYPPVT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
1	Dejnirattisai_Cell_Patients	COVOX-150	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGLIQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLEWVSIIYSGGTTYYADSVKGRFTISRDSSMNTLYLQMNSLRAEDTAVYYCARDLMVYGIDVWGQGTTVTVSS	nan	EIVMTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLDSYPPGYTFGQGTKVDIK	IGHV3-53*01	IGHJ6	nan	IGKV1-9*01	IGKJ1	ARDLMVYGIDV	QQLDSYPPGYT	7BEI,7ND5	Dejnirattisai et al. Cell 184:2183-2200.e22 (2021)	nan	nan
1	Xie_mix	BD-500	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMTWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCARDAMSYGMDVWGQGTTVTVSS	nan	DIQMTQSPSSLSASVGDRVTITCRASQSISNFLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTGFTLTISSLQPEDFATYYCQQSYSTPPDTFGQGTRLEIK	IGHV3-53*04	IGHJ6	nan	IGKV1-39*01	IGKJ5	ARDAMSYGMDV	QQSYSTPPDT	nan	Cao et al. Cell 182:73-84.e16 (2020)	nan	nan
1	IML3547	ADI-60783	nan	SARS-CoV-2	nan	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGACTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTAAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGGGGTACTACATACTACGGAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAAGAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGACGCAATGACTTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVETGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGTTYYGDSVKGRFTISRDNSKNTLYLQMKSLRAEDTAVYYCARDAMTYGMDVWGQGTTVTVSS	nan	nan	IGHV3-53*02	IGHJ6*02	IGHD2-21*02,IGHD3-9*01,IGHD4-11*01	IGKV1-39*01	nan	ARDAMTYGMDV	QQSYSTCS	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458052.1	nan
1	Cho-C012	C2404	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGAATCACCGTCAGTAGCAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGTTGTATCTTCAAATGAACAGCCTGAGAGGCGAGGACACGGCCGTGTATTACTGTGCGAGAGATGCCCAGATTTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGITVSSNYMTWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRGEDTAVYYCARDAQIYGMDVWGQGTTVTVSS	GACATCCAGATGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTATTAGTAGCTGGTTGGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATAAGGCGTCTACTTTAGAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACCATCACCAGCCTGCAGCCTGATGATTTTGCAACTTATTACTGCCAACAGTATAATAGTTTTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASTLESGVPSRFSGSGSGTEFTLTITSLQPDDFATYYCQQYNSFFGGGTKVEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV1-5*03	IGKJ4*01,IGKJ4*02	ARDAQIYGMDV	QQYNSF	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
1	Xie_mix	BD-508	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASGFIVSSNYMTWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRHNSKNTLFLQMNSLRAEDTAVYYCARDAQNYGMDVWGQGTTVTVSS	nan	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIFAASSLQTGAPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPYTFGQGTKLEIK	IGHV3-53*04	IGHJ6	nan	IGKV1-39*01	IGKJ2	ARDAQNYGMDV	QQSYSTPPYT	7E86	Cao et al. Cell 182:73-84.e16 (2020);Cao et al. Cell Res. 31:732-741 (2021)	nan	nan
1	Wheatley-CP4	PDI_42	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTAACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTTTTTATCCCGGTGGTAGCACATATAACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGACGCGGTCTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVFYPGGSTYNADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDAVYYGMDVWGQGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGACTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAATTTACTACTGTCAAGAGAGTTACAGTACCCCCGGCTTATTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAA	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFAIYYCQESYSTPGLFTFGPGTKVDIK	IGHV3-66*01	IGHJ6*02	nan	IGKV1-39*01,IGKV1D-39*01	IGKJ3*01	ARDAVYYGMDV	QESYSTPGLFT	7MZG	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
1	REGN_mouse	REGN10996	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;Humanized Mouse	nan	EVQMVESGGGLVQPGGSLRLSCAASGFTVSSNYMTWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCARDGVSYGMDVWGQGTTVTVSS	nan	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPITFGQGTRLEIK	IGHV3-53*04	IGHJ6	nan	IGKV1-39*01	IGKJ5	ARDGVSYGMDV	QQSYSTPPIT	nan	Patent: US10787501	nan	nan
1	COV096	C210	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGTACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCTTCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATTTGATGGCCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTFSRDNSKNTLYLQMNSLRAEDTAVYYCARDLMAYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCAGGGCACTTTCGGCGGAGGGACCAAGGTGGAAATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPQGTFGGGTKVEIK	IGHV3-53*01	IGHJ6*02	IGHD5-24*01	IGKV1-9*01	IGKJ4*01	ARDLMAYGMDV	QQLNSYPQGT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
1	COV096	COV096_HC_134-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGTACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCTTCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATTTGATGGCCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTFSRDNSKNTLYLQMNSLRAEDTAVYYCARDLMAYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCAGGGCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPQGTFGGGTKVEIK	IGHV3-53*01	IGHJ6*02	IGHD5-24*01	IGKV1-9*01	IGKJ4*01	ARDLMAYGMDV	QQLNSYPQGT	nan	Robbiani et al. Nature 584:437-442 (2020);Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW293085.1	MW293540.1
1	Wang-MOD8	MOD8_P2_IgG_E1-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTAACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTCATTTATAGCGGTGGTAGTACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTACAGTCCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLQSYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGATGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAAGAGCTTAATAGTTACCCCGTTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYDASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQELNSYPVFGGGTKVEIK	IGHV3-53*01	IGHJ6*02	IGHD4-11*01,IGHD4-4*01	IGKV1-9*01	IGKJ4*01	ARDLQSYGMDV	QELNSYPV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
1	Xie_mix	BD-506	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTNYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLVSYGMDVWGQGTTVTVSS	nan	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPLTFGGGTKVEIK	IGHV3-66*01	IGHJ6	nan	IGKV1-9*01	IGKJ4	ARDLVSYGMDV	QQLNSYPLT	nan	Cao et al. Cell 182:73-84.e16 (2020)	nan	nan
1	COV096	COV096_HC_68-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGGTCATCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGACGGGGGGCACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGVIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDGGHYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCCCGCCTTCGGCCAAGGGACACGACTGGAGATTAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPAFGQGTRLEIK	IGHV3-53*01	IGHJ6*02	IGHD3-10*01,IGHD3-10*02,IGHD3-16*01	IGKV1-9*01	IGKJ5*01	ARDGGHYGMDV	QQLNSYPPA	nan	Robbiani et al. Nature 584:437-442 (2020);Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW293083.1	MW293538.1
1	REGN_mouse	REGN11000	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;Humanized Mouse	nan	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVRGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCARDGSAYGMDVWGQGTTVTVSS	nan	DIQMTQSPSSLSASVGDRVTITCRASQSISSFLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSSPPITFGQGTRLEIK	IGHV3-53*04	IGHJ6	nan	IGKV1-39*01	IGKJ5	ARDGSAYGMDV	QQSYSSPPIT	nan	Patent: US10787501	nan	nan
1	Xie_mix	BD-605	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLGAYGMDVWGQGTTVTVSS	nan	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSDLYTFGQGTKLEIK	IGHV3-53*01	nan	nan	IGKV1-9*01	nan	ARDLGAYGMDV	QQLNSDLYT	nan	Du et al. Cell 183:1013-1023.e13 (2020)	nan	nan
1	COV072	COV072_P3_HC_80-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGAATCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGAGTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGTCGAGGACACGGCTGTGTATTACTGTGCGAGAGATCTGGGGGACTACGGAATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGITVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRVTISRDNSKNTLYLQMNSLRVEDTAVYYCARDLGDYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCCCCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPYTFGQGTKLEIK	IGHV3-66*01	IGHJ6*02	IGHD3-16*01,IGHD3-16*02,IGHD7-27*01	IGKV1-9*01	IGKJ2*01	ARDLGDYGMDV	QQLNSYPPYT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
1	Xie_mix	BD-604	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASGIIVSSNYMTWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMSSLRAEDTAVYYCARDLGPYGMDVWGQGTTVTVSS	nan	DIQLTQSPSFLSASVGDRVTITCRASQGISSDLAWYQQKPGKAPNLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSDLYTFGQGTKLEIK	IGHV3-53*01	IGHJ6	nan	IGKV1-9*01	IGKJ2	ARDLGPYGMDV	QQLNSDLYT	7CH4,7CHF,7E8C	Du et al. Cell 183:1013-1023.e13 (2020)	nan	nan
1	REGN_donor3	REGN10957	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLFLQMNSLRIEDTAVYYCARDLGPYGMDVWGQGTTVTVSS	nan	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTQFILTISSLQPEDFATYYCQQLNSYPGFTFGPGTKVDIK	IGHV3-66*01	IGHJ6	nan	IGKV1-9*01	IGKJ3	ARDLGPYGMDV	QQLNSYPGFT	nan	Patent: US10787501	nan	nan
1	PT34	34H6	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV3-53	nan	nan	IGKV1-9	nan	ARDLGPYGMDV	QQLNSYPPYT	nan	Zhou et al. Cell Rep. 35:109109 (2021)	nan	nan
1	Xie_mix	BD-603	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASGIIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNTMRAEDTAVYYCARDLGTYGMDVWGQGTTVTVST	nan	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYEQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISTLQPGDFATYYCQQLNSYLYTFGQGTKLEIK	IGHV3-53*01	nan	nan	IGKV1-9*01	nan	ARDLGTYGMDV	QQLNSYLYT	nan	Du et al. Cell 183:1013-1023.e13 (2020)	nan	nan
1	IML3558	ADI-63187	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGAATCACCGTCAGTAGCAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAATGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGACAGATTCACCATTTCTAGAGACAGTTCGAAGAACATACTGTATCTTCAAATGGACAGCCTGAGAGTCGGGGACACGGCTGTGTATTATTGTGCGAGAGATCTGTCCCACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLLESGGGLVQPGGSLRLSCAASGITVSSNYMTWVRQAPGKGLEWVSVIYSGGSTFYADSVKDRFTISRDSSKNILYLQMDSLRVGDTAVYYCARDLSHYGMDVWGQGTTVTVSS	nan	nan	IGHV3-66*01	IGHJ6*02	nan	IGKV1-9	nan	ARDLSHYGMDV	QQPNSYPHPT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458696.1	nan
1	IML3564	ADI-63408	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTTGTACAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGGAGCCTCTGGGTTAATCGTCAGTAGCAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTCATGTATGCCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACACTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTATATTACTGTGCGAGAGATTTGGCCTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLVQSGGGLIQPGGSLRLSCGASGLIVSSNYMTWVRQAPGKGLEWVSVMYAGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLAYYGMDVWGQGTTVTVSS	nan	nan	IGHV3-53*01	IGHJ6*02	IGHD3-16*01,IGHD3-16*02,IGHD3-3*01	IGKV1-9	nan	ARDLAYYGMDV	QQLNSYPPV	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458914.1	nan
1	Xie_mix	BD-598	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSTNTLYLQMNSLRAEDTAVYYCARDLDYYGMDVWGQGTTVTVSS	nan	AIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPNLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHLNSYPPITFGQGTRLEIK	IGHV3-53*01	nan	nan	IGKV1-9*01	nan	ARDLDYYGMDV	QHLNSYPPIT	nan	Du et al. Cell 183:1013-1023.e13 (2020)	nan	nan
1	Xie_mix	BD-600	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASGVIVSSNYMRWVRQAPGKGLEWVSVIYSGGTTYYADSVKGRFTISRHNSKNTLYLQMNSLRTEDTAVYYCARDLDYYGMDVWGQGTTVTVSS	nan	AIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQRGVPSRFSGSGSGTDFNLTISSLQPEDFGTYYCQQLNSYGLTFGGGTKVEIK	IGHV3-53*04	nan	nan	IGKV1-9*01	nan	ARDLDYYGMDV	QQLNSYGLT	nan	Du et al. Cell 183:1013-1023.e13 (2020)	nan	nan
1	Xie_mix	BD-607	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLDYYGMDVWGQGTTVTVSS	nan	AIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSYLAITFGQGTRLEIK	IGHV3-53*01	nan	nan	IGKV1-9*01	nan	ARDLDYYGMDV	QQLNSYLAIT	nan	Du et al. Cell 183:1013-1023.e13 (2020)	nan	nan
1	Xie_mix	BD-608	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASGIIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLDYYGMDVWGQGTTVTVSS	nan	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPFTFGPGTKVDIK	IGHV3-66*01	nan	nan	IGKV1-9*01	nan	ARDLDYYGMDV	QQLNSYPPFT	nan	Du et al. Cell 183:1013-1023.e13 (2020)	nan	nan
1	Aishun_Jin_mix	56D7	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMSSLRAEDTAVYYCARDLDYYGMDVWGQGTTVTVSS	nan	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPITFGQGTRLEIK	IGHV3-66*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ5*01	ARDLDYYGMDV	QQLNSYPPIT	nan	Han et al. Front Immunol. 12:653189 (2021)	nan	nan
1	Wang-C001	C001_P2_IgG_G5-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGGTCCAGCCTGGGGGGTCCCTCAGACTCTCCTGTGCAGCCTCTGGGCTCATCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTAGAGTGGGTCTCGGTTATTTATAGCGGTGGTAGCACATTTTACGCAGACTCCGTGAAGGGCCGATTAACCATCTCCAGACACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGACCTGAGGACACGGCCGTGTATTACTGTGCGAGAGATTTGGACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGLIVSSNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRLTISRHNSKNTLYLQMNSLRPEDTAVYYCARDLDYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACACAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCCTGCGGTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASVGDTVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPAVTFGGGTKVEIK	IGHV3-53*04	IGHJ6*02	IGHD3-16*01,IGHD3-16*02,IGHD3-3*01	IGKV1-9*01	IGKJ4*01	ARDLDYYGMDV	QQLNSYPPAVT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
1	Wang-MOD1	C613	Mod1_P2_IgG_E10-P1369	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGACTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGCAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTTTCTTGAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTTGACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLFLEMNSLRAEDTAVYYCARDLDYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCGTCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACTTCTTAATAGTTACCCTCGGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQLLNSYPRLTFGGGTKVEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ4*01	ARDLDYYGMDV	QLLNSYPRLT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
1	Wang-C001	C821	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAAGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGGTCCAGCCTGGGGGGTCCCTCAGACTCTCCTGTGCAGCCTCTGGGCTCATCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTAGAGTGGGTCTCGGTTATTTATAGCGGTGGTAGCACATTTTACGCAGACTCCGTGAAGGGCCGATTAACCATCTCCAGACACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGACCTGAGGACACGGCCGTGTATTACTGTGCGAGAGATTTGGACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGLIVSSNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRLTISRHNSKNTLYLQMNSLRPEDTAVYYCARDLDYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACACAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCCTGCGGTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASVGDTVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPAVTFGGGTKVEIK	IGHV3-53*04	IGHJ6*02	IGHD3-16*01,IGHD3-16*02,IGHD3-3*01	IGKV1-9*01	IGKJ4*01	ARDLDYYGMDV	QQLNSYPPAVT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
1	Wheatley-CP8	PDI_68	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATGCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGATCACCGTCAGTAGGAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATGTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGCGCGAGAGATCTTGACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAG	EVQLVESGGGLMQPGGSLRLSCAASGITVSRNYMSWVRQAPGKGLEWVSVMYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLDYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCAGTCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCATAAGCTCATTATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACTTGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAA	DIQLTQSPVSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAHKLIIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYLYTFGQGTKLEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ2*01	ARDLDYYGMDV	QQLNSYLYT	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
1	LiuL_Patient1	Fab1-20	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTAACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGGGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTATTTTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLFYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCCTGTTTCGGCCCTGGGACCAAAGTGGATATCAAA	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPCFGPGTKVDIK	IGHV3-53*01	IGHJ6*02	IGHD2-21*01,IGHD2-21*02,IGHD2/OR15-2a*01	IGKV1-9*01	IGKJ3*01	ARDLFYYGMDV	QQLNSYPC	nan	Liu et al. Nature 584:450-456 (2020)	MT712291.1	MT712306.1
1	Ehling_bioRxiv_pool	Ehling_mAb-64	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVETGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLHIYGMDVWGQGTTVTVSS	nan	DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPNFGGGTKVEIK	IGHV3-53	IGHJ6	nan	IGKV1-12	IGKJ4	ARDLHIYGMDV	QQANSFPN	nan	Ehling et al. bioRxiv. DOI: 10.1101/2021.02.12.430940	nan	nan
1	REGN_donor3	REGN10956	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLIKYGMDVWGQGTTVTVSS	nan	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPPHFGPGTKVDIK	IGHV3-66*01	IGHJ6	nan	IGKV1-33*01	IGKJ3	ARDLIKYGMDV	QQYDNLPPH	nan	Patent: US10787501	nan	nan
1	Cho-C034	C2119	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGTAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACACTGTATTTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTACTCGCGTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCVASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYFQMNSLRAEDTAVYYCARDLLAYGMDVWGQGTTVTVSS	CAGTCTGTGCTGACTCAGCCACCCTCAGCGTCTGGGACCCCCGGGCAGAGGGTCACCATCTCTTGTTCTGGAAGCAGCTCCAACATCGGAAGTAATTATGTATACTGGTACCAGCAGCTCCCAGGAACGGCCCCCAAACTCCTCATCTATAGGAATAATCAGCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCAGTGGGGTCCGGTCCGAGGATGAGGCTGATTATTACTGTGCAGCATGGGATGACAGCCTGAGTGGTCCCCTTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNYVYWYQQLPGTAPKLLIYRNNQRPSGVPDRFSGSKSGTSASLAISGVRSEDEADYYCAAWDDSLSGPLWVFGGGTKLTVL	IGHV3-53*01	IGHJ6*02	IGHD2-15*01	IGLV1-47*01	IGLJ3*02	ARDLLAYGMDV	AAWDDSLSGPLWV	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
1	Chen_Vax_p1	COV2-vax-25	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCTATTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTCAACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSIIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLNYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATATTGCAACTTATTACTGTCAACAGGTTAATAGTTACCCCATTTTCGGCCCTGGGACCAAAGTGGTTATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDIATYYCQQVNSYPIFGPGTKVVIK	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ3*01	ARDLNYYGMDV	QQVNSYPI	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555551.1	MZ555552.1
1	Li_SARS2_26	H712494+K711975	nan	SARS-CoV-2	SARS-CoV,MERS-CoV,OC43,HKU1,NL63	nan	nan	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASELTVSSNYMTWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLNYYGMDVWGQGTTVTVSS	nan	DIQLTQSPSFLSASVGDRVTITCRASQGINSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPADFATYYCQQLDSYPPFTFGPGTKVDIK	IGHV3-66*01	IGHJ6	nan	IGKV1-9*01	IGKJ3	ARDLNYYGMDV	QQLDSYPPFT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
1	Wang-MOD7	MOD7_P1_IgG_E11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTAGTCCAGCCTGGGGGGTCCCTGAGACTCTCTTGTGCAGCCTCTGGACTCACCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGACTGGAGTGGGTCTCAATTCTTTATAGCGGTGGTAGCACATATTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTTTCTCTTCAAATGAACAACCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGACCTTAACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMNWVRQAPGKGLEWVSILYSGGSTYYADSVKGRFTISRDNSKNTLSLQMNNLRAEDTAVYYCARDLNYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAATCATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGGTTAATAGTTACCCTCTTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISNHLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQVNSYPLFGGGTKVEIK	IGHV3-66*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ4*01	ARDLNYYGMDV	QQVNSYPL	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
1	Chen_Vax_p1	COV2-vax-54	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGGTCACCGTCAGTAGCAACTACATGAGTTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTACCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTATATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTACAGATCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLEWVSVIYSGGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLQIYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTCAGCTCCTGATCTATGCTGCATCCACTTTGCAGAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACACCTTAATAGTTACCCCGTTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPQLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQHLNSYPVFGPGTKVDIK	IGHV3-53*01	IGHJ6*02	IGHD4-11*01,IGHD4-4*01	IGKV1-9*01	IGKJ3*01	ARDLQIYGMDV	QHLNSYPV	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555610.1	MZ555611.1
1	IML3558	ADI-63179	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCCGGAGTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGCAGTGGGTCTCACTTATATATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACATTTCCAAGAACACACTGTATCTTCAGATGAACAGCCTGAGAGCCGAGGACACGGCCGTATATTTCTGTGCGAGAGATCTACAGATCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLLESGGGLVQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLQWVSLIYSGGSTFYADSVKGRFTISRDISKNTLYLQMNSLRAEDTAVYFCARDLQIYGMDVWGQGTTVTVSS	nan	nan	IGHV3-66*01	IGHJ6*02	IGHD4-11*01,IGHD4-4*01	IGKV1-9	nan	ARDLQIYGMDV	QHLNDSPPA	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458688.1	nan
1	Turner-22	Turner-22-2B06	nan	SARS-CoV-2	OC43,HKU1	nan	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGACTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTATTTATAGCGGTGGAAGTACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTACAACTCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVETGGGLIQPGGSLRLSCAASGFTVSSNYMTWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLQLYGMDVWGQGTTVTVSS	TCCTATGAGCTGACACAGCCACCCTCGGTGTCAGTGGCCCCAGGACAGACGGCCAGGATTACCTGTGGGGGAAACAACATTGGAAGTAACAGTGTGCACTGGTACCAGCAGAAGCCAGGCCAGGCCCCTGTGCTGGTCGTCTATGATGATAGCGACCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACGGCCACCCTGACCATCAGCAGGGTCGAAGCCGGGGATGAGGCCGACTATCACTGTCAGGTGTGGGATAGTAGTAGTGATCCCGTAGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	SYELTQPPSVSVAPGQTARITCGGNNIGSNSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYHCQVWDSSSDPVVFGGGTKLTVL	IGHV3-53*02	IGHJ6*02	IGHD1-1*01	IGLV3-21*02	IGLJ2*01,IGLJ3*01	ARDLQLYGMDV	QVWDSSSDPVV	nan	Turner et al. Nature 596:109-113 (2021)	MW926415.1	MW926438.1
1	Wang-C004	C1266	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGATCACCGTCAGTAGCAACTACATGAATTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGCAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAGTTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGACCCGAGGACACGGCCGTGTATTACTGTGCGAGGGACCTGCAAGTATACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGITVSSNYMNWVRQAPGKGLQWVSVIYSGGSTFYADSVKGRFTISRDSSKNTLYLQMNSLRPEDTAVYYCARDLQVYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAACTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGACTTTGCAACTTATTACTGTCAACAGCCTAACACTTATTCGATCTCCTTCGGCCAAGGGACACGACTGGAGATTAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQPNTYSISFGQGTRLEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ5*01	ARDLQVYGMDV	QQPNTYSIS	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
1	Wang-C004	C004_P2_IgG_E1-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGATCACCGTCAGTAGCAACTACATGAATTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGCAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAGTTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGACCCGAGGACACGGCCGTGTATTACTGTGCGAGGGACCTGCAAGTATACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGITVSSNYMNWVRQAPGKGLQWVSVIYSGGSTFYADSVKGRFTISRDSSKNTLYLQMNSLRPEDTAVYYCARDLQVYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAACTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGACTTTGCAACTTATTACTGTCAACAGCCTAACACTTATTCGATCTCCTTCGGCCAAGGGACACGACTGGAGATTAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQPNTYSISFGQGTRLEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ5*01	ARDLQVYGMDV	QQPNTYSIS	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
1	Wang-C004	C004_P2_IgG_E11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGATCACCGTCAGTAGCAACTACATGAATTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAATTATTTATAGCGGTGGTACCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGGGACCTGCAAGTATACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGITVSSNYMNWVRQAPGKGLEWVSIIYSGGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLQVYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCCGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGGCTGAAGATTTTGCAACTTATTACTGTCAACACCCTAATAGTTACTCGATCTCCTTCGGCCAAGGGACACGACTGGAGATTAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQAEDFATYYCQHPNSYSISFGQGTRLEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ5*01	ARDLQVYGMDV	QHPNSYSIS	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
1	PatientPhageLib1	MD62	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 S1/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVQSGGGLIQPGGSLRLSCAASGVTVSSNYMTWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLQYYGMDVWGQGTMVTVSS	nan	AIRMTQSPSSVSASVGDRVTITCRASQDIGSWLGWYQQKPGKAPKLLIYAASSLAGGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPLTFGGGTKLEIK	IGHV3-53*01	nan	nan	IGKV1-12*01	nan	ARDLQYYGMDV	QQANSFPLT	nan	Noy-Porat et al. Nat. Commun. 11:4303 (2020)	nan	nan
1	COV072	COV072_Plate2_HC_16-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGACTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGACTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTCATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCCAGAATACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTCTATTACTGTGCGAGAGACCTCCAATACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGDLVQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSQNTLYLQMNSLRAEDTAVYYCARDLQYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCCTGATAGCTTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQPDSFTFGPGTKVDIK	IGHV3-66*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ3*01	ARDLQYYGMDV	QQPDSFT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
1	IML3548	ADI-62965	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCCGGAGGAGGCTTGATCCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGAGTCATCGTCAGTAGGAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTATTTATGCCGGTGGTAGTACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAGTTCGAACAACACACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTCTATTACTGTGCGAGAGATCTACAGTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLLESGGGLIQPGGSLRLSCAASGVIVSRNYMTWVRQAPGKGLEWVSLIYAGGSTFYADSVKGRFTISRDSSNNTLYLQMNSLRAEDTAVYYCARDLQYYGMDVWGQGTTVTVSS	nan	nan	IGHV3-53*01	IGHJ6*02	IGHD4-11*01,IGHD4-4*01	IGKV1-9	nan	ARDLQYYGMDV	QQVNSYPPIT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458474.1	nan
1	Wang-PFZ10	PZF10_P2_IgG_D2-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTGATCGTCAGTAGTAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAATTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGAGAATTCCAAGAACACGCTTTATCTTCAGATGAATAGCCTGACAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTTCAATATTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLIVSSNYMSWVRQAPGKGLEWVSIIYSGGSTFYADSVKGRFTISRENSKNTLYLQMNSLTAEDTAVYYCARDLQYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCANCCNTCCTGTTTACATGGGTAGGAGACAGAGTCACCATCACTTGCCGGTCCAGTCAGGGCATTAGCAGTTATTTAGCATGGTATCAGCAAAAACCAGGGAAAGCCCATAAGCTCCTGATGTATGTTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCGAGAAGATTTTGCAACTTATTACTGTCAAGAGCTTAATACTTACCTTACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPXXLFTWVGDRVTITCRSSQGISSYLAWYQQKPGKAHKLLMYVASTLQSGVPSRFSGSGSGTDFTLTISSLQREDFATYYCQELNTYLTFGGGTKVEIK	IGHV3-53*01	IGHJ6*02	IGHD2/OR15-2a*01,IGHD2/OR15-2b*01	IGKV1-9*01	IGKJ4*01	ARDLQYYGMDV	QELNTYLT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
1	IML3549	ADI-57844	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACACTGTATCTTCAAATGAACAGCCTGAGAGCCGAAGACACGGCCGTGTATTACTGTGCGAGAGATTTATCGGTGTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCTTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSLIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLSVYGMDVWGQGTTVTVSS	nan	nan	IGHV3-53*01	IGHJ6*02	IGHD3-16*02	IGKV1-9	nan	ARDLSVYGMDV	QQLNSYPL	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457720.1	nan
1	Cho-C012	C2148	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGTAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTGTCCTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCVASGFTVSSNYMSWVRQAPGKGLEWVSLIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLSYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCTATTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYLFTFGPGTKVDIK	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ3*01	ARDLSYYGMDV	QQLNSYLFT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
1	Wang-MOD7	MOD7_P1_IgG_F12-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGACTCACCGTCAGTAGCAACTACATGAGTTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGATCTGAGCTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLSYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAATTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGACTTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAAGTTAATAGTTACCCTCCGGACACTTTTGGCCAGGGGACCAAGCTGGAAATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISNYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQVNSYPPDTFGQGTKLEIK	IGHV3-66*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ2*01	ARDLSYYGMDV	QQVNSYPPDT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
1	IML3564	ADI-62092	nan	SARS-CoV-2	nan	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTAATCGTCAGTAGAAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACAAATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTTACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTATATTACTGTGCGAGAGACCTGACTATTTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLLESGGGLIQPGGSLRLSCAASGLIVSRNYMTWVRQAPGKGLEWVSQIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLTIYGMDVWGQGTTVTVSS	nan	nan	IGHV3-53*01	IGHJ6*02	IGHD4/OR15-4a*01,IGHD4/OR15-4b*01	IGKV1-12	nan	ARDLTIYGMDV	QQTNSFPL	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458184.1	nan
1	Bullen_Pool	ION-336	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 S1/RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV3-66	IGHJ6	nan	nan	nan	ARDLVAYGMDV	nan	nan	Bullen et al. Front Immunol. 12:678570 (2021)	nan	nan
1	Wang-MOD9	MOD9_P2_IgG_A3-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATGCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTAACCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAATGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACACTATTTCTTCAAATGAGCAGCCTGAGAGCCGAGGACACGGCCGTTTATTACTGTGCGAGAGATCTAGTGGCCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLMQPGGSLRLSCAASGLTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLFLQMSSLRAEDTAVYYCARDLVAYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCAGTCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAACAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTTTGCTGCGTCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACTGCTTAATAGTAACCCCACTTTCGGCCCTGGGACCACAGTGGATATCAAAC	DIQLTQSPVSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIFAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQLLNSNPTFGPGTTVDIK	IGHV3-53*01	IGHJ6*02	IGHD5-12*01	IGKV1-9*01	IGKJ3*01	ARDLVAYGMDV	QLLNSNPT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
1	BG1	BG1-14	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASGLTVNSNYMTWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAR	nan	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTIRSLQPEDFATYYCQQLNSYP	IGHV3-53*01	nan	nan	IGKV1-9*01	nan	ARDLVDYGMDV	QQLNSYPPYT	nan	Scheid et al. Cell 184:3205-3221.e24 (2021)	nan	nan
1	Wang-PFZ10	PZF10_P2_IgG_A1-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCCTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGTAACTACATGAACTGGGTCCGCCAGCCTCCAGGGAAGGGGCTGGAGTGGGTCTCAATGATTTATGCCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGGGACAATTCCAAGAACACACTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGGGACTTGGTGGAGTACGGAATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMNWVRQPPGKGLEWVSMIYAGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLVEYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCACTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCTCTTTACAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCCGGAGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISTYLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSYPPETFGQGTKVEIK	IGHV3-53*01,IGHV3-53*03	IGHJ6*02	IGHD2-15*01,IGHD2-21*01,IGHD2-21*02	IGKV1-9*01	IGKJ1*01	ARDLVEYGMDV	QQLNSYPPET	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
1	Wang-MOD11	Mod11_P1_IgG_A10-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTAACCGTCAGTAGTAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATCCCGGTGGTAGCACAGACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTCGTGACATACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYPGGSTDYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLVTYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCANNNCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGTTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCCTTCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	DIQLTQSPSFLSASVGDRVTITCRASXXISSYLAWYQQKPGKAPKLLIYVASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSYPFTFGQGTRLEIK	IGHV3-53*01	IGHJ6*02	IGHD2-21*02,IGHD4-17*01,IGHD6-6*01	IGKV1-9*01	IGKJ5*01	ARDLVTYGMDV	QQLNSYPFT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
1	Xie_mix	BD-507	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNMVYLQMNSLRAEDTAVYYCARDLVVYGMDVWGQGTTVIVSS	nan	DIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCQQLNSNPPITFGPGTKVDIK	IGHV3-53*01	IGHJ6	nan	IGKV1-9*01	IGKJ3	ARDLVVYGMDV	QQLNSNPPIT	nan	Cao et al. Cell 182:73-84.e16 (2020)	nan	nan
1	Chen_Vax_p1	COV2-vax-53	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACAAACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATTTAGTAGTATACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTNYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLVVYGMDVWGQGTTVTVSS	GCCATCCAGTTGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCGAGCCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	AIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSYPRATFGPGTKVDIK	IGHV3-53*01	IGHJ6*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV1-9*01	IGKJ3*01	ARDLVVYGMDV	QQLNSYPRAT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555608.1	MZ555609.1
1	Xie_mix	BD-494	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASGFTVSRNYMSWVRQAPGKGLEWVSLIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNTLRSEDTAVYYCARDLVVYGMDVWGQGTTVTVSS	nan	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQVGVPSRFSGSGSGTEFTLTISSLQPEDFATYFCQQLNSYPFTFGPGTKVDIK	IGHV3-53*01	nan	nan	IGKV1-9*01	nan	ARDLVVYGMDV	QQLNSYPFT	nan	Du et al. Cell 183:1013-1023.e13 (2020)	nan	nan
1	Xie_mix	BD-498	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASGFTVSRNYMSWVRQAPGKGLEWVSVIYSGGTTHYADSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCARDLVVYGMDVWGQGTTVTVSS	nan	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSSFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPLTFGGGTKVEIK	IGHV3-53*04	nan	nan	IGKV1-9*01	nan	ARDLVVYGMDV	QQLNSYPLT	nan	Du et al. Cell 183:1013-1023.e13 (2020)	nan	nan
1	Xie_mix	BD-599	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASGFTVSRNYMSWVRQAPGKGLEWVSVIYSGGTTHYADSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCARDLVVYGMDVWGQGTTVTVSS	nan	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSSFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPLTFGGGTKVEIK	IGHV3-53*04	nan	nan	IGKV1-9*01	nan	ARDLVVYGMDV	QQLNSYPLT	nan	Du et al. Cell 183:1013-1023.e13 (2020)	nan	nan
1	Ju_P#2	P2C-1F11	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGAATCACCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGTTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATCACTGTGCGAGAGATCTGGTGGTATACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGITVSSNYMNWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYHCARDLVVYGMDVWGQGTTVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCCACTTTTGGCCAGGGGACCAAGCTGGAGATCAAA	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPTFGQGTKLEIK	IGHV3-66*01	IGHJ6*02	IGHD2-15*01,IGHD2-8*02	IGKV3-20*01	IGKJ2*01,IGKJ2*02	ARDLVVYGMDV	QQYGSSPT	7CDI,7E8M	Ju et al. Nature 584:115-119 (2020)	MW259138.1	MW259139.1
1	Chen_Vax_p1	COV2-vax-67	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGCGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTGGTTTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVASGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLVYYGMDVWGQGTTVTVSS	GCCATCCAGTTGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTGATAGTTACCCTCCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	AIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLDSYPPYTFGQGTKLEIK	IGHV3-53*01	IGHJ6*02	IGHD3-9*01,IGHD3/OR15-3a*01,IGHD3/OR15-3b*01	IGKV1-9*01	IGKJ2*01	ARDLVYYGMDV	QQLDSYPPYT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555536.1	MZ555537.1
1	Chen_Vax_p1	COV2-vax-68	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGAAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATTTGGTCTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSRNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLVYYGMDVWGQGTTVTVSS	GCCATCCAGTTGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTGACCCTCCGATCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	AIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSDPPITFGQGTRLEIK	IGHV3-53*01	IGHJ6*02	IGHD3-16*01,IGHD3-16*02,IGHD3-3*01	IGKV1-9*01	IGKJ5*01	ARDLVYYGMDV	QQLNSDPPIT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555538.1	MZ555539.1
1	54042	54042-11	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:Unk	SARS-CoV-2 spike, RBD, SARS-CoV RBD, and HCoV RBDs	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGTTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGGTCAACGTCAGTAGTAATTACATGAGTTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTATTTATAGCGGTGGTAGTACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACCCTGTATCTTCAAATGATCAGCCTGAGAGCCGACGACACGGCCGTGTATTACTGTGCGAGAGATCTGGTCTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGVNVSSNYMSWVRQAPGKGLEWVSLIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMISLRADDTAVYYCARDLVYYGMDVWGQGTTVTVSS	GCCATCCAGTTGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGGTTGATAGTTACTCCCCATTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	AIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQVDSYSPFTFGPGTKVDIK	IGHV3-53*01	IGHJ6*02	IGHD2-8*02,IGHD3-9*01,IGHD3/OR15-3a*01	IGKV1-9*01	IGKJ3*01	ARDLVYYGMDV	QQVDSYSPFT	nan	Kramer et al. Cell Rep. 37:109784 (2021)	MZ820103.1	MZ820112.1
1	Cho-C034	C2137	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGGTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTGTACGTCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLYVYGMDVWGQGTTVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGCCTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCAACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISSLEPEDFAVYYCQQYGSSPTFGQGTKVEIK	IGHV3-53*01	IGHJ6*02	IGHD2-8*01,IGHD2-8*02,IGHD3-16*01	IGKV3-20*01	IGKJ1*01	ARDLYVYGMDV	QQYGSSPT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
1	Chen_Vax_p1	COV2-vax-24	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTTTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLYYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGTTTAATAGTTACCCCCATTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQFNSYPHFGPGTKVDIK	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ3*01	ARDLYYYGMDV	QQFNSYPH	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555549.1	MZ555550.1
1	Chen_Vax_p1	COV2-vax-26	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAAGACACGGCCGTGTATTACTGTGCGAGAGATCTCTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLYYYGMDVWGQGTTVTVSS	GCCATCCAGTTGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCCCTTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	AIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSYPLFGPGTKVDIK	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ3*01	ARDLYYYGMDV	QQLNSYPL	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555553.1	MZ555492.1
1	Chen_Vax_p1	COV2-vax-27	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTTTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLYYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGTTTAATAGTTACCCCCATTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQFNSYPHFGPGTKVDIK	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ3*01	ARDLYYYGMDV	QQFNSYPH	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555493.1	MZ555494.1
1	Chen_Vax_p1	COV2-vax-28	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAAGACACGGCCGTGTATTACTGTGCGAGAGATCTCTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLYYYGMDVWGQGTTVTVSS	GCCATCCAGTTGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCCCTTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	AIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSYPLFGPGTKVDIK	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ3*01	ARDLYYYGMDV	QQLNSYPL	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555495.1	MZ555496.1
1	Chen_Vax_p1	COV2-vax-29	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTTTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLYYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGTTTAATAGTTACCCCCATTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQFNSYPHFGPGTKVDIK	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ3*01	ARDLYYYGMDV	QQFNSYPH	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555497.1	MZ555498.1
1	Chen_Vax_p1	COV2-vax-30	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAAGACACGGCCGTGTATTACTGTGCGAGAGATCTCTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLYYYGMDVWGQGTTVTVSS	GCCATCCAGTTGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCCCTTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	AIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSYPLFGPGTKVDIK	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ3*01	ARDLYYYGMDV	QQLNSYPL	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555499.1	MZ555500.1
1	Chen_Vax_p1	COV2-vax-31	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTTTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLYYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGTTTAATAGTTACCCCCATTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQFNSYPHFGPGTKVDIK	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ3*01	ARDLYYYGMDV	QQFNSYPH	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555501.1	MZ555502.1
1	Xie_mix	BD-606	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLYYYGMDVWGQGTTVTVSS	nan	AIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIFAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLDSYPLFGGGTKVEIK	IGHV3-53*01	nan	nan	IGKV1-9*01	nan	ARDLYYYGMDV	QQLDSYPL	nan	Du et al. Cell 183:1013-1023.e13 (2020)	nan	nan
1	CV07	HK_CV07-202	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	CTGCAACCCCGGTGTACATTCTGAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGATCTCAGTTATTTATAGCGGTGGTAGCACATTCTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTCTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGACCTCTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAGCCTCCACCAAGGGCCCATCGGTCTTCCCCCTGGCACCCTCCTCCAAGAGCACCTCTGGGGCACAGCGACCTTTGTTCTCG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWISVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLYYYGMDVWGQGTTVTVSS	CGGACCAGGCGGTTCTGGTATTATTTAACCCCCCAGCTCAGTCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAATTACTCTGTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAACGAACTGTGGCTGCACCATCTGTCTTCATCTTCCCGCCATCTGATGAGCAGTTGAAATCTGGAACTGCCTCTGTTGTGTGCCTGCTGAATAACTTCTATCCCAGAGAGGCCAAAGTACAGTGGAAGGTGGATAACGCCCTCCAATCGGTAATTCCCGGGTGGGGTTCGGG	VSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNNYSVTFGGGTKVEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ4*01	ARDLYYYGMDV	QQLNNYSVT	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
1	REGN_donor1	REGN10971	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYSDSVKGRFSISRDNSKNTLYLQMNSLRAEDTAVYYCARDLYYYGMDVWGQGTTVTVSS	nan	DIQLTQSPSFLSASVGDRVTITCRASQGISTYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLDSYPGLTFGGGTKVEIK	IGHV3-53*01	IGHJ6	nan	IGKV1-9*01	IGKJ4	ARDLYYYGMDV	QQLDSYPGLT	nan	Patent: US10787501	nan	nan
1	COV072	C140	COV072_Plate2_HC_36-P1369	SARS-CoV-2	SARS-CoV	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGAGTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCGAGAACACGCTGTATCTTCAAATGAACACCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGATCTGTATTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLEWVSLIYSGGSTFYADSVKGRFTISRDNSENTLYLQMNTLRAEDTAVYYCARDLYYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACTCTTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYSYTFGQGTKLEIK	IGHV3-66*01	IGHJ6*02	IGHD2-8*01,IGHD2-8*02	IGKV1-9*01	IGKJ2*01	ARDLYYYGMDV	QQLNSYSYT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
1	COV072	COV072_Plate2_HC_89-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGACTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGATCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAATTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATCCCAAGAACACTCTCTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTCTACTACTACGGTATGGACGTTTGGGGCCAAGGGACCACGGTCACCGTCTCC	EVQLVETGGGLIQPGGSLRLSCAASGITVSSNYMSWVRQAPGKGLEWVSIIYSGGSTFYADSVKGRFTISRDNPKNTLYLQMNSLRAEDTAVYYCARDLYYYGMDVWGQGTTVTVS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCAACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPTFGQGTKLEIK	IGHV3-53*02	IGHJ6*02	nan	IGKV1-9*01	IGKJ2*01,IGKJ2*02	ARDLYYYGMDV	QQLNSYPT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
1	IML3564	ADI-62061	nan	SARS-CoV-2	nan	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTAACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCATGTATTACTGTGCGAGAGATCTCTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAMYYCARDLYYYGMDVWGQGTTVTVSS	nan	nan	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9	nan	ARDLYYYGMDV	QQLDSYPT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458153.1	nan
1	Wang-C001	C001_P1_IgG_H5-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGACTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGACACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCTGAGGACACGGCCGTGTATTACTGTGCGAGAGATTTGTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGDLVQPGGSLRLSCAASGLTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCARDLYYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGATTAATAGTTACCCTCTTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQINSYPLFGQGTKLEIK	IGHV3-53*04	IGHJ6*02	nan	IGKV1-9*01	IGKJ2*01,IGKJ2*02,IGKJ2*03	ARDLYYYGMDV	QQINSYPL	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
1	Wang-C004	C836	C004_P1_IgG_B9-P1369	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGCCTCACCGTCAGTAGCAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAATAGCCTGAGAGCCGAGGATACGGCCATATATTACTGTGCGAGAGATCTCTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMTWVRQAPGKGLEWVSLIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAIYYCARDLYYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTCATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGACTGCAGCCAGAAGATTTTGCAACTTATTACTGTCAACAGATTAATGATTACCCTTTTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISRLQPEDFATYYCQQINDYPFFGGGTKVEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ4*01	ARDLYYYGMDV	QQINDYPF	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
1	Wang-MOD7	MOD7_P2_IgG_C2-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATGCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAATTATTTATAGCGGTGGTAGTACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACCACTCCAAGAACACGTTGTATCTTCAAATGAACACCCTGAGAGCCGAGGACACGGCCGTGTATTATTGTGCGAGAGATCTCTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLMQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSIIYSGGSTFYADSVKGRFTISRDHSKNTLYLQMNTLRAEDTAVYYCARDLYYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGGGACAGAGTCACCATCGCTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAGGATTTTGCAACTTATTACTGTCAACAGATTAATGATTACCCTGCGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQLTQSPSFLSASVGDRVTIACRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQINDYPAFGQGTKVEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ1*01	ARDLYYYGMDV	QQINDYPA	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
1	Wang-PFZ10	PZF10_P2_IgG_C10-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGGTCACCGTCAGTAGCAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGTGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAAGACACGGCCGTCTATTACTGTGCGAGAGATCTCTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGVTVSSNYMTWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLYYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCACTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCAACCACCTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAAGAGCTTAATAGTTACCCCCTTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISTYLAWYQQKPGKAPKLLIYAATTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQELNSYPLFGPGTKVDIK	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ3*01	ARDLYYYGMDV	QELNSYPL	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
1	Ju_P#22	P22A-1D1	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCGAGACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRDYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTTAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCTACACCTTAATAGTTACAGGACGTTCGGCCTAGGGACCAAGGTGGAAATCAAA	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLHLNSYRTFGLGTKVEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ1*01	ARDRDYYGMDV	LHLNSYRT	7CHS	Ju et al. Nature 584:115-119 (2020)	MZ151914.1	MZ151915.1
1	Wang-MOD6	MOD6_P2_IgG_A6-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCCCCGTCAGTAGCAATTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATGCCGGTGGTAGCACATTCTACGCAGAGTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACACTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGACCGAGACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGFPVSSNYMSWVRQAPGKGLEWVSVIYAGGSTFYAESVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRDYYGMDVWGQGTTVTVSS	GCCATCCAGTTGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTGGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGGGCATTTCCAATGCTTTAGCCTGGTTTCAGCAGAAACCAGGGAAACCTCCTAAGCTCCTGATCTATGGTGCCTCCAGTTTGGAAAGTGGGGTCCCATCCAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGACGATTTTGCAACTTATTACTGTCAACAGTTTAATAGTGACCCTCATCGGTTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	AIQLTQSPSSLSASVGDRVTITCRASQGISNALAWFQQKPGKPPKLLIYGASSLESGVPSRFSGSGSGTDFTLTISSLQPDDFATYYCQQFNSDPHRFTFGPGTKVDIK	IGHV3-66*01	IGHJ6*02	nan	IGKV1-13*02,IGKV1D-13*02	IGKJ3*01	ARDRDYYGMDV	QQFNSDPHRFT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
1	BG4	BG4-24	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCVR	nan	DIQLTQSPAFLSASVGDRVTITCRASQGISSYLAWYQQRPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSSP	IGHV3-53*01	nan	nan	IGKV1-9*01	nan	VRDLDYYGMDV	QQLNSSPGSLT	nan	Scheid et al. Cell 184:3205-3221.e24 (2021)	nan	nan
1	CC12	CC12.1	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTAACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATTTAGATGTCTACGGTTTGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLDVYGLDVWGQGTTVTVSS	GACATCGTGATGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCCAAAATTCACTTTCGGCCCTGGGACCAAGGTGGAAATCAAA	DIVMTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPKFTFGPGTKVEIK	IGHV3-53*01	IGHJ6*02	IGHD5-24*01	IGKV1-9*01	IGKJ3*01	ARDLDVYGLDV	QQLNSYPPKFT	6XC2,6XC3	Rogers et al. Science 369:956-963 (2020);Yuan et al. Science 369:1119-1123 (2020)	MT594038.1	MT594071.1
1	Crowe_mix	COV2-2080	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV,SARS-CoV-2	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCTCTGAGACTCTCCTGTGCAGCCTCTGGACTCACCGTCCGTAGCAACTACATGACCTGGGTCCGCCAGACTCCAGGGAAGGGGCTGGAATGGGTGTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGGTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGATCTCGTGACTTACGGTTTGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGLTVRSNYMTWVRQTPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTAVYYCARDLVTYGLDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAATTATTTAGCCTGGTATCAGCAAAAACCAGGGACAGCCCCTAACCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACTACTTAATAGTCACCCCCTCACCTTCGGCCAAGGGACACGACTGGAGATTAAA	DIQLTQSPSFLSASVGDRVTITCRASQGISNYLAWYQQKPGTAPNLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQLLNSHPLTFGQGTRLEIK	IGHV3-66*01	IGHJ6*02	IGHD2-21*02,IGHD4-17*01	IGKV1-9*01	IGKJ5*01	ARDLVTYGLDV	QLLNSHPLT	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665497.1	MT665110.1
1	Crowe_mix	COV2-2165	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCTCTGAGACTCTCCTGTGCAGCCTCTGGACTCACCGTCCGTAGCAACTACATGACCTGGGTCCGCCAGACTCCAGGGAAGGGGCTGGAATGGGTGTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGGTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGATCTCGTGACTTACGGTTTGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGLTVRSNYMTWVRQTPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTAVYYCARDLVTYGLDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAATTATTTAGCCTGGTATCAGCAAAAACCAGGGACAGCCCCTAACCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACTACTTAATAGTCACCCCCTCACCTTCGGCCAAGGGACACGACTGGAGATTAAA	DIQLTQSPSFLSASVGDRVTITCRASQGISNYLAWYQQKPGTAPNLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQLLNSHPLTFGQGTRLEIK	IGHV3-66*01	IGHJ6*02	IGHD2-21*02,IGHD4-17*01	IGKV1-9*01	IGKJ5*01	ARDLVTYGLDV	QLLNSHPLT	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665434.1	MT665047.1
1	Crowe_mix	COV2-2952	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCTCTGAGACTCTCCTGTGCAGCCTCTGGACTCACCGTCCGTAGCAACTACATGACCTGGGTCCGCCAGACTCCAGGGAAGGGGCTGGAATGGGTGTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGGTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGATCTCGTGACTTACGGTTTGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGLTVRSNYMTWVRQTPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTAVYYCARDLVTYGLDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAATTATTTAGCCTGGTATCAGCAAAAACCAGGGACAGCCCCTAACCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACTACTTAATAGTCACCCCCTCACCTTCGGCCAAGGGACACGACTGGAGATTAAA	DIQLTQSPSFLSASVGDRVTITCRASQGISNYLAWYQQKPGTAPNLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQLLNSHPLTFGQGTRLEIK	IGHV3-66*01	IGHJ6*02	IGHD2-21*02,IGHD4-17*01	IGKV1-9*01	IGKJ5*01	ARDLVTYGLDV	QLLNSHPLT	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665513.1	MT665126.1
1	COV072	C511	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCACTGAAATCACCGTCAGTAGCAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATCCTGGTGGCAGCACATTCTACGCAGACTCCGTGAAGGGCAGATTCTCCATCTCCAGAGACAATTCCAAGAACACTCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGATTTAGTTGTCTATGGACTTGACTGCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAATEITVSSNYMTWVRQAPGKGLEWVSVIYPGGSTFYADSVKGRFSISRDNSKNTLYLQMNSLRAEDTAVYYCARDLVVYGLDCWGQGTLVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATACTTACCCCCCTCCTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNTYPPPFGGGTKVEIK	IGHV3-66*01	IGHJ4*02	IGHD2/OR15-2a*01,IGHD2/OR15-2b*01,IGHD3-10*01	IGKV1-9*01	IGKJ4*01	ARDLVVYGLDC	QQLNTYPPP	nan	Gaebler et al. Nature 591:639-644 (2021)	nan	nan
1	Wang-MOD8	MOD8_P2_IgG_D8-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGATCACCGTCAGTGCCAACTACATGACGTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGACCTAGTAGTTTACGGATTGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGITVSANYMTWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLVVYGLDVWGQGTTVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAACTCACCTATTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGNSPIFGGGTKVEIK	IGHV3-53*01	IGHJ6*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-20*01	IGKJ4*01	ARDLVVYGLDV	QQYGNSPI	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
1	Wang-C003	C003_P2_IgG_G11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCTGCCTCTGGAGTCACCGTCAGTAGCAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATCCCGGTGGTAGCACATTCTACGCAGACTCCGTAAAGGGCCGATTCACCATCTCCAGACACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGATGAGGACACGGCCGTGTATTACTGTGCGAGAGACCTGGGTGAGGACGCGATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGVTVSSNYMTWVRQAPGKGLEWVSVIYPGGSTFYADSVKGRFTISRHNSKNTLYLQMNSLRDEDTAVYYCARDLGEDAMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAACTTAATAGTTACCCTCCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPYTFGQGTKLEIK	IGHV3-53*04	IGHJ6*02	IGHD2-21*01,IGHD2-21*02,IGHD4-17*01	IGKV1-9*01	IGKJ2*01	ARDLGEDAMDV	QQLNSYPPYT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
1	COV021	COVD21_P3_HC_C9-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGAGTCTCTTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGGAGCACATATTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTCTCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTTGGCGAACGGGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRVSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLSLQMNSLRAEDTAVYYCARDLGERGMDVWGQGTTVTVSS	CAGTCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACATTGGTGTTTATAACTATATCTCCTGGAGCCAACAACACCCAGGCAAAGCCCCCAAAGTCATGATTTATGATGTCACTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTATTGCAGCTCATATAGAGGCAGCAGCACTCCCTATGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	QSVLTQPASVSGSPGQSITISCTGTSSDIGVYNYISWSQQHPGKAPKVMIYDVTNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYRGSSTPYVFGTGTKVTVL	IGHV3-53*01	IGHJ6*02	IGHD1-1*01,IGHD1-20*01	IGLV2-14*03	IGLJ1*01	ARDLGERGMDV	SSYRGSSTPYV	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293087.1	MW293542.1
1	Aishun_Jin_mix	CQTS177	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGGTCACCGTCAGTAGCAATTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGACACAATTCCAAGAACACTCTTTATCTTCAAATGAACAGCCTGAGAGCTGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTAGGTCCTCTGGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGVTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCARDLGPLGMDVWGQGTTVTVSS	GACATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTCCTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGGAGTCTATTACTGTCAGCAGTATGGTAGCTCACCCCTCTTCGGCCAAGGGACACGACTGGAGATTAAAC	DIVLTQSPGTLSLSPGERATLSCRASQSVSSSSLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFGVYYCQQYGSSPLFGQGTRLEIK	IGHV3-53*04	IGHJ6*02	nan	IGKV3-20*01	IGKJ5*01	ARDLGPLGMDV	QQYGSSPL	nan	Patent: CN111925444A	MW587620.1	MW587621.1
1	REGN_mouse	REGN11004	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;Humanized Mouse	nan	EVQLVESGGGLVQPGGSLRLSCAASGLIVSRNYMIWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCARDLGTGGMDVWGQGTTVTVSS	nan	DIQLTQSPSFLSASVGDRVTITCWASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPLTFGGGTKVEIK	IGHV3-53*04	IGHJ6	nan	IGKV1-9*01	IGKJ4	ARDLGTGGMDV	QQLNSYPLT	nan	Patent: US10787501	nan	nan
1	Wang-MOD1	C616	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGCGGCCTCTGGGATCCTCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGATGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCATGTATTACTGTGCGAGAGATCTGGGGGTATCCGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGILVSSNYMNWVRQAPGMGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAMYYCARDLGVSGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAATGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACACCTTAATAGTTACTCCCTTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQNGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQHLNSYSLFGPGTKVDIK	IGHV3-53*01	IGHJ6*02	IGHD3-16*01,IGHD3-16*02,IGHD6-13*01	IGKV1-9*01	IGKJ3*01	ARDLGVSGMDV	QHLNSYSL	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
1	Wang-MOD1	Mod1_P2_IgG_F5-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGCGGCCTCTGGGATCCTCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGATGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCATGTATTACTGTGCGAGAGATCTGGGGGTATCCGGTATGGACGTCTGGGGCCAAGGGACCGCGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGILVSSNYMNWVRQAPGMGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAMYYCARDLGVSGMDVWGQGTAVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAATGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACACCTTAATAGTTACTCCCTTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQNGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQHLNSYSLFGPGTKVDIK	IGHV3-53*01	IGHJ6*02	IGHD3-16*01,IGHD3-16*02,IGHD6-13*01	IGKV1-9*01	IGKJ3*01	ARDLGVSGMDV	QHLNSYSL	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
1	Wang-MOD9	MOD9_P2_IgG_E7-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGAATCACCGTCAGTGCCAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCGGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGTTGAGGACACGGCTGTGTATTACTGTGTGAGAGATTTGGGTCCCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGITVSANYMTWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCVRDLGPYGMDVWGQGTTVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCGACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGAGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCACGAGGAAACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSDLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSESGTEFTLTISSLQSEDFAVYYCQHEETFGQGTRLEIK	IGHV3-66*02	IGHJ6*02	IGHD3-16*01,IGHD3-16*02	IGKV3-15*01	IGKJ5*01	VRDLGPYGMDV	QHEET	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
1	Dejnirattisai_Cell_Patients	COVOX-158	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLLESGGDLIQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLEWVSIIYPGGSTFYADSVKGRFTISRDNSKNTLYLQMHSLRAEDTAVYYCARDLGSGDMDVWGKGTTVTVSS	nan	DIVMTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIQAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYRYTFGQGTKVEIK	IGHV3-53*01	IGHJ6	nan	IGKV1-9*01	IGKJ1	ARDLGSGDMDV	QQLNSYRYT	7BEJ,7BEK	Dejnirattisai et al. Cell 184:2183-2200.e22 (2021)	nan	nan
1	Dejnirattisai_Cell_Patients	COVOX-40	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLLESGGDLIQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLEWVSIIYPGGSTFYADSVKGRFTISRDNSKNTLYLQMHSLRAEDTAVYYCARDLGSGDMDVWGKGTTVTVSS	nan	DIVMTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIQAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYRYTFGQGTKVEIK	IGHV3-53*01	IGHJ6	nan	IGKV1-9*01	IGKJ1	ARDLGSGDMDV	QQLNSYRYT	7ND6	Dejnirattisai et al. Cell 184:2183-2200.e22 (2021)	nan	nan
1	Cho-C030	C1287	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGTCGCCTCTGGAATCACCGTCAGTAGTAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGTGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACTCTGTTTCTTCAAATGAACAGCCTGACAGCCGAGGACACGGCTCTGTATTATTGTGCGAGAGATTTACATATCTATGGTCTTGACTGCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCVASGITVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLFLQMNSLTAEDTALYYCARDLHIYGLDCWGQGTLVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAATTATTTAGCCTGGTATCAGCAAAGACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGCATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACACCTTAATAGTTACCCTCCGGTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISNYLAWYQQRPGKAPKLLIYAASTLQSGVPSRFSGSASGTEFTLTISSLQPEDFATYYCQHLNSYPPVTFGGGTKVEIK	IGHV3-66*01	IGHJ4*02	IGHD3-10*01,IGHD4/OR15-4a*01,IGHD4/OR15-4b*01	IGKV1-9*01	IGKJ4*01	ARDLHIYGLDC	QHLNSYPPVT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
1	Cho-C030	C1302	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGGTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGAATCATCGTCAGTAGAAACTATATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGATTGCAATAATTTACAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCAGATTCAGCATCTCCAGGGACAATTCCAAGAACACACTGTTTCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTCTCTATTACTGTGCGAGAGATTTACACACCTATGGTCTTGACTATTGGGGCCAGGGAATCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGIIVSRNYMSWVRQAPGKGLEWIAIIYSGGSTFYADSVKGRFSISRDNSKNTLFLQMNSLRAEDTALYYCARDLHTYGLDYWGQGILVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCTTGTCTGCATCTGTCGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATCAGTAGTGATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGGTGCATCTACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCGGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACATCTTAATAGTTACCCTCCGGTCACTTTCGGCGGAGGGACCAAGGTGGAAATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSDLAWYQQKPGKAPKLLIYGASTLQSGVPSRFSGSGSGTEFTLTIGSLQPEDFATYYCQHLNSYPPVTFGGGTKVEIK	IGHV3-66*01	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGKV1-9*01	IGKJ4*01	ARDLHTYGLDY	QHLNSYPPVT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
1	Xie_mix	BD-504	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASGITVRSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLISRGMDVWGQGTTVTVSS	nan	DIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNGYPHSAFGPGTKVDIK	IGHV3-66*01	IGHJ6	nan	IGKV1-9*01	IGKJ3	ARDLISRGMDV	QQSYTTPLFT	nan	Cao et al. Cell 182:73-84.e16 (2020)	nan	nan
1	Wang-PFZ10	PZF10_P1_IgG_A3-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCATGGTCCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGACTCACCGTCAGTAGCAACTACATGAGGTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTATTTATAGCGGTGGTAGTACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGTTGTATCTTCAAATGATCAGTCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGATCTTATGGTTCGGGGGATGGACGTCTGGGGCCAAGGGACCACGGTCATCGTCTCCTCA	EVQLVESGGGMVQPGGSLRLSCAASGLTVSSNYMRWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMISLRAEDTAVYYCARDLMVRGMDVWGQGTTVIVSS	GACATCCAGATGACCCAGTCTCCATCTTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGTCGGGCGAGTCAGGGTATTAGCAGCTGGTTAGCCTGGTATCAACAGAAACCAGGGACAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGTATAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTACTATTGTCAACAGACTGACGATTTCCCGACTTTCGGCGGAGGGACCAAGGTGGAGATCAA	DIQMTQSPSSLSASVGDRVTITCRASQGISSWLAWYQQKPGTAPKLLIYAASSLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQTDDFPTFGGGTKVEI	IGHV3-66*02	IGHJ6*02	IGHD3-10*01	IGKV1-12*01,IGKV1-12*02,IGKV1D-12*02	IGKJ4*01	ARDLMVRGMDV	QQTDDFPT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
1	Wheatley-CP8	PDI_161	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTGTCACTTATTTATAGCGGTGGAAGCACAGACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTTGTTGCTCGGGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSLIYSGGSTDYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLVARGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCAATGCACTTTCGGCCCTGGGACCAAAGTGGATATCAAA	DIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPQCTFGPGTKVDIK	IGHV3-53*01	IGHJ6*02	IGHD2-21*01,IGHD6-6*01	IGKV1-9*01	IGKJ3*01	ARDLVARGMDV	QQLNSYPQCT	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
1	IML3558	ADI-63206	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGACTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGTACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTCTATTATTGTGCGAGAGACACAATACGAAGGGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACTGTCTCCTCA	EVQLVETGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDTIRRGMDVWGQGTTVTVSS	nan	nan	IGHV3-53*02	IGHJ6*02	IGHD3-3*01,IGHD3-9*01,IGHD5-12*01	IGKV1-33	nan	ARDTIRRGMDV	QQYDNVPPA	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458715.1	nan
1	Crowe_mix	COV2-2037	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGGTCCAGCCTGGGGAGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGATCACCGTCAGTAGCAACTACATGAGTTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCATCATCTCCAGACACAATTCCAAGAACACACTGTATCTTCAAATGAACAGCCTGAGAGCTGAGGACACGGCCGTGTATTACTGTGCGAGAGACCTCAACGAACACGGTCTGGACGTCTGGGGCCAAGGGACCACGGTCAGCGTCTCCTCA	EVQLVESGGGLVQPGESLRLSCAASGITVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFIISRHNSKNTLYLQMNSLRAEDTAVYYCARDLNEHGLDVWGQGTTVSVSS	GACATCCAGATGACCCAGTCTCCATCTTCCGTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGTCGGGCGAGTCAGGGTATTAGCAGCTGGTTAGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAACTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTACTATTGTCAACAGACTAACAGTTTCCCCACCTTCGGCCAAGGGACACGACTGGAGATTAGA	DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQTNSFPTFGQGTRLEI	IGHV3-53*04	IGHJ6*02	IGHD1-1*01,IGHD1-20*01	IGKV1-12*01,IGKV1-12*02,IGKV1D-12*02	IGKJ5*01	ARDLNEHGLDV	QQTNSFPT	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665501.1	MT665114.1
1	Ju_P#5	P5A-3C8	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAATGGGTCTCATTTATTTATAGCGGTGGTAGTACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTACAGGAACACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSFIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLQEHGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACACCTTAATAGTTACCCTCCGGGGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAA	DIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHLNSYPPGYTFGQGTKLEIK	IGHV3-53*01	IGHJ6*02	IGHD4-11*01,IGHD4-4*01	IGKV1-9*01	IGKJ2*01	ARDLQEHGMDV	QHLNSYPPGYT	7CHP	Ju et al. Nature 584:115-119 (2020)	MZ151912.1	MZ151913.1
1	CV-X1	CV-X1-126	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGACACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCGTGAGAGCTGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTTAGTGAGGGCGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAGCGTCG	EVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRHNSKNTLYLQMNSVRAEDTAVYYCARDLSEGGMDVWGQGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCTTCCGTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGTCGGGCGAGTCAGGGTATTAGCAGCTGGTTAGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTACTATTGTCAACAGGCTAACGGTTTCCCTCCACTTTTCGGCGGAGGGACCAAGGTGGAAATCAAA	DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANGFPPLFGGGTKVEIK	IGHV3-53*04	IGHJ6*02	IGHD1-26*01,IGHD2-15*01,IGHD3-22*01	IGKV1-12*01	IGKJ4*01	ARDLSEGGMDV	QQANGFPPL	nan	Kreye et al. Cell 183:1058-1069 (2020)	MW002782.1	MW002800.1
1	CV-X1	HK_CV-X1-126	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	ATTCTGCAACCCGGTGTACATTCCCAGGTGCAGCTGGTGCTCTGCAAACCCGTTACATTCTGAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGACACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCGTGAGAGCTGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTTAGTGAGGGCGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAGCCTCCACCAAGGGCCCATCGGTCTTCCCCCTGGCACCCTCCTCCAAGAGCACCTCTGGGGCACAGCCGCCTGGCGGGG	EVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRHNSKNTLYLQMNSVRAEDTAVYYCARDLSEGGMDVWGQGTTVTVSS	TTTTGTGCTGTTCCTGCTGTCCTGCTCAGCTGACTCTCTCTCTGTGCGTCTCCCGATTGTGTGCTGGTCCTGCTGTCGCGCTATGACCCCAAGTCTCCAGTCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGTCGGGCGAGTCAGGGTATTAGCAGCTGGTTAGCCTGGTATCAGCAGAAGCCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATGCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATATCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTACTATTGTCAACAGGCTAACGGTTTCTCTGCACTTTTCGGCGGAGGGACCAAGGTGGAGATCAAACGAACTGTGGCTGCACCATCTGTCTTCATCTTCCCGCCATCTGATGAGCAGTTGAAATCTGGAACTGCCTCTGTTGTGTGCCTGCTGAATAACTTCTATCCCAGAGAGGCCAAAGTACAGTGGAAGGTGGATAACGCTCTCCAATCCGGTAACCTCCAGGGATCGGTG	SRYDPKSPVSLSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAACTLQSGVPSRFSGSGSGTDITLTISSLQPEDFATYYCQQANGFSALFGGGTKVEIK	IGHV3-53*04	IGHJ6*02	IGHD1-26*01,IGHD2-15*01,IGHD3-22*01	IGKV1-12*01,IGKV1-12*02,IGKV1D-12*02	IGKJ4*01	ARDLSEGGMDV	QQANGFSAL	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
1	COV021	COVD21_P1_HC_B12-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGTGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGACTTGTCGGTCTTCGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCGTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLSVFGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCGTCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTACAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGGTTAATAGTTACTCCCATTTCGGCGGAGGGAGCAAGGCGGAGATCA	DIQLTQSPSFLSASVGDRVTVTCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQVNSYSHFGGGSKAEI	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ4*01	ARDLSVFGMDV	QQVNSYSH	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293086.1	MW293541.1
1	Xie_mix	BD-369	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASGITVSSNYMTWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRDNSKNTLHLQMNSLRGEDTAVYYCARDLVAFGMDVWGQGTTVTVSS	nan	AIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQGGVPSRFSGSGSGTDFTLTISSLQSEDSATYYCQQLNSDTPTFGPGTKVEIK	IGHV3-66*01	nan	nan	IGKV1-9*01	nan	ARDLVAFGMDV	QQLNSDTPT	nan	Du et al. Cell 183:1013-1023.e13 (2020)	nan	nan
1	IML3548	ADI-63009	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGGAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGACTGGGTCTCAGTTATTTACAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAACAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGACTTGGTGGACTGGGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLLESGGGLIQPGGSLRLSCAASGLTVSRNYMTWVRQAPGKGLDWVSVIYSGGSTFYADSVKGRFTISRDNSNNTLYLQMNSLRAEDTAVYYCARDLVDWGMDVWGQGTTVTVSS	nan	nan	IGHV3-53*01	IGHJ6*02	IGHD3/OR15-3a*01,IGHD3/OR15-3b*01	IGKV1-9	nan	ARDLVDWGMDV	QQLNSYPLYT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458518.1	nan
1	Tong_C98	C98C7	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike (and spike minus RBD)	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTAAGACTCTCCTGTGCAGCCTCTGGAATCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGTTGTATCTTCAAATGAGCAGCCTGAGAGCCGAGGATACGGCTGTGTATTACTGTGCGAGAGATTTAGTGGTTTTCGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGITVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMSSLRAEDTAVYYCARDLVVFGMDVWGQGTTVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAACAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTGGCAGCAGCTACTTAACCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCACTATGGTAGCTCACCGACGTTCGGCCAAGGGACCAAGGTGGAGATCAAA	EIVLTQSPGTLSLSPGETATLSCRASQSVGSSYLTWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHYGSSPTFGQGTKVEIK	IGHV3-66*01	IGHJ6*02	IGHD3-22*01	IGKV3-20*01	IGKJ1*01	ARDLVVFGMDV	QHYGSSPT	nan	Tong et al. Cell 184:4969-4980.e15 (2021)	MW718403.1	MW718555.1
1	COV107	COV107_Plate2_HC_78-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTACCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACACTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATTTGGTGGTTTGGGGGATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMTWVRQAPGKGLEWVSVIYSGGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLVVWGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACTCCTTAATAGTTACCCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQLLNSYPYTFGQGTKLEIK	IGHV3-53*01	IGHJ6*02	IGHD3-16*01,IGHD3-16*02	IGKV1-9*01	IGKJ2*01	ARDLVVWGMDV	QLLNSYPYT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
1	Aishun_Jin_mix	57B8	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVLLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLVTWGLDYWGQGTLVTVSS	nan	AIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQLLNTDPITFGQGTRLEIK	IGHV3-53*01	IGHJ4*02	IGHD2-21*02	IGKV1-9*01	IGKJ5*01	ARDLVTWGLDY	QLLNTDPIT	nan	Han et al. Front Immunol. 12:653189 (2021)	nan	nan
1	Aishun_Jin_mix	CQTS174	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGAGTCTCCTGTGCAGCCTCTGGATTCGCCGTCAGTAACAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGTACATTCTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAAGAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGATTTGGTGGTAGCTGGGATTGACTATTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRVSCAASGFAVSNNYMTWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMKSLRAEDTAVYYCARDLVVAGIDYWGQGTLVTVSS	GCCATCCAATTGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAATTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACTGCTTAATAGTGACTCCCCCACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	AIQLTQSPSSLSASVGDRVTITCRASQGISNYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQLLNSDSPTFGQGTKLEIK	IGHV3-66*01	IGHJ4*02	IGHD2-15*01	IGKV1-9*01	IGKJ2*01,IGKJ2*02	ARDLVVAGIDY	QLLNSDSPT	nan	Patent: CN111925444A	MW587616.1	MW587617.1
1	Wang-MOD7	MOD7_P2_IgG_E11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAGGTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATTTAGTGGTCCGGGGTGTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMRWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLVVRGVDYWGQGTLVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAAGAGCTTAATAGTTACCCGATCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQELNSYPITFGQGTRLEIK	IGHV3-53*01	IGHJ4*02	IGHD3-10*01	IGKV1-9*01	IGKJ5*01	ARDLVVRGVDY	QELNSYPIT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
1	COV072	C515	COV072_P3_HC_59-P1369	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCATCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAATTCTTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGATTTAGTTGTCTACGGAGCTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSILYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLVVYGADYWGQGTLVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCCCCTCCTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPPFGGGTKVEIK	IGHV3-66*01	IGHJ4*02	IGHD5/OR15-5a*01,IGHD5/OR15-5b*01	IGKV1-9*01	IGKJ4*01	ARDLVVYGADY	QQLNSYPPP	nan	Gaebler et al. Nature 591:639-644 (2021);Robbiani et al. Nature 584:437-442 (2020)	nan	nan
1	Cho-C011	C2308	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGATTTGGTGGTTCGGGGAACAAGCTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLVVRGTSYWGQGTLVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATAATAACTGGCCTCTATTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPLFTFGPGTKVDIK	IGHV3-66*01	IGHJ4*02	IGHD3-10*01	IGKV3-15*01	IGKJ3*01	ARDLVVRGTSY	QQYNNWPLFT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
1	Cho-C011	C2318	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGAGTTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGGACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGATTTGGTGGTTCGGGGAACAAGCTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMDSLRAEDTAVYYCARDLVVRGTSYWGQGTLVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATAATAACTGGCCTCTATTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPLFTFGPGTKVDIK	IGHV3-66*01	IGHJ4*02	IGHD3-10*01	IGKV3-15*01	IGKJ3*01	ARDLVVRGTSY	QQYNNWPLFT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
1	Xie_mix	BD-495	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDPIRNGMDVWGQGTTVTVSS	nan	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPRTFGQGTKVEIK	IGHV3-66*01	nan	nan	IGKV1-33*01	nan	ARDPIRNGMDV	QQYDNLPRT	nan	Du et al. Cell 183:1013-1023.e13 (2020)	nan	nan
1	Aishun_Jin_mix	52G9	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSNNTLYLQMNSLRAEDTAVYYCARDPMRPGMDVWGQGTTVTVSS	nan	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFIFTISSLQPEDIATYYCQQYDNLPRTFGQGTKVEIK	IGHV3-66*01	IGHJ6*02	IGHD6-25*01	IGKV1-33*01	IGKJ1*01	ARDPMRPGMDV	QQYDNLPRT	nan	Han et al. Front Immunol. 12:653189 (2021)	nan	nan
1	Aishun_Jin_mix	CQTS069	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAACAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTTTATTACTGTGCGAGAGATCCCATGCGGCCCGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSNNTLYLQMNSLRAEDTAVYYCARDPMRPGMDVWGQGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTATTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCTCGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFIFTISSLQPEDIATYYCQQYDNLPRTFGQGTKVEIK	IGHV3-66*01	IGHJ6*02	IGHD6-25*01	IGKV1-33*01,IGKV1D-33*01	IGKJ1*01	ARDPMRPGMDV	QQYDNLPRT	nan	Patent: CN111909262A	MW587458.1	MW587459.1
1	COV047	COV047_P5_IgG_8-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCGGGTTATCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRVIYGMDVWGQGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCTCAAACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPQTFGGGTKVEIK	IGHV3-53*01	IGHJ6*02	IGHD3-22*01,IGHD3-3*01,IGHD3-3*02	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	ARDRVIYGMDV	QQYDNLPQT	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293084.1	MW293539.1
1	COV047	COV047_P5_IgG_84-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCGGGTTATCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRVIYGMDVWGQGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCTCAAACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPQTFGGGTKVEIK	IGHV3-53*01	IGHJ6*02	IGHD3-22*01,IGHD3-3*01,IGHD3-3*02	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	ARDRVIYGMDV	QQYDNLPQT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
1	CV05	HL_CV05-129	nan	SARS-CoV-2	nan	nan	nan	S:S1	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	CTTCTGCAACCCGGTGTACATTCCTGAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATTACAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGAGATCGAGTATCAGGGGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAGCCTCCACCAAGGGCCCATCGGTCTTCCCCCTGGCACCCTCCTCCAAGAGCACCTCTGGGGCACAAGCGGCCGGGCGGG	EVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDRVSGGMDVWGQGTTVTVSS	TCGGGTAATAAGTAGCTCCGGTAAACCTTACCTAATCCCAGTCTGTGCTGACTCAGGAGGCAGAGCTCTGGGAATCTCACCATCTTCTTCACTCGTGTGTTGGAAACAAAAGTCTGCTACCCCGGGCCTGGGCCCAGTCTGTGCTGACTCAGCCACCCTCAGTGTCAGTGGCCCCAGGAAAGACGGCCAGGATTACCTGTGGGGGAAACAACATTGGAAGTAAAAGTGTGCACTGGTACCAGCAGAAGCCAGGCCAGGCCCCTGTGCTGGTCATCTATTATGATAGCGACCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACGGCCACCCTGACCATCAGCAGGGTCGAAGCCGGGGATGAGGCCGACTATTACTGTCAGGTGTGGGATAGTAGTAGTGATCATGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAGTCAGCCAAGCTGCCCCTTTTTTTAGT	QSVLTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVIYYDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL	IGHV4-59*01	IGHJ6*02	IGHD6-6*01	IGLV3-21*04	IGLJ2*01,IGLJ3*01	ARDRVSGGMDV	QVWDSSSDHVV	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
1	CV05	HL_CV05-182	nan	SARS-CoV-2	nan	nan	nan	S:S1	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	CGTCTGCAACCCCGGTGTACATTCCTGAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATTACAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGAGATCGAGTATCAGGGGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAGCCTCCACCAAGGGCCCATCGGTCTTCCCCCTGGCACCCTCCTCCAAGAGCACCTCTGGGGCACAAGCGGCCGGGCGGG	EVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDRVSGGMDVWGQGTTVTVSS	GGGGCTATGTCCTAGTCTGTGCTGACTCAGCCACCCTCAGTGTCAGTGGCCCCAGGAAAGACGGCCAGGATTACCTGTGGGGGAAACAACATTGGAAGTAAAAGTGTGCACTGGTACCAGCAGAAGCCAGGCCAGGCCCCTGTGCTGGTCATCTATTATGATAGCGACCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACGGCCACCCTGACCATCAGCAGGGTCGAAGCCGGGGATGAGGCCGACTATTACTGTCAGGTGTGGGATAGTAGTAGTGATCATGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAGTCAGCCCAAGCTGCCCTTTCGAGC	SVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVIYYDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL	IGHV4-59*01	IGHJ6*02	IGHD6-6*01	IGLV3-21*04	IGLJ2*01,IGLJ3*01	ARDRVSGGMDV	QVWDSSSDHVV	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
1	Xie_mix	BD-505	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRVVYGMDVWGQGTTVTVSS	nan	DIQMTQSPSSLSASVGDRVTITCQASQDIINYLNWYQQKPGKAPKLLIYGASNLETGVPSRFSGGGSGTDFTFTISSLQPEDIATYYCHQYDNLPPTFGQGTRLEIK	IGHV3-53*01	IGHJ6	nan	IGKV1-33*01	IGKJ5	ARDRVVYGMDV	HQYDNLPPT	nan	Cao et al. Cell 182:73-84.e16 (2020)	nan	nan
1	Xie_mix	BD-501	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRVVYGMDVWGQGTTVTVSS	nan	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPPTFGGGTKVEIK	IGHV3-53*01	nan	nan	IGKV1-33*01	nan	ARDRVVYGMDV	QQYDNLPPT	nan	Du et al. Cell 183:1013-1023.e13 (2020)	nan	nan
1	IML3558	ADI-60747	nan	SARS-CoV-2	nan	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGACTGGAGGAGGCCTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCGGATATCAGTGTCAGTAGCAACTATATGACCTGGGTCCGCCAGGCTCCAGGAAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAACTCCAAGAACACAGTACATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCATTTATTATTGTGCGAGAGATGTTAGGATCTATGGTATGGACGTCTGGGGCCAAGGGACCATGGTCACCGTCTCTTCA	EVQLLETGGGLIQPGGSLRLSCAASDISVSSNYMTWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTVHLQMNSLRAEDTAIYYCARDVRIYGMDVWGQGTMVTVSS	nan	nan	IGHV3-53*02	IGHJ6*02	IGHD2-15*01,IGHD2-2*01,IGHD2-2*02	IGLV1-47	nan	ARDVRIYGMDV	AVWDDSLSGPDWV	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458016.1	nan
1	Wang-MOD4	C664	Mod4_P4_IgG_B7-P1369	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGGTCACCGTCAGTAGCAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGTACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGATCGCTTGAGGCGTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGVTVSSNYMTWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSLEAYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACGGGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYGYTFGQGTKLEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ2*01	ARSLEAYGMDV	QQLNSYGYT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
1	Wang-MOD4	Mod4_P4_IgG_E8-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGATCGCTTGAGGCGTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSLEAYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTGAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGGTGCATCCACTTTGCAAAGTGGGGTCCCAACAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATCACTGTCAACAGCTTAATAGTTACGGGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASEGISSYLAWYQQKPGKAPKLLIYGASTLQSGVPTRFSGSGSGTEFTLTISSLQPEDFATYHCQQLNSYGYTFGQGTKLEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ2*01	ARSLEAYGMDV	QQLNSYGYT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
1	A VelocImmune mouse	REGN10939	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;Humanized Mouse	nan	EVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMNWVRQVPGKGLEWVSVIYSGGSKFYVDSVKGRFTISRHNSKNTLYLQMNSLRPEDTAVYYCTRDAQYYGMDVWGQGTTVTVSS	nan	DIQMTQSPSSLSASVGDRVTITCRASQSISTYLHWYQQKPGEAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPEIFGQGTKLEIK	IGHV3-53*04	IGHJ6	nan	IGKV1-39*01	IGKJ2	TRDAQYYGMDV	QQSYSTPPEI	nan	Patent: US10787501	nan	nan
1	Adreano-PT008	C14	nan	SARS-CoV-2	SARS-CoV,MERS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGACTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGACAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTATATTACTGTGTGAGAGATCTCTACTCCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAGCCTCC	EVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKDRFTISRDNSKNTLYLQMNSLRAEDTAVYYCVRDLYSYGMDVWGQGTTVTVSS	GCCATCCAGATGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCCTCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGGTTAATAGTTACCCCACCTTCGGCCAAGGGACACGACTGGAGATTAAACGAACT	AIQMTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQVNSYPTFGQGTRLEIK	IGHV3-66*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ5*01	VRDLYSYGMDV	QQVNSYPT	nan	Andreano et al. Cell 184:1821-1835.e16 (2021)	MW598305.1	MW598306.1
2	Li_SARS2_26	H712007+K711670	nan	SARS-CoV-2	SARS-CoV,MERS-CoV	nan	nan	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARAYGDYFFDYWGQGTLVTVSS	nan	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISCLQSEDFATYYCQQYYSFPPTFGQGTKVEIK	IGHV3-53*01	IGHJ4	nan	IGKV1-8*03	IGKJ1	ARAYGDYFFDY	QQYYSFPPT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
2	Chen_Vax_p1	COV2-vax-51	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGGTCATCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGCCTACGGTGACTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGVIVSSNYMNWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARAYGDYYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCCTTCGGCCAAGGGACACGACTGGAGATTAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSFGQGTRLEIK	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV3-20*01	IGKJ5*01	ARAYGDYYFDY	QQYGSS	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555604.1	MZ555605.1
2	Chen_Vax_p1	COV2-vax-52	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCATTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGCCTACGGTGACTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSFIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARAYGDYYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTCTGGTAGCTCCTTCGGCCAAGGGACACGACTGGAGATTAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQSGSSFGQGTRLEIK	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV3-20*01	IGKJ5*01	ARAYGDYYFDY	QQSGSS	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555606.1	MZ555607.1
2	IDHbnC	HbnC3t1p2_B10	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCATCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAACTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGATTATGGTGACTACTTCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDYFFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTCTGGTGCATCCAGCAGGGCCGCTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAACAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCTAGGACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLISGASSRAAGIPDRFSGSGSGTDFTLTINRLEPEDFAVYYCQQYGSSPRTFGQGTKLEIK	IGHV3-66*02	IGHJ4*02	IGHD2-21*02	IGKV3-20*01	IGKJ2*01,IGKJ2*02	ARDYGDYFFDY	QQYGSSPRT	nan	Kreer et al. Cell 182:843-854.e12 (2020)	MT658819.1	MT658847.1
2	Chen_Vax_p1	COV2-vax-23	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCATGTATTACTGTGCGAGAGATTACGGTGACTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAMYYCARDYGDYYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCTCGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV3-20*01	IGKJ1*01	ARDYGDYYFDY	QQYGSSPRT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555547.1	MZ555548.1
2	Cho-C006	C2430	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGGGACTACGGTGACTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDYYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTGGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGAGGACGTTCGGCCAAGGGACCAAGGTGGAGATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVGSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV3-20*01	IGKJ1*01	ARDYGDYYFDY	QQYGSSPRT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
2	Xie_mix	BD-628	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDYYFDYWGQGTLVTVSS	nan	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPERFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSTPRTFGQGTKVEIK	IGHV3-53*01	nan	nan	IGKV3-20*01	nan	ARDYGDYYFDY	QQYGSTPRT	nan	Du et al. Cell 183:1013-1023.e13 (2020)	nan	nan
2	Xie_mix	BD-629	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASEFIVSRNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLNLQMNSLRAEDTAVYYCARDYGDYYFDYWGQGTLVTVSS	nan	EIVLTQSPGTLSLSPGERATLSCRASQGVSSFLAWYQQKPGQAPRLLIHGASSRATGIPDRFSGSGSGTDFTLTITRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK	IGHV3-53*01	IGHJ4	nan	IGKV3-20*01	IGKJ1	ARDYGDYYFDY	QQYGSSPRT	7CH5,7CHC	Du et al. Cell 183:1013-1023.e13 (2020)	nan	nan
2	Aishun_Jin_mix	56H3	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSNNTLYLQMNSLRAEDTAVYYCARDYGDYYFDYWGQGTLVTVSS	nan	EIVLTQSPGTLSLSPGERATLSCRASQSVSSTYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK	IGHV3-66*01	IGHJ4*02	IGHD4-17*01	IGKV3-20*01	IGKJ1*01	ARDYGDYYFDY	QQYGSSPRT	nan	Han et al. Front Immunol. 12:653189 (2021)	nan	nan
2	Li_SARS2_26	DH1125	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASGFIVSYNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDYYFDYWGQGTLVTVSS	nan	EIVLTQSPATLSLSPGERATLSCGASQSVTSRYLAWYQQKPGLAPRLLIYDASSRATGIPDRFSGSGSGTEFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK	IGHV3-53*01	IGHJ4	nan	IGKV3D-20*01	IGKJ1	ARDYGDYYFDY	QQYGSSPRT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
2	Aishun_Jin_mix	CQTS098	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGAGTTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTCATTTATAGCGGAGGTAGCACATTCTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAACAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGATTACGGTGACTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSNNTLYLQMNSLRAEDTAVYYCARDYGDYYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCACCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCTCGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSTYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK	IGHV3-66*01	IGHJ4*02	IGHD4-17*01	IGKV3-20*01	IGKJ1*01	ARDYGDYYFDY	QQYGSSPRT	nan	Patent: CN111909261A	MW587498.1	MW587499.1
2	COV107	C102	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCATCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGGGACTACGGTGACTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGLIQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDYYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTCTATTACTGTCAGCAGTATGGTAGCTCACCTCGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV3-20*01	IGKJ1*01	ARDYGDYYFDY	QQYGSSPRT	7K8N,7K8M	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
2	COV047	COV047_P3_IgG_65-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGACTACGGTGACTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDYYFDYWGQGTLVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATAATAACTGGCCTCGAACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPRTFGQGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV3-15*01	IGKJ1*01	ARDYGDYYFDY	QQYNNWPRT	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293110.1	MW293565.1
2	COV107	COV107_Plate1_HC_36-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCATCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGTCGAGGACACGGCCGTGTATTACTGTGCGAGAGATTATGGGGACTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCARDYGDYYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATTTAGTAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCTCGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGAFSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD7-27*01	IGKV3-20*01	IGKJ1*01	ARDYGDYYFDY	QQYGSSPRT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
2	COV107	COV107_Plate2_HC_13-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCATCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGGGACTACGGTGACTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDYYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTCTATTACTGTCAGCAGTATGGTAGCTCACCTCGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV3-20*01	IGKJ1*01	ARDYGDYYFDY	QQYGSSPRT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
2	Wang-MOD4	C682	Mod4_P3_IgG_E12-P1369	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCACTGAGACTCTCCTGTGCAGCCTCTGGGTTCATCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTGTTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGGGACTACGGTGACTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSVVYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDYYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCTCGGACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKLEIK	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV3-20*01	IGKJ2*01,IGKJ2*02	ARDYGDYYFDY	QQYGSSPRT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
2	Wang-MOD7	MOD7_P2_IgG_A6-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCATCGTCAGTAGGAACTACATGAGTTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATCCCGGTGGTAGCACATACTACGGAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGGGACTACGGTGACTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFIVSRNYMSWVRQAPGKGLEWVSVIYPGGSTYYGDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDYYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCTCGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK	IGHV3-66*01	IGHJ4*02	IGHD4-17*01	IGKV3-20*01	IGKJ1*01	ARDYGDYYFDY	QQYGSSPRT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
2	Cho-C016	C2226	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACCCTGTATCTTCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGGCTACGGTGACTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMTWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGYGDYYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTATTAGTAGGTGGTTGGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCGAAGCTCCTGATCTATAAGGCGTCTAGTTTAGAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACCATCAGCAGCCTGCAGCCTGATGATTTTGCAACTTATTACTGCCAACAGTATAATAGTTACCCTATGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSTLSASVGDRVTITCRASQSISRWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYPMFGQGTKVEIK	IGHV3-66*02	IGHJ4*02	IGHD4-17*01	IGKV1-5*03	IGKJ1*01	ARGYGDYYFDY	QQYNSYPM	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
2	Cho-C016	C2227	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGGCTACGGTGACTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMTWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGYGDYYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTACTAGTAGCTGGTTGGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATAAGGCGTCTAGTTTAGAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACCATCAGCAGCCTGCAGCCTGATGATTTTGCAACTTATTACTGCCAACAGTATAATAGTTACCCTACGTTCGGCCAAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSTLSASVGDRVTITCRASQSTSSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYPTFGQGTKVEIK	IGHV3-66*02	IGHJ4*02	IGHD4-17*01	IGKV1-5*03	IGKJ1*01	ARGYGDYYFDY	QQYNSYPT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
2	COV021	COVD21_P1_HC_A2-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAGTTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAAGACACGGCCGTATATTACTGTGCGAGGGGCTACGGTGACTACTATTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMTWVRQAPGKGLEWVSLIYSGGSTFYADSVKGRFTISRDSSKNTLYLQMNSLRAEDTAVYYCARGYGDYYFDYWGQGTLVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTCTGCAACTTATTACTGTCAACATCTTAATGGGTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDSATYYCQHLNGFGPGTKVDIK	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV1-9*01	IGKJ3*01	ARGYGDYYFDY	QHLNG	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293116.1	MW293571.1
2	Kaku_patientB	3-5	nan	SARS-CoV-2	nan	SARS-CoV-2	SARS-CoV;MERS-CoV	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGACGACACGGCCGTGTATTACTGTGCGAGATCCTACGGTGACTACTTTATAGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLLESGGGLIQPGGSLRLSCAASGFTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRADDTAVYYCARSYGDYFIDYWGQGTLVTVSS	GATATTGTGTTGACACAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCCTGGTGGACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIVLTQSPGTLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWWTFGQGTKLEIK	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV3-20*01	IGKJ2*02	ARSYGDYFIDY	QQYGSSPWWT	nan	Kaku et al. Cell Rep. 36:109385 (2021)	MZ089619.1	MZ089624.1
2	Xie_mix	BD-631	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSYGDYYFDYWGQGTLVTVSS	nan	AIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSFGPGTKVDIK	IGHV3-53*01	nan	nan	IGKV1-9*01	nan	ARSYGDYYFDY	QQLNS	nan	Du et al. Cell 183:1013-1023.e13 (2020)	nan	nan
2	Graham_P008	P008_018	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCATTTATTTATCCCGGTGGTAGCACATACTACGTAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGATCCTACGGTGACTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCTTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSFIYPGGSTYYVDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSYGDYYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTCGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGGGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACTTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCACTCCAGGACGTTCGGCCAAGGGACCAAGCTGGAGATCAAAC	EIVLTQSPGTLSSSPGERATLSCRASQGVSSSYLAWYQQKLGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHSRTFGQGTKLEIK	IGHV3-66*02	IGHJ4*02	IGHD4-17*01	IGKV3-20*01	IGKJ1*01	ARSYGDYYFDY	QHSRT	nan	Graham et al. Immunity 54:1276-1289.e6 (2021)	MW802418.1	MW802311.1
2	IML3546	ADI-62836	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGACGGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTCAGACTCTCCTGTACAGCCTCTGGATTCACCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGCAGTGGGTCTCAATTATTTATAGTGGTGGTAGCTCATTCTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAAGACACGTTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTATATATTACTGTGCCAGATCGTACGGTGACTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVETGGGLVQPGGSLRLSCTASGFTVSSNYMNWVRQAPGKGLQWVSIIYSGGSSFYADSVKGRFTISRDNSKDTLYLQMNSLRAEDTAIYYCARSYGDYYFDYWGQGTLVTVSS	nan	nan	IGHV3-66*01,IGHV3-66*04	IGHJ4*02	IGHD4-17*01	IGKV1-12	nan	ARSYGDYYFDY	QQGNGLPLI	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458344.1	nan
2	Wang-MOD8	MOD8_P2_IgG_C5-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCATCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGATCCTACGGTGACTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFIVSSNYMNWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSYGDYYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSLTFGGGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV3-20*01	IGKJ4*01	ARSYGDYYFDY	QQYGSSLT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
2	IDHbnC	HbnC3t1p1_G4	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGACTTCGGTGACTTCTTCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDFGDFFFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCTATTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGTATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCTCGAACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYGVSSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK	IGHV3-66*02	IGHJ4*02	IGHD4-17*01	IGKV3-20*01	IGKJ1*01	ARDFGDFFFDY	QQYGSSPRT	nan	Kreer et al. Cell 182:843-854.e12 (2020)	MT658818.1	MT658846.1
2	CC12	CC12.3	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAGCACGCTGTATCTTCAAATGAACAGCCTGAGAGTCGAGGACACGGCCGTGTATTACTGTGCGAGAGACTTCGGTGACTTCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKSTLYLQMNSLRVEDTAVYYCARDFGDFYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGTAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCTCGAACGTTCGGCCAAGGGACCAAGCTGGAGATCAAA	EIVLTQSPGTLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKLEIK	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV3-20*01	IGKJ1*01	ARDFGDFYFDY	QQYGSSPRT	6XC4,6XC7,7KN6,7KN7	Rogers et al. Science 369:956-963 (2020);Yuan et al. Science 369:1119-1123 (2020)	MT594040.1	MT594073.1
2	Cho-C017	C2113	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	AGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATTTTGGGGAGTTTTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	VQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDFGEFYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGACTGTTAGCAGCAACTACTTAGCCTGGTACAAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCAGCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGATTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCTCGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQTVSSNYLAWYKQKPGQAPRLLIYGAASRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD3-16*01,IGHD3-16*02	IGKV3-20*01	IGKJ1*01	ARDFGEFYFDY	QQYGSSPRT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
2	COV047	C155	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCATCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGCCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATTTTGGAGAGTTCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDFGEFYFDYWGQGTLVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGCTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATAATAACTGGCCTCGGACGTTCGGCCAAGGGACCAAGGTGGAGATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATAIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPRTFGQGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD3-3*01,IGHD3-3*02	IGKV3-15*01	IGKJ1*01	ARDFGEFYFDY	QQYNNWPRT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
2	COV047	COV047_P5_IgG_27-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCATCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGCCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATTTTGGAGAGTTCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDFGEFYFDYWGQGTLVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGCTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATAATAACTGGCCTCGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATAIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPRTFGQGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD3-3*01,IGHD3-3*02	IGKV3-15*01	IGKJ1*01	ARDFGEFYFDY	QQYNNWPRT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
2	Cho-C005	C1361	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGAATTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGATTACGGTGACTTCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASEFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDFYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCTGGCGCCCAGGCTCCTCATCTATGATGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCTCGGACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGLAPRLLIYDASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKLEIK	IGHV3-66*01	IGHJ4*02	IGHD4-17*01	IGKV3D-20*01	IGKJ2*01,IGKJ2*02	ARDYGDFYFDY	QQYGSSPRT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
2	Cho-C011	C2019	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCATCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCGGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGACTACGGTGACTTCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDFYFDYWGQGTLVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATAATAACTGGCCTCGAACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPRTFGQGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV3-15*01	IGKJ1*01	ARDYGDFYFDY	QQYNNWPRT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
2	Cho-C011	C2319	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGTATTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGACTACGGTGACTTCTACTTTGACTACTGGGGCCGGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASVFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDFYFDYWGRGTLVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATAATAACTGGCCTCGAACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPRTFGQGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV3-15*01	IGKJ1*01	ARDYGDFYFDY	QQYNNWPRT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
2	Cho-C006	C2431	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATCCCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAAGACACGGCCGTGTATTACTGTGCGAGGGACTACGGTGACTTCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYPGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDFYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTGGCAGCAGCTACTTAGCCTGGTACCAGCAGACACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAGGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGAGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVGSSYLAWYQQTPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV3-20*01	IGKJ1*01	ARDYGDFYFDY	QQYGSSPRT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
2	Xie_mix	BD-632	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQVVESGGGLVQPGGSLRLSCAASGFTVSFNYMSWVRQAPGKGLEWVSVIYPGGSTYYADSVKGRFTISRHNSKNTVYLQMNSLRAEDTAVYYCARDYGDFYFDYWGQGTLVTVSS	nan	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAMYYCQQYDSSPRTFGQGTKVEIK	IGHV3-53*04	nan	nan	IGKV3-20*01	nan	ARDYGDFYFDY	QQYDSSPRT	nan	Du et al. Cell 183:1013-1023.e13 (2020)	nan	nan
2	Ju_P#5	P5A-3A1	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDFYFDYWGQGTLVTVSS	nan	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKLEIK	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV3-20*01	IGKJ2*02	ARDYGDFYFDY	QQYGSSPRT	7D0C	Ju et al. Nature 584:115-119 (2020)	nan	nan
2	Li_SARS2_26	H712442+K711940	nan	SARS-CoV-2	SARS-CoV,MERS-CoV,OC43,HKU1,NL63	nan	nan	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDFYFDYWGQGTLVTVSS	nan	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQHYYNWPRTFGQGTKVEVK	IGHV3-53*01	IGHJ4	nan	IGKV3-15*01	IGKJ1	ARDYGDFYFDY	QHYYNWPRT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
2	COV021	C003	COVD21_P1_HC_A10-p1369	SARS-CoV-2	SARS-CoV	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGGGGACACGGCCGTGTATTACTGTGCGAGGGATTACGGTGACTTCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAGDTAVYYCARDYGDFYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCACCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCTAGGACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSTYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKLEIK	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV3-20*01	IGKJ2*01,IGKJ2*02	ARDYGDFYFDY	QQYGSSPRT	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293115.1	MW293570.1
2	COV047	COV047_P3_IgG_47-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCGCATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGACTACGGTGACTTCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSAYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDFYFDYWGQGTLVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATAATAACTGGCCTCGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPRTFGQGTKVEIK	IGHV3-66*01	IGHJ4*02	IGHD4-17*01	IGKV3-15*01	IGKJ1*01	ARDYGDFYFDY	QQYNNWPRT	nan	Robbiani et al. Nature 584:437-442 (2020)	MW292959.1	MW293414.1
2	COV107	COV107_Plate1_HC_82-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCATCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGGAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTATTGTGCGAGAGACTACGGTGACTTCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDFYFDYWGQGTLVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAACAGAAACCTGGCCAGGCTCCCCGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATTATAACTGGCCCCGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYYNWPRTFGQGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV3-15*01	IGKJ1*01	ARDYGDFYFDY	QQYYNWPRT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
2	COV021	COVD21_P2_HC_F7-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGACTACGGTGACTTCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDFYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCGAGTCAGGGCATTAGCAATTCTTTAGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGCTCTATGCTGCATCCAGATTGGAAAGTGGGGTCCCATCCAGGTTCAGTGGCAGTGGATCTGGGACGGATTACACTCTCACCATCAACAGCCTGCAGCCTGAAGATTTTGCAACTTTTTACTGTCAACAGTATTATAGTACCCCCCGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQGISNSLAWYQQKPGKAPKLLLYAASRLESGVPSRFSGSGSGTDYTLTINSLQPEDFATFYCQQYYSTPRTFGQGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV1-NL1*01	IGKJ1*01	ARDYGDFYFDY	QQYYSTPRT	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293114.1	MW293569.1
2	COV096	COV096_HC_74-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCATCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGAAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGACTACGGTGACTTCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDFYFDYWGQGTLVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCGTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATAATAACTGGCCCCGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPRTFGQGTKVEIK	IGHV3-66*02	IGHJ4*02	IGHD4-17*01	IGKV3-15*01	IGKJ1*01	ARDYGDFYFDY	QQYNNWPRT	nan	Robbiani et al. Nature 584:437-442 (2020);Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292960.1	MW293415.1
2	IML3548	ADI-60702	nan	SARS-CoV-2	nan	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGAGTTCATCGTCAGTAGAAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTTTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACTCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTATATTACTGTGCGAGAGACTACGGTGACTTCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASEFIVSRNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDFYFDYWGQGTLVTVSS	nan	nan	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV3D-15	nan	ARDYGDFYFDY	QQYGNWPRT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457971.1	nan
2	IML3550	ADI-63156	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGAGTTCATCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACACTTCCAAAAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGACTACGGTGACTTCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASEFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDTSKNTLYLQMNSLRAEDTAVYYCARDYGDFYFDYWGQGTLVTVSS	nan	nan	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV3D-15	nan	ARDYGDFYFDY	QQYNNWPRT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458665.1	nan
2	COV021	COV021_P3_IgA_20-P1609	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGCGAGACTACGGTGACTTCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDFYFDYWGQGTLVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATAATAACTGGCCTAGGACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPRTFGQGTKLEIK	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV3-15*01	IGKJ2*01,IGKJ2*02	ARDYGDFYFDY	QQYNNWPRT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW293112.1	MW293567.1
2	Wheatley-CP25	PDI_79	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GATGTGCAGCTGGTGGAGACTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGACTACGGTGACTTCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	DVQLVETGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDFYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGTATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCTAGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAA	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGVSSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK	IGHV3-53*02	IGHJ4*02	IGHD4-17*01	IGKV3-20*01	IGKJ1*01	ARDYGDFYFDY	QQYGSSPRT	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
2	Cho-C016	C2236	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGACTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTGTTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAGATGAACAGCCTGAGAGCCGAGGACACGGCCGTCTATTACTGTGCGAGAGATAGGGGTGACTCGCTATTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVETGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVVYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRGDSLFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTTTTAGTACCTGGTTGGCCTGGTATCAACAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATAAGGCGTCTAGTTTAGAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACCATCAGCAGCCTGCAGCCTGATGATTTTGCTACTTATTACTGCCAACACTATAATAGTTATTCTCCGGGGGGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSTLSASVGDRVTITCRASQSFSTWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQHYNSYSPGGTFGQGTKVEIK	IGHV3-53*02	IGHJ4*02	IGHD2-21*02,IGHD4-17*01	IGKV1-5*03	IGKJ1*01	ARDRGDSLFDY	QHYNSYSPGGT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
2	Wheatley-CP4	PDI_37	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGAATTCATCGTCAGTAGGAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTCATTTATAGCGGTGGGACCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAGTTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGCGAGATCGCGGTGACTACCTCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASEFIVSRNYMSWVRQAPGKGLEWVSVIYSGGTTYYADSVKGRFTISRDSSKNTLYLQMNSLRAEDTAVYYCARDRGDYLFDYWGQGTLVTVSS	GACATCCAGATGACCCAGCCTCCATCCCCCCTGTTTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTATTAGTAGCTGGTTGGCCTGGTATCAACAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATAAGGCGTCTAGTTTAGAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGAGACAGAATTCACTCTCACCATCAGCAGCCTGCAGCCTGATGATTTTGCAACTTATTACTGCCAACAGTATAATAGTTATTTTCCGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAA	DIQMTQPPSPLFASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSETEFTLTISSLQPDDFATYYCQQYNSYFPTFGQGTKVEIK	IGHV3-66*01	IGHJ4*02	IGHD4-17*01	IGKV1-5*03	IGKJ1*01	ARDRGDYLFDY	QQYNSYFPT	7MZF	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
2	COV047	COV047_P3_IgA_12-P1609	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATTGGGGGGATGATTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDWGDDYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCGAGTCAGGGCATTAGCAATTCTTTAGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGCTCTATGCTGCATCCAGATTGGAAAGTGGGGTCCCATCCAGGTTCAGTGGCAGTGGATCTGGGACGGATTACACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGTATTATAGTACCCCTCGGACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQGISNSLAWYQQKPGKAPKLLLYAASRLESGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCQQYYSTPRTFGPGTKVDIK	IGHV3-53*01	IGHJ4*02	IGHD3-16*01,IGHD3-16*02	IGKV1-NL1*01	IGKJ3*01	ARDWGDDYFDY	QQYYSTPRT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW293113.1	MW293568.1
2	Wang-MOD3	C660	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGATTTCATCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAATGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGTCGAGGACACGGCCGTGTATTACTGTGCGAGAGATTGGGGGGATAACTATTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASDFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCARDWGDNYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCATTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTCTTAGCAGCAGGTTCTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGATGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGGGGCAGTGGGTCTGAGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTCGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCTCGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSLSSRFLAWYQQKPGQAPRLLIYDASSRATGIPDRFRGSGSETDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD3-16*01,IGHD3-16*02	IGKV3-20*01	IGKJ1*01	ARDWGDNYFDY	QQYGSSPRT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
2	Wang-MOD3	MOD3_P2_IgG_D12-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGATTTCATCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAATGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGTCGAGGACACGGCCGTGTATTACTGTGCGAGAGATTGGGGGGATAACTATTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASDFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCARDWGDNYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCATTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTCTTAGCAGCAGGTTCTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGATGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGGGGCAGTGGGTCTGAGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTCGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCTCGGACGTTCGGCCAAGGGACCAAGGTGGAAGTCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSLSSRFLAWYQQKPGQAPRLLIYDASSRATGIPDRFRGSGSETDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEVK	IGHV3-53*01	IGHJ4*02	IGHD3-16*01,IGHD3-16*02	IGKV3-20*01	IGKJ1*01	ARDWGDNYFDY	QQYGSSPRT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
2	COV021	COVD21_P1_HC_C8-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGACTGGGGAGACTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDWGDYYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCTCGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD7-27*01	IGKV3-20*01	IGKJ1*01	ARDWGDYYFDY	QQYGSSPRT	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293111.1	MW293566.1
2	Xie_mix	BD-396	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGTTYYADSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCARDWGEYYFDYWGQGTLVTVSS	nan	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK	IGHV3-53*04	nan	nan	IGKV3-20*01	nan	ARDWGEYYFDY	QQYGSSPRT	nan	Du et al. Cell 183:1013-1023.e13 (2020)	nan	nan
2	COV107	COV107_Plate1_HC_40-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGACTGGGGAGAGTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDWGEYYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTACCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGACCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCTCGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVTSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLDPEDFAVYYCQQYGSSPRTFGQGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD7-27*01	IGKV3-20*01	IGKJ1*01	ARDWGEYYFDY	QQYGSSPRT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
2	COV107	COV107_Plate1_HC_9-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGACTGGGGAGAGTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDWGEYYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTACCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGACCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCTCGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVTSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLDPEDFAVYYCQQYGSSPRTFGQGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD7-27*01	IGKV3-20*01	IGKJ1*01	ARDWGEYYFDY	QQYGSSPRT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
2	Wang-MOD1	C614	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCACTGGGTTCATCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGAGTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATTGGGGAGAATACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAATGFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYAESVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDWGEYYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGATTGTTAGCAGCAGTTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCGGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGATAGCTCACCTCGAACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQIVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISGLEPEDFAVYYCQQYDSSPRTFGQGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD3-10*01,IGHD3-10*02,IGHD3-16*01	IGKV3-20*01	IGKJ1*01	ARDWGEYYFDY	QQYDSSPRT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
2	Wang-MOD1	Mod1_P2_IgG_G5-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCACTGGGTTCATCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGAGTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATTGGGGAGAATACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAATGFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYAESVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDWGEYYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCANTCTCCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGATTGTTAGCAGCAGTTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCGGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGATAGCTCACCTCGAACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPXSLSLSPGERATLSCRASQIVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISGLEPEDFAVYYCQQYDSSPRTFGQGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD3-10*01,IGHD3-10*02,IGHD3-16*01	IGKV3-20*01	IGKJ1*01	ARDWGEYYFDY	QQYDSSPRT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
2	Wang-MOD9	MOD9_P2_IgG_E12-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGACTGGGGGGAGTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDWGEYYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCTCGAACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD3-16*01,IGHD3-16*02	IGKV3-20*01	IGKJ1*01	ARDWGEYYFDY	QQYGSSPRT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
2	Cho-C012	C2149	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCATCGTCAGTAGCAACTATATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGACTACGGTGACTTATACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDLYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTCTATTACTGTCAGCAGTATGGTAGCTCACCTCGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV3-20*01	IGKJ1*01	ARDYGDLYFDY	QQYGSSPRT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
2	Xie_mix	BD-397	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASEFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDLYFDYWGQGTLVTVSS	nan	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQTPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK	IGHV3-53*01	nan	nan	IGKV3-20*01	nan	ARDYGDLYFDY	QQYGSSPRT	nan	Du et al. Cell 183:1013-1023.e13 (2020)	nan	nan
2	COV107	COV107_Plate2_HC_95-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTTACAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAATTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCATTTATTACTGTGCGAGAGACTACGGTGACTTATACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSYNYMSWVRQAPGKGLEWVSIIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAIYYCARDYGDLYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCTCGGACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTRLEIK	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV3-20*01	IGKJ5*01	ARDYGDLYFDY	QQYGSSPRT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
2	CC12	CC12.2	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTTTTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGACTACGGTGACCTCTACTTTGACTACTGGGGCCAGGGAACGCTGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVFYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDLYFDYWGQGTLVTVSS	GAAATAGTGATGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGCCAGAGCGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCCCCCAGGCTCCTCATTTATGGTGTATCCAGTAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGAGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGAGTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCTCGGACGTTCGGCCAAGGGACCAAGCTGGAGATCAAA	EIVMTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGVSSRATGIPDRFSGSGSETDFTLTISRLEPEEFAVYYCQQYGSSPRTFGQGTKLEIK	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV3-20*01	IGKJ1*01	ARDYGDLYFDY	QQYGSSPRT	nan	Rogers et al. Science 369:956-963 (2020)	MT594039.1	MT594072.1
2	Wang-MOD7	MOD7_P1_IgG_H9-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTACATTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGACTACGGTGACTTATACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASTFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDLYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTGGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCTCGAACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVGSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK	IGHV3-66*01	IGHJ4*02	IGHD4-17*01	IGKV3-20*01	IGKJ1*01	ARDYGDLYFDY	QQYGSSPRT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
2	Wang-MOD3	MOD3_P2_IgG_H3-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGAGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGTACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAGTTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGGGATTACGGTGACTGGTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASEFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDSSKNTLYLQMNSLRAEDTAVYYCARDYGDWYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGAGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCTCGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSETDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV3-20*01	IGKJ1*01	ARDYGDWYFDY	QQYGSSPRT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
2	COV096	C211	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGAATTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGACCTGAGGACACGGCTGTGTATTACTGTGCGAGAGACTACGGTGACTTCTACTTTGACTTCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASEFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRPEDTAVYYCARDYGDFYFDFWGQGTLVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGGTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATAATAACTGGCCCCGGACGTTCGGCCAAGGGACCAAGGTGGAGATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQGPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPRTFGQGTKVEIK	IGHV3-66*02	IGHJ4*02	IGHD4-17*01	IGKV3-15*01	IGKJ1*01	ARDYGDFYFDF	QQYNNWPRT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
2	IML3548	ADI-56751	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTATTGTGCGAGAGACTACGGAGAATTCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVQSGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGEFYFDYWGQGTLVTVSS	nan	nan	IGHV3-53*01	IGHJ4*02	IGHD4-17*01,IGHD4-23*01	IGKV3D-15	nan	ARDYGEFYFDY	QQYNNWPRT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457664.1	nan
2	COV107	C101	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCATCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACACAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACTCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGTGCGGGACTACGGTGACTTCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGLIQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCVRDYGDFYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCGGTGGGTCTGAGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTGTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCCCGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGGGSETDFTLTISRLEPEDCAVYYCQQYGSSPRTFGQGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV3-20*01	IGKJ1*01	VRDYGDFYFDY	QQYGSSPRT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
2	COV107	COV107_Plate2_HC_93-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCATCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACACAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACTCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGTGCGGGACTACGGTGACTTCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCVRDYGDFYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCGGTGGGTCTGAGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTGTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCCCGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGGGSETDFTLTISRLEPEDCAVYYCQQYGSSPRTFGQGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV3-20*01	IGKJ1*01	VRDYGDFYFDY	QQYGSSPRT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
2	IML3547	ADI-62923	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGATCACCTTGAAGGAGTCTGGTCCTGTGAAGGTGAAACCCACAGAGACCCTCACGCTGACCTGCACCGTCTCTGGGTTCTCCCTCAGCAATGCTAGAATGGGTGTGAGCTGGATCCGTCAGCCCCCAGGGAAGGCCCTGGAGTGGCTTGCACACATTTTTTCGAATGACCAAAAATCCTATAGCACATCTCTGAAGAGCAGGCTCACCATCTCCAGGGACACCGCCAAAAGCCAAGTGGTCCTTACCATGACCAACATGGACCCTGTGGACACAGCCACATATTTCTGTGCACGGGACTATGGTGACTACTCTCTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QITLKESGPVKVKPTETLTLTCTVSGFSLSNARMGVSWIRQPPGKALEWLAHIFSNDQKSYSTSLKSRLTISRDTAKSQVVLTMTNMDPVDTATYFCARDYGDYSLDYWGQGTLVTVSS	nan	nan	IGHV2-26*01	IGHJ4*02	IGHD4-17*01	IGLV3-1	nan	ARDYGDYSLDY	LAWDSGTVV	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458432.1	nan
2	CV38	HK_CV38-221	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	TCCGCCAAGCCCCGTGTACATTCTGAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGAATCACCGTCAGTAGCAACTACATGATCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAATACGTTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGGTTTTGGCGATTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAGCCTCCACCAAGGGCCCATCGGTCTTCCCCCTGGCACCCTCCTCCAAGAGCACCTCTGGGGCACAGCGGCCGGCGGAA	EVQLVESGGGLVQPGGSLRLSCAASGITVSSNYMIWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGFGDYYFDYWGQGTLVTVSS	CGTCTTTTTTTTTTGCTGTCCTTGCTGTCCCGCTACGCAGGCTTGCGCATGACCATGGGGGCAATTTTTTTTTTACCCCCCCAGGTCAGTCTCCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTTGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTTGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAACGAACTGTGGCTGCACCATCTGTCTTCATCTTCCCGCCATCTGATGAGCAGTTGAAATCTGGAACTGCCTCTGTTGTGTGCCTGCTGAATAACTTCTATCCCAGAGAGGCCAAAGTACAGTGGAAGGTGGATAACGCCCTCCAATCGGGTATTCCCAGAGTGGGG	FFFYPPRSVSLSLSPGERATLSCRASQSVSSSYFAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQLYTFGQGTKLEIK	IGHV3-66*01	IGHJ4*02	IGHD3-3*01,IGHD3-3*02,IGHD3/OR15-3a*01	IGKV3-20*01	IGKJ2*01	ARGFGDYYFDY	QQLYT	nan	Kreye et al. Cell 183:1058-1069 (2020)	MW002783.1	MW002801.1
2	Cho-C012	C2395	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTATCAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGGGTACGGTGACTTGTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSINYMTWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGYGDLYFDYWGQGTLVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACACCTTAGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQHLRTFGQGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV1-9*01	IGKJ1*01	ARGYGDLYFDY	QHLRT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
2	Cho-C012	C2396	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCCGGAGGAGGCTTGATCCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCATCGTCAGTACCAACTACATGATTTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAATTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGATGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGACGACACGGCCGTCTATTATTGTGCGCGAGGGTACGGTGACTTGTACTTTGACTACTGGGGCCAGGGAGCCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFIVSTNYMIWVRQAPGKGLEWVSIIYSGGSTFYADSVMGRFTISRDNSKNTLYLQMNSLRADDTAVYYCARGYGDLYFDYWGQGALVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCTTTGGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATTCTTCATCCACTTCGCAAAGTGGGGTCCCATCAAGATTCAGCGGCAGTGGGTCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAGGATTCTGCAACTTATTACTGTCAACACCTTACGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGFGSYLAWYQQKPGKAPKLLIYSSSTSQSGVPSRFSGSGSGTEFTLTISSLQPEDSATYYCQHLTTFGQGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV1-9*01	IGKJ1*01	ARGYGDLYFDY	QHLTT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
2	CV01	HL_CV01-232	nan	SARS-CoV-2	nan	nan	nan	S:S1	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	CTTCCGCAACCCCCGGTTACATTCTGAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGGCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCTGTGTATTACTGTGCGAGGAAATACGGTGACTTACACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCCTTCTCCTCAGGGAGTCCTTCCGGCCCCACTTTCCC	EVQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARKYGDLHFDYWGQGTLVTLLL	TCTGCTACCCGGGTCCTGGTCCCAGTCTGTGCTGACTCAGGAGCCATCGTTCTCAGTGTCCCCTGGAGGGACAGTCACACTCACTTGTGGCTTGAGCTCTGGCTCAGTCTCTACTAGTTACTACCCCAGCTGGTACCAGCAGACCCCAGGCCAGGCTCCACGCACGCTCATCTACAGCACAAACACTCGCTCTTCTGGGGTCCCTGATCGCTTCTCTGGCTCCATCCTTGGGAACAAAGCTGCCCTCACCATCACGGGGGCCCAGGCAGATGATGAATCTGATTATTACTGTGTGCTGTATATGGGTAGTGGCATTTCGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAGTCAGCCCAAAGCTGCCCCCCCTCCGC	QSVLTQEPSFSVSPGGTVTLTCGLSSGSVSTSYYPSWYQQTPGQAPRTLIYSTNTRSSGVPDRFSGSILGNKAALTITGAQADDESDYYCVLYMGSGISVFGGGTKLTVL	IGHV4-39*01	IGHJ4*02	IGHD4-17*01	IGLV8-61*01	IGLJ3*02	ARKYGDLHFDY	VLYMGSGISV	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
2	Cho-C006	C2481	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGAAATCCTCGTCAGTAGAAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAATTATCTATAGCGGTGGAAGTACATTCTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAGTTCCAAGAACACCCTCTATCTTCAAATGAACAGCCTGAGAACCGAGGACACGGCTGTTTATTACTGTGCGAGATCCTACGGTGACTTCTATATGGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASEILVSRNYMNWVRQAPGKGLEWVSIIYSGGSTFYADSVKGRFTISRDSSKNTLYLQMNSLRTEDTAVYYCARSYGDFYMDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCGACTCAGGCCATTAGCAATTCTTTAGCCTGGTATCAGCAGAAGCCAGGGAAAGCCCCTAAACTCCTGCTCTATGCTGCATCCCGATTGGAAAGTGGGGTCCCATCCAGGTTCAGTGGCAGTGGATCTGGGACGGATTACACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTTCTGTCAACAGTATTATACTACCCCCTCGATCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	DIQMTQSPSSLSASVGDRVTITCRATQAISNSLAWYQQKPGKAPKLLLYAASRLESGVPSRFSGSGSGTDYTLTISSLQPEDFATYFCQQYYTTPSITFGQGTRLEIK	IGHV3-66*01,IGHV3-66*04	IGHJ4*02	IGHD4-17*01	IGKV1-NL1*01	IGKJ5*01	ARSYGDFYMDY	QQYYTTPSIT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
2	Wang-MOD3	C659	MOD3_P1_IgG_C2-P1369	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGTCTCTGGCTTCACCGTCAGTCGCAACTACTTGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGGGGGTCTCAATTATTTATCCCGGTGGTAGCACATTCTACGCAGACTCCCTTAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACTCGGCCGTCTATTACTGTGCGAGATCGTACGGCGATTACTACTTAGATTTCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAVSGFTVSRNYLNWVRQAPGKGLEGVSIIYPGGSTFYADSLKGRFTISRDNSKNTLYLQMNSLRAEDSAVYYCARSYGDYYLDFWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGACTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTATCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCTTCTATGGTGCATCCGGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGCGGGTCTGGGACAGACTTCACTCTCACCATCAACAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCACTATGGTAGAACGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLTPGERATLSCRASQSVSSSYLSWYQQKPGQAPRLLFYGASGRATGIPDRFSGSGSGTDFTLTINRLEPEDFAVYYCQHYGRTWTFGQGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD3-3*01,IGHD4-17*01,IGHD4-23*01	IGKV3-20*01	IGKJ1*01	ARSYGDYYLDF	QHYGRTWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
2	Wang-PFZ10	PZF10_P1_IgG_D11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCATCGTCAGTAGAAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGTACATTCTACACAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAGTTCCAAGAATACATTGTATCTTCACATGAACAGCCTGAGAGGTGAGGACACGGCTGTGTATTACTGTACGAGAATGTACGGTGACCTCTATTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFIVSRNYMSWVRQAPGKGLEWVSVIYSGGSTFYTDSVKGRFTISRDSSKNTLYLHMNSLRGEDTAVYYCTRMYGDLYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGTCGGGCCAGTCAGAGTATTGATAACTGGTTGGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATAAGGTGTCTAGTTTAGAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACCATCAGCAGCCTGCAGCCTGATGATTTTGCAACTTATTACTGCCAGCACTCAATGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSTLSASVGDRVTITCRASQSIDNWLAWYQQKPGKAPKLLIYKVSSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQHSMTFGQGTKVEIK	IGHV3-66*02	IGHJ4*02	IGHD4-17*01	IGKV1-5*03	IGKJ1*01	TRMYGDLYFDY	QHSMT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
2	Wang-PFZ10	PZF10_P1_IgG_A8-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCATCGTCAGTAGTAATTACATGAGCTGGGTCCGCCAGCCTCCAGGGAAGGGTCTGGAGTGGGTCTCAGTTATTTATCCCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCGAAGAACACGCTGTATCATCAAATGAACAGTCTGAGAGCTGAGGACACGGCTGTCTATTACTGTGTGAGAGATTGGGGGGAGTTCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFIVSSNYMSWVRQPPGKGLEWVSVIYPGGSTFYADSVKGRFTISRDNSKNTLYHQMNSLRAEDTAVYYCVRDWGEFYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTTCTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTCCTGTCAGCAGTATGGTACCTCACCTCGGACTTTTGGCCAGGGGACCAAGCTGGAGATCAA	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSFLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYSCQQYGTSPRTFGQGTKLEI	IGHV3-66*02	IGHJ4*02	IGHD3-16*01,IGHD3-16*02	IGKV3-20*01	IGKJ2*01,IGKJ2*02	VRDWGEFYFDY	QQYGTSPRT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
3	Turner-07	Turner-07-2C08	nan	SARS-CoV-2	OC43,HKU1	nan	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTAGTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAACACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCGGCATATTGTAGTGGTGGTAGCTGCTCCGATGGTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVQSGPEVKKPGTSVKVSCKASGFTFSSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTNTAYMELSSLRSEDTAVYYCAAAYCSGGSCSDGFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTGTGCTACATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGGAGACTGGAGCCTGAAGATTTTGCACTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLICATSSRATGIPDRFSGSGSGTDFTLTIRRLEPEDFALYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-15*01	IGKV3-20*01	IGKJ1*01	AAAYCSGGSCSDGFDI	QQYGSSPWT	nan	Turner et al. Nature 596:109-113 (2021)	MW926400.1	MW926423.1
3	COV057	COVD57_P1_HC_E6-1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTATGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCCAATCATTGTAGTGGTGGTAGCTGCTATGATGGTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAMQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAANHCSGGSCYDGFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAGACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGATGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQRPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWMFGQGTKVEIK	IGHV1-58*02	IGHJ3*02	IGHD2-15*01	IGKV3-20*01	IGKJ1*01	AANHCSGGSCYDGFDI	QQYGSSPWM	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
3	Cho-C034	C2066	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	TGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCAAACTATTGTAGTGGTGGTAGCTGCTCTGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAANYCSGGSCSDAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-15*01	IGKV3-20*01	IGKJ1*01	AANYCSGGSCSDAFDI	QQYGSSPWT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
3	COV021	COV021_P1_IgA_43-P1609	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCACCCCATTGTAGTGGTGGTAGCTGCTATGATGGTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPHCSGGSCYDGFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPYTFGQGTKLEIK	IGHV1-58*01	IGHJ3*02	IGHD2-15*01	IGKV3-20*01	IGKJ2*01	AAPHCSGGSCYDGFDI	QQYGSSPYT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW293181.1	MW293636.1
3	IDMnC5	MnC5t2p1_G1	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGTTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAGACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACGTGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCACCCCGCTGTAGTGGTGGTAGCTGCTACGATGGATTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTDYAQKFQERVTITRDVSTSTAYMELSSLRSEDTAVYYCAAPRCSGGSCYDGFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCATAAACCTGGCCAGGCTCCCAGGCTCCTCATCTGTGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGGCTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCCTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQHKPGQAPRLLICGASSRATGIPDRFSGSGSGTGFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-15*01	IGKV3-20*01	IGKJ1*01	AAPRCSGGSCYDGFDI	QQYGSSPWT	nan	Kreer et al. Cell 182:843-854.e12 (2020)	MT658833.1	MT658861.1
3	WangL_pB1	B1-182-1	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTATATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCCCCTTACTGTAGTGGTGGTAGCTGCTTTGATGGTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSGGSCFDGFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCTTCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAACTCACCCTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAGAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGFPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGNSPWTFGQGTKVEI	IGHV1-58*01	IGHJ3*02	IGHD2-15*01	IGKV3-20*01	IGKJ1*01	AAPYCSGGSCFDGFDI	QQYGNSPWT	7MM0,7MLZ	Wang et al. Science 373:eabh1766 (2021)	MZ458529.1	MZ458530.1
3	Wheatley-CP63	PDI_204	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCCTCTGGATTCAACTTTTATTACTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAAGGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGACATCCGAGGACGCGGCCGTCTATTACTGTGCGGCACCCTATTGTAGTGGTGGTAGCTGCCATGATGGTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	QVQLVQSGPEVKKPGTSVKVSCKASGFNFYYSAVQWVRQARGQGLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLTSEDAAVYYCAAPYCSGGSCHDGFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCTCCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGAAGCAACTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGGTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATCACTGTCAGCAGTATGGTAGTTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAA	EIVLTQSPGSLSLSPGERATLSCRASQSVRSNYLAWYQQKPGQAPRVLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYHCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-15*01	IGKV3-20*01	IGKJ1*01	AAPYCSGGSCHDGFDI	QQYGSSPWT	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
3	COV057	C037	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	TGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTATGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCCCCATATTGTAGTGGTGGTAGCTGCAATGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QLVQSGPEVKKPGTSVKVSCKASGFTFTSSAMQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSGGSCNDAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*02	IGHJ3*02	IGHD2-15*01	IGKV3-20*01	IGKJ1*01	AAPYCSGGSCNDAFDI	QQYGSSPWT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
3	COV057	COVD57_P2_HC_H6-1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTATGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCCCCATATTGTAGTGGTGGTAGCTGCAATGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAMQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSGGSCNDAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*02	IGHJ3*02	IGHD2-15*01	IGKV3-20*01	IGKJ1*01	AAPYCSGGSCNDAFDI	QQYGSSPWT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
3	COV107	C125	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCACCTTATTGTAGTGGTGGTAGCTGCTCTGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QVQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSGGSCSDAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-15*01	IGKV3-20*01	IGKJ1*01	AAPYCSGGSCSDAFDI	QQYGSSPWT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
3	COV107	COV107_Plate2_HC_81-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCACCTTATTGTAGTGGTGGTAGCTGCTCTGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSGGSCSDAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-15*01	IGKV3-20*01	IGKJ1*01	AAPYCSGGSCSDAFDI	QQYGSSPWT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
3	Wang-MOD8	MOD8_P1_IgG_C7-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCCCCCTATTGTAGTGGTGGTAGCTGCTACGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSGGSCYDAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-15*01	IGKV3-20*01	IGKJ1*01	AAPYCSGGSCYDAFDI	QQYGSSPWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
3	Wang-MOD8	MOD8_P1_IgG_E3-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCCCCCTATTGTAGTGGTGGTAGCTGCTACGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSGGSCYDAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-15*01	IGKV3-20*01	IGKJ1*01	AAPYCSGGSCYDAFDI	QQYGSSPWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
3	Wang-MOD8	MOD8_P1_IgG_F5-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCCCCCTATTGTAGTGGTGGTAGCTGCTACGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSGGSCYDAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-15*01	IGKV3-20*01	IGKJ1*01	AAPYCSGGSCYDAFDI	QQYGSSPWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
3	COV021	C043	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	TGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTTATAACTCTGCTGTGCAATGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGGTAGGATGGATCGTCGTTGGCAGTGGTAACACAGACTACGCACAGAAGTTCCAGGAAAGAGTCACCATGACCAGGGACTTGTCCACAAACACAGCCTACATGGAGGTGAACAGCCTGAGATCCGAGGACACGGCCGTCTATTACTGTGCGGCCCCTTATTGTAGTGGTGGTACCTGCTTAGATGGTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QLVQSGPEVKKPGTSVKVSCKASGFTFYNSAVQWVRQARGQRLEWVGWIVVGSGNTDYAQKFQERVTMTRDLSTNTAYMEVNSLRSEDTAVYYCAAPYCSGGTCLDGFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGGCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGAAGCAACTACTTAGCCTGGTATAAGCAGAGACCTGGCCAGGCTCCCAGGCTCCTCGTCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGTTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERGTLSCRASQSVRSNYLAWYKQRPGQAPRLLVYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-15*01	IGKV3-20*01	IGKJ1*01	AAPYCSGGTCLDGFDI	QQYGSSPWT	nan	Gaebler et al. Nature 591:639-644 (2021)	nan	nan
3	Veesler_S2E	S2E12	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVQSGPEVKKPGTSVRVSCKASGFTFTSSAVQWVRQARGQRLEWVGWIVVGSGNTNYAQKFHERVTITRDMSTSTAYMELSSLRSEDTAVYYCASPYCSGGSCSDGFDIWGQGTMVTVSS	nan	DIVLTQTPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYVGLTGWTFGQGTKVEIK	IGHV1-58*01	IGHJ3	IGHD2-15	IGKV3-20*01	IGKJ1	ASPYCSGGSCSDGFDI	QQYVGLTGWT	7K4N,7K45,7K3Q,7R6X	Tortorici et al. Science 370:950-957 (2020)	nan	nan
3	Bullen_Pool	ION-312	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 S1/RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV1-58	IGHJ3	nan	nan	nan	AAPDCSSTSCYDAFDI	nan	nan	Bullen et al. Front Immunol. 12:678570 (2021)	nan	nan
3	Dejnirattisai_Cell_Patients	COVOX-253	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVQSGPEVKKPGTSVKVSCKASGFTFTTSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTTTAYMELSSLRSEDTAVYFCAAPHCNSTSCYDAFDIWGQGTMVTVSS	nan	DIQMTQSPGTLSLSPGEGATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSGATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPYTFGQGTKVEIK	IGHV1-58*01	IGHJ3	nan	IGKV3-20*01	IGKJ1	AAPHCNSTSCYDAFDI	QQYGSSPYT	7BEN	Dejnirattisai et al. Cell 184:2183-2200.e22 (2021)	nan	nan
3	Dejnirattisai_Cell_Patients	COVOX-253H165L	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVQSGPEVKKPGTSVKVSCKASGFTFTTSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTTTAYMELSSLRSEDTAVYFCAAPHCNSTSCYDAFDIWGQGTMVTVSS	nan	DIVMTQSPGTLSLSPGERATLSCRASQSVRSSYLAWYQQKPGQAPRLLIYGASRRGTGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3	nan	IGKV3-20*01	IGKJ1	AAPHCNSTSCYDAFDI	QQYGSSPWT	7NDB	Dejnirattisai et al. Cell 184:2183-2200.e22 (2021)	nan	nan
3	Dejnirattisai_Cell_Patients	COVOX-253H55L	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVQSGPEVKKPGTSVKVSCKASGFTFTTSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTTTAYMELSSLRSEDTAVYFCAAPHCNSTSCYDAFDIWGQGTMVTVSS	nan	DIQMTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFGVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3	nan	IGKV3-20*01	IGKJ1	AAPHCNSTSCYDAFDI	QQYGSSPWT	7BEO,7ND9,7NDA	Dejnirattisai et al. Cell 184:2183-2200.e22 (2021)	nan	nan
3	COV021	COVD21_P1_HC_F10-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCACCCCATTGTAGTGGTGGTAGCTGCTATGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPHCSGGSCYDAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGTCTCCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPVSLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-15*01	IGKV3-20*01	IGKJ1*01	AAPHCSGGSCYDAFDI	QQYGSSPWT	nan	Robbiani et al. Nature 584:437-442 (2020)	MW292877.1	MW293332.1
3	COV021	COV021_P1_IgA_41-P1609	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCACCCCATTGTAGTGGTGGTAGCTGCTATGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPHCSGGSCYDAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-15*01	IGKV3-20*01	IGKJ1*01	AAPHCSGGSCYDAFDI	QQYGSSPWT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292872.1	MW293327.1
3	COV021	COV021_P1_IgA_47-P1609	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCACCCCATTGTAGTGGTGGTAGCTGCTATGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPHCSGGSCYDAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-15*01	IGKV3-20*01	IGKJ1*01	AAPHCSGGSCYDAFDI	QQYGSSPWT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292873.1	MW293328.1
3	COV021	COV021_P1_IgA_49-P1609	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCACCCCATTGTAGTGGTGGTAGCTGCTATGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPHCSGGSCYDAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-15*01	IGKV3-20*01	IGKJ1*01	AAPHCSGGSCYDAFDI	QQYGSSPWT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292874.1	MW293329.1
3	COV021	COV021_P1_IgA_83-P1609	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCACCCCATTGTAGTGGTGGTAGCTGCTATGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPHCSGGSCYDAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-15*01	IGKV3-20*01	IGKJ1*01	AAPHCSGGSCYDAFDI	QQYGSSPWT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292876.1	MW293331.1
3	COV021	COV021_P2_IgA_76-P1609	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCACCCCATTGTAGTGGTGGTAGCTGCTATGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPHCSGGSCYDAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-15*01	IGKV3-20*01	IGKJ1*01	AAPHCSGGSCYDAFDI	QQYGSSPWT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292878.1	MW293333.1
3	COV021	COV021_P2_IgA_92-P1609	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCACCCCATTGTAGTGGTGGTAGCTGCTATGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPHCSGGSCYDAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-15*01	IGKV3-20*01	IGKJ1*01	AAPHCSGGSCYDAFDI	QQYGSSPWT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292879.1	MW293334.1
3	COV021	Wang-C387	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCACCCCATTGTAGTGGTGGTAGCTGCTATGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QVQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPHCSGGSCYDAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-15*01	IGKV3-20*01	IGKJ1*01	AAPHCSGGSCYDAFDI	QQYGSSPWT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	nan	nan
3	COV021	Wang-C388	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCACCCCATTGTAGTGGTGGTAGCTGCTATGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QVQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPHCSGGSCYDAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-15*01	IGKV3-20*01	IGKJ1*01	AAPHCSGGSCYDAFDI	QQYGSSPWT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	nan	nan
3	COV021	Wang-C450	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCACCCCATTGTAGTGGTGGTAGCTGCTATGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QVQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPHCSGGSCYDAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPYTFGQGTKLEIK	IGHV1-58*01	IGHJ3*02	IGHD2-15*01	IGKV3-20*01	IGKJ2*01	AAPHCSGGSCYDAFDI	QQYGSSPYT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	nan	nan
3	IDHbnC	HbnC3t1p1_C6	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAATTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCACCTCATTGTAGTAGTACCATCTGTTATGATGGTTTTGATATTTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPHCSSTICYDGFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGAGTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRVEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-20*01	IGKJ1*01	AAPHCSSTICYDGFDI	QQYGSSPWT	nan	Kreer et al. Cell 182:843-854.e12 (2020)	MT658816.1	MT658844.1
3	COV107	COV107_Plate1_HC_53-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGTACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCCCCACATTGTAGTAGTACCAGCTGCTTCGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYVQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPHCSSTSCFDAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAACTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGNSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-20*01	IGKJ1*01	AAPHCSSTSCFDAFDI	QQYGNSPWT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
3	Bullen_Pool	ION-1000	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 S1/RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV1-58	IGHJ3	nan	nan	nan	AAPHCSSTSCNDAFDI	nan	nan	Bullen et al. Front Immunol. 12:678570 (2021)	nan	nan
3	Crowe_mix	COV2-2381	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGCCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCAGCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTATTGTGCGGCCCCTTATTGTAGTAGAACCAGCTGCCATGATGCTTTTGATATCTGGGGCCAAGGGACAAAGGTCACCGTCTCTTCA	QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIAVGSGNTNYAQKFQERVSITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSRTSCHDAFDIWGQGTKVTVSS	GAAGTTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATCACTGTCAGCACTTTGGTAGCTCATCTCAGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAA	EVVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYHCQHFGSSSQWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-20*01	IGKJ1*01	AAPYCSRTSCHDAFDI	QHFGSSSQWT	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665422.1	MT665035.1
3	CV07	HK_CV07-287	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	TCTGCAACCGGTGTACATTCCGAGGTGCAGCTGGTGGAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTATGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCACCCTATTGTAGTAGTACCAACTGCTATGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAGCCTCCACCAAGGGCCCATCGGTCTTCCCCCTGGCACCCTCCTCCAAGAGCACCTCTGGGGCACAGGCGACCTTGGCCTTCTT	EVQLVESGPEVKKPGTSVKVSCKASGFTFTSSAMQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSSTNCYDAFDIWGQGTMVTVSS	TTTTTTTGGACCCCAAGTCTCCATTCTCCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAACGAACTGTGGCTGCACCATCTGTCTTCATCTTCCCGCCATCTGATGAGCAGTTGAAATCTGGAACTGCCTCTGTTGTGTGCCTGCTGAATAACTTCTATCCCAGAGAGGCCAAAGTACAGTGGAAGGTGGATAACGCCCTCCAATCGGTATTCCCCGGGATGGGGTTGCCGGGGTTTCCGGG	FLDPKSPFSLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*02	IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-20*01	IGKJ1*01	AAPYCSSTNCYDAFDI	QQYGSSPWT	nan	Kreye et al. Cell 183:1058-1069 (2020)	MW002778.1	MW002796.1
3	IDHbnC	HbnC3t1p2_C6	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTAGTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATCGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGGAAGAGTCACCATTACCAGGGACATGTCCACACGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCATGTATTACTGTGCGGCACCCTATTGTAGTAGTACCAGGTGCTATGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QMQLVQSGPEVKKPGTSVKVSCKASGFTFSSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQGRVTITRDMSTRTAYMELSSLRSEDTAMYYCAAPYCSSTRCYDAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGGTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAA	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGRSPWTFGQGTKVEI	IGHV1-58*01	IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-20*01	IGKJ1*01	AAPYCSSTRCYDAFDI	QQYGRSPWT	nan	Kreer et al. Cell 182:843-854.e12 (2020)	MT658820.1	MT658848.1
3	Tong_G32	G32A4	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike (and spike minus RBD)	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGANCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCACCATATTGTAGTAGTACCAGCTGCCATGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	QVQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELXSLRSEDTAVYYCAAPYCSSTSCHDAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCCTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAA	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-20*01	IGKJ1*01	AAPYCSSTSCHDAFDI	QQYGSSPWT	nan	Tong et al. Cell 184:4969-4980.e15 (2021)	MW718404.1	MW718556.1
3	Wang-MOD11	Mod11_P1_IgG_D1-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAATACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCGCCATATTGTAGTAGTACCAGCTGCCATGATGGTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTNTAYMELSSLRSEDTAVYYCAAPYCSSTSCHDGFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-20*01	IGKJ1*01	AAPYCSSTSCHDGFDI	QQYGSSPWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
3	Aishun_Jin_mix	13G9	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	QMQLVQSGPEVKKPGTSVKVSCKASGFTFSGSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQRFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSSTSCRDGFDIWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKV	nan	EIVLTQSPGTLSLSPGERATLSCRASQSVRSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGRSPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC	IGHV1-58*01	IGHJ3*02	IGHD2-2*01	IGKV3-20*01	IGKJ1*01	AAPYCSSTSCRDGFDI	QQYGRSPWT	7E3K	Han et al. Front Immunol. 12:653189 (2021);Li et al. bioRxiv. DOI: 10.1101/2021.04.19.440481	nan	nan
3	Aishun_Jin_mix	CQTS004	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	QMQLVQSGPEVKKPGTSVKVSCKASGFTFSGSAVQWVRQARGQRLEWIGWIVVGSGDTDYAQRFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSSTSCRDGFDIWGQGTMVTVSS	nan	EIVLTQSPGTLSLSPGERATLSCRASQSVRSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGRSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3	nan	IGKV3-20*01	IGKJ1	AAPYCSSTSCRDGFDI	QQYGRSPWT	nan	Patent: CN111909263A	nan	nan
3	COV072	C597	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAACTCTGCTGTGCAGTGGGTGCGACAGTCTCGTAGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCAGTGGATTGTAATAGTACCAGCTGCTATGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QVQLVQSGPEVKKPGTSVKVSCKASGFTFTNSAVQWVRQSRRQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAVDCNSTSCYDAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTTTTAGGAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGTCAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGATATCTCACCTTGGACGTTCGGCCAGGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSFRSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGSDFTLTISRLEPEDFAVYYCQQYDISPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-20*01	IGKJ1*01	AAVDCNSTSCYDAFDI	QQYDISPWT	nan	Gaebler et al. Nature 591:639-644 (2021)	nan	nan
3	COV072	COV072_P3_HC_42-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAACTCTGCTGTGCAGTGGGTGCGACAGTCTCGTAGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCAGTGGATTGTAATAGTACCAGCTGCTATGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QMQLVQSGPEVKKPGTSVKVSCKASGFTFTNSAVQWVRQSRRQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAVDCNSTSCYDAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTTTTAGGAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGTCAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGATATCTCACCTTGGACGTTCGGCCAGGGGACCAAGGTGGAGATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSFRSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGSDFTLTISRLEPEDFAVYYCQQYDISPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-20*01	IGKJ1*01	AAVDCNSTSCYDAFDI	QQYDISPWT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
3	Wheatley-CP63	PDI_310	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGGTTCACCTACACTACCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGCTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAGGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTATATTACTGTGCGGCACCTGGTTGTAATACAACCATCTGCCCTGATGGTTTTGATATCTGGGGCCGAGGAACAATGGTCACCGTCTCTTCA	QVQLVQSGPEVKKPGTSVKVSCKASGFTYTTSAVQWVRQARGQRLEWIGWIVAGSGNTNYAQKFQERVTITRDMSTGTAYMELSSLRSEDTAVYYCAAPGCNTTICPDGFDIWGRGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCAGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGTTACTTAGCCTGGTATCAGCAGAAACCTGGCCAGGCTCCCAGGGTCCTTGTATATGGTGCATCCAGCAGGGCCAGGGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCTCCATCAGCAGAAGGGAGCGGGAAGATTGTGCAGTGTATTACTGTCAGCAGTATGGTAGCTTACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAGA	EIVLTQSPGTQSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRVLVYGASSRARGIPDRFSGSGSGTDFTLSISRREREDCAVYYCQQYGSLPWTFGQGTKVEI	IGHV1-58*01	IGHJ3*02	IGHD2/OR15-2a*01,IGHD2/OR15-2b*01	IGKV3-20*01	IGKJ1*01	AAPGCNTTICPDGFDI	QQYGSLPWT	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
3	Wheatley-CP63	PDI_306	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	AAAATTCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTACCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGCCGTTGGCAGTGGTAACACAGAGTACGAACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAACAGCCTGAAATCCGAGGACACGGCCGTGTATTACTGTGCGGCCCCCTATTGTAATACTACCAGCTGCGATGATGGTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	KIQLVQSGPEVKKPGTSVKVSCKASGFTFTTSAVQWVRQARGQRLEWIGWIAVGSGNTEYEQKFQERVTITRDMSTSTAYMELNSLKSEDTAVYYCAAPYCNTTSCDDGFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGAAGCAACTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGGTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATCACTGTCAGCAGTATGGTAGTTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAA	EIVLTQSPGTLSLSPGERATLSCRASQSVRSNYLAWYQQKPGQAPRVLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYHCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-20*01	IGKJ1*01	AAPYCNTTSCDDGFDI	QQYGSSPWT	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
3	Crowe_mix	COV2-2072	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTAAAAGTCTCCTGCAAGACTTCTGGATTCACCTTTACTAGCTCTGCTATACAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATTGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCTCCCCATTGTAATAGGACCAGCTGCTATGATGCTTTTGATCTCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	QMQLVQSGPEVKKPGTSVKVSCKTSGFTFTSSAIQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPHCNRTSCYDAFDLWGQGTMVTVSS	GAAATTGTGTTGACACAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGGCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAA	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLGWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*02	IGHJ3*01,IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-20*01	IGKJ1*01	AAPHCNRTSCYDAFDL	QQYGSSPWT	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665419.1	MT665032.1
3	Crowe_mix	COV2-2355	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTAAAAGTCTCCTGCAAGACTTCTGGATTCACCTTTACTAGCTCTGCTATACAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATTGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCTCCCCATTGTAATAGGACCAGCTGCTATGATGCTTTTGATCTCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	QMQLVQSGPEVKKPGTSVKVSCKTSGFTFTSSAIQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPHCNRTSCYDAFDLWGQGTMVTVSS	GAAATTGTGTTGACACAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGGCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAA	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLGWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*02	IGHJ3*01,IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-20*01	IGKJ1*01	AAPHCNRTSCYDAFDL	QQYGSSPWT	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665528.1	MT665141.1
3	Crowe_mix	COV2-2684	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTAAAAGTCTCCTGCAAGACTTCTGGATTCACCTTTACTAGCTCTGCTATACAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATTGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCTCCCCATTGTAATAGGACCAGCTGCTATGATGCTTTTGATCTCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	QMQLVQSGPEVKKPGTSVKVSCKTSGFTFTSSAIQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPHCNRTSCYDAFDLWGQGTMVTVSS	GAAATTGTGTTGACACAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGGCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGTCTGAAGATTTTGCACTTTATTACTGTCAGCAGTATAATAACTGGTGGCGCACGTTCGGCCAAGGGACCAAGGTGGAAATCAAA	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLGWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLESEDFALYYCQQYNNWWRTFGQGTKVEIK	IGHV1-58*02	IGHJ3*01,IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-20*01	IGKJ1*01	AAPHCNRTSCYDAFDL	QQYNNWWRT	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665481.1	MT665094.1
3	COV021	C005	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCTCCCCATTGTAGCGGTGGTAGCTGCCTTGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QVQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPHCSGGSCLDAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGAAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVRSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-15*01	IGKV3-20*01	IGKJ1*01	AAPHCSGGSCLDAFDI	QQYGSSPWT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
3	COV021	COVD21_P2_HC_F9-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCTCCCCATTGTAGCGGTGGTAGCTGCCTTGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPHCSGGSCLDAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGAAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVRSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-15*01	IGKV3-20*01	IGKJ1*01	AAPHCSGGSCLDAFDI	QQYGSSPWT	nan	Robbiani et al. Nature 584:437-442 (2020)	MW292875.1	MW293330.1
3	Xie_mix	BD-836	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVQSGPEVKKPGTSVRVSCKASGFTFSTSAVQWVRQARGQRLEWIGWIAVGSGKTDYLQKFQERVTMTRDESTNTAYMQLSSLRSEDTAVYYCAAPHCSGGTCYDGFDIWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDK	nan	EIVLTQSPGTLSLSPGERATLSCRASQSVRSGYFAWYQQRPGRAPRLLIYGASSRATAIPDRFSGSGSGTDFTLTINRLEPEDFAVYYCQQYGTSPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC	IGHV1-58*01	nan	nan	IGKV3-20*01	nan	AAPHCSGGTCYDGFDI	QQYGTSPWT	7EZV	Du et al. Cell 183:1013-1023.e13 (2020)	nan	nan
3	PT28	28F1	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV1-58	nan	nan	IGKV3-20	nan	AAPYCSGGTCYDAFDI	QQFGTSPWT	nan	Zhou et al. Cell Rep. 35:109109 (2021)	nan	nan
3	WangL_pA23	A23-58-1	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCACCGAATTGTAGTAATGTTGTATGCTATGATGGTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPNCSNVVCYDGFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATAGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTTCTGTCAGCAGTATGGTACCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYSASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYFCQQYGTSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-8*01	IGKV3-20*01	IGKJ1*01	AAPNCSNVVCYDGFDI	QQYGTSPWT	7LRT,7LRS	Wang et al. Science 373:eabh1766 (2021)	MZ458527.1	MZ458528.1
3	Wang-MOD3	MOD3_P2_IgG_B6-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAATACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTTTATTACTGTGCGGCCCCATATTGTAGTAATGGTGTATGCCATGATGGTTTTGATATTTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSNGVCHDGFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTCGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCCTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVRSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-8*01	IGKV3-20*01	IGKJ1*01	AAPYCSNGVCHDGFDI	QQYGSSPWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
3	Graham_P008	P008_081	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTATGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCCCCCAATTGTAGTAGAACCAGCTGCCAAGATGGTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCCTCAG	EVQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAMQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPNCSRTSCQDGFDIWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCCACTTAGCCTGGTATCAGCAGAAATCTGGCCAGGCTCCCAGGCTCTTCATTTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQLTQSPGTLSLSPGERATLSCRASQSVSSSHLAWYQQKSGQAPRLFIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPPWTFGQGTKVEIK	IGHV1-58*02	IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-20*01	IGKJ1*01	AAPNCSRTSCQDGFDI	QQYGSSPPWT	nan	Graham et al. Immunity 54:1276-1289.e6 (2021)	MW802451.1	MW802344.1
3	PT28	28G5	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV1-58	nan	nan	IGKV3-20	nan	AAPSCRGVTCYDGFNI	QQYDNSPWT	nan	Zhou et al. Cell Rep. 35:109109 (2021)	nan	nan
3	Wang-C004	C004_P1_IgG_C6-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGCATTCACCTTCACTAGTTCTGCTGTGCAGTGGGTGCGTCAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAGACTCCGCACAGAAGTTCCAGGACAGAGTCACCCTTTCCAGGGACACGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCCCCATATTGTAGTGGTGGTACTTGCTATGATGGTTTTAATATATGGGGCCAAGGGACAATGGTCACCGTCTCATCAG	QMQLVQSGPEVKKPGTSVKVSCKASAFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTDSAQKFQDRVTLSRDTSTSTAYMELSSLRSEDTAVYYCAAPYCSGGTCYDGFNIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGGAGCAGTTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGGTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAACAATATGATAGGTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVRSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRVSGSGSGTDFTLTISRLEPEDFAVYYCQQYDRSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-15*01	IGKV3-20*01	IGKJ1*01	AAPYCSGGTCYDGFNI	QQYDRSPWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
3	Jennewein_CV3	CV3-1_	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCCCCTGCAAGGCTTCTGGATTCACCTTTACCAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCCCCGTCCTGTAGTGGTGGTAGGTGCTACGATGGTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	EVQLVESGPEVKKPGTSVKVPCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPSCSGGRCYDGFDIWGQGTMVTVSS	GACATCGTGATGACCCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTACCTCACCCTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAACGAACTGTGGCTGCACCATCTGTCTTCATCTTCCCGCCATCTGATGAGCAGTTGAAATCCGGAACTGCCTCTGTTGTGTGCCTGCTGAATAACTTCTATCCCAGAGAGGCCAAAGTACAGTGGAAGGTGGATAACGCCCTCCAATCGGGTAACTCCCAGGAGAGTGTCACAGAGCNNACAGCAAGGACAGCACCTA	DIVMTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGTSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-15*01	IGKV3-20*01	IGKJ1*01	AAPSCSGGRCYDGFDI	QQYGTSPWT	nan	Jennewein et al. Cell Rep. 36:109353 (2021)	MW681558.1	MW681586.1
3	Wheatley-CP63	PDI_291	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTCTCTCTGCTGTGCAGTGGGTGCGACTGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCCCTGGGAGTGGTAACGTAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATCACCAGGGACATGTCCACAAACACAGACTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCACCATATTGTAATAAGACCAGGTGCTCCGATGGTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	QVQLVQSGPEVKKPGTSVKVSCKASGFTFTLSAVQWVRLARGQRLEWIGWIVPGSGNVNYAQKFQERVTITRDMSTNTDYMELSSLRSEDTAVYYCAAPYCNKTRCSDGFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCTCCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCTCTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACTCTTCACTTTCGGCCCTGGGACCAAAGTAGATATCAAA	EIVLTQSPGSLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRASGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSLFTFGPGTKVDIK	IGHV1-58*01	IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-20*01	IGKJ3*01	AAPYCNKTRCSDGFDI	QQYGSSLFT	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
3	Graham_P008	P008_086	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTATGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGAAACACACACTACGCACAGAAGTTTCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGCGATCCGAGGACACGGCCGTGTACTACTGTGCGGCGCCCTATTGTACTACTACCAGATGTCATGATGGTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCCTCAG	QVQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAMQWVRQARGQRLEWIGWIVVGSGNTHYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCTTTRCHDGFDIWGQGTMVTVSS	GATGTTGTGATGACTCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGAAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGTTTATTATTCACTTTCGGCCCTGGGACCAAGCTGGAGATCAAAC	DVVMTQSPGTLSLSPGERATLSCRASQSVSRSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSLLFTFGPGTKLEIK	IGHV1-58*02	IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-20*01	IGKJ3*01	AAPYCTTTRCHDGFDI	QQYGSLLFT	nan	Graham et al. Immunity 54:1276-1289.e6 (2021)	MW802455.1	MW802348.1
3	Crowe_mix	COV2-2808	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTGGTGCAATCAGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTATGAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCATTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCCCCATATTGTAGTAGTATCAGCTGCAATGATGGTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCT	QVQLVQSGAEVKKPGSSVKVSCKASGFTFMSSAVQWVRQARGQRLEWIGWIVIGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSSISCNDGFDIWGQGTMVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAACTATTTAAATTGGTATCAGCAGAAACCGGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGATGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCTCTGGCTTTCGGCCCTGGGACCAAAGTGGATATCAAA	DIQMTQSPSSLSASVGDRVTITCRASQSISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPDDIATYYCQQYDNLPLAFGPGTKVDIK	IGHV1-58*01	IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV1-33*01,IGKV1D-33*01	IGKJ3*01	AAPYCSSISCNDGFDI	QQYDNLPLA	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665547.1	MT665160.1
3	Crowe_mix	COV2-2838	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTATGAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCATTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCCCCATATTGTAGTAGTATCAGCTGCAATGATGGTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	QMQLVQSGPEVKKPGTSVKVSCKASGFTFMSSAVQWVRQARGQRLEWIGWIVIGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSSISCNDGFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAGAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCACTATGGTAGCTCACGGGGTTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAA	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHYGSSRGWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-20*01	IGKJ1*01	AAPYCSSISCNDGFDI	QHYGSSRGWT	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665525.1	MT665138.1
3	Crowe_mix	COV2-2941	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTATGAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCATTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCCCCATATTGTAGTAGTATCAGCTGCAATGATGGTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	QMQLVQSGPEVKKPGTSVKVSCKASGFTFMSSAVQWVRQARGQRLEWIGWIVIGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSSISCNDGFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAGAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCTCCGAGGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAA	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPPRYTFGQGTKLEIK	IGHV1-58*01	IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-20*01	IGKJ2*01	AAPYCSSISCNDGFDI	QQYGSSPPRYT	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665508.1	MT665121.1
3	Crowe_mix	COV2-2961	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTATGAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCATTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCCCCATATTGTAGTAGTATCAGCTGCAATGATGGTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	QMQLVQSGPEVKKPGTSVKVSCKASGFTFMSSAVQWVRQARGQRLEWIGWIVIGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSSISCNDGFDIWGQGTMVTVSS	GAAACTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAGAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCACTATGGTAGCTCACGGGGTTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAA	ETVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHYGSSRGWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-20*01	IGKJ1*01	AAPYCSSISCNDGFDI	QHYGSSRGWT	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665459.1	MT665072.1
3	Crowe_mix	COV2-3025	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTATGAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCATTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCCCCATATTGTAGTAGTATCAGCTGCAATGATGGTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	EVQLVQSGPEVKKPGTSVKVSCKASGFTFMSSAVQWVRQARGQRLEWIGWIVIGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSSISCNDGFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAGAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCACTATGGTAGCTCACGGGGTTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAA	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHYGSSRGWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-20*01	IGKJ1*01	AAPYCSSISCNDGFDI	QHYGSSRGWT	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665421.1	MT665034.1
3	Crowe_mix	COV2-2196	AZD8895	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTATGAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCATTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCCCCATATTGTAGTAGTATCAGCTGCAATGATGGTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	QMQLVQSGPEVKKPGTSVKVSCKASGFTFMSSAVQWVRQARGQRLEWIGWIVIGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSSISCNDGFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAGAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCACTATGGTAGCTCACGGGGTTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAA	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHYGSSRGWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-20*01	IGKJ1*01	AAPYCSSISCNDGFDI	QHYGSSRGWT	7L7E,7L7D	Zost et al. Nat. Med. 26:1422-1427 (2020);Dong et al. Nat. Microb. 6:1233-1244 (2021)	MT763531.1	MT763532.1
3	Adreano-PT100	I14	nan	SARS-CoV-2	SARS-CoV,MERS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTATGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAGACTACGTGCAGAAGTTCCAAGGAAGAGTCACCATTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCACCATATTGTAGTAGTACCACCTGCCATGATGGCTTTGATATTTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAGCCTCC	QVQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAMQWVRQARGQRLEWIGWIVVGSGNTDYVQKFQGRVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSSTTCHDGFDIWGQGTMVTVSS	GAAATTGTGATGACGCAGTCTCCAGGCACCCTGTCTTTGGCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGGCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGGTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAACGAACT	EIVMTQSPGTLSLAPGERATLSCRASQSVSSSYLGWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGRSPWTFGQGTKVEIK	IGHV1-58*02	IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-20*01	IGKJ1*01	AAPYCSSTTCHDGFDI	QQYGRSPWT	nan	Andreano et al. Cell 184:1821-1835.e16 (2021)	MW598289.1	MW598290.1
3	Wheatley-CP63	PDI_290	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGCGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTGATCTCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGCCGTTGGCAGTGGGAACACAGATTACGCACAGAAGTTCCAGGAAAGAGTCACCCTTACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGAGGACACGGCCGTATATTACTGTGCGGCCCCATATTGTTATAGTACCAGCTGTGCCGATGGTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	QVQLAQSGPEVKKPGTSVKVSCKASGFTFDLSAVQWVRQARGQRLEWIGWIAVGSGNTDYAQKFQERVTLTRDMSTSTAYMELSSLRSEDTAVYYCAAPYCYSTSCADGFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTTTCCATTCTCCCTGTCTCTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGAAGCGGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCGATGGAACATCCAGCAGGGCCACTGGCATCCCAGACAGGATCAGTGGCAGTGGGTTTGGGACACACTTCACTCTCACCATCAGCAGAGTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAA	EIVLTQFPFSLSLSPGERATLSCRASQSVRSGYLAWYQQKPGQAPRLLIDGTSSRATGIPDRISGSGFGTHFTLTISRVEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-20*01	IGKJ1*01	AAPYCYSTSCADGFDI	QQYGSSPWT	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
3	COV072	C501	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCCGGATTCACCTTTGGCAGTTCTGCTGTTCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAGATTACGCACAGAGGTTTCAGGAAAGAGTCACCATCACCAGGGACATGTCCACAAACACAGTCTACATGGAGCTGAGCAGCCTGAGATTCGAGGACACGGCCGTGTATTACTGTGCGGCAGTGTATTGTAGTGGGACCACCTGCCATGATGCATTTGACATCTGGGGCCGGGGGACAATGGTCACCGTCTCTTCAG	QVQLVQSGPEVKKPGTSVKVSCKASGFTFGSSAVQWVRQARGQRLEWIGWIVVGSGNTDYAQRFQERVTITRDMSTNTVYMELSSLRFEDTAVYYCAAVYCSGTTCHDAFDIWGRGTMVTVSS	GACATCCAGATGACCCAGTCTCCATGCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGACTCAGGACATTAGGAAGTATTTAAATTGGTTTCGGCGGAAACTAGAGAAAGCCCCTAAACTCCTGATCTACGATGCATCCACTTTGGATACAAGAGTCCCATCCAGGTTCAGTGGGAATAGATCTGCGACAGATTTTACTTTCACCATCTGCAGCCTGCAGCCTGAAGATAATGCAAGATATTCCTGTCAACAGTCTGACACTCTCCCTCCCCTTGGTGGCGACACACCGGACACTTTTGGCCACGGGACCAAGCTGGAGATCAAAC	DIQMTQSPCSLSASVGDRVTITCQATQDIRKYLNWFRRKLEKAPKLLIYDASTLDTRVPSRFSGNRSATDFTFTICSLQPEDNARYSCQQSDTLPPLGGDTPDTFGHGTKLEIK	IGHV1-58*01	IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV1-33*01,IGKV1D-33*01	IGKJ2*01	AAVYCSGTTCHDAFDI	QQSDTLPPLGGDTPDT	nan	Gaebler et al. Nature 591:639-644 (2021)	nan	nan
3	Wang-C004	C004_P2_IgG_E3-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTAGTAGTTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAGACTACGCACAGAAGTTCCAGGAAAGAGTCACCATGACCAGGGACATGTCCACAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCCGACGACACGGCCGTATATTACTGTGCGGCACCTGACTGTAATAGGACCACCTGCCGCGATGGTTTTGATATCTGGGGCCAAGGGACAAGGGTCACCGTCTCTTCAG	QMQLVQSGPEVKKPGTSVKVSCKASGFTFSSSAVQWVRQARGQRLEWIGWIVVGSGNTDYAQKFQERVTMTRDMSTSTAYMELSSLRSDDTAVYYCAAPDCNRTTCRDGFDIWGQGTRVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGAAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCAACCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTATATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSRSYLAWYQQKPGQAPRLLIYGATSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2/OR15-2a*01,IGHD2/OR15-2b*01	IGKV3-20*01	IGKJ1*01	AAPDCNRTTCRDGFDI	QQYGSSPWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
3	Wang-C004	C004_P1_IgG_G10-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAAATGCAGCTGGTGCAGTCTGGGCCTGAGATGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTGCTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGCACAAGGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGGAACACAAACTACGCACAGAAGTTTCAGGAAAGAGTCACCATTTCCAGGGACATGTCCACAAACACAGCCTACATGGAGCTGAGCAGCCTGGGATCCGAGGACACGGCCGTGTATTACTGTGCGGCACCACATTGTAACAGAACCAGCTGCTTTGATGGTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QMQLVQSGPEMKKPGTSVKVSCKASGFTFASSAVQWVRQARAQGLEWIGWIVVGSGNTNYAQKFQERVTISRDMSTNTAYMELSSLGSEDTAVYYCAAPHCNRTSCFDGFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAGGAGCCACCCTCTCCTGCAGGGCCAGTCAGACTGTTAGAAGCAGCTACTTAGGCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCCTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGEGATLSCRASQTVRSSYLGWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-20*01	IGKJ1*01	AAPHCNRTSCFDGFDI	QQYGSSPWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
3	Wang-C004	C827	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGCAGTCTGGGCCTGAGATGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTGCTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGCACAAGGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGGAACACAAACTACGCACAGAAGTTTCAGGAAAGAGTCACCATTTCCAGGGACATGTCCACAAACACAGCCTACATGGAGCTGAGCAGCCTGGGATCCGAGGACACGGCCGTGTATTACTGTGCGGCACCACATTGTAACAGAACCAGCTGCTTTGATGGTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QVQLVQSGPEMKKPGTSVKVSCKASGFTFASSAVQWVRQARAQGLEWIGWIVVGSGNTNYAQKFQERVTISRDMSTNTAYMELSSLGSEDTAVYYCAAPHCNRTSCFDGFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAGGAGCCACCCTCTCCTGCAGGGCCAGTCAGACTGTTAGAAGCAGCTACTTAGGCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCCTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGEGATLSCRASQTVRSSYLGWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-20*01	IGKJ1*01	AAPHCNRTSCFDGFDI	QQYGSSPWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
3	Wheatley-CP63	PDI_308	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGCCTGAGGTGAAGAAGCCTGGGACCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATTCACCTTTACTAGCTCTGCTGTGCAGTGGGTGCGACAGGCTCGTGGACAACGCCTTGAGTGGATAGGATGGATCGTCGTTGGCAGTGGTAACACAAACTACGCACAGAAGTTCCAGGAAAGAGTCACCATTACCAGGGACATGTCCACAACCACAGCCTACATGGAGGTGAGCAGCCTGAGATCCGAGGACACGGCCGTGTATTACTGTGCGGCCCCAAATTGTAACAGGACCATCTGCGCCGACGGTTTTGATATCTGGGGCCAAGGGACAATCGTCACCGTCTCTTCA	QVQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTTTAYMEVSSLRSEDTAVYYCAAPNCNRTICADGFDIWGQGTIVTVSS	GAAATTGGGTTGACCCAGTCCCCATGCACCGTGTCTTTGTCTCCTTGGGAAAGAACCACCCTCTCCTGCAGGGCCAGTCAGAGTGTCAGAAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTGTGCTACATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATTAAA	EIGLTQSPCTVSLSPWERTTLSCRASQSVRSSYLAWYQQKPGQAPRLLICATSSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-20*01	IGKJ1*01	AAPNCNRTICADGFDI	QQYGSSPWT	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
3	Aishun_Jin_mix	58G6	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	QMQLVQSGPEVKKPGTSVKVSCKASGFTFSSSAVQWVRQARGQHLEWIGWIVVGSGNTNYAQKFQERVTLTRDMSTRTAYMELSSLRSEDTAVYYCAAPNCNSTTCHDGFDIWGQGTVVTVSS	nan	EIVLTQSPGTLSLSPGERATLSCRASQSVRSSYLGWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLESEDFAVYYCQQYDNSPWTFGQGTKVEIK	IGHV1-58*01	IGHJ3*02	IGHD2-2*01	IGKV3-20*01	IGKJ1*01	AAPNCNSTTCHDGFDI	QQYDNSPWT	7E3L	Han et al. Front Immunol. 12:653189 (2021);Li et al. bioRxiv. DOI: 10.1101/2021.04.19.440481	nan	nan
4	Wang-PFZ10	PZF10_P1_IgG_F1-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGTAGGCACTGGAGTCACCGTCAGTAGGAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAATTATTTATAGCGGTGGTAGTACATATTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAATACATTGTATCTTCAAATGAATAGCCTGAGAGCTGAGGACACGGCTGTTTATTACTGTGCGAGAGATATTAGGCAGCGCGGGGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCTTCA	EVQLVESGGGLVQPGGSLRLSCVGTGVTVSRNYMNWVRQAPGKGLEWVSIIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDIRQRGGMDVWGQGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTCTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAACTACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTCATCTACGATGCGTCCAATTTGGTAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCACCAGTATGAAGATCTCCCCCCCCTTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQMTQSPSSLSASLGDRVTITCQASQDINYYLNWYQQKPGKAPKLLIYDASNLVTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCHQYEDLPPLFGQGTKLEIK	IGHV3-66*02	IGHJ6*02	IGHD2-15*01,IGHD2-2*01,IGHD2-2*02	IGKV1-33*01,IGKV1D-33*01	IGKJ2*01,IGKJ2*02,IGKJ2*03	ARDIRQRGGMDV	HQYEDLPPL	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
4	Wang-PFZ10	PZF10_P2_IgG_A8-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCGGGGGGGGTCCCTGAGACTCTCCTGTGTAGCCTCTGGATTAACCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTGTTTATGCCGGTGGTAGCACATATTACGCAGACTCCGTGCAGGGCCGATTCACCGTTTCCAGAGACAATTCCAAGAATACGCTGTATCTTCAAATGAACAGCCTGAGAGCTGACGACACGGCTGTGTATTACTGTGCGAGAGATATTAGGCAGCGCGGGGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCTTCA	EVQLVESGGGLVQRGGSLRLSCVASGLTVSSNYMNWVRQAPGKGLEWVSLVYAGGSTYYADSVQGRFTVSRDNSKNTLYLQMNSLRADDTAVYYCARDIRQRGGMDVWGQGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAACAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCATCAGTATGAAAATATCCCCCCCCTTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCHQYENIPPLFGQGTKLEIK	IGHV3-66*02	IGHJ6*02	IGHD2-15*01,IGHD2-2*01,IGHD2-2*02	IGKV1-33*01,IGKV1D-33*01	IGKJ2*01,IGKJ2*02,IGKJ2*03	ARDIRQRGGMDV	HQYENIPPL	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
4	Cho-C016	C2460	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGTAATCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTATTTATAGCGGTGGTAGCACATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTACCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTTCAGCAGCGGGGGGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASVITVSSNYMSWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLQQRGGMDVWGQGTTVTVSS	CATCCGGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTTGGAGACAGAGTCACCATCACCTGCCAGGCGAGTCAGGACATTAGCAACTTTTTAAATTGGTTTCAGCAGAAACCAGGGAAAGCCCCTAAACTCCTGATCTACGATGCATCCAATTTGGGAGCAGGGGTCCCATCGAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCGGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCGATCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	IRMTQSPSSLSASVGDRVTITCQASQDISNFLNWFQQKPGKAPKLLIYDASNLGAGVPSRFSGSGSGTDFTFTISGLQPEDIATYYCQQYDNLPITFGQGTRLEIK	IGHV3-53*01	IGHJ6*02	IGHD6-25*01	IGKV1-33*01,IGKV1D-33*01	IGKJ5*01	ARDLQQRGGMDV	QQYDNLPIT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
4	Li_SARS2_26	H712556+K712020	nan	SARS-CoV-2	SARS-CoV,MERS-CoV,OC43,HKU1,NL63	nan	nan	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCARDLAERGGMDVWGQGTTVTVSS	nan	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPITFGQGTRLEIK	IGHV3-53*01	IGHJ6	nan	IGKV1-9*01	IGKJ5	ARDLAERGGMDV	QQLNSYPIT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
4	Wang-MOD7	MOD7_P1_IgG_E2-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGAATCACCGTCAGGAGCAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTCTTTATAGTGGTGGAAGCACATTCTACGCAGACTCCGTGAAGGGCAGATTTACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGACTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGATTTAGCAGAACGGGGCGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGITVRSNYMTWVRQAPGKGLEWVSVLYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNRLRAEDTAVYYCARDLAERGGMDVWGQGTTVTVSS	GAAATTGTGTTGACGCAGTCTCCANTCNCCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTATCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTTGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	EIVLTQSPXXLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSLYTFGQGTKLEIK	IGHV3-66*01	IGHJ6*02	IGHD3-3*02,IGHD6-13*01,IGHD6-19*01	IGKV3-20*01	IGKJ2*01	ARDLAERGGMDV	QQYGSLYT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
4	Kaku_patientA	9-105	nan	SARS-CoV-2	nan	SARS-CoV-2	SARS-CoV;MERS-CoV	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGATCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTATTTATAGCGGGGGTAGTACATACTACGCAGACTCCGTGAAGGGCCGATTTACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTTGAGGAGGCTGGGGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGITVSSNYMSWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLEEAGGMDVWGQGTTVTVSS	GATATAGTGATGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTCCCAGCATCTACTTAGCCTGGTACCAGCAGAGACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGGGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIVMTQSPGTLSLSPGERATLSCRASQSVPSIYLAWYQQRPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPGTFGQGTKVEIK	IGHV3-53*01	IGHJ6*02	IGHD6-19*01	IGKV3-20*01	IGKJ1*01	ARDLEEAGGMDV	QQYGSSPGT	nan	Kaku et al. Cell Rep. 36:109385 (2021)	MZ089621.1	MZ089626.1
4	Aishun_Jin_mix	54F10	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV3-53*04	IGHJ6*02	IGHD5-24*01	IGKV3-20*01	IGKJ1*01	ARDLEERGAMDV	QQYGSSLWT	nan	Han et al. Front Immunol. 12:653189 (2021)	nan	nan
4	Aishun_Jin_mix	CQTS083	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTAACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTATTTATAGCGGTGGTAGTACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGACACAATTCCAAGAACACACTGTATCTTCAAATGAACAGCCTCAGAGCTGAGGACACGGCCGTGTATTACTGTGCGAGAGATTTAGAAGAGAGGGGCGCTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCARDLEERGAMDVWGQGTTVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCACCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATTTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGAGTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACTGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSTYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRVEPEDFAVYYCQQYGSSLWTFGQGTKVEIK	IGHV3-53*04	IGHJ6*02	IGHD5-24*01	IGKV3-20*01	IGKJ1*01	ARDLEERGAMDV	QQYGSSLWT	nan	Patent: CN111909262A	MW587484.1	MW587485.1
4	Wang-PFZ10	PZF10_P1_IgG_H5-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGGTCATCGTCAGTAGCAACTACATGAACTGGGTCCGTCAGACTCCAGGGAAGGGGCTGGAGTGGGTCTCAATTATTTATAGCGGTGGTAGCACATACTACGCAGAGTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACATTTTGTATCTTCAAATGAAGAGCCTGAGAGCCGAGGACACGGCCGTATATTACTGTGCGAGAGACCTATTTGAGGTGGGGGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGVIVSSNYMNWVRQTPGKGLEWVSIIYSGGSTYYAESVKGRFTISRDNSKNILYLQMKSLRAEDTAVYYCARDLFEVGGMDVWGQGTTVTVSS	CAGTCTGTGCTGACTCAGCCACCCTCAGCGTCTGGGACCCCCGGGCAGAGGGTCACCGTCTCTTGTTCTGGAAGCAGCTCCAACATCGGGAGTAATTATGTATACTGGTACCAGCAGCTCCCAGGAACGGCCCCCAAACTCCTCATCTATAGTAATAATCAGCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCAGTGGGCTCCGGTCCGAGGATGAGGCTGATTATTATTGTGCAGTATGGGATGACAGCCTGAGTGCTGATTATGTTTTCGGAACTGGGACCAAGGTCACCGTCCTAG	QSVLTQPPSASGTPGQRVTVSCSGSSSNIGSNYVYWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAVWDDSLSADYVFGTGTKVTVL	IGHV3-53*01	IGHJ6*02	IGHD2-21*01,IGHD2-21*02	IGLV1-47*02	IGLJ1*01	ARDLFEVGGMDV	AVWDDSLSADYV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
4	Xie_mix	BD-236	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASGITVSSNYMSWVRQAPGKGLEWVSVIYSGGSTDYADSVKGRFTISRDKSKNTLYLQMNSLRAEDTAVYYCARDLGEAGGMDVWGQGTTVTVSS	nan	AIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSYPPAFGGGTKVEIK	IGHV3-53*01	IGHJ6	nan	IGKV1-9*01	IGKJ4	ARDLGEAGGMDV	QQLNSYPPA	7CHB,7CHE	Du et al. Cell 183:1013-1023.e13 (2020)	nan	nan
4	Wang-MOD11	Mod11_P1_IgG_H10-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGTACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATTTAGGGCCTAGGGGCGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLGPRGGMDVWGQGTTVTVSS	GCCATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGGGCATTAGAAATGATTTAGGCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTACAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGCACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCTACAAGATTACAATTACCCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	AIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCLQDYNYPYTFGQGTKLEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV1-6*01	IGKJ2*01	ARDLGPRGGMDV	LQDYNYPYT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
4	Wang-MOD11	Mod11_P1_IgG_F8-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGATCACCGTCAGTAGGAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTACCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGTATGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTTATCGAAGCAGGGGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGITVSRNYMSWVRQAPGKGLEWVSVIYSGGTTYYADSVKGRFTISRDNSKNTLYLQMNSMRAEDTAVYYCARDLIEAGGMDVWGQGTTVTVSS	GACATCCAGATGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTATTAGTACCTGGTTGGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGATGCCTCCAGTTTGAAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACCATCAGCAGCCTGCAGCCTGATGATTTTGCAACTTATTACTGCCAACAGTATACTAGTTATCCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQMTQSPSTLSASVGDRVTITCRASQSISTWLAWYQQKPGKAPKLLIYDASSLKSGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYTSYPYTFGQGTKLEIK	IGHV3-53*01	IGHJ6*02	IGHD3-16*02	IGKV1-5*01	IGKJ2*01	ARDLIEAGGMDV	QQYTSYPYT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
4	Cho-C016	C2473	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATGCAGCCGGGGGGGTCCTTGAGACTCTCCTGTGCAGCCTCTGGGGTCATCGTCAGTCGCAACTACATGAGGTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTATTTATAGCGGTGGTAGCACATTCTACTCGGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACACTTCCAAGAACACACTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTATATTACTGTGCGAGAGATTTACTAGAGGCCGGCGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAG	EVQLVESGGGLMQPGGSLRLSCAASGVIVSRNYMRWVRQAPGKGLEWVSLIYSGGSTFYSDSVKGRFTISRDTSKNTLYLQMNSLRAEDTAVYYCARDLLEAGGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACAAGGGAAAGCCCCCAAGATCCTGGTCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACATCTTAATAGTCACCCTCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKQGKAPKILVYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQHLNSHPLTFGGGTKVEIK	IGHV3-53*01	IGHJ6*02	IGHD3-10*01,IGHD3-10*02,IGHD3-22*01	IGKV1-9*01	IGKJ4*01	ARDLLEAGGMDV	QHLNSHPLT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
4	Wang-PFZ10	PZF10_P2_IgG_G9-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGGTCATCGTCAGTCGCAATTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTTATCATCTCCAGAGACAATTCCAAGAACACGCTACATCTTCAAATGCACAGCCTGAGAGCCGAGGACACGGCCGTGTATTATTGTGCGAGAGATCTACTTGAGGTGGGGGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGVIVSRNYMNWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFIISRDNSKNTLHLQMHSLRAEDTAVYYCARDLLEVGGMDVWGQGTTVTVSS	CAGTCTGTGCTGACTCAGCCACCCTCAGCGTCTGGGACCCCCGGGCAGAGGGTCACCATCTCTTGTTCTGGAAGCAGCTCCAACATCGGAAGTACTTTATACTGGTACCAGCAGCTCCCAGGAACGGCCCCCAAACTCCTCATCTATAGTAATAATCAGCGGCCCTCAGGGGTCCCTGACCGCTTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGACCATCAGTGGGCTCCGGTCCGAGGATGAGGCTGATTATTACTGTGCAACATGGGATGACAGCCTGAGTGCTTCTTATGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	QSVLTQPPSASGTPGQRVTISCSGSSSNIGSTLYWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLTISGLRSEDEADYYCATWDDSLSASYVFGTGTKVTVL	IGHV3-53*01	IGHJ6*02	IGHD2-21*01,IGHD2-21*02	IGLV1-47*02	IGLJ1*01	ARDLLEVGGMDV	ATWDDSLSASYV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
4	PVI.V3	PVI.V3-9	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	nan	nan	nan	nan	IGHV3-53	IGHJ6	IGHD3-16	IGKV3-20	IGKJ1	ARDLMEGGGMDV	QQYGSSLGT	nan	Amanat et al. Cell 184:3936-3948.e10 (2021)	nan	nan
4	Wang-MOD9	MOD9_P2_IgG_C9-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGAAATCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTCTTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAGTTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGACCTGAGGACACGGCTGTGTATTACTGTGCGAGAGATCTGATGGAGGTAGGCGGCATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASEITVSSNYMSWVRQAPGKGLEWVSLLYSGGSTYYADSVKGRFTISRDSSKNTLYLQMNSLRPEDTAVYYCARDLMEVGGMDVWGQGTTVTVSS	CAGTCTGTGCTGACTCAGCCACCCTCAGCGTCTGGGACCCCCGGGCAGAGGGTCACCATCTCTTGTTCTGGAAGCAGCTCCAACATCGGCAGTGATTATGTATACTGGTACCAGCATCTCCCAGGAACGGCCCCCAAACTCCTCATCTATAGGATTAATCAGCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCAGTGGGCTCCGGTCCGAGGATGAGGCTGATTATTACTGTGCAGCATGGGATGACAGCCTGAGTGGTTATGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	QSVLTQPPSASGTPGQRVTISCSGSSSNIGSDYVYWYQHLPGTAPKLLIYRINQRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDDSLSGYVFGTGTKVTVL	IGHV3-66*02	IGHJ6*02	IGHD2-15*01	IGLV1-47*01	IGLJ1*01	ARDLMEVGGMDV	AAWDDSLSGYV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
4	Cho-C005	C1327	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGAAGTCCCTGAGACTCTCCTGTTCAGCCTCTGAAATCACTGTCAGCAGTAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAGGGGGCTGGAGTGGGTCTCACTTATTTATGCCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCTGACGACACGGCTGTGTATTACTGTGCGAGAGATTTATCGGTCCGCGGGGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGKSLRLSCSASEITVSSNYMTWVRQAPGRGLEWVSLIYAGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRADDTAVYYCARDLSVRGGMDVWGQGTTVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTATTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAGCCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACTGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSISSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSLYTFGQGTKLEIK	IGHV3-66*02	IGHJ6*02	IGHD3-16*02	IGKV3-20*01	IGKJ2*01	ARDLSVRGGMDV	QQYGSSLYT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
4	PatientPhageLib1	MD45	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 S1/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVQSGGGLVQPGGSLRLSCAASGFTVSSNYMTWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCARDLSVRGGMDVWGQGTMVTVSS	nan	EIVLTQSPGTLSLSPGERATLSCRASQSVNSSYLAWYQQKPGQAPRLLIYGASNRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGVSPEIIFGQGTRLEIK	IGHV3-53*04	nan	nan	IGKV3-20*01	nan	ARDLSVRGGMDV	QQYGVSPEII	nan	Noy-Porat et al. Nat. Commun. 11:4303 (2020)	nan	nan
4	PatientPhageLib1	MD67	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 S1/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMTWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCARDLSVRGGMDVWGQGTTVTVSS	nan	EIVLTQSPGTLSLSPGERATLPCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQFGSSPLTFGGGTKVEIK	IGHV3-53*04	nan	nan	IGKV3-20*01	nan	ARDLSVRGGMDV	QQFGSSPLT	nan	Noy-Porat et al. Nat. Commun. 11:4303 (2020)	nan	nan
4	Wang-MOD9	MOD9_P1_IgG_D11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGAAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACACTGTATCTTCAAATGAACAGCCTGAGTGCCGAAGACACGGCCGTGTATTACTGTGCGAGAGATCTGGATACAGCTGGCGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACGGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSRNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLSAEDTAVYYCARDLDTAGGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTAATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTAATCTATGTTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAGTAGTTACCCGTCGACGTTCGGCCAGGGGACCAAGGTGGAAATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSNLAWYQQKPGKAPKLLIYVASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLSSYPSTFGQGTKVEIK	IGHV3-53*01	IGHJ6*02	IGHD5-18*01,IGHD5-5*01	IGKV1-9*01	IGKJ1*01	ARDLDTAGGMDV	QQLSSYPST	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
4	Wang-MOD9	MOD9_P1_IgG_D12-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGATCACCGTCAGTAGAAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGATCTCAGTTATTTATAGTGGTGGTACCACATACTACGCAGGCTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTGGACACAGCTGGCGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGITVSRNYMNWVRQAPGKGLEWISVIYSGGTTYYAGSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLDTAGGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAATTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGGTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTATCCTAGTTACCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISNYLAWYQQKPGKAPKVLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPSYPWTFGQGTKVEIK	IGHV3-53*01	IGHJ6*02	IGHD5-18*01,IGHD5-5*01	IGKV1-9*01	IGKJ1*01	ARDLDTAGGMDV	QQLNSYPSYPWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
4	COSCA2	COVA2-13	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGACTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTCGATACTATGGGGGGTATGGACGTCTGGGGCCAAGGGACCAGGGTCACCGTCTCTTCA	QVQLVETGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLDTMGGMDVWGQGTRVTVSS	GAAATAGTGATGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGGGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVMTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPGTFGQGTKVEIK	IGHV3-53*02	IGHJ6*02	IGHD3-10*01	IGKV3-20*01	IGKJ1*01	ARDLDTMGGMDV	QQYGSSPGT	nan	Brouwer et al. Science 369:643-650 (2020)	nan	nan
4	Jennewein_CV1	CV1-30	CV30	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTACAATTGGTTGAGTCCGGGGGTGGCCTGATACAACCCGGAGGCTCCCTTCGGCTTTCTTGTGCCGCATCAGGAGTGATTGTCTCCTCAAACTACATGTCTTGGGTGCGACAGGCGCCGGGTAAAGGACTCGAGTGGGTGAGTGTTATCTATTCTGGGGGAAGCACGTATTATGCCGACAGTGTCAAAGGACGCTTCACAATTAGCCGAGATAATTCTAAAAATACGTTGTACCTCCAGATGAATAGTCTGCGCGCGGAAGACACAGCAGTCTATTACTGTGCCCGGGACCTGGATGTAAGCGGGGGTATGGATGTCTGGGGTCAAGGCACCACTGTTACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGVIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLDVSGGMDVWGQGTTVTVSS	GAAATAGTTCTCACTCAAAGTCCCGGTACATTGTCCCTGTCCCCTGGTGAACGGGCAACATTGTCCTGCCGGGCCTCCCAGAGCGTCTCTTCTTCTTACCTTGCATGGTACCAGCAGAAGCCAGGACAAGCGCCGAGATTGCTTATCTACGGTGCCTCATCTAGGGCCACTGGCATTCCTGATCGATTTTCTGGGAGCGGCTCCGGGACTGACTTTACACTCACTATTTCACGCTTGGAGCCGGAGGATTTCGCAGTCTATTATTGTCAACAGTACGGTTCAAGTCCGCAGACCTTCGGGCAAGGCACCAAACTTGAGATAAAA	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPQTFGQGTKLEIK	IGHV3-53*03	IGHJ6*01,IGHJ6*02	IGHD1-1*01,IGHD1-20*01,IGHD1-7*01	IGKV3-20*01	IGKJ5*01	ARDLDVSGGMDV	QQYGSSPQT	6XE1	Jennewein et al. Cell Rep. 36:109353 (2021);Seydoux et al. Immunity 53:98-105.e5 (2020)	MT462504.1	MT462561.1
4	Xie_mix	BD-601	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCARDLDYGGGMDVWGQGTTVTVSS	nan	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPHRFTFGPGTKVDIK	IGHV3-53*04	nan	nan	IGKV1-9*01	nan	ARDLDYGGGMDV	QQLNSYPHRFT	nan	Du et al. Cell 183:1013-1023.e13 (2020)	nan	nan
4	Wang-MOD1	C612	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCAACATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATTTAGAAGCAGCTGGGGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFNISRDNSKNTLYLQMNSLRAEDTAVYYCARDLEAAGGMDVWGQGTTVTVSS	CACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATGGTTACCCGCTCACTTTCGGCGGAGGGACCAAGGTGGAAATCAAAC	HIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNGYPLTFGGGTKVEIK	IGHV3-53*01	IGHJ6*02	IGHD6-13*01	IGKV1-9*01	IGKJ4*01	ARDLEAAGGMDV	QQLNGYPLT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
4	Wang-MOD1	Mod1_P1_IgG_A12-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCAACATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATTTAGAAGCAGCTGGGGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFNISRDNSKNTLYLQMNSLRAEDTAVYYCARDLEAAGGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTNGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATGGTTACCCGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSXVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNGYPLTFGGGTKVEIK	IGHV3-53*01	IGHJ6*02	IGHD6-13*01	IGKV1-9*01	IGKJ4*01	ARDLEAAGGMDV	QQLNGYPLT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
4	COSCA2	COVA2-04	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGACTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGTACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATTTGGAAAGGGCGGGGGGTATGGACGTCTGGGGCCAAGGGACCATGGTCACCGTCTCTTCA	QVQLVETGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLERAGGMDVWGQGTMVTVSS	GAAATAGTGATGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCCTGTACACTTTTGGCCAGGGGACCAAAGTGGATATCAAAC	EIVMTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSLYTFGQGTKVDIK	IGHV3-53*02	IGHJ6*02	IGHD3-3*01,IGHD3-3*02,IGHD3/OR15-3a*01	IGKV3-20*01	IGKJ2*01	ARDLERAGGMDV	QQYGSLYT	7JMO	Brouwer et al. Science 369:643-650 (2020);Wu et al. Cell Rep. 33:108274 (2020)	nan	nan
4	Wang-MOD8	MOD8_P1_IgG_D9-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTAACCGTCACTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTCGAGTGGGTCTCAGTTGTTTATAGCGGTGGTAGCACGTTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTTGAAGTGGCTGGAGGTATGGACGTCTGGGGCCAAGGGACCCCGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVTSNYMNWVRQAPGKGLEWVSVVYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLEVAGGMDVWGQGTPVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGGTCCTGATCTATGCTGCATCCACTTTGCAAAGAGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKVLIYAASTLQRGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSYPLTFGGGTKVEIK	IGHV3-53*01	IGHJ6*02	IGHD6-19*01	IGKV1-9*01	IGKJ4*01	ARDLEVAGGMDV	QQLNSYPLT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
4	Wang-MOD8	MOD8_P2_IgG_E5-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGTTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTTGAAGTGGCTGGAGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLEVAGGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTTTCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWFQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSYPLTFGGGTKVEIK	IGHV3-53*01	IGHJ6*02	IGHD6-19*01	IGKV1-9*01	IGKJ4*01	ARDLEVAGGMDV	QQLNSYPLT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
4	COV047	COV047_P5_IgM_19-P1348	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTAATTGTAGCCGGGGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLIVAGGMDVWGQGTTVTSP	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCTAGGGTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRVTFGPGTKVDIK	IGHV3-53*01	IGHJ6*02	IGHD2-15*01,IGHD2-2*01,IGHD2-2*02	IGKV3-20*01	IGKJ3*01	ARDLIVAGGMDV	QQYGSSPRVT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW293246.1	MW293701.1
4	Wang-MOD6	MOD6_P2_IgG_E12-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGAATTACCGTCAGGAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTAGTAGTTCATTCTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATACCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATCACTGTGCGAGAGATCTCCAAGCAGCAGGCGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGITVRSNYMSWVRQAPGKGLEWVSVIYSGSSSFYADSVKGRFTISRDNTKNTLYLQMNSLRAEDTAVYHCARDLQAAGGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGAGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACATCTTAATGGTTACCCACTCACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPEKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHLNGYPLTFGQGTKLEIK	IGHV3-66*01	IGHJ6*02	IGHD6-13*01	IGKV1-9*01	IGKJ2*01,IGKJ2*02	ARDLQAAGGMDV	QHLNGYPLT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
4	IML3549	ADI-61228	nan	SARS-CoV-2	nan	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGGTCATCGTCAGTAGCAACTACATGACTTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGATCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACCCTGTATCTTCAAATGAACAGCCTGAGAGCCGACGACACGGCCGTGTATTACTGTGCGAGAGACCTCGTGGTAGCTGGCGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACTGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGVIVSSNYMTWVRQAPGKGLEWISVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRADDTAVYYCARDLVVAGGMDVWGQGTTVTVSS	nan	nan	IGHV3-53*01	IGHJ6*02	IGHD2-15*01	IGKV3-20	nan	ARDLVVAGGMDV	QHYGSSPSIT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458085.1	nan
4	Wang-MOD7	MOD7_P1_IgG_A9-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGGTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTATTTATAGCGGTGGTAGTACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAGCAGCCTGAGAGCCGAGGACACGGCCGTATATTATTGTGCGAGAGATCTGGAGGAGGCTGGGGCTTATGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLIQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMSSLRAEDTAVYYCARDLEEAGAYDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGTAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACTTCAGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSLQTFGQGTKVEIK	IGHV3-53*01	IGHJ3*02	IGHD6-19*01	IGKV3-20*01	IGKJ1*01	ARDLEEAGAYDI	QQYGSSLQT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
4	Cho-C016	C2221	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGATCTCGAAGAGAAGGGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMTWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLEEKGAFDIWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPYTFGQGTKLEIK	IGHV3-66*02	IGHJ3*02	IGHD5-24*01	IGKV1-9*01	IGKJ2*01	ARDLEEKGAFDI	QQLNSYPPYT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
4	Cho-C011	C2244	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTAGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGACACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCTGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTAGAGGAACGGGGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMTWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCARDLEERGAFDIWGQGTMVTVSS	GACATCCAGATGACCCAGTCTCCATCTTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGTCGGGCGAGTCAGGGTATTAGCAGCTGGTTAGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGTTGCATCCAGTTTGCAAAGTGCGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTACTATTGTCAACAGGCTCACAGTTTCCCTCTGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYVASSLQSAVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQAHSFPLYTFGQGTKLEIK	IGHV3-53*04	IGHJ3*02	IGHD1-1*01,IGHD1-20*01	IGKV1-12*01	IGKJ2*01	ARDLEERGAFDI	QQAHSFPLYT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
4	Cho-C012	C2044	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTGTCCTGTGCAGCCTCTGGGTTCATCGTCAGTAACAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTATTTATAGCGGTGGTAGCACATACTATGCAGACTCCGTGAAGGGCCGATTCACCATTTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTATATTACTGTGCGAGAGATTTGGAGGAGGCTGGGGGCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFIVSNNYMSWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLEEAGGFDYWGQGTLVTVSS	TCCTATGAGCTGACTCAGCCACCCTCGGTGTCAGTGGCCCCAGGACAGACGGCCAGGATTACCTGTGGGGGAAACAACATTGGAATTAAAAGTGTGCACTGGTACCAGCAGAAGCCAGGCCAGGCCCCTGTGGTGGTCGTCTATGATGATAGCGACCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACGGCCACCCTGACCATCAGCAGGGTCGAAGCCGGGGATGAGGCCGACTATTACTGTCAGGTGTGGGATAGTAGTAGTGACCTTTATGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	SYELTQPPSVSVAPGQTARITCGGNNIGIKSVHWYQQKPGQAPVVVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDLYVFGTGTKVTVL	IGHV3-53*01	IGHJ4*02	IGHD3-16*01,IGHD3-16*02	IGLV3-21*02	IGLJ1*01	ARDLEEAGGFDY	QVWDSSSDLYV	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
4	Wang-C003	C1232	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGACTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGTCTCTGGGTTCACCGTCAGTCGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGGTATTTTTAGCGGTGGAAGTACATTCTACGCAGACTCCGTGCAGGGCCGATTCACCATCTCCAGAGACAGTTCCAAGAACACGCTGTTTCTTCAAATGGACAGCCTGAGAGCCGAGGACACGGCCGTCTATTACTGTGCGCGAGATTTAGAGATGGCAGGAGGGTTCGACTCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVETGGGLIQPGGSLRLSCAVSGFTVSRNYMSWVRQAPGKGLEWVSGIFSGGSTFYADSVQGRFTISRDSSKNTLFLQMDSLRAEDTAVYYCARDLEMAGGFDSWGQGTLVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACACCTTAATAGTTACCCTTCGATCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQHLNSYPSITFGQGTRLEIK	IGHV3-53*02	IGHJ5*01,IGHJ5*02	IGHD5-24*01	IGKV1-9*01	IGKJ5*01	ARDLEMAGGFDS	QHLNSYPSIT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
4	Wang-C003	C1234	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGAAGCCTCTGGAGTCATCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAATACATTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGATCTGCAGCAGGCTGGGGGATTTGACTACTGGGGCCAGGGAATCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCEASGVIVSSNYMNWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLQQAGGFDYWGQGILVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGAAATTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACAATGCATCCAATTTGGGAAGAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCGATCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDIRNYLNWYQQKPGKAPKLLIYNASNLGRGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPITFGQGTRLEIK	IGHV3-66*01	IGHJ4*02	IGHD3-16*01,IGHD3-16*02,IGHD6-13*01	IGKV1-33*01,IGKV1D-33*01	IGKJ5*01	ARDLQQAGGFDY	QQYDNLPIT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
4	Wang-MOD8	MOD8_P2_IgG_E9-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGAAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAACAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGACGACACGGCCGTGTATTACTGTGCGAGAGATCTTGAACTGGCTGGAGGTATAGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSRNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSNNTLYLQMNSLRADDTAVYYCARDLELAGGIDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCGGGGAAAGCCCCTAAGGTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKVLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSYPLTFGGGTKVEIK	IGHV3-53*01	IGHJ6*02	IGHD6-19*01	IGKV1-9*01	IGKJ4*01	ARDLELAGGIDV	QQLNSYPLT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
4	ZhouY_P1	XG038	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV1-18	IGHJ4	IGHD3-16*01	IGLV2-23	IGLJ3	ARDLELGGAFDY	CAYAGSSTWV	nan	Zhou et al. Cell Rep. 34:108699 (2021)	nan	nan
4	Cho-C012	C2033	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTGGAGCTAAAGGGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLELKGAFDIWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACTCCCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYSPWTFGQGTKVEIK	IGHV3-53*01	IGHJ3*02	IGHD1-26*01	IGKV1-9*01	IGKJ1*01	ARDLELKGAFDI	QQLNSYSPWT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
4	Cho-C012	C2037	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACCCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTGGAGCTAAAGGGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLELKGAFDIWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCCCCGTGGACGCTCGGCCAAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPWTLGQGTKVEIK	IGHV3-53*01	IGHJ3*02	IGHD1-26*01	IGKV1-9*01	IGKJ1*01	ARDLELKGAFDI	QQLNSYPPWT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
4	BG4	BG4-25	nan	SARS-CoV-2	SARS-CoV,MERS-CoV	SARS-CoV-2	SARS-CoV;MERS-CoV	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASGITVVRNYMTWVRQAPGKGLEWVSVIYSGGTTYYADSVKGRFTISRDNSKNTMYLQMNSLRAEDTAIYYCAR	nan	EIVLTQSPGTLSLSPGERATLSCRASQSVPSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGS	IGHV3-53*01	IGHJ6	nan	IGKV3-20*01	IGKJ2	ARDLEVVGAMDV	QQYGSPMYT	7M6D	Scheid et al. Cell 184:3205-3221.e24 (2021)	nan	nan
4	Wang-MOD8	MOD8_P2_IgG_C4-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCATCGTCAGTAGCAACTACATGTTCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTCATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAGTTCCAAGAATACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTGGGAGCTCGTGGTGGTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLIQPGGSLRLSCAASGLIVSSNYMFWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDSSKNTLYLQMNSLRAEDTAVYYCARDLGARGGFDIWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTGATACTTTCCCCCTTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLDTFPLFGGGTKVEIK	IGHV3-53*01	IGHJ3*02	IGHD1-26*01	IGKV1-9*01	IGKJ4*01	ARDLGARGGFDI	QQLDTFPL	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
4	Li_SARS2_26	DH1154	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLGAEDTAVYYCARDLGSRGAFDIWGQGTMVTVSS	nan	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSDPVPFGGGTKVEIK	IGHV3-53*01	IGHJ3	nan	IGKV1-9*01	IGKJ4	ARDLGSRGAFDI	QQLNSDPVP	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
4	Wang-MOD7	MOD7_P1_IgG_A8-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTAAGACTCTCCTGTGCAGCCTCTGGATTAACCGTCAGTAGGAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTACCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTATATCTTCAAATGAACAGCCTGAGAGCCGAGGACTCGGCAGTATATTACTGTGCGAGAGATCTTGGGATATCGGGCGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVQPGGSLRLSCAASGLTVSRNYMNWVRQAPGKGLEWVSVIYSGGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDSAVYYCARDLGISGAFDIWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTGATAGTTACCCTGCGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLDSYPALTFGGGTKVEIK	IGHV3-66*01	IGHJ3*02	IGHD2-15*01,IGHD2-2*01,IGHD2-2*02	IGKV1-9*01	IGKJ4*01	ARDLGISGAFDI	QQLDSYPALT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
4	Wang-MOD7	MOD7_P1_IgG_F3-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAATTATATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGATCTTGGGATATCGGGCGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLGISGAFDIWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTGATAGTTATTCTGCGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLDSYSALTFGGGTKVEIK	IGHV3-66*01	IGHJ3*02	IGHD2-15*01,IGHD2-2*01,IGHD2-2*02	IGKV1-9*01	IGKJ4*01	ARDLGISGAFDI	QQLDSYSALT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
4	54042	54042-10	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:Unk	SARS-CoV-2 spike, RBD, SARS-CoV RBD, and HCoV RBDs	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAACTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTAATCGTCAGTAGAAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAGGGGGCTGGAGTGGGTCTCAACTATTTATGCCGGTGGTAGCGCATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACACTATATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTACTACTGTGCGAGAGATCTGAACGTTCGGGGAGGGTTGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLIVSRNYMTWVRQAPGRGLEWVSTIYAGGSAFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLNVRGGLDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAACAATTATTTAGCCTGGTATCAGCAAAAACCAGGGAAGGCCCCTAAGCTCCTGATCTTTGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTGACCCCGCGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGINNYLAWYQQKPGKAPKLLIFAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSDPALTFGGGTKVEIK	IGHV3-53*01	IGHJ6*02	IGHD3-10*01,IGHD3-10*02	IGKV1-9*01	IGKJ4*01	ARDLNVRGGLDV	QQLNSDPALT	nan	Kramer et al. Cell Rep. 37:109784 (2021)	MZ820102.1	MZ820111.1
4	Wang-MOD6	MOD6_P1_IgG_C11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTATTTATGCCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTCCAAGAGAGGGGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMTWVRQAPGKGLEWVSLIYAGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLQERGAFDIWGQGTMVTVSS	GACATCGTGATGACCCAGTCTCCAGACTCCCTGGCTGTGTCTCTGGGCGAGAGGGCCACCATCAACTGCAAGTCCAGCCAGACTGTTTTATACAGCTCCAACAGTAAGAACTACTTAGCTTGGTACCAGCAGAAACCAGGACAGCCTCCTAAGCTGCTCATTTACTCGGCATCTACCCGGGAATCCGGGGTCCCTGACCGATTCAGTGGCAGCGGGTCTGAGACAGATTTCACTCTCACCATCAGCAGCCTGCAGGCTGAAGATGTGGCAGTTTATTACTGTCAGCAGTATTATAGTACTCCTCGAACTTTTGGCCAGGGGACCAAGCTGGAGATCAA	DIVMTQSPDSLAVSLGERATINCKSSQTVLYSSNSKNYLAWYQQKPGQPPKLLIYSASTRESGVPDRFSGSGSETDFTLTISSLQAEDVAVYYCQQYYSTPRTFGQGTKLEI	IGHV3-53*01	IGHJ3*02	IGHD5-24*01	IGKV4-1*01	IGKJ2*01,IGKJ2*02	ARDLQERGAFDI	QQYYSTPRT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
4	Wang-MOD7	MOD7_P2_IgG_D1-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGATCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTTCAGGAGTCGGGTGGTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLIQPGGSLRLSCAASGITVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLQESGGFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGATACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGATAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGACTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCATTCGTCACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSRYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSFVTFGQGTKLEIK	IGHV3-53*01	IGHJ3*02	IGHD2-15*01,IGHD2-21*01,IGHD2-21*02	IGKV3-20*01	IGKJ2*01,IGKJ2*02	ARDLQESGGFDI	QQYGSSFVT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
4	Cho-C016	C2232	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAATTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTCTATTACTGTGCGAGAGATCTGCAACAGCTGGGCGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSIIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLQQLGGMDVWGQGTTVTVSS	GCCATCCGGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCACCAGTATGATAATCTCCCGATCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	AIRMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCHQYDNLPITFGQGTRLEIK	IGHV3-53*01	IGHJ6*02	IGHD6-13*01	IGKV1-33*01,IGKV1D-33*01	IGKJ5*01	ARDLQQLGGMDV	HQYDNLPIT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
4	IML3564	ADI-63376	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTGGTGCAGTCTGGAGGAGGCTTGATCCAGTCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTACAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATGGCAAGAATACCCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTTCTGTGTGAGAGATCTGCAGCAGGTGGGCGGTATGGACGTCTGGGGCCAGGGGACCACGGTCACCGTCTCCTCA	QVQLVQSGGGLIQSGGSLRLSCAASGLTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNGKNTLYLQMNSLRAEDTAVYFCVRDLQQVGGMDVWGQGTTVTVSS	nan	nan	IGHV3-53*01	IGHJ6*02	IGHD6-13*01	IGKV1-33	nan	VRDLQQVGGMDV	QQFDNLPIT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458882.1	nan
4	IML3548	ADI-60736	nan	SARS-CoV-2	nan	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAATCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCATCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATATCTAGAGACAATTCCAAGAACACTCTGTATCTTCAAATGGACAGCCTGAGAGCCGAGGACACGGCCGTATATTACTGTACGAGAGATCTACTCTCTGTTGGGGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLIVSSNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMDSLRAEDTAVYYCTRDLLSVGGMDVWGQGTTVTVSS	nan	nan	IGHV3-53*01	IGHJ6*02	IGHD2/OR15-2a*01,IGHD2/OR15-2b*01	IGKV3-20	nan	TRDLLSVGGMDV	QHYGSSPPNT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458005.1	nan
4	A VelocImmune mouse	REGN10941	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:Unk	SARS-CoV-2 spike	B-cells;Humanized Mouse	nan	EVQLVESGGGLVQPGGSLRLSCAASGITVSSNYMTWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRHNSKNTLYLQMNNLRAEDTAVYYCVRDLEVRGGMDVWGQGTTVTVSS	nan	EIVLTQSPGTLSLSPGERATLSCRASQSFSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV3-53*04	IGHJ6	nan	IGKV3-20*01	IGKJ1	VRDLEVRGGMDV	QQYGSSPWT	nan	Patent: US10787501	nan	nan
4	Cho-C005	C1326	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTAATTTATAGCGGTGGTAGTACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACACTTCCAAGAACACGCTCTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGACCTAGCAGCAGCCGGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMTWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDTSKNTLYLQMNSLRAEDTAVYYCARDLAAAGAFDIWGQGTMVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCGAGTCAGGGCATTAGCAATTCTTTAGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGCTCTATGCTGCATCCAGATTGGAAAGTGGGGTCCCATCCAGGTTCAGTGGCAGTGGATCTGGGACGGATTACACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGTATTATAGTACCCTCCCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQGISNSLAWYQQKPGKAPKLLLYAASRLESGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCQQYYSTLPYTFGQGTKLEIK	IGHV3-53*01	IGHJ3*02	IGHD6-13*01	IGKV1-NL1*01	IGKJ2*01	ARDLAAAGAFDI	QQYYSTLPYT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
4	PatientPhageLib1	MD65	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 S1/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLGLSCAASGVTVSSNYMNWVRQTPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLAVAGAFDIWGQGTMVTVSS	nan	EIVMTQSPGTLSLSPGERATLSCRASQSISSSYLAWYQQKPGQAPRLLIYGASIRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYFCQQYGSSPLTFGGGTKVEIK	IGHV3-66*01	nan	nan	IGKV3-20*01	nan	ARDLAVAGAFDI	QQYGSSPLT	nan	Noy-Porat et al. Nat. Commun. 11:4303 (2020)	nan	nan
4	Aishun_Jin_mix	511D12	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV3-66*01	IGHJ3*02	IGHD5-12*01	IGKV1-9*01	IGKJ5*01	ARDLDIAGAFDI	QLLNSFPIT	nan	Han et al. Front Immunol. 12:653189 (2021)	nan	nan
4	Aishun_Jin_mix	CQTS173	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGACTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGAATCACCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGATCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTTTTTCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGACCTGGATATTGCGGGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGDLVQPGGSLRLSCAASGITVSSNYMNWVRQAPGKGLEWISVIYSGGSTYYADSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCARDLDIAGAFDIWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACTTCTTAATAGTTTCCCTATCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQLLNSFPITFGQGTRLEIK	IGHV3-66*01	IGHJ3*02	IGHD2-2*03	IGKV1-9*01	IGKJ5*01	ARDLDIAGAFDI	QLLNSFPIT	nan	Patent: CN111925444A	MW587614.1	MW587615.1
4	Wang-MOD11	Mod11_P1_IgG_F1-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGAAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTCGAGATCGCGGGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLIQPGGSLRLSCAASGLTVSRNYMNWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLEIAGAFDIWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCGATCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSYPITFGQGTRLEIK	IGHV3-53*01	IGHJ3*02	IGHD5-24*01	IGKV1-9*01	IGKJ5*01	ARDLEIAGAFDI	QQLNSYPIT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
4	Wang-MOD11	Mod11_P2_IgG_H11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGTAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTCGAGATCGCGGGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLEIAGAFDIWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGNAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCGATCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	DIQLTQSPSFLSASVXDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSYPITFGQGTRLEIK	IGHV3-53*01	IGHJ3*02	IGHD5-24*01	IGKV1-9*01	IGKJ5*01	ARDLEIAGAFDI	QQLNSYPIT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
4	Wang-MOD7	MOD7_P2_IgG_C5-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGAATCACCGTCAGTAGCAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTTCTGTGCGAGAGATCTTGAGATAGCGGGCGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVQPGGSLRLSCAASGITVSSNYMTWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYFCARDLEIAGAFDIWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATTTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGATTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTGCGCTCACTTTCGGCGGAGGGACCAAGGTGGATATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSYPALTFGGGTKVDIK	IGHV3-66*01	IGHJ3*02	IGHD3-22*01,IGHD5-24*01,IGHD6-13*01	IGKV1-9*01	IGKJ4*01	ARDLEIAGAFDI	QQLNSYPALT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
4	Wang-MOD9	MOD9_P2_IgG_F3-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGAAATCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGATCTATCAGTGGCAGGGGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVQPGGSLRLSCAASEITVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLSVAGAFDIWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAGAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGCGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTGATAGTTATTCGTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGRAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLDSYSFGPGTKVDIK	IGHV3-66*02	IGHJ3*02	IGHD6-19*01	IGKV1-9*01	IGKJ3*01	ARDLSVAGAFDI	QQLDSYS	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
4	Wang-MOD11	Mod11_P1_IgG_E8-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGATCACCGTCAGTAGCAATTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATGCCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTGGACATAGCAGGGGCCCTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLIQPGGSLRLSCAASGITVSSNYMSWVRQAPGKGLEWVSVIYAGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLDIAGALDIWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAATTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCCCGCCTCGCTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISNYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSYPRLAFGGGTKVEIK	IGHV3-53*01	IGHJ3*02	IGHD6-19*01,IGHD6-25*01	IGKV1-9*01	IGKJ4*01	ARDLDIAGALDI	QQLNSYPRLA	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
4	Aishun_Jin_mix	51A1	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASGLIVSRNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLNIAGGFDIWGQGTMVTVSS	nan	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHLNIDPITFGQGTRLEIK	IGHV3-66*01	IGHJ3*02	IGHD5-12*01	IGKV1-9*01	IGKJ5*01	ARDLNIAGGFDI	QHLNIDPIT	nan	Han et al. Front Immunol. 12:653189 (2021)	nan	nan
4	Aishun_Jin_mix	CQTS050	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGACTCATCGTCAGTCGGAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGACCTGAATATTGCGGGTGGTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVQPGGSLRLSCAASGLIVSRNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLNIAGGFDIWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGAAAAGCCCCTAAGCTCCTGATCTATGCTGCATCGACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGACTTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACATCTTAATATTGACCCTATCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHLNIDPITFGQGTRLEIK	IGHV3-66*01	IGHJ3*02	IGHD2/OR15-2a*01,IGHD2/OR15-2b*01	IGKV1-9*01	IGKJ5*01	ARDLNIAGGFDI	QHLNIDPIT	nan	Patent: CN111925440A	MW587428.1	MW587429.1
4	Cho-C005	C1366	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTCGATCCAGCCTGGGGGGTCCCTAAGACTCTCCTGTGCAGCCTCTGGGGTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGATGGGGCTGGATTGGGTCTCAGTTATTTATCCCGGTGGAAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAACTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATTTGTCTACAATGGGAGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGSIQPGGSLRLSCAASGVTVSSNYMSWVRQAPGMGLDWVSVIYPGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLSTMGAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTTGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSLYTFGQGTKLEIK	IGHV3-53*01	IGHJ3*02	IGHD5-24*01,IGHD5/OR15-5a*01,IGHD5/OR15-5b*01	IGKV3-20*01	IGKJ2*01	ARDLSTMGAFDI	QQYGSLYT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
4	COV107	C565	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTAATTGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTCTTTATAGCGGTGGTAGCACATACTACGCAGATTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAGATGAACAGCCTGAGACCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATTTATCCGTCGTGGGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLIQPGGSLRLSCAASGLIVSSNYMNWVRQAPGKGLEWVSLLYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRPEDTAVYYCARDLSVVGAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTCTTCCCAGCACCTACTTAGCCTGGTACCAGCAGAAACGTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGACTTTGCAGTGTATTACTGTCAGCAGTATGGTACCTCACCTCGGGTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSLPSTYLAWYQQKRGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGTSPRVTFGPGTKVDIK	IGHV3-53*01	IGHJ3*02	IGHD1-26*01,IGHD3-16*02	IGKV3-20*01	IGKJ3*01	ARDLSVVGAFDI	QQYGTSPRVT	nan	Gaebler et al. Nature 591:639-644 (2021)	nan	nan
4	Wang-MOD6	MOD6_P2_IgG_D5-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCATCGTCAGTAGGAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAATTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTTTATTCCTGTGCGAGAGATAGGTCCACGAGAGGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFIVSRNYMSWVRQAPGKGLEWVSIIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYSCARDRSTRGAFDIWGQGTMVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAACATCTATTTAAATTGGTTTCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCCCCAGCGTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDINIYLNWFQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPPAFGPGTKVDIK	IGHV3-53*01	IGHJ3*02	nan	IGKV1-33*01,IGKV1D-33*01	IGKJ3*01	ARDRSTRGAFDI	QQYDNLPPA	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
5	IML3546	ADI-60682	nan	SARS-CoV-2,SARS-CoV	nan	SARS-CoV	SARS-CoV-2	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCGGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCATCTTCAGTAGATATGGCATGCACTGGGTCCGCCAGGCTCCAGGCGAGGGGCTGGAGTGGGTGGCAGTTATATTATATGATGGAAGTGATAAATACTATGCAGAGTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACATGCTGTATCTGCAGACGAGCAGCCTGAGAGTTGAGGACACGGCTGTGTATTACTGTGCGAAAGCTGACGGACCGTATTGTAGTGGTGGTAGCTGCTACTCCGCCGACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCTTCA	EVQLLESGGGVVQPGRSLRLSCAASGFIFSRYGMHWVRQAPGEGLEWVAVILYDGSDKYYAESVKGRFTISRDNSKNMLYLQTSSLRVEDTAVYYCAKADGPYCSGGSCYSADFDYWGQGTLVTVSS	nan	nan	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-39*01	nan	AKADGPYCSGGSCYSADFDY	QQSYTAPPT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457951.1	nan
5	COV021	COVD21_P1_HC_C4-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAGCGGGAGGGCCCTATTGTAGTGGTGGTAGCTGCTACTCCAGTTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKAGGPYCSGGSCYSSYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGTCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGAAACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCGATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGGCGATCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	EIVLTQSPVTLSLSPGERATLSCRASQSVSSRNLAWYQQKPGQAPRLLIDGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPAITFGQGTRLEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV3-20*01	IGKJ5*01	AKAGGPYCSGGSCYSSYFDY	QQYGSSPAIT	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293190.1	MW293645.1
5	COV047	C154	COV047_P5_IgG_87-P1369	SARS-CoV,SARS-CoV-2	nan	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTCGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATGTCATATGATGGAAGTAGTAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTGTCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAACAGGCGGGCCCATATTGTAGTGGTGGTAGCTGCTACTCCGCGCCCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSRYGMHWVRQAPGKGLEWVAVMSYDGSSKYYADSVKGRFTISRDNSKNTLCLQMNSLRAEDTAVYYCAKQAGPYCSGGSCYSAPFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGGCATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCGATCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	DIQMTQSPSSLSASVGDRVTITCQASQGISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPITFGQGTRLEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ5*01	AKQAGPYCSGGSCYSAPFDY	QQYDNLPIT	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293189.1	MW293644.1
5	Cho-C034	C2061	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	AGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGAAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGCAAGTAATAAAGACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACATGGCTGTGTATTACTGTGCGAAAGCCAACGCGCCTTATTGTAGTGGTGGTAACTGCTACTCGGGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	VQLVESGGGVVQPGRSLRLSCAASGFTFRSYGMHWVRQAPGKGLEWVAVISYDASNKDYADSVKGRFTISRDNSKNTLYLQMNSLRAEDMAVYYCAKANAPYCSGGNCYSGYFDYWGQGTLVTVSS	CATCCGGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAATTTGGTATCAGCTGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAGCAGGGGTCCCTTCAAGGTTCCGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCCCTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	IRMTQSPSSLSASVGDRVTITCQASQDISNYLIWYQLKPGKAPKLLIYDASNLEAGVPSRFRGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGPGTKVDIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ3*01	AKANAPYCSGGNCYSGYFDY	QQYDNLPLT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
5	Chen_Vax_p1	COV2-vax-33	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCCGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAGGAACACGCTGTATCTGCAATTGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAGCCCGGGGTCCATATTGTAGTGGTGGTAACTGCTATGTCGGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGPEWVAVISYDGSNKYYADSVKGRFTISRDNSRNTLYLQLNSLRAEDTAVYYCAKARGPYCSGGNCYVGYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAGAGCCCCTAAGCTCCTGATCTCCGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCTCTGACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGRAPKLLISDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGPGTKVDIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ3*01	AKARGPYCSGGNCYVGYFDY	QQYDNLPLT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555567.1	MZ555568.1
5	Cho-C006	C2206	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	AGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTCAGTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACTGATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGTTGTCTCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAATTGGGGGGCCCGTATTGTAGTGGTGGTAACTGCTACTCAGGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	VQLVESGGGVVQPGRSLRLSCAASGFTFSQYGMHWVRQAPGKGLEWVAVISYDGTDKYYADSVKGRFTISRDNSKNTLSLQMNSLRAEDTAVYYCAKLGGPYCSGGNCYSGYFDYWGQGTLVTVSS	GCCATCCGGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATTTTACTGTCAACAGTATGATAATCTCCCTCTCACTTTCGGCGGAAGGACCAAGGTGGAGATCAAAC	AIRMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATFYCQQYDNLPLTFGGRTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	AKLGGPYCSGGNCYSGYFDY	QQYDNLPLT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
5	Wang-MOD8	MOD8_P1_IgG_A12-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAATGAATGGAGTTTATTGTAGTGGTGGTAACTGCTACTCTGGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKMNGVYCSGGNCYSGYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTATTAGTAGCTGGTTGGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATAAGGCATCTAGTTTAGAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACCATCAGCAGCCTGCAGCCTGATGATTTTGCAACTTATTACTGCCAACAGTATAATAGTTATGGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYGTFGQGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-5*03	IGKJ1*01	AKMNGVYCSGGNCYSGYFDY	QQYNSYGT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
5	Wang-MOD8	MOD8_P1_IgG_E4-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTGATAAATACTATGCAGACTCCGTGAAGGGCCGAATCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAATGAATGGAGTTTATTGTAGTGGTGGTAACTGCTACTCTGGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSDKYYADSVKGRITISRDNSKNTLYLQMNSLRAEDTAVYYCAKMNGVYCSGGNCYSGYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTATTAGTAGCTGGTTGGCCTGGTATCAGCATAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATAAGGCATCTAGTTTAGAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACCATCAGCAGCCTGCAGCCTGATGATTTTGCAACTTATTACTGCCAACAGTATAATAGTTATGGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQHKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYGTFGQGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-5*03	IGKJ1*01	AKMNGVYCSGGNCYSGYFDY	QQYNSYGT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
5	Cho-C012	C2004	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATTATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAAATGGGGCCCCCTATTGTAGTGGTGGTAGCTGCTACTCCGGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVILYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKNGAPYCSGGSCYSGYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	AKNGAPYCSGGSCYSGYFDY	QQYDNLPLT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
5	Wang-C004	C1462	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTACAGTCTCTGGATTCACCTTCAGAAAGTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACCAATGATGGAACCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATTTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAGGGGGGGGAGAATATTGTAGTGGTGGTAACTGCTACCAGAGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCTVSGFTFRKYAMHWVRQAPGKGLEWVAVISYDGTNDGTNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGGGEYCSGGNCYQSYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGGGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAAATATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAGCATATTACTGTCAACAGTATGATAATCTCCCTCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISKYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDFAAYYCQQYDNLPLTFGGGTKVEIK	IGHV3-30-3*01,IGHV3-30-3*02	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	AKGGGEYCSGGNCYQSYFDY	QQYDNLPLT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
5	Wang-C004	C004_P2_IgG_H11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTACAGTCTCTGGATTCACCTTCAGAAAGTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACCAATGATGGAACCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATTTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAGGGGGGGGAGAATATTGTAGTGGTGGTAACTGCTACCAGAGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCTVSGFTFRKYAMHWVRQAPGKGLEWVAVISYDGTNDGTNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGGGEYCSGGNCYQSYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGGGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAAATATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAGCATATTACTGTCAACAGTATGATAATCTCCCTCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISKYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDFAAYYCQQYDNLPLTFGGGTKVEIK	IGHV3-30-3*01,IGHV3-30-3*02	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	AKGGGEYCSGGNCYQSYFDY	QQYDNLPLT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
5	Wang-C001	C001_P1_IgG_C3-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAGGTGGGGGCGTTTATTGTAGTGGTGGTAACTGCTACTCTCACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGGGVYCSGGNCYSHYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTATTAGTAGCTGGTTGGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATAAGGCGTCTAGTTTAGAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACCATCAGCAGCCTGCAGCCTGATGATTTTGCAACTTATTACTGCCAACAGTATAATATCCAGGGCACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNIQGTFGQGTKLEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-5*03	IGKJ2*02	AKGGGVYCSGGNCYSHYFDY	QQYNIQGT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
5	Wang-MOD4	Mod4_P4_IgG_B6-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGGAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATTCCATATGATGGAAGTAATAAATACTATGCAGGCTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAATTGCGGGTTCATATTGTAGTGGTGGTAACTGCTACGTAGGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFRSYGMHWVRQAPGKGLEWVAVIPYDGSNKYYAGSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKIAGSYCSGGNCYVGYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAATTTGGTATCAGCAGAAACCAGGGAAGGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAGCATATTACTGTCAACAGTATGATAATCTCCCGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLIWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDFAAYYCQQYDNLPLTFGGGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	AKIAGSYCSGGNCYVGYFDY	QQYDNLPLT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
5	IML3548	ADI-63045	nan	SARS-CoV-2,SARS-CoV	nan	SARS-CoV,SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCGCCTGTGCAGCCTCTGGATTCACCTTCAGTACCTACGGCATGCACTGGGTCCGTCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAGGTAATAAGTACTATGGAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGGCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAACAGACCGGGTCATATTGTAGTGGTGGTAACTGCTATATTGGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLLESGGGVVQPGRSLRLACAASGFTFSTYGMHWVRQAPGKGLEWVAVISYDGGNKYYGDSVKGRFTISRDNSKNTLYLQMNRLRAEDTAVYYCAKQTGSYCSGGNCYIGYFDYWGQGTLVTVSS	nan	nan	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33	nan	AKQTGSYCSGGNCYIGYFDY	QQYDNVPVT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458554.1	nan
5	Crowe_mix	COV2-2740	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAACTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCCGTAGATATGGCATGTACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACTGATAAATACTATACAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAAAGGGGGGGCCATACTGTGGTGGTGGTAACTGCTACGCGGGGTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFRRYGMYWVRQAPGKGLEWVAVISYDGTDKYYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKKGGPYCGGGNCYAGYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCTTCCTCCCTGTCTGCGTCTATAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAATATTAGAAGCTATTTAAACTGGTATCAGCACAAACCAGGGAAAGCCCCTAAACTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCGTCAAGGTTCAGTGGCAGTGAATCTGGGACAGACTTCACTCTCACCATCAGCAGTCTGCAGCCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTCCAGTTCCCCGATCACTTTTGGCCAGGGGACCAAGCTGGAGATCAAA	DIQMTQSPSSLSASIGDRVTITCRASQNIRSYLNWYQHKPGKAPKLLIYAASTLQSGVPSRFSGSESGTDFTLTISSLQPEDFATYYCQQSSSSPITFGQGTKLEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-39*01,IGKV1D-39*01	IGKJ2*01,IGKJ2*02	AKKGGPYCGGGNCYAGYFDY	QQSSSSPIT	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665578.1	MT665191.1
5	Crowe_mix	COV2-2944	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAACTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCCGTAGATATGGCATGTACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACTGATAAATACTATACAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAAAGGGGGGGCCATACTGTGGTGGTGGTAACTGCTACGCGGGGTACTTTGACTACTGGGGCCAGGGAATCCTGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFRRYGMYWVRQAPGKGLEWVAVISYDGTDKYYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKKGGPYCGGGNCYAGYFDYWGQGILVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAAGCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGATGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCTCTGGCTTTCGGCCCTGGGACCAAAGTGGATGTGAAA	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKAGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPDDIATYYCQQYDNLPLAFGPGTKVD	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ3*01	AKKGGPYCGGGNCYAGYFDY	QQYDNLPLA	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665559.1	MT665172.1
5	Cho-C012	C2046	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	AGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCATCAGTAGATATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATTATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAGTGGGGGGGCCCTATTGTGGTGGTGGTAGCTGCTACGGGGGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	VQLVESGGGVVQPGRSLRLSCAASGFTISRYGMHWVRQAPGKGLEWVAVILYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKVGGPYCGGGSCYGGYFDYWGQGTLVTVSS	GCCATCCGGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCCTCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCTGGGTTCGGCCCTGGGACCAAAGTGGATATCAAAC	AIRMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPGFGPGTKVDIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ3*01	AKVGGPYCGGGSCYGGYFDY	QQYDNLPG	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
5	Wang-PFZ10	PZF10_P2_IgG_F8-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAAAGGGAGGTCCTTATTGTAGTGGTGGTAGCTGCAACGTCGGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKKGGPYCSGGSCNVGYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCTCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	AKKGGPYCSGGSCNVGYFDY	QQYDNLPLT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
5	Cho-C006	C2013	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAATTGGGGGGCCCATATTGTAGTGGTGGTAGCTGCTACTCAGGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKLGGPYCSGGSCYSGYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCTCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	AKLGGPYCSGGSCYSGYFDY	QQYDNLPLT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
5	Wang-PFZ10	C690	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGAACCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAAGAAATACTATGGAGACTCCGTGAGGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTTTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAACAGGGAGGTCCTTATTGTAGTGGTGGTAACTGCAACGTCGGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVISYDGSKKYYGDSVRGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKQGGPYCSGGNCNVGYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAATTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCTCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGGAACATATTACTGTCAACAGTATGATAATCTGCCTCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKFLIYDASNLETGVSSRFSGSGSGTDFTFTISSLQPEDIGTYYCQQYDNLPLTFGGGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	AKQGGPYCSGGNCNVGYFDY	QQYDNLPLT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
5	Wang-PFZ10	PZF10_P1_IgG_H8-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGAACCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAAGAAATACTATGGAGACTCCGTGAGGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTTTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAACAGGGAGGTCCTTATTGTAGTGGTGGTAACTGCAACGTCGGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCTTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVISYDGSKKYYGDSVRGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKQGGPYCSGGNCNVGYFDYWGQGTLVTFSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAATTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCTCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGGAACATATTACTGTCAACAGTATGATAATCTGCCTCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKFLIYDASNLETGVSSRFSGSGSGTDFTFTISSLQPEDIGTYYCQQYDNLPLTFGGGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	AKQGGPYCSGGNCNVGYFDY	QQYDNLPLT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
5	Cho-C012	C2035	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	AGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAGTGGGGGGGCCCTATTGTAGTGGTGGTAGCTGCTACGGGGGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	VQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKVGGPYCSGGSCYGGYFDYWGQGTLVTVSS	GCCATCCGGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCTGGGTTCGGCCCTGGGACCAAGGTGGAGATCAAAC	AIRMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPGFGPGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ3*01	AKVGGPYCSGGSCYGGYFDY	QQYDNLPG	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
5	Graham_P008	P008_022	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCCGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAATGATGGGTCAATATTGTAGTGGTGGTGACTGCTACTCGGGTTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKMMGQYCSGGDCYSGYFDYWGQGTLVTVSS	GAAATAGTGATGACGCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGGTCTCGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGATGATATTGCAACATATTACTGTCAACAGTATGACAAACCCCCGGTGACGTTCGGCCAAGGGACCAAAGTGGATATCAAAC	EIVMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSRTDFTFTISSLQPDDIATYYCQQYDKPPVTFGQGTKVDIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ1*01	AKMMGQYCSGGDCYSGYFDY	QQYDKPPVT	nan	Graham et al. Immunity 54:1276-1289.e6 (2021)	MW802419.1	MW802312.1
5	Graham_P008	P008_024	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATTTCATATGATGGAAGTAATAAATATTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAATGGTTGGGCAATATTGTAGTGGTGGTAACTGCTACTTAGGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKMVGQYCSGGNCYLGYFDYWGQGTLVTVSS	GATATTGTGATGACCCAGTCTCCATCCTCCCTGTCCGCATCTGAAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAACAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAGCAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCTCCGGCTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIVMTQSPSSLSASEGDRVTITCQASQDINNYLNWYQQKPGKAPKLLIYDASNLEAGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPPAFGPGTKVDIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ3*01	AKMVGQYCSGGNCYLGYFDY	QQYDNLPPA	nan	Graham et al. Immunity 54:1276-1289.e6 (2021)	MW802421.1	MW802314.1
5	Wheatley-CP63	PDI_234	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAGACAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGGTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAGCAACTGGGACAATATTGTAGTGGTGGTAATTGCTACTCGGGATACTTTGACTACTGGGGCCAAGGAACCCTTGTCACCGTCTCCTCA	EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGDNKYYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTAVYYCAKQLGQYCSGGNCYSGYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATTCTCCCTGTCTGCGTCTGTAGGTGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTCGCAACTATTTAACTTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAGCAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCGTTTCTTTCGGCGGAGGGACCAAGGTGGAGATCAAA	DIQMTQSPFSLSASVGDRVTITCQASQDIRNYLTWYQQKPGKAPKLLIYDASNLEAGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLVSFGGGTKVEIK	IGHV3-30-3*01	IGHJ4*01	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	AKQLGQYCSGGNCYSGYFDY	QQYDNLVS	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
5	COV021	COVD21_P3_HC_H4-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAACCTCTGGATTCACCTTCAGTAGCTATGGCCTGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCACTTATATCATATGATGGAAGTGATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACACTTCCAAGAACACGCTGTTTCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTTTATTACTGTGCGAAAGTCATGGGGCCGTATTGTAGTGGTGGTAGCTGCTACTCGGGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCATSGFTFSSYGLHWVRQAPGKGLEWVALISYDGSDKYYADSVKGRFTISRDTSKNTLFLQMNSLRAEDTAVYYCAKVMGPYCSGGSCYSGYFDYWGQGTLVTVSS	GAAATTGTGTTGACACAGTCTCCAGCCACCCTGTCTTTGTCTCCTGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCTACTTAGCCTGGTACCAACAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGATGCATCCAACAGGGCCACTGGCATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGCCTAGAGCCTGAAGATTTTGCAGTTTATTACTGTCAGCAGCGTAGCAACTGGCCTCTGACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPLTFGGGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV3-11*01	IGKJ4*01	AKVMGPYCSGGSCYSGYFDY	QQRSNWPLT	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293191.1	MW293646.1
5	Wang-MOD8	MOD8_P2_IgG_C1-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGGTATGCCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGCTGGCAGTTATATTATATGATGGAAGTGATAAATACTATGCAGACTCCGTGAAGGGCCGAATCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCTAAAATGAATGGAGTTTATTGTAGTGGTGGTAATTGTTACTCTGGATACTCTGACTACTGGGGCCAGGGAACCCTGGTCTCCGTNTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSRYAMHWVRQAPGKGLEWLAVILYDGSDKYYADSVKGRITISRDNSKNTLYLQMNSLRAEDTAVYYCAKMNGVYCSGGNCYSGYSDYWGQGTLVSVSS	GACATCCAGATGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTATTAGTAGCTGGTTGGCCTGGTATCAGCATAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATAAGGCATCTAGTTTAGAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACCATCAGCAGCCTGCAGCCTGATGATTTTGCAACTTATTACTGCCAACAGTATAATAGTTATGGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQHKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYGTFGQGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-5*03	IGKJ1*01	AKMNGVYCSGGNCYSGYSDY	QQYNSYGT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
5	S564	S564-152	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 spike/RBD/NP/ORF8/HCoVspike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTTACTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATGGTATGATGGAAGTAATAAACACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTACTACTGTGCGAAAAATGCGGCCCCCTATTGTAGTGGTGGTAGCTGCTACGGTACCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSYYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKNAAPYCSGGSCYGTYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAACAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGGAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGACAATGTCCCTCCGCACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDINNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNVPPHTFGQGTKLEIK	IGHV3-33*06	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ2*01	AKNAAPYCSGGSCYGTYFDY	QQYDNVPPHT	nan	Dugan et al. Immunity 54:1290-1303.e7 (2021)	nan	nan
5	Cho-C034	C2141	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	AGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAACCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAAATTTAGGGATATATTGTAGTGGTGGTAGCTGCTACTCCGGGAGCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	VQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKNLGIYCSGGSCYSGSFDYWGQGTLVTVSS	GCCATCCGGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAAGATATTACTGTCAACAGTATGATAATTTCGCTCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	AIRMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIARYYCQQYDNFALTFGGGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	AKNLGIYCSGGSCYSGSFDY	QQYDNFALT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
5	Cho-C016	C2407	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	AGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATACAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAACAGGGAGGAATATATTGTAGTGGTGGTAGCTGCTACTCGGGTTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	VQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKQGGIYCSGGSCYSGYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGAGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCGATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCATCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCAGGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIDGASSRATGIPDRFSGSGSGTDFTLIISRLEPEDFAVYYCQQYGSSPGTFGQGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV3-20*01	IGKJ1*01	AKQGGIYCSGGSCYSGYFDY	QQYGSSPGT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
5	Wang-MOD11	Mod11_P2_IgG_G6-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACCTATGGCCTGCACTGGGTCCGTCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCTTATGATGGAGGTAATAAATACTCTGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAGTAGTGGGGGGATATTGTAGTGGTGGTAGCTGCTACTCGGGGAGTTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGLHWVRQAPGKGLEWVAVISYDGGNKYSADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKVVGGYCSGGSCYSGSFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTATTAGTAGCTGGTTGGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCCCCTGATCTATGATGCCTCCAGTTTGGAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACCATCAGCAGCCTGCAGCCTGATGATTTTGCAACTTATTACTGCCAACAGTATAATAGTTACGTTTCGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKPLIYDASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYVSFGQGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-5*01	IGKJ1*01	AKVVGGYCSGGSCYSGSFDY	QQYNSYVS	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
5	Wang-MOD11	Mod11_P2_IgG_E12-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTAACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAAAACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAACAAGCGGGCACATATTGTAGTGGTGGTAGCTGCTACGAGGGCTACTTTGATTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGLTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKNYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKQAGTYCSGGSCYEGYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTATTAGTAGCTGGTTGGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTCTGATGCCTCCAGTTTGGAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACCATCAGCAGCCTGCAGCCTGATGATTTTGCAACTTATTACTGCCAACAGTATTATAGTTATTCTCCAATGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLISDASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYYSYSPMYTFGQGTKLEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-5*01	IGKJ2*01	AKQAGTYCSGGSCYEGYFDY	QQYYSYSPMYT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
5	Wang-MOD4	Mod4_P4_IgG_G9-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGGAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAAAAAAGACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACTCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAACAAGCGGGGGTATATTGTAGTGGTGGTACCTGCTACGAAGGGTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFRSYGMHWVRQAPGKGLEWVAVISYDGSKKDYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKQAGVYCSGGTCYEGYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTCTGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGAGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCCGGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLISGASSRATGIPDRFSGSESGTDFTLTISRLEPEDFAVYYCQQYGSSPGTFGQGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV3-20*01	IGKJ1*01	AKQAGVYCSGGTCYEGYFDY	QQYGSSPGT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
5	Cho-C034	C2063	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	AGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCGGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATTATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAACAAGGCGGGACTTATTGTAGTGGTGGTAGCTGCGGCAGTGGGTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	VQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRRAPGKGLEWVAVILYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKQGGTYCSGGSCGSGYFDYWGQGTLVTVSS	GCCATCCGGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTATTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCGCTCACTTTCGGCGGAGGGACCAAGGTGGAAATCAAAC	AIRMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFIFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	AKQGGTYCSGGSCGSGYFDY	QQYDNLPLT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
5	COV072	COV072_P3_HC_37-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACATGTTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAACAAAATGGTTTATATTGTAGTGGTGGTAGCTGCTACTTGGGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNMLYLQMNSLRAEDTAVYYCAKQNGLYCSGGSCYLGYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTTTCAGCAGAAACCAGGGAAGGCCCCTAAGCTCCTGATCTACGCTGCATCCGATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCATCATATTACTGTCTACAGTATGATAATCTCCCGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWFQQKPGKAPKLLIYAASDLETGVPSRFSGSGSGTDFTFTISSLQPEDIASYYCLQYDNLPLTFGGGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	AKQNGLYCSGGSCYLGYFDY	LQYDNLPLT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
5	S144	S144-877	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 spike/RBD/NP/ORF8/HCoVspike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATATTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAACAGCAAGGCACCTATTGCAGTGGTGGTAACTGCTACTCGGGATATTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKQQGTYCSGGNCYSGYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCGAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTAGTTTTAGTATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATGTCCCTCTTACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFSFSISSLQPEDIATYYCQQYDNVPLTFGGGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	AKQQGTYCSGGNCYSGYFDY	QQYDNVPLT	nan	Dugan et al. Immunity 54:1290-1303.e7 (2021)	nan	nan
5	Wang-MOD8	MOD8_P1_IgG_B4-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTACAGTCTCTGGATTCACCTTCAGTCGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTTTGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGGACACGGTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAGCAACGGGGAACCTATTGTAGTGGTGGTAGCTGCTACTCTGGAGAATTTGACTACTGGGGCCAGGGAAACCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCTVSGFTFSRYGMHWVRQAPGKGLEWVAVISYDGSNKYFADSVKGRFTISRDNSKDTVYLQMNSLRAEDTAVYYCAKQRGTYCSGGSCYSGEFDYWGQGNLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTCTTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCCCCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNSLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPPYTFGQGTKLEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ2*01	AKQRGTYCSGGSCYSGEFDY	QQYDNLPPYT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
5	Aishun_Jin_mix	82F6	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFSRYGLHWVRQAPGKGLEWVGVILYDGSDEHYADSVKGRFTISRDNSKNTLDLQMNSLRPEDTAVYYCAKQASPYCSGGSCYSGNFDYWGQGTLVTVSS	nan	DIQMTQSPSSLSASVGDRVTITCQANQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQHDNVPLTFGGGTKVEIK	IGHV3-30*18	IGHJ4*02	IGHD2-15*01	IGKV1-33*01	IGKJ4*01	AKQASPYCSGGSCYSGNFDY	QQHDNVPLT	nan	Han et al. Front Immunol. 12:653189 (2021)	nan	nan
5	Aishun_Jin_mix	CQTS033	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTCGCTATGGCTTGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGGAGTTATATTATATGATGGAAGTGATGAACACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAATACGCTGGATCTGCAAATGAACAGCCTGAGACCTGAGGACACGGCTGTATATTACTGTGCCAAACAAGCCTCTCCGTATTGTAGTGGTGGTAGCTGCTACTCCGGGAATTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSRYGLHWVRQAPGKGLEWVGVILYDGSDEHYADSVKGRFTISRDNSKNTLDLQMNSLRPEDTAVYYCAKQASPYCSGGSCYSGNFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAATCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGCATGATAATGTCCCGCTCACTTTCGGCGGAGGGACCAAGGTTGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQANQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQHDNVPLTFGGGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	AKQASPYCSGGSCYSGNFDY	QQHDNVPLT	nan	Patent: CN111925441A	MW587408.1	MW587409.1
5	Wang-MOD6	MOD6_P2_IgG_B7-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGTTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGATGTATGTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAACAGGAGGGGGAGTATTGTAGTGGTGGTAGCTGCTACTCGGGGAACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTMYVQMNSLRAEDTAVYYCAKQEGEYCSGGSCYSGNFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTCGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGTGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTGCTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATCACTGTCAACAGTATAATAATTTTCCTCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDIRNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFAFTISSLQPEDIATYHCQQYNNFPLTFGGGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	AKQEGEYCSGGSCYSGNFDY	QQYNNFPLT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
5	Wang-MOD8	MOD8_P2_IgG_G9-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCGGTTATATCATATGATGGAAGTGAAAAATATTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAGCACCCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTTTATTACTGTGCGAAACAACGGGGACCCTATTGTAGTGGTGGTAGTTGCTACTCTGGAGAATTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVAVISYDGSEKYYADSVKGRFTISRDNSKSTLYLQMNSLRAEDTAVYYCAKQRGPYCSGGSCYSGEFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAATTCTTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCGAAACTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCCCCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNSLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPPYTFGQGTKLEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ2*01	AKQRGPYCSGGSCYSGEFDY	QQYDNLPPYT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
5	IML3550	ADI-63146	nan	SARS-CoV-2,SARS-CoV	nan	SARS-CoV	SARS-CoV-2	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGTCTGGGAGGTCCCTGAGACTCTCCTGTGTAGCCTCTGGATTCACCTTCAGTCACTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAATGGGTGGCAGTCATATTATATGATGGAAGTAATACATACTATGTAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAACTCCAAGAATACGTTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAACAGGAAGGTCCCTACTGTAGTGGTGGTAATTGCTACTCCGGATACTTCCAGTATTGGGGCCAGGGTAGCCTGGTCACCGTCTCCTCA	EVQLLESGGGVVQSGRSLRLSCVASGFTFSHYGMHWVRQAPGKGLEWVAVILYDGSNTYYVDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKQEGPYCSGGNCYSGYFQYWGQGSLVTVSS	nan	nan	IGHV3-30*18,IGHV3-30-5*01	IGHJ1*01	IGHD2-15*01	IGKV1-33	nan	AKQEGPYCSGGNCYSGYFQY	QQYDNLPLT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458655.1	nan
5	Wang-C004	C004_P1_IgG_E11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGTAGCCTCTGGATTCACCTTCAGTCGCTATGCCATGCACTGGGCCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATTTGATGGAAGTAATAGATATTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAACAGGGGGGGGAATATTGTAGTGGTTATAACTGCTACTCCGGGTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCVASGFTFSRYAMHWARQAPGKGLEWVAVISFDGSNRYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKQGGEYCSGYNCYSGYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACGATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGAGAATCTCCCCCTTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYENLPLFGGGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	AKQGGEYCSGYNCYSGYFDY	QQYENLPL	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
5	Wang-C004	C004_P2_IgG_G11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTCACTATGGCATACACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATTTCATTTGATGGAACTCATAAATACTATGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAACAGGGGGGCCCATATTGTAGTGGTGGTGTATGCTATACGGGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSHYGIHWVRQAPGKGLEWVAVISFDGTHKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKQGGPYCSGGVCYTGYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCACGACATTACCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGTATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACCTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASHDITNYLNWYQQKPGKAPKLLIYDVSNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPTFGPGTKVDIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-8*02	IGKV1-33*01,IGKV1D-33*01	IGKJ3*01	AKQGGPYCSGGVCYTGYFDY	QQYDNLPT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
5	COV072	COV072_P3_HC_3-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGTCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAACATTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATGTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTATGTATTACTGTGCGAAACAGTTGGGCCTATATTGTAGTGGTGGCAACTGCTACTCTGGGGCCCTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAVSGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKHYADSVKGRFTISRDNSKNTLYVQMNSLRAEDTAMYYCAKQLGLYCSGGNCYSGALDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCATTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPFTFGPGTKVDIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ3*01	AKQLGLYCSGGNCYSGALDY	QQYDNLPFT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
5	Aishun_Jin_mix	56A3	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV3-30*03	IGHJ4*02	IGHD2-15*01	IGLV1-40*01	IGLJ3*02	AKRGGTYCSGGICYGGYFDY	QSYDSSLSDWGV	nan	Han et al. Front Immunol. 12:653189 (2021)	nan	nan
5	Aishun_Jin_mix	CQTS108	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGTCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAGTAAATACTATGCAGACTCCGTGAAGGGCCGATCCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAAGGGGGGGGACCTATTGTAGTGGTGGTATCTGCTACGGGGGCTACTTTGACTACTGGGGCCAGGGAATGCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYVMHWVRQAPGKGLEWVAVISYDGSSKYYADSVKGRSTISRDNSKNTLYLQMNSLRAEDTAVYYCAKRGGTYCSGGICYGGYFDYWGQGMLVTVSS	CAGTCTGTGCTGACGCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCGTCTCCTGCACTGGGAGCAGCTCCAACATCGGGGCAGGTTATGATGTACAGTGGTACCAGCACCTTCCAGGAACAGCCCCCAAACTCCTCATCTATGGTAACACCAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAGCAGCCTGAGTGATTGGGGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPPSVSGAPGQRVTVSCTGSSSNIGAGYDVQWYQHLPGTAPKLLIYGNTNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSDWGVFGGGTKLTVL	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGLV1-40*01	IGLJ3*02	AKRGGTYCSGGICYGGYFDY	QSYDSSLSDWGV	nan	Patent: CN111909261A	MW587516.1	MW587517.1
5	Cho-C034	C2058	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	AGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGACATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAGATGAACAGCCTGAGAGCTGAGGACACGGCTGTCTATTACTGTGCGAAAAGGGGCGGGACTTATTGTAGTGGTGGTAGCTGCGGCAGTGGGTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	VQLVESGGGVVQPGRSLRLSCAASGFTFSSYDMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKRGGTYCSGGSCGSGYFDYWGQGTLVTVSS	GCCATCCGGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCGCTCACTTTCGGCGGAGGGACCAAGGTGGAAATCAAAC	AIRMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	AKRGGTYCSGGSCGSGYFDY	QQYDNLPLT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
5	COV107	COV107_Plate2_HC_3-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATTATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAATCATTGGGCCCATATTGTAGTGGTGGTAACTGCTACTCCTCCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVILYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKSLGPYCSGGNCYSSYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTATTAGTAGCTGGTTGGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGAGGCGTCTAGTTTAGAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACCATCAGCAGCCTGCAGCCTGATGATTTTGCAACTTATTACTGCCAACAGTATAATAGTTATTCGACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYEASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSTFGPGTKVDIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-5*03	IGKJ3*01	AKSLGPYCSGGNCYSSYFDY	QQYNSYST	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
5	Wang-MOD8	MOD8_P1_IgG_C9-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCGTTTGATGGAAGTAATAAATACTATGCAGACTCCCTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAACGGTGGGACTGTATTGTAGTGGTGGTAGCTGCTACTCAGGGGTGTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISFDGSNKYYADSLKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKTVGLYCSGGSCYSGVFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAACCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACATATTACTGTCAACAGTATGATAATCTTCCATTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPNLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDFATYYCQQYDNLPFTFGPGTKVDIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ3*01	AKTVGLYCSGGSCYSGVFDY	QQYDNLPFT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
5	Wang-MOD8	MOD8_P1_IgG_E6-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCGTTTGATGGAAGTAATAAATACTATGCAGACTCCCTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAACGGTGGGACTGTATTGTAGTGGTGGTAGCTGCTACTCAGGGGTGTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISFDGSNKYYADSLKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKTVGLYCSGGSCYSGVFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAACCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACATATTACTGTCAACAGTATGATAATCTTCCATTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPNLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDFATYYCQQYDNLPFTFGPGTKVDIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ3*01	AKTVGLYCSGGSCYSGVFDY	QQYDNLPFT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
5	COV021	C016	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV,SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGATATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAGTGACCGCCCCTTATTGTAGTGGTGGTAGCTGCTACGGAGGTAACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGVVQPGRSLRLSCAASGFTFSRYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKVTAPYCSGGSCYGGNFDYWGQGTLVTVSS	GCCATCCGGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGCGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAACAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCTCCTACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	AIRMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTINSLQPEDIATYYCQQYDNLPPTFGGGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	AKVTAPYCSGGSCYGGNFDY	QQYDNLPPT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
6	IML3558	ADI-63197	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:NTD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCACCTTGAAGGAGTCTGGTCCTGCGCTGGTGAAACCCACACAGACCCTCACACTGACCTGCACCTTCTCTGGCCTCTCACTCAGTACTAGTGCAATGTGTGTGAGTTGGATCCGTCAGCCCCCAGGGAAGGCCCTGGAGTGGCTCGCACTCATTGATTGGGATGATGACAAATACTACAGCACATCTCTGAGGACCAGGCTCACCATCTCCAAGGACACCTCCAAAAACCAGGTGGCCCTTACAATGACCAACATGGACCCTGTGGACACAGGCACGTATTACTGTGCACACACACGGGGTGGATACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVTLKESGPALVKPTQTLTLTCTFSGLSLSTSAMCVSWIRQPPGKALEWLALIDWDDDKYYSTSLRTRLTISKDTSKNQVALTMTNMDPVDTGTYYCAHTRGGYYYYGMDVWGQGTTVTVSS	nan	nan	IGHV2-70*01	IGHJ6*02	IGHD2-15*01,IGHD2-21*01,IGHD2-21*02	IGKV1/OR2-108	nan	AHTRGGYYYYGMDV	LQDYTTPWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458706.1	nan
6	IML3558	ADI-63185	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:NTD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTTGTGCAGTCTGGTCCTGCGCTGGTGAAACCCACACAGACCCTCACACTGACCTGCACCTTCTCTGGGTTCTCACTCAGCACTAATGAAGTTTGTGTGAGCTGGATCCGTCAGCCCCCAGGGAAGGCCCTGGAGTGGCTTGCAGTCATTGATTGGGATGATGATAAGTACTACATCACATCTCTGAAGACCAGGCTCTCCATCTCCAAGGACACCTCCAAAAACCAGGTGGTCCTTACAATGACCAACATGGACCCTGTGGACACAGCCACGTATTACTGTGCACTGACACGGGGTGGATATTACCCATACGGAATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLVQSGPALVKPTQTLTLTCTFSGFSLSTNEVCVSWIRQPPGKALEWLAVIDWDDDKYYITSLKTRLSISKDTSKNQVVLTMTNMDPVDTATYYCALTRGGYYPYGMDVWGQGTTVTVSS	nan	nan	IGHV2-70*01	IGHJ6*02	IGHD3-22*01	IGKV1/OR2-108	nan	ALTRGGYYPYGMDV	LQDHSTPWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458694.1	nan
6	IML3549	ADI-63120	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGGCTCTGGATTCACTTTCAGTACCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCACTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAGATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCCCAAACTAGGGGGGGCAGTTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLLESGGGVVQPGRSLRLSCAGSGFTFSTYGMHWVRQAPGKGLEWVALISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAQTRGGSYYYGMDVWGQGTTVTVSS	nan	nan	IGHV3-30*03,IGHV3-30*18,IGHV3-30-5*01	IGHJ6*02	IGHD1-7*01,IGHD3-16*01,IGHD3-16*02	IGKV1-39*01	nan	AQTRGGSYYYGMDV	QQTYNTPVFT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458629.1	nan
6	Graham_P054	P054_045	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCACTTATATCATATGATGGAGGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAACAAGAGGTGGGAGTTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCTTCA	EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVALISYDGGNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARTRGGSYYYGMDVWGQGTTVTVSS	GAAATTGTGTTGACGCAGTCTCCATCCTCCCTGTCAGCATCTGTGGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCCCACCATCAGCAGTCTGCAGCCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCCCCGTACACTTTTGGCCAGGGGACCAAGGTGGAGATCAAAC	EIVLTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTPTISSLQPEDFATYYCQQSYSTPPYTFGQGTKVEIK	IGHV3-30*03,IGHV3-30*19,IGHV3-30-3*01	IGHJ6*02	IGHD1-26*01	IGKV1-39*01,IGKV1D-39*01	IGKJ2*01	ARTRGGSYYYGMDV	QQSYSTPPYT	nan	Graham et al. Immunity 54:1276-1289.e6 (2021)	MW802485.1	MW802378.1
6	IML3564	ADI-62102	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACCTATGCTGTACACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACTCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGGGCAGCTTTAGGAAACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLLESGGGVVQPGRSLRLSCAASGFTFSTYAVHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARAALGNYYYGMDVWGQGTTVTVSS	nan	nan	IGHV3-30-3*01	IGHJ6*02	IGHD6-13*01,IGHD6-6*01	IGKV1-39*01	nan	ARAALGNYYYGMDV	QQSYNTPLT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458194.1	nan
6	Jennewein_CV2	CV2-55	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTTGTTGAGTCTGGTGGTGGGGTAGTGCAACCAGGGCGAAGCCTGAGGCTGTCATGTGCCGCAAGCGGGTTCACGTTTAGTAGCTATGCGATGCATTGGGTGAGGCAGGCACCCGGCAAAGGTCTTGAGTGGGTGGCAGTAATATCTTACGACGGGTCCAATAAATATTACGCGGATTCCGTAAAAGGCAGATTTACGATAAGTCGCGATAATAGTAAAAACACCCTTTACTTGCAAATGAATAGCTTGCGCGCAGAAGATACTGCTGTTTACTATTGTGCGCGCGCTCTTACGGGCAACTATTATTACGGGATGGACGTGTGGGGGCAAGGGACAACGGTCACAGTAAGTTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARALTGNYYYGMDVWGQGTTVT	GACATCCAGATGACCCAGAGTCCATCCTCATTGTCAGCAAGTGTGGGTGATAGGGTAACGATTACATGCCGGGCTTCCCAGTCTATATCTTCCTACTTGAACTGGTACCAACAAAAGCCCGGCAAAGCTCCTAAACTTCTCATATACGCGGCATCAAGCCTCCAAAGTGGCGTACCATCAAGATTTAGTGGGTCCGGCAGCGGAACCGATTTTACGCTGACGATTAGTTCCCTTCAACCAGAGGACTTCGCCACTTATTACTGCCAGCAGTCCTATAGCACACCCTTTACTTTTGGCCCAGGTACGAAAGTCGATATAAAA	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPFTFG	IGHV3-30-3*01,IGHV3-30-3*02	IGHJ6*01	IGHD3-16*01,IGHD3-16*02,IGHD3-3*01	IGKV1-39*01,IGKV1D-39*01	IGKJ2*01,IGKJ2*02	ARALTGNYYYGMDV	QQSYSTPFT	nan	Jennewein et al. Cell Rep. 36:109353 (2021)	MW681718.1	MW681719.1
6	Li_SARS2_26	DH1145	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAIISYDGTNKYYPDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARANGGNYYYGMDVWGQGTTVTVSS	nan	EIVLTQSPSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPPGFALGPGSKSNNL	IGHV3-30*01	IGHJ6	nan	IGKV3-20*01	IGKJ3	ARANGGNYYYGMDV	QQYGSSPPGFA	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
6	Li_SARS2_26	H712073+H712073	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:S2	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAIISYDGTNKYYPDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARANGGNYYYGMDVWGQGTTVTVSS	nan	QSALTQSASVSGSPGQSITISCTGTSSDIAAYNYVSWYQQHPGEVPKLLVYDVSNRPSGVSDRFAGSRSGNTAYLTISGLQAEDDADYYCSSYTSSGGLVFGGGTKATVL	IGHV3-30*01	IGHJ6	nan	IGLV2-14*03	IGLJ3	ARANGGNYYYGMDV	SSYTSSGGLV	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
6	Li_SARS2_26	H712073+L711482	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:S2	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAIISYDGTNKYYPDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARANGGNYYYGMDVWGQGTTVTVSS	nan	SYELTQPLSVAVAPGETARITCSGDALSEEYTHWYQQRPGQASVLIIYKDTERPSGIPERFSGSTSGTTVTLTISGVQAEDEADYYCQSPDTTSTYRVFGGGTKLTVL	IGHV3-30*01	IGHJ6	nan	IGLV3-25*02	IGLJ3	ARANGGNYYYGMDV	QSPDTTSTYRV	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
6	Crowe_mix	COV2-2564	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGTTACGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGATACAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGCCCAGGGGGGGAACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGYNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARAQGGNYYYGMDVWGQGTTVTVSS	TCCTATGTGCTGACTCAGCCACCCTCGGTGTCAGTGGCCCCAGGAAAGACGGCCAGGATTACCTGTGGGGGAAACAACATTGGAACTAAAGGTGTGCACTGGTACCAGCAGAAGCCAGGCCAGGCCCCTGTGCTGGTCGTCTATGATGATAGCGACCGGCCCTCAGGGATCCCTGGGCGATTCTCTGGCTCCAACTCTGGGAACACGGCCACCCTGACCATCAGCAGGGTCGAAGCCGGGGATGAGGCCGACTATTTCTGTCAGGTGTGGGATAGTAGTAGTGATCATCATGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTA	SYVLTQPPSVSVAPGKTARITCGGNNIGTKGVHWYQQKPGQAPVLVVYDDSDRPSGIPGRFSGSNSGNTATLTISRVEAGDEADYFCQVWDSSSDHHVVFGGGTKLTVL	IGHV3-30-3*01	IGHJ6*02	IGHD3-16*01,IGHD3-16*02	IGLV3-21*03	IGLJ2*01,IGLJ3*01	ARAQGGNYYYGMDV	QVWDSSSDHHVV	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665773.1	MT665386.1
6	Crowe_mix	COV2-2844	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGGAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCATCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCGTATGATGGAGGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGCCCAGGGGGGGAACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVELVESGGGVVQPGRSLRLSCAASGFIFSSYAMHWVRQAPGKGLEWVAVISYDGGNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARAQGGNYYYGMDVWGQGTTVTVSS	TCCTATGTGCTGACTCAGCCACCCTCGGTGTCAGTGGCCCCAGGAAAGACGGCCAGGATTACCTGTGGGGGAAACAACATTGGAAGTAAAAATGTGCACTGGTACCAGCAGAAGCCAGGCCAGGCCCCTGTGAAGGTCGTCTATCATGATGGCGACCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACGGCCACCCTGACCATCAACAGGGTCGAAGCCGGGGATGAGGCCGACTATTCCTGTCAGGTGTGGGATAGTAGTAGTGATCATCATGTGGTTTTCGGCGGAGGGACCAAGCTGACCGTCCTA	SYVLTQPPSVSVAPGKTARITCGGNNIGSKNVHWYQQKPGQAPVKVVYHDGDRPSGIPERFSGSNSGNTATLTINRVEAGDEADYSCQVWDSSSDHHVVFGGGTKLTVL	IGHV3-30-3*01	IGHJ6*02	IGHD3-16*01,IGHD3-16*02	IGLV3-21*03	IGLJ2*01,IGLJ3*01	ARAQGGNYYYGMDV	QVWDSSSDHHVV	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665746.1	MT665359.1
6	Li_SARS2_26	DH1147	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYPDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARARGGNYYYGMDVWGQGTTVTVSS	nan	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPNTFGQGTKLEIK	IGHV3-30*01	IGHJ6	nan	IGKV1-39*01	IGKJ2	ARARGGNYYYGMDV	QQSYSTPNT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
6	IML3550	ADI-62175	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTTCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGTTCCAGGCAAGGGGCTGGAGTGGGTGGCACTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTTTTACTGTGCGAGAGCAACTCGAGGGAACTACTACTACGGTATGGACGTCTGGGGCCTAGGGACCACGGTCACCGTCTCCTCA	QVQLQESGGGVVQPGRSLRLSCSASGFTFSSYGMHWVRQVPGKGLEWVALISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVFYCARATRGNYYYGMDVWGLGTTVTVSS	nan	nan	IGHV3-30*03	IGHJ6*02	IGHD1-1*01,IGHD4-23*01	IGKV1-39*01	nan	ARATRGNYYYGMDV	QQSYSTPYT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458267.1	nan
6	Jennewein_CV2	CV2-45	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTCGTGGAGAGTGGGGGTGGAGTTGTGCAACCGGGCAGATCCCTTCGACTTTCATGCGCTGCGAGCGGATTCACCTTCAGTTCTTATGCAATGCATTGGGTTCGGCAAGCGCCGGGAAAGGGTCTTGAGTGGGTAGCGGTAATATCATACGATGGTAGTAATAAGTACTATGCCGATTCCGTAAAAGGCCGCTTCACGATCTCCCGAGACAACAGTAAAAATACACTTGATTTGCAGATGAACAGTCTTCGGGCGGAGGATACCGCTGTCTACTATTGTGCCCGCGCGTATGGGGGAAATTATTACTACGGGATGGATGTCTGGGGACAGGGAACGACCGTTACTGTAAGCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLDLQMNSLRAEDTAVYYCARAYGGNYYYGMDVWG	GCCATCCAGCTCACTCAAAGTCCCAGTTCTCTCTCCGCATCTGTTGGGGACAGAGTTACTATAACGTGCCGAGCAAGTCAGGGCATAAGTAGTGCGCTTGCTTGGTACCAACAGAAACCTGGAAAAGCACCCAAGCTGCTGATATACGATGCCTCTAGCCTTGAAAGCGGCGTGCCGAGTCGCTTTTCCGGCTCTGGGTCTGGAACGGACTTTACCCTCACAATCTCCTCCCTTCAACCAGAAGATTTTGCCACGTACTATTGTCAACAGTTTAATAACTATCCATTGACATTTGGTGGGGGGACGAAAGTAGAAATAAAA	AIQLTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNNYP	IGHV3-30*11,IGHV3-30*17,IGHV3-33*05	IGHJ6*01,IGHJ6*02,IGHJ6*04	IGHD3-16*01,IGHD3-16*02	IGKV1D-13*01	nan	ARAYGGNYYYGMDV	nan	nan	Jennewein et al. Cell Rep. 36:109353 (2021)	MW681700.1	MW681701.1
6	Shiakolas_Cellero	Shiakolas_5317-8	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV3-30-3	IGHJ6	nan	IGLV3-1	IGLJ1	ARAYGGNYYYGMDV	QAWDSSTASFV	nan	Shiakolas et al. bioRxiv. DOI: 10.1101/2021.06.02.446813 (2021)	nan	nan
6	IML3558	ADI-63242	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGTCTCTGGATTCATATTCAGTAGTTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTAGAGTGGGTGGCACTTATATCATATGATGGAAGTAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAACCCCAAGAACATGCTGTATGTGCAAATGAACAGCCTGAGAGCTGACGACACGGCTGTGTATTACTGTGCGAGAGCCAAGGGCGGCGGATACTACTACGGTATGGACGTCTGGGGCCAGGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGVVQPGRSLRLSCAVSGFIFSSYAMHWVRQAPGKGLEWVALISYDGSNKYYADSVKGRFTISRDNPKNMLYVQMNSLRADDTAVYYCARAKGGGYYYGMDVWGQGTTVTVSS	nan	nan	IGHV3-30*01	IGHJ6*02	IGHD6-25*01	IGKV1-9	nan	ARAKGGGYYYGMDV	QQLNSYPTYT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458751.1	nan
6	Tong_G32	G32M2	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike (and spike minus RBD)	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCCGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAACAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTATGTATTACTGTGCGAGAGCAAAAGGCGGGGGCTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGNNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAMYYCARAKGGGYYYGMDVWGQGTTVTVSS	TCCTATGAGCTGACACAGCCACCCTCGGTGTCAGTGGCCCCAGGACAGACGGCCAGGATTACCTGTGGGGGAAACAACATTGGAAGTAAAAGTGTGCACTGGTACCAGCAGAAGCCAGGCCAGGCCCCTGTGCTGGTCGTCTATGATGATAGCGACCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACGGCCACCCTGACCATCAGCAGGGTCGAAGCCGGGGATGAGGCCGACTATTACTGTCAGGTGTGGGATAGTAGTAGTGATCCTTATTGGGTGTTCAGCGGAGGGACCAAGCTGACCGTCCTA	SYELTQPPSVSVAPGQTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDPYWVFSGGTKLTVL	IGHV3-30-3*01	IGHJ6*02	IGHD3-10*01,IGHD3-10*02,IGHD3-16*01	IGLV3-21*02	IGLJ3*02	ARAKGGGYYYGMDV	QVWDSSSDPYWV	nan	Tong et al. Cell 184:4969-4980.e15 (2021)	MW718467.1	MW718619.1
6	IML3558	ADI-63244	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCTTTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACCCATGCTTTACACTGGGTCCGCCAGGCTCCAGGCAGGGGGCTGGAGTGGATGACACTTATATCATATGATGGAATTAATAAATACTACGCAGACTCCGTGAACGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACACTGTATCTGCAAATGAACAGCCTGAGACCTGAGGACACGGCTGTATATTACTGTGCGAGAGCCCGCGGGGGATCGTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLLESGGGVVQPGRSLRLSCAASGFTFSTHALHWVRQAPGRGLEWMTLISYDGINKYYADSVNGRFTISRDNSKNTLYLQMNSLRPEDTAVYYCARARGGSYYYGMDVWGQGTTVTVSS	nan	nan	IGHV3-30*04,IGHV3-30-3*03	IGHJ6*02	IGHD3-16*01,IGHD3-16*02	IGKV1-39*01	nan	ARARGGSYYYGMDV	QQSYSSPLT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458753.1	nan
6	Li_SARS2_26	DH1202	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAIISYDGSNKYYADSVKGRFAISRENSKNTLYLQMNSLRAEDTAVYYCARAYSGGYYYGMDVWGQGTTVAVSS	nan	DIQMTQSPSSLSASVGDRVTITCRASQTIISYLNWYQQKPGKAPNLLIYAASSLQSGVPSRFSGSGSGTAFTLTISSLQPEDFATYYCQQSYSLHSFGQGTKLEIK	IGHV3-30*09	IGHJ6	nan	IGKV1-39*01	IGKJ2	ARAYSGGYYYGMDV	QQSYSLHS	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
6	IML3558	ADI-60572	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGACCGCAAAGGGTGGGAGCTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLLESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCATAKGGSYYYGMDVWGQGTTVTVSS	nan	nan	IGHV3-30*03,IGHV3-30*18,IGHV3-30-5*01	IGHJ6*02	IGHD1-26*01	IGKV1-39*01	nan	ATAKGGSYYYGMDV	QQSYSTPYT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457903.1	nan
6	Li_SARS2_26	H712485+K711969	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:S2	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASEFTFSSYAMHWVRQAPGKGLEWVALISYDGSNEYYADSVKGRFTVSRDNSKTTLYLQMNSLRAEDTAVYYCARARSGSYYYGMDVWGQGTTVTVSS	nan	DIQMTQSPASLSASVGDRLTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSAPRLTFGGGTKVEIK	IGHV3-30*01	IGHJ6	nan	IGKV1-39*01	IGKJ4	ARARSGSYYYGMDV	QQSYSAPRLT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
6	Li_SARS2_26	DH1149	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVALISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRADDTALYYCARATRGSYYYGMDVWGQGTTVTVSS	nan	DIQMTQSPSSLSASVGDRVTITCRASQSISSFLNWYQQKPGKAPKLLIYAASTLQSGVPSRFSGGGSGTDFTLTISSLQPEDFATYFCQQSYSTEFTFGPGTKVDIK	IGHV3-30*01	IGHJ6	nan	IGKV1-39*01	IGKJ3	ARATRGSYYYGMDV	QQSYSTEFT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
6	IML3550	ADI-60756	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGCCTGGAGTGGGTGGCAGTTATATCATATGATGGAACCAATAAATACTACGCGGACTCCGTGAGGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAAGTCGGGGTGGGAGCTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVISYDGTNKYYADSVRGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSRGGSYYYGMDVWGQGTTVTVSS	nan	nan	IGHV3-30-3*01	IGHJ6*02	IGHD1-26*01	IGKV1-5	nan	ARSRGGSYYYGMDV	QQYNSYLWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458025.1	nan
6	Crowe_mix	COV2-2147	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV,SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGCGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAATGGGTGGCAGTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAAGCACGAGTGGGAGCTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLAESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSTSGSYYYGMDVWGQGTTVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGATTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGAATATTACTGCAGCTCATATACAAGCAGCAGCACTCTACTTTATGTCTTCGGAACTGGGACCAAGGTCACCGTCCTA	QSALTQPASVSGSPGQSITISCTGTSSDVGDYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEAEYYCSSYTSSSTLLYVFGTGTKVTVL	IGHV3-30-3*01	IGHJ6*02	IGHD1-26*01	IGLV2-14*03	IGLJ1*01	ARSTSGSYYYGMDV	SSYTSSSTLLYV	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665651.1	MT665264.1
6	Crowe_mix	COV2-2159	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGCGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAATGGGTGGCAGTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAAGCACGAGTGGGAGCTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLAESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSTSGSYYYGMDVWGQGTTVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGATTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGAATATTACTGCAGCTCATATACAAGCAGCAGCACTCTACTTTATGTCTTCGGAACTGGGACCAAGGTCACCGTCCTA	QSALTQPASVSGSPGQSITISCTGTSSDVGDYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEAEYYCSSYTSSSTLLYVFGTGTKVTVL	IGHV3-30-3*01	IGHJ6*02	IGHD1-26*01	IGLV2-14*03	IGLJ1*01	ARSTSGSYYYGMDV	SSYTSSSTLLYV	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665797.1	MT665410.1
6	Crowe_mix	COV2-2160	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGCGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAATGGGTGGCAGTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAAGCACGAGTGGGAGCTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLAESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSTSGSYYYGMDVWGQGTTVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGATTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGAATATTACTGCAGCTCATATACAAGCAGCAGCACTCTACTTTATGTCTTCGGAACTGGGACCAAGGTCACCGTCCTA	QSALTQPASVSGSPGQSITISCTGTSSDVGDYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEAEYYCSSYTSSSTLLYVFGTGTKVTVL	IGHV3-30-3*01	IGHJ6*02	IGHD1-26*01	IGLV2-14*03	IGLJ1*01	ARSTSGSYYYGMDV	SSYTSSSTLLYV	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665795.1	MT665408.1
6	Crowe_mix	COV2-2341	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGCGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAATGGGTGGCAGTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAAGCACGAGTGGGAGCTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLAESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSTSGSYYYGMDVWGQGTTVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGATTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGAATATTACTGCAGCTCATATACAAGCAGCAGCACTCTACTTTATGTCTTCGGAACTGGGACCAAGGTCACCGTCCTA	QSALTQPASVSGSPGQSITISCTGTSSDVGDYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEAEYYCSSYTSSSTLLYVFGTGTKVTVL	IGHV3-30-3*01	IGHJ6*02	IGHD1-26*01	IGLV2-14*03	IGLJ1*01	ARSTSGSYYYGMDV	SSYTSSSTLLYV	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665739.1	MT665352.1
6	IML3549	ADI-63136	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGGTTCACCTTCAATACCTATGGCATGCACTGGGTTCGCCAGGCTCCAGGCAAGGGGCTGGACTGGGTGGCACTTATATCATATGATGGGATTAATAAATACTATACAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACACTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTCTATTACTGTGCGAGAACAAATAGTGGGAGCTATTACTACGGTATGGACGTCTGGGGCCTAGGGACCACGGTCACCGTCTCCTCA	EVQLLESGGGVVQPGRSLRLSCAASGFTFNTYGMHWVRQAPGKGLDWVALISYDGINKYYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARTNSGSYYYGMDVWGLGTTVTVSS	nan	nan	IGHV3-30*03,IGHV3-30*19,IGHV3-33*05	IGHJ6*02	IGHD1-26*01	IGKV1-9	nan	ARTNSGSYYYGMDV	QQLNSYPPFT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458645.1	nan
6	Jennewein_CV2	CV2-29	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAACTCGTCGAATCCGGTGGCGGTGTGGTCCAGCCGGGAAGATCCTTGCGGTTGAGCTGTGCCGCAAGTGGCTTCACTTTTTCCACATACGCCATGCACTGGGTGAGGCAAGCTCCGGGCAAGGGGCTCGAATGGGTGGCCGTCATCTCATACGACGGATCTAACAAGTACTACGCTGATAGCGTAAAGGGTCGGTTCACGATAAGTAGAGATAACTCAAAAAATACTCTCTACCTTCAGATGAACAGCCTTCGCGCGGAAGATACCGCCGTATATTACTGCGCGAGAGCTTACGGCGGTTCTTACTTTTACGGTATGGACGTCTGGGGGCAAGGTACAACAGTAACCGTATCTTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARAYGGSYFYGMDVWGQGTTVTVSS	GAAATAGTCCTCACTCAGTCCCCTGGCACACTCAGCCTGTCCCCGGGTGAAAGAGCGACCCTCAGTTGCCGAGCATCTCAATCCGTCTCTTCCAGTTATCTGGCCTGGTACCAACAGAAGCCAGGGCAAGCTCCTCGCTTGCTTATCTATGGGGCCAGTTCCAGGGCAACTGGGATACCCGATAGATTCTCAGGTTCAGGGAGCGGCACTGACTTCACGCTTACTATATCCCGACTCGAACCGGAAGACTTTGCGGTGTATTACTGTCAGCAATATGGTAGCTTCGGGGGAGGTACAAAAGTGGAAATTAAA	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSFGGGTKVEIK	IGHV3-30*14,IGHV3-30*17	IGHJ6*01	IGHD3-22*01	IGKV3-20*01	IGKJ1*01	ARAYGGSYFYGMDV	nan	nan	Jennewein et al. Cell Rep. 36:109353 (2021)	MW681670.1	MW681671.1
6	Jennewein_CV1	CV1-34	CV34	SARS-CoV-2	SARS-CoV	nan	SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGTTGGTTGAATCCGGTGGTGGCGTAGTGCAACCGGGCCGGAGCCTTAGGCTGTCCTGTGCAGCTTCAGGGTTCACTTTCAGCTCTTACGCCATGCACTGGGTACGACAAGCACCGGGGAAAGGTCTGGAGTGGGTTGCGGTTATTTCCTACGACGGCAGCAACAAATATTACGCTGATTCAGTTAAAGGACGATTCACGATTTCTAGAGACAATAGCAAAAATACTCTGTACCTTCAAATGAATTCTCTGAGAGCCGAGGATACCGCCGTGTATTACTGCGCGAGGTCCTATGGAGGAAGTTACTACTACGGCATGGATGTTTGGGGTCAAGGGACCACTGTAACCGTCTCTTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSYGGSYYYGMDVWGQGTTVTVSS	TCCTATGAGTTGACTCAGCCTCATAGCGTATCAGTCGCAACTGCACAGATGGCGCGCATCACATGCGGTGGAAACAATATAGGCAGTAAGGCGGTACATTGGTATCAGCAAAAACCTGGTCAAGACCCCGTGTTGGTAATCTACTCCGATTCAAATCGACCCTCAGGGATTCCAGAACGCTTCTCCGGGTCAAATCCGGGGAACACGGCTACACTCACTATAAGCAGAATTGAAGCGGGAGATGAGGCGGACTATTACTGTCAAGTATGGGATTCCAGCTCAGATCATGTTGTCTTCGGGGGCGGCACAAAACTCACAGTCCTA	SYELTQPHSVSVATAQMARITCGGNNIGSKAVHWYQQKPGQDPVLVIYSDSNRPSGIPERFSGSNPGNTATLTISRIEAGDEADYYCQVWDSSSDHVVFG	IGHV3-30*14,IGHV3-30-3*01	IGHJ6*01,IGHJ6*02	IGHD3-10*01,IGHD4/OR15-4a*01,IGHD4/OR15-4b*01	IGLV3-12*02	IGLJ1*01	ARSYGGSYYYGMDV	QVWDSSSDHVV	nan	Jennewein et al. Cell Rep. 36:109353 (2021);Seydoux et al. Immunity 53:98-105.e5 (2020)	MT462508.1	MT462537.1
6	IML3564	ADI-63341	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GGGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACCTATGCTATGCACTGGGTCCGCCAGACTCCAGGCAAGGGGCTGGAGTGGATGGCAGTTATATCATATGATGGAAGCAATACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGATCACGCTGTATCTGCAAATGAACAGCCTGAGACCTGAGGACACGGCTGTCTATTACTGTGCGAGAAGTTATGGTGGGAGCTACTACTACGGCATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	GVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQTPGKGLEWMAVISYDGSNTYYADSVKGRFTISRDNSKITLYLQMNSLRPEDTAVYYCARSYGGSYYYGMDVWGQGTTVTVSS	nan	nan	IGHV3-30-3*01	IGHJ6*02	IGHD1-26*01	IGLV2-11	nan	ARSYGGSYYYGMDV	CSFAVSFYV	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458847.1	nan
6	IML3564	ADI-63390	nan	SARS-CoV-2,SARS-CoV	nan	SARS-CoV-2	SARS-CoV	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCCGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACCTATACTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCACTTATATCATATGATGGAGACAATAAGTACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTCTCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGGTTTTGGTGGGAACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLQESGGGVVQPGRSLRLSCAASGFTFSTYTMHWVRQAPGKGLEWVALISYDGDNKYYADSVKGRFTISRDNSKNTLSLQMNSLRAEDTAVYYCARGFGGNYYYGMDVWGQGTTVTVSS	nan	nan	IGHV3-30-3*01	IGHJ6*02	IGHD1-26*01,IGHD2-15*01,IGHD2-21*01	IGKV1-39*01	nan	ARGFGGNYYYGMDV	QQSSSSPFT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458896.1	nan
6	Crowe_mix	COV2-2011	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGCACCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTGACTCTTATATCATATGATGGAGGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACGCGGCTGTGTATTTCTGTGCGAGAGGTCATACGGGTAACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVTLISYDGGNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDAAVYFCARGHTGNYYYGMDVWGQGTTVTVSS	ATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCGGTGGCAGTGCATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCTTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAA	ITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFGGSASGTDFTLTISSLQPEDFATYYCQQSYSTFTFGPGTKVDIK	IGHV3-30-3*01	IGHJ6*02	IGHD4-17*01,IGHD4-23*01,IGHD6-13*01	IGKV1-39*01,IGKV1D-39*01	IGKJ3*01	ARGHTGNYYYGMDV	QQSYSTFT	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665769.1	MT665382.1
6	Crowe_mix	COV2-2203	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGCGTGGGTGGCACTTATATCATATGATGGATATAATAAATACTACGCAGACTCCGTGAGGGGCCGATTCACCATCTCCAGAATCAATTCCAAGAACACGCTGTCTCTGCAGATGAACAGCCTGAGAGCTGAGGACACGGCTGTCTATTACTGTGCGAGAGGGTCAGCTGGAAACTACTACTACGGTATGGACGTCTGGGGCCAGGGGACCACGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLAWVALISYDGYNKYYADSVRGRFTISRINSKNTLSLQMNSLRAEDTAVYYCARGSAGNYYYGMDVWGQGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGACCATTACCAACTATTTAAATTGGTATCAGCTGAAATCAGGGAGAGCCCCCAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACGCCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAA	DIQMTQSPSSLSASVGDRVTITCRASQTITNYLNWYQLKSGRAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPYTFGQGTKLEIK	IGHV3-30*04,IGHV3-30-3*03	IGHJ6*02	IGHD6-13*01	IGKV1-39*01,IGKV1D-39*01	IGKJ2*01	ARGSAGNYYYGMDV	QQSYSTPYT	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665726.1	MT665339.1
6	Crowe_mix	COV2-2250	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGCGTGGGTGGCACTTATATCATATGATGGATATAATAAATACTACGCAGACTCCGTGAGGGGCCGATTCACCATCTCCAGAATCAATTCCAAGAACACGCTGTCTCTGCAGATGAACAGCCTGAGAGCTGAGGACACGGCTGTCTATTACTGTGCGAGAGGGTCAGCTGGAAACTACTACTACGGTATGGACGTCTGGGGCCAGGGGACCACGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLAWVALISYDGYNKYYADSVRGRFTISRINSKNTLSLQMNSLRAEDTAVYYCARGSAGNYYYGMDVWGQGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGACCATTACCAACTATTTAAATTGGTATCAGCTGAAATCAGGGAGAGCCCCCAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACGCCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAA	DIQMTQSPSSLSASVGDRVTITCRASQTITNYLNWYQLKSGRAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPYTFGQGTKLEIK	IGHV3-30*04,IGHV3-30-3*03	IGHJ6*02	IGHD6-13*01	IGKV1-39*01,IGKV1D-39*01	IGKJ2*01	ARGSAGNYYYGMDV	QQSYSTPYT	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665745.1	MT665358.1
6	Crowe_mix	COV2-2643	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV,SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTCTATTACTGTGCGAGAGGGTCAGCTGGAAACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARGSAGNYYYGMDVWGQGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTATGCAACTTACTACTGTCAACAGAGTTACAGTACCCCTGGCACCTTCGGCCAAGGGACACGACTGGAGATTAAA	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDYATYYCQQSYSTPGTFGQGTRLEIK	IGHV3-30*03	IGHJ6*02	IGHD6-13*01	IGKV1-39*01,IGKV1D-39*01	IGKJ5*01	ARGSAGNYYYGMDV	QQSYSTPGT	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665694.1	MT665307.1
6	IML3558	ADI-63173	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCGGGCAAGGGGCTAGAGTGGGTGGCACTTATATCATATGATGGAAGTAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACACTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGGGACCGGGGGGAGCTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVALISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGTGGSYYYGMDVWGQGTTVTVSS	nan	nan	IGHV3-30*17	IGHJ6*02	IGHD3-16*01,IGHD3-16*02	IGKV1-9	nan	ARGTGGSYYYGMDV	QQLNSYPPYT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458682.1	nan
6	IML3558	ADI-63239	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAATCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGAACCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGACTAGAGTGGGTGGCAGTTACATCATATGATGGAATTAATAAATATTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGGACACGCTATTTCTGCAGATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGACCCCTTGGTGGGAACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGVVQPGRSLRLSCAASGFTFRTYAMHWVRQAPGKGLEWVAVTSYDGINKYYADSVKGRFTISRDNSKDTLFLQMNSLRAEDTAVYYCARPLGGNYYYGMDVWGQGTTVTVSS	nan	nan	IGHV3-30*01	IGHJ6*02	IGHD1-26*01,IGHD2-15*01,IGHD2-21*01	IGKV3-20	nan	ARPLGGNYYYGMDV	QQYGSSSWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458748.1	nan
6	Jennewein_PCV1	PCV1-43	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAAGTTTCGGGGGGAACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLLESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSFGGNYYYGMDVWGQGTTVTVSS	GATATTGTGATGACTCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAA	DIVMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPYTFGQGTKLEIK	IGHV3-33*05	IGHJ6*02	IGHD3-10*01,IGHD3-10*02	IGKV1-39*01,IGKV1D-39*01	IGKJ2*01	ARSFGGNYYYGMDV	QQSYSTPYT	nan	Jennewein et al. Cell Rep. 36:109353 (2021)	MW806126.1	MW806157.1
6	Jennewein_CV1	CV1-27	CV27	SARS-CoV-2	SARS-CoV	nan	SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAACTCGTTGAAAGCGGGGGAGGTGTAGTCCAGCCAGGGCGGAGCCTCCGACTCAGTTGCGCTGCAAGTGGATTCACTTTCAGTTCCTACGCGATGCACTGGGTACGGCAGGCTCCGGGGAAAGGGTTGGAATGGGTAGCCTTGATCTCATATGACGGAAGTAATAAATATTACGCAGATAGCGTTAAGGGACGGTTCACAATATCTCGCGACAATTCTAAGAATACGCTGTACCTTCAAATGAATTCTTTGCGCGCAGAGGATACGGCGGTATATTATTGCGCAAGAAGCTTCGGCGGATCTTACTATTATGGAATGGATGTGTGGGGTCAAGGAACAACGGTCACCGTGAGTTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVALISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSFGGSYYYGMDVWGQGTTVTV	CAGTCTGCTCTGACTCAACCCGCATCAGTTTCTGGTTCTCCGGGTCAGTCTATCACCATATCATGCACCGGCACTAGCTCTGACGTAGGAGGATATAACTACGTTAGTTGGTACCAACAACACCCTGGAAAAGCACCGAAATTGATGATATATGATGTCAGTAACCGACCTAGCGGAGTTTCCAATCGATTCTCCGGTTCAAAGAGCGGCAATACGGCTTCCTTGACAATCTCCGGGCTTCAAGCGGAAGATGAAGCTGACTACTATTGTTCTTCTTACACATCTAGCTCCACGCCATATGTGTTCGGAACAGGCACTAAAGTGACAGTACTA	QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTPYVFGTGTKVT	IGHV3-30*14	IGHJ6*01,IGHJ6*02	IGHD3-10*01,IGHD3-10*02	IGLV2-14*03	IGLJ6*01	ARSFGGSYYYGMDV	SSYTSSSTPYV	nan	Jennewein et al. Cell Rep. 36:109353 (2021);Seydoux et al. Immunity 53:98-105.e5 (2020)	MT462501.1	MT462532.1
6	IML3558	ADI-60578	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTTGTACAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATTCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAATCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAAGTAGAGGTGGGAACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLVQSGGGVVQPGRSLRLSCAASGFTFSSYAIHWVRQAPGKGLEWVAVISYDGINKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSRGGNYYYGMDVWGQGTTVTVSS	nan	nan	IGHV3-30-3*01	IGHJ6*02	IGHD2-15*01,IGHD5-24*01	IGLV1-51	nan	ARSRGGNYYYGMDV	GTWDSSLSVV	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457909.1	nan
6	IML3564	ADI-62068	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACCTATGCTCTGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTACGTGGCCGTTATATCATATGATGGAAACAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACACTGTATCTGCAGATGAACGGCCTGAGAGCTGAGGACACGGCTCTATATTACTGTGCGAGACATCGGGGGGGGAATTACTACTACGGTTTGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYALHWVRQAPGKGLEYVAVISYDGNNKYYADSVKGRFTISRDNSKNTLYLQMNGLRAEDTALYYCARHRGGNYYYGLDVWGQGTTVTVSS	nan	nan	IGHV3-30-3*01	IGHJ6*02	IGHD3-10*01,IGHD3-10*02,IGHD3-16*01	IGKV1-39	nan	ARHRGGNYYYGLDV	QQSYSAWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458160.1	nan
6	Li_SARS2_26	H712441+K711939	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:S2	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAIHWVRQAPGKGLEWVTLISYDGSNKYYADSVKGRITISRDNSKNTLYLQMNSLRAEDTAVYYCARSTGGSYYYGMDVWGQGTTVTVSS	nan	DIQMTQSPASLSASVGDRLTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSAPRLTFGGGTKVEIK	IGHV3-30*01	IGHJ6	nan	IGKV1-39*01	IGKJ4	ARSTGGSYYYGMDV	QQSYSAPRLT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
6	Li_SARS2_26	H712447+K711943	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:S2	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAIHWVRQAPGKGLEWVTLISYDGSNKYYADSVKGRITISRDNSKNTLYLQMNSLRAEDTAVYYCARSTGGSYYYGMDVWGQGTTVTVSS	nan	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQFGGSPLFTFGPGTKVDIK	IGHV3-30*01	IGHJ6	nan	IGKV3-20*01	IGKJ3	ARSTGGSYYYGMDV	QQFGGSPLFT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
6	IML3564	ADI-63351	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGCGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCATCTTCAGTACTTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCCGGCGTGGGTGGCTCTTATCTCATATGATGGAGACAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTATATCTGCAAATCAACAGCCTGAGAGCTGAGGACACGGCTATATATTACTGTGCGAGAAGTTATGGTGGGAACTACTACTCCGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLLESGGGAVQPGRSLRLSCAASGFIFSTYAMHWVRQAPGKGPAWVALISYDGDNKYYADSVKGRFTISRDNSKNTLYLQINSLRAEDTAIYYCARSYGGNYYSGMDVWGQGTTVTVSS	nan	nan	IGHV3-30-3*01	IGHJ6*02	IGHD1-26*01	IGLV2-11	nan	ARSYGGNYYSGMDV	CSYAGSFFV	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458857.1	nan
6	CC12	CC12.24	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV-2,SARS-CoV	S:non-RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTTCAGCCTCTGGATTCACCTTCAGTATCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAGATCGCACCGGAAACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGVVQPGRSLRLSCSASGFTFSIYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDRTGNYYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAATTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAA	DIQLTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASNLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPWTFGQGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ6*02	IGHD1-14*01	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	AKDRTGNYYYGMDV	QQSYSTPWT	nan	Rogers et al. Science 369:956-963 (2020)	MT594061.1	MT594094.1
6	Wheatley-CP42	PDI_196	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGACCGCTCAGGGAACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRSGNYYYGMDVWGQGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCTCTGTTTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGTTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGTTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGCGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTTTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCTCGATTCGGCCCTGGGACCAAAGTGGATATCAAA	DIQMTQSPSSLFASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYVASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPRFGPGTKVDIK	IGHV3-30*04,IGHV3-30-3*03	IGHJ6*02	nan	IGKV1-39*01,IGKV1D-39*01	IGKJ3*01	ARDRSGNYYYGMDV	QQSYSTPR	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
7	Wang-C001	C1246	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTGGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGGGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTCTATTACTGTGCCCCACAGCTATGGTTACGAGGCGCTTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMSWIRQAPGKGLEWVSYISSSGSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAPQLWLRGAFDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCCGCAGCAGTGGCAGCATTGCCAGCAACTATGTCCAGTGGTACCAGCAGCGCCCGGGCAGTTCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCAGCAATCATGCTGTGTTCGGAGGAGGCACCCAGCTGACCGTCCTCG	NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSSPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNHAVFGGGTQLTVL	IGHV3-11*01	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGLV6-57*01	IGLJ7*01	APQLWLRGAFDY	QSYDSSNHAV	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
7	Wang-C001	C001_P1_IgG_H4-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTGGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGGGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTCTATTACTGTGCCCCACAGCTATGGTTACGAGGCGCTTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMSWIRQAPGKGLEWVSYISSSGSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAPQLWLRGAFDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCCGCAGCAGTGGCAGCATTGCCAGCAACTATGTCCAGTGGTACCAGCAGCGCCCGGGCAGTTCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCAGCAATCATGCTGTGTTCGGAGGAGGCACCCAGCTGACCGTCCTCG	NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSSPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNHAVFGGGTQLTVL	IGHV3-11*01	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGLV6-57*01	IGLJ7*01	APQLWLRGAFDY	QSYDSSNHAV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
7	COV107	COV107_Plate1_HC_32-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGACTCTGGATTCACCTTTAGTAGCTATTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTGGCCAACATAAAGCAAGATGGAAGTGAGAAATACTATGTGGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCCGTACAGCTATGGTTACGGGGGAACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCADSGFTFSSYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAVQLWLRGNFDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCGGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCGCCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCAGCAATCATGTGGTATTCGGCGGTGGGACCAAGCTGACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLAISGLKTEDEADYYCQSYDSSNHVVFGGGTKLTVL	IGHV3-7*01	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGLV6-57*02	IGLJ2*01,IGLJ3*01	AVQLWLRGNFDY	QSYDSSNHVV	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
7	Wang-C003	C1208	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTTACTCCATCAGCAGTGATTACTTCTGGGGCTGGATCCGGCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGACTATCTATCGTAGTGGGAACACCTACTACAGCCCGTCCCTCAAGAGTCGAGTCACCGTATCAGTCGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGACCTCTGTGACCGCCGCAGACACGGCCGTGTATTACTGTGCGAGTAATAAGTGGTTGCGGGGAAATTTTGACTACTGGGGTCAGGGAAATCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSETLSLTCAVSGYSISSDYFWGWIRQPPGKGLEWIGTIYRSGNTYYSPSLKSRVTVSVDTSKNQFSLKLTSVTAADTAVYYCASNKWLRGNFDYWGQGNLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCCGCAGCGGTGACAACATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTTCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATGTCAGCAATTTTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCT	NFMLTQPHSVSESPGKTVTISCTRSGDNIASNYVQWYQQRPGSSPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDVSNFWVFGGGTKLTVL	IGHV4-38-2*01	IGHJ4*02	IGHD3-22*01,IGHD3-3*01,IGHD3-3*02	IGLV6-57*01	IGLJ3*02	ASNKWLRGNFDY	QSYDVSNFWV	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
7	Li_SARS2_26	DH1045	nan	SARS-CoV,SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QLQLQESGPGLVKPSETLSLTCTVSGGSISSSGYYWGWIRQPPGKGLEWIGTIYYGGSTYYSPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCASQQWLRGNFDYWGQGTLVTVSS	nan	NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSTYWVFGGGTKLTVL	IGHV4-39*01	IGHJ4	nan	IGLV6-57*02	IGLJ3	ASQQWLRGNFDY	QSYDSSTYWV	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
7	Li_SARS2_26	H712568+L711801	nan	SARS-CoV-2	SARS-CoV,MERS-CoV,OC43,HKU1,NL63	nan	nan	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCASQQWLRGNFDYWGQGTLVTVSS	nan	NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSTYWVFGGGTKLTVL	IGHV4-39*01	IGHJ4	nan	IGLV6-57*02	IGLJ3	ASQQWLRGNFDY	QSYDSSTYWV	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
7	IML3558	ADI-60738	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTAGTTCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACCTACTGGATGCACTGGGTCCGCCAAGCTCCAGGGAAGGGGCTGGTGTGGGTCTCACGTATTAATAGTGATGGGAGTAGCACAAGCTACGCGGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACACGCTGTATCTGCAAATGAACAGTCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCAAGCGTTCAGTGGCTGGGAGGGAACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGFTFSTYWMHWVRQAPGKGLVWVSRINSDGSSTSYADSVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCASVQWLGGNFDYWGQGTLVTVSS	nan	nan	IGHV3-74*02	IGHJ4*02	IGHD6-19*01	IGLV6-57	nan	ASVQWLGGNFDY	QSYDSSNHV	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458007.1	nan
7	Chen_Vax_p1	COV2-vax-47	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCACACATTAGTAGTAGTGGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGGGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAAGTCCTTGGTTACGTGGCCGATTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMSWIRQAPGKGLEWVSHISSSGSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARSPWLRGRFDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCGGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCAGCAGTCCTAATTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSSPNWVFGGGTKLTVL	IGHV3-11*01	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGLV6-57*02	IGLJ3*02	ARSPWLRGRFDY	QSYDSSSPNWV	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555596.1	MZ555597.1
7	Chen_Vax_p1	COV2-vax-48	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGATGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTTCATGAGCTGGATCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTGGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGGGACAACGCCAGGAACTCACTGTTTCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAAGTCCTTGGTTACGTGGCCGATTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QMQLVESGGGLVKPGGSLRLSCAASGFTFSDYFMSWIRQAPGKGLEWVSYISSSGSTIYYADSVKGRFTISRDNARNSLFLQMNSLRAEDTAVYYCARSPWLRGRFDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCGGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCAGCAGTCCTAATTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSSPNWVFGGGTKLTVL	IGHV3-11*01	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGLV6-57*02	IGLJ3*02	ARSPWLRGRFDY	QSYDSSSPNWV	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555598.1	MZ555599.1
7	IML3558	ADI-60546	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCGGGCCCAGGACTGGTGAAGTCTTCGGAGACCCTGTTCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTTCTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTCTATCTATTACAGTGGGAGCACCAACTTCAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGAAGCCAGTGGCTACGCGGGAACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLLESGPGLVKSSETLFLTCTVSGGSISSYFWSWIRQPPGKGLEWIGSIYYSGSTNFNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARSQWLRGNFDYWGQGTLVTVSS	nan	nan	IGHV4-59*01	IGHJ4*02	IGHD5-12*01	IGLV6-57	nan	ARSQWLRGNFDY	QSYDSSNHWV	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457877.1	nan
7	Turner-07	Turner-07-3D07	nan	SARS-CoV-2	OC43,HKU1	nan	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAAGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTCGCTATACTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCTTTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACCCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGTCCTATGGTTACGTGGGATGTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGVVQPGRSLRLSCAASGFTFSRYTMHWVRQAPGKGLEWVAFISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARVLWLRGMFDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCGGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATATTAGCAATCATTGGGTGTTCGGCGGAGGGACCAAGTTGACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDISNHWVFGGGTKLTVL	IGHV3-30-3*01	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGLV6-57*02	IGLJ3*02	ARVLWLRGMFDY	QSYDISNHWV	nan	Turner et al. Nature 596:109-113 (2021)	MW926401.1	MW926424.1
7	105	105-38	nan	SARS-CoV-2	SARS-CoV,MERS-CoV	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 S1/RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	nan	nan	nan	nan	nan	ARVQWLRGEFDY	nan	nan	Wan et al. Cell Rep. 32:107918 (2020)	nan	nan
7	Wang-MOD1	C606	Mod1_P1_IgG_A10-P1369	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGCTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGCCTCCGTCAGCAGTAGTACTTACTACTGGGTCTGGATCCGCCGGCCCCCCGGGAAGGGGCTGGAGTGGATTGGGACTATCTATTATAGTGGGAGCACCTACTACAGCCCGTCCCTCAAGAGTCGACTCACCATATCAGTTGACACGTCCAAGAACCAGTTCTCCCTGAGGCTGAGTTCTGTGACCGCCGCGGACACGGCCATTTATTACTGTGCGCAGTCAACGTGGCTAAGGGGATCCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QLQLQESGPGLVKPSETLSLTCTVSGASVSSSTYYWVWIRRPPGKGLEWIGTIYYSGSTYYSPSLKSRLTISVDTSKNQFSLRLSSVTAADTAIYYCAQSTWLRGSFDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGTAAGACGGTAACCATCTCCTGCACCGGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAATTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCACCAATCATTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSTNHWVFGGGTKLTVL	IGHV4-39*07	IGHJ4*02	IGHD5-12*01	IGLV6-57*02	IGLJ3*02	AQSTWLRGSFDY	QSYDSTNHWV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
7	Wang-MOD1	Mod1_P2_IgG_B8-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGCTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTTCTGGGGCTGGATCCGCCAGCCCCCAGGGAAGGGACTGGAGTCGATTGGAAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCAGTGGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATTACTGTGCGAGGTCAAGGTGGCTAAGGGGATCCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYFWGWIRQPPGKGLESIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARSRWLRGSFDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCGGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCAGCAATCATTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNHWVFGGGTKLTVL	IGHV4-39*07	IGHJ4*02	IGHD5-12*01	IGLV6-57*02	IGLJ3*02	ARSRWLRGSFDY	QSYDSSNHWV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
7	Wang-C003	C003_P1_IgG_H8-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCCGGGGGAGGCTTAGTTCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGAGTCACCTTCAGTAGCTACTGGATGTACTGGGTCCGCCAAGCTCCAGGGAAGGGGCTGGTGTGGGTCTCACGTATTAATAGTGATGGGAGTAGCACAAGCTACGCGGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGTACACGCTGTATCTGCAAATGAACAGTCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCAAGAGCGAGATGGCTACAGGGAGAATTTGATTACTGGGGTCGGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGVTFSSYWMYWVRQAPGKGLVWVSRINSDGSSTSYADSVKGRFTISRDNAKYTLYLQMNSLRAEDTAVYYCARARWLQGEFDYWGRGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCCGCAGCAGTGGCAGCATTGCCACCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTTCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCAGCAATGGGGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTRSSGSIATNYVQWYQQRPGSSPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNGVVFGGGTKLTVL	IGHV3-74*01	IGHJ4*02	IGHD5-24*01	IGLV6-57*01	IGLJ2*01,IGLJ3*01	ARARWLQGEFDY	QSYDSSNGVV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
7	Wang-MOD8	MOD8_P1_IgG_H3-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGTAGCTATTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTGGCCAACATAAAGCAAGATGGAAGTGAGAAATACTATGTGGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAAAGAGATGGCTACAAGGAGACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARKRWLQGDFDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCCGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCGGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCAGCAATCATGGGGTATTCGGCGGAGGGACCAAGCTGACCGTC	NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYRQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNHGVFGGGTKLTV	IGHV3-7*01	IGHJ4*02	IGHD5-24*01	IGLV6-57*03	IGLJ2*01,IGLJ3*01	ARKRWLQGDFDY	QSYDSSNHGV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
7	Wang-MOD8	MOD8_P2_IgG_F12-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGTAGCTATTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTGGCCAACATAAAGCAAGATGGAAGTGAGAAATACTATGTGGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAAAGAGATGGCTACAAGGAGACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARKRWLQGDFDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCCGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCGGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCAGCAATCATGGGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYRQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNHGVFGGGTKLTVL	IGHV3-7*01	IGHJ4*02	IGHD5-24*01	IGLV6-57*03	IGLJ2*01,IGLJ3*01	ARKRWLQGDFDY	QSYDSSNHGV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
7	CV24	HL_CV24-223	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	CTTCTGCAAACCCGGTGTACATTCCTGAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGGCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCTGTGTATTACTGTGCGAGACTGAGGTGGCTACGGGGCGAATTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTTCCTCAGGGAGGCTTCCGCCCCACTTCCCCCT	EVQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARLRWLRGEFDYWGQGTLVTV	GCGGCCTCTGCTAACCGGGTCCTGGGCCCAGTCTGTGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCGGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCAGCACCTATTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTTAGGTTCCAGCCCAAGGCTCCCCCTTTT	QSVLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSTYWVFGGGTKLTVL	IGHV4-39*01	IGHJ4*02	IGHD5-12*01	IGLV6-57*02	IGLJ3*02	ARLRWLRGEFDY	QSYDSSTYWV	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
7	CV24	HL_CV24-226	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	CTTCTGCAAACCCGGTGTACATTCCTGAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGGCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCTGTGTATTACTGTGCGAGACTGAGGTGGCTACGGGGCGAATTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTTCCTCAGGGAGGCTTCCGCCCCACTTCCCGGC	EVQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARLRWLRGEFDYWGQGTLVTV	CTGCCTCTGCTACCCCGGTCCTGGGCCCAGTCTGTGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCGGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCAGCACCTATTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTTAAGGTCCAGCCCAAAGGCTTCCCCCTTTTTTT	QSVLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSTYWVFGGGTKLTVL	IGHV4-39*01	IGHJ4*02	IGHD5-12*01	IGLV6-57*02	IGLJ3*02	ARLRWLRGEFDY	QSYDSSTYWV	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
7	COV107	C585	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGACTCCATCAGTAGTTACTTCTGGAGCTGGATCCGGCAGCCCCCAGGGAGGGGACTGGAGTGGATTGGATATATCCATGATAGTGTTAACACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAGCCAGTTCTCCCTGAGGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGCGATGCGCGTGGCTTCGAGGGTCCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSETLSLTCTVSGDSISSYFWSWIRQPPGRGLEWIGYIHDSVNTNYNPSLKSRVTISVDTSKSQFSLRLSSVTAADTAVYYCARCAWLRGSFDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCGGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAATCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTTAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATTTCAGCAGTCATTATGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDFSSHYVFGTGTKVTVL	IGHV4-59*01	IGHJ4*02	IGHD5-12*01	IGLV6-57*02	IGLJ1*01	ARCAWLRGSFDY	QSYDFSSHYV	nan	Gaebler et al. Nature 591:639-644 (2021)	nan	nan
7	COV021	COVD21_P1_HC_A12-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATCCATTAGTAGTAGTGGAAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGGGACAACGCCAAGACCTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGGGAAGTGGTTAAGGGGAAGTTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMSWIRQAPGKGLEWVSSISSSGSTIYYADSVKGRFTISRDNAKTSLYLQMNSLRAEDTAVYYCARGKWLRGSFDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCGGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCAGCAATCATTGGGTGTTCGGCGGGGGGACCAAGCTGACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNHWVFGGGTKLTVL	IGHV3-11*01	IGHJ4*02	IGHD3-22*01,IGHD3-3*01,IGHD3-3*02	IGLV6-57*02	IGLJ3*02	ARGKWLRGSFDY	QSYDSSNHWV	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293245.1	MW293700.1
7	Wang-MOD4	Mod4_P3_IgG_A5-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGCTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGGCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGACTATCCATTATAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCGTATCCGTAGACACGTCCAAGAACCACTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCTGTGTATTACTGTGCGAGACTATGGTGGCTACGTGGGTCCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGTIHYSGSTYYNPSLKSRVTVSVDTSKNHFSLKLSSVTAADTAVYYCARLWWLRGSFDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCCGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTTCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCAGCAATTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTA	NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSSPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNWVFGGGTKLTVL	IGHV4-39*02	IGHJ4*02	IGHD5-12*01	IGLV6-57*01	IGLJ3*02	ARLWWLRGSFDY	QSYDSSNWV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
7	Veesler_S2A	S2A4	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMNWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLFLQMNSLRAEDTAVYYCARVWWLRGSFDYWGQGTLVTVSS	nan	NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNHVVFGGGTKLTVL	IGHV3-7*01	IGHJ4	nan	IGLV6-57*02	IGLJ3	ARVWWLRGSFDY	QSYDSSNHVV	7JVA,7JVC,7JXD	Piccoli et al. Cell 183:1024-1042.e21 (2020)	nan	nan
7	Wang-MOD7	MOD7_P1_IgG_B8-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAAGTGCAGCTGGTGCAGTCCGGAGCAGAGGTGAAAAAGCCCGGGGAGTCTCTGAGGATCTCCTGTAAGGGTTCTGGAGACAGCTTTACCAGCTACTGGATCAACTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATGGGGAGGATTGATCTAAGTGACTCTTCTACCAACTACAGCCCGTCCTTCCAAGGCCACGTCACCATCTCAGCTGACAAGTCCATCAGCACTGCCTACCTGCAGTGGAGCAGCCTGAAGGCCTCGGACACCGCCAAGTATTACTGTGCGAGACTGAAGTGGCTACGGGGGGATTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVQSGAEVKKPGESLRISCKGSGDSFTSYWINWVRQMPGKGLEWMGRIDLSDSSTNYSPSFQGHVTISADKSISTAYLQWSSLKASDTAKYYCARLKWLRGDFDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCGGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAGGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCAACAATCAGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLRTEDEADYYCQSYDSNNQVFGGGTKLTVL	IGHV5-10-1*03	IGHJ4*02	IGHD5-12*01	IGLV6-57*02	IGLJ3*02	ARLKWLRGDFDY	QSYDSNNQV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
7	Crowe_mix	COV2-2677	nan	SARS-CoV,SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGCTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGGCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATGTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCTGTGTATTACTGTGCGAGACTTCTGTGGCTACGCGGCCACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSMYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARLLWLRGHFDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCGGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCAGCAATTATTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTA	NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNYWVFGGGTKLTVL	IGHV4-39*01	IGHJ4*02	IGHD5-12*01	IGLV6-57*02	IGLJ3*02	ARLLWLRGHFDY	QSYDSSNYWV	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665452.1	MT665065.1
7	Wang-MOD8	MOD8_P2_IgG_C10-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGCTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGGCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAATGCATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCTGTGTATTACTGTGCGAGACTTCAGTGGCTAAGGGGGTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLECIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARLQWLRGYFDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCCGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATATCAGCAATCATTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDISNHWVFGGGTKLTVL	IGHV4-39*01	IGHJ4*02	IGHD5-12*01,IGHD6-19*01	IGLV6-57*03	IGLJ3*02	ARLQWLRGYFDY	QSYDISNHWV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
7	COV021	COVD21_P1_HC_F1-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGTAGCTATTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTGACCAACATAAAGCTAGATGGAAGTGAGAAATACTATGTGGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGATTGCGGTGGCTACGAGCGGACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVTNIKLDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLRWLRADFDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCGGCAGCAGCGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAACGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCGGCAATGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSGNVVFGGGTKLTVL	IGHV3-7*01	IGHJ4*02	IGHD5-12*01	IGLV6-57*02	IGLJ2*01,IGLJ3*01	ARLRWLRADFDY	QSYDSGNVV	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293014.1	MW293469.1
7	Wang-C001	C001_P2_IgG_F7-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGCTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCATTGTCTCTGGTGGCTCCATCAGCAGTAGTCGTCACTACTGGGGCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGAATTATGTATTATAGTGGGATTACCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATTTCCGTAGACACGTCCAAGAACCACTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCTGTCTATTACTGTGCGAGACTACGGTGGTTGCGAGGGGATTTTGACTCCTGGGGCCCGGGAACCCTGGTCACCGTCTCCTCAG	QLQLQESGPGLVKPSETLSLTCIVSGGSISSSRHYWGWIRQPPGKGLEWIGIMYYSGITYYNPSLKSRVTISVDTSKNHFSLKLSSVTAADTAVYYCARLRWLRGDFDSWGPGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGTTAACCATCTCCTGCACCGCCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGTAGCACTCATGTCTTCGGAACTGGGACCAAGGTCACCGTCCT	NFMLTQPHSVSESPGKTLTISCTASSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSTHVFGTGTKVTVL	IGHV4-39*02	IGHJ4*02	IGHD4-23*01	IGLV6-57*02	IGLJ1*01	ARLRWLRGDFDS	QSYDSSTHV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
7	Wang-C001	C820	C001_P1_IgG_H11-P1369	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGCTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGAAGTAATCCTTACTACTGGGGCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGCATTATCTATTATAGTGGGACCACCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCTGTCTATTACTGTGCGAGACTACGGTGGTTGCGAGGGGATTTTGAGTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QLQLQESGPGLVKPSETLSLTCTVSGGSIRSNPYYWGWIRQPPGKGLEWIGIIYYSGTTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARLRWLRGDFEYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCTCTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCGGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCACCAATCATGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	NFMLTQPLSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSTNHVFGTGTKVTVL	IGHV4-39*01	IGHJ4*02	IGHD4-23*01	IGLV6-57*02	IGLJ1*01	ARLRWLRGDFEY	QSYDSTNHV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
7	Wang-C001	C1253	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGCTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTTCTGGGGCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGACTATCTACTTTAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAGGCTGAGCTCTGTGACCGCCGCAGACACGGCTGTGTATTACTGTGCGAGACTAACCTGGCTGCGGGGGAACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYFWGWIRQPPGKGLEWIGTIYFSGSTYYNPSLKSRVTISVDTSKNQFSLRLSSVTAADTAVYYCARLTWLRGNFDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCGGCAGCAGTGGCTACATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCGCCAATTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTGSSGYIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSANWVFGGGTKLTVL	IGHV4-39*01	IGHJ4*02	IGHD3-16*01,IGHD3-16*02,IGHD6-19*01	IGLV6-57*02	IGLJ3*02	ARLTWLRGNFDY	QSYDSANWV	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
7	Wang-C001	C001_P1_IgG_A6-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGCTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTTCTGGGGCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGACTATCTACTTTAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAGGCTGAGCTCTGTGACCGCCGCAGACACGGCTGTGTATTACTGTGCGAGACTAACCTGGCTGCGGGGGAACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYFWGWIRQPPGKGLEWIGTIYFSGSTYYNPSLKSRVTISVDTSKNQFSLRLSSVTAADTAVYYCARLTWLRGNFDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCGGCAGCAGTGGCTACATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCGCCAATTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTGSSGYIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSANWVFGGGTKLTVL	IGHV4-39*01	IGHJ4*02	IGHD3-16*01,IGHD3-16*02,IGHD6-19*01	IGLV6-57*02	IGLJ3*02	ARLTWLRGNFDY	QSYDSANWV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
7	Cho-C016	C2023	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGCTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGGCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCTGTGTATTACTGTGCGAGACAAAAGTGGCTACGATCAGACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARQKWLRSDFDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCGGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCAGCAATTATTATGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNYYVFGTGTKVTVL	IGHV4-39*01	IGHJ4*02	IGHD5-12*01	IGLV6-57*02	IGLJ1*01	ARQKWLRSDFDY	QSYDSSNYYV	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
7	Wang-C003	C1224	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGCTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGACTCCATCAGCAGTAATAGTTTCTTCTGGGGCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGCGACTATCTCTTATAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCCGTAGACACGTCCAACAACCAGTTCTCCCTGAGGCTGAGCTCTGTGACCGCCGCAGACACGGCTGTGTATTACTGTGCGAGACTTCGGTGGCTTAGAGGGAAGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QLQLQESGPGLVKPSETLSLTCAVSGDSISSNSFFWGWIRQPPGKGLEWIATISYSGSTYYNPSLKSRVTISVDTSNNQFSLRLSSVTAADTAVYYCARLRWLRGKFDPWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGGGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCGGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGAAGCGCCCGGGCAGTTCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATTTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCAGCATCCATGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	NFMLTQPHSVSGSPGKTVTISCTGSSGSIASNYVQWYQKRPGSSPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSIHVVFGGGTKLTVL	IGHV4-39*01	IGHJ5*02	IGHD4-23*01,IGHD5-12*01,IGHD6-19*01	IGLV6-57*01,IGLV6-57*02	IGLJ2*01,IGLJ3*01	ARLRWLRGKFDP	QSYDSSIHVV	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
7	Tong_C63	C63C8	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike (and spike minus RBD)	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGTAGTTATTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTGGCCAACATAAAGCAAGATGGAAGTGAGAAATACTATGTGGACTCTGTGAAGGGCCGATTCACCATGTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGCCTGAGATGGCTACAAGCCGACTTTGAGTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTMSRDNAKNSLYLQMNSLRAEDTAVYYCASLRWLQADFEYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCCGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTTCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCACCAATCATGTCTTCGGAACTGGGACCAAGGTCACCGTCCTA	NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSSPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSTNHVFGTGTKVTVL	IGHV3-7*01	IGHJ4*02	IGHD5-24*01	IGLV6-57*01	IGLJ1*01	ASLRWLQADFEY	QSYDSTNHV	nan	Tong et al. Cell 184:4969-4980.e15 (2021)	MW718390.1	MW718542.1
7	COV096	COV096_P1_IgM_33-P1348	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGTAGCTATTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTGGCCAACATAAAGCAAGATGGAAGTGAGAAATACTATGTGGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGAGACGGCTGTGTATTACTGTGCGAGTCTGAGATGGCTACAAGGAGACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEETAVYYCASLRWLQGDFDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCCGCAGCAGTGGCAGCATTGCCAGCAATTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTTTCCCCATCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCAGCAAAGGAGCGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSFPITVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSKGAVFGGGTKLTVL	IGHV3-7*01	IGHJ4*02	IGHD5-24*01	IGLV6-57*01	IGLJ2*01,IGLJ3*01	ASLRWLQGDFDY	QSYDSSKGAV	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW293016.1	MW293471.1
7	Wang-MOD8	MOD8_P2_IgG_B6-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTGCCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTGTATTACTGTGCGACATTGGGGTGGCTACGGGGGAGCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSYISSSSSAIYYADSVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYCATLGWLRGSFDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACTTGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCAGCAAACCCGATTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTCSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSKPDWVFGGGTKLTVL	IGHV3-48*02	IGHJ4*02	IGHD5-12*01	IGLV6-57*02,IGLV6-57*03	IGLJ3*02	ATLGWLRGSFDY	QSYDSSKPDWV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
7	Wang-C001	C1251	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGCTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTTCTGGGGCTGGATCCGCCAGCCCCCAGGGAGGGGGCTGGAGTGGATTGGGAATATCTATTACAGTGGGACCACCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCCGTTGACGCGTCCAAGAACCAGTTCTCCCTAAAGCTGACCTCTGTGACCGCCGCAGACACGGCTGTGTATTACTGTGCGACACAAGGGTGGCTACGAGGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QLQLQESGPGLVKPSETLSLTCAVSGGSISSSSYFWGWIRQPPGRGLEWIGNIYYSGTTYYNPSLKSRVTISVDASKNQFSLKLTSVTAADTAVYYCATQGWLRGYFDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCGGCAGAAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCAGCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCAGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGATTATTACTGTCAGTCCTATGACAGCAGCAATCTTGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTGRSGSIASNYVQWYQQRPGSAPSTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNLVVFGGGTKLTVL	IGHV4-39*01	IGHJ4*02	IGHD5-12*01	IGLV6-57*02	IGLJ2*01,IGLJ3*01	ATQGWLRGYFDY	QSYDSSNLVV	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
7	Wang-C001	C001_P1_IgG_E9-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGCTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTTCTGGGGCTGGATCCGCCAGCCCCCAGGGAGGGGGCTGGAGTGGATTGGGAATATCTATTACAGTGGGACCACCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCCGTTGACGCGTCCAAGAACCAGTTCTCCCTAAAGCTGACCTCTGTGACCGCCGCAGACACGGCTGTGTATTACTGTGCGACACAAGGGTGGCTACGAGGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QLQLQESGPGLVKPSETLSLTCAVSGGSISSSSYFWGWIRQPPGRGLEWIGNIYYSGTTYYNPSLKSRVTISVDASKNQFSLKLTSVTAADTAVYYCATQGWLRGYFDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCGGCAGAAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCAGCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCAGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGATTATTACTGTCAGTCCTATGACAGCAGCAATCTTGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTGRSGSIASNYVQWYQQRPGSAPSTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNLVVFGGGTKLTVL	IGHV4-39*01	IGHJ4*02	IGHD5-12*01	IGLV6-57*02	IGLJ2*01,IGLJ3*01	ATQGWLRGYFDY	QSYDSSNLVV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
7	COV047	COV047_P4_IgG_52-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGACTCTGGATTCACCTTCAGTACCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCACTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCGGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGCCGAGTGGCTACGTGGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QVQLVESGGGVVQPGRSLRLSCADSGFTFSTYGMHWVRQAPGKGLEWVALISYDGSNKYYADSVKGRFTISGDNSKNTLYLQMNSLRAEDTAVYYCARAEWLRGAFDIWGQGTMVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCGGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCACCAATCATTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSTNHWVFGGGTKLTVL	IGHV3-30*03	IGHJ3*02	IGHD5-12*01	IGLV6-57*02	IGLJ3*02	ARAEWLRGAFDI	QSYDSTNHWV	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293236.1	MW293691.1
7	COV107	C126	COV107_Plate2_HC_28-P1369	SARS-CoV-2	SARS-CoV	nan	SARS-CoV,SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCTCCTGCGCTGTCTCTGGTGGCTCCATCGGTAGTTACTTCTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGATATCTCCATTACAGTGGGAGCACCAACTACAACCCCTCCCTGAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAATCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGATTGCAGTGGCTACGCGGAGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QVQLQESGPGLVKPSETLSLSCAVSGGSIGSYFWSWIRQPPGKGLEWIGYLHYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARLQWLRGAFDIWGQGTMVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCGGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCAATGAAGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCAGCAATTTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVINEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNLVFGGGTKLTVL	IGHV4-59*01	IGHJ3*02	IGHD5-12*01	IGLV6-57*02	IGLJ2*01,IGLJ3*01	ARLQWLRGAFDI	QSYDSSNLV	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
7	Wang-MOD8	MOD8_P2_IgG_H10-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATTACAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGAGCGGGGTGGCTACGGGGGCCCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARAGWLRGPFDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCCGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTGCCAGCAGCGCCCGGGCAGTTCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCCTTGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWCQQRPGSSPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSLVVFGGGTKLTVL	IGHV4-59*01	IGHJ4*02	IGHD5-12*01	IGLV6-57*01	IGLJ2*01,IGLJ3*01	ARAGWLRGPFDY	QSYDSLVV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
7	Aishun_Jin_mix	54G7	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV3-66*01	IGHJ5*02	IGHD3-16*02	IGLV3-21*02	IGLJ3*02	ARAGWLRGRFDP	QVWDSTTDLPHWV	nan	Han et al. Front Immunol. 12:653189 (2021)	nan	nan
7	Aishun_Jin_mix	CQTS086	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGAATCACCGTCAATAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAACGGTGTTACCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACATTTCCAAGAACACGGTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGCGGGGTGGCTTCGTGGCCGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCATCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGITVNSNYMSWVRQAPGKGLEWVSVIYNGVTTYYADSVKGRFTISRDISKNTVYLQMNSLRAEDTAVYYCARAGWLRGRFDPWGQGTLVIVSS	TCCTATGTGCTGACTCAGCCACCCTCGGTGTCAGTGGCCCCAGGACAGACGGCCAGCATTACCTGTGGGGGAAGCAACATTGGAAGTAAAAATGTCCACTGGTACCAGCAGAAGTCAGGCCAGGCCCCTGTGCTGGTCGTCTATGATGATAGCGACCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACGGCCACCCTGATCATCAACAGGGTCGAAGCCGGGGATGAGGCCGACTATTACTGTCAGGTGTGGGATAGTACTACTGATCTTCCCCATTGGGTGTTCGGCGGAGGGACCAAACTGACCGTCCTAC	SYVLTQPPSVSVAPGQTASITCGGSNIGSKNVHWYQQKSGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLIINRVEAGDEADYYCQVWDSTTDLPHWVFGGGTKLTVL	IGHV3-66*01	IGHJ5*02	IGHD5-12*01,IGHD6-19*01	IGLV3-21*02	IGLJ3*02	ARAGWLRGRFDP	QVWDSTTDLPHWV	nan	Patent: CN111909262A	MW587488.1	MW587489.1
7	Wang-C001	C001_P2_IgG_E5-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGCTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCACTAGTAGTTACTACTGGGGCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGGTTGGGATTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCTGTGTATTACTGTGCGAGACTAATGTGGCTCCGAGGTCCTTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QLQLQESGPGLVKPSETLSLTCTVSGGSISTSSYYWGWIRQPPGKGLEWVGIIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARLMWLRGPFDYWGQGTLVTVSS	AATTTTGTGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCGGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACGACTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCAGCACTCATGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	NFVLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDDSSNSASLTISGLKTEDEADYYCQSYDSSTHVVFGGGTKLTVL	IGHV4-39*01	IGHJ4*02	IGHD5-12*01	IGLV6-57*02	IGLJ2*01,IGLJ3*01	ARLMWLRGPFDY	QSYDSSTHVV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
7	Wang-C001	C814	C001_P1_IgG_D4-P1369	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGCTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTCGTTACTACTGGGGCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGATTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCTGTGTATTACTGTGCGAGACTAATGTGGCTACGAGGTCCTTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QLQLQESGPGLVKPSETLSLTCTVSGGSISSSRYYWGWIRQPPGKGLEWIGIIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARLMWLRGPFDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCGGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCAGCACTCATGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSTHVVFGGGTKLTVL	IGHV4-39*01	IGHJ4*02	IGHD5-12*01	IGLV6-57*02	IGLJ2*01,IGLJ3*01	ARLMWLRGPFDY	QSYDSSTHVV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
8	IML3549	ADI-63107	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTTGTGCAGTCTGGAGGAGGCTTGATCCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGGAGCCTCTGGGCTCATCGTCAGTAGCAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATCCCGGTGGCAGCACATTCTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATTTTCAAATGAACAGCCTGAGAGCCGAGGACACGGGCGTATATTACTGTGCGAGGGACGCCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLVQSGGGLIQPGGSLRLSCGASGLIVSSNYMTWVRQAPGKGLEWVSVIYPGGSTFYADSVKGRFTISRDNSKNTLYFQMNSLRAEDTGVYYCARDAYGMDVWGQGTTVTVSS	nan	nan	IGHV3-53*01	IGHJ6*02	nan	IGKV3-20	nan	ARDAYGMDV	QLYGTSLGT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458616.1	nan
8	Xie_mix	BD-609	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASGVTVSRNYMSWVRQAPGKGLEWVSVIYSGGSTDYADSVKGRFTISRHNSKNTLYLQMNSLRVEDTAVYYCARDGYGMDVWGQGTTVTVSS	nan	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPNLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPAFGPGTKVDIK	IGHV3-53*04	nan	nan	IGKV1-9*01	nan	ARDGYGMDV	QQLNSYPPA	nan	Du et al. Cell 183:1013-1023.e13 (2020)	nan	nan
8	COSCA2	COVA2-07	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGGAGACTGGAGGAGGCTTGATCCAGCCTGGGGGATCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAGGCCTACGGTATGGACGTCTGGGGCCAAGGGACCATGGTCACCGTCTCTTCA	EVQLVETGGGLIQPGGSLRLSCAASGLTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREAYGMDVWGQGTMVTVSS	GAAATTGTGTTGACACAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCCGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTTGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCTGGGACGTTCGGCCAAGGGACCAAAGTGGATATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSWSGTDFTLTISRLEPEDFAVYYCQQYGSSPGTFGQGTKVDIK	IGHV3-53*02	IGHJ6*02	nan	IGKV3-20*01	IGKJ1*01	AREAYGMDV	QQYGSSPGT	nan	Brouwer et al. Science 369:643-650 (2020)	nan	nan
8	Wang-MOD3	MOD3_P2_IgG_E1-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTAACCGTCAGTCGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATCCCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAGCAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTATTGTGCGAGAGAGGCCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSRNYMNWVRQAPGKGLEWVSVIYPGGSTFYADSVKGRFTISRDNSSNTLYLQMNSLRAEDTAVYYCAREAYGMDVWGQGTTVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGACTGGGACAGACTTCACTCTCAGCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTATTGTCAGCAGTATGGTAGCTCACCGGGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGTGTDFTLSISRLEPEDFAVYYCQQYGSSPGTFGQGTKVEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV3-20*01	IGKJ1*01	AREAYGMDV	QQYGSSPGT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
8	Wang-MOD4	Mod4_P3_IgG_D12-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTCTTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCATCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGGGAGGCCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMTWVRQAPGKGLEWVSVLYSGGSTYYADSVKGRFIISRDNSKNTLYLQMNSLRAEDTAVYYCAREAYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTATCGGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYRYTFGQGTKLEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ2*01	AREAYGMDV	QQLNSYRYT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
8	COV047	COV047_P5_IgA_43-P1609	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGGTGTATCTTCAAATGAACAGCGTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAGCATACGGTATGGACGTATGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTVYLQMNSVRAEDTAVYYCAREAYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCGAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACTCCGTGACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYSVTFGQGTKLEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ2*01,IGKJ2*02	AREAYGMDV	QQLNSYSVT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW293067.1	MW293522.1
8	WuY_p1	B38	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCAREAYGMDVWGQGTTVTVSS	nan	DIVMTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPYTFGQGTKLEIK	IGHV3-53*04	IGHJ6	nan	IGKV1-9*01	IGKJ2	AREAYGMDV	QQLNSYPPYT	7BZ5	Wu et al. Science 368:1274-1278 (2020)	nan	nan
8	Wang-C003	C1206	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGACTCACCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCAGATTCATGATCTCCAGAGACAATTCCAAGAACACGTTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGAGTCCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFMISRDNSKNTLYLQMNSLRAEDTAVYYCARESYGMDVWGQGTTVTVSS	CAGTCTGTGCTGACGCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGGTCCAACATCGGGGCAGGTTATGACGTACACTGGTACCAGCATCTTCCAGGAACAGCCCCCAAACTCCTCATCTATGTTAACAACAATCGGCCCTCAGGGGTCCCTGACCGAATCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAACGACGTGAGTGGTTACGTATTCGGCGGAGGGACCAAGGTGACCGTCCTAG	QSVLTQPPSVSGAPGQRVTISCTGSRSNIGAGYDVHWYQHLPGTAPKLLIYVNNNRPSGVPDRISGSKSGTSASLAITGLQAEDEADYYCQSYDNDVSGYVFGGGTKVTVL	IGHV3-66*01	IGHJ6*02	nan	IGLV1-40*01	IGLJ2*01,IGLJ3*01	ARESYGMDV	QSYDNDVSGYV	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
8	Wang-C003	C1207	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCGGGGGGGTCGCTGAGACTCTCCTGTGCAGCCTCTGGAGTCATTGTCAGTAGTAATTATATGAATTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACTCTATATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTCTATTACTGTGCGAGAGAGTCCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGVIVSSNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARESYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGTAGTGATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCCGAGGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSDLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPRYTFGQGTKLEIK	IGHV3-66*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ2*01	ARESYGMDV	QQLNSYPPRYT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
8	Graham_P008	P008_042	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGAATCACCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGGGGTAGTACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGAATCCTATGGTATGGACGTCTGGGGCCAAGGGACCACGATCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGITVSSNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARESYGMDVWGQGTTITVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTATTAGCAGCACCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCCATGGTGCATCCAGCAGGGCCACTGGCATCTCAGACAGGATCAGTGGCAGTGGGTCTGGGACAGACTTCATTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGTTCACCGGGAACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSISSTYLAWYQQKPGQAPRLLIHGASSRATGISDRISGSGSGTDFILTISRLEPEDFAVYYCQQYGSSPGTFGQGTKVEIK	IGHV3-66*02	IGHJ6*02	nan	IGKV3-20*01	IGKJ1*01	ARESYGMDV	QQYGSSPGT	nan	Graham et al. Immunity 54:1276-1289.e6 (2021)	MW802428.1	MW802321.1
8	COV096	Wang-C382	COV096_HC_183-p1369	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGGAACTACATGAACTGGGTCCGCCAGGCCCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATGTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTATATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAAGCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSRNYMNWVRQAPGKGLEWVSVMYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARESYGMDVWGQGTTVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTTTTAGCAGCACCTACTTAGCCTGGTACCAGCAGAAGCCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGTTACCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSFSSTYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYVTSPWTFGQGTKVEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV3-20*01	IGKJ1*01	ARESYGMDV	QQYVTSPWT	nan	Robbiani et al. Nature 584:437-442 (2020);Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292827.1	MW293282.1
8	IML3564	ADI-63273	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCATCGTCAGTAGCAACTATATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTTTAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAAGCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCTTCA	EVQLLESGGGLIQPGGSLRLSCAASGLIVSSNYMNWVRQAPGKGLEWVSVIFSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARESYGMDVWGQGTTVTVSS	nan	nan	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9	nan	ARESYGMDV	QQLNSYPPA	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458782.1	nan
8	BG4	BG4-17	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGFLRLSCAASGLTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAR	nan	EIVLTQSPGTLSLSPGERATLSCRASQSISSTYLAWYQQKLGQAPRLLMYGASSRATGIPDRFSGSGSGSDFTLTISRLEPEDFAVYFCQQYGSSP	IGHV3-53*01	nan	nan	IGKV3-20*01	nan	ARESYGMDV	QQYGSSPGT	nan	Scheid et al. Cell 184:3205-3221.e24 (2021)	nan	nan
8	Wang-C003	C003_P1_IgG_E2-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGACTCACCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCAGATTCATGATCTCCAGAGACAATTCCAAGAACACGTTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGAGTCCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCTTCA	EVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFMISRDNSKNTLYLQMNSLRAEDTAVYYCARESYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCCGAGGGACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPRDTFGQGTKLEIK	IGHV3-66*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ2*01	ARESYGMDV	QQLNSYPPRDT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
8	COV096	COV096_P1_IgM_19-P1348	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATGTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAAGCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVMYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARESYGMDVWGQGTTVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGTTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYVSSPWTFGQGTKVEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV3-20*01	IGKJ1*01	ARESYGMDV	QQYVSSPWT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292810.1	MW293265.1
8	COV096	COV096_P1_IgM_35-P1348	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATGTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAAGCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVMYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARESYGMDVWGQGTTVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGTTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYVSSPWTFGQGTKVEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV3-20*01	IGKJ1*01	ARESYGMDV	QQYVSSPWT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292811.1	MW293266.1
8	COV096	COV096_P1_IgM_37-P1348	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATGTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAAGCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVMYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARESYGMDVWGQGTTVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGTTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYVSSPWTFGQGTKVEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV3-20*01	IGKJ1*01	ARESYGMDV	QQYVSSPWT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292812.1	MW293267.1
8	COV096	COV096_P1_IgM_47-P1348	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATGTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAAGCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVMYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARESYGMDVWGQGTTVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGTTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYVSSPWTFGQGTKVEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV3-20*01	IGKJ1*01	ARESYGMDV	QQYVSSPWT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292813.1	MW293268.1
8	COV096	COV096_P1_IgM_49-P1348	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATGTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAAGCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVMYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARESYGMDVWGQGTTVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGTTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYVSSPWTFGQGTKVEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV3-20*01	IGKJ1*01	ARESYGMDV	QQYVSSPWT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292814.1	MW293269.1
8	COV096	COV096_P1_IgM_64-P1348	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATGTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAAGCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVMYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARESYGMDVWGQGTTVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGTTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYVSSPWTFGQGTKVEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV3-20*01	IGKJ1*01	ARESYGMDV	QQYVSSPWT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292815.1	MW293270.1
8	COV096	COV096_P1_IgM_73-P1348	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATGTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAAGCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVMYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARESYGMDVWGQGTTVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGTTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYVSSPWTFGQGTKVEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV3-20*01	IGKJ1*01	ARESYGMDV	QQYVSSPWT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292816.1	MW293271.1
8	COV096	COV096_P1_IgM_89-P1348	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATGTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAAGCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVMYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARESYGMDVWGQGTTVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGTTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYVSSPWTFGQGTKVEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV3-20*01	IGKJ1*01	ARESYGMDV	QQYVSSPWT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292817.1	MW293272.1
8	COV096	COV096_P1_IgM_9-P1348	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATGTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAAGCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVMYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARESYGMDVWGQGTTVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGTTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYVSSPWTFGQGTKVEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV3-20*01	IGKJ1*01	ARESYGMDV	QQYVSSPWT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292809.1	MW293264.1
8	COV096	COV096_P2_IgM_1-P1348	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATGTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAAGCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVMYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARESYGMDVWGQGTTVTSP	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGTTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYVSSPWTFGQGTKVEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV3-20*01	IGKJ1*01	ARESYGMDV	QQYVSSPWT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292818.1	MW293273.1
8	COV096	COV096_P2_IgM_23-P1348	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATGTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAAGCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVMYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARESYGMDVWGQGTTVTSP	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGTTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYVSSPWTFGQGTKVEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV3-20*01	IGKJ1*01	ARESYGMDV	QQYVSSPWT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292819.1	MW293274.1
8	COV096	COV096_P2_IgM_29-P1348	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATGTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAAGCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVMYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARESYGMDVWGQGTTVTSP	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGTTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYVSSPWTFGQGTKVEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV3-20*01	IGKJ1*01	ARESYGMDV	QQYVSSPWT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292820.1	MW293275.1
8	COV096	COV096_P2_IgM_47-P1348	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATGTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAAGCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVMYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARESYGMDVWGQGTTVTSP	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGTTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYVSSPWTFGQGTKVEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV3-20*01	IGKJ1*01	ARESYGMDV	QQYVSSPWT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292821.1	MW293276.1
8	COV096	COV096_P2_IgM_50-P1348	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATGTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAAGCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVMYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARESYGMDVWGQGTTVTSP	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGTTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYVSSPWTFGQGTKVEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV3-20*01	IGKJ1*01	ARESYGMDV	QQYVSSPWT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292822.1	MW293277.1
8	COV096	COV096_P2_IgM_54-P1348	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATGTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAAGCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVMYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARESYGMDVWGQGTTVTSP	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGTTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYVSSPWTFGQGTKVEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV3-20*01	IGKJ1*01	ARESYGMDV	QQYVSSPWT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292823.1	MW293278.1
8	COV096	COV096_P2_IgM_55-P1348	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATGTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAAGCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVMYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARESYGMDVWGQGTTVTSP	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGTTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYVSSPWTFGQGTKVEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV3-20*01	IGKJ1*01	ARESYGMDV	QQYVSSPWT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292824.1	MW293279.1
8	COV096	COV096_P2_IgM_81-P1348	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATGTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAAGCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVMYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARESYGMDVWGQGTTVTSP	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGTTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYVSSPWTFGQGTKVEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV3-20*01	IGKJ1*01	ARESYGMDV	QQYVSSPWT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292825.1	MW293280.1
8	COV096	COV096_P2_IgM_94-P1348	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATGTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAAGCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVMYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARESYGMDVWGQGTTVTSP	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGTTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYVSSPWTFGQGTKVEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV3-20*01	IGKJ1*01	ARESYGMDV	QQYVSSPWT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292828.1	MW293283.1
8	COV096	COV096_P2_IgM_82-P1348	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGTACGTTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACACTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAACATATGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMTWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARETYGMDVWGQGTTVTSP	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGGGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSNYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV3-53*01	IGHJ6*02	IGHD2-21*01,IGHD2-21*02	IGKV3-20*01	IGKJ1*01	ARETYGMDV	QQYGSSPWT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292826.1	MW293281.1
8	COV096	Wang-C194	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGTACGTTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACACTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAACATATGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMTWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARETYGMDVWGQGTTVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGGGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSNYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV3-53*01	IGHJ6*02	IGHD2-21*01,IGHD2-21*02	IGKV3-20*01	IGKJ1*01	ARETYGMDV	QQYGSSPWT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	nan	nan
8	IML3564	ADI-62075	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGGTCACCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACACTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTATATTACTGTGCGAGAGAGGTGTACGGTATGGACGTCTGGGGCCAAGGGACCACTGTCACTGTCTCCTCA	EVQLLESGGGLIQPGGSLRLSCAASGVTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREVYGMDVWGQGTTVTVSS	nan	nan	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9	nan	AREVYGMDV	QQLNSHPGI	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458167.1	nan
8	Wang-MOD4	C663	Mod4_P4_IgG_D8-P1369	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGACTCATCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGTGTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAGTCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSVRAEDTAVYYCAREVYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATATTTACCCTCCACCTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNIYPPPFGPGTKVDIK	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ3*01	AREVYGMDV	QQLNIYPPP	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
8	Wang-MOD4	Mod4_P4_IgG_A5-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGTACAGACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAGTCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTDYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREVYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCCACCTTTCGGCCCTGGGACCAAAGTGGATGTCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPPFGPGTKVDVK	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ3*01	AREVYGMDV	QQLNSYPPP	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
8	Cho-C016	C2237	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTCTTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCTTTTATTACTGTGCGAGAGAGGTGTACGCTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVLYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAFYYCAREVYAMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCCGGGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPGYTFGQGTKLEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ2*01	AREVYAMDV	QQLNSYPGYT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
9	IML3564	ADI-63306	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTGGTGCAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAACAGCTCTGGCATGTACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGATGGCAGTTATATCATATGATGGATATAATAAATACTATGTGGACTCCGTAAGGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAATATGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAACCTCATGGTGGGAGCTACCTTGGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVQSGGGVVQPGRSLRLSCAASGFTFNSSGMYWVRQAPGKGLEWMAVISYDGYNKYYVDSVRGRFTISRDNSKNMLYLQMNSLRAEDTAVYYCAKPHGGSYLGYFDYWGQGTLVTVSS	nan	nan	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD1-26*01	IGKV3-20	nan	AKPHGGSYLGYFDY	QQYGSLPLT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458814.1	nan
9	IML3547	ADI-62217	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S1	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGACCGCATAGTGGGAGCTACTTGGGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLLESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARPHSGSYLGYFDYWGQGTLVTVSS	nan	nan	IGHV3-30-3*01	IGHJ4*02	IGHD1-26*01	IGKV3-20	nan	ARPHSGSYLGYFDY	QQYGSSQT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457940.1	nan
9	IML3547	ADI-62190	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAAGAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAACCGTATAGTGGGAGCTACTCGTCCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLLESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSKKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKPYSGSYSSYFDYWGQGTLVTVSS	nan	nan	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD1-26*01	IGKV3D-20	nan	AKPYSGSYSSYFDY	QQYGSLTPIT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457914.1	nan
9	IML3547	ADI-62194	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAAGAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAACCGTATAGTGGGAGCTACTCGTCCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCTTCA	EVQLLESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSKKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKPYSGSYSSYFDYWGQGTLVTVSS	nan	nan	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD1-26*01	IGKV3-20	nan	AKPYSGSYSSYFDY	QQYGSSPLT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457918.1	nan
9	Graham_P008	P008_088	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCCGGATTCACGTTCAGTGGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAGGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGGTGTATCTGCAGATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAACCGTATAGTGGGAGCTACTGGTCCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGVVQPGRSLRLSCAASGFTFSGYGMHWVRQAPGRGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTAVYYCAKPYSGSYWSYFDYWGQGTLVTVSS	GATATTGTGATGACTCAGTCTCCAGACTCCCTGGCTGTGTCTCTGGGCGAGAGGGCCACCATCAACTGCAAGTCCAGCCAGAGTGTTTTACACAGCTCCAACAATAAGAACTACGTAGCTTGGTACCAGCAGAAACCAGGACAGCCTCCTAAGCTGCTCATTTACTGGGCATCTACCCGGGAATCCGGGGTCCCTGACCGATTCAGTGGCAGCGGGTCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGGCTGAAGATGTGGCAGTTTATCACTGTCAGCAATATTATAGTACTCCTCTCACTTTCGGCGGAGGGACCAAAGTGGAGATCAAAC	DIVMTQSPDSLAVSLGERATINCKSSQSVLHSSNNKNYVAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYHCQQYYSTPLTFGGGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD1-26*01	IGKV4-1*01	IGKJ4*01	AKPYSGSYWSYFDY	QQYYSTPLT	nan	Graham et al. Immunity 54:1276-1289.e6 (2021)	MW802457.1	MW802350.1
9	IML3546	ADI-57837	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAACCTTATAGTGGGAGCTACTACGGATACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLLESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKPYSGSYYGYFDYWGQGTLVTVSS	nan	nan	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD1-26*01	IGKV3D-15	nan	AKPYSGSYYGYFDY	QQYNNWPPLT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457713.1	nan
9	IML3546	ADI-57838	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTTGTGCAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAACCTTATAGTGGGAGCTACTACGGATACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVQSGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKPYSGSYYGYFDYWGQGTLVTVSS	nan	nan	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD1-26*01	IGKV3D-15	nan	AKPYSGSYYGYFDY	QQYNNWPPLT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457714.1	nan
9	IML3564	ADI-62046	nan	SARS-CoV-2,SARS-CoV	nan	SARS-CoV	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCCCTGGATTCATATTCAGTTCCTATGCCATGTACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGATACAATAAATATTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGTACACTGTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGACCTTATAGTGGGAGCTACCTTAGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLLESGGGVVQPGRSLRLSCAAPGFIFSSYAMYWVRQAPGKGLEWVAVISYDGYNKYYADSVKGRFTISRDNSKYTVYLQMNSLRAEDTAVYYCARPYSGSYLSYFDYWGQGTLVTVSS	nan	nan	IGHV3-30-3*01	IGHJ4*02	IGHD1-26*01	IGKV3-20	nan	ARPYSGSYLSYFDY	QQYGSSPPLT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458138.1	nan
9	IML3548	ADI-60733	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTGGTGCAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCATCTTCAGTAGCTATGGCTTGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATTTCATATGATGGAATTAATAAATACTATGCAGACTCCGTGAGGGGCCGATTCACCATCTCCAGAGACAATTCTAAGAACACACTCTATCTGCAAATGAACAGCCTGAGAACTGAGGACACGGCTGTTTATTACTGTGCGAGGGGGTATAGTGGGAGCTACTACGGACACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVQSGGGVVQPGRSLRLSCAASGFIFSSYGLHWVRQAPGKGLEWVAVISYDGINKYYADSVRGRFTISRDNSKNTLYLQMNSLRTEDTAVYYCARGYSGSYYGHFDYWGQGTLVTVSS	nan	nan	IGHV3-30*03	IGHJ4*02	IGHD1-26*01	IGLV4-69	nan	ARGYSGSYYGHFDY	QTWGTGSPAV	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458002.1	nan
9	IML3549	ADI-57828	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGGCCGTATAGTGGGAGCTACTACGGGTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACTGTCTCCTCA	QVQLVQSGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARPYSGSYYGYFDYWGQGTLVTVSS	nan	nan	IGHV3-30-3*01	IGHJ4*02	IGHD1-26*01	IGKV1-5	nan	ARPYSGSYYGYFDY	QQYNSYWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457704.1	nan
9	Jennewein_CV3	CV3-23	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATCCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCCGTTATATCATATGATGGAATTAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCAGCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTTCTGTGCGAGAATGTATAGTGGGAGCTACTTGGGGTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLQESGGGVVQPGRSLRLSCAASGFTFSSYAIHWVRQAPGKGLEWVAVISYDGINKYYADSVKGRFTSSRDNSKNTLYLQMNSLRAEDTAVYFCARMYSGSYLGYFDYWGQGTLVTVSS	GAAATTGTGTTGACACAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATAATAAGTGGCCTCCGATCACCTTCGGCCAAGGGACACGACTGGAGATTAAA	EIVLTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNKWPPITFGQGTRLEIK	IGHV3-30*04,IGHV3-30-3*03	IGHJ4*02	IGHD1-26*01	IGKV3-15*01	IGKJ5*01	ARMYSGSYLGYFDY	QQYNKWPPIT	nan	Jennewein et al. Cell Rep. 36:109353 (2021)	MW681574.1	MW681602.1
9	IML3564	ADI-62030	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCGGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATCTACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAATCAACAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTTCAACAACACGCTGTATCTGCAAATGAACAGCCTGACAGCTGAGGACACGGCTGTGTATTACTGTGCGAGGCCTTATAGTGGGAGCTACGGGGGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACTGTCTCCTCA	EVQLLESGGGVVQPGRSLRLSCAASGFTFSSYAIYWVRQAPGKGLEWVAVISYDGINKYYADSVKGRFTISRDNFNNTLYLQMNSLTAEDTAVYYCARPYSGSYGGYFDYWGQGTLVTVSS	nan	nan	IGHV3-30-3*01	IGHJ4*02	IGHD1-26*01	IGKV4-1	nan	ARPYSGSYGGYFDY	QQYYSTPLT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458122.1	nan
9	IML3549	ADI-63118	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GGGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGTCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATTTCATATGATGGAAACAATAAATATTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCCGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGACCTGAGGACACGGCTGTGTATAACTGTGCGAGATCGTATAGTGGGAGCTATCTATCATACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	GVQLLESGGGVVQPGRSLRLSCAVSGFTFSSYAMHWVRQAPGKGLEWVAVISYDGNNKYYADSVKGRFTISRDNSKNTLYLQMNSLRPEDTAVYNCARSYSGSYLSYFDYWGQGTLVTVSS	nan	nan	IGHV3-30-3*01	IGHJ4*02	IGHD1-26*01	IGKV3-20	nan	ARSYSGSYLSYFDY	QHYGSSPGT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458627.1	nan
9	Jennewein_CV2	CV2-12	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTTCAGCTTGTTGAATCAGGAGGCGGGGTAGTGCAACCGGGGCGGAGCCTGAGACTGAGTTGTGCGGCTAGTGGCTTTACCTTTTCTAGCTATGGCATTCACTGGGTACGACAAGCGCCCGGTAAGGGACTTGAATGGGTGGCCGTGATCTCTTATGACGGTATAAATAAATATTACGCCGACTCAGTTAAAGGTCGATTCACAATCTCAAGAGATAACAGCAAAAACACACTCTACCTGCACATGAACTCTTTGAGGGCGGAAGACACTGCGGTGTACTATTGTGCCCGCCCGAACAGTGGGAGTTATCACAGTTATTTCGACTATTGGGGACAAGGGACATTGGTCACAGTGAGTTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGIHWVRQAPGKGLEWVAVISYDGINKYYADSVKGRFTISRDNSKNTLYLHMNSLRAEDTAVYYCARPNSGSYHSYFDYWGQGTLVT	GAAATTGTTCTGACTCAATCCCCAGCAACTCTGTCCCTTTCACCAGGAGAACGCGCAACCTTGTCATGTGGAGCTTCACAGAGTGTGTCAAGTTCCTATTTGGCATGGTATCAGCAGAAACCTGGCTTGGCGCCTCGACTGGTGATTTATGACGCTAGTAGTAGAGCGACTGGCATACCGGATAGGTTCAGTGGTTCAGGATCTGGCACGGATTTTACTCTTACGATTAGCAGACTGGAACCAGAAGACTTTGCTGTTTACTATTGCCAACAGTACGGAAGCTCACCCCAAACTTTCGGGCAGGGGACCCGGTTGGAAATTAAA	EIVLTQSPATLSLSPGERATLSCGASQSVSSSYLAWYQQKPGLAPRLVIYDASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPQTFGQGTRLEIK	IGHV3-30*06,IGHV3-30*12,IGHV3-30*19	IGHJ4*03	IGHD3-16*02	IGKV3D-20*01	IGKJ1*01	ARPNSGSYHSYFDY	QQYGSSPQT	nan	Jennewein et al. Cell Rep. 36:109353 (2021)	MW681636.1	MW681637.1
9	Graham_P008	P008_005	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACTAATAAATACTATGCAGACTCAGTGAACGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGGACAGCCTGAGAGCTGGGGACACGGCTGTGTATTACTGTGCGAGACCTAACAGTGGGAGCTATTCCAGCTATCTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGTNKYYADSVNGRFTISRDNSKNTLYLQMDSLRAGDTAVYYCARPNSGSYSSYLDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTTTTAGTAGCTGGTTGGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATAAGGCGTCTAGTTTAGAGAGTGGGGTCCCATCAAGATTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACCACCAGCAGCCTGCAGCCTGATGATTTTGCAACTTATTACTGCCAACAGTATAGTACTTATTCTCCGCTCACTTTCGGCGGAGGGACCAAAGTGGATATCAAAC	DIQMTQSPSTLSASVGDRVTITCRASQSFSSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTTSSLQPDDFATYYCQQYSTYSPLTFGGGTKVDIK	IGHV3-30*03	IGHJ4*02	IGHD1-26*01	IGKV1-5*03	IGKJ4*01	ARPNSGSYSSYLDY	QQYSTYSPLT	nan	Graham et al. Immunity 54:1276-1289.e6 (2021)	MW802409.1	MW802302.1
9	IML3550	ADI-62165	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACCTATGCTGTGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAATGGGTGGCAGTTATATCATATGATGGAAACAATAAATACTACGCAGACGCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGACGACACGGCTGTGTACTACTGTGCGAGACCATCTAGTGGGAGCTACTTTTCGTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLLESGGGVVQPGRSLRLSCAASGFTFSTYAVHWVRQAPGKGLEWVAVISYDGNNKYYADAVKGRFTISRDNSKNTLYLQMNSLRADDTAVYYCARPSSGSYFSYFDYWGQGTLVTVSS	nan	nan	IGHV3-30-3*01	IGHJ4*02	IGHD1-26*01	IGKV3-20	nan	ARPSSGSYFSYFDY	QQYGSSPFT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458257.1	nan
9	Crowe_mix	COV2-2422	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGTACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAATTAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGTGAACAGTGGGAGCTACTATTCCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMYWVRQAPGKGLEWVAVISYDGINKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARVNSGSYYSYFDYWGQGTLVTVSS	GACATCGTGATGACCCAGTCTCCAGACTCCCTGGCTGTGTCTCTGGGCGAGAGGGCCACCATCAACTGCAAGTCCAGCCAGAGTGTTTTATACAGCTCCAACAATAAGAACTACTTAGCTTGGTACCAGCAGAAACCAGGACAGCCTCCTAAGCTGCTCATTTACTGGGCATCTACCCGGGAATCCGGGGTCCCTGACCGATTCAGTGGCAGCGGGTCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGGCTGAAGATGTGGCAGTTTATTACTGTCAGCAATATTATAGTACTCCTTTAACGTTCGGCCAAGGGACCAAGGTGGAAATCAAA	DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPLTFGQGTKVEIK	IGHV3-30*04,IGHV3-30-3*03	IGHJ4*02	IGHD1-26*01	IGKV4-1*01	IGKJ1*01	ARVNSGSYYSYFDY	QQYYSTPLT	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665744.1	MT665357.1
9	Crowe_mix	COV2-2239	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAATCAATAAATACTACGCAGACGCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGGCCACGAAGTGGGAGCTACTACGCCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGINKYYADAVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARPRSGSYYAYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCACTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGTCGGGCGAGTCAGGGCATTAGCAATTATTTAGCCTGGTTTCAGCAGAAACCAGGGAAAGCCCCTAAGTCCCTGATCTATGCTGCATCCAGTTTACAAAGTGGGGTCCCATCAAAGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATGTTGCAACTTATTACTGCCAACAGTATAATAGTCACCCTCCCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAA	DIQMTQSPSSLSASVGDRVTITCRASQGISNYLAWFQQKPGKAPKSLIYAASSLQSGVPSKFSGSGSGTDFTLTISSLQPEDVATYYCQQYNSHPPTFGGGTKVEIK	IGHV3-30-3*01	IGHJ4*02	IGHD1-26*01	IGKV1-16*02	IGKJ4*01	ARPRSGSYYAYFDY	QQYNSHPPT	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665763.1	MT665376.1
9	Jennewein_CV2	CV2-1_	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTTGTAGAGAGTGGCGGGGGAGTCGTGCAGCCGGGTCGATCACTGAGACTTTCCTGCGCTGCAAGTGGTTTCACCTTCAGCTCATACGCCATGCATTGGGTTCGGCAAGCACCAGGGAAGGGCCTTGAATGGGTCGCCGTAATATCCTATGACGGAAGTAATAAATACTATGCCGATAGTGTTAAAGGACGATTCACGATCTCCAGGGACAATTCCAAAAACACACTTTACCTGCAAATGAACTCTCTCAGAGCGGAAGATACGGCGATTTATTATTGTGCGCGGCCTTATTCAGGATCTTATTACGCTTATTTCGATTATTGGGGGCAAGGTACTCTGGTAACAGTGTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAIYYCARPYSGSYYAYFDYWGQGTLVTVSS	GAAATCGTAATGACCCAGAGCCCCGCTACATTGAGCGTCAGCCCCGGTGAGAGAGCTACTCTTAGCTGTCGGGCATCTCAATCAGTCTCCTCAAATCTCGCCTGGTATCAACAGAAGCCAGGCCAAGCACCTCGGCTTTTGATATATGGTGCGTCAACACGAGCGACCGGCATTCCTGCACGCTTCTCAGGCTCAGGCAGTGGAACCGAGTTCACCCTTACGATAAGTTCTCTCCAATCTGAAGATTTTGCTGTCTACTACTGCCAGCAATATAACAATTGGCTTGCACTGACATTTGGAGGCGGAACTAAAGTAGAAATAAAA	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNW	IGHV3-30*03,IGHV3-30*12,IGHV3-30*18	IGHJ4*01,IGHJ4*03,IGHJ5*01	IGHD3-16*01,IGHD3-3*01	IGKV3D-15*01	nan	ARPYSGSYYAYFDY	nan	nan	Jennewein et al. Cell Rep. 36:109353 (2021)	MW681614.1	MW681615.1
9	IML3547	ADI-62919	nan	SARS-CoV-2,SARS-CoV	nan	SARS-CoV-2	SARS-CoV	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCGGCCTCTGGATTCACCTTCAGTAGCTATACTATGTACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCACTTATTTCATATGATGGAGACAATAAATACTACGTAGACTCCGTGAGGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACTCTGTCTCTGCAAATGAACAGCCTGAGAACTGAGGACACGGCTGTTTATTACTGTGCGCGGCCCTCGAGTGGGAACTACATGTCCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACTGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYTMYWVRQAPGKGLEWVALISYDGDNKYYVDSVRGRFTISRDNSKNTLSLQMNSLRTEDTAVYYCARPSSGNYMSYFDYWGQGTLVTVSS	nan	nan	IGHV3-30-3*01	IGHJ4*02	IGHD1-26*01	IGKV4-1	nan	ARPSSGNYMSYFDY	QQYYSTPLT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458428.1	nan
9	Jennewein_CV1	CV1-28	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTACAGTTGGTCGAAAGCGGCGGAGGTGTTGTCCAACCCGGTCGATCATTGCGCTTGTCATGCGCGGCAAGCGGCTTCACATTTAGTTCATATGCGATGCATTGGGTTAGACAGGCGCCGGGAAAGGGCCTTGAGTGGGTTGCAGTGATATCTTACGACGGTTCAAATAAGTACTACGCAGATTCCGTCAAGGGTCGCTTCACCATATCCCGGGACAATAGTAAGAATACTTTGTATTTGCAAATGAATAGCCTCCGGGCTGAAGACACCGCCGTTTACTACTGCGCCCGACCCTACTCAGGATCCTATTGGGGCTACCTCGATTACTGGGGACAAGG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARPYSGSYWGYLDYWGQG	GACATTCAGATGACACAGAGTCCCTCAACGCTGTCCGCTAGCGTTGGCGACAGGGTAACTATTACTTGTAGGGCGTCTCAATCTATCTCTTCTTGGTTGGCGTGGTATCAGCAAAAGCCAGGAAAAGCCCCCAAACTGTTGATATACAAGGCGTCCAGTTTGGAATCAGGGGTGCCTAGCCGATTTAGTGGCTCTGGCTCAGGGACCGAATTTACTCTTACCATTTCTTCTTTGCAGCCGGATGATTTTGCAACTTACTACTGCCAGCAGTACAACTCCTACTCATATACCTTTGGGCAAGGAACCAAATTGGAAATCAAA	DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSYTFGQGTKLEIK	IGHV3-30*17	IGHJ4*03	IGHD2-15*01	IGKV1-5*03	IGKJ1*01	ARPYSGSYWGYLDY	nan	nan	Jennewein et al. Cell Rep. 36:109353 (2021)	nan	nan
9	IML3547	ADI-60794	nan	SARS-CoV-2,SARS-CoV	nan	SARS-CoV-2	SARS-CoV	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTGCAGCCCGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCGTTTGATGGAATCAATAAGTACTACGCAGGCTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCGAGAACACGCTGTATCTGGAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTCTATTACTGTGCGAGACCTTATAGTGGGACCTACCACGCCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGGVVQPGRSLRLSCAASGFTFSGYAMHWVRQAPGKGLEWVAVISFDGINKYYAGSVKGRFTISRDNSENTLYLEMNSLRAEDTAVYYCARPYSGTYHAYFDYWGQGTLVTVSS	nan	nan	IGHV3-30-3*01	IGHJ4*02	IGHD1-26*01	IGKV4-1	nan	ARPYSGTYHAYFDY	QQYYTPPVT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458063.1	nan
9	Li_SARS2_26	DH1175	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSSSGSYLYYFDYWGQGTLVTVSS	nan	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPGTFGPGTKVDIK	IGHV3-30*01	IGHJ4	nan	IGKV3-15*01	IGKJ3	ARSSSGSYLYYFDY	QQYNNWPGT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
9	Li_SARS2_26	H511600+K511320	nan	SARS-CoV-2	SARS-CoV,MERS-CoV	nan	nan	S:S2	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSSSGSYLYYFDYWGQGTLVTVSS	nan	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPGTFGPGTKVDIK	IGHV3-30*01	IGHJ4	nan	IGKV3-15*01	IGKJ3	ARSSSGSYLYYFDY	QQYNNWPGT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
9	IML3564	ADI-63407	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTGGTGCAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAATATCTATGCTTTGTACTGGGTCCGCCAGGCTCCAGGCACGGGGCTGGAGTGGGTGGCAGTTATTTCGTATGATGGAATCAATAAATACTACGCAGACTCCGTGAGGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACTCGGCTGTGTATTACTGTGCGAGATCCTATAGTGGAAACTACTTAGCCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVQSGGGVVQPGRSLRLSCAASGFTFNIYALYWVRQAPGTGLEWVAVISYDGINKYYADSVRGRFTISRDNSKNTLYLQMNSLRAEDSAVYYCARSYSGNYLAYFDYWGQGTLVTVSS	nan	nan	IGHV3-30-3*01	IGHJ4*02	IGHD1-26*01	IGKV1-5	nan	ARSYSGNYLAYFDY	QQYNSYPIT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458913.1	nan
9	IML3545	ADI-62147	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGAACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTAGAGTGGGTGGCAGTTATATCATATGATGGAGATAATAAATACTACGCTGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACCCTGTATCTGCAAATGAACAGCCTGAGACCTGAGGACACGGCTGTGTATTACTGTGCGAGGTCCTACAGTGGGAGCTACTTAACCCACTTTGACTACTGGGGCCAGGGAGCCCTGGTCACCGTCTCCTCA	EVQLLESGGGVVQPGRSLRLSCAASGFTFSSYAMNWVRQAPGKGLEWVAVISYDGDNKYYADSVKGRFTISRDNSKNTLYLQMNSLRPEDTAVYYCARSYSGSYLTHFDYWGQGALVTVSS	nan	nan	IGHV3-30*01	IGHJ4*02	IGHD1-26*01	IGKV3D-15	nan	ARSYSGSYLTHFDY	QQYNNWPLA	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458239.1	nan
9	IML3550	ADI-57823	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGGTCGTATAGTGGGAGCTACTGGGCCCACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCTTCA	EVQLLESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSYSGSYWAHFDYWGQGTLVTVSS	nan	nan	IGHV3-30-3*01	IGHJ4*02	IGHD1-26*01	IGKV3-20	nan	ARSYSGSYWAHFDY	QQYGSSPYT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457699.1	nan
9	Li_SARS2_26	DH1174	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARTYSGSYYSYFDYWGQGTLVTVSS	nan	DIQMTQSPSSLSASVGDRVTITCQASQDIRNYLNWWQQKPGKAPNLLIYDESNLEAGVPSRFSGTGSGTDFTLTISSLQPEDIATYYCQQYDDLWTFGQGTKVEIK	IGHV3-30*01	IGHJ4	nan	IGKV1-33*01	IGKJ1	ARTYSGSYYSYFDY	QQYDDLWT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
10	IML3546	ADI-62794	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAATTATTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATTCCAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGAAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGGGTTCTGTGACCGCCGCAGACACGGCCATTTATTACTGTGCGAGGGGGTTTGACTTCTGGGGCCAGGGAACCCTGGTCACTGTCTCCTCA	EVQLVESGPGLVKPSETLSLTCTVSGGSISNYYWSWIRQPPGKGLEWIGYIYSSGSTNYNPSLKSRVTISEDTSKNQFSLKLGSVTAADTAIYYCARGFDFWGQGTLVTVSS	nan	nan	IGHV4-59*08	IGHJ4*02	nan	IGKV3-20	nan	ARGFDF	HQYGSSPWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458302.1	nan
10	IML3564	ADI-63330	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCCGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCGCCTGCACTGTCTCTGGTGACTCCATCAGTGGTTACTTCTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGATATATCTATTACAGTGGGAGCACAAATTACAACCCCTCCCTGAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAACCTGACTTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGAGGATTTGACTTCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGPGLVKPSETLSLACTVSGDSISGYFWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTMSVDTSKNQFSLNLTSVTAADTAVYYCARGFDFWGQGTLVTVSS	nan	nan	IGHV4-59*01	IGHJ4*02	nan	IGKV3-20	nan	ARGFDF	QQYGTSPWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458838.1	nan
10	ZhouY_P1	XG002	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV4-59	IGHJ4	nan	IGKV3-20	IGKJ1	ARGFDF	QQHSSSPWT	nan	Zhou et al. Cell Rep. 34:108699 (2021)	nan	nan
10	IML3547	ADI-60795	nan	SARS-CoV-2,SARS-CoV	nan	SARS-CoV-2	SARS-CoV	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGACTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATTACAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGACTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGGTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGGGGATTCGATCTCTGGGGCCGTGGCACCCTGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCTVSGDSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRLTISVDTSKNQFSLKLRSVTAADTAVYYCARGFDLWGRGTLVTVSS	nan	nan	IGHV4-59*01	IGHJ2*01	nan	IGKV3-20	nan	ARGFDL	QQYGSSPWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458064.1	nan
10	IML3564	ADI-62023	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCAGTGTCTCTGGTGACTCCATCAATACATACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATTACAGTGGGAGCATCAACTACAACCCCTCCCTCAAGAATCGCGTCACCATGTCAGTAGACACGTCCAAGAACCAGCTCTCCCTGAAGCTGAGCTCTCTAACCGCTGCGGACACGGCCGTCTATTACTGTGCGAGGGGTTTCGATCTCTGGGGCCGTGGCACCCTGGTCACCGTCTCCTCA	EVQLLESGPGLVKPSETLSLTCSVSGDSINTYYWSWIRQPPGKGLEWIGYIYYSGSINYNPSLKNRVTMSVDTSKNQLSLKLSSLTAADTAVYYCARGFDLWGRGTLVTVSS	nan	nan	IGHV4-59*01	IGHJ2*01	nan	IGKV3-20	nan	ARGFDL	LQYTSSPWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458115.1	nan
10	IML3564	ADI-63264	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTTGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGACTCCATCAGTAGTTATTACTGGAGCTGGATCCGGCAACCCCCAGGGAAGGGACTGGAGTACATTGGGTATGTGCATTACAGTGGGAGCACTAATTACAACCCCTCCCTCAAGAGTCGAGTCACCATTTCACTGGACACGTCCAAGAACCAGTTCTCCCTGAAGATGAGGTCTGTGACCGCTGCGGACACGGCCGTGTATTTCTGTGCGAGAGGATTTGACTTGTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCTVSGDSISSYYWSWIRQPPGKGLEYIGYVHYSGSTNYNPSLKSRVTISLDTSKNQFSLKMRSVTAADTAVYFCARGFDLWGQGTLVTVSS	nan	nan	IGHV4-59*01	IGHJ4*02	nan	IGKV3-20	nan	ARGFDL	HQYGNTPWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458773.1	nan
10	IML3548	ADI-62946	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGCCTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCAATGTCTCTGGTGACTCCATCAGTAATTATTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATTCCAGTGGGACCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATGTCACTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGGTCTGTGACCGCTGCGGACACGGCCGTGTATTATTGTGCGAGAGGCTTTGACAACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCNVSGDSISNYYWSWIRQPPGKGLEWIGYIYSSGTTNYNPSLKSRVTMSLDTSKNQFSLKLRSVTAADTAVYYCARGFDNWGQGTLVTVSS	nan	nan	IGHV4-59*01	IGHJ4*02	nan	IGKV3-20	nan	ARGFDN	HQYGSSLTWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458455.1	nan
10	IML3547	ADI-62879	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCAGTGTCTCTGGTGACTCCATCAGTGGTTACTACTGGACCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGATATATCTCTTCCAGTGGGAGCACCAACTACAGCCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAACCTGAGGTCTGTGGCCGCCGCAGACACGGCCGTGTATTACTGTGCGAGAGGATTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLLESGPGLVKPSETLSLTCSVSGDSISGYYWTWIRQPPGKGLEWIGYISSSGSTNYSPSLKSRVTISVDTSKNQFSLNLRSVAAADTAVYYCARGFDPWGQGTLVTVSS	nan	nan	IGHV4-59*08	IGHJ5*02	nan	IGKV3-20	nan	ARGFDP	QQYGSSPWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458387.1	nan
10	IML3558	ADI-63208	nan	SARS-CoV-2,SARS-CoV	nan	SARS-CoV-2	SARS-CoV	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCAGTGTCTCTGGTGGCTCCATAAGTGGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATTCCAGTGGGAACACCAACTACAACCCCTCCCTCAAGAGTCGGGTCACCATATCAGTAGACACGTCCAATAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGGGGCTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGPGLVKPSETLSLTCSVSGGSISGYYWSWIRQPPGKGLEWIGYIYSSGNTNYNPSLKSRVTISVDTSNNQFSLKLSSVTAADTAVYYCARGFDPWGQGTLVTVSS	nan	nan	IGHV4-59*01	IGHJ5*02	nan	IGKV3-20	nan	ARGFDP	QQYGSSPWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458717.1	nan
10	IML3564	ADI-63301	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCATGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTGGTTACTATTGGACCTGGATACGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATCACAGTGGGAGCACCAAATACAACCCCTCCCTCAAGAGTCGAGTCACCATATCACTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTATTGTGCGAGAGGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLLESGPGLVKPSETMSLTCTVSGGSISGYYWTWIRQPPGKGLEWIGYIYHSGSTKYNPSLKSRVTISLDTSKNQFSLKLSSVTAADTAVYYCARGFDPWGQGTLVTVSS	nan	nan	IGHV4-59*01	IGHJ5*02	nan	IGKV3-20	nan	ARGFDP	HQYGSSLLWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458809.1	nan
10	IML3564	ADI-63354	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GGGGTGCAGCTGTTGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCAATTGCACTGTCTCTGGTGACTCCATCAGTGGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATTACAGTGGGAGCACCAATTACAACCCCTCCCTCAAGAGTCGAGTCTCCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGTTGACCTCTGTGACCGCTGCGGACACGGCCGTCTATTACTGTGCGAGGGGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	GVQLLESGPGLVKPSETLSLNCTVSGDSISGYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVSISVDTSKNQFSLKLTSVTAADTAVYYCARGFDPWGQGTLVTVSS	nan	nan	IGHV4-59*01	IGHJ5*02	nan	nan	nan	ARGFDP	nan	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458860.1	nan
10	Wheatley-CP8	PDI_124	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATGTATTACAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAATCAGTTCTTCCTGAAGCTGAGGTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGGGGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYMYYSGSTNYNPSLKSRVTISVDTSKNQFFLKLRSVTAADTAVYYCARGFDPWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTCAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTAGTCTATGCTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCGGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACTCCGGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAA	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLVYAASSRATGIPDRFSGGGSGTDFTLTISRLEPEDFAVYYCQQYGSSLRWTFGQGTKVEIK	IGHV4-59*01	IGHJ5*02	nan	IGKV3-20*01	IGKJ1*01	ARGFDP	QQYGSSLRWT	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
10	Jennewein_CV2	CV2-49	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTCCAAGAGTCCGGTCCAGAGTTGGTAAAGCCTAGTGAAACTCTCTCCTTGACATGTAGCGTCAGCGGTGGAAGTATTTCATCTTACTATTGGTCATGGATACGACAGCCTCCTGGGAAAGGACTGGAATGGATCGGTTATATTTACTACTCTGGTTCAACGAATTACAATCCATCCCTCAGTGGGTCTACGAACTATAACCCGTCACTGAAAAGCCGCGTAACTGTGAGCGTTGACACCTCTAAGAACCAGTTCTCCCTTAAAGTTTCATCTGTAACCGCTGCGGATACGGCCGTGTACTACTGTGCGAGGGGATTCGACTATTGGGGTCAGGGCACACTCGTAACAGTCTCCTCAG	QVQLQESGPELVKPSETLSLTCSVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLSGSTNYNPSLKSRVTVSVDTSKNQFSLKVSSVTAADTAVYYCARGFDYWGQGTLVTVSS	GAAATCGTCCTCACACAGAGCCCAGGTACGCTTAGCCTTAGTCCGGGCGAGAGGGCGACGCTCTCATGTAGGGCATCCCAAAGTGTATCATCTATCTACCTGGCTTGGTATCAACAAAAACCCGGCCAAGCGCCACGCCTCCTCATTTACGGAGCGAGTTCAAGAGCGACCGGCATACCGGACAGGTTTAGCGGGAGTGGCTCAGGGACTGACTTCACACTGACTATCAGCCGATTGGAACCGGAGGACTTCGCCGTTTACTACTGCCAGCAGTATGGCAGTTCCCCGTGGACATTCGGGCAAGGGACTAAGGTCGAGATTAAA	EIVLTQSPGTLSLSPGERATLSCRASQSVSSIYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV4-59*01,IGHV4-59*07,IGHV4-59*13	IGHJ4*02	nan	IGKV3-20*01	IGKJ1*01	ARGFDY	QQYGSSPWT	nan	Jennewein et al. Cell Rep. 36:109353 (2021)	MW681708.1	MW681709.1
10	Jennewein_CV1	CV1-10	CV10	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTTCAGCTCCAGGAAAGTGGGCCGGGTCTGGTTAAACCAAGCGAGACGTTGTCCCTTACGTGTAATGTCTCTGGAGGGTCTATAAGTTCTTATTACTGGTCTTGGATTCGCCAGCCCCCAGGGAAAGGGCTCGAGTGGATCGGCTATATTTATTACTCAGGTTCTACGAACTATAATCCTTCCTTGAAATCCCGGGTGACCATCTCAGTTGACACAAGCAAGAACCAATTCAGTCTCAAACTCTCTAGCGTCACTGCTGCGGATACGGCTGTGTACTATTGTGCTCGAGGTTTCGACTACTGGGGCCAGGGCACATTGGTCACAGTATCATCA	QVQLQESGPGLVKPSETLSLTCNVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGFDYWGQGTLVTVSS	GAAATTGTGCTTACGCAGTCACCCGGAACTCTCAGTCTGTCCCCCGGTGAAAGGGCCACTCTCTCCTGTAGGGCATCCCAAAGCGTTTCTAGCATATATCTCGCTTGGTACCAACAGAAGCCGGGTCAAGCTCCGCGGCTGCTGATTTATGGCGCCTCTAGTCGGGCAACTGGTATCCCTGATCGGTTTAGTGGGTCAGGAAGTGGTACAGATTTCACCCTTACGATTTCTCGGCTCGAGCCCGAGGATTTTGCCGTATACTATTGTCAACAGTACGCAGGGTCTCCTTGGACGTTTGGCCAGGGCACAAAGGTCGAGATCAAA	EIVLTQSPGTLSLSPGERATLSCRASQSVSSIYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYAGSPWTFGQGTKVEIK	IGHV4-59*03	IGHJ4*02	nan	IGKV3-20*01	IGKJ1*01	ARGFDY	QQYAGSPWT	nan	Jennewein et al. Cell Rep. 36:109353 (2021);Seydoux et al. Immunity 53:98-105.e5 (2020)	MT462486.1	MT462551.1
10	VRC_SARS1	H712427+K711927	nan	SARS-CoV,SARS-CoV-2	MERS-CoV	nan	nan	S:S2	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV Human Patient	nan	QVQLQESGPGLVKPSETLSLTCTVSGGSISNYYWSWLRQSPGKGLEWIGYIYDSGTTNYNPSLKSRVTISIDTSKNHFSLKLNSVTAADTAVYYCARGFDYWGQGTLVTVSS	nan	EIVLTQSPGTLSLSPGERATLSCRASQSVSSNYLAWFQQKPGQAPRLLIYATFSRSIGIADRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV4-4*08	IGHJ4	nan	IGKV3-20*01	IGKJ1	ARGFDY	QQYGSSPWT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
10	Li_SARS2_26	H712443+K711941	nan	SARS-CoV-2,MERS-CoV	SARS-CoV	nan	nan	S:S2	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRITISVDTSKNQFSLKLSSVTAADTAMYYCARGFDYWGQGTLVTVSS	nan	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRAIGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQFGSSPWTFGQGTKVEIK	IGHV4-59*01	IGHJ4	nan	IGKV3-20*01	IGKJ1	ARGFDY	QQFGSSPWT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
10	IML3548	ADI-60732	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCGGGTGGCTCCATCAGTAGTTTCTACTGGAGCTGGATCCGGCAGTCCCCAGGGAGGGGACTGGAGTGGATTGGGTATATCTATTCCAGTGGGAACACCAACTACAACCCCTCCCTCAAGAGTCGAGTTAACATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAGGCTGAGTTCTGTGACCGCTGCGGACACGGCCATATATTACTGTGCGAGAGGATTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCTVSGGSISSFYWSWIRQSPGRGLEWIGYIYSSGNTNYNPSLKSRVNISVDTSKNQFSLRLSSVTAADTAIYYCARGFDYWGQGTLVTVSS	nan	nan	IGHV4-59*01	IGHJ4*02	nan	IGKV3-20	nan	ARGFDY	QQYGSSPWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458001.1	nan
10	IML3547	ADI-60784	nan	SARS-CoV-2,SARS-CoV	nan	SARS-CoV-2	SARS-CoV	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCCGGCCCAGAACTGGTGATGCCTTCGGAGACCCTGTCCCTCAATTGCACTGTCTCTGGTGGCTCCATCAGTGGATACTACTGGAGCTGGATAAGGCAGTCCCCGGGGAAGGGACTGGAGTGGATTGGGTATATCTATTACGGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAACCTGATCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGGGGCTTTGACTACTGGGGCCAGGGAACCCTGGTCACTGTCTCCTCA	QVQLQESGPELVMPSETLSLNCTVSGGSISGYYWSWIRQSPGKGLEWIGYIYYGGSTNYNPSLKSRVTMSVDTSKNQFSLNLISVTAADTAVYYCARGFDYWGQGTLVTVSS	nan	nan	IGHV4-59*13	IGHJ4*02	nan	IGKV3-20	nan	ARGFDY	QQYGSFPWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458053.1	nan
10	IML3564	ADI-62062	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGCCCAGAACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACGTGCACTGTCTCTGGTGACTCCATCAATGGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATTCCAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGACTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTTTATTACTGTGCGAGAGGGTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGPELVKPSETLSLTCTVSGDSINGYYWSWIRQPPGKGLEWIGYIYSSGSTNYNPSLKSRLTISVDTSKNQFSLKLSSVTAADTAVYYCARGFDYWGQGTLVTVSS	nan	nan	IGHV4-59*01	IGHJ4*02	nan	IGKV3-20	nan	ARGFDY	QQYGSTPWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458154.1	nan
10	IML3564	ADI-62108	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTATTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGCTATGTCTATTACAGTGGAAGCTCCAAATACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAAGTCTCCCTGAACCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGAGGATTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYVYYSGSSKYNPSLKSRVTISVDTSKNQVSLNLSSVTAADTAVYYCARGFDYWGQGTLVTVSS	nan	nan	IGHV4-59*01	IGHJ4*02	nan	IGKV3-20	nan	ARGFDY	QQYGSSPWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458200.1	nan
10	IML3548	ADI-63050	nan	SARS-CoV-2,SARS-CoV	nan	SARS-CoV-2	SARS-CoV	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATTACAGTGGGAGCACCAAGTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGAGGTTTCGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTKYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGFDYWGQGTLVTVSS	nan	nan	IGHV4-59*01	IGHJ4*02	nan	IGKV3-20	nan	ARGFDY	QQYGSSPWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458559.1	nan
10	IML3564	ADI-63277	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCGGGCCCACGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGACTCCGTCAGTAATTATTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATAACAGTGGGACCACCAAGTATAATCCCTCCCTCAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAACTCTGTGGCCGCTGCGGACACGGCCGTCTATTACTGTGCGAGGGGGTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCTTCA	EVQLLESGPRLVKPSETLSLTCTVSGDSVSNYYWSWIRQPPGKGLEWIGYIYNSGTTKYNPSLKSRVTMSVDTSKNQFSLKLNSVAAADTAVYYCARGFDYWGQGTLVTVSS	nan	nan	IGHV4-59*02	IGHJ4*02	nan	IGKV3-20	nan	ARGFDY	HQYDSSLHWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458786.1	nan
10	IML3564	ADI-63303	nan	SARS-CoV-2,SARS-CoV	nan	SARS-CoV	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAAGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCAGCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGAGACTGGAGTGGATTGGGTATATACATTATAGTGGGAGTATCAGCTACAACCCCTCCCTCAGGGGTCGAGTCACCATATCAGTAGACAAGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGAGGCTTCGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLQESGPRLVKPSETLSLTCTVSGGSSSSYYWSWIRQPPGKRLEWIGYIHYSGSISYNPSLRGRVTISVDKSKNQFSLKLSSVTAADTAVYYCARGFDYWGQGTLVTVSS	nan	nan	IGHV4-59*01	IGHJ4*02	nan	IGKV3-20	nan	ARGFDY	QQYGSSPWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458811.1	nan
10	Shiakolas_Cellero	Shiakolas_53181-5	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV4-59	IGHJ4	nan	IGKV3-20	IGKJ1	ARGFDY	QQYGSSPWT	nan	Shiakolas et al. bioRxiv. DOI: 10.1101/2021.06.02.446813 (2021)	nan	nan
10	Wheatley-CP4	PDI_38	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGACTCCATTAGTAGTTACTATTGGAGCTGGATCCGGCAGCCCCCCGGGAAGGGACTGGAGTGGATTGGGTATACCTATTACAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGTTGAGTTCTGTGACCGCTGCGGACACGGCCGTTTATTACTGTGCGAGGGGGTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSETLSLTCTVSGDSISSYYWSWIRQPPGKGLEWIGYTYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTGGCAGCATCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATGTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCACCAGTATGGTAGCTCACGCGCCTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAA	EIVLTQSPGTLSLSPGERATLSCRASQSVGSIYLAWYQQKPGQAPRLLMYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCHQYGSSRAWTFGQGTKVEIK	IGHV4-59*01,IGHV4-59*13	IGHJ4*02	nan	IGKV3-20*01	IGKJ1*01	ARGFDY	HQYGSSRAWT	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
10	ZhouY_P1	XG001	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV4-59	IGHJ4	nan	IGKV3-20	IGKJ1	ARGFDY	QQFGSSPWT	nan	Zhou et al. Cell Rep. 34:108699 (2021)	nan	nan
10	Graham_P008	P008_016	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCAGCTGCACTGTCTCTGGTGGCTCCATCAGTCCTTACTACTGGAGCTGGATCCGGCAGCTCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATTACACTGGGAGCACCAACTACAACCCCTCCCTCAAGGGTCGAGTCACCATGTCAGCAGACATGTCCAAGAACCAGTTCTCCCTGAACCTGAGCTCTGTGACCGCTGCGGACACGGCCATGTATTACTGTGCGAGGGGCTACGATTTTTGGAGCCGGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSETLSLSCTVSGGSISPYYWSWIRQLPGKGLEWIGYIYYTGSTNYNPSLKGRVTMSADMSKNQFSLNLSSVTAADTAMYYCARGYDFWSRGTLVTVSS	GAAATTGTGTTGACACAGTCTCCAGGTACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCATCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGCTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTACCTCACCGTGGACGTTCGGCCAAGGGACCAAGCTGGAGATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSIYLAWYQQKPGQAPRLLIYAASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGTSPWTFGQGTKLEIK	IGHV4-59*01	IGHJ4*02,IGHJ5*02	IGHD5-12*01	IGKV3-20*01	IGKJ1*01	ARGYDF	QQYGTSPWT	nan	Graham et al. Immunity 54:1276-1289.e6 (2021)	MW802417.1	MW802310.1
10	Wheatley-CP63	PDI_211	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGACTCCATCAGTAGTTACTACTGGAGCTGGATTCGGCAGCCCCCAGGGAAGGGACTGGAATATATTGGGTATATCTATTACAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGGCCAAGAACCAGTTCTCCCTGAAACTGAGGTCTGTGACCGCAGCGGACACGGCCATATATTACTGTACGAGGGGGTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCTVSGDSISSYYWSWIRQPPGKGLEYIGYIYYSGSTNYNPSLKSRVTISVDTAKNQFSLKLRSVTAADTAIYYCTRGFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCTCCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTATTAACAGCATCTACTTAGCCTGGTACCAGCAGAGACCTGGCCAGGCTCCCAGGCTTTTCATCTATGCTACATCCAGCAGGGCCATTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCTTGGACGTTCGGCCAAGGGACCAAGGTGGATATCAAG	EIVLTQSPGSLSLSPGERATLSCRASQSINSIYLAWYQQRPGQAPRLFIYATSSRAIGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVDI	IGHV4-59*01,IGHV4-59*12	IGHJ4*02	nan	IGKV3-20*01	IGKJ1*01	TRGFDY	QQYGSSPWT	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
11	IML3548	ADI-62976	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCTCTGAGACTCTCCTGTGCAGCCTCTGGATTCATCTTCAGTACCTATGCCATCCACTGGGTCCGCCAGACTCCGGGCAAGGGGCTGGAGTGGATGGCAGTCATATTATATGATGGTTTTAAAAAATACTATGCAGATTCCGTGAGGGGCCGATTCTCCATCTCCAGAGACAACTCCAAGAACACACTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAGCCCGTGGTGGTAATTACTTCGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	EVQLLESGGGVVQPGRSLRLSCAASGFIFSTYAIHWVRQTPGKGLEWMAVILYDGFKKYYADSVRGRFSISRDNSKNTLYLQMNSLRAEDTAVYYCAKARGGNYFDAFDIWGQGTMVTVSS	nan	nan	IGHV3-30*18,IGHV3-30-5*01	IGHJ3*02	IGHD2-21*01,IGHD3-22*01	IGKV1-5	nan	AKARGGNYFDAFDI	QQYNNYWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458485.1	nan
11	IML3548	ADI-63040	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACCTATGCCATATACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCACTTATATCATATGATGGAGGTAATAAATACTATGTAGACTCCGTGAGGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAACCACGTGGTGGGAACTACAGAGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAIYWVRQAPGKGLEWVALISYDGGNKYYVDSVRGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKPRGGNYRDAFDIWGQGTMVTVSS	nan	nan	IGHV3-30*18,IGHV3-30-5*01	IGHJ3*02	IGHD1-26*01	IGKV4-1	nan	AKPRGGNYRDAFDI	QQYYSTPS	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458549.1	nan
11	Li_SARS2_26	DH1133	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSFALHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKSRGGNYFDAFDIWGQGTMVTVSS	nan	DIVMTQSPDSLAVPLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTRTFGQGTKVEIK	IGHV3-30-3*	IGHJ3	nan	IGKV4-1*01	IGKJ1	AKSRGGNYFDAFDI	QQYYSTRT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
11	IML3564	ADI-62052	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCAGCTTCAGTGGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAGATAATAAATACTATGAAGACTCCGTGAAGGGCCGATTCACCGTCTCCCGAGACAATTCCAAGAGCACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTTTATTACTGTGCGAAAAGCCGCGGTGGGAACTACTTCGATGCTTTTGACATCTGGGGCCACGGGACAATGGTCACCGTCTCTTCA	EVQLVESGGGVVQPGRSLRLSCAASGFSFSGYGMHWVRQAPGKGLEWVAVISYDGDNKYYEDSVKGRFTVSRDNSKSTLYLQMNSLRAEDTAVYYCAKSRGGNYFDAFDIWGHGTMVTVSS	nan	nan	IGHV3-30*18,IGHV3-30-5*01	IGHJ3*02	IGHD1-26*01	IGKV1-5	nan	AKSRGGNYFDAFDI	QQYKTYGLT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458144.1	nan
11	Graham_P008	P008_091	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV-2	S:NTD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCAATGCCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCATTTATATCATATGATGGAAGTAATCAATACTCTACAGACCCCGTGAAGGGCCGATTCACCTTCGCCAGAGACAATTCCAAGGACACGCTGTATCTGCAAATGAACAGCCTGAGAGGTGACGACACGGCTGTCTATTACTGTGCGAAATCCCGCGGTGGAAACTATTTCGATGCTTTTGATATGTGGGGCCAAGGGACAATGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSNAMHWVRQAPGKGLEWVAFISYDGSNQYSTDPVKGRFTFARDNSKDTLYLQMNSLRGDDTAVYYCAKSRGGNYFDAFDMWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACTATCACTTGCCGGGCCAGTCAGAGCATTAGTAGCTGGTTGGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATAAGGCGTCTAGTTTAGAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACCATCAGCAGCCTGCAGCCTGATGATTTTGCAACTTATTACTGCCAACAGTATAATAGTTATCCCTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQLTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYPWTFGQGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ3*02	IGHD4-23*01	IGKV1-5*03	IGKJ1*01	AKSRGGNYFDAFDM	QQYNSYPWT	nan	Graham et al. Immunity 54:1276-1289.e6 (2021)	MW802459.1	MW802352.1
11	IML3564	ADI-62019	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAACAATAAATACTACACAGACTCCATGAAGGGCCGATTCACCATCTCCAGAGACAACTCCAAGAACACGCTGTATATGCAAATGAACAGTTTGAGAGTTGAGGACACGGCTGTGTATTACTGTGCGAAATCGAGGGGTGGGAACTACCATGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCCTCA	EVQLLESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVISYDGNNKYYTDSMKGRFTISRDNSKNTLYMQMNSLRVEDTAVYYCAKSRGGNYHDAFDIWGQGTMVTVSS	nan	nan	IGHV3-30-3*02	IGHJ3*02	IGHD1-26*01	IGKV1-5	nan	AKSRGGNYHDAFDI	QQYSSLWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458111.1	nan
11	IML3564	ADI-62060	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGGGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGCCTATGCTATGCACTGGGTCCGCCAGACTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCGTTTGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAGTTCCAAGAATACGGTGTATTTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAGTCGAGGGGTGGAAACTACCATGATGCTTTTGATATCTGGGGCCAAGGGACCACGGTCACCGTCTCTTCA	EVQLLESGGGVVQPGRSLRLSCAASGFTFSAYAMHWVRQTPGKGLEWVAVISFDGSNKYYADSVKGRFTISRDSSKNTVYLQMNSLRAEDTAVYYCAKSRGGNYHDAFDIWGQGTTVTVSS	nan	nan	IGHV3-30-3*01	IGHJ3*02	IGHD4-23*01	IGKV1-5	nan	AKSRGGNYHDAFDI	QQYNSLWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458152.1	nan
11	IML3548	ADI-56711	nan	SARS-CoV-2,SARS-CoV	nan	SARS-CoV	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTATCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATTTGATGGAAGTAATAAATACTATGCAGACTCCGTGAGGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTCTATTACTGTGCGAAATCGCGCGGTGGGAGCTACTTTGATGCTTTTGATATCTGGGGCCAAGGGACCACGGTCACTGTCTCCTCA	EVQLLESGGGVVQPGRSLRLSCAASGFTFSIYGMHWVRQAPGKGLEWVAVISFDGSNKYYADSVRGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKSRGGSYFDAFDIWGQGTTVTVSS	nan	nan	IGHV3-30*18,IGHV3-30-5*01	IGHJ3*02	IGHD1-26*01	IGKV4-1	nan	AKSRGGSYFDAFDI	QQYYSSPFT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457651.1	nan
11	IML3564	ADI-63275	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTATCTATTCTATACACTGGGTCCGCCAGACTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAACAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGTTGTATCTGCAAATGAACAGCCTGAGACCTGAGGACACGGCTGTATATTACTGTGCGAAAACCCGCGGTGGGAACTACTTTGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCCTCA	QVQLVQSGGGVVQPGRSLRLSCAASGFTFSIYSIHWVRQTPGKGLEWVAVISYDGNNKYYADSVKGRFTISRDNSKNTLYLQMNSLRPEDTAVYYCAKTRGGNYFDAFDIWGQGTMVTVSS	nan	nan	IGHV3-30-3*02	IGHJ3*02	IGHD1-26*01	IGKV1-5	nan	AKTRGGNYFDAFDI	QQYNSDSMYT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458784.1	nan
11	IML3548	ADI-63043	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGATCACCTTGAAGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACCTATGCCATACACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATACGATGGAAATAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAACCTCTGGTGGAAACTACTTTGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCCTCA	QITLKESGGGVVQPGRSLRLSCAASGFTFSTYAIHWVRQAPGKGLEWVAVISYDGNNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKTSGGNYFDAFDIWGQGTMVTVSS	nan	nan	IGHV3-30*18,IGHV3-30-5*01	IGHJ3*02	IGHD4/OR15-4a*01,IGHD4/OR15-4b*01	IGKV1-5	nan	AKTSGGNYFDAFDI	QHYNSYFT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458552.1	nan
11	Tong_C81	C81H4	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike (and spike minus RBD)	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTGTCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAGGTCGGGGTGGTAGCTACTATGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLCLQMNSLRAEDTAVYYCAKGRGGSYYDAFDIWGQGTMVTVSS	GACATCGTGATGACCCAGTCTCCAGACTCCCTGGCTGTGTCTCTGGGCGAGAGGGCCACCATCAACTGCAAGTCCAGCCAGAGTGTTTTATACAGCTCCAACAATAAGAACTACTTAGCTTGGTACCAGCAGAAACCAGGACAGCCTCCTAAGCTGCTCATTTACTGGGCATCTACCCGGGAATCCGGGGTCCCTGACCGATTCAGTGGCAGCGGGTCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGGCTGAAGATGTGGCAGTTTATTACTGTCAGCAATATTATAGTACTCTCCCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAA	DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTLPYTFGQGTKLEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ3*02	IGHD2-15*01	IGKV4-1*01	IGKJ2*01	AKGRGGSYYDAFDI	QQYYSTLPYT	nan	Tong et al. Cell 184:4969-4980.e15 (2021)	MW718464.1	MW718616.1
11	IML3564	ADI-62025	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAATACCTATACTTTGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATCTCATATGATGGACTCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAATTGAGCAGCCTGAGAGCCGAGGACACGGCTGTCTATTACTGTGCGAAATCCCAGGGTGGCAACTATTTCGACGCTTCTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	EVQLVESGGGVVQPGRSLRLSCAASGFTFNTYTLHWVRQAPGKGLEWVAVISYDGLNKYYADSVKGRFTISRDNSKNTLYLQLSSLRAEDTAVYYCAKSQGGNYFDASDIWGQGTMVTVSS	nan	nan	IGHV3-30-3*02	IGHJ3*02	IGHD4-23*01	IGKV3D-15	nan	AKSQGGNYFDASDI	QQYNNWYT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458117.1	nan
11	COSCA1	COVA1-02	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV,SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTATCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGCAATCAATACTACGCAGACTCCGTGAGGGGCCGATTCACCATCTCCAGAGGCAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGACCTGAGGACACGGCTGTGTACTACTGTGCGAGAGCGAGGGGTGGGAGCTACAATGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGVVQPGRSLRLSCAASGFTFSIYAMHWVRQAPGKGLEWVAVISYDGSNQYYADSVRGRFTISRGNSKNTLYLQMNSLRPEDTAVYYCARARGGSYNDAFDIWGQGTMVTVSS	AATTTTATGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAGCCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCAGCACCCCCGTGGTATTCGGCGGAGGGACCGAACTGACCGTCCTAG	NFMLTQPASVSGSPGQSITISCTGASSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTPVVFGGGTELTVL	IGHV3-30-3*01	IGHJ3*02	IGHD1-26*01	IGLV2-14*03	IGLJ2*01,IGLJ3*01	ARARGGSYNDAFDI	SSYTSSSTPVV	nan	Brouwer et al. Science 369:643-650 (2020)	MT599821.1	MT599905.1
11	IML3545	ADI-60524	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCACGTTGAAGGAGACTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCGGGCAAGGGGCTAGAGTGGGTGGCAGTTATATCATATGATGGAGATAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGACTGTGTATTACTGTGCGAGAGCGAGGGGGGGGAGCTACAATGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCCTCA	QVTLKETGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGDNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTTVYYCARARGGSYNDAFDIWGQGTMVTVSS	nan	nan	IGHV3-30*17	IGHJ3*02	IGHD1-26*01	IGKV3-20	nan	ARARGGSYNDAFDI	QQYGSLYT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457855.1	nan
11	Tong_C83	C83B10	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike (and spike minus RBD)	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTATCTATGCTATCCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCACTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGCGCGGGGTGGGAGCTACTCGGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSIYAIHWVRQAPGKGLEWVALISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARARGGSYSDAFDIWGQGTMVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATAATAACTGGCCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAA	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPYTFGQGTKLEIK	IGHV3-30-3*01	IGHJ3*02	IGHD1-26*01	IGKV3-15*01	IGKJ2*01	ARARGGSYSDAFDI	QQYNNWPYT	nan	Tong et al. Cell 184:4969-4980.e15 (2021)	MW718465.1	MW718617.1
11	Jennewein_PCV1	PCV1-44	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGATCCCGGGGTGGGAGCTACCATGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSRGGSYHDAFDIWGQGTMVTVSS	GATATTGTGATGACTCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCCATGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAA	DIVMTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPMYTFGQGTKLEIK	IGHV3-30*03	IGHJ3*02	IGHD1-26*01	IGKV3-20*01	IGKJ2*01	ARSRGGSYHDAFDI	QQYGSSPMYT	nan	Jennewein et al. Cell Rep. 36:109353 (2021)	MW806127.1	MW806158.1
11	IML3549	ADI-61222	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAATCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGGCTATGCTTTGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCGGTTATATCATATGATGGAGACAAAAAATACTATGCAGACTCCGTGCGGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATATAGTAATGAACAGCCTGAGCGTAGAGGACACGGCTGTCTATTACTGTGCGCGTGCCCGGAGGGGGAGTTATTCTGATTCTTTTGATATCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSGYALHWVRQAPGKGLEWVAVISYDGDKKYYADSVRGRFTISRDNSKNTLYIVMNSLSVEDTAVYYCARARRGSYSDSFDIWGQGTTVTVSS	nan	nan	IGHV3-30-3*01	IGHJ3*02	IGHD3-10*01,IGHD3-10*02,IGHD3-16*01	IGKV1-5	nan	ARARRGSYSDSFDI	QQYNSYWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458079.1	nan
11	IML3564	ADI-62103	nan	SARS-CoV-2	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAATCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAATTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACACTTCCAAGAACACACTGTATCTGCAAATGAACAGCCTGAGAGATGACGACACGGCTGTATATTACTGTGCGAGAGCGCAGGGCGGGAGCTACTACGGTGCTTTTGATATCTGGGGCCGAGGGACAATGGTCACCGTCTCTTCA	EVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAIISYDGSNKYYADSVKGRFTISRDTSKNTLYLQMNSLRDDDTAVYYCARAQGGSYYGAFDIWGRGTMVTVSS	nan	nan	IGHV3-30-3*01	IGHJ3*02	IGHD1-26*01	IGKV1-5	nan	ARAQGGSYYGAFDI	QQSNTYWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458195.1	nan
11	IML3549	ADI-61231	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCATCCTGGGAGGTCCCTGCGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCACTTATATCTTATGATGGAATCAATAAATACTTTACAGACTCCGTGAAGGGCCGATTCACCGTCTCCAGAGACAATTCCAAGAACACCCTGTATCTGCAAATGAACAGCCTGCGAGCTGAGGACACGGCTATATATTACTGTGCGAGAGCCCGGGGTGGGAGCTACTTTGGCGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	QVQLVESGGGVVHPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVALISYDGINKYFTDSVKGRFTVSRDNSKNTLYLQMNSLRAEDTAIYYCARARGGSYFGAFDIWGQGTMVTVSS	nan	nan	IGHV3-30-3*01	IGHJ3*02	IGHD1-26*01	IGKV1-5	nan	ARARGGSYFGAFDI	QQSNSPWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458088.1	nan
11	Turner-07	Turner-07-2C12	nan	SARS-CoV-2	OC43,HKU1	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAAGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAATACCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCACTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGCGCGGGGTGGGAGCTACTCCGGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAGC	EVQLVESGGGVVQPGRSLRLSCAASGFTFNTYAMHWVRQAPGKGLEWVALISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARARGGSYSGAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCTATGTACACTTTTGGCCAGGGGACCAAGGTGGAAATCAAA	EIVLTQSPGTLSLSPGERATLSCRASQSVSSNYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPMYTFGQGTKVEIK	IGHV3-30-3*01	IGHJ3*02	IGHD1-26*01	IGKV3-20*01	IGKJ2*01	ARARGGSYSGAFDI	QQYGSSPMYT	nan	Turner et al. Nature 596:109-113 (2021)	MZ292489.1	MZ292490.1
11	IML3558	ADI-63259	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCATCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTAGAGTGGGTGGTAGTTATCTCATATGATGGAAATAATAAATATTACGCAGACTCCGTGAGGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGCATCTGCAAATGAACATCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGACCGAGGGGTGGGAGCTACTACGGTGCTTTTGATATCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLLESGGGVVQPGRSLRLSCAASGFIFSSYAMHWVRQAPGKGLEWVVVISYDGNNKYYADSVRGRFTISRDNSKNTLHLQMNILRAEDTAVYYCARPRGGSYYGAFDIWGQGTTVTVSS	nan	nan	IGHV3-30*01	IGHJ3*02	IGHD1-26*01	IGKV2D-28	nan	ARPRGGSYYGAFDI	MQALQTPHT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458768.1	nan
11	Li_SARS2_26	DH1132	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARARGGSYAGGFDIWGQGTMVTVSS	nan	DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYWTFGQGTKVEIK	IGHV3-30*01	IGHJ3	nan	IGKV1-5*03	IGKJ1	ARARGGSYAGGFDI	QQYNSYWT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
11	IML3550	ADI-60759	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCACTACCTATGCTATACACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATCTCATATGATGGATTCAATAAATACTACCCAGACTCCGTGAGGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGATAGAAGTGGGAGCTACTTCGGTGCCTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	EVQLVESGGGVVQPGRSLRLSCAASGFTFTTYAIHWVRQAPGKGLEWVAVISYDGFNKYYPDSVRGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRSGSYFGAFDIWGQGTMVTVSS	nan	nan	IGHV3-30-3*01	IGHJ3*02	IGHD1-26*01	IGLV1-40	nan	ARDRSGSYFGAFDI	QSFDSSLSGSV	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458028.1	nan
11	IML3547	ADI-62189	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGCCCGTAGTGGGAGCTACTCTGGGCCCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARARSGSYSGPFDYWGQGTLVTVSS	nan	nan	IGHV3-30-3*01	IGHJ4*02	IGHD1-26*01	IGKV1-5	nan	ARARSGSYSGPFDY	QQYNSYHT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457913.1	nan
11	Li_SARS2_26	DH1177	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFNNYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLSLQVNSLRAEDTALYYCARDRSGSYFGPFDYWGQGTLVTVSS	nan	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATDIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQCGSSPRTFGQGTKVEIK	IGHV3-30*01	IGHJ4	nan	IGKV3-20*01	IGKJ1	ARDRSGSYFGPFDY	QQCGSSPRT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
12	Chen_Vax_p1	COV2-vax-13	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCCTGGTCAAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGAATCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCATCCATTAGTAGGAGTAGTAGTTTCATATACTACGCAGACTCAGTGAAGGGCCGATTCACCATCTCCAGAGACACCGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGCCAAGGGGCATTACTATGATAGTAGTGGTTATTACCCCGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVKPGGSLRLSCAASGITFSSYSMNWVRQAPGKGLEWVSSISRSSSFIYYADSVKGRFTISRDTAKNSLYLQMNSLRAEDTAVYYCARAKGHYYDSSGYYPDAFDIWGQGTMVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGGCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATAATAACTGGCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPWTFGQGTKVEIK	IGHV3-21*01	IGHJ3*02	IGHD3-22*01	IGKV3-15*01	IGKJ1*01	ARAKGHYYDSSGYYPDAFDI	QQYNNWPPWT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555627.1	MZ555628.1
12	Chen_Vax_p1	COV2-vax-6	nan	SARS-CoV-2	nan	nan	nan	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCCTGGTCAAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGAATCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCATCCATTAGTAGGAGTAGTAGTTTCATATACTACGCAGACTCAGTGAAGGGCCGATTCACCATCTCCAGAGACACCGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGCCAAGGGGCATTACTATGATAGTAGTGGTTATTACCCCGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVKPGGSLRLSCAASGITFSSYSMNWVRQAPGKGLEWVSSISRSSSFIYYADSVKGRFTISRDTAKNSLYLQMNSLRAEDTAVYYCARAKGHYYDSSGYYPDAFDIWGQGTMVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGGCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATAATAACTGGCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPWTFGQGTKVEIK	IGHV3-21*01	IGHJ3*02	IGHD3-22*01	IGKV3-15*01	IGKJ1*01	ARAKGHYYDSSGYYPDAFDI	QQYNNWPPWT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555589.1	MZ555590.1
12	Li_SARS2_26	DH1206	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:NTD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISFRSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVRNHYYDSSGYYPDAFDIWGQGTMVTVSS	nan	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTITSLQSEDFAVYYCQQYYNWPPWSFGQGTKLEIK	IGHV3-21*01	IGHJ3	nan	IGKV3-15*01	IGKJ2	ARVRNHYYDSSGYYPDAFDI	QQYYNWPPWS	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
12	Chen_Vax_p1	COV2-vax-11	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCCTGGTCAAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCATCCATTAGTAGTAGTAGTAGTTACATATACTACGCAGACTCAGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGACCGACCCCATTACTATGATAGTAGTGGTTATTACCGTGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDRPHYYDSSGYYRDAFDIWGQGTMVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGGCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATTATAACTGGCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYYNWPPWTFGQGTKVEIK	IGHV3-21*01	IGHJ3*02	IGHD3-22*01	IGKV3-15*01	IGKJ1*01	ARDRPHYYDSSGYYRDAFDI	QQYYNWPPWT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555623.1	MZ555624.1
12	Chen_Vax_p1	COV2-vax-7	nan	SARS-CoV-2	nan	nan	nan	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCCTGGTCAAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCATCCCTTAGTATTAGTAGTAGTTTCATATACTACGCAGACTCAGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGACCGACCCCATTACTATGATAGTAGTGGTTATTACCGTGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSLSISSSFIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDRPHYYDSSGYYRDAFDIWGQGTMVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGGCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATAATAACTGGCCTCCGTGGACATTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPWTFGQGTKVEIK	IGHV3-21*01	IGHJ3*02	IGHD3-22*01	IGKV3-15*01	IGKJ1*01	ARDRPHYYDSSGYYRDAFDI	QQYNNWPPWT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555591.1	MZ555616.1
12	Chen_Vax_p1	COV2-vax-14	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCCTGGTCAAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCATCCATTAGTAGTAGTGGTAGTTACATATACTACGCAGACTCACTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGACCGACCCCATTACTATGATAGTACTGGTTATTACCGTGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSGSYIYYADSLKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDRPHYYDSTGYYRDAFDIWGQGTMVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGGCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATTATAACTGGCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYYNWPPWTFGQGTKVEIK	IGHV3-21*01	IGHJ3*02	IGHD3-22*01	IGKV3-15*01	IGKJ1*01	ARDRPHYYDSTGYYRDAFDI	QQYYNWPPWT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555554.1	MZ555555.1
12	Chen_Vax_p1	COV2-vax-20	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCCTGGTCAAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATACCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCATCCATTAGTAGTAGTAGTAGTTTCATATACTACGCAGACTCAGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGCATTACTGTGCGAGAGTACGACCGACATACTATGATAGTAGTGGTTATTACCCTGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYTMNWVRQAPGKGLEWVSSISSSSSFIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVHYCARVRPTYYDSSGYYPDAFDIWGQGTMVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCGGAAACCTGGGCAGGCTCCCAGCCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAATTTATTACTGTCAGCAGTATTATAACTGGCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQRKPGQAPSLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAIYYCQQYYNWPPWTFGQGTKVEIK	IGHV3-21*01	IGHJ3*02	IGHD3-22*01	IGKV3-15*01	IGKJ1*01	ARVRPTYYDSSGYYPDAFDI	QQYYNWPPWT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555541.1	MZ555542.1
12	Chen_Vax_p1	COV2-vax-4	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCCTGGTCAAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGTTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCATCCATTAGTAGTAGTAGTAGTTTCATATACTACGCAGACTCAGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGTACGACCGACATACTATGATAGTAGTGGTTATTACCCTGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSFIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVRPTYYDSSGYYPDAFDIWGQGTMVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGGCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAATATTATAACTGGCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYYNWPPWTFGQGTKVEIK	IGHV3-21*01	IGHJ3*02	IGHD3-22*01	IGKV3-15*01	IGKJ1*01	ARVRPTYYDSSGYYPDAFDI	QQYYNWPPWT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555585.1	MZ555586.1
12	Chen_Vax_p1	COV2-vax-17	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCCTGGTCAAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCATCCATTAGTAGTAGTGGTAGTTACATATACTACGCAGACTCAGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTTCTGTGCGAGAGTCGTCCCACATTACTATGATAGTAGTGGTTATTACCCTGGCGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSGSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYFCARVVPHYYDSSGYYPGAFDIWGQGTMVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGGCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTTCTGTCAGCAGTATTATAACTGGCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGACATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYFCQQYYNWPPWTFGQGTKVDIK	IGHV3-21*01	IGHJ3*02	IGHD3-22*01	IGKV3-15*01	IGKJ1*01	ARVVPHYYDSSGYYPGAFDI	QQYYNWPPWT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555560.1	MZ555561.1
12	Chen_Vax_p1	COV2-vax-18	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCCTGGTCAAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCATCCATTAGTAGTAGTGGTAGTTACATATACTACGCAGACTCAGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTTCTGTGCGAGAGTCGTCCCACATTACTATGATAGTAGTGGTTATTACCCTGGCGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSGSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYFCARVVPHYYDSSGYYPGAFDIWGQGTMVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGGCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTTCTGTCAGCAGTATTATAACTGGCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGACATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYFCQQYYNWPPWTFGQGTKVDIK	IGHV3-21*01	IGHJ3*02	IGHD3-22*01	IGKV3-15*01	IGKJ1*01	ARVVPHYYDSSGYYPGAFDI	QQYYNWPPWT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555562.1	MZ555563.1
12	Chen_Vax_p1	COV2-vax-21	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCCTGGTCAAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCATCCATTAGTAGTAGTAGTAGTTACATATACTACGCAGACTCAGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGTCGTCCCACACTACTATGATAGTAGTGGTTATTACCCTGGCGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVVPHYYDSSGYYPGAFDIWGQGTMVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGGCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTTCTGTCAGCAGTATTATAACTGGCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGACATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYFCQQYYNWPPWTFGQGTKVDIK	IGHV3-21*01	IGHJ3*02	IGHD3-22*01	IGKV3-15*01	IGKJ1*01	ARVVPHYYDSSGYYPGAFDI	QQYYNWPPWT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555543.1	MZ555544.1
12	Chen_Vax_p1	COV2-vax-22	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCCTGGTCAAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCATCCATTAGTAGTAGTGGTAGTTACATATACTACGCAGACTCAGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTTCTGTGCGAGAGTCGTCCCACATTACTATGATAGTAGTGGTTATTACCCTGGCGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSGSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYFCARVVPHYYDSSGYYPGAFDIWGQGTMVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGGCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTTCTGTCAGCAGTATTATAACTGGCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGACATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYFCQQYYNWPPWTFGQGTKVDIK	IGHV3-21*01	IGHJ3*02	IGHD3-22*01	IGKV3-15*01	IGKJ1*01	ARVVPHYYDSSGYYPGAFDI	QQYYNWPPWT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555545.1	MZ555546.1
12	Chen_Vax_p1	COV2-vax-8	nan	SARS-CoV-2	nan	nan	nan	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCCTGGTCAAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGGAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCATCCATTAGTAGTAGTAGTAGTTACATATACTACGCAGACTCAGTGAAGGGCCGATTCACCATAACCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCAGTGTATTACTGTGCGAGAGTCGTCCCACATTACTATGACAGTAGTGGTTATTACCCTGGCGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVKPGGSLRLSCAASGFTFRSYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTITRDNAKNSLYLQMNSLRAEDTAVYYCARVVPHYYDSSGYYPGAFDIWGQGTMVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAACCCTGGGCAGGCTCCCAGGCTCCTCATCTATGGTACATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGTGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTCGCAGTTTATTACTGTCAGCAGTATTATAACTGGCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQNPGQAPRLLIYGTSTRATGIPARFSGSVSGTEFTLTISSLQSEDFAVYYCQQYYNWPPWTFGQGTKVEIK	IGHV3-21*01,IGHV3-21*04	IGHJ3*02	IGHD3-22*01	IGKV3-15*01	IGKJ1*01	ARVVPHYYDSSGYYPGAFDI	QQYYNWPPWT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555617.1	MZ555618.1
12	Chen_Vax_p1	COV2-vax-10	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCCTGGTCAAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCATCCATTAGTAGTAGTAGTAGTTACATATACTACGGAGACTCAGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGCGGACACGGCTGTGTATTACTGTGCGAGAGTCGTCCCACATTACTATGATAGTAGTGGTTATTACCCTGGCGCTTTTGATATGTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSYIYYGDSVKGRFTISRDNAKNSLYLQMNSLRAADTAVYYCARVVPHYYDSSGYYPGAFDMWGQGTMVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAACAGAAACCTGGTCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATTATAACTGGCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYYNWPPWTFGQGTKVEIK	IGHV3-21*01	IGHJ3*02	IGHD3-22*01	IGKV3-15*01	IGKJ1*01	ARVVPHYYDSSGYYPGAFDM	QQYYNWPPWT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555621.1	MZ555622.1
12	Chen_Vax_p1	COV2-vax-2	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCCTGGTCAAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCATCCATTAGTAGTAGTAGTAGTTACATATACTACGGAGACTCAGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGCGGACACGGCTGTGTATTACTGTGCGAGAGTCGTCCCACATTACTATGATAGTAGTGGTTATTACCCTGGCGCTTTTGATATGTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSYIYYGDSVKGRFTISRDNAKNSLYLQMNSLRAADTAVYYCARVVPHYYDSSGYYPGAFDMWGQGTMVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAACAGAAACCTGGTCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATTATAACTGGCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYYNWPPWTFGQGTKVEIK	IGHV3-21*01	IGHJ3*02	IGHD3-22*01	IGKV3-15*01	IGKJ1*01	ARVVPHYYDSSGYYPGAFDM	QQYYNWPPWT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555581.1	MZ555582.1
12	Chen_Vax_p1	COV2-vax-3	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCCTGGTCAAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCATCCATTAGTAGTAGTAGTAGTTATTTATACTACGCAGACTCACTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGTCGTCCCAAATTACTTTGATAGAAGTGGTTATTACCCTGGCGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSYLYYADSLKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVVPNYFDRSGYYPGAFDIWGQGTMVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGGCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATTATAACTGGCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAGATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYYNWPPWTFGQGTKVEIK	IGHV3-21*01	IGHJ3*02	IGHD3-22*01	IGKV3-15*01	IGKJ1*01	ARVVPNYFDRSGYYPGAFDI	QQYYNWPPWT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555583.1	MZ555584.1
12	Chen_Vax_p1	COV2-vax-16	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCCTGGTCAAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCATCTTCAGTAGCTCTAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCATCCATTAGTAGTAGTGGTAGTTACATATACTACGCAGACTCAGTGAGGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGTCGTCCCAAATTACTATGATAGTAGAGGTTATTACCCTGGCGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVKPGGSLRLSCAASGFIFSSSSMNWVRQAPGKGLEWVSSISSSGSYIYYADSVRGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVVPNYYDSRGYYPGAFDIWGQGTMVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGGCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATAATAACTGGCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPWTFGQGTKVEIK	IGHV3-21*01	IGHJ3*02	IGHD3-22*01	IGKV3-15*01	IGKJ1*01	ARVVPNYYDSRGYYPGAFDI	QQYNNWPPWT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555558.1	MZ555559.1
12	Chen_Vax_p1	COV2-vax-9	nan	SARS-CoV-2	nan	nan	nan	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCCTGGTCAAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCATCTTCAGTAGCTCTAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCATCCATTAGTAGTAGTGGTAGTTACATATACTACGCAGACTCAGTGAGGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGTCGTCCCAAATTACTATGATAGTAGAGGTTATTACCCTGGCGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVKPGGSLRLSCAASGFIFSSSSMNWVRQAPGKGLEWVSSISSSGSYIYYADSVRGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVVPNYYDSRGYYPGAFDIWGQGTMVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGGCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATAATAACTGGCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPWTFGQGTKVEIK	IGHV3-21*01	IGHJ3*02	IGHD3-22*01	IGKV3-15*01	IGKJ1*01	ARVVPNYYDSRGYYPGAFDI	QQYNNWPPWT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555619.1	MZ555620.1
12	Chen_Vax_p1	COV2-vax-12	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCCTGGTCAAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCATCCATTAGTAGTAGTAGTAGTTACATATACTACGCAGACTCAGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGTCGTCCCATATTACTATGATAGTAGTGGTTATTACCCTGGCGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVVPYYYDSSGYYPGAFDIWGQGTMVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGGCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTTCTGTCAGCACTATTATAACTGGCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGACATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYFCQHYYNWPPWTFGQGTKVDIK	IGHV3-21*01	IGHJ3*02	IGHD3-22*01	IGKV3-15*01	IGKJ1*01	ARVVPYYYDSSGYYPGAFDI	QHYYNWPPWT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555625.1	MZ555626.1
12	Chen_Vax_p1	COV2-vax-15	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCCTGGTCAAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCATCCATTAGTAGTAGTAGTAGTTACATATACTACGCAGACTCAGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGTCGTCCCATATTACTATGATAGTAGTGGTTATTACCCTGGCGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVVPYYYDSSGYYPGAFDIWGQGTMVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGGCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTTCTGTCAGCACTATTATAACTGGCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGACATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYFCQHYYNWPPWTFGQGTKVDIK	IGHV3-21*01	IGHJ3*02	IGHD3-22*01	IGKV3-15*01	IGKJ1*01	ARVVPYYYDSSGYYPGAFDI	QHYYNWPPWT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555556.1	MZ555557.1
12	Chen_Vax_p1	COV2-vax-19	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCCTGGTCAAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCATCCATTAGTAGAAGTAGTAGTTACATATACTACGTAGACTCAGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGTCGTCCCATATTACTATGATAGTAGTGGTTATTACCCTGGCGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISRSSSYIYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVVPYYYDSSGYYPGAFDIWGQGTMVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGGCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTTCTGTCAGCAGTATTATAACTGGCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGACATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYFCQQYYNWPPWTFGQGTKVDIK	IGHV3-21*01	IGHJ3*02	IGHD3-22*01	IGKV3-15*01	IGKJ1*01	ARVVPYYYDSSGYYPGAFDI	QQYYNWPPWT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555564.1	MZ555565.1
12	Chen_Vax_p1	COV2-vax-5	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCCTGGTCAAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCATCCATTAGTAGTAGTAGGAGTTACATATACTACGCAGACTCAGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAAGTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGTCGTCCCATATTACTATGATAGTAGTGGTTATTACCCTGGCGCTTTTGATATCTGGGGCCAAGGGACAGTGGTCACCGTCTCTTCAG	EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSRSYIYYADSVKGRFTISRDNAKKSLYLQMNSLRAEDTAVYYCARVVPYYYDSSGYYPGAFDIWGQGTVVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGGCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATTATAACTGGCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYYNWPPWTFGQGTKVEIK	IGHV3-21*01,IGHV3-21*06	IGHJ3*02	IGHD3-22*01	IGKV3-15*01	IGKJ1*01	ARVVPYYYDSSGYYPGAFDI	QQYYNWPPWT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555587.1	MZ555588.1
13	IML3547	ADI-62197	nan	SARS-CoV-2,HKU1	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGTAGCCTCTGGACTCACCTTCGGTACCTATATTTTCCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCACTTATGTCACATGATGGAACCATTCAATACAACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCCAGGACACGCTGTATCTGCAAATGAACAGCCTGAGAGTTGAGGACACGGCTGTGTATTACTGTGCGAAAGAGGCGGGTAGTTCGGGGAGGGCCGGGTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGGVVQPGRSLRLSCVASGLTFGTYIFHWVRQAPGKGLEWVALMSHDGTIQYNADSVKGRFTISRDNSQDTLYLQMNSLRVEDTAVYYCAKEAGSSGRAGWFDPWGQGTLVTVSS	nan	nan	IGHV3-30-3*01,IGHV3-30-3*02	IGHJ5*02	IGHD3-10*01,IGHD3-10*02	IGKV1-5	nan	AKEAGSSGRAGWFDP	QHYNHYPIT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457921.1	nan
13	IML3547	ADI-62882	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGACTGGGGGAGGCGTGGTCCAGCCCGGGGGGGGGTCCCTGAGACTCTCCTGTGCAGGCTCTGGATTCACCTTCAGTACTTCTGTCATACACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGCTATATCACATGATGGATACGGTAAATATTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAGGAACACGGTGTATCTGCAAGTGGACAGCCTGACAATTGAAGACACGGCTGTGTATTACTGTGCGAAAGAGGCGGGTAGTTCGGGGAGAGCCGGGTACTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLLETGGGVVQPGGGSLRLSCAGSGFTFSTSVIHWVRQAPGKGLEWVAAISHDGYGKYYADSVKGRFTISRDNSRNTVYLQVDSLTIEDTAVYYCAKEAGSSGRAGYFDPWGQGTLVTVSS	nan	nan	IGHV3-30*18,IGHV3-30-3*01,IGHV3-30-3*02	IGHJ5*02	IGHD3-10*01,IGHD3-10*02	nan	nan	AKEAGSSGRAGYFDP	nan	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458390.1	nan
13	IML3547	ADI-62926	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCACCTTGAAGGAGTCTGGGGGAGGAGTGGTCCAGCCTGGGAGGTCCCTGAGAATCTCCTGTGTAGTCTCTGGGCTCACCTTCGAGACCTCTATTTTCCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTTCAGTGGGTGGGTCTCACATCATTTAATGGAAACATTGACTACAACCCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACGATTCTCAGAACACCTTGTATCTACAAATGAACAGCCTGAGAGTTGAGGACACGGCTGTGTATTTTTGTGCAAAAGAGGCGGGTAGTTCGGGGAGTGCCGGGTGGTTCGCCCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVTLKESGGGVVQPGRSLRISCVVSGLTFETSIFHWVRQAPGKGLQWVGLTSFNGNIDYNPDSVKGRFTISRDDSQNTLYLQMNSLRVEDTAVYFCAKEAGSSGSAGWFAPWGQGTLVTVSS	nan	nan	IGHV3-30-3*01,IGHV3-30-3*02	IGHJ5*02	IGHD3-10*01,IGHD3-10*02	IGKV1-5	nan	AKEAGSSGSAGWFAP	QQYNNYPIT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458435.1	nan
13	IML3564	ADI-60567	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTTGTGCAGTCTGGGGGAGGCGTGGTCCAGCCTGGGTGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACGCTCAGTTCCTTTCCTATGCACTGGGTCCGCCAGGGTCCAGGCACGGGGCTTCAGTGGGTGGCAGTTTTATCAACTGATGGAAGGAATGAACAGTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACACTTCCAAGAACACACTGTATCTGCAAATGAACAGCCTGAGACTTGAGGACACGGCTGTGTATTACTGTGCGAAAGAAGGCGGTAGTAGTGGGCGGGGTGGATGGTTCGACCCCTGGGGCCAGGGAGCCCTGGTCACCGTCTCCTCA	QVQLVQSGGGVVQPGWSLRLSCAASGFTLSSFPMHWVRQGPGTGLQWVAVLSTDGRNEQYADSVKGRFTISRDTSKNTLYLQMNSLRLEDTAVYYCAKEGGSSGRGGWFDPWGQGALVTVSS	nan	nan	IGHV3-30*01,IGHV3-30*04,IGHV3-30*18	IGHJ5*02	IGHD3-22*01	IGKV1-5	nan	AKEGGSSGRGGWFDP	QQYDSYPLT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457898.1	nan
13	IML3547	ADI-62903	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGTCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGACTCAGCCTCAACAACGCTATTATACACTGGGTCCGCCAGGCTCCAGGCAAGGGCCTGGAGTGGTTGGCACTTATATCACATGATGAAAAGACTAAATTCTACACAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACACTTCGAAGAACACGGTGTATTTGCAAATGAACAGCCTGAGCCCTGAGGACACGGCTGTGTATTACTGTGCGCAAGAGGCGGGTAGTTCGGGGAGAGCCGGGTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVESGGGVVQSGRSLRLSCAASGLSLNNAIIHWVRQAPGKGLEWLALISHDEKTKFYTDSVKGRFTISRDTSKNTVYLQMNSLSPEDTAVYYCAQEAGSSGRAGWFDPWGQGTLVTVSS	nan	nan	IGHV3-30*04,IGHV3-30*10,IGHV3-30-3*01	IGHJ5*02	IGHD3-10*01,IGHD3-10*02	IGKV1-5	nan	AQEAGSSGRAGWFDP	QQYESYPVT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458411.1	nan
13	IML3547	ADI-62913	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTGGTACAGTCTGGGGGAGGCATGGTCCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGCAGTCTCTGGATCTGTTATACACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGACAGCTATATCGCATGATTCAGAAGGCAAACATTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAAGGACACGGTGTATGTACAAATGAACAGCCTGACAACAGAGGACACGGCTGTGTATTATTGTGCGAGAGAGGCGGGTAGTTCGGGGAAAGCCGGGTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVQSGGGMVQPGGSLRLSCAVSGSVIHWVRQAPGKGLEWVTAISHDSEGKHYADSVKGRFTISRDKDTVYVQMNSLTTEDTAVYYCAREAGSSGKAGWFDPWGQGTLVTVSS	nan	nan	IGHV3-30*04,IGHV3-30*14,IGHV3-30-3*01	IGHJ5*02	IGHD3-10*01,IGHD3-10*02	nan	nan	AREAGSSGKAGWFDP	nan	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458422.1	nan
13	IML3547	ADI-60777	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGTGGCGTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCCCCAGTGATTCTACAATACATTGGGTCCGCCAGGCTCCGGGCAAGGGGCTGGAATGGGTGTCAGCCATCTCACCTGATGGACCTGGTCAGTTTTACGCACACTCCGTGAGGGGCCGATTCACCGTCTCCAGAGACAATTCCAAGAACAGTGTATATTTGCAAATGAGTAGCCTGAGACCTGAGGACACGGCTGTCTATTACTGTGCGAGAGAGGCGGGAAGTTCGGGGAGAGCCGGGTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGGSLRLSCAAPSDSTIHWVRQAPGKGLEWVSAISPDGPGQFYAHSVRGRFTVSRDNSKNSVYLQMSSLRPEDTAVYYCAREAGSSGRAGWFDPWGQGTLVTVSS	nan	nan	IGHV3-30*04,IGHV3-30*15,IGHV3-30*17	IGHJ5*02	IGHD3-10*01,IGHD3-10*02	IGKV1-5	nan	AREAGSSGRAGWFDP	QHYNAYPIA	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458046.1	nan
13	IML3547	ADI-62204	nan	SARS-CoV-2,HKU1	nan	nan	SARS-CoV-2	S:S1	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGACGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGCGCAGTCTCTGGATTCGCCTTGAGTAGTTCTGTTATGCACTGGGTCCGCCAGGCTCCAGTCAAGGGGCTGGAATGGGTGTCTGCTATTTCAAAAGATGGAGGCTCTCAACACTACAGAGAGTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACCCTATATCTGCAGATGAACAGCCTGGGACCTGACGACACGGCTTTATATTTCTGTGCGAGAGAGGCGGGAAGTTCGGGGAGAGCCGGGTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGDVVQPGRSLRLSCAVSGFALSSSVMHWVRQAPVKGLEWVSAISKDGGSQHYRESVKGRFTISRDNSKNTLYLQMNSLGPDDTALYFCAREAGSSGRAGWFDPWGQGTLVTVSS	nan	nan	IGHV3-30-3*01	IGHJ5*02	IGHD3-10*01,IGHD3-10*02	IGKV1-5	nan	AREAGSSGRAGWFDP	QHYVSYPVT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457928.1	nan
13	IML3547	ADI-62899	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGACGTCCCTGAGAGTCTCCTGTTCTGCCTCCAATACATTTATTATTCACTGGGTCCGCCAGGCTCCAAACAAGGGGCTGGAATGGGTGGCAGCAATCTCACATGATGGAAATGGTAAATATTACGCAGACTCCGTGAAGGGCCGATTCACCGTCTCCAGAGACAATTCCAAGAACATGGTGTATCTGCAAATGAACAGCCTGAGACCTGAGGACACGGCTGTGTTTTACTGTGCGAGAGAGGCGGGTAGTTCGGGGAGAGCCGGGTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLLESGGGVVQPGTSLRVSCSASNTFIIHWVRQAPNKGLEWVAAISHDGNGKYYADSVKGRFTVSRDNSKNMVYLQMNSLRPEDTAVFYCAREAGSSGRAGWFDPWGQGTLVTVSS	nan	nan	IGHV3-30*04,IGHV3-30-3*03	IGHJ5*02	IGHD3-10*01,IGHD3-10*02	IGKV1-5	nan	AREAGSSGRAGWFDP	LQYDHYPIT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458407.1	nan
13	IML3547	ADI-60780	nan	SARS-CoV-2,HKU1	nan	SARS-CoV-2	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGTAGGCTCTGGACTCATGTTCAGTAACTACATTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGTTGGCAGTTTTTTCCCATGATGCAATCAATCACATCTATGCAGAGTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAGCTCGAAAAACACGGTGTACTTGGAGATGAACAGCCTCATACCTGAGGACACGGCTATATATTACTGTGCGAGAGAGGCGGGAAGTTCGGGGAGAGCCGGGTACTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVQSGGGVVQPGRSLRLSCVGSGLMFSNYIMHWVRQAPGKGLEWLAVFSHDAINHIYAESVKGRFTISRDSSKNTVYLEMNSLIPEDTAIYYCAREAGSSGRAGYFDPWGQGTLVTVSS	nan	nan	IGHV3-30-3*01	IGHJ5*02	IGHD3-10*01,IGHD3-10*02	IGKV1-5	nan	AREAGSSGRAGYFDP	QQYNNYPVT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458049.1	nan
13	IML3564	ADI-60570	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGTGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCCTCACTTCCTTTCCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTACAGTGGGTGGCAGTTGTATCAAATGATGGAAGTATTGAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACACTTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTTTATTACTGTGCGAGAGAAGGGGGTAGCAGTGGGCGGGCTGGATGGTTCGACCCCTGGGGCCAGGGAGCCCCGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGWSLRLSCAASGFTLTSFPMHWVRQAPGKGLQWVAVVSNDGSIEYYADSVKGRFTISRDTSKNTLYLQMNSLRAEDTAVYYCAREGGSSGRAGWFDPWGQGAPVTVSS	nan	nan	IGHV3-30*01	IGHJ5*02	IGHD6-19*01	IGKV1-5	nan	AREGGSSGRAGWFDP	QQYDSYPLT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457901.1	nan
13	IML3547	ADI-62900	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGAGAGGTCTCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTGCGTAGTTTTATTATACACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGACAGCTATATCATCTGATGGAGGGAGTAAATACTACGCAGACTCCGTGAAGGACCGATTCACCATCTCCAGAGACAATTCCAAGAACACGGTGGATGTGCAAATGAACAGCCTGAGACTTGAGGACACGGCTGTGTATTACTGTGCGACAGAGGCGGGTAGTTCGGGGAGAGCCGGGTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLLESGGGVVQPERSLRLSCAASGFTLRSFIIHWVRQAPGKGLEWVTAISSDGGSKYYADSVKDRFTISRDNSKNTVDVQMNSLRLEDTAVYYCATEAGSSGRAGWFDPWGQGTLVTVSS	nan	nan	IGHV3-30*04,IGHV3-30-3*01,IGHV3-30-3*03	IGHJ5*02	IGHD3-10*01,IGHD3-10*02	nan	nan	ATEAGSSGRAGWFDP	nan	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458408.1	nan
13	IML3547	ADI-62198	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:S1	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGATGTCCCTGAGACTCTCCTGTGGAGGCTCTGGATTCACCTTCAGTACCTCTGTAATACACTGGGTCCGCCAGGCCCCAGGCAAGGGGCTGGAGTGGGTAACAGCTATATCACATGATGGAAAGGGAAAATACTACGCAGACTCCGTGAAGGGCCGGTTCGACATCTCCAGAGACAACTCCAAGAACACGGTGTTTCTGCAAGTCAACACCCTGACAACTGAAGACACGGCTGTGTATCATTGTGTGAAAGAGGCGGGTAGTTCGGGGAGAGCCGGGTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLLESGGGVVQPGMSLRLSCGGSGFTFSTSVIHWVRQAPGKGLEWVTAISHDGKGKYYADSVKGRFDISRDNSKNTVFLQVNTLTTEDTAVYHCVKEAGSSGRAGWFDPWGQGTLVTVSS	nan	nan	IGHV3-30*09	IGHJ5*02	IGHD3-10*01,IGHD3-10*02	IGKV1-5	nan	VKEAGSSGRAGWFDP	QQYDNYPIK	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457922.1	nan
13	IML3547	ADI-62915	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCTGCCTGGGAGGTCCCTAACAGTCTCCTGTGTAGGCTCTGGATTCACCTTCAGTTCCTCTGTTATACACTGGGTCCGCCAGGCCCCAGGCAAGGGGCTGGAGTGGGTGACAGGTATTTCACATGATGGAAGGGGAAAATACTTCGCAGACTCCGTGAAGGGCCGGTTCGACATCTCCAGAGACAATTCCAAGAACACGGTGTTTCTGCACGTCCACAGTCTGACAAGTGAGGACACGGCTGTTTACCACTGTGTGAAAGAGGCGGGTAGTTCGGGGAGAGCCGGGTGGTTCGACCCGTGGGGCCAGGGAACATCGGTCACCGTCTCCTCA	EVQLVESGGGVVLPGRSLTVSCVGSGFTFSSSVIHWVRQAPGKGLEWVTGISHDGRGKYFADSVKGRFDISRDNSKNTVFLHVHSLTSEDTAVYHCVKEAGSSGRAGWFDPWGQGTSVTVSS	nan	nan	IGHV3-30*09	IGHJ5*02	IGHD3-10*01,IGHD3-10*02	nan	nan	VKEAGSSGRAGWFDP	nan	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458424.1	nan
13	IML3547	ADI-62210	nan	SARS-CoV-2,HKU1	nan	nan	SARS-CoV,SARS-CoV-2	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTACAGCCTCTGAGTTCACCTTCAGCACCTCTGTTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGTCTGGAGTGGGTGGCAGGTTTATCAGTTGATGGAAATAGGGAACACTACCCAGGCACCGTGGAGGGCCGATTCATCATCTCCAGAGACAATTCTAAGAACACACTATTTCTGCAAATGAACAGCCTGAAATCTGAGGACACGGCTGTGTATTATTGTGCGAGAGAGGCGGGTTCTTCGGGGAAAGCCGGATACTTCGACCCCTGGGGCCAGGGAACCCTGGTCACTGTCTCCTCA	EVQLLESGGGVVQPGRSLRLSCTASEFTFSTSVMHWVRQAPGKGLEWVAGLSVDGNREHYPGTVEGRFIISRDNSKNTLFLQMNSLKSEDTAVYYCAREAGSSGKAGYFDPWGQGTLVTVSS	nan	nan	IGHV3-30*04,IGHV3-30-3*03	IGHJ5*02	IGHD3-10*01,IGHD3-10*02	IGKV1-5	nan	AREAGSSGKAGYFDP	QHYHSYPIT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457934.1	nan
13	IML3550	ADI-62163	nan	SARS-CoV-2	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGGCGTCCCTGAGACTCGCCTGTGCAGCCTCTACCTTCACCTTCAGTACCAAACCAATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGGAATATCAGATGATGGAGACAGGAAACACTACCCCGACTCCGTGAAGGGCCGATTCAGCATCTCCAGAGACAATTCCAAGAACACACTTTATTTGCAAATGAACAGCCTGACACCTGATGACACGGCTGTCTATTACTGTGCGAGAGAGGCGGGAAGCAGTGGCTCGGCTGGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLLESGGGVVQPGASLRLACAASTFTFSTKPMHWVRQAPGKGLEWVAGISDDGDRKHYPDSVKGRFSISRDNSKNTLYLQMNSLTPDDTAVYYCAREAGSSGSAGYFDYWGQGTLVTVSS	nan	nan	IGHV3-30-3*01	IGHJ4*02	IGHD6-19*01	IGKV1-5	nan	AREAGSSGSAGYFDY	QHYKTYPVT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458255.1	nan
13	IML3547	ADI-62909	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGACGTGGTCCAGCCTGGAGAATCCCTGATATTGTCCTGTGCAGCCTCTGGACCCACACTCAGTTCCTCTATTGTACACTGGGTCCGCCAGACTCCAGGCGAGGGGCTGGAGTGGGTGGCGACTATAACGCCTGATGGAAGCGATAAACATTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAACTCCAAGAACATGATATATCTGCAGGTGATCAGCCTGAGAGCTGAGGACACGGCTGTATATTACTGTTCGAGAGAGGCGGGTTCTTCGGGGAGAGCCGGCTACTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGDVVQPGESLILSCAASGPTLSSSIVHWVRQTPGEGLEWVATITPDGSDKHYADSVKGRFTISRDNSKNMIYLQVISLRAEDTAVYYCSREAGSSGRAGYFDPWGQGTLVTVSS	nan	nan	IGHV3-30-3*01	IGHJ5*02	IGHD3-10*01,IGHD3-10*02	IGKV1-5	nan	SREAGSSGRAGYFDP	QQYNNYPMT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458417.1	nan
13	IML3547	ADI-62933	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGGCTCTGGACTCATCTTCAGTAATAACATCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGTTGGCAGTTTTTTCCCATGACGCAATCAATCACCTCTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCGAAGAACACGGTGTATTTGGAGATGAACAGTCTGATACCTGAGGACACGGCTATATATTACTGTACGAGAGAGGCGGGAAGTTCGGGGAGAGCCGGGTACTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGGVVQPGRSLRLSCAGSGLIFSNNIMHWVRQAPGKGLEWLAVFSHDAINHLYADSVKGRFTISRDNSKNTVYLEMNSLIPEDTAIYYCTREAGSSGRAGYFDPWGQGTLVTVSS	nan	nan	IGHV3-30*03	IGHJ5*02	IGHD3-10*01,IGHD3-10*02	IGKV1-5	nan	TREAGSSGRAGYFDP	QQYNNYPIT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458442.1	nan
13	IML3547	ADI-62892	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTACAGCCTCCGCAGCCTCCGAATTCACCTTCAGTACCTCTGTTATACACTGGGTCCGCCAGGCTCCAGGCAAGGGTCTGGAGTGGGTGGCAGGTATATCATCTGATGGAAACAGTGAACACTACCCAGAATCTGTGAAGGGCCGATTCACTATCTCCAGAGACAATTCCAAGAACACACTGTATCTGCAAATGGACAGCCTGAAATCTGAGGACACGGCTGTGTATTATTGTGTGAGAGAGGCGGGTTCTTCGGGGAAAGCCGGGTACTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVQSGGGVVQPGRSLRLSCTASAASEFTFSTSVIHWVRQAPGKGLEWVAGISSDGNSEHYPESVKGRFTISRDNSKNTLYLQMDSLKSEDTAVYYCVREAGSSGKAGYFDPWGQGTLVTVSS	nan	nan	IGHV3-30-3*01	IGHJ5*02	IGHD3-10*01,IGHD3-10*02	IGKV1-5	nan	VREAGSSGKAGYFDP	QQYNSYPIT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458400.1	nan
14	COV047	C051	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGGCTGGGGGGTCCCTGAGACTCTCTTGTGCAGCCTCTGGGTTCGGCGTCAGAAACAACTACATGAGTTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTACGACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAACTCCAAGAACACGGTGTTTCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAGGAGACGTAGAAGGGTTTTCCGATTTGTGGAGTGGTTATTCTAGAGACCGTTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQAGGSLRLSCAASGFGVRNNYMSWVRQAPGKGLEWVSVIYSGGTTYYADSVKGRFTISRDNSKNTVFLQMNSLRAEDTAVYYCAREGDVEGFSDLWSGYSRDRYYFDYWGQGTLVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCTTCTCCTGCACCGGAACCAGCAGTGACGTTGGTGGTTACAACTATGTCTCCTGGTATCAACAATACCCAGGCAAAGCCCCCAAACTGTTGATTTATGATGTCACTAATCGGCCCTCAGGGGTTTCTGATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCGTTCACAAGCAGCAACACTCGAGTCTTCGGAACTGGGACCAAGGTCACCGTCCTA	QSALTQPASVSGSPGQSITFSCTGTSSDVGGYNYVSWYQQYPGKAPKLLIYDVTNRPSGVSDRFSGSKSGNTASLTISGLQAEDEADYYCSSFTSSNTRVFGTGTKVTVL	IGHV3-53*01	IGHJ4*02	IGHD3-3*01	IGLV2-14*03	IGLJ1*01	AREGDVEGFSDLWSGYSRDRYYFDY	SSFTSSNTRV	7R8N	Gaebler et al. Nature 591:639-644 (2021)	nan	nan
14	COV047	C050	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGTTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCAGCGTCAGAAACAACTACGTGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGTGGTGGTACCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACATTTCCGAGAACACACTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTCTATTACTGTGCGAGAGAAGGGGACGTAGAGGGGCTTCACGACTTTTGGAGTGGTTACTCTAGAGACCGTTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLFQPGGSLRLSCAASGFSVRNNYVSWVRQAPGKGLEWVSVIYSGGTTYYADSVKGRFTISRDISENTLYLQMNSLRAEDTAVYYCAREGDVEGLHDFWSGYSRDRYYFDYWGQGTLVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCATCATCTCCTGCACTGGAACCAGCGGTGACATTGGTGGTTATAACTATGTCTCCTGGTATCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTTTTCGGCCCTCAGGGGTTTCTAATCGTTTCTCTGGCTCCAAGTCTGACAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATTTACAGGCAACAATACTCGAGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	QSALTQPASVSGSPGQSIIISCTGTSGDIGGYNYVSWYQQHPGKAPKLMIYDVSFRPSGVSNRFSGSKSDNTASLTISGLQAEDEADYYCSSFTGNNTRVFGTGTKVTVL	IGHV3-53*01	IGHJ4*02	IGHD3-3*01	IGLV2-14*03	IGLJ1*01	AREGDVEGLHDFWSGYSRDRYYFDY	SSFTGNNTRV	nan	Gaebler et al. Nature 591:639-644 (2021)	nan	nan
14	COV047	C053	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCATCGTCAGTAACAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGATTGGGTCTCAGTTATTTATAGTGGTGGTACTACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTTTATTACTGTGCGAGAGAAGGAGATGTAGAAGGATATCACGATTCTTGGAGTGGTTATTCAAGAGACCGCTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFIVSNNYMSWVRQAPGKGLDWVSVIYSGGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREGDVEGYHDSWSGYSRDRYYFDYWGQGTLVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAAGCAGCAGTGACGTTGGTGGTTATAATTTTGTCTCCTGGTACCAACAACACCCAGGCAGAGCCCCCAAACTCATGATTTATGATGTCAGCAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGTTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAACAACAACACTCGAGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	QSALTQPASVSGSPGQSITISCTGSSSDVGGYNFVSWYQQHPGRAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQVEDEADYYCSSYTNNNTRVFGTGTKVTVL	IGHV3-53*01	IGHJ4*02	IGHD3-3*01	IGLV2-14*03	IGLJ1*01	AREGDVEGYHDSWSGYSRDRYYFDY	SSYTNNNTRV	nan	Gaebler et al. Nature 591:639-644 (2021)	nan	nan
14	COV047	C052	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCCGGAGGAGGCTTGATCCGGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCCGGATTCAGCGTCAGTAACAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTACCACATACTACGCAGACTCCGTGAAGGGCCGATTCAACATCTCCAGAGACAACTCCAAGAATACGGTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTATATTATTGTGCGAGAGAAGGGGACGTAGAAGGCTATTACGATTTTTGGAGTGGTTATTCTAGAGACCGTTACTATTTTGACTACTGGGGCCAGGGAGCCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIRPGGSLRLSCAASGFSVSNNYMSWVRQAPGKGLEWVSVIYSGGTTYYADSVKGRFNISRDNSKNTVYLQMNSLRAEDTAVYYCAREGDVEGYYDFWSGYSRDRYYFDYWGQGALVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAACTCATATACAAGCAACAACACTCGAGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCNSYTSNNTRVFGTGTKVTVL	IGHV3-53*01	IGHJ4*02	IGHD3-3*01	IGLV2-14*03	IGLJ1*01	AREGDVEGYYDFWSGYSRDRYYFDY	NSYTSNNTRV	nan	Gaebler et al. Nature 591:639-644 (2021)	nan	nan
14	COV047	C054	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAACAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACGACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGCGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAGGGGACGTAGAAGGGTATTACGATTTTTGGAGTGGTTATTCTAGAGACCGTTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSNNYMSWVRQAPGKGLEWVSVIYSGGSTYDADSVKGRFTISRDNSKNTLYLQMNSLSAEDTAVYYCAREGDVEGYYDFWSGYSRDRYYFDYWGQGTLVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCAGCGCTCGAGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSARVFGTGTKVTVL	IGHV3-53*01	IGHJ4*02	IGHD3-3*01	IGLV2-14*03	IGLJ1*01	AREGDVEGYYDFWSGYSRDRYYFDY	SSYTSSSARV	nan	Gaebler et al. Nature 591:639-644 (2021)	nan	nan
14	COV047	COV047_P5_IgG_26-P1369	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATATTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCTTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAGGGGACGTAGAAGGGTATTACGATTTTTGGAGTGGTTATTCTAGAGACCGTTACTATTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREGDVEGYYDFWSGYSRDRYYFDYWGQGTLVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCAGCACTCGAGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTRVFGTGTKVTVL	IGHV3-53*01	IGHJ4*02	IGHD3-3*01	IGLV2-14*03	IGLJ1*01	AREGDVEGYYDFWSGYSRDRYYFDY	SSYTSSSTRV	nan	Robbiani et al. Nature 584:437-442 (2020)	MW292861.1	MW293316.1
14	Wang-MOD6	MOD6_P1_IgG_E5-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAACAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACGACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGCGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAGGGGACGTAGAAGGGTATTACGATTTTTGGAGTGGTTATTCTAGAGACCGTTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSNNYMSWVRQAPGKGLEWVSVIYSGGSTYDADSVKGRFTISRDNSKNTLYLQMNSLSAEDTAVYYCAREGDVEGYYDFWSGYSRDRYYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCTTCTGTAGGAGACAGNTNCNCCCCCCNCTCCCGGGCAAGTCAGAGCGTTAGCAGNTATTTAAATCGGTATCACCAAAAACCAGGGAGAGCCCATAAGCTCCTGATTTATGCTGCATCCAGTTTGCAAAGGGGGGTCCCATCAAGGTTCAGTGGCAGAGGATGTGGGTCAGATTTCAGTGTCACCATCAGCAGTCGGCAGCGGGAAGTTTGTGCAAGTTATTACTGTCAGCAGAGTTACAGTTCACCGTACAGTTTTGGCCAGGGGACCACANCGGAGATCAAA	DIQMTQSPSSLSASVGDXXXPXSRASQSVSXYLNRYHQKPGRAHKLLIYAASSLQRGVPSRFSGRGCGSDFSVTISSRQREVCASYYCQQSYSSPYSFGQGTTXEIK	IGHV3-53*01	IGHJ4*02	IGHD3-3*01	IGKV1-39*01,IGKV1D-39*01	IGKJ2*03	AREGDVEGYYDFWSGYSRDRYYFDY	QQSYSSPYS	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
14	Wang-PFZ10	PZF10_P2_IgG_G8-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAACAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACGACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGCGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAGGGGACGTAGAAGGGTATTACGATTTTTGGAGTGGTTATTCTAGAGACCGTTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSNNYMSWVRQAPGKGLEWVSVIYSGGSTYDADSVKGRFTISRDNSKNTLYLQMNSLSAEDTAVYYCAREGDVEGYYDFWSGYSRDRYYFDYWGQGTLVTVSS	TCCTATGTGCTGACTCAGCCACCCTCGGTGTCAGTGTCCCCAGGACAGACGGCCAGGATCACCTGCTCTGGAGATGCATTGCCAAAGCAATATGCTTATTGGTACCAGCAGAAGCCAGGCCAGGCCCCTGTGCTGGTGATATATAAAGACAGTGAGAGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAGCTCAGGGACAACAGTCACGTTGACCATCAGTGGAGTCCAGGCAGAAGACGAGGCTGACTATTACTGTCAATCAGCAGACAGCAGTGGTACTTATTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	SYVLTQPPSVSVSPGQTARITCSGDALPKQYAYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSSGTYWVFGGGTKLTVL	IGHV3-53*01	IGHJ4*02	IGHD3-3*01	IGLV3-25*03	IGLJ3*02	AREGDVEGYYDFWSGYSRDRYYFDY	QSADSSGTYWV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
14	COV047	COV047_P3_IgA_18-P1609	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATATTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCTTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAGGGGACGTAGAAGGGTATTACGATTTTTGGAGTGGTTATTCTAGAGACCGTTACTATTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREGDVEGYYDFWSGYSRDRYYFDYWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCAGCACTCGAGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	QSVLTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTRVFGTGTKVTVL	IGHV3-53*01	IGHJ4*02	IGHD3-3*01	IGLV2-14*03	IGLJ1*01	AREGDVEGYYDFWSGYSRDRYYFDY	SSYTSSSTRV	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292855.1	MW293310.1
14	COV047	COV047_P4_IgA_79-P1609	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATGCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAGGGGACGTAGAAGGGTATTACGATTTTTGGAGTGGTTATTCTAGAGACCGTTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTCYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREGDVEGYYDFWSGYSRDRYYFDYWGQGTLVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCAGCACTCGAGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTRVFGTGTKVTVL	IGHV3-53*01	IGHJ4*02	IGHD3-3*01	IGLV2-14*03	IGLJ1*01	AREGDVEGYYDFWSGYSRDRYYFDY	SSYTSSSTRV	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292859.1	MW293314.1
14	COV047	Wang-C394	COV047_P4_IgA_88-P1609	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATATTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCTTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAGGGGACGTAGAAGGGTATTACGATTTTTGGAGTGGTTATTCTAGAGACCGTTACTATTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREGDVEGYYDFWSGYSRDRYYFDYWGQGTLVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCAGCACTCGAGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTRVFGTGTKVTVL	IGHV3-53*01	IGHJ4*02	IGHD3-3*01	IGLV2-14*03	IGLJ1*01	AREGDVEGYYDFWSGYSRDRYYFDY	SSYTSSSTRV	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292860.1	MW293315.1
14	COV047	C144	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAACAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAAATCCAAGAACACGCTGTATCTTCAAATGAACAGGCTGAGAGCCGAGGACACGGCCGTGTATTATTGTGCGAGAGAAGGGGAGGTAGAAGGGTATAACGATTTTTGGAGTGGTTATTCTAGAGACCGTTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSNNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDKSKNTLYLQMNRLRAEDTAVYYCAREGEVEGYNDFWSGYSRDRYYFDYWGQGTLVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCAGCACTCGAGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTRVFGTGTKVTVL	IGHV3-53*01	IGHJ4*02	IGHD3-3*01	IGLV2-14*03	IGLJ1*01	AREGEVEGYNDFWSGYSRDRYYFDY	SSYTSSSTRV	7K90	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
14	COV047	COV047_P3_IgG_43-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAACAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAAATCCAAGAACACGCTGTATCTTCAAATGAACAGGCTGAGAGCCGAGGACACGGCCGTGTATTATTGTGCGAGAGAAGGGGAGGTAGAAGGGTATAACGATTTTTGGAGTGGTTATTCTAGAGACCGTTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSNNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDKSKNTLYLQMNRLRAEDTAVYYCAREGEVEGYNDFWSGYSRDRYYFDYWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCAGCACTCGAGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	QSVLTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTRVFGTGTKVTVL	IGHV3-53*01	IGHJ4*02	IGHD3-3*01	IGLV2-14*03	IGLJ1*01	AREGEVEGYNDFWSGYSRDRYYFDY	SSYTSSSTRV	nan	Robbiani et al. Nature 584:437-442 (2020)	MW292856.1	MW293311.1
14	COV047	C145	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCAGCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGTACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAGGGGAGGTAGAAGGGTATTACGATTTTTGGAGTGGTTATTCTAGAGACCGTTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFSVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREGEVEGYYDFWSGYSRDRYYFDYWGQGTLVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCACCACTCGAGTCTTCGGAACTGGGACCAGGGTCACCGTCCTAG	QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSTTRVFGTGTRVTVL	IGHV3-53*01	IGHJ4*02	IGHD3-3*01	IGLV2-14*03	IGLJ1*01	AREGEVEGYYDFWSGYSRDRYYFDY	SSYTSSTTRV	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
14	COV047	COV047_P4_IgG_57-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCAGCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGTACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAGGGGAGGTAGAAGGGTATTACGATTTTTGGAGTGGTTATTCTAGAGACCGTTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFSVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREGEVEGYYDFWSGYSRDRYYFDYWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCACCACTCGAGTCTTCGGAACTGGGACCAGGGTCACCGTCCTAG	QSVLTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSTTRVFGTGTRVTVL	IGHV3-53*01	IGHJ4*02	IGHD3-3*01	IGLV2-14*03	IGLJ1*01	AREGEVEGYYDFWSGYSRDRYYFDY	SSYTSSTTRV	nan	Robbiani et al. Nature 584:437-442 (2020)	MW292857.1	MW293312.1
14	COV047	COV047_P4_IgG_58-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAACAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCTTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAGGGGAGGTAGAAGGGTATTACGATTTTTGGAGTGGTTATTCTAGAGACCGTTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSNNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSLKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREGEVEGYYDFWSGYSRDRYYFDYWGQGTLVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCATCAGCACTCGAGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSISTRVFGTGTKVTVL	IGHV3-53*01	IGHJ4*02	IGHD3-3*01	IGLV2-14*03	IGLJ1*01	AREGEVEGYYDFWSGYSRDRYYFDY	SSYTSISTRV	nan	Robbiani et al. Nature 584:437-442 (2020)	MW292858.1	MW293313.1
14	COV047	COV047_P5_IgG_41-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATTCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGAAACAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAGGGGAGGTAGAAGGGTATTACGATTTTTGGAGTGGTTATTCTAGAGACCGTTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVRNNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREGEVEGYYDFWSGYSRDRYYFDYWGQGTLVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCAGCACTCGAGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTRVFGTGTKVTVL	IGHV3-53*01	IGHJ4*02	IGHD3-3*01	IGLV2-14*03	IGLJ1*01	AREGEVEGYYDFWSGYSRDRYYFDY	SSYTSSSTRV	nan	Robbiani et al. Nature 584:437-442 (2020)	MW292862.1	MW293317.1
14	COV047	COV047_P5_IgG_49-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCAGCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGTACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAGGGGAGGTAGAAGGGTATTACGATTTTTGGAGTGGTTATTCTAGAGACCGTTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFSVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREGEVEGYYDFWSGYSRDRYYFDYWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCACCACTCGAGTCTTCGGAACTGGGACCAGGGTCACCGTCCTAG	QSVLTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSTTRVFGTGTRVTVL	IGHV3-53*01	IGHJ4*02	IGHD3-3*01	IGLV2-14*03	IGLJ1*01	AREGEVEGYYDFWSGYSRDRYYFDY	SSYTSSTTRV	nan	Robbiani et al. Nature 584:437-442 (2020)	MW292863.1	MW293318.1
14	COV047	Wang-C412	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATTTTGAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAGGGGAGGTAGAAGGGTATTACGATTTTTGGAGTGGTTATTCTAGAGACCGTTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYFEMNSLRAEDTAVYYCAREGEVEGYYDFWSGYSRDRYYFDYWGQGTLVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCAGCACTCGAGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTRVFGTGTKVTVL	IGHV3-53*01	IGHJ4*02	IGHD3-3*01	IGLV2-14*03	IGLJ1*01	AREGEVEGYYDFWSGYSRDRYYFDY	SSYTSSSTRV	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	nan	nan
15	Chi-Donor2	2M-8E7	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGGAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATGCTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAGGGATCATCCCTATCTTTGGTACAGCAAACTACGCACAGAAGTTCCAGGGCAGAGTCACGGTTACCGCGGACGAATCCACGAGCACAGCCTACATGGAGCTAAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGCGCGAGAACGTATTCCTTTGATAGTAGTGGATATTACTACGACTACTGGGGCCAGGGAACCATGGTCACCGTCTCTTCA	EVQLVESGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTVTADESTSTAYMELSSLRSEDTAVYYCARTYSFDSSGYYYDYWGQGTMVTVSS	GAAATTGTGTTGACACAGTCTCCAGCCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCTACTTAGCCTGGTACCAACAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGATGCATCCAACAGGGCCACTGGCATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGCCTAGAGCCTGAAGATTTTGCAGTTTATTACTGTCAGCAGCGTAGCAACTGGCCTCCGAAGATCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPKITFGQGTRLEIK	IGHV1-69*01,IGHV1-69D*01	IGHJ4*02	IGHD3-22*01	IGKV3-11*01	IGKJ5*01	ARTYSFDSSGYYYDY	QQRSNWPPKIT	nan	Chi et al. Science 369:650-655 (2020)	MT622712.1	MT622713.1
15	IML3558	ADI-60563	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTTGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATGCTATCAGCTGGGTGCGTCAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAGGGATCATCCCTTTCTTTGGTACAGCAAACTACGCACAGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACGAATCCACGAACACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAACGTATTCCTATGATAGTAGTGGTTATTACTCCGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPFFGTANYAQKFQGRVTITADESTNTAYMELSSLRSEDTAVYYCARTYSYDSSGYYSDYWGQGTLVTVSS	nan	nan	IGHV1-69*12	IGHJ4*02	IGHD3-22*01	IGKV3-11	nan	ARTYSYDSSGYYSDY	QYRNNWPPRLT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457894.1	nan
15	Chen_Vax_p1	COV2-vax-37	nan	SARS-CoV-2	nan	nan	nan	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATGCTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAGGGATCATCCCTATCTTTGGTACAGCAAACTACGCACAGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACGAATCCACGAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAACGTATTCCTATGATAGTAGTGGTTATTACTACGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARTYSYDSSGYYYDYWGQGTLVTVSS	GAAATTGTGTTGACACAGTCTCCAGCCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCTACTTAGCCTGGTACCAACAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGATGCATCCAACAGGGCCACTGGCATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGCCTAGAGCCTGAAGATTTTGCAGTTTATTACTGTCAGCAGCGTAGCAACTGGCCTCCGAGGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPRLTFGGGTKVEIK	IGHV1-69*01,IGHV1-69D*01	IGHJ4*02	IGHD3-22*01	IGKV3-11*01	IGKJ4*01	ARTYSYDSSGYYYDY	QQRSNWPPRLT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555575.1	MZ555576.1
15	IML3564	ADI-62080	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTTGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATGCTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAGGGATCATCCCTATCTTTGGTACAGGAAACTACCCACAGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACGAATCCACGAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGGACGTATTCCTATGATAGTAGTGGTTATTACTACGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTGNYPQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARTYSYDSSGYYYDYWGQGTLVTVSS	nan	nan	IGHV1-69*12	IGHJ4*02	IGHD3-22*01	IGKV3-11	nan	ARTYSYDSSGYYYDY	HHRSNWPPRLT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458172.1	nan
15	COSCA2	COVA2-14	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV,SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTGGTACAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATGCTATCATCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAGGGATCATCCCTATCTTTGGTACAGCAAACTACGCACAGAAGTTCCAGGGCAGAGTCACGATTACCACGGACGAATCCACGAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGTAAGATACTATGATAGTAGTGGTTATTATGAGGACTACTGGGGCCAGGGAACGCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAIIWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITTDESTSTAYMELSSLRSEDTAVYYCARVRYYDSSGYYEDYWGQGTLVTVSS	GAAATTGTGTTGACACAGTCTCCAGCCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCTACTTAGCCTGGTACCAACAGGAACCTGGCCAGGCTCCCAGGCTCCTCATTTATGATGCATCCAACAGGGCCACTGGCATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGCCTAGAGCCTGAAGATTTTGCAGTTTATTACTGTCAGCAGCGTAGCAACTGGCCTCCTATGTACACTTTTGGCCAGGGGACCAAGGTGGAGATCAAAC	EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQEPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPMYTFGQGTKVEIK	IGHV1-69*05	IGHJ4*02	IGHD3-22*01	IGKV3-11*01	IGKJ2*01	ARVRYYDSSGYYEDY	QQRSNWPPMYT	nan	Brouwer et al. Science 369:643-650 (2020)	nan	nan
15	Jennewein_CV2	CV2-54	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTTCAGTTGGTTCAGAGCGGCGCGGAAGTGAAGAAGCCTGGGTCTAGCGTTAAAGTAAGCTGTAAGGCTAGCGGGGGCACTTTCAGTAGTTATACTATCTCTTGGGTCCGCCAGGCTCCTGGACAGGGGCTTGAATGGATGGGCGGCATCATACCTATATTTGGTACAGCCAATTACGCTCAGAATTTTCAAGGACGCGTGACGATTACCGCAGACGAGTCTACTTCTACTGCATATATGGAGTTGAGCAGTCTGCGGAGTGAGGATACGGCTGTGTACTATTGTGCAAGGGTATCTTATTATGACTCAAGTGGGTATTATACAGACTACTGGGGGCAGGGAACACTTGTTACGGTTAGTTCAG	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYTISWVRQAPGQGLEWMGGIIPIFGTANYAQNFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARVSYYDSSGYYTDYWGQGT	GAAATAGTGCTCACACAATCCCCCGCCACATTGAGTTTGAGCCCCGGAGAGAGGGCGACTCTCAGTTGCAGGGCTTCTCAAAGCGTTTCATCCTTTCTCGCATGGTATCAGCAAAAACCGGGACAGGCTCCACGATTGTTGATCTATGATGCTTCCAATAGAGCGACAGGGATACCCGCGAGATTCTCTGGAAGCGGCTCTGGCACTGACTTCACATTGACCATCAACTCTTTGGAGCCAGAAGATTTTGCAGTTTACTATTGCCAACAGAGGTCCAATTGGCCACCTGAATACACTTTTGGCCAAGGGACAAAACTTGAAATTAAA	EIVLTQSPATLSLSPGERATLSCRASQSVSSFLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTINSLEPEDFAVYYCQQRSNWPPEYTFGQGTKLEIK	IGHV1-69*01,IGHV1-69*12,IGHV1-69*13	IGHJ4*02	IGHD3-3*01,IGHD3-3*02	IGKV3-11*01	IGKJ2*01	ARVSYYDSSGYYTDY	QQRSNWPPEYT	nan	Jennewein et al. Cell Rep. 36:109353 (2021)	MW681716.1	MW681717.1
15	Wheatley-CP13	PDI_128	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATGCTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAGGGATCATCCCTATCTTTGGTACAGCAAACTACGCACAGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACGAATCCACGAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGTATATTACTATGATAGTAGTGGTTATTACTACGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARVYYYDSSGYYYDYWGQGTLVTVSS	GAAATTGTGTTGACACAGTCTCCAGCCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCTACTTAGCCTGGTACCAACAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGATGCATCCAACAGGGCCACTGGCATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGCCTAGAGCCTGAAGATTTTGCAGTTTATTACTGTCAGCAGCGTAGCAACTGGCCTCCGAAGGTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAA	EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPKVTFGPGTKVDIK	IGHV1-69*01,IGHV1-69D*01	IGHJ4*02	IGHD3-22*01	IGKV3-11*01	IGKJ3*01	ARVYYYDSSGYYYDY	QQRSNWPPKVT	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
15	Tong_C163	C163D1	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike (and spike minus RBD)	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATGCTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAGGGATCATCCCTATCTTTGGTACAGCAAACTACGCACAGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACGAATCCACGAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGTGAGCGGCTATGATAGTAGTGGTTACAGCCCTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARVSGYDSSGYSPDYWGQGTLVTVSS	GAAATTGTGTTGACACAGTCTCCAGCCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCTACTTAGCCTGGTACCAACAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGATGCATCCAACAGGGCCACCGGCATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGCCTAGAGCCTGAAGATTTTGCAGTTTATTACTGTCAGCAGCGTAGCAACTGGCCTCCGAGGCTCACTTTCGGCGGAGGGACCAAGGTGGAAATCAAA	EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPRLTFGGGTKVEIK	IGHV1-69*01,IGHV1-69D*01	IGHJ4*02	IGHD3-22*01	IGKV3-11*01	IGKJ4*01	ARVSGYDSSGYSPDY	QQRSNWPPRLT	nan	Tong et al. Cell 184:4969-4980.e15 (2021)	MW718430.1	MW718582.1
15	IDCnC2	CnC2t1p1_B10	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATGCTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAGGGATCATCCCTATCTTTGGTACAGCAAACTACGCACAGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACAAATCCACGAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGTCTCGGGGTATGATAGTAGTGGTTACTGGGGTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARVSGYDSSGYWGDYWGQGTLVTVSS	GAAATTGTGTTGACACAGTCTCCAGCCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCTACTTAGCCTGGTACCAACAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGATGCATCCAACAGGGCCACTGGCATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGCCTAGAGCCTGAAGATTTTGCAGTTTATTACTGTCAGCAGCGTAGCAACTGGCCTCCGGCGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPALTFGGGTKVEIK	IGHV1-69*06	IGHJ4*02	IGHD3-22*01	IGKV3-11*01	IGKJ4*01	ARVSGYDSSGYWGDY	QQRSNWPPALT	nan	Kreer et al. Cell 182:843-854.e12 (2020)	MT658806.1	MT658834.1
15	Chen_Vax_p1	COV2-vax-38	nan	SARS-CoV-2	nan	nan	nan	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAACAGCTATGCTATCAGCTGGGTGCGGCGGGCCCCTGGACAAGGGCTTGAGTGGATGGGAGGGATCATCCCTATCTTTGGTACAACAAACTACGCACAGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACGAATCCACGAGCACAGCCTACATGGAGCTGAGCAGGCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGTCTCGGGCTATGATAGTAGTGGTTATTACTACGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGSSVKVSCKASGGTFNSYAISWVRRAPGQGLEWMGGIIPIFGTTNYAQKFQGRVTITADESTSTAYMELSRLRSEDTAVYYCARVSGYDSSGYYYDYWGQGTLVTVSS	GAAATTGTGTTGACACAGTCTCCAGCCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCTACTTAGCCTGGTACCAACAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGATGCATCCAACAGGGCCACTGGCATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGCCTAGAGCCTGAAGATTTTGCAGTTTATTACTGTCAGCAGCGTAGCAACTGGCCTCCCTCGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPSLTFGGGTKVEIK	IGHV1-69*01,IGHV1-69D*01	IGHJ4*02	IGHD3-22*01	IGKV3-11*01	IGKJ4*01	ARVSGYDSSGYYYDY	QQRSNWPPSLT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555577.1	MZ555578.1
15	Jennewein_CV2	CV2-16	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTGGTTCAAAGCGGTGCCGAAGTCAAAAAACCCGGTTCTTCTGTAAAAGTTTCATGCAAGGCGTCTGGGGGGACCTTCTCTAGTTTTGCATTTATCTGGGTTAGACAGGCGCCCGGTCAAGGTCTGGAATGGATGGGAGGTATTATTCCCATTTTCGGCACGGCCAAATATACGCAAAAATTTCAAGGACGAGTGACGATTACGGCTGATGAATCAACGTCTACTGCGTATATGGAGTTGAGCAGCCTGCGAAGCGAAGATACAGCTGTCTACTACTGCGCTAGAGTAAGTTATTACGACAGTAGCGGCTTTTACACGGACTATTGGGGACAGGGGACTCTCGTCACAGTTTCTTCAG	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSFAFIWVRQAPGQGLEWMGGIIPIFGTAKYTQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARVSYYDSSGFYTDYWGQGTLVTVSS	GATATTGTGATGACTCAGTCTCCAGCCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCTTCTTAGCCTGGTACCAACAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGATGCATCCAACAGGGCCACTGGCATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGCCTAGAGCCTGAAGATTTTGCAGTTTATTACTGTCAGCAGCGTAGCAACTGGCCTCCGGAGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAA	DIVMTQSPATLSLSPGERATLSCRASQSVSSFLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPEYTFGQGTKLEIK	IGHV1-69*12,IGHV1-69*13,IGHV1-69*19	IGHJ3*01,IGHJ3*02	IGHD3-10*01,IGHD3-10*02,IGHD3-22*01	IGKV3-11*01	IGKJ2*01	ARVSYYDSSGFYTDY	QQRSNWPPEYT	nan	Jennewein et al. Cell Rep. 36:109353 (2021)	MW681644.1	MW681645.1
15	IML3564	ADI-63373	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTTGTACAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATGCTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAGGGATCATCCCTATCTTTGGTACAACAAACTACGCACAGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACGAATCCACGAGCACAGCCTACATGGAGCTGAGCAGTCTGAGATCTGAGGACACGGCCGTGTATTTCTGTGTGAGAACACATTCCTATGATAGTAGTGGTTATTACTCTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTTNYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYFCVRTHSYDSSGYYSDYWGQGTLVTVSS	nan	nan	IGHV1-69*12	IGHJ4*02	IGHD3-22*01	IGKV3-11	nan	VRTHSYDSSGYYSDY	QQRSNWPPRIT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458879.1	nan
15	CC40	CC40.2	nan	SARS-CoV-2,SARS-CoV	MERS-CoV,HKU1,OC43,NL63,229E	nan	SARS-CoV-2,SARS-CoV	S:Unk	SARS-CoV-2 spike, HKU1 spike, NL63 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATGCTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAGGGATCATCCCTATCTTTGATACAACAAACTACGCACAGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACGAATCCACGAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGTCGGGGACTATGATAGTAGTGGTTACTATAGTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFDTTNYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARVGDYDSSGYYSDYWGQGTLVTVSS	GAAATTGTGATGACGCAGTCTCCAGCCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCTTTTTAGCCTGGTACCAACAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGATGCATCCAACAGGGCCACTGGCATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGCCTAGAGCCTGAAGATTTTGCAGTTTATTACTGTCAGCAGCGTAGCAACTGGCCTCCGGCGGTCACTTTCGGCCCTGGGACCAAGGTGGAGATCAAAC	EIVMTQSPATLSLSPGERATLSCRASQSVSSFLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPAVTFGPGTKVEIK	IGHV1-69*01,IGHV1-69D*01	IGHJ4*02	IGHD3-22*01	IGKV3-11*01	IGKJ3*01	ARVGDYDSSGYYSDY	QQRSNWPPAVT	nan	Song et al. Nat Commun. 12:2938 (2021)	MW532189.1	MW532190.1
15	IML3564	ADI-62056	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGACACCTTCAGCAGCTATGCTCTCACCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAGGGATCATCCCTATCTTTGGTACAGCGAACTACGCACAGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACGAATCCACGAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTATATTACTGTGCGAGAGTTGGGGAGTATGATAGTAGTGGTTATTACTATGACTACTGGGGCCAGGGAACCCTGGTCACTGTCTCCTCA	EVQLVESGAEVKKPGSSVKVSCKASGDTFSSYALTWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARVGEYDSSGYYYDYWGQGTLVTVSS	nan	nan	IGHV1-69*01,IGHV1-69D*01	IGHJ4*02	IGHD3-22*01	IGKV3-11	nan	ARVGEYDSSGYYYDY	QQRSNWPPRLT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458148.1	nan
15	Tong_C83	C83A10	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike (and spike minus RBD)	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATGCTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAGGGATCATCCCTATCTTTGGTACAGCAAAATACGCACAGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACGAATCCACGAGCACAGCCTACTTGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGTAGGCCCCTATGATAGTAGTGGTTATTACTACGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTAKYAQKFQGRVTITADESTSTAYLELSSLRSEDTAVYYCARVGPYDSSGYYYDYWGQGTLVTVSS	GAAATTGTGTTGACACAGTCTCCAGCCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCTACTTAGCCTGGTACCAACAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGATGCATCCAACAGGGCCACTGGCATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGCCTAGAGCCTGAAGATTTTGCAGTTTATTACTGTCAGCAGCGTAGCAACTGGCCCCCTATGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAA	EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPMYTFGQGTKLEIK	IGHV1-69*01,IGHV1-69D*01	IGHJ4*02	IGHD3-22*01	IGKV3-11*01	IGKJ2*01	ARVGPYDSSGYYYDY	QQRSNWPPMYT	nan	Tong et al. Cell 184:4969-4980.e15 (2021)	MW718428.1	MW718580.1
16	Wang-MOD1	C601	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAATAGTTACTACTGGAACTGGATCCGGCAGCCCCCAGGGAGGGGACTGGAGTGGATTGCGTATATATTTTACAGTGGGGGCACCAACTACAATCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAATTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTTCTGTGCGAGAGCCGCTGGAGTTCGTTCAGTGCTGGCAGCTGCTTCTAGCTACTACTACTACTACGGACTGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCTVSGGSINSYYWNWIRQPPGRGLEWIAYIFYSGGTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYFCARAAGVRSVLAAASSYYYYYGLDVWGQGTTVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACGAGCAGTGACGTTGGTGGTTATAATTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCGCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCGGTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTA	QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGAKSGNTASLTISGLQAEDEADYYCSSYTSSGWVFGGGTKLTVL	IGHV4-59*01	IGHJ6*02	IGHD2-15*01	IGLV2-14*03	IGLJ3*02	ARAAGVRSVLAAASSYYYYYGLDV	SSYTSSGWV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
16	Wang-MOD1	Mod1_P1_IgG_D9-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAATAGTTACTACTGGAACTGGATCCGGCAGCCCCCAGGGAGGGGACTGGAGTGGATTGCGTATATATTTTACAGTGGGGGCACCAACTACAATCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAATTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTTCTGTGCGAGAGCCGCTGGAGTTCGTTCAGTGCTGGCAGCTGCTTCTAGCTACTACTACTACTACGGACTGGACGTCTGGGGCCAAGGGACCACGGTCACAGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCTVSGGSINSYYWNWIRQPPGRGLEWIAYIFYSGGTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYFCARAAGVRSVLAAASSYYYYYGLDVWGQGTTVTVSS	CAGTCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACGAGCAGTGACGTTGGTGGTTATAATTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCGCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCGGTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTA	QSVLTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGAKSGNTASLTISGLQAEDEADYYCSSYTSSGWVFGGGTKLTVL	IGHV4-59*01	IGHJ6*02	IGHD2-15*01	IGLV2-14*03	IGLJ3*02	ARAAGVRSVLAAASSYYYYYGLDV	SSYTSSGWV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
16	Wang-MOD1	Mod1_P1_IgG_B1-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCGCCATCAGTAGTTACTACTGGAACTGGATCCGGCAGCCCCCAGGGAGGGGGCTGGAGTGGATTGGGTATATCTTTTACAGTGGCGTCATCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGAGCCGCTGGAGTTCGTTCAGTAGTAGCAGCTGCTTCTACCCACTACTACTACTACGGTCTGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCTVSGGAISSYYWNWIRQPPGRGLEWIGYIFYSGVINYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARAAGVRSVVAAASTHYYYYGLDVWGQGTTVTVSS	CAGTCTGTGCTGACTCAGTCTGCCTCCGTGTCTGGGGCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGTTTATAATTATGTCTCCTGGTACCAACAACACCCAGACAAAGCCCCCAAACTCATTATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGCCAACACGGCCTCCCTGACCATCTCTGGCCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCGGTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQSASVSGAPGQSITISCTGTSSDVGVYNYVSWYQQHPDKAPKLIIYDVSNRPSGVSNRFSGSKSANTASLTISGLQAEDEADYYCSSYTSSGWVFGGGTKLTVL	IGHV4-59*01	IGHJ6*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGLV2-14*03	IGLJ3*02	ARAAGVRSVVAAASTHYYYYGLDV	SSYTSSGWV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
16	Wang-MOD1	Mod1_P1_IgG_A2-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGAAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAGGGGACTGGAGTGGATTGGGTATATCTATTACAGTGGGGGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGAGCCGCTGGAGTTCGTTCAGTAGTAGCAGCTGCTTCCACCTACTACCACTATTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCTVSGGSIRSYYWSWIRQPPGRGLEWIGYIYYSGGTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARAAGVRSVVAAASTYYHYYGMDVWGQGTTVTVSS	CAGTCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCGGTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSGWVFGGGTKLTVL	IGHV4-59*01	IGHJ6*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGLV2-14*03	IGLJ3*02	ARAAGVRSVVAAASTYYHYYGMDV	SSYTSSGWV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
16	Wang-MOD1	Mod1_P1_IgG_C3-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAGGGGACTGGAGTGGATTGGGTATATCTATTACAGTGGGGGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGAGCCGCTGGAGTTCGTTCAGTAGTAGCAGCTGCTTCTACCTACTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGRGLEWIGYIYYSGGTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARAAGVRSVVAAASTYYYYYGMDVWGQGTTVTVSS	CAGTCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACATTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCGGTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPASVSGSPGQSITISCTGTSSDIGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSGWVFGGGTKLTVL	IGHV4-59*01	IGHJ6*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGLV2-14*03	IGLJ3*02	ARAAGVRSVVAAASTYYYYYGMDV	SSYTSSGWV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
16	Wang-MOD1	Mod1_P1_IgG_G11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAGGGGACTGGAGTGGATTGGGTATATCTATTACAGTGGGGGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGAGCCGCTGGAGTTCGTTCAGTAGTAGCAGCTGCTTCTACCTACTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGRGLEWIGYIYYSGGTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARAAGVRSVVAAASTYYYYYGMDVWGQGTTVTVSS	CAGTCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCGGTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSGWVFGGGTKLTVL	IGHV4-59*01	IGHJ6*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGLV2-14*03	IGLJ3*02	ARAAGVRSVVAAASTYYYYYGMDV	SSYTSSGWV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
16	Wang-MOD1	Mod1_P2_IgG_A1-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATTACAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCTTGTATTACTGTGCGAGAGCCGCTGGAGTTCGTTCAGTAGTAGCAGCTGCTTCTACCTACTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTALYYCARAAGVRSVVAAASTYYYYYGMDVWGQGTTVTVSS	CAGTCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAATCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCGGTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPASVSGSPGQSITISCTGISSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSGWVFGGGTKLTVL	IGHV4-59*01	IGHJ6*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGLV2-14*03	IGLJ3*02	ARAAGVRSVVAAASTYYYYYGMDV	SSYTSSGWV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
16	Wang-MOD1	Mod1_P2_IgG_A12-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTCGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAGGGGACTGGAGTGGATTGGGTATATTTATTACAGTGGGGGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGAGCCGCTGGAGTTCGTTCAGTAGTAGCAGCTGCTTCTACCTACTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCTVSRGSISSYYWSWIRQPPGRGLEWIGYIYYSGGTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARAAGVRSVVAAASTYYYYYGMDVWGQGTTVTVSS	CAGTCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATGACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGCCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCGGTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPASVSGSPGQSITISCTGTSSDVGGYDYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSANTASLTISGLQAEDEADYYCSSYTSSGWVFGGGTKLTVL	IGHV4-59*01	IGHJ6*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGLV2-14*03	IGLJ3*02	ARAAGVRSVVAAASTYYYYYGMDV	SSYTSSGWV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
16	Wang-MOD1	Mod1_P2_IgG_A2-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAGGGGACTGGAGTGGATTGGGTATATCTATTACAGTGGGGGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGAGCCGCTGGAGTTCGTTCAGTAGTAGCAGCTGCTTCTACCTACTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGRGLEWIGYIYYSGGTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARAAGVRSVVAAASTYYYYYGMDVWGQGTTVTVSS	CAGTCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCGGTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSGWVFGGGTKLTVL	IGHV4-59*01	IGHJ6*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGLV2-14*03	IGLJ3*02	ARAAGVRSVVAAASTYYYYYGMDV	SSYTSSGWV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
16	Wang-MOD1	Mod1_P2_IgG_B12-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAGGGGACTGGAGTGGATTGGGTATATCTATTACAGTGGGGGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGAGCCGCTGGAGTTCGTTCAGTAGTAGCAGCTGCTTCTACCTACTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGRGLEWIGYIYYSGGTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARAAGVRSVVAAASTYYYYYGMDVWGQGTTVTVSS	CAGTCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCGGTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSGWVFGGGTKLTVL	IGHV4-59*01	IGHJ6*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGLV2-14*03	IGLJ3*02	ARAAGVRSVVAAASTYYYYYGMDV	SSYTSSGWV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
16	Wang-MOD1	Mod1_P2_IgG_D10-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTCGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAGGGGACTGGAGTGGATTGGGTATATTTATTACAGTGGGGGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGAGCCGCTGGAGTTCGTTCAGTAGTAGCAGCTGCTTCTACCTACTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCTVSRGSISSYYWSWIRQPPGRGLEWIGYIYYSGGTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARAAGVRSVVAAASTYYYYYGMDVWGQGTTVTVSS	CAGTCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATGACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGCCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCGGTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPASVSGSPGQSITISCTGTSSDVGGYDYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSANTASLTISGLQAEDEADYYCSSYTSSGWVFGGGTKLTVL	IGHV4-59*01	IGHJ6*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGLV2-14*03	IGLJ3*02	ARAAGVRSVVAAASTYYYYYGMDV	SSYTSSGWV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
16	Wang-MOD1	Mod1_P2_IgG_D9-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAGGGGACTGGAGTGGATTGGGTATATCTATTACAGTGGGGGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGAGCCGCTGGAGTTCGTTCAGTAGTAGCAGCTGCTTCTACCTACTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGRGLEWIGYIYYSGGTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARAAGVRSVVAAASTYYYYYGMDVWGQGTTVTVSS	CAGTCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACATTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCGGTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPASVSGSPGQSITISCTGTSSDIGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSGWVFGGGTKLTVL	IGHV4-59*01	IGHJ6*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGLV2-14*03	IGLJ3*02	ARAAGVRSVVAAASTYYYYYGMDV	SSYTSSGWV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
16	Wang-MOD1	Mod1_P2_IgG_F10-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAGGGGACTGGAGTGGATTGGGTATATCTATTACAGTGGGGGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGAGCCGCTGGAGTTCGTTCAGTAGTAGCAGCTGCTTCTACCTACTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGRGLEWIGYIYYSGGTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARAAGVRSVVAAASTYYYYYGMDVWGQGTTVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACATTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCGGTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSALTQPASVSGSPGQSITISCTGTSSDIGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSGWVFGGGTKLTVL	IGHV4-59*01	IGHJ6*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGLV2-14*03	IGLJ3*02	ARAAGVRSVVAAASTYYYYYGMDV	SSYTSSGWV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
16	Wang-MOD2	Mod2_P1_IgG_A4-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAGGGGACTGGAGTGGATTGGGTATATCTATTACAGTGGGGGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGAGCCGCTGGAGTTCGTTCAGTAGTAGCAGCTGCTTCAACCTACTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGRGLEWIGYIYYSGGTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARAAGVRSVVAAASTYYYYYGMDVWGQGTTVTVSS	CAGTCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACATTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCGGTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPASVSGSPGQSITISCTGTSSDIGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSGWVFGGGTKLTVL	IGHV4-59*01	IGHJ6*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGLV2-14*03	IGLJ3*02	ARAAGVRSVVAAASTYYYYYGMDV	SSYTSSGWV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
16	Wang-MOD2	Mod2_P1_IgG_E2-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAGGGGACTGGAGTGGATTGGGTATATCTATTACAGTGGGGGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTTTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGAGCCGCTGGAGTTCGTTCAGTAGTAGCAGCTGCTTCTACCTACTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGRGLEWIGYIYYSGGTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARAAGVRSVVAAASTYYYYYGMDVWGQGTTVTVSS	CAGTCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCGGTTGGGTGTTCGGCGGAGGGACCAAGGTGACCGTCCTAG	QSVLTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSGWVFGGGTKVTVL	IGHV4-59*01	IGHJ6*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGLV2-14*03	IGLJ3*02	ARAAGVRSVVAAASTYYYYYGMDV	SSYTSSGWV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
17	COV107	C163	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTACAGCAGTGGGGCGCAGGACTGTTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGGGTCACTCAGTGGTTTCTACTGGACCTGGATCCGCCAGCCCCCAGGAAAGGGGCTGGAGTGGATTGGGGAAACCAATCATTTTGGAAGCACCGACTACAAGCCGTCCCTCAAGAGTCGAGTCACCATATCAGTAGACATGTCCAGGAACCAGTTCTCCCTGAAGGTGACCTCTGTGACCGCCGCGGACACGGCTGTTTATTACTGTGCGAGAAAGCCCCTCCTCCACAGTGACTTATCTCCTGGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QVQLQQWGAGLLKPSETLSLTCAVSGGSLSGFYWTWIRQPPGKGLEWIGETNHFGSTDYKPSLKSRVTISVDMSRNQFSLKVTSVTAADTAVYYCARKPLLHSDLSPGAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGACTGTTTCCGCCAACTACTTAGCCTGGTACCAGCAGAAAGCTGGCCAGGCTCCCAGACTCCTCATCTATGGTGCATCCAAGAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCAGCATCAGCAGACTGGAGCCTGAAGATTTTGCTGTGTATTACTGTCAGCAGTATGTTACTACACCTCGGACTTTCGGCGGAGGGACCAAGGTGGAAATCAA	EIVLTQSPGTLSLSPGERATLSCRASQTVSANYLAWYQQKAGQAPRLLIYGASKRATGIPDRFSGSGSGTDFTLSISRLEPEDFAVYYCQQYVTTPRTFGGGTKVEI	IGHV4-34*01	IGHJ3*02	IGHD4-11*01,IGHD4-4*01	IGKV3-20*01	IGKJ4*01	ARKPLLHSDLSPGAFDI	QQYVTTPRT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
17	COV107	COV107_Plate2_HC_31-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTACAGCAGTGGGGCGCAGGACTGTTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGGGTCACTCAGTGGTTTCTACTGGACCTGGATCCGCCAGCCCCCAGGAAAGGGGCTGGAGTGGATTGGGGAAACCAATCATTTTGGAAGCACCGACTACAAGCCGTCCCTCAAGAGTCGAGTCACCATATCAGTAGACATGTCCAGGAACCAGTTCTCCCTGAAGGTGACCTCTGTGACCGCCGCGGACACGGCTGTTTATTACTGTGCGAGAAAGCCCCTCCTCCACAGTGACTTATCTCCTGGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCGCCGTCTCTTCAG	QVQLQQWGAGLLKPSETLSLTCAVSGGSLSGFYWTWIRQPPGKGLEWIGETNHFGSTDYKPSLKSRVTISVDMSRNQFSLKVTSVTAADTAVYYCARKPLLHSDLSPGAFDIWGQGTMVAVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGACTGTTTCCGCCAACTACTTAGCCTGGTACCAGCAGAAAGCTGGCCAGGCTCCCAGACTCCTCATCTATGGTGCATCCAAGAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCAGCATCAGCAGACTGGAGCCTGAAGATTTTGCTGTGTATTACTGTCAGCAGTATGTTACTACACCTCGGACTTTCGGCGGAGGGACCAAGGTGGAGATCAA	EIVLTQSPGTLSLSPGERATLSCRASQTVSANYLAWYQQKAGQAPRLLIYGASKRATGIPDRFSGSGSGTDFTLSISRLEPEDFAVYYCQQYVTTPRTFGGGTKVEI	IGHV4-34*01	IGHJ3*02	IGHD4-11*01,IGHD4-4*01	IGKV3-20*01	IGKJ4*01	ARKPLLHSDLSPGAFDI	QQYVTTPRT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
17	Shiakolas_Cellero	Shiakolas_5317-4	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV4-34	IGHJ3	nan	IGKV3-20	IGKJ2	ARKPLLHSSVNPGAFDI	QQYATSPRT	nan	Shiakolas et al. bioRxiv. DOI: 10.1101/2021.06.02.446813 (2021)	nan	nan
17	COV107	C103	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTACAGCAGTGGGGCGCAGGACTGTTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGGGTCACTCAGTGGTTTCTACTGGACCTGGATCCGCCAGCCCCCAGGAAAGGGGCTGGAGTGGATTGGGGAAACCAATCATTTTGGAAGCACCGGCTACAAGCCGTCCCTCAAGAGTCGAGTCACCATATCAGTAGACATGTCCAGGAACCAGTTCTCCCTGAAGGTGACCTCTGTGACCGCCGCGGACACGGCTGTGTATTACTGTGCGAGAAAGCCCCTCCTCTACAGTGACTTCTCTCCTGGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QVQLQQWGAGLLKPSETLSLTCAVSGGSLSGFYWTWIRQPPGKGLEWIGETNHFGSTGYKPSLKSRVTISVDMSRNQFSLKVTSVTAADTAVYYCARKPLLYSDFSPGAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGACTGTTACCGCCAACTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGACTCCTCATCTATGGTGCATCCAAGAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCAGCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATACTACTACACCTCGGACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQTVTANYLAWYQQKPGQAPRLLIYGASKRATGIPDRFSGSGSGTDFTLSISRLEPEDFAVYYCQQYTTTPRTFGGGTKVEIK	IGHV4-34*01	IGHJ3*02	IGHD4-11*01,IGHD4-17*01,IGHD4-4*01	IGKV3-20*01	IGKJ4*01	ARKPLLYSDFSPGAFDI	QQYTTTPRT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
17	COV107	COV107_Plate1_HC_11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTACAGCAGTGGGGCGCAGGACTGTTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGGGTCACTCAGTGGTTTCTACTGGACCTGGATCCGCCAGCCCCCAGGAAAGGGGCTGGAGTGGATTGGGGAAACCAATCATTTTGGAAGCACCGACTACAAGGCGTCCCTCAAGAGTCGAGTCACCATATCAGTAGGCATGTCCAGGAACCAATTTTCCCTGAAGGTGACTTCTCTGACCGCCGCGGACACGGCTGTGTATTACTGTGCGAGAAAGCCCCTCCTCTACAGTGACTTTTCTCCTGGTGCTTTTGATATCTGGGGCCAAGGGACAATGATCGTAGTCTCTTCAG	QVQLQQWGAGLLKPSETLSLTCAVSGGSLSGFYWTWIRQPPGKGLEWIGETNHFGSTDYKASLKSRVTISVGMSRNQFSLKVTSLTAADTAVYYCARKPLLYSDFSPGAFDIWGQGTMIVVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGACTCTTACCGCCAACTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGACTCCTCATCTATGGTGCATCCAAGAGGGCCGCTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCAGCATCACCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATCATACTACACCTCGGACTTTCGGCGGAGGGACCAAGGTGGAGATCAA	EIVLTQSPGTLSLSPGERATLSCRASQTLTANYLAWYQQKPGQAPRLLIYGASKRAAGIPDRFSGSGSGTDFTLSITRLEPEDFAVYYCQQYHTTPRTFGGGTKVEI	IGHV4-34*01	IGHJ3*02	IGHD4-11*01,IGHD4-17*01,IGHD4-4*01	IGKV3-20*01	IGKJ4*01	ARKPLLYSDFSPGAFDI	QQYHTTPRT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
17	COV107	COV107_Plate2_HC_53-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTACAGCAGTGGGGCGCAGGACTGTTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGGGTCACTCAGTGGTTTCTACTGGACCTGGATCCGCCAGCCCCCAGGAAAGGGGCTGGAGTGGATTGGGGAAACCAATCATTTTGGAAGCACCGGCTACAAGCCGTCCCTCAAGAGTCGAGTCACCATATCAGTAGACATGTCCAGGAACCAGTTCTCCCTGAAGGTGACCTCTGTGACCGCCGCGGACACGGCTGTGTATTACTGTGCGAGAAAGCCCCTCCTCTACAGTGACTTCTCTCCTGGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCGCCGTCTCTTCAG	QVQLQQWGAGLLKPSETLSLTCAVSGGSLSGFYWTWIRQPPGKGLEWIGETNHFGSTGYKPSLKSRVTISVDMSRNQFSLKVTSVTAADTAVYYCARKPLLYSDFSPGAFDIWGQGTMVAVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGACTGTTACCGCCAACTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGACTCCTCATCTATGGTGCATCCAAGAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCAGCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATACTACTACACCTCGGACTTTCGGCGGAGGGACCAAGGTGGAGATCAA	EIVLTQSPGTLSLSPGERATLSCRASQTVTANYLAWYQQKPGQAPRLLIYGASKRATGIPDRFSGSGSGTDFTLSISRLEPEDFAVYYCQQYTTTPRTFGGGTKVEI	IGHV4-34*01	IGHJ3*02	IGHD4-11*01,IGHD4-17*01,IGHD4-4*01	IGKV3-20*01	IGKJ4*01	ARKPLLYSDFSPGAFDI	QQYTTTPRT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
17	COV107	C162	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTACAGCAGTGGGGCGCAGGACTGTTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGGGTCACTCAGTGGTTTCTACTGGACCTGGATCCGCCAGCCCCCAGGAAAGGGGCTGGAGTGGATTGGGGAAACCAATCATTTTGGAAGCACCGACTACAAGGCGTCCCTCAAGAGTCGAGTCACCATATCAGTAGGCATGTCCAGGAACCAATTTTCCCTGAAGGTGACTTCTCTGACCGCCGCGGACACGGCTGTGTATTACTGCGCGAGAAAGCCCCTCCTCTACAGTGACTTTTCTCCTGGTGCTTTTGATGTCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QVQLQQWGAGLLKPSETLSLTCAVSGGSLSGFYWTWIRQPPGKGLEWIGETNHFGSTDYKASLKSRVTISVGMSRNQFSLKVTSLTAADTAVYYCARKPLLYSDFSPGAFDVWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGACTCTTACCGCCAACTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGACTCCTCATCTATGGTGCATCCAAGAGGGCCGCTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCAGCATCACCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATCATACTACACCTCGGACTTTCGGCGGAGGGACCAAGGTGGAGATCAA	EIVLTQSPGTLSLSPGERATLSCRASQTLTANYLAWYQQKPGQAPRLLIYGASKRAAGIPDRFSGSGSGTDFTLSITRLEPEDFAVYYCQQYHTTPRTFGGGTKVEI	IGHV4-34*01	IGHJ3*01	IGHD4-11*01,IGHD4-17*01,IGHD4-4*01	IGKV3-20*01	IGKJ4*01	ARKPLLYSDFSPGAFDV	QQYHTTPRT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
17	Cho-C030	C1304	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:non-RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTACAGCAGTGGGGCGCAGGACTGTTGAAGCCTTCGGAGACCCTGTCCCTCTCCTGCGCTGTCTATGGTGGGTCCCTCAGTGGTTACTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGGAGATCAATCATTTTGGAAGCACCGGCTACAACCCGTCCCTCAAGAGTCGAGTCACCATCTCCGTGGACACGTCCAAGAGCCAGTTCTCCGTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCTGTCTATTACTGCGCGAGAAAGCCCCTCCTCTACAGTAACTTATCCCCTGGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QVQLQQWGAGLLKPSETLSLSCAVYGGSLSGYYWSWIRQPPGKGLEWIGEINHFGSTGYNPSLKSRVTISVDTSKSQFSVKLSSVTAADTAVYYCARKPLLYSNLSPGAFDIWGQGTMVTVSS	TCCTATGAGCTGACTCAGCCACCCTCGGTGTCAGTGTCCCCAGGACAGACGGCCAGGATCACCTGCTCTGGAGATGCATTGCCAAAGCAATATGCTTATTGGTACCAGCAGAAGCCAGGCCAGGCCCCTGTGCTGGTGATATATAAAGACAGTGAGAGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAGCTCAGGGACAACAGTCACGTTGACCATCAGTGGAGTCCAGGCAGAAGACGAGGCTGACTATTACTGTCAATCAGCAGACAGCAGTGGTACTTATTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	SYELTQPPSVSVSPGQTARITCSGDALPKQYAYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSSGTYWVFGGGTKLTVL	IGHV4-34*01	IGHJ3*02	IGHD4-11*01,IGHD4-4*01	IGLV3-25*03	IGLJ3*02	ARKPLLYSNLSPGAFDI	QSADSSGTYWV	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
17	Cho-C016	C2238	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTACAGCAGTGGGGCGCAGGACTGTTGAAGCCTTCGGAGACCCTGTCCCTCTCCTGCGCTGTCTATGGTGGGTCCCTCAGTGGTTACTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGGAGATCAATCATTTTGGAAGCACCGGCTACAACCCGTCCCTCAAGAGTCGAGTCACCATCTCCGTGGACACGTCCAAGAGCCAGTTCTCCGTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCTGTCTATTACTGCGCGAGAAAGCCCCTCCTCTACAGTAACTTATCCCCTGGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QVQLQQWGAGLLKPSETLSLSCAVYGGSLSGYYWSWIRQPPGKGLEWIGEINHFGSTGYNPSLKSRVTISVDTSKSQFSVKLSSVTAADTAVYYCARKPLLYSNLSPGAFDIWGQGTMVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATCACTATGTCTATGTCTCCTGGTACCAACAGCACCCAGGCAAAGCCCCCAAACTCATGATTTATGAGGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCAGCGCCCTTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSALTQPASVSGSPGQSITISCTGTSSDVGGYHYVYVSWYQQHPGKAPKLMIYEVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSALWVFGGGTKLTVL	IGHV4-34*01	IGHJ3*02	IGHD4-11*01,IGHD4-4*01	IGLV2-14*01	IGLJ3*02	ARKPLLYSNLSPGAFDI	SSYTSSSALWV	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
17	COV107	C104	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTACAGCAGTGGGGCGCAGGACTGTTGAAGCCTTCGGAGACCCTGTCCCTCTCCTGCGCTGTCTATGGTGGGTCCCTCAGTGGTTACTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGGAGATCAATCATTTTGGAAGCACCGGCTACAACCCGTCCCTCAAGAGTCGAGTCACCATCTCCGTGGACACGTCCAAGAGCCAGTTCTCCGTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCTGTCTATTACTGCGCGAGAAAGCCCCTCCTCTACAGTAACTTATCCCCTGGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QVQLQQWGAGLLKPSETLSLSCAVYGGSLSGYYWSWIRQPPGKGLEWIGEINHFGSTGYNPSLKSRVTISVDTSKSQFSVKLSSVTAADTAVYYCARKPLLYSNLSPGAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCGTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCTGGGCCAGTCAGAGTGTTAGCGCCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGTAGACTGGAGCCTGAAGATTTTGCAGTATATTACTGTCAGCAGTACGGTACTACACCTCGGACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	EIVLTQSPGTVSLSPGERATLSCWASQSVSASYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGTTPRTFGGGTKVEIK	IGHV4-34*01	IGHJ3*02	IGHD4-11*01,IGHD4-4*01	IGKV3-20*01	IGKJ4*01	ARKPLLYSNLSPGAFDI	QQYGTTPRT	7K8U	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
17	COV107	COV107_Plate1_HC_42-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTACAGCAGTGGGGCGCAGGACTGTTGAAGCCTTCGGAGACCCTGTCCCTCTCCTGCGCTGTCTATGGTGGGTCCCTCAGTGGTTACTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGGAGATCAATCATTTTGGAAGCACCGGCTACAACCCGTCCCTCAAGAGTCGAGTCACCATCTCCGTGGACACGTCCAAGAGCCAGTTCTCCGTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCTGTCTATTACTGTGCGAGAAAGCCCCTCCTCTACAGTAACTTATCCCCTGGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QVQLQQWGAGLLKPSETLSLSCAVYGGSLSGYYWSWIRQPPGKGLEWIGEINHFGSTGYNPSLKSRVTISVDTSKSQFSVKLSSVTAADTAVYYCARKPLLYSNLSPGAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCTGGGCCAGTCAGAGTGTTAGCGCCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGTAGACTGGAGCCTGAAGATTTTGCAGTATATTACTGTCAGCAGTACGGTACTACACCTCGGACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	EIVLTQSPGTLSLSPGERATLSCWASQSVSASYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGTTPRTFGGGTKVEIK	IGHV4-34*01	IGHJ3*02	IGHD4-11*01,IGHD4-4*01	IGKV3-20*01	IGKJ4*01	ARKPLLYSNLSPGAFDI	QQYGTTPRT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
17	COV107	C161	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTACAGCAGTGGGGCGCAGGACTGTTGAAGCCTTCGGAGACCCTGTCTCTCACCTGCGCTGTCTCTGGTGGGTCACTCAGTGGTTTCTACTGGACCTGGATCCGCCAGCCCCCCGGAAAGGGGCTGGAGTGGATTGGGGAAACCAATCATTTTGGAAGCACCGACTACAAGCCGTCCCTCAAGAGTCGAGTCACCATATCAGTAGACATGTCCAGGAACCAATTTTCCCTGATTATGACCTCTGTGACCGCCGCGGACACGGCTGTGTATTACTGTGCGAGAAAGACCCTCCTCTTCAGTGACTTTTCTCCTGGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QVQLQQWGAGLLKPSETLSLTCAVSGGSLSGFYWTWIRQPPGKGLEWIGETNHFGSTDYKPSLKSRVTISVDMSRNQFSLIMTSVTAADTAVYYCARKTLLFSDFSPGAFDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGACTCTTACCGCCAACTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGACTCCTCATCTATGGTGCATCCAAGAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCAGCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTACTACACCTCGGACTTTCGGCGGAGGGACCAAGGTGGAAATCAA	EIVLTQSPGTLSLSPGERATLSCRASQTLTANYLAWYQQKPGQAPRLLIYGASKRATGIPDRFSGSGSGTDFTLSISRLEPEDFAVYYCQQYGTTPRTFGGGTKVEI	IGHV4-34*01	IGHJ3*02	IGHD2-21*02,IGHD4-17*01	IGKV3-20*01	IGKJ4*01	ARKTLLFSDFSPGAFDI	QQYGTTPRT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
17	COV107	COV107_Plate1_HC_84-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTACAGCAGTGGGGCGCAGGACTGTTGAAGCCTTCGGAGACCCTGTCTCTCACCTGCGCTGTCTCTGGTGGGTCACTCAGTGGTTTCTACTGGACCTGGATCCGCCAGCCCCCCGGAAAGGGGCTGGAGTGGATTGGGGAAACCAATCATTTTGGAAGCACCGACTACAAGCCGTCCCTCAAGAGTCGAGTCACCATATCAGTAGACATGTCCAGGAACCAATTTTCCCTGATTATGACCTCTGTGACCGCCGCGGACACGGCTGTGTATTACTGTGCGAGAAAGACCCTCCTCTTCAGTGACTTTTCTCCTGGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCGTAGTCTCTTCAG	QVQLQQWGAGLLKPSETLSLTCAVSGGSLSGFYWTWIRQPPGKGLEWIGETNHFGSTDYKPSLKSRVTISVDMSRNQFSLIMTSVTAADTAVYYCARKTLLFSDFSPGAFDIWGQGTMVVVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGACTCTTACCGCCAACTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGACTCCTCATCTATGGTGCATCCAAGAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCAGCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTACTACACCTCGGACTTTCGGCGGAGGGACCAAGGTGGAGATCAA	EIVLTQSPGTLSLSPGERATLSCRASQTLTANYLAWYQQKPGQAPRLLIYGASKRATGIPDRFSGSGSGTDFTLSISRLEPEDFAVYYCQQYGTTPRTFGGGTKVEI	IGHV4-34*01	IGHJ3*02	IGHD2-21*02,IGHD4-17*01	IGKV3-20*01	IGKJ4*01	ARKTLLFSDFSPGAFDI	QQYGTTPRT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
18	IML3550	ADI-60750	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTACAGCCTCTGGATTCACTTTCAATCTCTATTGGATGAGTTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTGGCCAACATAAAGCAAGATGGAAGTGAGAAATACTATGTGGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAAGTCAGTGTTCCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGGGACTCAGTAGCAGTGCCTGGTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACTGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCTASGFTFNLYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKKSVFLQMNSLRAEDTAVYYCAGLSSSAWYFDYWGQGTLVTVSS	nan	nan	IGHV3-7*01	IGHJ4*02	IGHD6-19*01	IGLV3-1	nan	AGLSSSAWYFDY	QAWGSSTGV	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458019.1	nan
18	Chen_Vax_p1	COV2-vax-46	nan	SARS-CoV-2	nan	nan	nan	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTCCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGTAGCTATTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTGGCCAACATAAAGCAAGATGGAAGTGAGAAATACTATGTGGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGACTGTCTAGCAGCAGCTGGTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLSSSSWYFDYWGQGTLVTVSS	TCCTATGAGCTGACTCAGCCACCCTCAGTGTCCGTGTCCCCAGGACAGACAGCCAGCATCACCTGCTCTGGAGATAAATTGGGGGATAAATATGCTTGCTGGTATCAGCAGAAGCCAGGCCAGTCCCCTGTGCTGGTCATCTATCAAGATAGCAAGCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACAGCCACTCTGACCATCAGCGGGACCCAGGCTATGGATGAGGCTGACTATTACTGTCAGGCGTGGGACAGCAGCACTGGAGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQKPGQSPVLVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTGVFGTGTKVTVL	IGHV3-7*01	IGHJ4*02	IGHD6-13*01	IGLV3-1*01	IGLJ1*01	ARLSSSSWYFDY	QAWDSSTGV	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555594.1	MZ555595.1
18	Crowe_mix	COV2-2333	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCATCTATTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGCAGTGGGTGGCCAACATAAAGCAAGATGCAAGTGAGAAATACTATGTGGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGACTGGGGGGCAGCAGCTGGCATTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGFTFSIYWMSWVRQAPGKGLQWVANIKQDASEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLGGSSWHFDYWGQGTLVTVSS	TCCTATGAGCTGACTCAGCCACCCTCAGTGTCCGTGTCCCCAGGACAGACAGCCAGCATCACCTGCTCTGGAGATAAATTGGGAGATAAATATTCTTCCTGGTATCAGCAGAAGCCAGGCCAGTCCCCTGTGCTGGTCATCTATGAAGATACCAAGCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACAGCCACTCTGACCATCAGCGGGACCCAGGCTATGGATGAGGCTGACTATTACTGTCAGGCGTGGAGCAGCAGCACTGCGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTA	SYELTQPPSVSVSPGQTASITCSGDKLGDKYSSWYQQKPGQSPVLVIYEDTKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWSSSTAVFGGGTKLTVL	IGHV3-7*01	IGHJ4*02	IGHD6-13*01	IGLV3-1*01	IGLJ3*02	ARLGGSSWHFDY	QAWSSSTAV	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665750.1	MT665363.1
18	Li_SARS2_26	H026080+L024040	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:S2	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASGFTFSFYWMSWVRQAPGKGLEWVANIKQDGGEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYFCARLGGSSWYWDYWGQGTLVTVSS	nan	SYELTQPPSVSVSPGQTASITCSGDKLGDKYVCWYQQKPGQSPVLVIYQDTKRPSGIPERFSGANSGNTATLTISGTQAMDEADYYCQAWDSSTGVIGGGTKLTVL	IGHV3-7*01	IGHJ4	nan	IGLV3-1*01	IGLJ3	ARLGGSSWYWDY	QAWDSSTGV	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
18	Crowe_mix	COV2-2406	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGTTCCCTGAGACTCTCCTGTGCAGACTCTGCATTCACCTTTAGTAGTTTTTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTGGCCAACATAAAGCAAGATGGAAGTGAGAAATTCTATTTGGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGACTAGGTCGCAGCAGCTGGAACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCADSAFTFSSFWMSWVRQAPGKGLEWVANIKQDGSEKFYLDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLGRSSWNFDYWGQGTLVTVSS	TCCTATGAACTGACTCAGCCACCCTCAGTGTCCGTGTCCCCAGGACAGACAGCCAGCATCACCTGCTCTGGAGATAAATTGGGGGATAAGTTTGTTTGCTGGTATCAGCAGAAGCCAGGCCAGTCCCCTGTCCTGGTCATCTATCAAGATAACAAGCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACAGCCACTCTGACCATCAGCGGGACCCAGGCTCTGGATGAGGCTGACTATTACTGTCAGGCGTGGGACAGCAGCACTGGGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTA	SYELTQPPSVSVSPGQTASITCSGDKLGDKFVCWYQQKPGQSPVLVIYQDNKRPSGIPERFSGSNSGNTATLTISGTQALDEADYYCQAWDSSTGVFGGGTKLTVL	IGHV3-7*01	IGHJ4*02	IGHD6-13*01	IGLV3-1*01	IGLJ2*01,IGLJ3*01	ARLGRSSWNFDY	QAWDSSTGV	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665771.1	MT665384.1
18	Chen_Vax_p1	COV2-vax-55	nan	SARS-CoV-2	nan	nan	nan	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGTAGCTATTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTGGCCAACATAAAGCAAGATGGAAGTGAGAAATACTATGTGGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGACTGTCTGGTGGGAGCTGGCACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLSGGSWHFDYWGQGTLVTVSS	TCCTATGAGCTGACTCAGCCACCCTCAGTGTCCGTGTCCCCAGGACAGACAGCCAGCATCACCTGCTCTGGAGATAAATTGGGGGATAAATATGCTTGCTGGTATCAGCAGAAGCCAGGCCAGTCCCCTGTGCTGGTCATCTATCAAGATAGCAAGCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACAGCCACTCTGACCATCAGCGGGACCCAGGCTATGGATGAGGCTGACTATTACTGTCAGGCGTGGGACAGCAGCACTGGGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQKPGQSPVLVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTGVFGGGTKLTVL	IGHV3-7*01	IGHJ4*02	IGHD2-15*01	IGLV3-1*01	IGLJ2*01,IGLJ3*01	ARLSGGSWHFDY	QAWDSSTGV	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555612.1	MZ555613.1
18	Crowe_mix	COV2-2171	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGTAGCCTCTGGATTCACCTTTAGTTTCTATTGGATGAGCTGGGTCCGCCAGGCTCCAGGAAAGGGGCTCGAGTGGGTGGCCAACATAAAGCAAGATGGAGGTGAGAAATACTATGTGGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGACTGTCTGGCAGCAGCTGGGACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCVASGFTFSFYWMSWVRQAPGKGLEWVANIKQDGGEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLSGSSWDFDYWGQGTLVTVSS	TCCTATGAGCTGACTCAGCCACCCTCAGTGTCCGTGTCCCCAGGACAGACAGCCAGCATCACCTGCTCTGGAGATAAATTGGGGGATAAATATGCTTGTTGGTACCAACAGAGGCCAGGCCAGTCCCCTGTGCTGGTCATCTATCAAGATAGTAAGCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACAGCCACTCTGACCATCAGCGGGACCCAGGCTATGGATGAGGCTGACTATTACTGTCAGGCGTGGGACAGCAGCACTGGAGTCTTCGGAACTGGGACCAAGGTCACCGTCCTA	SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQRPGQSPVLVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTGVFGTGTKVTVL	IGHV3-7*01	IGHJ4*02	IGHD6-13*01	IGLV3-1*01	IGLJ1*01	ARLSGSSWDFDY	QAWDSSTGV	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665792.1	MT665405.1
18	Crowe_mix	COV2-2175	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGTAGCCTCTGGATTCACCTTTAGTTTCTATTGGATGAGCTGGGTCCGCCAGGCTCCAGGAAAGGGGCTCGAGTGGGTGGCCAACATAAAGCAAGATGGAGGTGAGAAATACTATGTGGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGACTGTCTGGCAGCAGCTGGGACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCVASGFTFSFYWMSWVRQAPGKGLEWVANIKQDGGEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLSGSSWDFDYWGQGTLVTVSS	TCCTATGAGCTGACACAGCCACCCTCAGTGTCCGTGTCCCCAGGACAGACAGCCAGCATCACCTGCTCTGGAGATAAATTGGGGGATAAATATGCTTGTTGGTACCAACAGAGGCCAGGCCAGTCCCCTGTGCTGGTCATCTATCAAGATAGTAAGCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACAGCCACTCTGACCATCAGCGGGACCCAGGCTATGGATGAGGCTGACTATTACTGTCAGGCGTGGGACAGCAGCACTGGAGTCTTCGGAACTGGGACCAAGGTCACCGTCCTA	SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQRPGQSPVLVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTGVFGTGTKVTVL	IGHV3-7*01	IGHJ4*02	IGHD6-13*01	IGLV3-1*01	IGLJ1*01	ARLSGSSWDFDY	QAWDSSTGV	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665804.1	MT665417.1
18	Crowe_mix	COV2-2397	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGTAGCCTCTGGATTCACCTTTAGTTTCTATTGGATGAGCTGGGTCCGCCAGGCTCCAGGAAAGGGGCTCGAGTGGGTGGCCAACATAAAGCAAGATGGAGGTGAGAAATACTATGTGGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGACTGTCTGGCAGCAGCTGGGACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCVASGFTFSFYWMSWVRQAPGKGLEWVANIKQDGGEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLSGSSWDFDYWGQGTLVTVSS	TCCTATGAGCTGACTCAGCCACCCTCAGTGTCCGTGTCCCCAGGACAGACAGCCAGCATCACCTGCTCTGGAGATAAATTGGGGGATAAATATGCTTGTTGGTACCAACAGAGGCCAGGCCAGTCCCCTGTGCTGGTCATCTATCAAGATAGTAAGCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACAGCCACTCTGACCATCAGCGGGACCCAGGCTATGGATGAGGCTGACTATTACTGTCAGGCGTGGGACAGCAGCACTGGAGTCTTCGGAACTGGGACCAAGGTCACCGTCCTA	SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQRPGQSPVLVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTGVFGTGTKVTVL	IGHV3-7*01	IGHJ4*02	IGHD6-13*01	IGLV3-1*01	IGLJ1*01	ARLSGSSWDFDY	QAWDSSTGV	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665755.1	MT665368.1
18	Tong_C15	C15C10	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike (and spike minus RBD)	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGTAGCTATTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTGGCCAACATAAAGCAAGATGGAAGTGAGAAATACTATGTGGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGTCTCGGGCAGCAGCTGGCACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVSGSSWHFDYWGQGTLVTVSS	TCCTATGAGCTGACTCAGCCACCCTCAGTGTCCGTGTCCCCAGGACAGACAGCCAGCATCACCTGCTCTGGAGATAAATTGGGGGATAAATATGCTTGCTGGTATCAGCAGAAGCCAGGCCAGTCCCCTGTGCTGGTCATCTATCAAGATAGCAAGCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACAGCCACTCTGACCATCAGCGGGACCCAGGCTATGGATGAGGCTGACTATTACTGTCAGGCGTGGGACAGCAGCACTGCGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTA	SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQKPGQSPVLVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTAVFGGGTKLTVL	IGHV3-7*01	IGHJ4*02	IGHD6-13*01	IGLV3-1*01	IGLJ2*01,IGLJ3*01	ARVSGSSWHFDY	QAWDSSTAV	nan	Tong et al. Cell 184:4969-4980.e15 (2021)	MW718470.1	MW718622.1
18	Jennewein_CV3	CV3-44	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACTTTTAGTAGTTATTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTGGCCAACATAAAGCAAGATGGAAGTGAGAAATACTATGTGGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGTGGGACTCAGCAGCTGGTATTTTGAATACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVGLSSWYFEYWGQGTLVTVSS	CAGTCTGCCCTGACTCAGCCACCCTCAGTGTCCGTGTCCCCAGGACAGACAGCCAGCATCACCTGCTCTGGAGATAAATTGGGGGATAAATATGTTTGTTGGTATCAGCAGAAGCCAGGCCAGTCCCCTGTGCTGGTCATCTATCAAGATACCAAGCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACAGCCACTCTGACCATCAGCGGGACCCAGACTATGGATGAGGCTGACTATTACTGTCAGGCGTGGGACAGCAGCACTGGGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTA	QSALTQPPSVSVSPGQTASITCSGDKLGDKYVCWYQQKPGQSPVLVIYQDTKRPSGIPERFSGSNSGNTATLTISGTQTMDEADYYCQAWDSSTGVFGGGTKLTVL	IGHV3-7*01	IGHJ4*02	IGHD6-13*01	IGLV3-1*01	IGLJ2*01,IGLJ3*01	ARVGLSSWYFEY	QAWDSSTGV	nan	Jennewein et al. Cell Rep. 36:109353 (2021)	MW681581.1	MW681609.1
18	Crowe_mix	COV2-2002	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASGFTFSFYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRSTISRDNAKNSLYLQMNSLRAEDTAVYYCARVGSSSWYFDYWGQGTLVTVSS	nan	SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQKPGQSPVLVIYQDIKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTGVFGGGTKLTVL	IGHV3-7*01	IGHJ4	nan	IGLV3-1*01	IGLJ3	ARVGSSSWYFDY	QAWDSSTGV	nan	Chen et al. Cell Rep. 36:109604 (2021)	nan	nan
18	Crowe_mix	COV2-2178	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTAAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGTACCTATTGGATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTGGCCAACATAAAGCAAGATGGAAGTGAGAAATACTATGTGGACTCTGTTAAGTACCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGTCGGGAGCAGCAGCTGGTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGFTFSTYWMTWVRQAPGKGLEWVANIKQDGSEKYYVDSVKYRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVGSSSWYFDYWGQGTLVTVSS	TCCTATGAACTGACTCAGCCACCCTCAGTGTCCGTGTCCCCAGGACAGACAGCCAGCATCACCTGCTCTGGAGATAAATTGGGGGATAAATATGCTTGCTGGTATCAGCAGAAGCCAGGCCAGTCCCCTGTGGTGGTCATCTATCAAGATAGCAAGCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACAGCCACTCTGACCATCAGCGGGACCCAGGCTATGGATGAGGCTGACTATTACTGTCAGGCGTGGGACAGCAGCACTGCGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTA	SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQKPGQSPVVVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTAVFGGGTKLTVL	IGHV3-7*01	IGHJ4*02	IGHD6-13*01	IGLV3-1*01	IGLJ2*01,IGLJ3*01	ARVGSSSWYFDY	QAWDSSTAV	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665796.1	MT665409.1
19	PVI.V6	PVI.V6-13	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	nan	nan	nan	nan	IGHV3-30	IGHJ4	IGHD5-18	IGKV1-33	IGKJ3	AKAGYSYAYGDYYFDY	QHYDNLPPAVT	nan	Amanat et al. Cell 184:3936-3948.e10 (2021)	nan	nan
19	Graham_P008	P008_036	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTGGTAGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATGAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGTTGAGGACACGGCTGTGTATTACTGTGCGAAAAAAGGATACAGCTATGGTTACTTTGATTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCATCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVAVISYDGSNEYYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCAKKGYSYGYFDYYFDYWGQGTLVTISS	GATATTGTGATGACTCAGACTCCACTCTCTCTGTCCGTCACCCCTGGGCAGCCGGCCTCCATCTCCTGCAAGTCTAGTCAGAGCCTCCTGCATAGTGATGGAAAGACCTATTTGTATTGGTACCTGCAGAGGCCAGGCCAGCCTCCACAGCTCCTGATCTATGAGGTTTCTGACCGGTTCTCTGGAGTGCCAGATAGGTTCAGTGGCAGCGGGTCAGGGACAGATTTCACACTGAAAATCAGCCGGGTGGAGGCTGAGGATGTTGGGGTTTATTACTGCATGCAAAGTATCCAGCTTCCGGTCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	DIVMTQTPLSLSVTPGQPASISCKSSQSLLHSDGKTYLYWYLQRPGQPPQLLIYEVSDRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQSIQLPVTFGQGTRLEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGKV2D-29*01	IGKJ5*01	AKKGYSYGYFDYYFDY	MQSIQLPVT	nan	Graham et al. Immunity 54:1276-1289.e6 (2021)	MW802424.1	MW802317.1
19	Graham_P008	P008_044	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATGAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGTTGAGGACACGGCTGTGTATTACTGTGCGAAAAAAGGATACAGCTATGGTTACTTTGATTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCTTCAG	EVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVAVISYDGSNEYYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCAKKGYSYGYFDYYFDYWGQGTLVTVSS	GATGTTGTGATGACCCAGACTCCACTCTCTCTGTCCGTCACCCCTGGACAGCCGGCCTCCATCTCCTGCAAGTCTAGTCAGAGCCTCCTGCATAGTGATGGAAAGACCTATTTGTATTGGTACCTGCAGAGGCCAGGCCAGCCTCCACAGCTCCTGATCTATGAGGTTTCTGACCGGTTCTCTGGAGTGCCAGATAGGTTCAGTGGCAGCGGGTCAGGGACAGATTTCACACTGAAAATCAGCCGGGTGGAGGCTGAGGATGTTGGGGTTTATTACTGCATGCAAAGTATCCAGCTTCCGGTCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	DVVMTQTPLSLSVTPGQPASISCKSSQSLLHSDGKTYLYWYLQRPGQPPQLLIYEVSDRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQSIQLPVTFGQGTRLEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGKV2D-29*01	IGKJ5*01	AKKGYSYGYFDYYFDY	MQSIQLPVT	nan	Graham et al. Immunity 54:1276-1289.e6 (2021)	MW802429.1	MW802322.1
19	Wheatley-CP8	PDI_64	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTATGGCATACACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGACAATTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAGGGCGGTTACGGCTATGGTTACCAGGCCTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGIHWVRQAPGKGLEWVTIISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGGYGYGYQAYYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATTCTCCCTGTCTGCATCTGTAGGAGACCGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGCAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCGATCACCTTCGGCCAAGGGACACGACTGGAGATTAAA	DIQMTQSPFSLSASVGDRVTITCQASQDISNYLNWYQQQPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPITFGQGTRLEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGKV1-33*01,IGKV1D-33*01	IGKJ5*01	AKGGYGYGYQAYYFDY	QQYDNLPIT	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
19	COV096	COV096_HC_149-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAGGCGGATACAGCTATGGTTACAGTTTGTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGGYSYGYSLYYFDYWGQGTLVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGCACCAACAGCACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCAGCACCCTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWHQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTLVFGGGTKLTVL	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGLV2-14*01,IGLV2-14*03	IGLJ2*01,IGLJ3*01	AKGGYSYGYSLYYFDY	SSYTSSSTLV	nan	Robbiani et al. Nature 584:437-442 (2020);Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW293173.1	MW293628.1
19	Cho-C034	C2059	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	AGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAGTCGGATACAGCTATGGTTACTCTTATAACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	VQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKVGYSYGYSYNYFDYWGQGTLVTVSS	CATCCGGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCTCCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	IRMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPPYTFGQGTKLEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGKV1-33*01,IGKV1D-33*01	IGKJ2*01	AKVGYSYGYSYNYFDY	QQYDNLPPYT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
19	COV107	COV107_Plate1_HC_43-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTATTGTGCGAAAGCGGGATACAGCTATGGTTACCCCCAACAATACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKAGYSYGYPQQYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTATTAGTAGCTGGTTGGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAACTCCTGATCTCTGAGGCGTCTAGTTTAGAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACCATCAGCAGCCTGCAGCCTGATGATTTTGCAACTTATTACTGCCAACAGTATAATAGTTATTCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLISEASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSYTFGQGTKLEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGKV1-5*03	IGKJ2*01	AKAGYSYGYPQQYFDY	QQYNSYSYT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
19	Chen_Vax_p1	COV2-vax-62	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATCCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAGGGGGATACAGCTATGGTTATCCGGTGTTCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGIHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGGYSYGYPVFYFDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCGGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCAGCTCTGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSSVVFGGGTKLTVL	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGLV6-57*02	IGLJ2*01,IGLJ3*01	AKGGYSYGYPVFYFDY	QSYDSSSVV	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555526.1	MZ555527.1
19	Aishun_Jin_mix	8B2D11	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV3-33*01	IGHJ4*02	IGHD5-18*01	IGKV1-33*01	IGKJ2*02	AKNGYSYAYPRQYFDY	QHYDNLKVT	nan	Han et al. Front Immunol. 12:653189 (2021)	nan	nan
19	Aishun_Jin_mix	CQTS188	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGATGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAACTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAATGGGTGGCAGTAATATGGTATGATGGAACTAATGAAAAATATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAGTGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAAAAATGGATACAGCTATGCTTACCCACGGCAGTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLMESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVAVIWYDGTNEKYADSVKGRFTISRDNSKNTLYLQVNSLRAEDTAVYYCAKNGYSYAYPRQYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACGATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTCCGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACACTATGATAATCTCAAGGTCACTTTTGGCCAGGGGACCAAACTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNDLNWYQQKPGKAPKLLISDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQHYDNLKVTFGQGTKLEIK	IGHV3-33*06	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGKV1-33*01,IGKV1D-33*01	IGKJ2*01,IGKJ2*02	AKNGYSYAYPRQYFDY	QHYDNLKVT	nan	Patent: CN111925444A	MW587634.1	MW587635.1
19	Tong_C12	C12E7	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike (and spike minus RBD)	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAAGCGGATACAGCTATGCTTACCCAATGGTCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKSGYSYAYPMVYFDYWGQGTLVTVSS	TCCTATGAGCTGACTCAGCCACCCTCGGTGTCAGTGGCCCCAGGAAAGACGGCCAGGATTACCTGTGGGGGAAACAACATTGGAAGTAAAAGTGTGCACTGGTACCAGCAGAAGCCAGGCCAGGCCCCTGTGCTGGTCGTCTATGATGATAGCGACCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACGGCCACCCTGACCATCAGCAGGGTCGAAGCCGGGGATGAGGCCGACTATTACTGTCAGGTGTGGGATAGTAGTAGTGATCATCCAGGGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTA	SYELTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHPGVFGGGTKLTVL	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGLV3-21*03	IGLJ2*01,IGLJ3*01	AKSGYSYAYPMVYFDY	QVWDSSSDHPGV	nan	Tong et al. Cell 184:4969-4980.e15 (2021)	MW718386.1	MW718538.1
20	COV096	COV096_HC_48-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTGTATTACTGTGCGAGAGCCTCTGGGCTAAGGAGCTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSYISSSSSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYCARASGLRSYYYYGMDVWGQGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCTGCGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPATFGQGTKVEIK	IGHV3-48*02	IGHJ6*02	IGHD4/OR15-4a*01,IGHD4/OR15-4b*01,IGHD5-12*01	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	ARASGLRSYYYYGMDV	QQSYSTPAT	nan	Robbiani et al. Nature 584:437-442 (2020);Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW293118.1	MW293573.1
20	Wang-MOD2	Mod2_P2_IgG_D7-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTGTATTACTGTGCGAGACATTCAGGAGCTACCTCCTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSYISSSSSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYCARHSGATSYYYYGMDVWGQGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGGTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCGGGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYGASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPGTFGQGTKVEIK	IGHV3-48*02	IGHJ6*02	IGHD1-26*01	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	ARHSGATSYYYYGMDV	QQSYSTPGT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
20	Cho-C030	C1413	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTGCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTTCTTATAACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTGGTACTAGTACTACCATATACTATGCAGACTCTGTGCAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTATATTACTGTGCGAGAGGACTGGGACCTAAGTCCTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYNMNWVRQAPGKGLEWVSYISGTSTTIYYADSVQGRFTISRDNAKNSLYLQMNSLRDEDTAVYYCARGLGPKSYYYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCAACATCGCTTGTCGGGCAAGTCAGAGCATTGCCAGTTATTTAAGTTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTCTGGTGCATCCAGTTTGCAAGGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGTGGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGACTTACAGTACCCCTCAGGTTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQLTQSPSSLSASVGDRVNIACRASQSIASYLSWYQQKPGKAPKLLISGASSLQGGVPSRFSGSGSGTDFTLTISGLQPEDFATYYCQQTYSTPQVFGQGTKLEIK	IGHV3-48*02	IGHJ6*02	IGHD1-26*01	IGKV1-39*01,IGKV1D-39*01	IGKJ2*01,IGKJ2*02,IGKJ2*03	ARGLGPKSYYYYGMDV	QQTYSTPQV	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
20	Cho-C006	C2012	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTGTATTACTGTGCGAGACACGGTGGGCCCACTTCCTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSYISSSSSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYCARHGGPTSYYYYGMDVWGQGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCGTGCACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPCTFGQGTKLEIK	IGHV3-48*02	IGHJ6*02	IGHD4-23*01	IGKV1-39*01,IGKV1D-39*01	IGKJ2*02	ARHGGPTSYYYYGMDV	QQSYSTPCT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
20	Wang-C001	C001_P2_IgG_F11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTGTATTACTGTGCGAGACACCTGGGAGCTACTTCCTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSYISSSSSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYCARHLGATSYYYYGMDVWGQGTTVTVSS	GACATCCAGATGACCCAGTCTCCAGTCNCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCTCCCACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPVXLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPTFGQGTKVEIK	IGHV3-48*02	IGHJ6*02	IGHD1-26*01	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	ARHLGATSYYYYGMDV	QQSYSTPPT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
20	Wang-PFZ10	PZF10_P1_IgG_C11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTTCCTATAACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTTCCAGTAGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTTTATCTGCAAATGAATAGCCTGAGAGACGACGACACGGCTGTGTATTACTGTGCGAGAGTTCTGGGACCTACCAGCTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCTTCA	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYNMNWVRQAPGKGLEWVSYISSSSSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRDDDTAVYYCARVLGPTSYYYYGMDVWGQGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGGACATTCACAGCTATTTAAGTTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGGTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCCGTGACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQDIHSYLSWYQQKPGKAPKLLIYGASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPVTFGQGTKLEIK	IGHV3-48*02	IGHJ6*02	IGHD1-26*01	IGKV1-39*01,IGKV1D-39*01	IGKJ2*01,IGKJ2*02	ARVLGPTSYYYYGMDV	QQSYSTPVT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
20	Cho-C016	C2163	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTGTATTACTGTGCGAGACACGGGGGAGCTATGTCCTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSYISSSSSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYCARHGGAMSYYYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCTCCCACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQLTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPTFGQGTKLEIK	IGHV3-48*02	IGHJ6*02	IGHD3-16*01	IGKV1-39*01,IGKV1D-39*01	IGKJ2*01,IGKJ2*02	ARHGGAMSYYYYGMDV	QQSYSTPPT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
20	Wang-MOD8	MOD8_P1_IgG_G11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCGTGTGCAGCCTCTGGATTCACCTTCAGTACCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTATATTACTGTGCGAGACACTACGGTGACTACTCCTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGFTFSTYSMNWVRQAPGKGLEWVSYISSSSSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYCARHYGDYSYYYYGMDVWGQGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATGTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCAATCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGAATCTGGGTCAGTTTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCTCCAACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSISSYVNWYQQKPGKAPKLLIYAAISLQSGVPSRFSGSESGSVFTLTISSLQPEDFATYYCQQSYSTPPTFGGGTKVEIK	IGHV3-48*02	IGHJ6*02	IGHD4-17*01	IGKV1-39*01,IGKV1D-39*01	IGKJ4*01	ARHYGDYSYYYYGMDV	QQSYSTPPT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
20	Wang-MOD2	C635	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCACTACCTATAATATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTGATAGTGGTGGCACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTCAGAGACGAGGACACGGCTGTGTATTACTGTGCGAGAGTTAAGGGGAGGAGTAGCTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGFTFTTYNMNWVRQAPGKGLEWVSYISDSGGTIYYADSVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYCARVKGRSSYYYYGMDVWGQGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAACATTTACATCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGGTCCTGATCTATGGTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTGTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCGGTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQNIYIYLNWYQQKPGKAPKVLIYGASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDCATYYCQQSYSTPVTFGPGTKVDIK	IGHV3-48*02	IGHJ6*02	IGHD3-10*01,IGHD3-10*02,IGHD3-16*01	IGKV1-39*01,IGKV1D-39*01	IGKJ3*01	ARVKGRSSYYYYGMDV	QQSYSTPVT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
20	Wang-MOD2	Mod2_P2_IgG_E7-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCACTACCTATAATATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTGATAGTGGTGGCACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTCAGAGACGAGGACACGGCTGTGTATTACTGTGCGAGAGTTAAGGGGAGGAGTAGCTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGFTFTTYNMNWVRQAPGKGLEWVSYISDSGGTIYYADSVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYCARVKGRSSYYYYGMDVWGQGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAACATTTACATCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGGTCCTGATCTATGGTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTGTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCGGTCACTTTCGGCCCTGGGACCACAGTGGATANCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQNIYIYLNWYQQKPGKAPKVLIYGASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDCATYYCQQSYSTPVTFGPGTTVDXK	IGHV3-48*02	IGHJ6*02	IGHD3-10*01,IGHD3-10*02,IGHD3-16*01	IGKV1-39*01,IGKV1D-39*01	IGKJ3*01	ARVKGRSSYYYYGMDV	QQSYSTPVT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
20	COV096	COV096_HC_79-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCACTAACTATAACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTGTATTACTGTGCGAGAGTGGTTGGTTCGGGGAGTTATTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGFTFTNYNMNWVRQAPGKGLEWVSYISSSSSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYCARVVGSGSYYYYGMDVWGQGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGGTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCTGCCACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYGASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPATFGQGTKLEIK	IGHV3-48*02	IGHJ6*02	IGHD3-10*01	IGKV1-39*01,IGKV1D-39*01	IGKJ2*01,IGKJ2*02	ARVVGSGSYYYYGMDV	QQSYSTPAT	nan	Robbiani et al. Nature 584:437-442 (2020);Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW293117.1	MW293572.1
21	Wang-MOD11	Mod11_P2_IgG_G3-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTTTTAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGATGAGTCGAAGGATACAGCTATGGTTACGCTATTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSFKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDESKDTAMVTLFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCCACTTACTACTGTCAACAGAGTTACAGTACCCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPWTFGQGTKVEIK	IGHV3-30*03,IGHV3-30*19	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	ARDESKDTAMVTLFDY	QQSYSTPPWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
21	COV107	COV107_Plate1_HC_10-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGCAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATTATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAATACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGATCAGGACCTGGATACAGCTATGGTTACTCTTTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVILYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDQDLDTAMVTLFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAAGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGTAGTCTGCAACCTGAAGATTTGGCAACTTACTACTGTCAACAGAGTTACAGTACCCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVRDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDLATYYCQQSYSTPPWTFGQGTKVEIK	IGHV3-30-3*01	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	ARDQDLDTAMVTLFDY	QQSYSTPPWT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
21	COV021	C010	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV,SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGCCAAGGGGCTGGAGTGGGTGGCAGTTATATTATATGATGGAAGCGGTAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGTTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGACGGGATCGTGGATACAGCTCTGGTTACGTGGTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPAKGLEWVAVILYDGSGKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDGIVDTALVTWFDYWGQGTLVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCACCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSSLSASVGDRVTITCRASQSISTYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPWTFGQGTKVEIK	IGHV3-30-3*01	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	ARDGIVDTALVTWFDY	QQSYSTPPWT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
21	COV021	COVD21_P2_HC_H7-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGCCAAGGGGCTGGAGTGGGTGGCAGTTATATTATATGATGGAAGCGGTAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGTTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGACGGGATCGTGGATACAGCTCTGGTTACGTGGTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPAKGLEWVAVILYDGSGKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDGIVDTALVTWFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCACCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSISTYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPWTFGQGTKVEIK	IGHV3-30-3*01	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	ARDGIVDTALVTWFDY	QQSYSTPPWT	nan	Robbiani et al. Nature 584:437-442 (2020)	MW292970.1	MW293425.1
21	COV072	COV072_Plate2_HC_83-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAACCAATAAATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTTTTACTGTGCGAGAGATTCGGACGTGGATACAGCTATGGTTACTTGGTTCGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVISYDGTNKFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVFYCARDSDVDTAMVTWFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCACAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTTCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQHKPGKAPKLLIYASSSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPWTFGQGTKVEIK	IGHV3-30-3*01	IGHJ5*01,IGHJ5*02	IGHD5-18*01,IGHD5-5*01	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	ARDSDVDTAMVTWFDY	QQSYSTPPWT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
21	COV072	C133	COV072_P3_HC_53-P1369	SARS-CoV-2	SARS-CoV	nan	SARS-CoV,SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATTATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGATTCGGACGTAGATACATCTATGGTTACTTGGTTCGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVILYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDSDVDTSMVTWFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPWTFGQGTKVEIK	IGHV3-30-3*01	IGHJ5*01,IGHJ5*02	IGHD5-18*01,IGHD5-5*01	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	ARDSDVDTSMVTWFDY	QQSYSTPPWT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
21	Wang-MOD3	MOD3_P2_IgG_F10-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTTTGCCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATGGCATGATGGAAGTAATAAATTCCTTGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTTTCTACAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTATTGTGCGAGAGATGGTTTCGTGGATACAGTTATGGTTACTTGGCCTGACTATTGGGGCCGGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSFAMHWVRQAPGKGLEWVAVIWHDGSNKFLADSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCARDGFVDTVMVTWPDYWGRGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGGAGATTTTGCAACTTACTACTGTCAACAGAGTTACAATACCCCCCCGTGGACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSISNYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPGDFATYYCQQSYNTPPWTFGQGTKLEIK	IGHV3-33*01	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGKV1-39*01,IGKV1D-39*01	IGKJ2*02	ARDGFVDTVMVTWPDY	QQSYNTPPWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
21	COV021	COVD21_P2_HC_A11-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTACAGTGGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATTAGATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGACGGGATCGTGGATACAGCTATGGTTACGTGGTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTYSGYAMHWVRQAPGKGLEWVAVILDDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDGIVDTAMVTWFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCGTCTGTTGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCACCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATACTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYHQKPGKAPKLLIYTASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPWTFGQGTKVEIK	IGHV3-30-3*01	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	ARDGIVDTAMVTWFDY	QQSYSTPPWT	nan	Robbiani et al. Nature 584:437-442 (2020)	MW292969.1	MW293424.1
21	COV096	C562	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAAGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGGAGCTATGCCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATTTGGGATGATGGAAGTTCTAAACACTATTCAGACTCCGTGAAGGGCCACTTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGATAGCAACGTGGATACAGTTATGGTTACGTGGTTTGACTACTGGGGCCAGGGAACAATGGTCACCGTCTCTTCAG	EVQLVESGGGVVQPGKSLRLSCAASGFTFRSYAMHWVRQAPGKGLEWVAVIWDDGSSKHYSDSVKGHFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDSNVDTVMVTWFDYWGQGTMVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAACTATTTAAATTGGTATCAGCAGAAACCGGGGAAAGCCCCTAACCTCCTGATCTATACTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATAAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCTCCCTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSISNYLNWYQQKPGKAPNLLIYTASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPWTFGQGTKVEIK	IGHV3-33*01	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	ARDSNVDTVMVTWFDY	QQSYSTPPWT	nan	Gaebler et al. Nature 591:639-644 (2021)	nan	nan
21	Wheatley-CP63	PDI_206	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTTACCTTCAGTACCTATGCCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTAGAGTGGGTGGCGGTTATATTATATGATGGAAGTTATAAAGACTACTCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGATCATGGCGTGGATACAGTTATGGTTACCTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVILYDGSYKDYSDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDHGVDTVMVTWFDPWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTTTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCATAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCGGCAATCTGAAGATTGTGCAAGTTATTACTGTCAACAGAGTTACAGTACCCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAA	DIQMTQSPSSLFASVGDRVTITCRASQSISSYLNWYQHKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSRQSEDCASYYCQQSYSTPPWTFGQGTKVEIK	IGHV3-30*01,IGHV3-30*10	IGHJ5*02	IGHD5-18*01,IGHD5-5*01	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	ARDHGVDTVMVTWFDP	QQSYSTPPWT	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
21	Wang-MOD4	Mod4_P4_IgG_C10-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCGGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATTATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGATGTGTCCGTGGATACAGTTATGGTTAGCTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVILYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDVSVDTVMVSWFDPWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCCTCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPSWTFGQGTKVEIK	IGHV3-30-3*01	IGHJ5*02	IGHD5-18*01,IGHD5-5*01	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	ARDVSVDTVMVSWFDP	QQSYSTPSWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
22	Wang-MOD8	MOD8_P2_IgG_D1-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAAGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGCAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTGATGATTATGCCATGCACTGGGTCCGGCAAGCTCCAGGGAAGGGCCTGGAGTGGGTCTCAGGTATTAGTTGGAATAGTGGTAGCATAGACTATGCGGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCCCTGTATCTGCAAATGAACAGTCTGAGAGCTGAGGACACGGCCTTGTATTACTGTGCAAAAGAGGATTACTATGATAGTAGTGGTTCATTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSGSIDYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCAKEDYYDSSGSFDYWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCAGCACTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTWVFGGGTKLTVL	IGHV3-9*01	IGHJ4*02	IGHD3-22*01	IGLV2-14*03	IGLJ3*02	AKEDYYDSSGSFDY	SSYTSSSTWV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
22	Li_SARS2_26	DH1179	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFTNNAMHWVRQAPGKGLEWVAVISYDGSNRYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREDYYDSSGSFDHWGQGILVTVSS	nan	QSALTQPASVSESPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMTYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYSSSSTWVFGGGTKLTVL	IGHV3-30*01	IGHJ4	nan	IGLV2-14*03	IGLJ3	AREDYYDSSGSFDH	SSYSSSSTWV	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
22	COSCA1	COVA1-08	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV,SARS-CoV-2	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGAGGATTACTATGATAGTAGTGGTTCTTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGVVQPGGSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREDYYDSSGSFDYWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCAGCACTCGCCATTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTRHWVFGGGTKLTVL	IGHV3-30-3*01	IGHJ4*02	IGHD3-22*01	IGLV2-14*03	IGLJ3*02	AREDYYDSSGSFDY	SSYTSSSTRHWV	nan	Brouwer et al. Science 369:643-650 (2020)	MT599827.1	MT599911.1
22	COV107	C112	COV107_Plate1_HC_22-P1369	SARS-CoV-2	SARS-CoV	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCCATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGAGGATTACTATGATAGTAGTGGTTCTTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSHAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREDYYDSSGSFDYWGQGTLVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACCGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCAGCACTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTWVFGGGTKLTVL	IGHV3-30-3*01	IGHJ4*02	IGHD3-22*01	IGLV2-14*03	IGLJ3*02	AREDYYDSSGSFDY	SSYTSSSTWV	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
22	COV107	COV107_Plate2_HC_88-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGGCATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGAGGATTACTATGATAGTAGTGGTTCTTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSRHAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREDYYDSSGSFDYWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCAGCACTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTWVFGGGTKLTVL	IGHV3-30-3*01	IGHJ4*02	IGHD3-22*01	IGLV2-14*03	IGLJ3*02	AREDYYDSSGSFDY	SSYTSSSTWV	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
22	Wang-MOD1	Mod1_P1_IgG_B11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTTTGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATTTCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGAAGATTACTATGATAGTAGTGGCAGCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSFAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREDYYDSSGSFDYWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGACTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCAGCACTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMTYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTWVFGGGTKLTVL	IGHV3-30-3*01	IGHJ4*02	IGHD3-22*01	IGLV2-14*03	IGLJ3*02	AREDYYDSSGSFDY	SSYTSSSTWV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
22	Li_SARS2_26	DH1180	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPDKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQLNSLRTEDTAVYYCAREDYYDSSGSLDYWGQGTLVTVSS	nan	QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYFCSSYTSSSTWVFGGGTKLTVL	IGHV3-30*01	IGHJ4	nan	IGLV2-14*03	IGLJ3	AREDYYDSSGSLDY	SSYTSSSTWV	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
22	Li_SARS2_26	DH1183	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREDYYDSSGSLDYWGQGTLVTVSS	nan	QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTWVFGGGTKLTVL	IGHV3-30*01	IGHJ4	nan	IGLV2-14*03	IGLJ3	AREDYYDSSGSLDY	SSYTSSSTWV	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
22	COV047	Wang-C443	COV047_P5_IgA_86-P1609	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATACGGTATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACAAGCTGTATCTCCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGAGGATTACTATGATAGTAGTGGCTCACTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIRYDGSNKYYADSVKGRFTISRDNSKNKLYLQMNSLRAEDTAVYYCAREDYYDSSGSLDYWGQGTLVTVSS	CAGTCTGCCCTGACTCAGCCTCGCTCAGTGTCCGGGTCTCCTGGACAGTCAGTCACCATCTCCTGCACTGGAACCAGCAGTGATGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAGCACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAAGCGGCCCTCAGGGGTCCCTGATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCTGCTCATATGCAGGCAGTCCTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSALTQPRSVSGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSPWVFGGGTKLTVL	IGHV3-33*01	IGHJ4*02	IGHD3-22*01	IGLV2-11*01	IGLJ3*02	AREDYYDSSGSLDY	CSYAGSPWV	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW293091.1	MW293546.1
22	COV021	COVD21_P3_HC_A5-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGACCGAGGATTACTATGATAGTAGTGGTTCCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCATEDYYDSSGSFDYWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCTCGCTCAGTGTCCGGGTCTCCTGGACAGTCAGTCACCATCTCCTGCACTGGAACCAGCAGTGATGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAGCACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAAGCGGCCCTCAGGGGTCCCTGATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCTGCTCATATGCAGGCAGCTTTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPRSVSGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSFWVFGGGTKLTVL	IGHV3-30-3*01	IGHJ4*02	IGHD3-22*01	IGLV2-11*01	IGLJ3*02	ATEDYYDSSGSFDY	CSYAGSFWV	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293255.1	MW293710.1
23	Li_SARS2_26	DH1043	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSRYAINWVRQAPGQGLEWMGRIIPIFGIANYAQKFQGKVTITADKSTSTAYMELSSLRSEDTAVYYCARADYYYDSSGYFFDYWGQGTLVTVSS	nan	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQTPRLLIYGASSRATGIPARFSGSGSGTNFTLTISRLEPEDFAVYYCQQYSSSRTFGQGTKVEIK	IGHV1-69*04	IGHJ4	nan	IGKV3-20*01	IGKJ1	ARADYYYDSSGYFFDY	QQYSSSRT	7LJR	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
23	Li_SARS2_26	H026367+K024035	nan	SARS-CoV-2	SARS-CoV,MERS-CoV,OC43,HKU1,NL63	nan	nan	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSNYAINWVRQAPGQGLEWMGRIIPMFDIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARAGYYYDSSGYPFDYWGQGTLVTVSS	nan	DIQMTQSPSSLSASVGDRVTITCRASQNISNYLNWYQQKPRKAPNLLIYAASSLQSGVPSRFSGSGSGTDFTLTINSLQPEDFATYYCQQSYNAPRTFGQGTKVEIT	IGHV1-69*04	IGHJ4	nan	IGKV1-39*01	IGKJ1	ARAGYYYDSSGYPFDY	QQSYNAPRT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
23	Li_SARS2_26	H712574+K712026	nan	SARS-CoV-2	SARS-CoV,MERS-CoV,OC43,HKU1,NL63	nan	nan	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAINWVRQAPGQGLEWMGRIIPLFGIANYAQKFQGRVTITADNSTTTAYMELSSLRSEDTAVYYCARAGYYYDSSPYPFDYWGQGTLVTVSS	nan	DIQMTQSPSSLSASVGDRVTFTCRASQNISSYLNWYQHKPGKAPKLLIYGASSLQSGVPSRVSGSGSGTDFTLTISSLQPEDFATYYCQQSYSSPRTFGQGTKVEIK	IGHV1-69*15	IGHJ4	nan	IGKV1-39*01	IGKJ1	ARAGYYYDSSPYPFDY	QQSYSSPRT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
23	Li_SARS2_26	H712574+L711805	nan	SARS-CoV,SARS-CoV-2,MERS-CoV,OC43	HKU1,NL63	nan	nan	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAINWVRQAPGQGLEWMGRIIPLFGIANYAQKFQGRVTITADNSTTTAYMELSSLRSEDTAVYYCARAGYYYDSSPYPFDYWGQGTLVTVSS	nan	SYELTQPLSVAVAPGETARITCSGDALSEEYTHWYQQRPGQAPVLIIYKDTERPSGIPERFSGSTSGTTVTLTISGVQAEDEADYYCQSPDTTSTYRVFGGGTKLAVL	IGHV1-69*15	IGHJ4	nan	IGLV3-25*02	IGLJ3	ARAGYYYDSSPYPFDY	QSPDTTSTYRV	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
23	Li_SARS2_26	H026368+K024036	nan	SARS-CoV-2	SARS-CoV,MERS-CoV,OC43,HKU1,NL63	nan	nan	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVQSGAEVKHLWGSVKAPCKASGGTFSSYAINWVRQAPGQGLEWMGRIIPMFGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARAGYYYESSGYHFDYWGQGTLVTVSS	nan	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSRTFGQGTKVEIK	IGHV1-69*04	IGHJ4	nan	IGKV3-20*01	IGKJ1	ARAGYYYESSGYHFDY	QQYGSSRT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
23	Li_SARS2_26	DH1186	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSNYAINWVRQAPGQGLEWMGRIIPIFGIANYAQEFQGRVTITADKSTSTVYMELSSLRSEDTAVYYCARANYYYESSGYYFDYWGQGTLVTVSS	nan	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSFLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCLQYGSSRTFGQGTKVEIK	IGHV1-69*04	IGHJ4	nan	IGKV3-20*01	IGKJ1	ARANYYYESSGYYFDY	LQYGSSRT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
23	Li_SARS2_26	H026085+L024042	nan	SARS-CoV-2	SARS-CoV,MERS-CoV,OC43,HKU1,NL63	nan	nan	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSNYAINWVRQAPGQGLEWMGRIIPIFGIANYAQEFQGRVTITADKSTSTVYMELSSLRSEDTAVYYCARANYYYESSGYYFDYWGQGTLVTVSS	nan	NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSTYWVFGGGTKLTVL	IGHV1-69*04	IGHJ4	nan	IGLV6-57*02	IGLJ3	ARANYYYESSGYYFDY	QSYDSSTYWV	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
23	Wang-C003	C1219	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATGCTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAAGGATCATCCCTTTCCATGATATAGCAAACTACGCACAGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACAAATCCACGAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGCTTCTTATTACTATGATAGTAGTGGTTACCACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPFHDIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARASYYYDSSGYHFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGAGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGCTAGCTCCCCGCGCACTTTCGGCGGAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYASSPRTFGGGTKVEIK	IGHV1-69*09	IGHJ4*02	IGHD3-22*01	IGKV3-20*01	IGKJ4*01	ARASYYYDSSGYHFDY	QQYASSPRT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
23	Wang-C003	C003_P2_IgG_A6-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATGCTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAAGGATCATCCCTTTCCATGATATAGCAAACTACGCACAGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACAAATCCACGAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGCTTCTTATTACTATGATAGTAGTGGTTACCACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPFHDIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARASYYYDSSGYHFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGAGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGCTAGCTCCCCGCGCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYASSPRTFGGGTKVEIK	IGHV1-69*09	IGHJ4*02	IGHD3-22*01	IGKV3-20*01	IGKJ4*01	ARASYYYDSSGYHFDY	QQYASSPRT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
23	PT28	282C4	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV1-69	nan	nan	IGKV3-20	nan	ARSAYYSDSSGYHFDY	QQYHSSPRT	nan	Zhou et al. Cell Rep. 35:109109 (2021)	nan	nan
24	Wang-C001	C001_P1_IgG_E11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTCCAGCTGGTGCAATCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGTCACCTTCAGCACCTATACTATCTCCTGGATGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAAGCATCATCCCTATCCTTGGTATAGCAAACTACGCACAGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACAAATCCACGAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATGTGAGGACACGGCCGTGTTTTACTGTGCGATAGAACGTGGATATAGTGGCTACGGAGCATCTGCCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCAGCGTCTCCTCAG	QVQLVQSGAEVKKPGSSVKVSCKASGVTFSTYTISWMRQAPGQGLEWMGSIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRCEDTAVFYCAIERGYSGYGASAYFDYWGQGTLVSVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGCTCCAACATCGGGGCAGGTTATGATGTACACTGGTACCAGCAGCTTCCAGGAACAGCCCCCAAACTCCTCATCTATGTTAACAGCAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGCCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAGCAGCCTGAGTGGTTCGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYVNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGSVFGGGTKLTVL	IGHV1-69*08	IGHJ4*02	IGHD5-12*01	IGLV1-40*01	IGLJ2*01,IGLJ3*01	AIERGYSGYGASAYFDY	QSYDSSLSGSV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
24	Wang-MOD11	Mod11_P2_IgG_F9-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATGCTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAAGGATCATCCCTATCCTTGGTATAGCAAACTACGCACAGAAGTTCCAGGGCAGAGTCACGATAACCGCGGACAAATCCACGAGCAGAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTCTATTACTGTGCGAGAGAGCGGGGATATAGTGGCTACGGTGCGGCCGAGTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSRAYMELSSLRSEDTAVYYCARERGYSGYGAAEYFDYWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGCTCCAACATCGGGGCAGGTTATGATGTACACTGGTACCAGCAGCTTCCAGGAACAGCCCCCAAACTCCTCATCTATGTTAACAGCAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAGCAGCCTGAGTGGTTCGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYVNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGSVFGGGTKLTVL	IGHV1-69*09	IGHJ4*02	IGHD5-12*01	IGLV1-40*01	IGLJ2*01,IGLJ3*01	ARERGYSGYGAAEYFDY	QSYDSSLSGSV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
24	Wang-PFZ12	C807	PZF12_P1_IgG_C5-P1369	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGCGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAAGAGTTATATTATTAATTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAGAGATCATCCCTATCTTTGGTACAGCAAACTACGCACAGAAGTTCCAGGGCAGAGTCACGAGTACCGCGGACGAATCCACGAGCACAGCCTACATGGAGCTGAGCAGCCTGAAATCTGAGGACACGGCCGTGTATTATTGTGCGAGAGGGAGAGGATATAGTGGCTACGGCGCGTCGTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEAKKPGSSVKVSCKASGGTFKSYIINWVRQAPGQGLEWMGEIIPIFGTANYAQKFQGRVTSTADESTSTAYMELSSLKSEDTAVYYCARGRGYSGYGASYYFDYWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAACTCCAACATCGGGGCAGGTTATGATGTACACTGGTACCAGCAGCTTCCAGGAACAGCCCCCAAACTCCTCATCTATGCTAACAGCAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAGCGGCCTGAGTGGTTCGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPPSVSGAPGQRVTISCTGSNSNIGAGYDVHWYQQLPGTAPKLLIYANSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSGLSGSVFGGGTKLTVL	IGHV1-69*01,IGHV1-69D*01	IGHJ4*02	IGHD5-12*01	IGLV1-40*01	IGLJ2*01,IGLJ3*01	ARGRGYSGYGASYYFDY	QSYDSGLSGSV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
24	Wang-MOD11	Mod11_P1_IgG_C10-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTCCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCTCCTATGCTATCAGCTGGGTGCGACAGGCCCCTGGACATGGGCTTGAGTGGATGGGAAAGATCATCCCTATCCTTGGTATAGCAAACTACCCACAGAAGTTCCAGGGCAGATTCACGATTACCGCGGACAAATCCACGGGCTCAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTTCTGTGCGAGAGAGCGGGGATATAGTGACTACGGTGCGGCCGAGTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGHGLEWMGKIIPILGIANYPQKFQGRFTITADKSTGSAYMELSSLRSEDTAVYFCARERGYSDYGAAEYFDYWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCGTCTCCTGCACTGGGAGCAGCTCCAACATCGGGGCAGGTTATGATGTACACTGGTACCAGCAGCTTCCAGGAACAGCCCCCAAACTCCTCATCTATGGTAACACCAATCGCCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAGCAGCCTGAGTGGTTCGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPPSVSGAPGQRVTVSCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNTNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGSVFGGGTKLTVL	IGHV1-69*04	IGHJ4*02	IGHD5-12*01,IGHD5/OR15-5a*01,IGHD5/OR15-5b*01	IGLV1-40*01	IGLJ2*01,IGLJ3*01	ARERGYSDYGAAEYFDY	QSYDSSLSGSV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
24	Wang-MOD11	Mod11_P2_IgG_C8-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTCCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATGCTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAAGGATCATCCCTATTCTTGGTATAGCAAACTACGCACAGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACAAATCCACGACCACAGCCTACATGGAACTGAACAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGAGCGGGGATATAGTGGCTACGGTGCGGCCGAGTACTTTGACTTCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTTTAYMELNSLRSEDTAVYYCARERGYSGYGAAEYFDFWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCGCTGGGAGCAGCTCCAACGTCGGGGCAGGTTATGATGTACACTGGTACCAGCAGCTTTCAGGAACAGCCCCCAAACTCCTCATCTATGGTAACAGCAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAGCAGCCTGAGTGGTTCGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPPSVSGAPGQRVTISCAGSSSNVGAGYDVHWYQQLSGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGSVFGGGTKLTVL	IGHV1-69*04	IGHJ4*02	IGHD5-12*01	IGLV1-40*01	IGLJ2*01,IGLJ3*01	ARERGYSGYGAAEYFDF	QSYDSSLSGSV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
24	Wang-PFZ10	PZF10_P2_IgG_F2-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTCCAGCTGGTGCAATCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCCTCTGGAGGCACCTTCAGCAGTTATACTATCAACTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGCATGGGACGGATCATCCCTCTCCTTGGAATAGCGAACTACGCAGAGAAGCTCCAGGGCAGAGTCACGATTACCGCGGACAAATCCACGAGCACAGCCTACATGGAGCTCAACAGCCTCAGATCTGAGGACACGGCCGTATATTACTGTGCGAGGCTTCGTGGATATAGTGACTACGGAGCCGCTGCCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYTINWVRQAPGQGLECMGRIIPLLGIANYAEKLQGRVTITADKSTSTAYMELNSLRSEDTAVYYCARLRGYSDYGAAAYFDYWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAACTCCAACATCGGGGCAGGTTATGATGTACACTGGTACCAGCAGCTTCCAGGAACAGCCCCCAAACTCCTCATCTATCGTAACAACAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTCAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAGCAGCCTGAGTGTGGAAGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	QSVLTQPPSVSGAPGQRVTISCTGSNSNIGAGYDVHWYQQLPGTAPKLLIYRNNNRPSGVPDRFSGSKSGTSASLAITGLQAQDEADYYCQSYDSSLSVEVFGTGTKVTVL	IGHV1-69*02	IGHJ4*02	IGHD5-12*01,IGHD5/OR15-5a*01,IGHD5/OR15-5b*01	IGLV1-40*01	IGLJ1*01	ARLRGYSDYGAAAYFDY	QSYDSSLSVEV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
24	Wang-PFZ10	PZF10_P1_IgG_C4-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTCCAGCTGGTGCAATCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATACTATCATTTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAAGGATCATCCCTATCCTTGGTATACCAAACTACGCACAGAAGTTCCAGGACAGAGTCACGATTACCGCGGACAAGGCCACGAACACAGTTTACATGGACCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGGCTTCGTGGATATAGTGGCTACGGAGCCGCTGGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYTIIWVRQAPGQGLEWMGRIIPILGIPNYAQKFQDRVTITADKATNTVYMDLSSLRSEDTAVYYCARLRGYSGYGAAGYFDYWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAACTCCAACATCGGGGCAGGTTATGATGTACACTGGTACCGACAACTTCCAGGAACAGCCCCCAAACTCCTCATCTATATTAACACCAATCGACCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCATTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAGCAGCCTGAGTGTGGAAGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	QSVLTQPPSVSGAPGQRVTISCTGSNSNIGAGYDVHWYRQLPGTAPKLLIYINTNRPSGVPDRFSGSKSGTSASLAIIGLQAEDEADYYCQSYDSSLSVEVFGTGTKVTVL	IGHV1-69*02	IGHJ4*02	IGHD5-12*01	IGLV1-40*01	IGLJ1*01	ARLRGYSGYGAAGYFDY	QSYDSSLSVEV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
24	Crowe_mix	COV2-2054	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV,SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTGGTGCAATCAGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGACACCTTCAGCAGCTATACTATCAACTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAAGGATCATCCCTATCCTTGGTATACCAAACTACGCACAGAAATTCCAGGGCAGAGTCACCATTACCGCGGACAAATCCACGAGCACAGCCTTCATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTCTATTACTGTGCGAGAGGGAGGGGCTACAGTAACTACGGGGCCTCCTACTACATGGACGTCTGGGGCAAAGGGACCACGGTCACCGTCTCCTCA	QVQLVQSGAEVKKPGSSVKVSCKASGDTFSSYTINWVRQAPGQGLEWMGRIIPILGIPNYAQKFQGRVTITADKSTSTAFMELSSLRSEDTAVYYCARGRGYSNYGASYYMDVWGKGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAACCACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACCGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCACCAGCCTGCAGCCTGAAGATGTTGCAACATATTACTGTCAACAGTCTGATAATCTCCCCATGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAA	DIQMTQSPSSLSASVGDRVTITCQASQDINHYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTITSLQPEDVATYYCQQSDNLPMYTFGQGTKLEIK	IGHV1-69*02	IGHJ6*03	IGHD4-11*01,IGHD4-4*01	IGKV1-33*01,IGKV1D-33*01	IGKJ2*01	ARGRGYSNYGASYYMDV	QQSDNLPMYT	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665662.1	MT665275.1
24	Crowe_mix	COV2-2114	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV,SARS-CoV-2	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTGGTGCAATCAGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGACACCTTCAGCAGCTATACTATCAACTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAAGGATCATCCCTATCCTTGGTATACCAAACTACGCACAGAAATTCCAGGGCAGAGTCACCATTACCGCGGACAAATCCACGAGCACAGCCTTCATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTCTATTACTGTGCGAGAGGGAGGGGCTACAGTAACTACGGGGCCTCCTACTACATGGACGTCTGGGGCAAAGGGACCACGGTCACCGTCTCCTCA	QVQLVQSGAEVKKPGSSVKVSCKASGDTFSSYTINWVRQAPGQGLEWMGRIIPILGIPNYAQKFQGRVTITADKSTSTAFMELSSLRSEDTAVYYCARGRGYSNYGASYYMDVWGKGTTVTVSS	CAGTCTGTGCTGACGCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGCTCCAACATCGGGGCAGGTTATGATGTACACTGGTACCAGCAGCTTCCAGAAACAGCCCCCAAACTCCTCATCTATGCTAACAGCAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAGCAGCCTGAGTGGTTCGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTA	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPETAPKLLIYANSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGSVFGGGTKLTVL	IGHV1-69*02	IGHJ6*03	IGHD4-11*01,IGHD4-4*01	IGLV1-40*01	IGLJ2*01,IGLJ3*01	ARGRGYSNYGASYYMDV	QSYDSSLSGSV	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665466.1	MT665079.1
24	Crowe_mix	COV2-2909	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV,SARS-CoV-2	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTGGTGCAATCAGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGACACCTTCAGCAGCTATACTATCAACTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAAGGATCATCCCTATCCTTGGTATACCAAACTACGCACAGAAATTCCAGGGCAGAGTCACCATTACCGCGGACAAATCCACGAGCACAGCCTTCATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTCTATTACTGTGCGAGAGGGAGGGGCTACAGTAACTACGGGGCCTCCTACTACATGGACGTCTGGGGCAAAGGGACCACGGTCACCGTCTCCTCA	QVQLVQSGAEVKKPGSSVKVSCKASGDTFSSYTINWVRQAPGQGLEWMGRIIPILGIPNYAQKFQGRVTITADKSTSTAFMELSSLRSEDTAVYYCARGRGYSNYGASYYMDVWGKGTTVTVSS	CAGTCTGTGCTGACGCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGCTCCAACATCGGGGCAGGTTATGATGTACACTGGTACCAGCAGCTTCCAGAAACAGCCCCCAAACTCCTCATCTATGCTAACAGCAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAGCAGCCTGAGTGGTTCGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTA	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPETAPKLLIYANSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGSVFGGGTKLTVL	IGHV1-69*02	IGHJ6*03	IGHD4-11*01,IGHD4-4*01	IGLV1-40*01	IGLJ2*01,IGLJ3*01	ARGRGYSNYGASYYMDV	QSYDSSLSGSV	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665492.1	MT665105.1
25	BG1	BG1-25	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASGFIVSRNYMSWVRQAPGKGLEWVSVIYSGGSTFYADAVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAR	nan	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSSP	IGHV3-53*01	nan	nan	IGKV1-9*01	nan	ARDMGGDVFDI	QQLNSSPPKLT	nan	Scheid et al. Cell 184:3205-3221.e24 (2021)	nan	nan
25	Wheatley-CP63	PDI_230	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCAAGGTGAAGATGTTTTTGATATTTGGGGCCAAGGGACAATGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDQGEDVFDIWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCATTATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCCAGGGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAA	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLIIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSYPPGLTFGGGTKVEIK	IGHV3-53*01	IGHJ3*02	IGHD2-21*01,IGHD2-21*02,IGHD4-17*01	IGKV1-9*01	IGKJ4*01	ARDQGEDVFDI	QQLNSYPPGLT	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
25	Chen_Vax_p1	COV2-vax-49	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACCCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCGGGGCGAGGATGTTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRGEDVFDIWGQGTMVTVSS	GCCATCCAGTTGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCGGGTTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	AIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSYPGYTFGQGTKLEIK	IGHV3-53*01	IGHJ3*02	IGHD3-10*01,IGHD3-10*02	IGKV1-9*01	IGKJ2*01	ARDRGEDVFDI	QQLNSYPGYT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555600.1	MZ555601.1
25	Chen_Vax_p1	COV2-vax-50	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCGGGGCGAGGATGTTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRGEDVFDIWGQGTMVTVSS	GCCATCCAGTTGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCGGGTTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	AIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSYPGYTFGQGTKLEIK	IGHV3-53*01	IGHJ3*02	IGHD3-10*01,IGHD3-10*02	IGKV1-9*01	IGKJ2*01	ARDRGEDVFDI	QQLNSYPGYT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555602.1	MZ555603.1
25	IML3547	ADI-60792	nan	SARS-CoV-2	nan	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGGTCATCGTCAGTCGCAACTACATGAATTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATCCCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGACTCACCATCTCCAGAGACAATTCCAAGAACACACTGTATCTTCAAATGGACAGCCTGAGAGCCGACGACACGGCCGTGTATTACTGTGCGAGAGATCAGGGGGAGGGGACTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	EVQLVESGGGLIQPGGSLRLSCAASGVIVSRNYMNWVRQAPGKGLEWVSVIYPGGSTFYADSVKGRLTISRDNSKNTLYLQMDSLRADDTAVYYCARDQGEGTFDIWGQGTMVTVSS	nan	nan	IGHV3-53*01	IGHJ3*02	IGHD3-16*01,IGHD3-16*02	IGKV1-9	nan	ARDQGEGTFDI	QLLNSYPLLT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458061.1	nan
25	Wang-MOD7	MOD7_P1_IgG_H6-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTCATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACGTGCTGCATCTTCAAATGAACAGCCTGAGAGTCGAGGACACGGCTGTGTATTACTGTGCGAGAGATCGGGGGGAGGATGTTTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNVLHLQMNSLRVEDTAVYYCARDRGEDVFDYWGQGTLVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAACTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATGGTTACCCTCCGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNGYPPTFGQGTKVEIK	IGHV3-66*01	IGHJ4*02	IGHD3-16*01,IGHD3-16*02	IGKV1-9*01	IGKJ1*01	ARDRGEDVFDY	QQLNGYPPT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
25	Wang-C003	C1439	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGACTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGATCATCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTTTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAACTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCGCGGCAATGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVETGGGLIQPGGSLRLSCAASGIIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRGNDAFDIWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCCTTCGGTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPSVTFGGGTKVEIK	IGHV3-53*02	IGHJ3*02	IGHD6-25*01	IGKV1-9*01	IGKJ4*01	ARDRGNDAFDI	QQLNSYPPSVT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
25	Wang-C003	C003_P1_IgG_G11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGACTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGATCATCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTTTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAACTCCAAGTACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCGCGGCAATGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVETGGGLIQPGGSLRLSCAASGIIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKYTLYLQMNSLRAEDTAVYYCARDRGNDAFDIWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCCTTCGGTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPSVTFGGGTKVEIK	IGHV3-53*02	IGHJ3*02	IGHD6-25*01	IGKV1-9*01	IGKJ4*01	ARDRGNDAFDI	QQLNSYPPSVT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
25	IML3564	ADI-63305	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:NTD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCATCTTCAGTAACTATAGAATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTGGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTTTCTGCAAATGAACAGCCTGAGAGACGAGGACACGGCTGTATATTACTGTGCGAGAGATTACGTCAATGACGCTTTTGATATCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLLESGGGLVQPGGSLRLSCAASGFIFSNYRMNWVRQAPGKGLEWVSYISSSGSTIYYADSVKGRFTISRDNAKNSLFLQMNSLRDEDTAVYYCARDYVNDAFDIWGQGTTVTVSS	nan	nan	IGHV3-48*02	IGHJ3*02	IGHD3-16*01,IGHD3-16*02	IGKV1-12	nan	ARDYVNDAFDI	QQTHNFPFA	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458813.1	nan
26	Cho-C034	C2056	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCCGGCTCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGGCTCCATCAGCAGTGGTGGTTACTCCTGGAGCTGGATCCGGCAGCCACCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATCATAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCAGTAGACAGGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATTACTGTGCCAGAGCATATTGTGGTGGTGACTGCCCCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGSGLVKPSQTLSLTCAVSGGSISSGGYSWSWIRQPPGKGLEWIGYIYHSGSTYYNPSLKSRVTISVDRSKNQFSLKLSSVTAADTAVYYCARAYCGGDCPFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTATTAGTAGCTGGTTGGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGATGCCTCCAGTTTGGAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACCATCAGCAGCCTGCAGCCTGATGATTTTGCAACTTATTACTGCCAACAGTATAATAGTTATCGGACGTTCGGCCAAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYRTFGQGTKVEIK	IGHV4-30-2*01	IGHJ4*02	IGHD2-21*02	IGKV1-5*01	IGKJ1*01	ARAYCGGDCPFDY	QQYNSYRT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
26	Wang-MOD11	Mod11_P2_IgG_C5-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCCGGGGGAGGCTTAGTTCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGAAGCTACTGGATGCACTGGGTCCGCCAAGCTCCAGGGAAGGGGCTGGTGTGGGTCTCACGTATTGATAGTGATGGGAGTAGCACAAGCTACGCGGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACACGCTGTATCTGCAAATGAACAGTCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCAAGAGGGTATTGTGGTGGTGACTGCCCCGTGGACTACTGGGGCCCGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTFRSYWMHWVRQAPGKGLVWVSRIDSDGSSTSYADSVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCARGYCGGDCPVDYWGPGTLVTVSS	GACATCCAGATGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTATTAGTAGCTGGTTGGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGTTCCTGATCTATGATGCCTCCAATTTGGAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACCATCAGCAGCCTGCAGCCTGATGATTTTGCAACTTATTACTGCCAACACTATAATAGTTACCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKFLIYDASNLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQHYNSYPWTFGQGTKVEIK	IGHV3-74*01	IGHJ4*02	IGHD2-21*02	IGKV1-5*01	IGKJ1*01	ARGYCGGDCPVDY	QHYNSYPWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
26	Cho-C017	C2112	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGCAGTCTGGAGCAGAGGCGAAAAAGCCCGGGGAGTCTCTGAAGATCTCCTGTAAGGGTTCTGGATACAGCTTTACCAGCTACTGGATCGGCTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATGGGGATCATCTATCCTGGTGACTCTGATACCAGATACAGCCCGTCCTTCCAAGGCCAGGTCACCATCTCAGCCGACAAGTCCATCAGCACCGCCTACCTGCAGTGGAGCAGCCTGAAGGCCTCGGACACCGCCATGTATTACTGTGCGAGACTATATTGTGGTGGTGATTGCCCCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVQSGAEAKKPGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARLYCGGDCPFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTATTAGTAGCTGGTTGGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGATGCCTCCAGTTTGGAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCATTCTCACCATCAGTAGCCTGCAGCCTGATGATTTTGCAACTTATTACTGCCAACAGTATAATAGTTATTCTCGCACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTEFILTISSLQPDDFATYYCQQYNSYSRTFGQGTKVEIK	IGHV5-51*01	IGHJ4*02	IGHD2-21*01	IGKV1-5*01	IGKJ1*01	ARLYCGGDCPFDY	QQYNSYSRT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
26	Cho-C005	C1364	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGCAGTCTGGAGCAGAGGTGAAAAAGCCGGGGGAGTCTCTGAAGATCTCCTGTAAGGGTTCTGGATACAGCTTTACCAGTTACTGGATCGCCTGGGTGCGCCGGATGCCCGGGAAAGGCCTGGAGTGGATGGGGATCATCTATCCTGGTGACTCTGAGACCAGATACAGCCCGTCCTTCCAAGGCCAGGTCACCATCTCAGCCGACAAGTCCATCAGCACCGCCTACCTGCAGTGGAGCAGCCTGGAGGCCTCGGACACCGCCATGTATTACTGTGCGAGACAATATTGTGGTGGTGACTGCCCCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVQSGAEVKKPGESLKISCKGSGYSFTSYWIAWVRRMPGKGLEWMGIIYPGDSETRYSPSFQGQVTISADKSISTAYLQWSSLEASDTAMYYCARQYCGGDCPFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCTGGCGCCCAGGCTCCTCATCTATGATACATCCAACAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCAAAATTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGLAPRLLIYDTSNRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSKFTFGPGTKVDIK	IGHV5-51*01	IGHJ4*02	IGHD2-21*02	IGKV3D-20*01	IGKJ3*01	ARQYCGGDCPFDY	QQYGSSKFT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
26	Cho-C017	C2168	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGCAGTCTGGAGCAGAGGTGAAAAAGCCCGGGGAGTCTCTGAAGATCTCCTGTAAGGGTTCTGGATACAGCTTTACCAGGTACTGGATCGGCTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATGGGGATCATCGATCCTGGTGACTCTGAGACCAGATACAGCCCGTCCTTCCAAGGCCAGGTCACCATCTCAGCCGACAAGTCCATCAGCACCGCCTACCTGCAGTGGAGCAGCCTGAAGGCCTCGGACACCGCCATGTATTACTGTGCGAGACAATATTGTGGTGGTGATTGCCCCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVQSGAEVKKPGESLKISCKGSGYSFTRYWIGWVRQMPGKGLEWMGIIDPGDSETRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARQYCGGDCPFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTATTAGTACTTGGTTGGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGATGCCTCCAGTTTGGAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTGTCACCATCAGCAGCCTGCAGCCTGATGATTTTGCAACTTATTACTGCCAACAGTATAAAAGTTATTCTCGCACGTTCGGCCAAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSTLSASVGDRVTITCRASQSISTWLAWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTEFTVTISSLQPDDFATYYCQQYKSYSRTFGQGTKVEIK	IGHV5-51*01	IGHJ4*02	IGHD2-21*01	IGKV1-5*01	IGKJ1*01	ARQYCGGDCPFDY	QQYKSYSRT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
26	Cho-C034	C2064	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCCGGCTCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGGCTCCATCAGCAGTGGTGGTTACTCCTGGAGCTGGATCCGGCAGCCACCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATCATAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCAGTAGACAGGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATTACTGTGCCAGAACATTATGTGGTGGTGACTGCCCCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGSGLVKPSQTLSLTCAVSGGSISSGGYSWSWIRQPPGKGLEWIGYIYHSGSTYYNPSLKSRVTISVDRSKNQFSLKLSSVTAADTAVYYCARTLCGGDCPFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTATTAGTAGCTGGTTGGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGATGCCTCCAGTTTGGAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACCATCAGCAGCCTGCAGCCTGATGATTTTGCAACTTATTACTGCCAACAGTATAATAGTTATCGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYRTFGQGTKVEIK	IGHV4-30-2*01	IGHJ4*02	IGHD2-21*02	IGKV1-5*01	IGKJ1*01	ARTLCGGDCPFDY	QQYNSYRT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
26	Wang-PFZ12	PZF12_P1_IgG_H8-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGCAGTCTGGAGCAGAGGTGAAAAAGCCCGGGGAGTCTCTGAAGATCTCCTGTAAGGGTTCTGGATACAGCTTTACCAGCTACTGGATCGGCTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATGGGAGTCATCGATCCTGGTGACTCAGAAACCAGATACAGCCCGTCCTTCCAAGGCCAGGTCACCATCTCAGCCGACAAGTCCATCAGCACCGCCTACCTGCAGTGGAGCAGCCTGAAGGCCTCGGACACCGCCATATATTACTGTGCGAGACTCCTTTGTGGTGGTGACTGTCCCTTTGAATACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGVIDPGDSETRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAIYYCARLLCGGDCPFEYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGCCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCGGGGCCAGTCAGAGTGTTAGCAGCAGCTCCTTAGCCTGGTACCAGCAGAAACCTGGCCTGGCGCCCAGGCTCCTCATCTATGATGCCTCCACCAGGGCCACTGGCATCCCAAACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCACTGTATTACTGTCAGCAGTATGGTTACTCACCTCGCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	EIVLTQSPATLSLSPGERATLSCGASQSVSSSSLAWYQQKPGLAPRLLIYDASTRATGIPNRFSGSGSGTDFTLTISRLEPEDFALYYCQQYGYSPRTFGQGTRLEIK	IGHV5-51*01	IGHJ4*02	IGHD2-21*02	IGKV3D-20*01	IGKJ5*01	ARLLCGGDCPFEY	QQYGYSPRT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
26	Tong_C53	C53F10	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike (and spike minus RBD)	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGCAGTCCGGAGCAGAGGTGAAAAAGCCCGGGGAGTCTCTGAGGATCTCCTGTAAGGGTGCAGGATACAGCTTTACCAGCTACTGGATCACCTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATGGGGAGGATTGATCCTAGTGACTCTTATACCAACTACAGCCCGTCCTTCGAAGGCCACGTCACCATCTCAGCTGACAAGTCCATCAGCACTGCCTACCTGCAGTGGAGCAGCCTGAAGGCCTCGGACACCGCCATGTATTACTGTGCGAGACTGTATTGTGGTGGTGACTGCCCCCCGGGCTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVQSGAEVKKPGESLRISCKGAGYSFTSYWITWVRQMPGKGLEWMGRIDPSDSYTNYSPSFEGHVTISADKSISTAYLQWSSLKASDTAMYYCARLYCGGDCPPGYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTATTAGTAGCTGGTTGGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGATGCCTCCAGTTTGGAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACCATCAGCAGCCTGCAGCCTGATGATTTTGCAACTTATTACTGCCAACAGTATAATAGTTATTGGACGTTCGGCCAAGGGACCAAGGTGGAGATCAAA	DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYWTFGQGTKVEIK	IGHV5-10-1*03	IGHJ4*02	IGHD2-21*02	IGKV1-5*01	IGKJ1*01	ARLYCGGDCPPGY	QQYNSYWT	nan	Tong et al. Cell 184:4969-4980.e15 (2021)	MW718384.1	MW718536.1
26	Cho-C034	C2140	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGCAGTCTGGAGCAGAGGTGAAAAAGCCCGGGGAGTCTCTGAAGATCTCCTGTAAGGGTTCTGGATATAGCTTTACCAGCTACTGGATCGGCTGGGTGCGCCAGATGCCCGGGACTGGCCTGGAGTGGATGGGGATCATCTATCCTGGTGACTCTGATACCACATACAGCCCGTCCTTCCAAGGCCAGGTCACCATGACAGCCGACAAGTCCATCAGCACCGCCTACCTGCAGTGGAGCAGCCTGAAGGCCTCGGACACCGCCATGTATTACTGTGCGAGACAGATTTGTGGTGGTGACTGCCCGATTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQMPGTGLEWMGIIYPGDSDTTYSPSFQGQVTMTADKSISTAYLQWSSLKASDTAMYYCARQICGGDCPIDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTATTAGTAGCTGGTTGGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGATGCCTCCAGTTTGGAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACCATCAGCAGCCTGCAGCCTGATGATTTTGCAACTTATTACTGCCAACAGTATAACAGTTATTGGACGTTCGGCCAAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYWTFGQGTKVEIK	IGHV5-51*01	IGHJ4*02	IGHD2-21*02	IGKV1-5*01	IGKJ1*01	ARQICGGDCPIDY	QQYNSYWT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
27	Wang-MOD8	MOD8_P2_IgG_C2-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCGGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTGGTGGTTTCTACTGGAGCTGGATCCGCCAGCACCCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTTCTACAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGGCACGTCTAAGAACCAGTTCTCCCTGAGGCTGAGCTCTGTGACTGCCGCGGACACGGCCGTGTATTACTGTGCGAGAGATTTCGGTGGTAACTCTAACTACTTTGCCTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGFYWSWIRQHPGKGLEWIGYIYYSGSTFYNPSLKSRVTISVGTSKNQFSLRLSSVTAADTAVYYCARDFGGNSNYFAYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAAGTATTTAAGTTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCTTCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTAACCATCAGCAGCCTGCAGCCTGGAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCGCTCACTTTCGGCGGAGGGGCCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISKYLSWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTLTISSLQPGDIATYYCQQYDNLPLTFGGGAKVEIK	IGHV4-31*03	IGHJ4*02	IGHD4-23*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	ARDFGGNSNYFAY	QQYDNLPLT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
27	Wang-MOD11	Mod11_P1_IgG_E12-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTGGTGGTTACTACTGGAGCTGGATCCGCCAGCACCCAGGGAAGGGCCTGGAGTGGATTGGGAACATCTATCACAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTATGACCCAGTTCTCCCTGAAGCTGACCTCTGTGACTGCCGCGGACACGGCCGTGTATTACTGTGCGAGAGACTTCGGTGGTAACTCAAACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGYYWSWIRQHPGKGLEWIGNIYHSGSTYYNPSLKSRVTISVDTSMTQFSLKLTSVTAADTAVYYCARDFGGNSNYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGGCAGGACATCAGCAACTATATAAGTTGGTATCAGCAGAAATCAGNGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQARQDISNYISWYQQKSXKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK	IGHV4-31*03	IGHJ4*02	IGHD4-23*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	ARDFGGNSNYFDY	QQYDNLPLT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
27	Wang-MOD11	Mod11_P1_IgG_F11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCACCAGTGGTGGTTTCTACTGGAGCTGGATCCGCCAGCACCCAGGGAAGGGCCTGGAGTGGATTGGGAACATCTATTACAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCGTGTATTACTGTGCGAGAGACTACGGTGGTAACTCAAACTACTTTGGCTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSQTLSLTCTVSGGSITSGGFYWSWIRQHPGKGLEWIGNIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDYGGNSNYFGYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGGCAGGACATCAGCAACTATATAAGTTGGTATCAGCAGAAATCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQARQDISNYISWYQQKSGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK	IGHV4-31*03	IGHJ4*02	IGHD4-23*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	ARDYGGNSNYFGY	QQYDNLPLT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
27	Wang-PFZ10	PZF10_P2_IgG_F7-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTGGTGGTTTCTACTGGAGCTGGATCCGCCAGCACCCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAACACCTACTACAATCCGTCCCTCAAGAGTCGAGTTATCATATCAGTAGACACGTCTAAGAACCAGTTCTCCCTGAAGTTGAGCTCTGTGACTGCCGCGGACACGGCCGTGTATTATTGTGCGAGGGACTACGGTGGTAACTCCAATTACTTTGGCTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGFYWSWIRQHPGKGLEWIGYIYYSGNTYYNPSLKSRVIISVDTSKNQFSLKLSSVTAADTAVYYCARDYGGNSNYFGYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTGGGAGACAGAGTCACCATCACTTGCCAGGCGACTCAGGACATTAGTAGATACTTAAGTTGGTATCAACAGAAACCAGGGAAAGCCCCTAAACTCCTGATCTACGATGTATCCGATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTCACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATAATAATCTCCCGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQATQDISRYLSWYQQKPGKAPKLLIYDVSDLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYNNLPLTFGGGTKVEIK	IGHV4-31*03	IGHJ4*02	IGHD4-23*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	ARDYGGNSNYFGY	QQYNNLPLT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
27	Wheatley-CP8	PDI_71	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTGGTGGTTATTATTGGAGCTGGATCCGCCAGCACCCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTTATCATATCAGTAGACACGTCTAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCGTGTATTTCTGTGCGAGGGACTACGGTGGTAACTCGAACTACTTTGGCTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGYYWSWIRQHPGKGLEWIGYIYYSGSTYYNPSLKSRVIISVDTSKNQFSLKLSSVTAADTAVYFCARDYGGNSNYFGYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAACTTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATTTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAA	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLTWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK	IGHV4-31*03	IGHJ4*02	IGHD4-23*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	ARDYGGNSNYFGY	QQYDNLPLT	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
27	Aishun_Jin_mix	510G4	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGYYWSWIRQHPGKGLDWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDYGGNSNYFHYWGQGTLVTVSP	nan	DIQMTQSPSSLSASVGDRVTITCQASQDISKYLSWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGADFTFTISSLQPEDIATYYCQQYDTLPLTFGGGTKVEIK	IGHV4-31*02	IGHJ4*02	IGHD4-23*01	IGKV1-33*01	IGKJ4*01	ARDYGGNSNYFHY	QQYDTLPLT	nan	Han et al. Front Immunol. 12:653189 (2021)	nan	nan
27	Aishun_Jin_mix	CQTS145	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGCGGCTCCATCAGCAGTGGTGGTTACTACTGGAGTTGGATCCGCCAGCACCCAGGGAAGGGCCTGGACTGGATTGGGTACATCTATTACAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCGTGTATTACTGTGCGAGAGACTACGGTGGTAACTCCAACTACTTTCACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCCCAG	QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGYYWSWIRQHPGKGLDWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDYGGNSNYFHYWGQGTLVTVSP	GACATCCAGATGACCCAGTCTCCCTCCTCCCTGTCTGCATCTGTGGGAGACAGAGTCACCATCACCTGCCAGGCGAGTCAGGACATTAGCAAGTATTTAAGTTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGGAGTGGATCTGGGGCAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAGGATATTGCAACATATTACTGTCAACAATATGATACTCTCCCGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISKYLSWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGADFTFTISSLQPEDIATYYCQQYDTLPLTFGGGTKVEIK	IGHV4-31*03	IGHJ4*02	IGHD4-23*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	ARDYGGNSNYFHY	QQYDTLPLT	nan	Patent: CN111925443A	MW587570.1	MW587571.1
27	Wang-PFZ10	PZF10_P2_IgG_B3-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCAGTGTCTCTGGTGGCTCCATCAGCAGTGGTGGTTACTACTGGAACTGGATCCGCCAGCACCCAGGGAAGGGCCTGGAGTGGATTGGGAGCATCTATTACAGTGGGAGCACCTACTACAATCCGTCCCTCAAGAGTCGAGTAACCGTATCAGTAGACACGTCTAAGAACCAGTTTTCCCTGAAGCTAAACTCTGTGACTGCCGCGGACACGGCCGTGTATTACTGTGCGAGGGACTACGGTGGTAACGCCAACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSQTLSLTCSVSGGSISSGGYYWNWIRQHPGKGLEWIGSIYYSGSTYYNPSLKSRVTVSVDTSKNQFSLKLNSVTAADTAVYYCARDYGGNANYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAAGTATTTAACTTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAACTCCTGATCTACGATGCATCCAATTTGGAAGCAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTTCTTTCACCATCAGCTACCTGCAGCCTGAAGATCTTGCAACATATTACTGTCAACAGTATGGTTATCTCCCGCTCACTTTCGGCGGGGGGACCAAGGTGGAGATGAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISKYLTWYQQKPGKAPKLLIYDASNLEAGVPSRFSGSGSGTDFSFTISYLQPEDLATYYCQQYGYLPLTFGGGTKVEMK	IGHV4-31*03	IGHJ4*02	IGHD4-23*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	ARDYGGNANYFDY	QQYGYLPLT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
27	Cho-C016	C2413	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGCTGAAGCCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGAGGTGGTTTCTACTGGAGCTGGATCCGCCACCACCCAGTGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTGGACACGTCTAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCGTGTATTACTGTGCGAGAGACTACGGTGGTAACGCCAACTACTTTCACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLLKPSQTLSLTCTVSGGSISRGGFYWSWIRHHPVKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDYGGNANYFHYWGQGTLVTVSS	GCCATCCGGATGACCCAGTCTCCATCCTCCCAGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAGTTGGTATCAGCAGAAAGCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGCTAATCTCCCTCTCACTTTCGGCGGAGGGACCAAGGTGGAAATCAAAC	AIRMTQSPSSQSASVGDRVTITCQASQDISNYLSWYQQKAGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYANLPLTFGGGTKVEIK	IGHV4-31*03	IGHJ4*02	IGHD4-23*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	ARDYGGNANYFHY	QQYANLPLT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
28	Wang-PFZ12	PZF12_P1_IgG_A3-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGCTATATCTATTACAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATGTCAGTAGACACGTCCAAGAATAAGTTCTCCCTGAAGCTGAGTTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGCGATTACTATGATACTAGTGGTTATTGTTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTMSVDTSKNKFSLKLSSVTAADTAVYYCASDYYDTSGYCYGMDVWGQGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCTTCCGTGTCTGCATCTGTTGGAGACAGAGTCACCATCACTTGTCGGGCGAGTCAGGGTATTAACAGCTGGTTAGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTACAACCAATTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTACTATTGTCAACAGGCTAACAGTTTCCCTCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCA	DIQMTQSPSSVSASVGDRVTITCRASQGINSWLAWYQQKPGKAPKLLIYATTNLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPLTFGGGTKVEI	IGHV4-59*01	IGHJ6*02	IGHD3-22*01	IGKV1-12*01	IGKJ4*01	ASDYYDTSGYCYGMDV	QQANSFPLT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
28	Cho-C006	C2011	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATTACAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCCGTGTATTACTGTGCTTCCTATTACTATGATAGTAGTGGTTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCASYYYDSSGYYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCTTACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYLTFGQGTRLEIK	IGHV4-59*08	IGHJ6*02	IGHD3-22*01	IGKV1-9*01	IGKJ5*01	ASYYYDSSGYYYGMDV	QQLNSYLT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
28	Aishun_Jin_mix	56H7	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV4-59*01	IGHJ6*02	IGHD3-22*01	IGKV1D-12*01	IGKJ4*01	ATDYYDSSGYRYGMDV	QQANSFPLT	nan	Han et al. Front Immunol. 12:653189 (2021)	nan	nan
28	Aishun_Jin_mix	CQTS101	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCATTTGCACTGTCTCTGGTGGCTCCATCACTAGTTACTACTGGACCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATTATAATGGGAGCTCCAACTACAATCCCTCCCTCGAGAGTCGAGTCACCATATCAGTAGACGCGTCCAAGAACCAGTTTTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGACTGATTATTATGATAGTAGTGGTTATCGTTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSETLSLICTVSGGSITSYYWTWIRQPPGKGLEWIGYIYYNGSSNYNPSLESRVTISVDASKNQFSLKLSSVTAADTAVYYCATDYYDSSGYRYGMDVWGQGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCTTCTGTGTCTGCATCATTAGGAGACAGAGTCACCATCACTTGTCGGGCGAGTCAGGGTATTAGCGGCTGGTTAGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTATGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCAGTATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTACTATTGTCAACAGGCTAACAGTTTCCCCCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSVSASLGDRVTITCRASQGISGWLAWYQQKPGKAPMLLIYAASSLQSGVPSRFSGSGSGTDFTLSISSLQPEDFATYYCQQANSFPLTFGGGTKVEIK	IGHV4-59*01	IGHJ6*02	IGHD3-22*01	IGKV1D-12*01	IGKJ4*01	ATDYYDSSGYRYGMDV	QQANSFPLT	nan	Patent: CN111909261A	MW587502.1	MW587503.1
28	Li_SARS2_26	DH1096	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCASYYYDSSGYYYGFDIWGQGTMVTVSS	nan	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYLTFGGGTKVEIK	IGHV4-59*03	IGHJ3	nan	IGKV1-9*01	IGKJ4	ASYYYDSSGYYYGFDI	QQLNSYLT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
28	COV107	C570	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGCCTCCATCAGTAGTTATTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATTACAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCACTAGACACGTCCAAGAACCAGTTCTCCCTGCAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGACTTATTACTTTGATAATAGTGGTTATTCATACGGTCTGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCTVSGASISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISLDTSKNQFSLQLSSVTAADTAVYYCATYYFDNSGYSYGLDVWGQGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCGCTTGCCGGGCAAGTCAGAGCATTTCTAGTTATTTACATTGGTATCAGCAGCAGCCAGGGAAGGCCCCTAAGCTCCTGATCTATGCTGTAACCAATTTACAAAGTGGGGTCCCATCTAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGTAGTCTCCAACCTGAAGATTTTGCTACTTACTACTGTCAACAGAGTTACAGTCTCCCTCAGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTIACRASQSISSYLHWYQQQPGKAPKLLIYAVTNLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSLPQTFGQGTKVEIK	IGHV4-59*01	IGHJ6*02	IGHD3-22*01	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	ATYYFDNSGYSYGLDV	QQSYSLPQT	nan	Gaebler et al. Nature 591:639-644 (2021)	nan	nan
28	Chen _CellMolImmunol_mix	31B9	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	nan	nan	nan	nan	nan	ATYYYDSSGYSYGMDV	nan	nan	Chen et al. Cell Mol. Immunol. 17:647-649 (2020)	nan	nan
28	IML3564	ADI-62069	nan	SARS-CoV-2	nan	SARS-CoV,SARS-CoV-2	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGACCTGGATCCGACAGCCCCCAGGGAAGGGACTGGAGTGGATTGGCTATATCTTTTACGATGGGAGCGCCAACTACAGCCCCTCCCTCCGGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTCTATTACTGTGCGACCTATTACTATGATAGTAGTGGTTTTTCGTTCGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGPGLVKPSETLSLTCTVSGGSISSYYWTWIRQPPGKGLEWIGYIFYDGSANYSPSLRSRVTISVDTSKNQFSLKLSSVTAADTAVYYCATYYYDSSGFSFGMDVWGQGTTVTVSS	nan	nan	IGHV4-59*01	IGHJ6*02	IGHD3-22*01	IGKV1-12	nan	ATYYYDSSGFSFGMDV	QQGNSFPLT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458161.1	nan
28	CV38	HK_CV38-124	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	TCCGCCAAACCCCGGGTCATTCTGAGGTGCCAGCTCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATTACAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGACTTATTACTATGATAGTAGTGGTTACCCCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAGCCTCCACCAAGGGCCCATCGGTCTTCCCCCTGGCACCCTCCTCCAAGAGCACCTCTGGGGCACAGCGCCCGGCGAGG	EVPAQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCATYYYDSSGYPYGMDVWGQGTTVTVSS	AGGGGTTCTTTTTTCCCCCCCGTCCATTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCCGGTTTCGGCCCTGGGACCAAAGTGGATATCAAACGAACTGTGGCTGCACCATCTGTCTTCATCTTCCCGCCATCTGATGAGCAGTTGAAATCTGGAACTGCCTCTGTTGTGTGCCTGCTGAATAACTTCTATCCCAGAGAGGCCAAAGTACAGTGGAAGGTGGATAACGCCCTCCAATCGGTAACTCCCAGAGTTGGAA	RGSFFPPVHSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSYPGFGPGTKVDIK	IGHV4-59*01	IGHJ6*02	IGHD3-22*01	IGKV1-9*01	IGKJ3*01	ATYYYDSSGYPYGMDV	QQLNSYPG	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
29	COV047	C066	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCCTCGTCAGTAGAAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTACAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAGGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGTTGTATCTTCAAATGGACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATGTTGGAGACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLLVSRNYMTWVRQAPGKGLEWVSVIYSGGSTFYADSVRGRFTISRDNSKNTLYLQMDSLRAEDTAVYYCARDVGDYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCAGCCTTCCTGTCTGCATCTGTAGGAGACAGAGTTACCATCACTTGCCGGGCCAGTCAGGGCATGAGCAATTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAACCTCCTGATCTATACTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACTTCTTAATAGTTACCCTCAGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPAFLSASVGDRVTITCRASQGMSNYLAWYQQKPGKAPNLLIYTASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQLLNSYPQLTFGGGTKVEIK	IGHV3-53*01	IGHJ6*02	IGHD3-3*01,IGHD3-3*02	IGKV1-9*01	IGKJ4*01	ARDVGDYYGMDV	QLLNSYPQLT	nan	Gaebler et al. Nature 591:639-644 (2021)	nan	nan
29	Wang-MOD7	MOD7_P1_IgG_D3-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGTCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGACTCATCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGGGGGTCTCAGTTATTTATAGTGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAATAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGGAAGTGGTGATTATTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQSGGSLRLSCAASGLIVSSNYMSWVRQAPGKGLEGVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGSGDYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAGGATCTTGCAACTTATTACTGTCAACGTCTTAATAGTTACCCTCCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDLATYYCQRLNSYPPYTFGQGTKLEIK	IGHV3-66*01	IGHJ6*02	IGHD3-3*01,IGHD3-3*02	IGKV1-9*01	IGKJ2*01	ARGSGDYYGMDV	QRLNSYPPYT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
29	Wang-C003	C1445	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGACTTGGTCCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGAATCACCGTCAGTAGGAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGAAGTGGGTCTCAACTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGGGGTGCTGGCTATTATTATGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAG	EVQLVESGGDLVQPGGSLRLSCAASGITVSRNYMSWVRQAPGKGLKWVSTIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGAGYYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTATAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGTATTAGCAATTATTTAGCCTGGTATCAACAAAAACCAGGGAAAGCCCCTAAGCTCCTTATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCGGCAAGGTTCAGCGGCACTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAACTTGATGATAATTCTAATTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASIGDRVTITCRASQGISNYLAWYQQKPGKAPKLLIYAASTLQSGVPARFSGTGSGTEFTLTISSLQPEDFATYYCQQLDDNSNFGGGTKVEIK	IGHV3-66*01,IGHV3-66*04	IGHJ6*02	IGHD4/OR15-4a*01,IGHD4/OR15-4b*01	IGKV1-9*01	IGKJ4*01	ARGAGYYYGMDV	QQLDDNSN	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
29	Xie_mix	BD-610	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASGITVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGGAYYYGMDVWGQGTTVTVSS	nan	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNTYPPFGFGPGTKVDIK	IGHV3-53*01	nan	nan	IGKV1-9*01	nan	ARGGAYYYGMDV	QQLNTYPPFG	nan	Du et al. Cell 183:1013-1023.e13 (2020)	nan	nan
29	Cho-C030	C1303	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCGGCCTCTGGGATCACTGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCCGGAGTGGGTCTCAACTCTTCATAGCGGTGGTAGCACATTTTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACGATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTTTACTACTGTGCGAGAGGAGGTGGGCACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGITVSSNYMSWVRQAPGKGPEWVSTLHSGGSTFYADSVKGRFTISRDDSKNTLYLQMNSLRAEDTAVYYCARGGGHYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCTTCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCCATTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAACTCCTGATCTATGGTGCATCCACTTTGCAAAATGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACGTCTTAATAGTTACCCTCCGATCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISHYLAWYQQKPGKAPKLLIYGASTLQNGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQRLNSYPPITFGQGTRLEIK	IGHV3-53*01	IGHJ6*02	IGHD1-26*01,IGHD2-15*01,IGHD2-21*01	IGKV1-9*01	IGKJ5*01	ARGGGHYYGMDV	QRLNSYPPIT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
29	Wang-MOD2	C637	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTAAGACTCTCCTGTGCAGCCTCTGGGGTCACCGTCAGAAGTAATTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTAATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGGGGGGGGGGCCACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGVTVRSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGGGHYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPYTFGQGTKLEIK	IGHV3-53*01	IGHJ6*02	IGHD3-16*01,IGHD3-16*02	IGKV1-9*01	IGKJ2*01	ARGGGHYYGMDV	QQLNSYPPYT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
29	Wang-MOD2	Mod2_P1_IgG_F11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTAAGACTCTCCTGTGCAGCCTTTGGGGTCACCGTCAGAAGTAATTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCAGTAATTTATAGCGGTGGTAGCACATTTTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATTTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGGGGGGGGGGCCACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAAFGVTVRSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYFQMNSLRAEDTAVYYCARGGGHYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPYTFGQGTKLEIK	IGHV3-53*01	IGHJ6*02	IGHD3-16*01,IGHD3-16*02	IGKV1-9*01	IGKJ2*01	ARGGGHYYGMDV	QQLNSYPPYT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
29	Cho-C030	C1402	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGGTCCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCAGGGATCATCGTCAGTAGGAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAATTATTTACAGTGGTGGCAGTACATTCTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGACACAATTCCAATAACACCTTGCATCTTCAAATGAACAGCCTGAGACCTGAGGACACGGCCGTGTATTACTGTGCCAGAGGCGGAGGCTACTTCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGIIVSRNYMSWVRQAPGKGLEWVSIIYSGGSTFYADSVKGRFTISRHNSNNTLHLQMNSLRPEDTAVYYCARGGGYFYGMDVWGQGTTVTVSS	GAAATTGTGTTGACACAGTCTCCAGCCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCTACTTAGCCTGGTACCAACAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGATGCATCCAACAGGGCCACTGGCATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGCCTAGAGCCTGAAGATTTTGCAGTTTATTACTGTCAGCAGCGTAGCAACTGGCCGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPTFGQGTKVEIK	IGHV3-53*04	IGHJ6*02	nan	IGKV3-11*01	IGKJ1*01	ARGGGYFYGMDV	QQRSNWPT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
29	Wang-PFZ12	PZF12_P2_IgG_A11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGACTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGTAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAATTATTTATAGTGGTGGCAGTACATACTACGCAGACTCCGTGAAGGGCCGATTCAACATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGGGGGTTCCTACTATTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVETGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSIIYSGGSTYYADSVKGRFNISRDNSKNTLYLQMNSLRAEDTAVYYCARGGSYYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATGGTATCCCTCTCCCCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNGIPLPTFGGGTKVEIK	IGHV3-53*02	IGHJ6*02	IGHD3-10*01	IGKV1-9*01	IGKJ4*01	ARGGSYYYGMDV	QQLNGIPLPT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
30	Wang-MOD6	MOD6_P1_IgG_G8-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGAGTGGTCCGGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGCCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATTATATGATGGAAGTTATAAAGACTATGCAGACTCCGTGAAGGGCCGATACACCATCTCCAGAGACAATTCCAGGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTCTATTACTGTGCGAGAGATGAAGGGGAAGTGGTTACCCACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVRPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVILYDGSYKDYADSVKGRYTISRDNSRNTLYLQMNSLRAEDTAVYYCARDEGEVVTHFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACCTGCCGGGCAAGTCAGAGCATTAGCAACTATTTATCTTGGTATCAACAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTTCTGTCAACAGAGTTACAATACCCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSISNYLSWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYFCQQSYNTPPWTFGQGTKVEIK	IGHV3-33*05	IGHJ4*02	IGHD3-22*01,IGHD3-3*01,IGHD3-3*02	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	ARDEGEVVTHFDY	QQSYNTPPWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
30	Wang-MOD6	MOD6_P2_IgG_G3-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCAGCTTCAGAAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATGGTCTGATGGAAGTGGTAAACACTATGCAGACCCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATCCCAAGAACACCCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGATGAAGGGGAAGTGGTTACTCACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFSFRSYGMHWVRQAPGKGLEWVAVIWSDGSGKHYADPVKGRFTISRDNPKNTLYLQMNSLRAEDTAVYYCARDEGEVVTHFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGGAGCTACTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCGTGATCTATGGTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAATACCCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSIRSYLNWYQQKPGKAPKLVIYGASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYNTPPWTFGQGTKVEIK	IGHV3-33*01	IGHJ4*02	IGHD3-22*01,IGHD3-3*01,IGHD3-3*02	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	ARDEGEVVTHFDY	QQSYNTPPWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
30	Wang-PFZ10	PZF10_P2_IgG_E1-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTGGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTACATCGTATGATGGAAGTTATAAATCCTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGATAGTCGAGGACACGGCTGTATATTACTGTGCGAGAGATGGGGGCGAGGTGGTGACTGTCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSGYGMHWVRQAPGKGLEWVAVTSYDGSYKSYADSVKGRFTISRDNSKNTLYLQMNSLIVEDTAVYYCARDGGEVVTVFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTGGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTGGCACCTATTTAAATTGGTATCAGCAGAAACCAGGAAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGAGGATCTGGGACAGATTTCACTCTCACCATCAGCGGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTAGTCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSIGTYLNWYQQKPGKAPKLLIYAASTLQSGVPSRFSGRGSGTDFTLTISGLQPEDFATYYCQQSYSSPPWTFGQGTKVEIK	IGHV3-33*01,IGHV3-33*05	IGHJ4*02	IGHD2-21*02	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	ARDGGEVVTVFDY	QQSYSSPPWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
30	Crowe_mix	COV2-2705	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTTATAAATACTTCGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGATCAGGGTACGGTGGTAACTCATTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSYKYFADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDQGTVVTHFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTACATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTCGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGTTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAGCCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCACCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAA	DIQMTQSPSSLSTSVGDRVTITCRASQSIRSYLNWYQQKPGKAPKLLIYVASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPWTFGQGTKVEIK	IGHV3-30*04,IGHV3-30-3*03	IGHJ4*02	IGHD4-23*01	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	ARDQGTVVTHFDY	QQSYSTPPWT	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665570.1	MT665183.1
30	Chen_Vax_p1	COV2-vax-64	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATTATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATGTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGATCAGGGGGTGGTGGTGACCCACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCGTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVILYDGSNKYYADSVKGRFTISRDNSKNTLYVQMNSLRAEDTAVYYCARDQGVVVTHFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTCCTGTCAACAGAGTTACAGTACCCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYSCQQSYSTPPWTFGQGTKVEIK	IGHV3-30-3*01	IGHJ4*02	IGHD2-21*02	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	ARDQGVVVTHFDY	QQSYSTPPWT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555530.1	MZ555531.1
30	Wang-MOD7	MOD7_P2_IgG_B7-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGTTATGCTATGCACTGGGTCCGCCAGACTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATTATATGATGGAAGTAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGATACGGCTGTGTATTACTGTGCGAGAGATCAGGGAGTAGTGGTTACTCACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQTPGKGLEWVAVILYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDQGVVVTHFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCAGTCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACAAGGGAAAGCCCCTAAGCTCCTGATCTATGTTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPVSLSASVGDRVTITCRASQSISSYLNWYQQKQGKAPKLLIYVASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPWTFGQGTKVEIK	IGHV3-30*04,IGHV3-30-3*03	IGHJ4*02	IGHD3-22*01	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	ARDQGVVVTHFDY	QQSYSTPPWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
30	COV096	COV096_HC_122-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAACTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATGGTATGATGGAAGTAATAAGCACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGAGTATTACTGTGCGAGAGATATGGGTACGTTGGTAACACACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAEYYCARDMGTLVTHFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAATTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTTCCCCTCCTTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASNLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSSPPWTFGQGTKVEIK	IGHV3-33*01	IGHJ4*02	IGHD4-23*01	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	ARDMGTLVTHFDY	QQSYSSPPWT	nan	Robbiani et al. Nature 584:437-442 (2020);Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW293071.1	MW293526.1
30	Wang-MOD7	MOD7_P1_IgG_H5-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTAGATTCACCTTTAGTAACTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGACTGGGTGGCAGTTATATCAGATGATGGAAATAATAAATTGTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTATATTACTGTGCGAGAGATCAGGGAGTAATGGTTACCCACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASRFTFSNYAMHWVRQAPGKGLDWVAVISDDGNNKLYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDQGVMVTHFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGACAAGTCAGAGCATTAGGAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGATGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAATACCCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCRTSQSIRNYLNWYQQKPGKAPKLLIYDASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYNTPPWTFGQGTKVEIK	IGHV3-30*04,IGHV3-30-3*03	IGHJ4*02	IGHD3-16*01,IGHD3-16*02	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	ARDQGVMVTHFDY	QQSYNTPPWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
31	Aishun_Jin_mix	81A1	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV4-59*01	IGHJ3*02	IGHD6-19*01	IGLV2-23*01	IGLJ3*02	ARDQGYSSGWNDAFDI	CSYAGSRFWV	nan	Han et al. Front Immunol. 12:653189 (2021)	nan	nan
31	Aishun_Jin_mix	CQTS036	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCGGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGACCTGGATCCGGCAGGCCCCAGGGAAGGGACTGGAGTGGATTGGATATATATATAACAGTGGGAGCACCAACTACAACCCCTCCCTCAGGGGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAACCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTATTGTGCGAGAGATCAGGGGTATAGCAGTGGCTGGAATGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWTWIRQAPGKGLEWIGYIYNSGSTNYNPSLRGRVTISVDTSKNQFSLNLSSVTAADTAVYYCARDQGYSSGWNDAFDIWGQGTMVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGATGTTGGGAGTTATAACCTTGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGAGGGCAGTAAGCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACAATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATCACTGCTGCTCATATGCAGGTAGTAGGTTTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEGSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYHCCSYAGSRFWVFGGGTKLTVL	IGHV4-59*01	IGHJ3*02	IGHD6-19*01	IGLV2-23*01,IGLV2-23*03	IGLJ3*02	ARDQGYSSGWNDAFDI	CSYAGSRFWV	nan	Patent: CN111925441A	MW587414.1	MW587415.1
31	Wang-PFZ10	PZF10_P1_IgG_G3-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGACTCCATCAGTACCTATTATTGGAGCTGGATCCGGCAGCCCCCAGGGAAGCGACTGGAGTGGATTGGATATATCTTTAACAGTGGGGGCACCAACTACAATCCCTCCCTCAGGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTAAAGCTGAACTCTGTGACCGCTGCGGACACGGCCGTATATTACTGTGCGAGAGATAGGGGGTATAGCAGTGGCTGGCCCGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QVQLQESGPGLVKPSETLSLTCTVSGDSISTYYWSWIRQPPGKRLEWIGYIFNSGGTNYNPSLRSRVTISVDTSKNQFSLKLNSVTAADTAVYYCARDRGYSSGWPDAFDIWGQGTMVTVSS	GAAATTGTGTTGACACAGTCTCCAGCCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTTACAGCTACTTAGCCTGGTACCAACAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGATGCATCCAACAGGGCCACTGGCATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGCCTAGACCCTGAAGATTTTGCAGTTTATTACTGCCAGCAGCATAGCAACTGGCCGGGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPATLSLSPGERATLSCRASQSVYSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLDPEDFAVYYCQQHSNWPGTFGQGTKVEIK	IGHV4-59*01	IGHJ3*02	IGHD6-19*01	IGKV3-11*01	IGKJ1*01	ARDRGYSSGWPDAFDI	QQHSNWPGT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
31	Jennewein_PCV1	PCV1-19	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAATTACTACTGGAGCTGGATCCGGCAGCCCCCGGGGAAGGGACTGGAGTGGATTGGATATATCTTTTACAGTGGGAGCACCAACTACAACCCCTCCCTCAGGAGTCGAGTCACCATATCAGTTGACACGTCCAAGAACCAATTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGAGATAGGGGATATAGCAGTGGCTGGCCTGATGCTTTTGATATGTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	EVQLVESGPGLVKPSETLSLTCTVSGGSISNYYWSWIRQPPGKGLEWIGYIFYSGSTNYNPSLRSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDRGYSSGWPDAFDMWGQGTMVTVSS	GAAATTGTGTTGACACAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTTTTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTTCCTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAA	EIVLTQSPSSLSASVGDRVTITCQASQDISNFLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFSFTISSLQPEDIATYYCQQYDNLPYTFGQGTKLEIK	IGHV4-59*13	IGHJ3*02	IGHD6-19*01	IGKV1-33*01,IGKV1D-33*01	IGKJ2*01	ARDRGYSSGWPDAFDM	QQYDNLPYT	nan	Jennewein et al. Cell Rep. 36:109353 (2021)	MW806108.1	MW806152.1
31	Wang-PFZ10	C694	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCCTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAATTACTACTGGAGCTGGATCCGGCAGTCCCCAGGGGAGAGACTGGAGTGGATTGGATATATCTTTCACAGTGGGAGCACCAACTACAGCCCCTCCCTCAGGGGTCGAGTCACCGTATCAGTAGACACGTCCAAGAAGCAGTTCTCCCTGAAACTGCGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGAGATCGGGGATATGATAGTAGTGGTCCCGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QVQLQESGPGLVKPSETLSLTCTVSGGSISNYYWSWIRQSPGERLEWIGYIFHSGSTNYSPSLRGRVTVSVDTSKKQFSLKLRSVTAADTAVYYCARDRGYDSSGPDAFDIWGQGTMVTVSS	GAAATTGTGTTGACACAGTCTCCAGCCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGGTACTTAGCCTGGTACCAACAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGATGCATCCAACAGGGCCACTGGCATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGCCTAGAGCCTGAAGATTTTGCAGTTTATTACTGTCACCAGCGTAGCAACTGGCCGGGCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	EIVLTQSPATLSLSPGERATLSCRASQSVSRYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCHQRSNWPGTFGQGTRLEIK	IGHV4-59*01	IGHJ3*02	IGHD3-22*01	IGKV3-11*01	IGKJ5*01	ARDRGYDSSGPDAFDI	HQRSNWPGT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
31	Wang-PFZ10	PZF10_P1_IgG_F3-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCGTCGGAGATCCTGTCCCTCACCTGCAGTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGTATATCTTTTACAGTGGGAGCACCAACTACAACCCCTCCCTCAGGAGTCGAGTCGCCATATCAGTTGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGAGATCGGGGGTATGATAGTAGTGGTCCCGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QVQLQESGPGLVKPSEILSLTCSVSGGSISSYYWSWIRQPPGKGLEWIGYIFYSGSTNYNPSLRSRVAISVDTSKNQFSLKLSSVTAADTAVYYCARDRGYDSSGPDAFDIWGQGTMVTVSS	GAAATTGTGTTGACACAGTCTCCANTCTCCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCTACTTAGCCTGGTACCAACAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGATGCATCCAACAGGGCCACTGGCATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGTAGCCTAGAGCCTGAAGATTTTGCAGTTTATTTCTGTCAGCAGCGTAGCAACTGGCCGGGCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	EIVLTQSPXSLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYFCQQRSNWPGTFGQGTRLEIK	IGHV4-59*01	IGHJ3*02	IGHD3-22*01	IGKV3-11*01	IGKJ5*01	ARDRGYDSSGPDAFDI	QQRSNWPGT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
31	Wang-PFZ10	PZF10_P1_IgG_F8-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCCTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAATTACTACTGGAGCTGGATCCGGCAGTCCCCAGGGGAGAGACTGGAGTGGATTGGATATATCTTTCACAGTGGGAGCACCAACTACAGCCCCTCCCTCAGGGGTCGAGTCACCGTATCAGTAGACACGTCCAAGAAGCAGTTCTCCCTGAAACTGCGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGAGATCGGGGATATGATAGTAGTGGTCCCGATGCTTTTGATATCTGGGGCCAAGGGACAAGGGTCACCGTCTCTTCAG	QVQLQESGPGLVKPSETLSLTCTVSGGSISNYYWSWIRQSPGERLEWIGYIFHSGSTNYSPSLRGRVTVSVDTSKKQFSLKLRSVTAADTAVYYCARDRGYDSSGPDAFDIWGQGTRVTVSS	GAAATTGTGTTGACACAGTCTCCAGCCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGGTACTTAGCCTGGTACCAACAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGATGCATCCAACAGGGCCACTGGCATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGCCTAGAGCCTGAAGATTTTGCAGTTTATTACTGTCACCAGCGTAGCAACTGGCCGGGCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	EIVLTQSPATLSLSPGERATLSCRASQSVSRYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCHQRSNWPGTFGQGTRLEIK	IGHV4-59*01	IGHJ3*02	IGHD3-22*01	IGKV3-11*01	IGKJ5*01	ARDRGYDSSGPDAFDI	HQRSNWPGT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
31	Wang-PFZ10	PZF10_P1_IgG_H2-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAAGACTGGTGAAGCCTTCGGAGATCCTGTCCCTCACCTGCAGTGTCTCTGGTGGCTCCATCAGTAATTACTACTGGAGCTGGATCCGGCAGCCCCCTGGGAAGGGACTGGAGTGGATTGGATATGTCTTTAACAGTGGGGGCACCAACTACAACCCCTCCCTCAGGAGTCGAGTCACCATTTCAGTAGACACGTCCAACAACCAGATCTCCCTGAAGCTGAGGTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGAGATCGGGGGTATGATACTGGTGGTCCCGATGCTTTTGAAATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QVQLQESGPRLVKPSEILSLTCSVSGGSISNYYWSWIRQPPGKGLEWIGYVFNSGGTNYNPSLRSRVTISVDTSNNQISLKLRSVTAADTAVYYCARDRGYDTGGPDAFEIWGQGTMVTVSS	GAAATTGTGTTGACACAGTCTCCAGCCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTACCAGCTACTTAGCCTGGTACCAACAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGATGCATCCAACAGGGCCACTGGCATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGCCTAGAGCCTGAAGATTTTGCAGTTTATTTCTGTCAGCAGCGTTACAACTGGCCGGGCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	EIVLTQSPATLSLSPGERATLSCRASQSVTSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYFCQQRYNWPGTFGQGTRLEIK	IGHV4-59*01,IGHV4-59*13	IGHJ3*02	IGHD2-8*02	IGKV3-11*01	IGKJ5*01	ARDRGYDTGGPDAFEI	QQRYNWPGT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
32	Wang-C001	C001_P1_IgG_B8-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATCCTCTCAGCTGGGTGCGACAGGCCCCTGGACAGGGGCTTGAGTGGATGGGAAGGATCATTCCTATCCTTGGTATAGCAAACTACGCACAGACGTTCCAGGGCAGAGTCACGATTACCGCGGAAAAATATACGACCACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGATCAGGGTTACTCTGGTTCAGGGAGTAACTACTACATGGACGTCTGGGGCAAAGGGACCACGGTCATCGTCTCCTCA	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYPLSWVRQAPGQGLEWMGRIIPILGIANYAQTFQGRVTITAEKYTTTAYMELSSLRSEDTAVYYCARDQGYSGSGSNYYMDVWGKGTTVIVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGGGGCCCCAGGACAGAGGGTCACCATCTCCTGCACTGGGAGCAGCTCCAACATCGGGGCAGGTTATGATGTACACTGGTACCAGCACCTTCCGGGAACAGCCCCCAAACTCCTCATCTATGGTAACAGCAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGACACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAGCAGCCTGAGTGATTATGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQHLPGTAPKLLIYGNSNRPSGVPDRFSGSKSDTSASLAITGLQAEDEADYYCQSYDSSLSDYVFGTGTKVTVL	IGHV1-69*09	IGHJ6*03	IGHD3-10*01	IGLV1-40*01	IGLJ1*01	ARDQGYSGSGSNYYMDV	QSYDSSLSDYV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
32	COV057	C091	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATACTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAAGGATCATCCCTATCCTTGGTATAGCAAACTACGCACAGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACAAATCCACGAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGATAGTGGATATAGTGGCTACGGAAGCACATACTACATGGACGTCTGGGGCAAAGGGACCACGGTCACCGTCTCCTCA	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYTISWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARDSGYSGYGSTYYMDVWGKGTTVTVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGCTCCAACATCGGGGCAGGTTATGATGTACACTGGTACCAGCAGCTTCCAGGAACAGCCCCCAAACTCCTCATCTATGGTAACAGCAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAGCAGCCTGAGTGGTTCTGTCTTCGGAACTGTGACCAAGGTCACCGTCCTAG	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGSVFGTVTKVTVL	IGHV1-69*09	IGHJ6*03	IGHD5-12*01	IGLV1-40*01	IGLJ1*01	ARDSGYSGYGSTYYMDV	QSYDSSLSGSV	nan	Gaebler et al. Nature 591:639-644 (2021)	nan	nan
32	COV057	C092	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCAGCTTCACCAACCATTTTATCAGTTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGTAGGATCATCCCTATCCTTGGTACAGCAAACTACGCACAGAACTTCCAAGGCAGAGTCATGATGACCGCGGACAAATCCACGAGCACAGCCTACATGGAGCTAAGTAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGATAGTGGATATAGTGGGTACGGAAGTACATACTATATGGACGTCTGGGGCAAAGGGACCACGGTCACCGTCTCCTCA	QVQLVQSGAEVKKPGSSVKVSCKASGGSFTNHFISWVRQAPGQGLEWMGRIIPILGTANYAQNFQGRVMMTADKSTSTAYMELSSLRSEDTAVYYCARDSGYSGYGSTYYMDVWGKGTTVTVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAACTCCAACATCGGGGCAGGTTATGATGTACACTGGTACCAGCAACTTCCAGGAGCAGCCCCCAAACTCCTCATCTATGGTAACAACAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGACACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGTTGAGGATGAGGCTGATTATTACTGTCAGTCCTATGACAGCAGTCTGAGTGATTCTGTCTTCGGAAGTGGGACCAAGGTCACCGTCCTAG	QSVLTQPPSVSGAPGQRVTISCTGSNSNIGAGYDVHWYQQLPGAAPKLLIYGNNNRPSGVPDRFSGSKSDTSASLAITGLQVEDEADYYCQSYDSSLSDSVFGSGTKVTVL	IGHV1-69*09	IGHJ6*03	IGHD5-12*01	IGLV1-40*01	IGLJ1*01	ARDSGYSGYGSTYYMDV	QSYDSSLSDSV	nan	Gaebler et al. Nature 591:639-644 (2021)	nan	nan
32	COV057	COVD57_P2_HC_B1-1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTGGTGCAATCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATACTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAAGGATCATCCCTATCCTTGGTATAGCAAACTACGCACAGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACAAATCCACGAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGATAGTGGATATAGTGGCTACGGAAGCACATACTACATGGACGTCTGGGGCAAAGGGACCACGGTCACCGTCTCCTCA	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYTISWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARDSGYSGYGSTYYMDVWGKGTTVTVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGCTCCAACATCGGGGCAGGTTATGATGTACACTGGTACCAGCAGCTTCCAGGAACAGCCCCCAAACTCCTCATCTATGGTAACAGCAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAGCAGCCTGAGTGGTTCTGTCTTCGGAACTGTGACCAAGGTCACCGTCCTAG	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGSVFGTVTKVTVL	IGHV1-69*08	IGHJ6*03	IGHD5-12*01	IGLV1-40*01	IGLJ1*01	ARDSGYSGYGSTYYMDV	QSYDSSLSGSV	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
32	Wang-MOD2	Mod2_P2_IgG_A10-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTCCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAAGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATGCTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAAGGATCATCCCTATCCTTGCTATAGCAAACTACGCACAGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACAAATCCACGAGCACGGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGTTGTTGGTTACTCTGGTTCGGGGAGTTCCTACTACATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPILAIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARVVGYSGSGSSYYMDVWGQGTTVTVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGCTCCAACATCGGGGCAGGTTATGATGTACACTGGTACCAGCAGCTTCCAGGAACAGCCCCCAAACTCCTCATCTATGGTAACAGTAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGGCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAGCAGCCTGAGTGGTTCGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKAGTSASLAITGLQAEDEADYYCQSYDSSLSGSVFGGGTKLTVL	IGHV1-69*04	IGHJ6*03	IGHD3-10*01	IGLV1-40*01	IGLJ2*01,IGLJ3*01	ARVVGYSGSGSSYYMDV	QSYDSSLSGSV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
32	Wang-C004	C004_P1_IgG_A7-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTCCAGCTGGTGCAATCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGTTATAGTATCAGTTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAAGGATCATCCCTATCCTTGGTATAGCAAGCTACGCACAGAAGTTCCAGGGCAGAGTCACTATTACCGCGGACAAATCCACGAGCACAGTCTACATGGAGCTGACCGGCCTGAGATCTGACGACACGGCCGTGTATTACTGTGCGAGAGATCGGGGATATAGTGACTACGGGAGCCACTACTACATGGACGTCTGGGGCAAAGGGACCACGGCCACCGTCTCCTCA	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYSISWVRQAPGQGLEWMGRIIPILGIASYAQKFQGRVTITADKSTSTVYMELTGLRSDDTAVYYCARDRGYSDYGSHYYMDVWGKGTTATVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGCTCCAACATCGGGGCAGGTTATGATGTACACTGGTACCAGCAACTTCCAGGAACAGCCCCCAAACTCCTCATTTATATTAATAGCAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAGCAGCCTGAGTGATTCAGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYINSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSDSVFGGGTKLTVL	IGHV1-69*08	IGHJ6*03	IGHD5-12*01,IGHD5/OR15-5a*01,IGHD5/OR15-5b*01	IGLV1-40*01	IGLJ3*02	ARDRGYSDYGSHYYMDV	QSYDSSLSDSV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
32	Wang-C004	C832	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGTTATAGTATCAGTTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAAGGATCATCCCTATCCTTGGTATAGCAAGCTACGCACAGAAGTTCCAGGGCAGAGTCACTATTACCGCGGACAAATCCACGAGCACAGTCTACATGGAGCTGACCGGCCTGAGATCTGACGACACGGCCGTGTATTACTGTGCGAGAGATCGGGGATATAGTGACTACGGGAGCCACTACTACATGGACGTCTGGGGCAAAGGGACCACGGTCACCGTCTCCTCA	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYSISWVRQAPGQGLEWMGRIIPILGIASYAQKFQGRVTITADKSTSTVYMELTGLRSDDTAVYYCARDRGYSDYGSHYYMDVWGKGTTVTVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGCTCCAACATCGGGGCAGGTTATGATGTACACTGGTACCAGCAACTTCCAGGAACAGCCCCCAAACTCCTCATTTATATTAATAGCAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAGCAGCCTGAGTGATTCAGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYINSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSDSVFGGGTKLTVL	IGHV1-69*09	IGHJ6*03	IGHD5-12*01,IGHD5/OR15-5a*01,IGHD5/OR15-5b*01	IGLV1-40*01	IGLJ3*02	ARDRGYSDYGSHYYMDV	QSYDSSLSDSV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
32	Wang-C004	C004_P1_IgG_B7-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTCCAGCTGGTGCAATCTGGGGCTGAGGTGAAGAAGTCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATCCTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAAGGATCATCCCTTTCCTTGGTGCAGCAGACTACGCACAGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACAAATCCACGAGCACAGCCTACATGGAGCTGAACAGCCTGACATCTGAGGACACGGCCCTTTATTATTGTGCGAGAGATCGGGGATATAGTGGCTACGGGGCCCACTACTACACGGACGTCTGGGGCAAAGGGACTACGGTCACCGTCTCCTCA	QVQLVQSGAEVKKSGSSVKVSCKASGGTFSSYPISWVRQAPGQGLEWMGRIIPFLGAADYAQKFQGRVTITADKSTSTAYMELNSLTSEDTALYYCARDRGYSGYGAHYYTDVWGKGTTVTVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGCTCCAACATCGGGGCAGGTTATGATGTACACTGGTACCAGCAGGTTCCAGGAACAGCCCCCAAACTCCTCATCTATCGTAACACCAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGACTATTACTGCCAGTCCCATGACAGCAGCCTGAGTGGTTCAGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQVPGTAPKLLIYRNTNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSHDSSLSGSVFGGGTKLTVL	IGHV1-69*08	IGHJ6*03	IGHD5-12*01	IGLV1-40*01	IGLJ3*02	ARDRGYSGYGAHYYTDV	QSHDSSLSGSV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
33	Graham_P003	P003_017	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGGAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGATTTTCGAGAGGGAGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTYYGDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDFREGAFDIWGQGTMVTVSS	GACATCGTGATGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACACGCTCACTTTCGGCGGAGGGACCAAAGTGGATATCAAAC	DIVMTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYTLTFGGGTKVDIK	IGHV3-66*01	IGHJ3*02	nan	IGKV1-9*01	IGKJ4*01	ARDFREGAFDI	QQLNSYTLT	nan	Graham et al. Immunity 54:1276-1289.e6 (2021)	MW802389.1	MW802282.1
33	Turner-07	Turner-07-1H09	nan	SARS-CoV-2	OC43,HKU1	nan	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGAATCATCGTCAGTAGTAATTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAGCAGCCTGAGAGCCGAGGACACGGCTGTATATTACTGTGCGCGAGATTTTCGGGAGGGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVQPGGSLRLSCAASGIIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMSSLRAEDTAVYYCARDFREGAFDIWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCCGACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPTFGGGTKVEIK	IGHV3-66*01	IGHJ3*02	IGHD3-10*01,IGHD3-10*02	IGKV1-9*01	IGKJ4*01	ARDFREGAFDI	QQLNSYPPT	nan	Turner et al. Nature 596:109-113 (2021)	MW926397.1	MW926420.1
33	Dejnirattisai_Cell_Patients	COVOX-269	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGLIQPGGSLRLSCAASGLTVNRNYMSWIRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLSLQMNSLRAEDTAIYYCARDFYEGSFDIWGQGTMVTVSS	nan	AIQLTQSPSFLSASIGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFASYYCQQLNSYPAPVFGPGTKVDIK	IGHV3-53*01	IGHJ3	nan	IGKV1-9*01	IGKJ3	ARDFYEGSFDI	QQLNSYPAPV	7BEM,7NEG,7NEH	Dejnirattisai et al. Cell 184:2183-2200.e22 (2021);Supasa et al. Cell 184:2201-2211.e7 (2021)	nan	nan
33	Wang-PFZ10	PZF10_P1_IgG_C9-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCCGGGGTCACCGTCAGTAGAAACTACATGAGTTGGGTCCGCCAGGCTCCAGGAAAGGGCCTGGAGTGGGTCTCAGTTATTTATAGTGGTGGTAGCACATTCTACACAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAGGAACACCTTGTTTCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCGTTTTGAGGGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLIQPGGSLRLSCAASGVTVSRNYMSWVRQAPGKGLEWVSVIYSGGSTFYTDSVKGRFTISRDNSRNTLFLQMNSLRAEDTAVYYCARDRFEGAFDIWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTTCTATCACCTTCGGCCATGGGACACGACTGGAGATTAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPSITFGHGTRLEIK	IGHV3-53*01	IGHJ3*02	IGHD3-9*01	IGKV1-9*01	IGKJ5*01	ARDRFEGAFDI	QQLNSYPSIT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
33	Wang-PFZ10	PZF10_P2_IgG_A9-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGACGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGGTCATCGTCAGAAGCAATTATATGACTTGGGTCCGCCAGTCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGTGGTGGTAGTACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGACGAGGACACGGCCATTTATTACTGTGCGAGAGATCGTTTTGAGGGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGRLIQPGGSLRLSCAASGVIVRSNYMTWVRQSPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRDEDTAIYYCARDRFEGAFDIWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGACTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGTTATTACTTAGCCTGGTATCAGCAAAAACCAGGGCAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAGGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTTCTATCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	DIQLTQSPSFLSASVGDRLTITCRASQGISYYLAWYQQKPGQAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPSITFGQGTRLEIK	IGHV3-53*01	IGHJ3*02	IGHD3-9*01	IGKV1-9*01	IGKJ5*01	ARDRFEGAFDI	QQLNSYPSIT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
33	Wang-MOD9	MOD9_P1_IgG_C8-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTTTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATTTTCAAATGAACAGCCTGAGAGCCGACGACACGGCCGTGTATTACTGTGCGAGAGATGTATTCGAAGGCGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYFQMNSLRADDTAVYYCARDVFEGAFDIWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCTGGTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPLVTFGGGTKVEIK	IGHV3-53*01	IGHJ3*02	IGHD2-21*01,IGHD2-21*02,IGHD2-8*01	IGKV1-9*01	IGKJ4*01	ARDVFEGAFDI	QQLNSYPLVT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
33	Cho-C030	C1384	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTACAGCCTCTGGATTAACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACTTTCTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACCCTGTTTCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGATGTCTATGAGGGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVQPGGSLRLSCTASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCARDVYEGAFDIWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCGTCACTTGCCGGGCCAGTCAGGGCATTAGCAATTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCGACTTATTACTGTCAACAGCTTAGTACTTACCCTCCGAGGAGCAGTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTVTCRASQGISNYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLSTYPPRSSFGQGTKLEIK	IGHV3-66*01	IGHJ3*02	IGHD2/OR15-2a*01,IGHD2/OR15-2b*01,IGHD3-22*01	IGKV1-9*01	IGKJ2*04	ARDVYEGAFDI	QQLSTYPPRSS	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
34	IML3550	ADI-63163	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCTTGTGCAGCCTCTGGATTCACCTTCAATACCTATGCTCTACACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCCCTTATATCATATGATGGAAACAATAAATACTACAGAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGACCTGAGGACACGGCTGTCTACTACTGTGCGAGAGCCGGGGGTGGGAGCTACAAAGGGCCTTTTGACTACTGGGGCCAGGGAACCCTGGTCACTGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFNTYALHWVRQAPGKGLEWVALISYDGNNKYYRDSVKGRFTISRDNSKNTLYLQMNSLRPEDTAVYYCARAGGGSYKGPFDYWGQGTLVTVSS	nan	nan	IGHV3-30-3*01	IGHJ4*02	IGHD1-26*01	IGKV3-20	nan	ARAGGGSYKGPFDY	QQYGNSPLYT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458672.1	nan
34	Crowe_mix	COV2-2639	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGAAATTAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGACCACTCTGGATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGCTGGGGGTGGGAGCTACCGGGGGCCCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDEINKYYADSVKGRFTISRDNSKTTLDLQMNSLRAEDTAVYYCARAGGGSYRGPFDYWGQGTLVTVSS	CAGTCTGCCCTGACTCAGCCTCGCTCAGTGTCCGGGTCTCCTGGACAGTCAGTCACCATCTCCTGCACTGGAACCAGCAGTGATGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAGCACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAAGCGGCCCTCAGGGGTCCCTGATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCGTCTCTGGGCTCCAGGCTGAGGATGAGGCTGAATATTACTGCAGCGCATATGCAGGCAGCAACAATTTGGTATTCGGCGGAGGGACCAAATTGACCGTCCTA	QSALTQPRSVSGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEAEYYCSAYAGSNNLVFGGGTKLTVL	IGHV3-30*04,IGHV3-30-3*03	IGHJ4*02	IGHD1-26*01	IGLV2-11*01	IGLJ2*01,IGLJ3*01	ARAGGGSYRGPFDY	SAYAGSNNLV	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665712.1	MT665325.1
34	Jennewein_CV2	CV2-19	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAACTGGTTGAATCCGGGGGAGGGGTTGTCCAACCTGGCCGCTCCCTTCGCCTGTCATGTGCTGCCAGTGGTTTTACGTTCTCCAGCTATGCCATGCATTGGGTACGGCAAGCTCCAGGAAAAGGCTTGGAGTGGGTCGCTATAATATCCTATGATGGTATAAATAAATACTATGCAGACTCAGTAAAGGGCAGGTTTACTATCTCACGAGACAACTCTAAGAATACACTCTATCTGCAAATGAACTCACTTCGCGTCGAGGACACGGCGGTGTATTATTGCGCGCGACCAGGGGGTGGTTCATACTACGGTCCCTTTGATTATTGGGGGCAGGGAACTCTTGTTACTGTGTCTTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAIISYDGINKYYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCARPGGGSYYGPFDYWGQGTLVTVSS	CAGTCCGCGTTGACGCAGCCGGCGTCTGTAAGTGGAAGTCCCGGACAGAGCATAACTATCTCATGTACGGGGACCTCTAGCGACGTTGGTAGTTATAATTATGTCTCATGGTACCAACAACATCCGGGTAAAGCACCAAAACTGATGATCTATGAGGTTTCCAATCGGCCAAGCGGAGTCAGTAATAGGTTCAGCGGATCAAAGAGTGGGAATACGGCCTCTTTGACGTTGTCCGGCTTGCAAGCGGAGGATGAGGCTGATTATTATTGTAGCTCTTATACAAGCAGTTCAACACTCTACGTGTTCGGCACAGGAACTAAGGTGACTGTACTG	QSALTQPASVSGSPGQSITISCTGTSSDVGSYNYVSWYQQHPGKAPKLMIYEVSNRPSGVSNRFSGSKSGNTASLTLSGLQAEDEADYYCSSYTSSSTLYVFGTGTKVT	IGHV3-30*03,IGHV3-33*05,IGHV3-33*08	IGHJ4*02	IGHD3-22*01	IGLV2-14*01,IGLV2-14*03	IGLJ6*01	ARPGGGSYYGPFDY	SSYTSSSTLYV	nan	Jennewein et al. Cell Rep. 36:109353 (2021)	MW681650.1	MW681651.1
34	Chi-Donor2	2M-14E5	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACCTATTCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTACCTGCAAGTGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGATCTGGGGGTGGGAGCTACCGGGGTCCCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGGVVQPGRSLRLSCAASGFTFSTYSMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQVNSLRAEDTAVYYCARSGGGSYRGPFDYWGQGTLVTVSS	GCCATCCGGATGACCCAGTCTCCATCCTTCCTGTCTGTATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTACTACTGTCAACAGCTTAATAGTTACGTCACATTCGGCGGAGGGACCAAGGTGGAGATCAAA	AIRMTQSPSFLSVSVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYVTFGGGTKVEIK	IGHV3-30*04,IGHV3-30-3*03	IGHJ4*02	IGHD1-26*01	IGKV1-9*01	IGKJ4*01,IGKJ4*02	ARSGGGSYRGPFDY	QQLNSYVT	nan	Chi et al. Science 369:650-655 (2020)	MT622732.1	MT622733.1
34	IML3558	ADI-63207	nan	SARS-CoV-2,SARS-CoV	nan	SARS-CoV	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTGGTACAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTAGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCCTCTCCAGAGACAATTCCAAGAACACGCTGTCTCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTATTTATTACTGTGCGAGAGCCGGTGGTGGGAGCTACCGGACCCGATTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVQSGGGVVQPGRSLRLSCAASGFTFSGYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTLSRDNSKNTLSLQMNSLRAEDTAIYYCARAGGGSYRTRFDYWGQGTLVTVSS	nan	nan	IGHV3-30*01	IGHJ4*02	IGHD1-26*01	IGKV3D-15	nan	ARAGGGSYRTRFDY	HQYNNWPPFT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458716.1	nan
34	IML3548	ADI-62995	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACCTATGGCATCCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAATTAATAAATATTATGCAGCCTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGGTGTTTCTGCATCTGAACAACTTGAGAGCTGAGGACACGGCTGTGTATTTCTGTGCGAGGATGATGGGTGGGAGCTACTACGGGCCCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLLESGGGVVQPGRSLRLSCAASGFTFSTYGIHWVRQAPGKGLEWVAVISYDGINKYYAASVKGRFTISRDNSKNTVFLHLNNLRAEDTAVYFCARMMGGSYYGPFDYWGQGTLVTVSS	nan	nan	IGHV3-30*03	IGHJ4*02	IGHD1-26*01	IGKV3-20	nan	ARMMGGSYYGPFDY	QQYGSSYT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458504.1	nan
34	IML3564	ADI-63418	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAACCTCTGGATTCACCTTCAGTAGCTATGCTTTGCACTGGGTCCGCCAGGTTCCAGGCAAGGGGCTGCAGTGGGTGGCAATTATATCATATGATGGAGCCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCTCCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTACAAATGAACAGCCTGAGAGGTGTGGACACGGCTATATATTACTGTGCGAGAAGCCGTGGTGGTGGTTATCGGGGGCCATTTGACTACTGGGGCCAGGGAACCCTGGTCACTGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCATSGFTFSSYALHWVRQVPGKGLQWVAIISYDGANKYYADSVKGRFSISRDNSKNTLYLQMNSLRGVDTAIYYCARSRGGGYRGPFDYWGQGTLVTVSS	nan	nan	IGHV3-30-3*01	IGHJ4*02	IGHD2-21*01,IGHD2-21*02	IGKV1-5	nan	ARSRGGGYRGPFDY	QQYNSYWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458924.1	nan
35	S376	S376-780	nan	SARS-CoV-2	nan	nan	nan	S:non-RBD	SARS-CoV-2 spike/RBD/NP/ORF8/HCoVspike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAGAGGGTGGGAGCTACTCCTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKEGGSYSYYYYGMDVWGQGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCGAGTCAGGGCATTAGCAATTATTTAGCCTGGTATCAGCAGAAACCAGGGAAAGTTCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAATCAGGGGTCCCATCTCGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATGTTGCAACTTATTACTGTCAAAAGTATAACAGTGCCCCTCGGACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQGISNYLAWYQQKPGKVPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCQKYNSAPRTFGPGTKVDIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ6*02	IGHD1-26*01	IGKV1-27*01	IGKJ3*01	AKEGGSYSYYYYGMDV	QKYNSAPRT	nan	Dugan et al. Immunity 54:1290-1303.e7 (2021)	nan	nan
35	Wang-MOD3	MOD3_P2_IgG_C6-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCACTTATATCATATGATGGAAGTGACAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCAGTATCTACAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAAATATGGGCAGCTATGGTTATTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVALISYDGSDKYYADSVKGRFTISRDNSKNTQYLQMNSLRAEDTAVYYCAKNMGSYGYYYYGMDVWGQGTTVTVSS	CAGTCTGTGCTGACTCAGCCTCCCTCCGCGTCCGGGTCTCCTGGACAGTCAGTCACCATCTCCTGCACTGGAAGCAGCAGTGACGTTGGTGGTTATAACTCTGTCTCCTGGTACCAACTGCACCCAGGCAAAGCCCCCAAACTCATGATTTATGAGGTCTTTGAGCGGCCCTCAGGGGTCCCTGATCGCTTCTCTGGCTCCAAGTCTGGCAAAACGGCCTCCCTGACCGTCTCTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCAGCTCATTTGCAGGCAGCAACACTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPPSASGSPGQSVTISCTGSSSDVGGYNSVSWYQLHPGKAPKLMIYEVFERPSGVPDRFSGSKSGKTASLTVSGLQAEDEADYYCSSFAGSNTWVFGGGTKLTVL	IGHV3-30*18,IGHV3-30-5*01	IGHJ6*02	IGHD5-18*01,IGHD5-5*01	IGLV2-8*01	IGLJ3*02	AKNMGSYGYYYYGMDV	SSFAGSNTWV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
35	CC12	CC12.17	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGAAACTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGGGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAGTCGAGTGGGAGCTACTACTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGVVQPGRSLRLSCAASGFTFRNYGMHWVRQAPGKGLEGVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKSSGSYYYYYYGMDVWGQGTTVTVSS	TCCTATGAGCTGACACAGCCACCTTCGGTGTCAGTGGCCCCAGGAAAGACGGCCAGGATTACCTGTGGGGGAAACAACATTGGAAGTAAAAGTGTGCACTGGTACCAGCAGAAGCCAGGCCAGGCCCCTGTGCTGGTCGTCTATGATGATACCGACCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAGCTCTGGGAACACGGCCACCCTGACCATCAGCAGGGTCGAAGCCGGGGATGAGGCCGACTATTACTGTCAGGTGTGGGATAGTAGTAGTGATCATCCTGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTA	SYELTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDTDRPSGIPERFSGSSSGNTATLTISRVEAGDEADYYCQVWDSSSDHPVVFGGGTKLTVL	IGHV3-30*18,IGHV3-30-5*01	IGHJ6*02	IGHD1-26*01	IGLV3-21*03	IGLJ2*01,IGLJ3*01	AKSSGSYYYYYYGMDV	QVWDSSSDHPVV	nan	Rogers et al. Science 369:956-963 (2020)	MT594054.1	MT594087.1
35	COV047	COV047_P4_IgG_20-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAGTTGATGGGAGCTACTATTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKVDGSYYYYYYGMDVWGQGTTVTVSS	CAGTCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGCTTATAACTATGTCTCCTGGTACCAACAGCACCCAGGCAAAGCCCCCAAACTCATGATTTATGAGGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCAGCACTGCTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPASVSGSPGQSITISCTGTSSDVGAYNYVSWYQQHPGKAPKLMIYEVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTAWVFGGGTKLTVL	IGHV3-30*18,IGHV3-30-5*01	IGHJ6*02	IGHD1-26*01	IGLV2-14*01	IGLJ3*02	AKVDGSYYYYYYGMDV	SSYTSSSTAWV	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293180.1	MW293635.1
35	TAU-2	TAU-2310	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCCTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGTAATTATGTCATGAGTTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGGTATAGGTGGTAGTGGTGATAGCACATACTACGCAGACTCCGTGAAGGGCCGGTTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATAAACAGCCTGAGAGCCGAGGACACGGCCGTATATTACTGTGCGAAAGGGGCAGCTCCATATTACTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLLESGGGLVQPGGSLRLSCAASGFTFSNYVMSWVRQAPGKGLEWVSGIGGSGDSTYYADSVKGRFTISRDNSKNTLYLQINSLRAEDTAVYYCAKGAAPYYYYYYGMDVWGQGTTVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATGACTATGTCTCCTGGTACCAACAGCACCCAGGCAAAGCCCCCAAACTCATGATTTATGAGGTCAGTGATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAGCACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCAGCGCCCTTTATGTCTTCGGAACTGGGACCAAGGTCACCGTCCTA	QSALTQPASVSGSPGQSITISCTGTSSDVGGYDYVSWYQQHPGKAPKLMIYEVSDRPSGVSNRFSGSKSGSTASLTISGLQAEDEADYYCSSYTSSSALYVFGTGTKVTVL	IGHV3-23*01,IGHV3-23D*01	IGHJ6*02	IGHD6-6*01	IGLV2-14*01	IGLJ1*01	AKGAAPYYYYYYGMDV	SSYTSSSALYV	nan	Mor et al. PLoS Pathog. 17:e1009165 (2021)	MW367331.1	MW367332.1
35	Crowe_mix	COV2-2007	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGATACGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGGAATTATATCATATGATGCAAGTGATAAAACCTATGCAGAGTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAATACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAGTGTCTGCTACCTATTACTACTATTATTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSRYGMHWVRQAPGKGLEWVGIISYDASDKTYAESVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKVSATYYYYYYGMDVWGQGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCACCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCTATTCACTTTCGGCCCTGGGACCAAAGTGGATGTCAAG	DIQMTQSPSSLSASVGDRVTITCQASQDISTYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLLFTFGPGTKVDV	IGHV3-30*18,IGHV3-30-5*01	IGHJ6*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ3*01	AKVSATYYYYYYGMDV	QQYDNLLFT	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665589.1	MT665202.1
35	Tong_G32	G32B1	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike (and spike minus RBD)	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAGTGGTTGCTCCTTATTACTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKVVAPYYYYYYGMDVWGQGTTVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAGCACCCAGGCAAAGCCCCCAAACTCATGATTTATGAGGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCAGCACTTCTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTA	QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYEVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTSWVFGGGTKLTVL	IGHV3-30*18,IGHV3-30-5*01	IGHJ6*02	IGHD2-21*01,IGHD3-10*01,IGHD3-22*01	IGLV2-14*01	IGLJ3*02	AKVVAPYYYYYYGMDV	SSYTSSSTSWV	nan	Tong et al. Cell 184:4969-4980.e15 (2021)	MW718389.1	MW718541.1
36	Li_SARS2_26	DH1160	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVQSGGEVKKPGALLRVSCKASGDTSTNHAISWVRQAPGQGLEWMAWINVYNGRTNYAPHLQGRVTLTTDTATSTAYMQLSSLRSDDTAVYYCARWIHRDFDWLPYGMFMDVWGQGTTVTVSS	nan	QSALTQPPSASGSPGQSVTISCTGTSIDLGVYKYVSWYQHHPGKAPKLIIYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCTSYEGDNTLVFGGGTKLTVL	IGHV1-18*01	IGHJ6	nan	IGLV2-8*01	IGLJ3	ARWIHRDFDWLPYGMFMDV	TSYEGDNTLV	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
36	Li_SARS2_26	DH1161-1	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVQSGAEVKKPGALLRVSCKASGDTSTNHGISWVRQAPGQGLEWMGWINVYNGRTNYAQKVQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARWIHRDFDWLPYGMFMDVWGQGTTVTVSS	nan	QSALTQPPSASGSPGQSVTISCTGTSSDVGVYKYVSWYQHHPGKAPKLMVYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCTSYEGDNTLVFGGGTKLTVL	IGHV1-18*01	IGHJ6	nan	IGLV2-8*01	IGLJ3	ARWIHRDFDWLPYGMFMDV	TSYEGDNTLV	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
36	VRC_SARS1	DH1161-2	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV Human Patient	nan	QVQLVQSGAEVKKPGALLRVSCKGSGDTSTNHAIAWVRQAPGQGLEWMGWINVYNGRTNYAQKFQGRVTLTTDTATSTAYMELSSLRSDDTAVYYCARWIHRDFDWLPYGMFMDVWGQGTTVTVSS	nan	QSALTQPPSASGSPGQSVTISCTGTSSDVGVYKYVSWYQHHPGKTPKVIIYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCTSYEADNTLVLGGGTKLTVL	IGHV1-18*01	IGHJ6	nan	IGLV2-8*01	IGLJ2	ARWIHRDFDWLPYGMFMDV	TSYEADNTLV	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
36	Li_SARS2_26	H026058+L024028	nan	SARS-CoV-2	SARS-CoV,MERS-CoV,OC43,HKU1,NL63	nan	nan	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVQSGAEVKKPGALLRVSCKGSGDTSTNHAIAWVRQAPGQGLEWMGWINVYNGRTNYAQKFQGRVTLTTDTATSTAYMELSSLRSDDTAVYYCARWIHRDFDWLPYGMFMDVWGQGTTVTVSS	nan	QSALTQPPSASGSPGQSVTISCTGTSSDVGVYKYVSWYQHHPGKTPKVIIYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCTSYEADNTLVLGGGTKLTVL	IGHV1-18*01	IGHJ6	nan	IGLV2-8*01	IGLJ3	ARWIHRDFDWLPYGMFMDV	TSYEADNTLV	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
36	Li_SARS2_26	H026337+L024149	nan	SARS-CoV-2	SARS-CoV,MERS-CoV,OC43,HKU1,NL63	nan	nan	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVQSGAEVKKPGALLRVSCKASGDTSTNHGISWVRQAPGQGLEWMGWINVYNGRTNYAQKVQGRVTMTTDTSTRTAYMELRSLRSDDTAVYYCARWIHRDFDWLPYGMFMDVWGQGTTVTVSS	nan	QSALTQPPSASGSPGQSVTISCTGTSSDVGVYKYVSWYQHHPGKAPKLMLYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCTSYEGDNTLVFGGGTKLTVL	IGHV1-18*01	IGHJ6	nan	IGLV2-8*01	IGLJ3	ARWIHRDFDWLPYGMFMDV	TSYEGDNTLV	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
36	Li_SARS2_26	H712070+L711478	nan	SARS-CoV-2	SARS-CoV,MERS-CoV,OC43,HKU1,NL63	nan	nan	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVQSGGEVKKPGALLRVSCKASGDTSTNHAISWVRQAPGQGLEWMAWINVYNGRTNYAPHLQGRVTLTTDTATSTAYMQLSSLRSDDTAVYYCARWIHRDFDWLPYGMFMDVWGQGTTVTVSS	nan	QSALTQPPSASGSPGQSVTISCTGTSIDLGVYKYVSWYQHHPGKAPKLIIYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCTSYEGDNTLVFGGGTKLTVL	IGHV1-18*01	IGHJ6	nan	IGLV2-8*01	IGLJ3	ARWIHRDFDWLPYGMFMDV	TSYEGDNTLV	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
36	Li_SARS2_26	H712076+L711485	nan	SARS-CoV-2	SARS-CoV,MERS-CoV,OC43,HKU1,NL63	nan	nan	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVQSGAEVKKPGALLRVSCKASGDTSTNHGITWVRQAPGQGLEWMGWITVYNGRTNYAQKVQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARWIHRDFDWLPYGMFMDVWGQGTTVTVSS	nan	QSALTQPPSASGSPGQSVTISCTGTSSDLGVYKYVSWYQHHPGKAPKLMVYEVSKRPSGVPDRFSGSKSGNAASLTVSGLQAEDEADYYCTSYEGDNTLVFGGGTKLTVL	IGHV1-18*01	IGHJ6	nan	IGLV2-8*01	IGLJ3	ARWIHRDFDWLPYGMFMDV	TSYEGDNTLV	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
37	Li_SARS2_26	DH1119	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:NTD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVKPGGSLRLSCAASGFTFSNAWMSWVRQAPGKGLEWVGRIKSKTDGGTTDYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTDRDYDYIWGSYRYRDYWGQGTLVTVSS	nan	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSPLFGPGTKVDIK	IGHV3-15*01	IGHJ4	nan	IGKV1-39*01	IGKJ3	TTDRDYDYIWGSYRYRDY	QQSYSPL	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
37	Li_SARS2_26	H712135+K711770	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:NTD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVKPGGSLRLSCAASGFTFSNAWMSWVRQAPGKGLEWVGRIKSKTDGGTTDYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTDRDYDYIWGSYRYRDYWGQGTLVTVSS	nan	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSPLFGPGTKVDIK	IGHV3-15*01	IGHJ4	nan	IGKV1-39*01	IGKJ3	TTDRDYDYIWGSYRYRDY	QQSYSPL	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
37	Tong_C63	C63D6	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:NTD	SARS-CoV-2 spike (and spike minus RBD)	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTAAAGCCTGGGGGGTCCCTTAGACTCTCCTGTGCAGCCTCTGGATTCACTTTCAGTAACGCCTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTGGCCGTATTAAAAGCAAAACTGATGGTGGGACAACAGACTACGCTGCACCCGTGAAAGGCAGATTCACCATCTCAAGAGATGATTCAAAAAACACGCTGTATCTGCAAATGAACAGCCTGAAAACCGAGGACACAGCCGTGTATTACTGTACCACAGATCGGATATATGATTACATTTGGGGGAGTTATCGTTATGCCGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGGLVKPGGSLRLSCAASGFTFSNAWMSWVRQAPGKGLEWVGRIKSKTDGGTTDYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTDRIYDYIWGSYRYADYWGQGTLVTVSS	CAGTCTGTGCTGACGCAGCCACCCTCAGCGTCTGGGACCCCCGGGCAGAGGGTCACCATCTCTTGTTCTGGAAGCAGCTCCAACATCGGAAGTAATTATGTATACTGGTACCAGCAGCTCCCAGGAACGGCCCCCAAACTCCTCATCTATAGGAATAATCAGCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCAGTGGGCTCCGGTCCGAGGATGAGGCTGATTATTACTGTGCAGCATGGGATGACAGCCTGAGTGGTTATGTCTTCGGAACTGGGACCAAGGTCACCGTCCTA	QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNYVYWYQQLPGTAPKLLIYRNNQRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDDSLSGYVFGTGTKVTVL	IGHV3-15*01	IGHJ4*02	IGHD3-16*02	IGLV1-47*01	IGLJ1*01	TTDRIYDYIWGSYRYADY	AAWDDSLSGYV	nan	Tong et al. Cell 184:4969-4980.e15 (2021)	MW718356.1	MW718508.1
37	Li_SARS2_26	DH1118	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:NTD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVKPGGSLRLSCAASGFTFSNAWMNWVRQAPGKGLEWVGRIKSKTDGGTTDYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTDRIYDYVWGSYRYKDYWGQGTLVTVSS	nan	DIQMTQSPSSLSASVGDRVTITCRASQGISNSLAWYQQKPGKAPKLLLYAASRLESGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCQQYYSTPMYTFGQGTKLEIK	IGHV3-15*07	IGHJ4	nan	IGKV1-NL1*01	IGKJ2	TTDRIYDYVWGSYRYKDY	QQYYSTPMYT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
37	CV05	HK_CV05-185	nan	SARS-CoV-2	nan	nan	nan	S:S1	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	TTCTGCAAACCCCGTGTCATTCTGAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTAAAGCCTGGGGGGTCCCTTAGACTCTCCTGTGCAGCCTCTGGATTCACTTTCAGTAACGCCTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTGGCCGTATTAAAAGCAAAACTGATGGTGGGACAACAGACTACGCTGCACCCGTGAAAGGCAGATTCACCATCTCAAGAGATGATTCAAAAAACACGCTGTATCTGCAAATGAACAGCCTGAAAACCGAGGACACAGCCGTGTATTACTGTACCACAGATCGAACTTATGATTACGTTTGGGGGAGTTATCGTTATCGTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTTCAGGGAGGTCCTTCCGGCCCCACTTCCCCT	EVQLVESGGGLVKPGGSLRLSCAASGFTFSNAWMSWVRQAPGKGLEWVGRIKSKTDGGTTDYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTDRTYDYVWGSYRYRDYWGQGTLVTVS	TTTATGACCCCAGGTTCCACTCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCTTCCTCGCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAACGAACTGTGGCTGCACCATCTGTCTTCATCTTCCCGCCATCTGATGAGCAGTTGAAATCTGGAACTGCCTCTGTTGTGTGCCTGCTGAATAACTTCTATCCCAGAGAGGCCAAAGTACAGTGGAAGGTGGATAACGCCCTCCAATCGGGAATTCCCCGGGAGGCGGA	LSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTLPRTFGGGTKVEIK	IGHV3-15*01	IGHJ4*02	IGHD3-16*02	IGKV1-39*01,IGKV1D-39*01	IGKJ4*01	TTDRTYDYVWGSYRYRDY	QQSYSTLPRT	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
37	CV07	HK_CV07-172	nan	SARS-CoV-2	nan	nan	nan	S:S1	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	TCCGCAAAACCCGTTGACATTCTGAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTAAAGCCTGGGGGGTCCCTTAGACTCTCCTGTGCAGCCTCTGGATTCACTTTCAGTAACGCCTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTGGCCGTATTAAAAGCAAAACTGATGGTGGGACAACAGACTACGCTGCACCCGTGAAAGGCAGATTCACCATCTCAAGAGATGATTCAAAAAACACGCTGTATCTGCAAATGAACAGCCTGAAAACCGAGGACACAGCCGTGTATTACTGTACCACAGATCGAACTTATGATTACGTTTGGGGGAGTTATCGTTATCGTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAGGGAGTTCTTCCGCCCCACTTCCCCCC	EVQLVESGGGLVKPGGSLRLSCAASGFTFSNAWMSWVRQAPGKGLEWVGRIKSKTDGGTTDYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTDRTYDYVWGSYRYRDYWGQGTLVTVSS	TTTTTTTCCCCCCCCCCGCTCCAGTCTCCCTGTCTGCAGCTGTAGGAGACAGAGTCTCCATCACTTGCCGGGCAAGTCAGAGCATTACTACATATTTAAATTGGTATCAGCAGAAACCAGGGAAACCCCCTAACCTCCTCATCTATGCTGCATCCACTTTGCGAAGTGGGGTCCCATCAAGATTCAGTGGTTTTGGATCTGGGACAGATTTCACCCTCATTATCAGTAGTCTGCAACCTGAGGATTATGGAACTTACTACTGTCAACAGACTTTCAGTTCACCCCCGTGGACGTTCGGCCGAGGGACCAAGGTGGAAATCAAACGAACTGTGGCTGCACCATCTGTCTTCATCTTCCCGCCATCTGATGAGCAGTTGAAATCTGGAACTGCCTCTGTTGTGTGCCTGCTGAATAACTTCTATCCCAGAGAGGCCAAAGTACAGTGGAAGGTGGATAACGCCCTCCAATCGGGTACTCCCAGAGACGGG	FFPPPAPVSLSAAVGDRVSITCRASQSITTYLNWYQQKPGKPPNLLIYAASTLRSGVPSRFSGFGSGTDFTLIISSLQPEDYGTYYCQQTFSSPPWTFGRGTKVEIK	IGHV3-15*01	IGHJ4*02	IGHD3-16*02	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	TTDRTYDYVWGSYRYRDY	QQTFSSPPWT	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
37	CV05	HK_CV05-152	nan	SARS-CoV-2	nan	nan	nan	S:S1	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	CTGCGGCAATCTAATAGATTCTGCAAATCCGTGTACAATCCGAGGTGCAGCTGGTGCATCTGCAACCCCGGGTACATTCTGAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTAAAGCCTGGGGGGTCCCTTAGACTCTCCTGTGCAGCCTCTGGATTCACTTTCAGTAACGCCTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTGGCCGTATTAAAAGCAAAACTGATGGTGGGACAACAGACTACGCTGCACCCGTGAAAGGCAGATTCACCATCTCAAGAGATGATTCAAAAAACACGCTGTATCTGCAAATGAACAGCCTGAAAACCGAGGACACAGCCGTGTATTACTGTACCACCGAAAGAATTTATGATTACGTTTGGGGGAGTTATCGTTATTCTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAGGGAGTGCTCGCCCACCTGCGGC	EVQLVESGGGLVKPGGSLRLSCAASGFTFSNAWMSWVRQAPGKGLEWVGRIKSKTDGGTTDYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTERIYDYVWGSYRYSDYWGQGTLVTVSS	CCATTTGTGCTGTTCTTGCCGTCCTGCTTTTTTTGTTTTGTGCTGTCCTTGCTGTCCTTCTTTTTTTGACCCCCGGTTCAGTCTCCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCTGTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAACGAACTGTGGCTGCACCATCTGTCTTCATCTTCCCGCCATCTGATGAGCAGTTGAAATCTGGAACTGCCTCTGTTGTGTGCCTGCTGAATAACTTCTATCCCAGAGAGGCCAAAGTACAGTGGAAGGTGGATAACGCCCTCCAATCGGGTAATTCCCGGGTGCGGA	LLFLTPGSVSLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPVTFGPGTKVDIK	IGHV3-15*01	IGHJ4*02	IGHD3-16*02	IGKV3-20*01	IGKJ3*01	TTERIYDYVWGSYRYSDY	QQYGSSPVT	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
38	IML3546	ADI-57880	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTTGTACAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGACTGGGTGGCAGTTATATCATATGATGGAAGTATTAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAGGATTACGGTGACTACGGTGCTTTTGATATCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLVQSGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLDWVAVISYDGSIKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDYGDYGAFDIWGQGTTVTVSS	nan	nan	IGHV3-30*18,IGHV3-30-5*01	IGHJ3*02	IGHD4-17*01	IGKV4-1	nan	AKDYGDYGAFDI	QQYYSTPPYS	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457756.1	nan
38	IML3546	ADI-62845	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGACATCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACGTTCAGTAACTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGACTGGGTGGCAGTTATGTCATATGATGGAAGTATTAAAGACTATACAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACACTATATTTACAAATGAACAGCCTGAGACCTGAGGACACGGCTCTGTATTACTGTGCGAAAGACTACGGTGACTACGGCGCTTTTGATAATTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLQESGGGVVQPGTSLRLSCAASGFTFSNYGMHWVRQAPGKGLDWVAVMSYDGSIKDYTDSVKGRFTISRDNSKNTLYLQMNSLRPEDTALYYCAKDYGDYGAFDNWGQGTTVTVSS	nan	nan	IGHV3-30*18,IGHV3-30-5*01	IGHJ6*02	IGHD4-17*01	IGKV3-20	nan	AKDYGDYGAFDN	QQYAS	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458353.1	nan
38	Li_SARS2_26	DH1102	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDYGDYGAFDYWGQGTLVTVSS	nan	DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPLTFGGGTKVEIK	IGHV3-30*18	IGHJ4	nan	IGKV4-1*01	IGKJ4	AKDYGDYGAFDY	QQYYSTPLT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
38	IML3549	ADI-63069	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTGGTGCAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCGGCCTCTGGATTCACCTTCAGTACCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTCATAAATATTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAGGAACACGCTGTATCTGCAAGTGAACAGCCTGAGAGCTGAGGACACGGCTGTCTATTACTGTGCGAAAGACTACGGTGACTACGGTGCTCTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCCTCA	QVQLVQSGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVAVISYDGSHKYYADSVKGRFTISRDNSRNTLYLQVNSLRAEDTAVYYCAKDYGDYGALDIWGQGTMVTVSS	nan	nan	IGHV3-30*18,IGHV3-30-5*01	IGHJ3*02	IGHD4-17*01	IGKV4-1	nan	AKDYGDYGALDI	QRYYTTPL	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458578.1	nan
38	IML3549	ADI-61239	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCGCCTTCAATAACTTTGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATGTCATATGATGGAAGTCATATATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGGTGAGGACACGGCTGTGTATTACTGTGCGAAAGATTACGGTGACTACGGGGCTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLLESGGGVVQPGRSLRLSCAASGFAFNNFGMHWVRQAPGKGLEWVAVMSYDGSHIYYADSVKGRFTISRDNSKNTLYLQMNSLRGEDTAVYYCAKDYGDYGAMDVWGQGTTVTVSS	nan	nan	IGHV3-30*18,IGHV3-30-5*01	IGHJ6*02	IGHD4-17*01	IGKV4-1	nan	AKDYGDYGAMDV	QQYYSTPL	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458096.1	nan
38	IML3550	ADI-57866	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTGGTGCAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGCAGTATTAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAGATTATGGTGACTACGGCAGCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVQSGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSIKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDYGDYGSFDYWGQGTLVTVSS	nan	nan	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD4-17*01,IGHD4-23*01	IGKV4-1	nan	AKDYGDYGSFDY	QQYYSTPF	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457742.1	nan
38	Ehling_bioRxiv_pool	Ehling_mAb-93	nan	SARS-CoV-2	nan	nan	nan	S:S1 non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDYGDYGGLDYWGQGTLVTVSS	nan	DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPLTFGQGTKVEIK	IGHV3-30	IGHJ4	nan	IGKV4-1	IGKJ1	AKDYGDYGGLDY	QQYYSTPLT	nan	Ehling et al. bioRxiv. DOI: 10.1101/2021.02.12.430940	nan	nan
39	Tong_C882	C882C6	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike (and spike minus RBD)	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTTTGCTATCCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTGTATCATATGATGGAGGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGTCTGTGTATTACTGTGCGAGATCCGGTTCGGGAAATTATTATGGCTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSNFAIHWVRQAPGKGLEWVAVVSYDGGNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTSVYYCARSGSGNYYGWFDPWGQGTLVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGATGTTGGGAGTTATAACCTTGTCTCCTGGTACCAACAGCACCCAGGCAAAGCCCCCAAACTCATGATTTATGAGGGCAGTAAGCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAATCTGGCAACACGGCCTCCCTGACAATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCTGCTCATATGCAGGTAGTAGCACTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTA	QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEGSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSTWVFGGGTKLTVL	IGHV3-30-3*01	IGHJ5*02	IGHD3-10*01	IGLV2-23*01,IGLV2-23*03	IGLJ3*02	ARSGSGNYYGWFDP	CSYAGSSTWV	nan	Tong et al. Cell 184:4969-4980.e15 (2021)	MW718460.1	MW718612.1
39	Li_SARS2_26	DH1142-1	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSGSGNYYHWFDPWGQGTLVTVSS	nan	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGGGTKVEIK	IGHV3-30*01	IGHJ5	nan	IGKV3-20*01	IGKJ4	ARSGSGNYYHWFDP	QQYGSSPRT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
39	Li_SARS2_26	DH1142-2	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSGSGNYYHWFDPWGQGTLVTVSS	nan	EIVMTQSPATLSVSPGERATLSCRASQSLSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPQTFGQGTKVEIK	IGHV3-30*01	IGHJ5	nan	IGKV3-15*01	IGKJ1	ARSGSGNYYHWFDP	QQYNNWPQT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
39	Li_SARS2_26	H712065+L711472	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:S2	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSGSGNYYHWFDPWGQGTLVTVSS	nan	QSVLTQPPSVSAALGQKVTISCSGSSSNIESNYVSWYQQFPGTVPTLLIYENNKRPSGIPDRFSASKFGTSATLGISGLQTGDEADYYCGTWDRSLSAWVFGGGTKVTVL	IGHV3-30*01	IGHJ5	nan	IGLV1-51*02	IGLJ3	ARSGSGNYYHWFDP	GTWDRSLSAWV	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
39	Li_SARS2_26	H712132+L711532	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:S2	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSGSGNYYHWFDPWGQGTLVTVSS	nan	QSVLTQPPSVSAALGQKVTISCSGSSSNIESNYVSWYQQFPGTVPTLLIYENNKRPSGIPDRFSASKFGTSATLGISGLQTGDEADYYCGTWDRSLSAWVFGGGTKVTVL	IGHV3-30*01	IGHJ5	nan	IGLV1-51*02	IGLJ3	ARSGSGNYYHWFDP	GTWDRSLSAWV	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
39	Li_SARS2_26	H712133+L711533	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:S2	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSGSGNYYHWFDPWGQGTLVTVSS	nan	QSVLTQPPSVSAALGQKVTISCSGSSSNIESNYVSWYQQFPGTVPTLLIYENNKRPSGIPDRFSASKFGTSATLGISGLQTGDEADYYCGTWDRSLSAWVFGGGTKVTVL	IGHV3-30*01	IGHJ5	nan	IGLV1-51*02	IGLJ3	ARSGSGNYYHWFDP	GTWDRSLSAWV	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
40	Wang-C004	C004_P1_IgG_E6-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTACAGCAGTGGGGCGCAGGACTGTTGAAGCCCTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGAGAAATCAATCATAGTGGAAGCACCACCTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCTGTGTATTACTGTGCGAGAGCTACGTATTACTTTGATAGTAGTGGTTATGGGATCAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWNWIRQPPGKGLEWIGEINHSGSTTYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARATYYFDSSGYGINWFDPWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGCTCCAACATCGGGGCAGGTTATGATGTACACTGGTACCAGCAGCTTCCAGGAACAGCCCCCAAACTCCTCATCTATGCTAACAGCTATCGGCCCTCAGGGGTCCCTGACCGATGCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACGTCAGCCTGAGTGCTTACGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYANSYRPSGVPDRCSGSKSGTSASLAITGLQAEDEADYYCQSYDVSLSAYVFGGGTKLTVL	IGHV4-34*01	IGHJ5*02	IGHD3-22*01	IGLV1-40*01	IGLJ2*01,IGLJ3*01	ARATYYFDSSGYGINWFDP	QSYDVSLSAYV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
40	Wang-C004	C004_P1_IgG_C8-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTACAGCAGTGGGGCGCAGGACTGTTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGGAAATCAATCATAGCGGAAGCACCAACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAAGCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCTGTGTATTACTGTGCGAGAGCTACGTATTACTATGATAGTAGTGGTTACGGGATCAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWNWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVDTSKKQFSLKLSSVTAADTAVYYCARATYYYDSSGYGINWFDPWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGCTCCAACATCGGGGCAGGTTATGATGTACACTGGTACCAGCAACTTCCAGGAACAGCCCCCAAACTCCTCATCTATGGTAACAGCAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAGCAGCCTGAGTGCTTACGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSAYVFGGGTKLTVL	IGHV4-34*01	IGHJ5*02	IGHD3-22*01	IGLV1-40*01	IGLJ2*01,IGLJ3*01	ARATYYYDSSGYGINWFDP	QSYDSSLSAYV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
40	Wang-C004	C829	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTACAGCAGTGGGGCGCAGGACTGTTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGGTTACTACTGGAACTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGGAAATCAATCATAGCGGAAGCACCAACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAAGCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCTGTGTATTACTGTGCGAGAGCTACGTATTACTATGATAGTAGTGGTTACGGGATCAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWNWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVDTSKKQFSLKLSSVTAADTAVYYCARATYYYDSSGYGINWFDPWGQGTLVTVSS	CAGTCTGTGCTGACGCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGCTCCAACATCGGGGCAGGTTATGATGTACACTGGTACCAGCAACTTCCAGGAACAGCCCCCAAACTCCTCATCTATGGTAACAGCAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAGCAGCCTGAGTGCTTACGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSAYVFGGGTKLTVL	IGHV4-34*01	IGHJ5*02	IGHD3-22*01	IGLV1-40*01	IGLJ2*01,IGLJ3*01	ARATYYYDSSGYGINWFDP	QSYDSSLSAYV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
40	Wang-C004	C1187	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTACAGCAGTGGGGCGCAGGACTGAGGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTACGGTGGATCCTTCAGTGCTTACTACTGGAACTGGATCCGCCAGTCCCCAGGGAAGGGGCTGGAGTGGATTGGGGAAACCCATCATACTGGAAGCACCAAATACAACCCGTCCCTCAAGAGTCGAGTCACCATATCAGTGGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCTGTGTATTACTGTGCGAGAGCTACGTATTATTATGATAGCAGTTCTTACGGCATCAACTGGTTCGCCCCTTGGGGCCCGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQQWGAGLRKPSETLSLTCAVYGGSFSAYYWNWIRQSPGKGLEWIGETHHTGSTKYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARATYYYDSSSYGINWFAPWGPGTLVTVSS	CAGTCTGTGCTGACGCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGGTCCAACATCGGGGCAGGTTATGACGTACACTGGTACCAGCATCTTCCAGGAACAGCCCCCAAACTCCTCATCTATGTTAACAACAATCGGCCCTCAGGGGTCCCTGACCGAATCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAACGACGTGAGTGGTTACGTATTCGGCGGAGGGACCAAGGTGACCGTCCTAG	QSVLTQPPSVSGAPGQRVTISCTGSRSNIGAGYDVHWYQHLPGTAPKLLIYVNNNRPSGVPDRISGSKSGTSASLAITGLQAEDEADYYCQSYDNDVSGYVFGGGTKVTVL	IGHV4-34*01	IGHJ5*02	IGHD3-22*01	IGLV1-40*01	IGLJ2*01,IGLJ3*01	ARATYYYDSSSYGINWFAP	QSYDNDVSGYV	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
40	Wang-MOD6	MOD6_P1_IgG_E11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCAAACCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGTTGGATCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCAGACATTAGTGGTAGTAGTTTTTACACAAATTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAAGTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGACGACACGGCTGTGTATTACTGTGCGAGGGCCACTTATTACTATGATAGTAGTGACCACGGGGTCAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMSWIRQAPGKGLEWVSDISGSSFYTNYADSVKGRFTISRDNAKKSLYLQMNSLRADDTAVYYCARATYYYDSSDHGVNWFDPWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGCAGCAGCTCCAACATCGGGGCAGGTTATGATGTACACTGGTACCAGCAGCTTCCAGGAACAGCCCCCAAACTCCTCATCTATAATAACAACAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTTTTACTGCCAGTCCTATGACAGCAGCCTGAATGATTATGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYNNNNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADFYCQSYDSSLNDYVFGTGTKVTVL	IGHV3-11*06	IGHJ5*02	IGHD3-22*01	IGLV1-40*01	IGLJ1*01	ARATYYYDSSDHGVNWFDP	QSYDSSLNDYV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
40	Wang-C004	C004_P1_IgG_D8-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTACAGCAGTGGGGCGCAGGACTGTTGAAGCCTTCGGAGACCCTGGCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTCGTTACTACTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGGAAATCAATCATAGTGGAAGCACCAACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCAATAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCTGTGTATTATTGTGCGACAACTACGTATTACTATGATAGTAGTGCTTACGGGATCAACTGGTTCGACCCCTGGGGCCAGGGGTCGCTAGTCACCGTCTCCTCAG	QVQLQQWGAGLLKPSETLALTCAVYGGSFSRYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISIDTSKNQFSLKLSSVTAADTAVYYCATTTYYYDSSAYGINWFDPWGQGSLVTVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGCTCCAACATCGGGGCAGGTTATGATGTACACTGGTACCAGCAGCTTCCAGGAACAGCCCCCAAACTCCTCATCTATGGTAACAGCAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACAGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACACCAATATGAGTGGTTACGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDTNMSGYVFGGGTKLTVL	IGHV4-34*01	IGHJ5*02	IGHD3-22*01	IGLV1-40*01	IGLJ2*01,IGLJ3*01	ATTTYYYDSSAYGINWFDP	QSYDTNMSGYV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
41	Chen_Vax_p1	COV2-vax-58	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTCTTACAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCCGTGTATTACTGTGCGAGGCATTACGATATTTTGAGTCGACTGAGCTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYISYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARHYDILSRLSWFDPWGQGTLVTVSS	CAGTCTGTGTTGACGCAGCCGCCCTCAGTGTCTGCGGCCCCAGGACAGAAGGTCACCATCTCCTGCTCTGGAAGCAGCTCCAACATTGGGAATAATTATGTATCCTGGTACCAGCAGCTCCCAGGAACAGCCCCCAAACTCCTCATTTATGACAATAATAAGCGACCCTCAGGGATTCCTGACCGATTCTCTGGCTCCAAGTCTGGCACGTCAGCCACCCTGGGCATCACCGGACTCCAGACTGGGGACGAGGCCGATTATTACTGCGGAACATGGGATAGCAGCCTGAGTCCTGGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSPGVFGGGTKLTVL	IGHV4-59*08	IGHJ5*02	IGHD3-9*01	IGLV1-51*01	IGLJ3*02	ARHYDILSRLSWFDP	GTWDSSLSPGV	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555518.1	MZ555519.1
41	Chen_Vax_p1	COV2-vax-59	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTCTTACAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCCGTGTATTACTGTGCGAGGCATTACGATATTTTGAGTCGACTGAGCTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYISYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARHYDILSRLSWFDPWGQGTLVTVSS	CAGTCTGTGTTGACGCAGCCGCCCTCAGTGTCTGCGGCCCCAGGACAGAAGGTCACCATCTCCTGCTCTGGAAGCAGCTCCAACATTGGGAATAATTATGTATCCTGGTACCAGCAGCTCCCAGGAACAGCCCCCAAACTCCTCATTTATGACAATAATAAGCGACCCTCAGGGATTCCTGACCGATTCTCTGGCTCCAAGTCTGGCACGTCAGCCACCCTGGGCATCACCGGACTCCAGACTGGGGACGAGGCCGATTATTACTGCGGAACATGGGATAGCAGCCTGAGTGCTGGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSAGVFGGGTKLTVL	IGHV4-59*08	IGHJ5*02	IGHD3-9*01	IGLV1-51*01	IGLJ3*02	ARHYDILSRLSWFDP	GTWDSSLSAGV	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555520.1	MZ555521.1
41	Cho-C030	C1291	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCCATTACAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCCGTGTATTACTGTGCGAGACATTACGATATTTTGACTGCCCTGAGCTGGTTCGACCCCTGGGGCCAAGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIHYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARHYDILTALSWFDPWGQGTLVTVSS	GATATTGTGATGACTCAGTCTCCACTCTCCCTGCCCGTCACCCCTGGAGAGCCGGCCTCCATCTCCTGCAGGTCTAGTCAGAGCCTCCTGCATAGTAATGGATACAACTATTTGGATTGGTACCTGCAGAAGCCAGGGCAGTCTCCACAGCTCCTGATCTATTTGGGTTCTAATCGGGCCTCCGGGGTCCCTGACAGGTTCAGTGGCAGTGGATCAGGCACAGATTTTACACTGAAAATCAGCAGAGTGGAGGCTGAGGATGTTGGGGTTTATTACTGCATGCAAGCTCTACAAACTCCTATCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPITFGPGTKVDIK	IGHV4-59*08	IGHJ5*01,IGHJ5*02	IGHD3-9*01	IGKV2-28*01,IGKV2D-28*01	IGKJ3*01	ARHYDILTALSWFDP	MQALQTPIT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
41	Cho-C016	C2411	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:non-RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCCATTACAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCCGTGTATTACTGTGCGAGACATTACGATATTTTGACTGCCCTGAGCTGGTTCGACCCCTGGGGCCAAGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIHYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARHYDILTALSWFDPWGQGTLVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPYTFGQGTKLEIK	IGHV4-59*08	IGHJ5*01,IGHJ5*02	IGHD3-9*01	IGKV1-9*01	IGKJ2*01	ARHYDILTALSWFDP	QQLNSYPPYT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
41	COV057	C093	COVD57_P2_HC_F8-1369	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCCATTACAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCCGTGTATTACTGTGCGAGACATTACGATATTTTGACTGCCCTGAGCTGGTTCGACCCCTGGGGCCAAGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIHYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARHYDILTALSWFDPWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGCGGCCCCAGGACAGAAGGTCACCATCTCCTGCTCTGGAAGCAGCTCCAACATTGGGAATAATTATGTATCCTGGTACCAGCAGCTCCCAGGAACAGCCCCCAAACTCCTCATTTATGACAATAATAAGCGACCCTCAGGGATTCCTGACCGATTCTCTGGCTCCAAGTCTGGCACGTCAGCCACCCTGGGCATCACCGGACTCCAGACTGGGGACGAGGCCGATTATTACTGCGGAACATGGGATAGCAGCCTGAGTGCCTATTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSAYWVFGGGTKLTVL	IGHV4-59*08	IGHJ5*01,IGHJ5*02	IGHD3-9*01	IGLV1-51*01	IGLJ3*02	ARHYDILTALSWFDP	GTWDSSLSAYWV	nan	Gaebler et al. Nature 591:639-644 (2021);Robbiani et al. Nature 584:437-442 (2020)	nan	nan
41	COV057	C094	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCAATGTCTCTGGTGTCTCCATCAGTACTGACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGATATATCTATTACAGTGGGAACACCAAGGACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGATGCTGAGCTCTGTGACCGCCGCAGACACGGCCGTATATTACTGTGCGAGACATTACGATATTTTGACTTCCCTGAGTTGGTTCGATCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSETLSLTCNVSGVSISTDYWSWIRQPPGKGLEWIGYIYYSGNTKDYNPSLKSRVTISVDTSKNQFSLMLSSVTAADTAVYYCARHYDILTSLSWFDPWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGCGGCCCCAGGACAGAAGGTCACCATCTCCTGCTCTATAACCAACTCCAACCTTGGGAATATTTATGTATCCTGGTACCAGCAGCTCCCAGGAACAGCCCCCAAACTCCTCATTTATGGCAATAATAAGCGACCCTCAGGGATTCCTGACCGATTCTCTGGCTCCAAGTCTGGCACGTCGGCCACCCTGGGCATCACCGGACTCCAGACTGGGGACGAGGCCCATTATTACTGCGGAACCTGGGATAGTAGCCTGAGTGCCAATTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPPSVSAAPGQKVTISCSITNSNLGNIYVSWYQQLPGTAPKLLIYGNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEAHYYCGTWDSSLSANWVFGGGTKLTVL	IGHV4-59*08	IGHJ5*02	IGHD3-9*01	IGLV1-51*01	IGLJ3*02	ARHYDILTSLSWFDP	GTWDSSLSANWV	nan	Gaebler et al. Nature 591:639-644 (2021)	nan	nan
42	ZhouY_P1	XG017	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV3-66	IGHJ4	IGHD1-26*01	IGLV2-8	IGLJ3	ARGEGWDLPFDF	SSYAGSNNLM	nan	Zhou et al. Cell Rep. 34:108699 (2021)	nan	nan
42	Wang-MOD11	Mod11_P2_IgG_G2-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTGATCGTCAGTAGCAANTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTTCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGGCGAGGGGTGGGACCTACCCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGLIVSSXYMSWVRQAPGKGLEWVSVIYSGGSTFYADFVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGEGWDLPFDYWGQGTLVTVSS	CAGTCTGCCCTGACTCAGCCTCCCTCCGCGTCCGGGTCTCCTGGACAGTCAGTCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAAATATGTCTCCTGGTACCAACAGCACCCAGGCAAAGCCCCCAAACTCATGATTTATGAGGTCAGTAAGCGGCCCTCAGGGGTCCCTGATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCGTCTCTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCAGCTCATATGCAGGCAGCAACAATTTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSALTQPPSASGSPGQSVTISCTGTSSDVGGYKYVSWYQQHPGKAPKLMIYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYAGSNNLVFGGGTKLTVL	IGHV3-53*01	IGHJ4*02	IGHD1-26*01	IGLV2-8*01	IGLJ2*01,IGLJ3*01	ARGEGWDLPFDY	SSYAGSNNLV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
42	COV107	COV107_Plate1_HC_29-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGCACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGGCGAGGGGTGGGACCTACCATACGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMHSLRAEDTAVYYCARGEGWDLPYDYWGQGTLVTVSS	CAGTCTGCCCTGACTCAGCCTCCCTCCGCGTCCGGGTCTCCTGGACAGTCAGTCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAGCACCCAGGCAAAGCCCCCAAACTCATGATTTATGAGGTCAGTAAGCGGCCCTCAGGGGTCCCTGATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCGTCTCTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCAGCTCATATGCAGGCAGCAACAATTTTGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSALTQPPSASGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYAGSNNFVVFGGGTKLTVL	IGHV3-53*01	IGHJ4*02	IGHD1-26*01	IGLV2-8*01	IGLJ2*01,IGLJ3*01	ARGEGWDLPYDY	SSYAGSNNFVV	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
42	COV107	COV107_Plate1_HC_35-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATACCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTATATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCATGTATTACTGTGCGAGAGGCGAGGGGTGGGACCTACCATACGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYTGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAMYYCARGEGWDLPYDYWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCTCCCTCCGCGTCCGGGTCTCCTGGACAGTCAGTCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAGCACCCAGGCAAAGCCCCCAAACTCATGATTTATGAGGTCAGAAAGCGGCCCTCAGGGGTCCCTGATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCGTCTCTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCAGCTCATATGCAGGCAGCAACAATTTTGTGCTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPPSASGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYEVRKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYAGSNNFVLFGGGTKLTVL	IGHV3-53*01	IGHJ4*02	IGHD1-26*01	IGLV2-8*01	IGLJ2*01,IGLJ3*01	ARGEGWDLPYDY	SSYAGSNNFVL	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
42	COV107	C105	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGTACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGGCGAGGGGTGGGAGCTACCATACGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGEGWELPYDYWGQGTLVTVSS	CAGTCTGCCCTGACTCAGCCTCCCTCCGCGTCCGGGTCTCCTGGACAGTCAGTCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAAGTATGTCTCCTGGTACCAACAGCACCCAGGCAAAGCCCCCAAACTCATGATTTATGAGGTCAGTAAGCGGCCCTCAGGGGTCCCTGATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCGTTTCTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCAGCTCATATGAAGGCAGCAACAATTTTGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSALTQPPSASGSPGQSVTISCTGTSSDVGGYKYVSWYQQHPGKAPKLMIYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSNNFVVFGGGTKLTVL	IGHV3-53*01	IGHJ4*02	IGHD1-26*01	IGLV2-8*01	IGLJ2*01,IGLJ3*01	ARGEGWELPYDY	SSYEGSNNFVV	6XCA,6XCN,6XCM	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
42	COV107	COV107_Plate2_HC_4-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGTACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGGCGAGGGGTGGGAGCTACCATACGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGEGWELPYDYWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCTCCCTCCGCGTCCGGGTCTCCTGGACAGTCAGTCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAAGTATGTCTCCTGGTACCAACAGCACCCAGGCAAAGCCCCCAAACTCATGATTTATGAGGTCAGTAAGCGGCCCTCAGGGGTCCCTGATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCGTTTCTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCAGCTCATATGAAGGCAGCAACAATTTTGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPPSASGSPGQSVTISCTGTSSDVGGYKYVSWYQQHPGKAPKLMIYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSNNFVVFGGGTKLTVL	IGHV3-53*01	IGHJ4*02	IGHD1-26*01	IGLV2-8*01	IGLJ2*01,IGLJ3*01	ARGEGWELPYDY	SSYEGSNNFVV	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
43	Wang-C003	C1441	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGAATTCACCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTAGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACCCTGTATCTTCAAATGAACAGCCTGAGAGTCGAGGACACGGCTGTATATTACTGTGCGAGAGAACTACGAGGTTACTTTGATTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASEFTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCARELRGYFDYWGQGTLVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAGCAGCTTAATAGTTACCCGATGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPMYTFGQGTKLEIK	IGHV3-66*01	IGHJ4*02	IGHD4-17*01,IGHD4-23*01,IGHD5-12*01	IGKV1-9*01	IGKJ2*01	ARELRGYFDY	QQLNSYPMYT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
43	Xie_mix	BD-243	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCARELRGYFDYWGQGTLVTVSS	nan	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPSFTFGPGTKVDIK	IGHV3-53*04	nan	nan	IGKV1-33*01	nan	ARELRGYFDY	QQYDNLPSFT	nan	Du et al. Cell 183:1013-1023.e13 (2020)	nan	nan
43	REGN_mouse	REGN11008	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;Humanized Mouse	nan	EVQLVESGGGLVQPGGSLRLSCAASGFIVSRNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRHNSKNTLYLQMNSLKAEDTAVYYCARELRGYFDYWGQGTLVTVSS	nan	DIQLTQSPSFLSASVGDRVTITCWASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQLLNSYPYTFGQGTKLEIK	IGHV3-53*04	IGHJ4	nan	IGKV1-9*01	IGKJ2	ARELRGYFDY	QLLNSYPYT	nan	Patent: US10787501	nan	nan
43	Wang-C003	C003_P2_IgG_A7-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGAATTCACCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTAGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACCCTGTATCTTCAAATGAACAGCCTGAGAGTCGAGGACACGGCTGTATATTACTGTGCGAGAGAACTACGAGGTTACTTTGATTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASEFTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCARELRGYFDYWGQGTLVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAGCAGCTTAATAGTTACCCGATGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPMYTFGQGTKLEIK	IGHV3-66*01	IGHJ4*02	IGHD4-17*01,IGHD4-23*01,IGHD5-12*01	IGKV1-9*01	IGKJ2*01	ARELRGYFDY	QQLNSYPMYT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
43	Graham_P008	P008_067	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGGAGTCGGGGGGAGCCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGAAGCCTCTGAATTCATCGTCAGTAGGAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCATCATCTCCAGAGACAATTCCAAGAACACGTTGTATCTTCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTCTATTACTGTGCGAGAGAGCTCGTGGGGTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGALVQPGGSLRLSCEASEFIVSRNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFIISRDNSKNTLYLQMNSLRAEDTAVYYCARELVGYFDYWGQGTLVTVSS	GACATCGTGATGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGGGCATTAGAAATGATTTAGGCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCGCCTGATCTATGCTGCATCCAGTTTGCAGAGTGGGGTCCCATCAAGGTTCAGCGGCTATGGATCTGGGACAGAATTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACACCTTAATAGTTACCCTCGGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIVMTQSPSFLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKRLIYAASSLQSGVPSRFSGYGSGTEFTLTISSLQPEDFATYYCQHLNSYPRYTFGQGTKLEIK	IGHV3-66*02	IGHJ4*02	IGHD6-6*01	IGKV1-17*01	IGKJ2*01	ARELVGYFDY	QHLNSYPRYT	nan	Graham et al. Immunity 54:1276-1289.e6 (2021)	MW802441.1	MW802334.1
43	Wang-MOD8	MOD8_P2_IgG_E6-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGTATTCACCGTCAGTAGCAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGGAAACTACGAGGGTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASVFTVSSNYMTWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARKLRGYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCGAGTCAGGGCATTAGCAATTCTTTAGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGCTCTATGCTGCATCCAGATTGGAAAGTGGGGTCCCATCCAGGTTCAGTGGCAGTGGATCTGGGACGGATTACACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGTATTATAGTACCCCTCAGGTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQGISNSLAWYQQKPGKAPKLLLYAASRLESGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCQQYYSTPQVTFGGGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD1-7*01,IGHD4-11*01,IGHD4-17*01	IGKV1-NL1*01	IGKJ4*01	ARKLRGYFDY	QQYYSTPQVT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
44	COV096	C552	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTAGAGTGGGTGGCACTTATATCATATGATGGAAGTAACAAACACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGCGGGAACTACTAATAGCGACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVALISYDGSNKHYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARAGTTNSDYFDYWGQGTLVTVSS	TCCTATGAGCTGACACAGCCACCCTCAGTGTCAGTGGCCCCAGGAAAGACGGCCAGGATTACCTGTGGGGGAAACAACATTGGAAGTAAAAGTGTGCACTGGTACCAGCAGAAGCCAGGCCAGGCCCCTGTGCTGGTCATCTATTATGATACCGACCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACGGCCACCCTGACCATCAGCAGGGTCGAAGCCGGGGATGAGGCCGACTATTACTGTCAGGTGTGGGATAGTAGTAGTGCCCTTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	SYELTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVIYYDTDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSALWVFGGGTKLTVL	IGHV3-30*01	IGHJ4*02	IGHD1-26*01	IGLV3-21*04	IGLJ3*02	ARAGTTNSDYFDY	QVWDSSSALWV	nan	Gaebler et al. Nature 591:639-644 (2021)	nan	nan
44	COV096	C553	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTATGAAATACACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTAGAGTGGGTGGCAGGTATATCATATGATGGAAGTACTAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGACCTGAGGACACGGCTGTGTTTTACTGTGCGAGAGCGGGAACTACTAATAGCGACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYEIHWVRQAPGKGLEWVAGISYDGSTKYYADSVKGRFTISRDNSKNTLYLQMNSLRPEDTAVFYCARAGTTNSDYFDYWGQGTLVTVSS	TCCTATGAGCTGACTCAGCCACCCTCAGTGTCAGTGGCCCCAGGAATGACGGCCAGGATTACCTGTGGGGGAAACACCATTGGAAGTAAAAGTGTGCACTGGTACCAGCAGAAGGCAGGCCAGGCCCCTGTGTTGGTCATCTATTATGATAGCGACCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACGGCCACCCTGACCATCAGCAGGGTCGAAGCCGGGGATGAGGCCGACTATTACTGTCAGGTGTGGGATAGTAGTAGTGTCCTTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	SYELTQPPSVSVAPGMTARITCGGNTIGSKSVHWYQQKAGQAPVLVIYYDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSVLWVFGGGTKLTVL	IGHV3-30*01	IGHJ4*02	IGHD1-26*01	IGLV3-21*04	IGLJ3*02	ARAGTTNSDYFDY	QVWDSSSVLWV	nan	Gaebler et al. Nature 591:639-644 (2021)	nan	nan
44	COV096	COV096_HC_40-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTAGAGTGGGTGGCACTTATATCATATGATGGAAGTAACAAACACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGCGGGAACTACTAATAGCGACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVALISYDGSNKHYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARAGTTNSDYFDYWGQGTLVTVSS	TCCTATGTGCTGACTCAGCCACCCTCAGTGTCAGTGGCCCCAGGAAAGACGGCCAGGATTACCTGTGGGGGAAACAACATTGGAAGTAAAAGTGTGCACTGGTACCAGCAGAAGCCAGGCCAGGCCCCTGTGCTGGTCATCTATTATGATACCGACCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACGGCCACCCTGACCATCAGCAGGGTCGAAGCCGGGGATGAGGCCGACTATTACTGTCAGGTGTGGGATAGTAGTAGTGCCCTTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	SYVLTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVIYYDTDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSALWVFGGGTKLTVL	IGHV3-30*01	IGHJ4*02	IGHD1-26*01	IGLV3-21*04	IGLJ3*02	ARAGTTNSDYFDY	QVWDSSSALWV	nan	Robbiani et al. Nature 584:437-442 (2020);Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW293035.1	MW293490.1
44	Wang-MOD1	C619	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTAGAGTGGGTGGCACTTATATCATATGATGGAAGTAACAAACACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGCGGGAACTACTAATAGCGACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVALISYDGSNKHYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARAGTTNSDYFDYWGQGTLVTVSS	GATGTTGTGATGACTCAGTCTCCACTCTCCCTGCCCGTCACCCTTGGACAGCCGGCCTCCATCTCCTGCAGGTCTAGTCAAAGCCTCGTATATAGTGATGGAAACACCTACTTGAATTGGTTTCAGCAGAGGCCAGGCCAATCTCCAAGGCGCCTAATTTATCAGGTTTCTAACCGGGACTCTGGGGTCCCAGACAGATTCAGCGGCAGTGGGTCAGGCACTGATTTCACACTGCAAATCAGCACGGTGGAGGCTGAGGATGTTGGGGTTTATTACTGCATACAAGGTTCACTCTGGCCCCGGGCTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DVVMTQSPLSLPVTLGQPASISCRSSQSLVYSDGNTYLNWFQQRPGQSPRRLIYQVSNRDSGVPDRFSGSGSGTDFTLQISTVEAEDVGVYYCIQGSLWPRAFGQGTKLEIK	IGHV3-30*01	IGHJ4*02	IGHD1-26*01	IGKV2-30*01	IGKJ2*01,IGKJ2*02	ARAGTTNSDYFDY	IQGSLWPRA	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
44	Wang-MOD1	Mod1_P2_IgG_H5-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTAGAGTGGGTGGCACTTATATCATATGATGGAAGTAACAAACACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGCGGGAACTACTAATAGCGACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVALISYDGSNKHYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARAGTTNSDYFDYWGQGTLVTVSS	GATGTTGTGATGACTCAGTCTCCACTCTCCCTGCCCGTCACCCTTGGACAGCCGGCCTCCATCTCCTGCAGGTCTAGTCAAAGCCTCGTATATAGTGATGGAAACACCTACTTGAATTGGTTTCAGCAGAGGCCAGGCCAATCTCCAAGGCGCCTAATTTATCAGGTTTCTAACCGGGACTCTGGGGTCCCAGACAGATTCAGCGGCAGTGGGTCAGGCACTGATTTCACACTGCAAATCAGCACGGTGGAGGCTGAGGATGTTGGGGTTTATTACTGCATACAAGGTTCACTCTGGCCCCGGGCTTTTGGCCAGGGGACCAAGCTGGAGGTCAAAC	DVVMTQSPLSLPVTLGQPASISCRSSQSLVYSDGNTYLNWFQQRPGQSPRRLIYQVSNRDSGVPDRFSGSGSGTDFTLQISTVEAEDVGVYYCIQGSLWPRAFGQGTKLEVK	IGHV3-30*01	IGHJ4*02	IGHD1-26*01	IGKV2-30*01	IGKJ2*01,IGKJ2*02	ARAGTTNSDYFDY	IQGSLWPRA	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
45	Wang-MOD1	C609	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTTTCCTGCAAGGCATCTGGATACACCTTCACCATGTACCATATGCACTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAATAATCAACCCTAGTGGTGGAAGTACAAGGTACGCACAGCAGTTACAGGGTAGAGTCAGCATGACCAGGGACACGTCCACGAGCACAGTCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCTTTTATTACTGTGCGAGAGAAGACGTGGGAGGTACGGGGTATTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGASVKVSCKASGYTFTMYHMHWVRQAPGQGLEWMGIINPSGGSTRYAQQLQGRVSMTRDTSTSTVYMELSSLRSEDTAFYYCAREDVGGTGYFDYWGQGTLVTVSS	TCCTATGAGCTGACTCAGCCACCCTCGGTGTCAGTGGCCCCAGGACAGACGGCCAGGATTACCTGTGGGGCAAACAACATTGGAAGTAAAAGTGTGCACTGGTACCAGCAGAAGCCAGGCCAGGCCCCTGTGCTGGTCGTCTATGATGATAGCGACCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACGGCCACCCTGACCATCAGCAGGGTCGAAGCCGGGGATGAGGCCGACTATTACTGTCAGGTGTGGGATGGTAGTAGTGATCATTTTTATGTCTTCGGAACTGGGACCACGGTCACCGTCCTAG	SYELTQPPSVSVAPGQTARITCGANNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDGSSDHFYVFGTGTTVTVL	IGHV1-46*01,IGHV1-46*04	IGHJ4*02	IGHD1-26*01	IGLV3-21*02	IGLJ1*01	AREDVGGTGYFDY	QVWDGSSDHFYV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
45	Wang-MOD1	Mod1_P2_IgG_D12-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTTTCCTGCAAGGCATCTGGATACACCTTCACCATGTACCATATGCACTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAATAATCAACCCTAGTGGTGGAAGTACAAGGTACGCACAGCAGTTACAGGGTAGAGTCAGCATGACCAGGGACACGTCCACGAGCACAGTCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCTTTTATTACTGTGCGAGAGAAGACGTGGGAGGTACGGGGTATTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGASVKVSCKASGYTFTMYHMHWVRQAPGQGLEWMGIINPSGGSTRYAQQLQGRVSMTRDTSTSTVYMELSSLRSEDTAFYYCAREDVGGTGYFDYWGQGTLVTVSS	TCCTATGTGCTGACTCAGCCACCCTCGGTGTCAGTGGCCCCAGGACAGACGGCCAGGATTACCTGTGGGGCAAACAACATTGGAAGTAAAAGTGTGCACTGGTACCAGCAGAAGCCAGGCCAGGCCCCTGTGCTGGTCGTCTATGATGATAGCGACCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACGGCCACCCTGACCATCAGCAGGGTCGAAGCCGGGGATGAGGCCGACTATTACTGTCAGGTGTGGGATGGTAGTAGTGATCATTTTTATGTCTTCGGAACTGGGACCACGGTCACCGTCCTAG	SYVLTQPPSVSVAPGQTARITCGANNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDGSSDHFYVFGTGTTVTVL	IGHV1-46*01,IGHV1-46*04	IGHJ4*02	IGHD1-26*01	IGLV3-21*02	IGLJ1*01	AREDVGGTGYFDY	QVWDGSSDHFYV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
45	COV096	COV096_HC_2-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTTTCCTGCAAGGCATCTGGATACACCTTCACCAGCTACTATATGCACTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAATAATCAACCCTAGTGGTGGTAGCACAAGGTACGCACAGAAGTTCCAGGGCAGAGTCACCATGACCAGGGACACGTCCACGAGCACAGTCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGAAGGAGTGGGAGGTACTTCCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGIINPSGGSTRYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCAREGVGGTSYFDYWGQGTLVTVSS	TCCTATGTGCTGACTCAGCCACCCTCGGTGTCAGTGGCCCCAGGAAAGACGGCCAGGATTACCTGTGGGGGAAACAACATTGGAAGTAAAAGTGTGCACTGGTACCAGCAGAAGCCAGGCCAGGCCCCTGTGCTGGTCGTCTATGATGATAGCGACCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACGGCCACCCTGACCATCAGCAGGGTCGAAGCCGGGGATGAGGCCGACTATTACTGTCAGGTGTGGGATAGTAGTAGTGATCCTTATGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	SYVLTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDPYVFGTGTKVTVL	IGHV1-46*01	IGHJ4*02	IGHD1-26*01	IGLV3-21*03	IGLJ1*01	AREGVGGTSYFDY	QVWDSSSDPYV	nan	Robbiani et al. Nature 584:437-442 (2020);Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW293132.1	MW293587.1
45	IML3547	ADI-60793	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGAATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGAAGGGGTGGGAGCTACGTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLLESGGGVVQPGRSLRLSCAASEFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREGVGATYYFDYWGQGTLVTVSS	nan	nan	IGHV3-30-3*01	IGHJ4*02	IGHD1-26*01	IGLV3-1	nan	AREGVGATYYFDY	QAWDSSAV	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458062.1	nan
45	IML3550	ADI-57816	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGTTATGAAATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGGAGTGGTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTTTATTACTGTGCGAGAAGCGGAGTGGGAGCTACCTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCTTCA	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYEMNWVRQAPGKGLEWVSYISRSGSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARSGVGATYYFDYWGQGTLVTVSS	nan	nan	IGHV3-48*03	IGHJ4*02	IGHD1-26*01	IGLV3-1	nan	ARSGVGATYYFDY	QAWDSSTGV	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457692.1	nan
46	IML3545	ADI-62149	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAATCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCGCCTGTGCAGCCTCTGGATTCACCTTCAGTAGTTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCACTTATATCATATGATGGAATCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGGGGAGGAGGAGGGAACTACCACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGGVVQPGRSLRLACAASGFTFSSYAMHWVRQAPGKGLEWVALISYDGINKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGGGGNYHYFDYWGQGTLVTVSS	nan	nan	IGHV3-30-3*01	IGHJ4*02	IGHD1-7*01	IGKV3-20	nan	ARGGGGNYHYFDY	QQYGSSPIFT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458241.1	nan
46	IML3564	ADI-63377	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGGGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACGTTCAGTACCCATGCTATGCACTGGGTCAGGCAGGCTCCAGGCAGGGGGCTGGAGTGGGTGGCCCTAATAGCCTATGATGGAGACAAGAGATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAATACTCTGTATCTACAAATGAACAACCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGGGGGGGGTGGAAACTACTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGGVVQPGRSLRLSCAASGFTFSTHAMHWVRQAPGRGLEWVALIAYDGDKRYYADSVKGRFTISRDNSKNTLYLQMNNLRAEDTAVYYCARGGGGNYYYFDYWGQGTLVTVSS	nan	nan	IGHV3-30-3*01	IGHJ4*02	IGHD4-23*01	IGKV3-11	nan	ARGGGGNYYYFDY	QQRSNWPLT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458883.1	nan
46	IML3564	ADI-62097	nan	SARS-CoV-2,SARS-CoV	nan	SARS-CoV-2	SARS-CoV	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGTCTATGCTATGCACTGGGTCCGCCAGGCTCCAGACAAGGGGCTGGAGTGGGTGGCACTTATATCATATGATGGAGACAATAAATATTATGTAGACTCCGTGCAGGGCCGGTTCACCATCTCCAGAGACAATTCCAAGAATACCCTGTATCTACAAATGAACAGCCTGAGACCTGAGGACACGGCTGTGTATTACTGTGCGAGGGGCCTGGGTGGGAACTACTACTACTTTGACTACTGGGGCCAGGGAACCACGGTCACCGTCTCTTCA	EVQLLESGGGVVQPGRSLRLSCAASGFTFSVYAMHWVRQAPDKGLEWVALISYDGDNKYYVDSVQGRFTISRDNSKNTLYLQMNSLRPEDTAVYYCARGLGGNYYYFDYWGQGTTVTVSS	nan	nan	IGHV3-30-3*01	IGHJ4*02	IGHD1-26*01	IGKV3-11	nan	ARGLGGNYYYFDY	QQRSNWPPL	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458189.1	nan
46	CC36	CC36.4	nan	SARS-CoV-2,SARS-CoV	MERS-CoV,HKU1,OC43,NL63,229E	nan	SARS-CoV-2,SARS-CoV	S:Unk	SARS-CoV-2 spike, HKU1 spike, NL63 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATACACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGGTTTAGGTGGGAACTACTACGCTGTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAIHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGLGGNYYAVDYWGQGTLVTVSS	GAAATAGTGATGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACCGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGCAGGGAACGTTCGGCCAAGGGACCAAGCTGGAGATCAAAC	EIVMTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQQGTFGQGTKLEIK	IGHV3-30-3*01	IGHJ4*02	IGHD1-26*01	IGKV3-20*01	IGKJ1*01	ARGLGGNYYAVDY	QQQGT	nan	Song et al. Nat Commun. 12:2938 (2021)	MW532181.1	MW532182.1
46	IML3564	ADI-62082	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAATAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAATTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGGGTCGGGTGGAAACTACTATTACGGGGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLLESGGGVVQPGRSLRLSCAASGFTFNSYAMHWVRQAPGKGLEWVAIISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGSGGNYYYGDYWGQGTLVTVSS	nan	nan	IGHV3-30-3*01	IGHJ4*02	IGHD2-21*02	IGKV3-11	nan	ARGSGGNYYYGDY	QQRSNWLT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458174.1	nan
47	COV096	C550	COV096_HC_12-p1369	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGCAGTCTGGAGCAGAGGTGAAAAAGCCCGGGGAGTCTCTGAAGATCTCCTGTAAGGGTTCTGGATACAGATTTACCAACTACTGGATCGGCTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATGGGGATCATCTATCCTGGTGACTCTGATACCAGATACAGCCCGTCCTTCCAAGGCCAGGTCACCATCTCAGCCGACAAGTCCATCACCACCGCCTACCTGCAGTGGAGCAGCCTGAAGGCCTCGGACACCGCCATGTATTACTGTGCGAGACTCAGTGACCGCTGGTACAGTCCGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVQSGAEVKKPGESLKISCKGSGYRFTNYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSITTAYLQWSSLKASDTAMYYCARLSDRWYSPFDPWGQGTLVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATAATAACTGGCCTCCGGGGGGATTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPGGFTFGPGTKVDIK	IGHV5-51*01	IGHJ5*02	IGHD6-13*01,IGHD6-19*01	IGKV3-15*01	IGKJ3*01	ARLSDRWYSPFDP	QQYNNWPPGGFT	nan	Gaebler et al. Nature 591:639-644 (2021);Robbiani et al. Nature 584:437-442 (2020);Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW293252.1	MW293707.1
47	COV047	C147	nan	SARS-CoV-2	nan	nan	SARS-CoV,SARS-CoV-2	S:non-RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGCAGTCTGGAGCAGAGGTGAAAAAGCCCGGGGAGTCTCTGAAGATCTCCTGTAAGGGTTCTGGATACAGATTTACCAACTACTGGATCGGCTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATGGGGATCATCTATCCTGGTGACTCTGATACCAGATACAGCCCGTCCTTCCAAGGCCAGGTCACCATCTCAGCCGACAAGTCCATCACCACCGCCTACCTGCAGTGGAGCAGCCTGAAGGCCTCGGACACCGCCATGTATTACTGTGCGAGACTCAGTGACCGCTGGTACAGTCCGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVQSGAEVKKPGESLKISCKGSGYRFTNYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSITTAYLQWSSLKASDTAMYYCARLSDRWYSPFDPWGQGTLVTVSS	CAGGCTGTGGTGACCCAGGAGCCCTCACTGACTGTGTCCCCAGGAGGGACAGTCACTCTCACCTGTGGCTCCAGCACTGGAGCTGTCACCAGTGGTCATTATCCCTACTGGTTCCAGCAGAAGTCTGGCCAAGCCCCCAGGACACTGATTTATGAAACAAGCATCAAACACTCCTGGACCCCTGCCCGGTTCTCAGGCTCCCTCCTTGGGGGCAAAGCTGCCCTGACCCTTTCGGGTGCGCAGCCTGAGGATGAGGCTGATTATTACTGCTTGCTCTCCTATAGTGGTGCTCGGCCGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QAVVTQEPSLTVSPGGTVTLTCGSSTGAVTSGHYPYWFQQKSGQAPRTLIYETSIKHSWTPARFSGSLLGGKAALTLSGAQPEDEADYYCLLSYSGARPVFGGGTKLTVL	IGHV5-51*01	IGHJ5*02	IGHD6-13*01,IGHD6-19*01	IGLV7-46*01	IGLJ3*02	ARLSDRWYSPFDP	LLSYSGARPV	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
47	COV047	COV047_P3_IgG_8-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGCAGTCTGGAGCAGAGGTGAAAAAGCCCGGGGAGTCTCTGAAGATCTCCTGTAAGGGTTCTGGATACAGATTTACCAACTACTGGATCGGCTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATGGGGATCATCTATCCTGGTGACTCTGATACCAGATACAGCCCGTCCTTCCAAGGCCAGGTCACCATCTCAGCCGACAAGTCCATCACCACCGCCTACCTGCAGTGGAGCAGCCTGAAGGCCTCGGACACCGCCATGTATTACTGTGCGAGACTCAGTGACCGCTGGTACAGTCCGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVQSGAEVKKPGESLKISCKGSGYRFTNYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSITTAYLQWSSLKASDTAMYYCARLSDRWYSPFDPWGQGTLVTVSS	CAGTCTGTGCTGACTCAGGAGCCCTCACTGACTGTGTCCCCAGGAGGGACAGTCACTCTCACCTGTGGCTCCAGCACTGGAGCTGTCACCAGTGGTCATTATCCCTACTGGTTCCAGCAGAAGTCTGGCCAAGCCCCCAGGACACTGATTTATGAAACAAGCATCAAACACTCCTGGACCCCTGCCCGGTTCTCAGGCTCCCTCCTTGGGGGCAAAGCTGCCCTGACCCTTTCGGGTGCGCAGCCTGAGGATGAGGCTGATTATTACTGCTTGCTCTCCTATAGTGGTGCTCGGCCGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQEPSLTVSPGGTVTLTCGSSTGAVTSGHYPYWFQQKSGQAPRTLIYETSIKHSWTPARFSGSLLGGKAALTLSGAQPEDEADYYCLLSYSGARPVFGGGTKLTVL	IGHV5-51*01	IGHJ5*02	IGHD6-13*01,IGHD6-19*01	IGLV7-46*01	IGLJ3*02	ARLSDRWYSPFDP	LLSYSGARPV	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293007.1	MW293462.1
47	COV047	COV047_P3_IgG_91-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGCAGTCTGGAGCAGAGGTGAAAAAGCCCGGGGAGTCTCTGAAGATCTCCTGTAAGGGTTCTGGATACAGATTTACCAACTACTGGATCGGCTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATGGGGATCATCTATCCTGGTGACTCTGATACCAGATACAGCCCGTCCTTCCAAGGCCAGGTCACCATCTCAGCCGACAAGTCCATCACCACCGCCTACCTGCAGTGGAGCAGCCTGAAGGCCTCGGACACCGCCATGTATTACTGTGCGAGACTCAGTGACCGCTGGTACAGTCCGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVQSGAEVKKPGESLKISCKGSGYRFTNYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSITTAYLQWSSLKASDTAMYYCARLSDRWYSPFDPWGQGTLVTVSS	CAGTCTGTGCTGACTCAGGAGCCCTCACTGACTGTGTCCCCAGGAGGGACAGTCACTCTCACCTGTGGCTCCAGCACTGGAGCTGTCACCAGTGGTCATTATCCCTACTGGTTCCAGCAGAAGTCTGGCCAAGCCCCCAGGACACTGATTTATGAAACAAGCATCAAACACTCCTGGACCCCTGCCCGGTTCTCAGGCTCCCTCCTTGGGGGCAAAGCTGCCCTGACCCTTTCGGGTGCGCAGCCTGAGGATGAGGCTGATTATTACTGCTTGCTCTCCTATAGTGGTGCTCGGCCGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQEPSLTVSPGGTVTLTCGSSTGAVTSGHYPYWFQQKSGQAPRTLIYETSIKHSWTPARFSGSLLGGKAALTLSGAQPEDEADYYCLLSYSGARPVFGGGTKLTVL	IGHV5-51*01	IGHJ5*02	IGHD6-13*01,IGHD6-19*01	IGLV7-46*01	IGLJ3*02	ARLSDRWYSPFDP	LLSYSGARPV	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293008.1	MW293463.1
47	COV096	C532	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGCAGTCTGGAGCAGAGGTGAAAAAGCCCGGGGAGTCTCTGAAGATCTCCTGTAAGGGTTCTGGATACAGATTTACCAACTACTGGATCGGCTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATAGGGAACATCTTTCCCGGTGACTCTGATTCCAGATACAGCCCGTCCTTCCAAGGCCAGGTCACCATCTCAGTCGACATGTCCATCACCACCGCCTACCTGCACTGGAGCAGCCTGAAGGCCTCGGACACCGCCATCTATTACTGTGCGAGACTCAGTGAGCGCTGGTACAGTCCGTTCGACTCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVQSGAEVKKPGESLKISCKGSGYRFTNYWIGWVRQMPGKGLEWIGNIFPGDSDSRYSPSFQGQVTISVDMSITTAYLHWSSLKASDTAIYYCARLSERWYSPFDSWGQGTLVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAGCCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTTTCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTTCTGTCAGCAGTATAATAACTGGCCTCCGGGGGGATTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGFPARFSGSGSGTEFTLTISSLQSEDFAVYFCQQYNNWPPGGFTFGPGTKVDIK	IGHV5-51*01	IGHJ5*01,IGHJ5*02	IGHD6-13*01,IGHD6-19*01	IGKV3-15*01	IGKJ3*01	ARLSERWYSPFDS	QQYNNWPPGGFT	nan	Gaebler et al. Nature 591:639-644 (2021)	nan	nan
48	COV096	COV096_HC_45-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCCGGGGGAGGCTTAGTTCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCAATTTCAGTACCCACTGGATGCACTGGGTCCGCCAAGCTCCAGGGAAGGGGCTGGTGTGGGTCTCACGTATTAACAGTGATGGGAGTAGGAGAGCCTATGCGACTTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACACGCTGTATCTGCAAATGGACAGTCTGAGAGACGAGGACACGGCCGTATATTACTGTACAAGAGACGACAGCAGCTGGCCACACTTCTTTGACAATTGGGGCCAGGGAACCCTTGTCGCCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFNFSTHWMHWVRQAPGKGLVWVSRINSDGSRRAYATSVKGRFTISRDNAKNTLYLQMDSLRDEDTAVYYCTRDDSSWPHFFDNWGQGTLVAVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCTCCGAAGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPPKLTFGGGTKVEIK	IGHV3-74*01,IGHV3-74*03	IGHJ4*02	IGHD6-13*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	TRDDSSWPHFFDN	QQYDNLPPKLT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
48	COV021	COVD21_P3_HC_H10-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCCGGGGGAGGCTTAGTTCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCAATTTCAGTACCCACTGGATGCACTGGGTCCGCCAAGCTCCAGGGAAGGGGCTGGTGTGGGTCTCACGTATTAACAGTGATGGGAGTAGGAGAGCCTATGCGACTTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACACGCTGTATCTGCAAATGGACAGTCTGAGAGACGAGGACACGGCCGTATATTACTGTACAAGAGACGACAGCAGCTGGCCACACTTCTTTGACAATTGGGGCCAGGGAACCCTTGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFNFSTHWMHWVRQAPGKGLVWVSRINSDGSRRAYATSVKGRFTISRDNAKNTLYLQMDSLRDEDTAVYYCTRDDSSWPHFFDNWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGTTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYVASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTRTFGQGTKVEIK	IGHV3-74*01,IGHV3-74*03	IGHJ4*02	IGHD6-13*01	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	TRDDSSWPHFFDN	QQSYSTRT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
48	COV057	COVD57_P1_HC_G3-1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCCGGGGGAGGCTTAGTTCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCAATTTCAGTACCCACTGGATGCACTGGGTCCGCCAAGCTCCAGGGAAGGGGCTGGTGTGGGTCTCACGTATTAACAGTGATGGGAGTAGGAGAGCCTATGCGACTTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACACGCTGTATCTGCAAATGGACAGTCTGAGAGACGAGGACACGGCCGTATATTACTGTACAAGAGACGACAGCAGCTGGCCACACTTCTTTGACAATTGGGGCCAGGGAACCCTTGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFNFSTHWMHWVRQAPGKGLVWVSRINSDGSRRAYATSVKGRFTISRDNAKNTLYLQMDSLRDEDTAVYYCTRDDSSWPHFFDNWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTATCAACTATTTAAATTGGTATCAGCAGAAGCCAGGGAAAGCCCCTAAGCTCCTGATCTATACTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTTCTGTCAACAGAGTTACAGTAGCCCTCTGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSIINYLNWYQQKPGKAPKLLIYTASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYFCQQSYSSPLWTFGQGTKVEIK	IGHV3-74*01,IGHV3-74*03	IGHJ4*02	IGHD6-13*01	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	TRDDSSWPHFFDN	QQSYSSPLWT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
48	COV057	COVD57_P2_HC_B7-1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCCGGGGGAGGCTTAGTTCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCAATTTCAGTACCCACTGGATGCACTGGGTCCGCCAAGCTCCAGGGAAGGGGCTGGTGTGGGTCTCACGTATTAACAGTGATGGGAGTAGGAGAGCCTATGCGACTTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACACGCTGTATCTGCAAATGGACAGTCTGAGAGACGAGGACACGGCCGTATATTACTGTACAAGAGACGACAGCAGCTGGCCACACTTCTTTGACAATTGGGGCCAGGGAACCCTTGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFNFSTHWMHWVRQAPGKGLVWVSRINSDGSRRAYATSVKGRFTISRDNAKNTLYLQMDSLRDEDTAVYYCTRDDSSWPHFFDNWGQGTLVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCATCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATGATAACTGGCCACTCTTCGGCCAAGGGACACGACTGGAGATTAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYHQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYDNWPLFGQGTRLEIK	IGHV3-74*01,IGHV3-74*03	IGHJ4*02	IGHD6-13*01	IGKV3-15*01	IGKJ5*01	TRDDSSWPHFFDN	QQYDNWPL	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
48	COV096	COV096_HC_126-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCCGGGGGAGGCTTAGTTCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCAATTTCAGTACCCACTGGATGCACTGGGTCCGCCAAGCTCCAGGGAAGGGGCTGGTGTGGGTCTCACGTATTAACAGTGATGGGAGTAGGAGAGCCTATGCGACTTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACACGCTGTATCTGCAAATGGACAGTCTGAGAGACGAGGACACGGCCGTATATTACTGTACAAGAGACGACAGCAGCTGGCCACACTTCTTTGACAATTGGGGCCAGGGAACCCTTGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFNFSTHWMHWVRQAPGKGLVWVSRINSDGSRRAYATSVKGRFTISRDNAKNTLYLQMDSLRDEDTAVYYCTRDDSSWPHFFDNWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTTGGAGACAGAGTCACCATTCCTTGCCGGGCAAGTCAGAACATTGACAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTTTGCTGCATCTGGTTTGCAAGATGAAGCCCCATCTAGGTTCAGTGGCGTTGGATCTGGGACAGATTTCACGCTCACCATCAGCAGTCTTCAACCTGAAGACTCTGCAACCTACTACTGTCAACAGAGTTATATTTCCCCGTACACTTTTGGCCGGGGGACCAAGCTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTIPCRASQNIDNYLNWYQQKPGKAPKLLIFAASGLQDEAPSRFSGVGSGTDFTLTISSLQPEDSATYYCQQSYISPYTFGRGTKLEIK	IGHV3-74*01,IGHV3-74*03	IGHJ4*02	IGHD6-13*01	IGKV1-39*01,IGKV1D-39*01	IGKJ2*01	TRDDSSWPHFFDN	QQSYISPYT	nan	Robbiani et al. Nature 584:437-442 (2020);Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW293263.1	MW293718.1
49	Chen_Vax_p1	COV2-vax-45	nan	SARS-CoV-2	nan	nan	nan	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGTACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAAGTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAGTACGATATTTTGACTGGTTACCTTGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDKSKNTLYLQMNSLRAEDTAVYYCAREYDILTGYLDAFDIWGQGTMVTVSS	CAGTCTGTGCTGACGCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGCTCCAACATCGGGGCAGGTTATGATGTACACTGGTACCAGCAGCTTCCAGGAACAGCCCCCAAACTCCTCATCTATGGTAACAGCAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCAGTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAGCAGCCTGAGTGCCCATGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAISGLQAEDEADYYCQSYDSSLSAHVVFGGGTKLTVL	IGHV3-53*01	IGHJ3*02	IGHD3-9*01	IGLV1-40*01	IGLJ2*01,IGLJ3*01	AREYDILTGYLDAFDI	QSYDSSLSAHVV	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555592.1	MZ555593.1
49	Crowe_mix	COV2-2068	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGGTCCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATCCCGGTGGTAGCGCATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGACACAATTCCAACAACACACTGTGTCTTCAAATGAACAGCCTGCGAACTGAGGACACGGCCGTGTATTATTGTGCGAGATCTTACGATATTTTGACTGGTTATAGAGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCT	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYPGGSAFYADSVKGRFTISRHNSNNTLCLQMNSLRTEDTAVYYCARSYDILTGYRDAFDIWGQGTMVTVSS	CAGTCTGTGCTGACGCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGCTCCAACATCGGGTCAGGTTCTGATGTACACTGGTACCAGCAGCTTCCAGGAACAGCCCCCAAACTCCTCATCTATGGCAACACCAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAGCAGGCTGAGTGGTTTTGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTA	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGSGSDVHWYQQLPGTAPKLLIYGNTNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSRLSGFVVFGGGTKLTVL	IGHV3-53*04	IGHJ3*02	IGHD3-9*01	IGLV1-40*01	IGLJ2*01,IGLJ3*01	ARSYDILTGYRDAFDI	QSYDSRLSGFVV	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665441.1	MT665054.1
49	Crowe_mix	COV2-2767	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV,SARS-CoV-2	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGGTCCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATCCCGGTGGTAGCGCATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGACACAATTCCAACAACACACTGTGTCTTCAAATGAACAGCCTGCGAACTGAGGACACGGCCGTGTATTATTGTGCGAGATCTTACGATATTTTGACTGGTTATAGAGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYPGGSAFYADSVKGRFTISRHNSNNTLCLQMNSLRTEDTAVYYCARSYDILTGYRDAFDIWGQGTMVTVSS	CAGTCTGTGCTGACGCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGCTCCAACATCGGGGCAGGTTATGATGTACACTGGTACCAGCAGCTTCCAGAAACAGCCCCCAAACTCCTCATCTATGCTAACAGCAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCAGTGGCCTCCAGTCTGAGGCTGAGGCTGATTATTACTGTGTGGCATGGGATGACAGCCGGAATGGCCTGGTATTCGGCGGCGGGGCCAAGCTGACCGTCCTC	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPETAPKLLIYANSNRPSGVPDRFSGSKSGTSASLAISGLQSEAEADYYCVAWDDSRNGLVFGGGAKLTVL	IGHV3-53*04	IGHJ3*02	IGHD3-9*01	IGLV1-50*01	IGLJ2*01,IGLJ3*01	ARSYDILTGYRDAFDI	VAWDDSRNGLV	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665477.1	MT665090.1
49	Crowe_mix	COV2-2790	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGGTCCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATCCCGGTGGTAGCGCATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGACACAATTCCAACAACACACTGTGTCTTCAAATGAACAGCCTGCGAACTGAGGACACGGCCGTGTATTATTGTGCGAGATCTTACGATATTTTGACTGGTTATAGAGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCT	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYPGGSAFYADSVKGRFTISRHNSNNTLCLQMNSLRTEDTAVYYCARSYDILTGYRDAFDIWGQGTMVTVSS	CAGTCTGTGCTGACGCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGCTCCAACATCGGGTCAGGTTCTGATGTACACTGGTACCAGCAGCTTCCAGGAACAGCCCCCAAACTCCTCATCTATGGCAACACCAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAGCAGGCTGAGTGGTTTTGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTA	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGSGSDVHWYQQLPGTAPKLLIYGNTNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSRLSGFVVFGGGTKLTVL	IGHV3-53*04	IGHJ3*02	IGHD3-9*01	IGLV1-40*01	IGLJ2*01,IGLJ3*01	ARSYDILTGYRDAFDI	QSYDSRLSGFVV	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665509.1	MT665122.1
49	Crowe_mix	COV2-2901	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV,SARS-CoV-2	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGGTCCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATCCCGGTGGTAGCGCATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGACACAATTCCAACAACACACTGTGTCTTCAAATGAACAGCCTGCGAACTGAGGACACGGCCGTGTATTATTGTGCGAGATCTTACGATATTTTGACTGGTTATAGAGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCT	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYPGGSAFYADSVKGRFTISRHNSNNTLCLQMNSLRTEDTAVYYCARSYDILTGYRDAFDIWGQGTMVTVSS	CAGTCTGTGCTGACGCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGCTCCAACATCGGGTCAGGTTCTGATGTACACTGGTACCAGCAGCTTCCAGGAACAGCCCCCAAACTCCTCATCTATGGCAACACCAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGTGTGGCATGGGATGACAGCCGGAATGGCCTGGTATTCGGCGGAGGGGCCAAGCTGACCGTCCTC	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGSGSDVHWYQQLPGTAPKLLIYGNTNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCVAWDDSRNGLVFGGGAKLTVL	IGHV3-53*04	IGHJ3*02	IGHD3-9*01	IGLV1-40*01	IGLJ2*01,IGLJ3*01	ARSYDILTGYRDAFDI	VAWDDSRNGLV	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665461.1	MT665074.1
50	COV021	COV021_P3_IgA_68-P1609	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGGTTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTATATTACTGTGCGAAAAGGGGCGGATATTGTAGTAGTACCAGCTGCTATACGCGGTACTACTACATGGACGTCTGGGGCAAAGGGACCACGGTCACCGTCTCCTCA	EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKRGGYCSSTSCYTRYYYMDVWGKGTTVTVSS	CAGTCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACATTGGTGTTTATAACTATATCTCCTGGAGCCAACAACACCCAGGCAAAGCCCCCAAAGTCATGATTTATGATGTCACTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTATTGCAGCTCATATAGAGGCAGCAGCACTCCCTATGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	QSVLTQPASVSGSPGQSITISCTGTSSDIGVYNYISWSQQHPGKAPKVMIYDVTNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYRGSSTPYVFGTGTKVTVL	IGHV3-23*01,IGHV3-23D*01	IGHJ6*03	IGHD2-2*02	IGLV2-14*03	IGLJ1*01	AKRGGYCSSTSCYTRYYYMDV	SSYRGSSTPYV	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW293203.1	MW293658.1
50	PT47	47A4	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV3-23	nan	nan	IGKV1-12	nan	AKRGGYCTDTICYTRYYYMDV	QQANSFPLT	nan	Zhou et al. Cell Rep. 35:109109 (2021)	nan	nan
50	PT47	47F4	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV4-59	nan	nan	IGLV6-57	nan	AKRGGYCTDTICYTRYYYMDV	QSYDSSNPVV	nan	Zhou et al. Cell Rep. 35:109109 (2021)	nan	nan
50	Wang-C004	C004_P1_IgG_E4-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGGTATTAGTGCTAGTGATGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGGTTCACCGTCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCTTATGAACAGCCTGAGAGCCGAGGACACGGCCGTATATTACTGTGCGAAGAGGGGAGGATATTGTACTAGTACCATCTGCTATACAAGATACTACTACATGGACGTCTGGGGCAAAGGGACCACGGTCACCGTCTCCTCA	EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSGISASDGSTYYADSVKGRFTVSRDNSKNTLYLLMNSLRAEDTAVYYCAKRGGYCTSTICYTRYYYMDVWGKGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCTTCCGTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGTCGGGCGAGTCAGGATATTAGCAGCTGGTTAGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTACTATTGTCAACAGGCTAACAGTTTCCCGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSVSASVGDRVTITCRASQDISSWLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPLTFGGGTKVEIK	IGHV3-23*01,IGHV3-23D*01	IGHJ6*03	IGHD2-2*02	IGKV1-12*01,IGKV1-12*02,IGKV1D-12*02	IGKJ4*01	AKRGGYCTSTICYTRYYYMDV	QQANSFPLT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
50	PT47	472F6	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV3-23	nan	nan	IGKV1-12	nan	AKRGGYCTTTICYTRYYYMDV	QQANSFPLT	nan	Zhou et al. Cell Rep. 35:109109 (2021)	nan	nan
51	Aishun_Jin_mix	8B5A6	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV3-33*01	IGHJ4*02	IGHD6-13*01	IGKV2-28*01	IGKJ1*01	AKGGWYSSKWYYFDY	MQALQMGT	nan	Han et al. Front Immunol. 12:653189 (2021)	nan	nan
51	Aishun_Jin_mix	8B5C1	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV3-33*01	IGHJ4*02	IGHD6-13*01	IGKV2-28*01	IGKJ1*01	AKGGWYSSKWYYFDY	MQALQMGT	nan	Han et al. Front Immunol. 12:653189 (2021)	nan	nan
51	Aishun_Jin_mix	CQTS216	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATGGTATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAAAGGGGGCTGGTATAGCAGCAAGTGGTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCTTCAC	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGGWYSSKWYYFDYWGQGTLVTVSS	GATATTGTGATGACTCAGTCGCCAGTCTCCCTGCCCGTCACCCCTGGAGAGCCGGCCTCCATGTCCTGTAGGTCTAGTCAGAGCCTCCTGCATAGCAATGGATACATCTATTTGGATTGGTACGTGCAGAAGCCAGGGCAGTCTCCACAGCTCCTGTTCTACTTGGGTTCTAACCGGGCCCCCGGGGTCCCTGTCAGGTTCAGTGCCAGTGGATCAGGCACAGATTTTACACTGAAAATCAGCAGAGTGGAGGCTGAGGATGTTGGGGTTTACTACTGCATGCAAGCTCTACAAATGGGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIVMTQSPVSLPVTPGEPASMSCRSSQSLLHSNGYIYLDWYVQKPGQSPQLLFYLGSNRAPGVPVRFSASGSGTDFTLKISRVEAEDVGVYYCMQALQMGTFGQGTKVEIK	IGHV3-33*06	IGHJ4*02	IGHD6-13*01	IGKV2-28*01,IGKV2D-28*01	IGKJ1*01	AKGGWYSSKWYYFDY	MQALQMGT	nan	Patent: CN111925442A	MW587668.1	MW587669.1
51	Wang-C001	C1261	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAACTGAGGACACGGCTGTGTATTACTGTGCGAAAGGCGGTTGGTATAGCAGCCCGACGTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRTEDTAVYYCAKGGWYSSPTYYFDYWGQGTLVTVSS	TCCTATGAGCTGACTCAGCCACCCTCGGTGTCAGTGGCCCCAGGACAGACGGCCAGGATTACCTGTGGGGGAAACAACATTGGAAGTAAAAGTGTGCACTGGTACCAGCAGAAGCCAGGCCAGGCCCCTGTGCTGGTCGTCTATGATGATAGCGACCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACGGCCACCCTGACCATCAGCAGGGTCGAAGCCGGGGATGAGGCCGACTATTACTGTCAGGTGTGGGATAGTAGTAGTGATCATCTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	SYELTQPPSVSVAPGQTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHLVFGGGTKLTVL	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD6-13*01,IGHD6-25*01	IGLV3-21*02	IGLJ2*01,IGLJ3*01	AKGGWYSSPTYYFDY	QVWDSSSDHLV	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
51	Wang-C001	C001_P2_IgG_B9-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAACTGAGGACACGGCTGTGTATTACTGTGCGAAAGGCGGTTGGTATAGCAGCCCGACGTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRTEDTAVYYCAKGGWYSSPTYYFDYWGQGTLVTVSS	TCCTATGTGCTGACTCAGCCACCCTCGGTGTCAGTGGCCCCAGGACAGACGGCCAGGATTACCTGTGGGGGAAACAACATTGGAAGTAAAAGTGTGCACTGGTACCAGCAGAAGCCAGGCCAGGCCCCTGTGCTGGTCGTCTATGATGATAGCGACCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACGGCCACCCTGACCATCAGCAGGGTCGAAGCCGGGGATGAGGCCGACTATTACTGTCAGGTGTGGGATAGTAGTAGTGATCATCTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	SYVLTQPPSVSVAPGQTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHLVFGGGTKLTVL	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD6-13*01,IGHD6-25*01	IGLV3-21*02	IGLJ2*01,IGLJ3*01	AKGGWYSSPTYYFDY	QVWDSSSDHLV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
52	COV021	C029	COVD21_P1_HC_E6-p1369	SARS-CoV-2	SARS-CoV	nan	SARS-CoV,SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTGGTGGTTACTACTGGAGCTGGATCCGCCAGCACCCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCGTGTATTACTGTGCGAGAACAATGTATTACTATGATAGTAGTGGTTCCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGYYWSWIRQHPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARTMYYYDSSGSFDYWGQGTLVTVSS	GATATTGTGATGACTCAGTCTCCACTCTCCCTGCCCGTCACCCCTGGAGAGCCGGCCTCCATCTCCTGCAGGTCTAGTCAGAGCCTCCTGCATAGTAATGGATACAACTATTTGGATTGGTACCTGCAGAAGCCAGGGCAGTCTCCACAGCTCCTGATCTATTTGGGTTCTAATCGGGCCTCCGGGGTCCCTGACAGGTTCAGTGGCAGTGGATCAGGCACAGATTTTACACTGAAAATCAGCAGAGTGGAGGCTGAGGATGTTGGGGTTTATTACTGCATGCAAGCTCTACAAACTCCTCACACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPHTFGGGTKVEIK	IGHV4-31*03	IGHJ4*02	IGHD3-22*01	IGKV2-28*01,IGKV2D-28*01	IGKJ4*01	ARTMYYYDSSGSFDY	MQALQTPHT	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293120.1	MW293575.1
52	Chen_Vax_p1	COV2-vax-56	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTGGTGGTTACTACTGGAGCTGGATCCGCCAGCACCCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCGTGTATTACTGTGCGAGAACGTGGTATTACTATGATAGTAGTGGTTCCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGYYWSWIRQHPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARTWYYYDSSGSFDYWGQGTLVTVSS	GATATTGTGATGACTCAGTCTCCACTCTCCCTGCCCGTCACCCCTGGAGAGCCGGCCTCCATCTCCTGCAGGTCTAGTCAGATCCTCCTGCATAGTAATGGATACAACTATTTGGATTGGTACCTGCAGAAGCCAGGGCAGTCTCCACAGCTCCTGCTCTATTTGGGTTCTAATCGGGCCTCCGGGGTCCCTGACAGGTTCAGTGGCAGTGGGTCAGGCACAGATTTTACACTGAAAATCAGCAGAGTGGAGGCTGAGGATGTTGGGGTTTATTACTGCATGCAAGCTCTACAAACTCCTGCCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIVMTQSPLSLPVTPGEPASISCRSSQILLHSNGYNYLDWYLQKPGQSPQLLLYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPATFGGGTKVEIK	IGHV4-31*03	IGHJ4*02	IGHD3-22*01	IGKV2-28*01,IGKV2D-28*01	IGKJ4*01	ARTWYYYDSSGSFDY	MQALQTPAT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555614.1	MZ555615.1
52	Chen_Vax_p1	COV2-vax-57	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTGGTGGTTACTACTGGAGCTGGATCCGCCAGCACCCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCGTGTATTACTGTGCGAGAACGTGGTATTACTATGATAGTAGTGGTTCCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGYYWSWIRQHPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARTWYYYDSSGSFDYWGQGTLVTVSS	GATATTGTGATGACTCAGTCTCCACTCTCCCTGCCCGTCACCCCTGGAGAGCCGGCCTCCATCTCCTGCAGGTCTAGTCAGATCCTCCTGCATAGTAATGGATACAACTATTTGGATTGGTACCTGCAGAAGCCAGGGCAGTCTCCACAGCTCCTGCTCTATTTGGGTTCTAATCGGGCCTCCGGGGTCCCTGACAGGTTCAGTGGCAGTGGGTCAGGCACAGATTTTACACTGAAAATCAGCAGAGTGGAGGCTGAGGATGTTGGGGTTTATTACTGCATGCAAGCTCTACAAACTCCTGCCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIVMTQSPLSLPVTPGEPASISCRSSQILLHSNGYNYLDWYLQKPGQSPQLLLYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPATFGGGTKVEIK	IGHV4-31*03	IGHJ4*02	IGHD3-22*01	IGKV2-28*01,IGKV2D-28*01	IGKJ4*01	ARTWYYYDSSGSFDY	MQALQTPAT	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555516.1	MZ555517.1
52	COV021	C021	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV,SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTGGTGGTTACTACTGGAGCTGGATCCGCCAGCACCCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCGTGTATTACTGTGCGAGAGTTTGGCAATACTATGATAGTAGTGGTTCCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGYYWSWIRQHPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARVWQYYDSSGSFDYWGQGTLVTVSS	GATATTGTGATGACTCAGTCTCCACTCTCCCTGCCCGTCACCCCTGGAGAGCCGGCCTCCATCTCCTGCAGGTCTAGTCAGAGCCTCCTGCATAGTAATGGATACAACTATTTGGATTGGTACCTGCAGAAGCCAGGGCAGTCTCCACAGCTCCTGATCTATTTGGGTTCTAATCGGGCCTCCGGGGTCCCTGACAGGTTCAGTGGCAGTGGATCAGGCACAGATTTTACACTGAAAATCAGCAGAGTGGAGGCTGAGGATGTTGGGGTTTATTACTGCATGCAAGCTCTACAAACTCCATTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPFTFGPGTKVDIK	IGHV4-31*03	IGHJ4*02	IGHD3-22*01	IGKV2-28*01,IGKV2D-28*01	IGKJ3*01	ARVWQYYDSSGSFDY	MQALQTPFT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
52	COV021	C097	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCAATCAGCAGTGGTCCTTACTACTGGAGTTGGATCCGCCAGCACCCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTGGACACGTCTAAGAAGCAGTTCTCCCTGAACCTGAACTCTGTGACTGCCGCGGACACGGCCGTGTATTACTGTGCGAGAGTTTGGCAATACTATGATAGTACTGGATCCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGPYYWSWIRQHPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKKQFSLNLNSVTAADTAVYYCARVWQYYDSTGSFDYWGQGTLVTVSS	GATATTGTGATGACTCAGTCTCCACTCTCCCTGCCCGTCACCCCTGGAGAGCCGGCCTCCATCTCCTGCAGGTCTAGTCGGGGCCTCCTCCATAGTAATGGATACAACTATTTGGATTGGTACCTGCAGAAGCCAGGGCAGTCTCCACAGCTCCTGATCTATTTGGGTTCTAATCGGGCCTCCGGGGTCCCTGACAGGTTCAGCGGCAGTGGGTCAGTCACAGATTTTACACTGAACATCAGCAGAGTGGAGGCTGAGGATGTTGGGGTTTATTACTGCATGCAAGCTCTACAAACTCCATTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIVMTQSPLSLPVTPGEPASISCRSSRGLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSVTDFTLNISRVEAEDVGVYYCMQALQTPFTFGPGTKVDIK	IGHV4-31*03	IGHJ4*02	IGHD3-22*01	IGKV2-28*01,IGKV2D-28*01	IGKJ3*01	ARVWQYYDSTGSFDY	MQALQTPFT	nan	Gaebler et al. Nature 591:639-644 (2021)	nan	nan
53	Wang-C001	C001_P1_IgG_F3-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTACGACATGCACTGGGTCCGCCAAACTACAGGCAAAAGTCTGGAGTGGGTCTCAACTATTGGTACTGCTGGTGACACATACTATCCAGGCTCCGTGAAGGGCCGATTCACCATCTCCAGAGAAAATGCCAAGAACTCCTTGTATCTTCAAATGAACAGCCTGAGAGCCGGGGACACGGCTGTGTATTACTGTGCAAGAGTGGAGTATAGCAGTGACATCTACTGGTACTTCGATCTCTGGGGCCGTGGCACCCTGGTCACTGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDMHWVRQTTGKSLEWVSTIGTAGDTYYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARVEYSSDIYWYFDLWGRGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATGACTTGCCGGGCAAGTCAGAGCATTGGCAGGTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGTTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTAACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACACTAACCCTCAGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTMTCRASQSIGRYLNWYQQKPGKAPKLLIYVASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYTNPQYTFGQGTKLEIK	IGHV3-13*01	IGHJ2*01	IGHD6-19*01,IGHD6-6*01	IGKV1-39*01,IGKV1D-39*01	IGKJ2*01	ARVEYSSDIYWYFDL	QQSYTNPQYT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
53	Wang-C003	C003_P2_IgG_H10-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTACGACATGCACTGGGTCCGCCAAACTACAGGCAAAAGTCTGGAGTGGGTCTCAACTATTGGTACTGCTGGTGACACATACTATCCAGGCTCCGTGAAGGGCCGATTCACCATCTCCAGAGAAAATGCCAAGAACTCCTTGTATCTTCAAATGAACAGCCTGAGAGCCGGGGACACGGCTGTGTATTACTGTGCAAGAGTGGAGTATAGCAGTGACATCTACTGGTACTTCGATCTCTGGGGCCGTGGCACCCTGGTCACTGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDMHWVRQTTGKSLEWVSTIGTAGDTYYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARVEYSSDIYWYFDLWGRGTLVTVSS	TCCTATGTGCTGACTCAGCCACCCTCAGTGTCAGTGGCCCCAGGAAGGACGGCCAGCATTGCCTGTGAGGGAAACAACTTTGGAGGTAGAAGTGTGCACTGGTACCGGCAGAAGCCAGGCCAGGCCCCTGTGCTGGTCGTCTATGATGATAGCGACCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAAGTCTGGCAACACGGCCACCCTGACCATCAGCAGAGTCGAAGCCGGGGATGAGGCCGACTATTACTGTCAGGTGTGGGATAGTAGTAGTGATCATGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	SYVLTQPPSVSVAPGRTASIACEGNNFGGRSVHWYRQKPGQAPVLVVYDDSDRPSGIPERFSGSKSGNTATLTISRVEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL	IGHV3-13*01	IGHJ2*01	IGHD6-19*01,IGHD6-6*01	IGLV3-21*03	IGLJ2*01,IGLJ3*01	ARVEYSSDIYWYFDL	QVWDSSSDHVV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
53	Wang-C001	C001_P1_IgG_G5-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAACTATTGGTACTGATGGTGACACATACTATCCAGGCTCCGTGAAGGGCCGATTCACCATCTCCAGAGAAAATGCCAAGAACTCCTTGTATCTTCAAATGAACAGCCTGAGAGCCGGGGACACGGCTGTGTATTACTGTGCAAGAGTGGAGTATAGCAGTGGCATCTACTGGTACTTCGATCTCTGGGGCCGTGGCACCCTGGTCACTGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDMHWVRQATGKGLEWVSTIGTDGDTYYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARVEYSSGIYWYFDLWGRGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTATAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGAATTAGCAGGTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATACTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACCGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTAACCCTCAGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQMTQSPSSLSASIGDRVTITCRASQRISRYLNWYQQKPGKAPKLLIYTASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSNPQYTFGQGTKLEIK	IGHV3-13*01	IGHJ2*01	IGHD6-19*01	IGKV1-39*01,IGKV1D-39*01	IGKJ2*01	ARVEYSSGIYWYFDL	QQSYSNPQYT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
53	Wang-C001	C001_P1_IgG_G8-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGTTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAACTATTGGTACTGCTGGTGACACATACTATCCAGGCTCCGTGAAGGGCCGATTCACCATCTCCAGAGAAAATGCCAAGAACTCCTTGTATCTTCAAATGACCAGCCTGACAGCCGGGGACACGGCTGTGTATTACTGTGCAAGAGTGGAGTATAGCAGTGGCATCTACTGGTACTTCGATCTCTGGGGCCGTGGCACCCTGGTCACTGTCTCCTCAG	EVQLVESGGGLLQPGGSLRLSCAASGFTFSNYDMHWVRQATGKGLEWVSTIGTAGDTYYPGSVKGRFTISRENAKNSLYLQMTSLTAGDTAVYYCARVEYSSGIYWYFDLWGRGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGTATTAGCGGGTATTTAAACTGGTATCAGCAGAAACCAGGGAAATCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACACTAACCCTCACTACACTTTTGGCCAGGGGACCAAGCTGGACATCA	DIQMTQSPSSLSASVGDRVTITCRASQSISGYLNWYQQKPGKSPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYTNPHYTFGQGTKLDI	IGHV3-13*01	IGHJ2*01	IGHD6-19*01	IGKV1-39*01,IGKV1D-39*01	IGKJ2*01	ARVEYSSGIYWYFDL	QQSYTNPHYT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
53	Wang-C001	C815	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGTTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAACTATTGGTACTGCTGGTGACACATACTATCCAGGCTCCGTGAAGGGCCGATTCACCATCTCCAGAGAAAATGCCAAGAACTCCTTGTATCTTCAAATGACCAGCCTGACAGCCGGGGACACGGCTGTGTATTACTGTGCAAGAGTGGAGTATAGCAGTGGCATCTACTGGTACTTCGATCTCTGGGGCCGTGGCACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLLQPGGSLRLSCAASGFTFSNYDMHWVRQATGKGLEWVSTIGTAGDTYYPGSVKGRFTISRENAKNSLYLQMTSLTAGDTAVYYCARVEYSSGIYWYFDLWGRGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGTATTAGCGGGTATTTAAACTGGTATCAGCAGAAACCAGGGAAATCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACACTAACCCTCACTACACTTTTGGCCAGGGGACCAAGCTGGAGATCA	DIQMTQSPSSLSASVGDRVTITCRASQSISGYLNWYQQKPGKSPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYTNPHYTFGQGTKLEI	IGHV3-13*01	IGHJ2*01	IGHD6-19*01	IGKV1-39*01,IGKV1D-39*01	IGKJ2*01	ARVEYSSGIYWYFDL	QQSYTNPHYT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
54	Cho-C017	C2188	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGATCACCGTCAGTAGCAACTACATGAGTTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATGTATGCCGGTGGCAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACGATTCCAAGAACACGCTGTTTCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCATATATTACTGTGCGAGAGACCTGTATAGCAGTGGCGGGACCGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLIQPGGSLRLSCAASGITVSSNYMSWVRQAPGKGLEWVSVMYAGGSTFYADSVKGRFTISRDDSKNTLFLQMNSLRAEDTAIYYCARDLYSSGGTDIWGQGTMVTVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGCTCCAACATCGGGGCAGGTTATGATGTACACTGGTACCAGCAGCTTCCAGGAACAGCCCCCAAACTCCTCATCTATGGTAACAGCAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAGCAGCCTGAGTGGTTCGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGSVFGGGTKLTVL	IGHV3-53*01	IGHJ3*02	IGHD6-19*01	IGLV1-40*01	IGLJ2*01,IGLJ3*01	ARDLYSSGGTDI	QSYDSSLSGSV	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
54	COV021	C098	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGACCTGTATAGCAGTGGCGGGACCGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLYSSGGTDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGGGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPGTFGQGTKVEIK	IGHV3-53*01	IGHJ3*02	IGHD6-19*01	IGKV3-20*01	IGKJ1*01	ARDLYSSGGTDI	QQYGSSPGT	7N3G,7N3I	Gaebler et al. Nature 591:639-644 (2021)	nan	nan
54	COV021	C099	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGATCACCGTCAGTAGCAACTACATGAGTTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATGTATGCCGGTGGCAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACGATTCCAAGAACACGCTGTTTCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCATATATTACTGTGCGAGAGACCTGTATAGCAGTGGCGGGACCGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLIQPGGSLRLSCAASGITVSSNYMSWVRQAPGKGLEWVSVMYAGGSTFYADSVKGRFTISRDDSKNTLFLQMNSLRAEDTAIYYCARDLYSSGGTDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCATTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTATTGGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCTGGCTCCCAGACTCCTCATCTATGGTGCATCCAGGAGGGCCACTGGCATCCCAGACAAATTCAGTGGCAGTGGGTCTGGGGCAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGAAGCTCACCGGGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSIGSSYLAWYQQKPGLAPRLLIYGASRRATGIPDKFSGSGSGADFTLTISRLEPEDFAVYYCQQYGSSPGTFGQGTKVEIK	IGHV3-53*01	IGHJ3*02	IGHD6-19*01	IGKV3-20*01	IGKJ1*01	ARDLYSSGGTDI	QQYGSSPGT	7N3H,7R8L	Gaebler et al. Nature 591:639-644 (2021)	nan	nan
54	COV021	COVD21_P1_HC_A3-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGACCTGTATAGCAGTGGCGGGACCGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLYSSGGTDIWGQGTMVTVSS	GAAATTGTGTTGACGCAGTCTCCAGTCTCCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGGGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVLTQSPVSLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPGTFGQGTKVEIK	IGHV3-53*01	IGHJ3*02	IGHD6-19*01	IGKV3-20*01	IGKJ1*01	ARDLYSSGGTDI	QQYGSSPGT	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293241.1	MW293696.1
54	COV021	COVD21_P3_HC_G1-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGACCTGTATAGCAGTGGCGGGACCGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLYSSGGTDIWGQGTMVTVSS	CAGTCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACATTGGTGTTTATAACTATATCTCCTGGAGCCAACAACACCCAGGCAAAGCCCCCAAAGTCATGATTTATGATGTCACTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTATTGCAGCTCATATAGAGGCAGCAGCACTCCCTATGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	QSVLTQPASVSGSPGQSITISCTGTSSDIGVYNYISWSQQHPGKAPKVMIYDVTNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYRGSSTPYVFGTGTKVTVL	IGHV3-53*01	IGHJ3*02	IGHD6-19*01	IGLV2-14*03	IGLJ1*01	ARDLYSSGGTDI	SSYRGSSTPYV	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293242.1	MW293697.1
55	Aishun_Jin_mix	81B2	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV3-66*02	IGHJ4*02	IGHD6-19*01	IGKV1-33*01	IGKJ1*01	ARDGRAVAGTD	HQYDNLPRT	nan	Han et al. Front Immunol. 12:653189 (2021)	nan	nan
55	Aishun_Jin_mix	CQTS020	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGGGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTTCCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTTTCTTCAAATGAACAGCCTGAGACCTGAGGACACGGCTGTGTATTACTGTGCGAGAGATGGCCGAGCAGTGGCTGGTACTGACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVGSGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRDNSKNTLFLQMNSLRPEDTAVYYCARDGRAVAGTDWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCTTCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAACAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGTAGATATTGCAACATATTACTGTCATCAGTATGATAATCTCCCTCGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDINNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPVDIATYYCHQYDNLPRTFGQGTKVEIK	IGHV3-66*02	IGHJ4*02	IGHD6-19*01	IGKV1-33*01,IGKV1D-33*01	IGKJ1*01	ARDGRAVAGTD	HQYDNLPRT	nan	Patent: CN111909263A	MW587386.1	MW587387.1
55	COV047	COV047_P5_IgA_42-P1609	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCGCATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGATGGAAGAGCAGTGGCTGGTACGAACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSAYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDGRAVAGTNWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCTCGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPRTFGQGTKVEIK	IGHV3-66*01	IGHJ4*02	IGHD6-19*01	IGKV1-33*01,IGKV1D-33*01	IGKJ1*01	ARDGRAVAGTN	QQYDNLPRT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW293093.1	MW293548.1
55	COV047	Wang-C482	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCGCATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGATGGAAGAGCAGTGGCTGGTACGAACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSAYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDGRAVAGTNWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCTCGGACGTTCGGCCAAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPRTFGQGTKVEIK	IGHV3-66*01	IGHJ4*02	IGHD6-19*01	IGKV1-33*01,IGKV1D-33*01	IGKJ1*01	ARDGRAVAGTN	QQYDNLPRT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	nan	nan
56	Wheatley-CP8	PDI_170	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTCTCTTCTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGCCTGGAGTGGCTTGGATATATCTATTATAGAGGGAGTACCAACTACAACCCCTCCCTCGAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAACCTGACGTCTGTGACCGCTGCTGACACGGCCATATATTTCTGTGCGAGAGAGACTCGAGACAACTGGTTCGACTCCTGGGGCCAGGGAATCATGGTCTCCGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCTVSGGSISSLFWSWIRQPPGKGLEWLGYIYYRGSTNYNPSLESRVTISVDTSKNQFSLNLTSVTAADTAIYFCARETRDNWFDSWGQGIMVSVSS	GACATCGTGATGACCCAGCCTCCATTCTCCCTGGCTGTGTCTCTGGGTGAGAGGGCCACCATCAACTGCAAGTCCAGCCAGACTATTTTATACAACTCCAACAATAAGAACTACTTAGCTTGGTACCAGCAGAAACCAGGACAGCCTCCGAGGCTGCTCATTTATTGGGCATCTACCCGGGAATCCGGGGTCCCTGACCGATTCAGTGGCAGCGGGTCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAGGCTGAAGATGTGGCAGTTTATCACTGTCAGCAATATCATGATACTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAGTCAAA	DIVMTQPPFSLAVSLGERATINCKSSQTILYNSNNKNYLAWYQQKPGQPPRLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYHCQQYHDTPWTFGQGTKVEVK	IGHV4-59*11	IGHJ5*01,IGHJ5*02	nan	IGKV4-1*01	IGKJ1*01	ARETRDNWFDS	QQYHDTPWT	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
56	BG1	BG1-13	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLQESGPGLVKPSETLSLTCTVSGGSMSSDYWSWIRQPPGKGLEWIGYIYYRGSTNLNPSLQSRLTMSVDTSKNQFSLKLSSVTAADTAVYYCAR	nan	DIVMTQSPDSLAVSLGERATISCKSSQSVSYTSNNKSYLAWYQQKAGQPPKLLIYWASTRESGVPDRFSGSGSGTDFSLTISSLQAEDVAVYYCQQYHNTP	IGHV4-59*11	nan	nan	IGKV4-1*01	nan	ARETRWNWIDS	QQYHNTPWT	nan	Scheid et al. Cell 184:3205-3221.e24 (2021)	nan	nan
56	CC9	CC9.3	nan	SARS-CoV-2,SARS-CoV,MERS-CoV,OC43,HKU1	NL63,229E	nan	SARS-CoV-2,SARS-CoV	S:Unk	SARS-CoV-2 spike, HKU1 spike, NL63 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACTTGCACTGTCTCTGGTGGCTCCATCAGAAGTGACTTCTGGAGCTGGATCCGGCAGTTCCCAGGAAAGGGACTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCAATTACAATCCCTCCCTCGAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAATGAGTTCTCCCTGAAGCTGAACTATGTGACCGCTGCGGACACGGCCATTTATTACTGTGCGAGAGAGACTAGGTGGAACTGGCTCGACTCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSETLSLTCTVSGGSIRSDFWSWIRQFPGKGLEWIGYIYYSGSTNYNPSLESRVTISVDTSKNEFSLKLNYVTAADTAIYYCARETRWNWLDSWGQGTLVTVSS	GACATTGTGATGACCCAGTCTCCGGACTCCCTGGCTGTGTCTCTGGGCGAGAGGGCCTCCATCAACTGCAAGTCCAGCCAGACTATTTCATATATCTCCAACAATAAGAACTACTTAGCTTGGTACCAGCAGAAACCAGGACAGCCTCCTAGGCTGCTCATTTACTGGGCATCTACCCGGGAATCCGGGGTCCCTGACCGATTCAGTGGCGGCGGGTTTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGGCTGAAGATGTGGCAGTTTATTACTGTCAGCAATATTTTAATACTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAGATCAAAC	DIVMTQSPDSLAVSLGERASINCKSSQTISYISNNKNYLAWYQQKPGQPPRLLIYWASTRESGVPDRFSGGGFGTDFTLTISSLQAEDVAVYYCQQYFNTPWTFGQGTKVEIK	IGHV4-59*01,IGHV4-59*11	IGHJ5*01,IGHJ5*02	IGHD2-15*01,IGHD2-21*01,IGHD2-21*02	IGKV4-1*01	IGKJ1*01	ARETRWNWLDS	QQYFNTPWT	nan	Song et al. Nat Commun. 12:2938 (2021)	MW426543.1	MW426544.1
56	Tong_C15	C15C3	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike (and spike minus RBD)	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCCTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGCTATATCTATTACAGAGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAATCACCATGTCAGTGGACCCGTCCAAGAACCAGTTCTCCCTTAACCTGAGCTCTGTGAGTGCTGCGGACACGGCCGTGTATTACTGTGCGAGAGAGACCCGGTACAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYRGSTNYNPSLKSRITMSVDPSKNQFSLNLSSVSAADTAVYYCARETRYNWFDPWGQGTLVTVSS	GACATCGTGATGACCCAGTCTCCACACTCCCTGGCTGTGTCTCTGGGCGAGAGGGCCACCATCAACTGCAAGTCCAGCCAGACTATTTTATACACCTCCAACAATAAGAACTACTTAGCCTGGTACCAGCAGAAACCAGGACAGCCTCCTAGGCTACTCATTTACTGGGCATCTACCCGGGAATCCGGGGTCCCTGACCGATTCAGTGGCAGCGGGTCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGGCTGAAGATGTGGCAATTTATTACTGTCAGCAATATTTTACTACTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAA	DIVMTQSPHSLAVSLGERATINCKSSQTILYTSNNKNYLAWYQQKPGQPPRLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAIYYCQQYFTTPWTFGQGTKVEIK	IGHV4-59*01	IGHJ5*02	nan	IGKV4-1*01	IGKJ1*01	ARETRYNWFDP	QQYFTTPWT	nan	Tong et al. Cell 184:4969-4980.e15 (2021)	MW718421.1	MW718573.1
57	Wang-MOD7	MOD7_P2_IgG_D2-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTATGGTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCCGGAGTGGGTGGCAGTTATGTCATATGATGGAAGTTATAAAGACTACACAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTCTATTACTGTGCGAGAGATTACGGTGACCTAGTCACCTACTTTGACTACTGGGGCCAAGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGPEWVAVMSYDGSYKDYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDLVTYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATTGGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGTATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATACTGCATCCAGTTTGCAAAGTGGGGTCCCGTCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAATACCCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSALVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYTASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYNTPPWTFGQGTKVEIK	IGHV3-30*04,IGHV3-30*10,IGHV3-30-3*03	IGHJ4*01	IGHD4-17*01	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	ARDYGDLVTYFDY	QQSYNTPPWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
57	Wang-MOD4	C674	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATGGTATGATGGAAGTAATAAACACTATGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTACTACTGTGCGAGGGACTACGGTGACTACGTCACATACCCAGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDYVTYPDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCTTCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCTTCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTATTGTCAACAGAGTTACAGTACCCCTCCTTGGACGTTCGGCCAAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPWTFGQGTKVEIK	IGHV3-33*01	IGHJ4*02	IGHD4-17*01	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	ARDYGDYVTYPDY	QQSYSTPPWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
57	Wang-MOD4	Mod4_P3_IgG_H2-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATGGTATGATGGAAGTAATAAACACTATGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTACTACTGTGCGAGGGACTACGGTGACTACGTCACATACCCAGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDYVTYPDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCTTCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTATTGTCAACAGAGTTACAGTACCCCTCCTTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPWTFGQGTKVEIK	IGHV3-33*01	IGHJ4*02	IGHD4-17*01	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	ARDYGDYVTYPDY	QQSYSTPPWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
57	Wang-MOD4	Mod4_P4_IgG_G7-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATGGTATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGGGACTACGGTGACTACGTCACACACCCAGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDYVTHPDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCTCCTTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPWTFGQGTKVEIK	IGHV3-33*01	IGHJ4*02	IGHD4-17*01	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	ARDYGDYVTHPDY	QQSYSTPPWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
58	Wang-MOD11	Mod11_P2_IgG_D4-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGATCACCGTCAGCAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGGAGAGGGTGCTAACCCCTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGITVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGEGANPYGMDVWGQGTTVTVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGCTCCAACATCGGGGCCGGTTATGATGTACACTGGTACCAGCAGCTTCCAGGAACAGCCCCCAAACTCCTCATCTATGGTAACAACAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAGCAGCCTGAGTGGCCATGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTA	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNNNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGHVVFGGGTKLTVL	IGHV3-53*01	IGHJ6*02	IGHD4/OR15-4a*01,IGHD4/OR15-4b*01	IGLV1-40*01	IGLJ2*01,IGLJ3*01	ARGEGANPYGMDV	QSYDSSLSGHVV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
58	A VelocImmune mouse	REGN10982	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGTTYYADSVKGRFTISRHNSKNTLSLQMNSLRAEDTAVYYCARGEGANYYGMDVWGQGTTVTVSS	nan	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGTGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGYVVFGGGTKLTVL	IGHV3-53*04	IGHJ6	nan	IGLV1-40*01	IGLJ3	ARGEGANYYGMDV	QSYDSSLSGYVV	nan	Patent: US10787501	nan	nan
58	Li_SARS2_26	DH1188	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSFAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLFLQMNSLRDEDTDVYYCARGFGGNYYGMDVWGQGTTVTVSS	nan	DIQMTQSPSSVSASVGDRVTITCRASQGISSRLAWYQQKPGKAPKLLIYGASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPLTFGGGTKVEIK	IGHV3-30*01	IGHJ6	nan	IGKV1-12*01	IGKJ4	ARGFGGNYYGMDV	QQANSFPLT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
58	IML3547	ADI-62902	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGCGCAGTCTCTGGATTCACCTTCAGGACCTATGCCATGCACTGGGTCCGCCAGGCTCCGGCCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAGGTAATAAATACTTTGCAGACTCCATGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGGTGTACTTACAAATGAACAGCCTGAGAAGAGAGGACTCGGCTGTGTATTACTGTGCGAGGGGGCTGGGGGGAAATTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGVVQPGRSLRLSCAVSGFTFRTYAMHWVRQAPAKGLEWVAVISYDGGNKYFADSMKGRFTISRDNSKNTVYLQMNSLRREDSAVYYCARGLGGNYYGMDVWGQGTTVTVSS	nan	nan	IGHV3-30*03	IGHJ6*02	IGHD3-16*01,IGHD3-16*02,IGHD6-19*01	IGKV1-12	nan	ARGLGGNYYGMDV	QQTDSFPLT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458410.1	nan
59	Cho-C006	C2467	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTAAAGCCTGGGGGGTCCCTTAGACTCTCCTGTGCAGCCTCTGGATTCACTTTCAGTAACGCCTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTGGCCATATTAAAAGCAAAACTGATGGTGGGACAACAGACTACGCTGCACCCGTGAAAGGCAGATTCACCATCTCAAGAGATGATTCAAAAAACACGCTGTATCTGCAAATGAACAGCCTGAAAACCGAGGACACAGCCGTGTATTACTGTACCACAATAAGTGACTACGGTGACTACTCCCCCGTGTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVKPGGSLRLSCAASGFTFSNAWMSWVRQAPGKGLEWVGHIKSKTDGGTTDYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTISDYGDYSPVYWGQGTLVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATACTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGAGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTGCTGTCAACAGAGTTACAGTACCCCCCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYTASSLQSGVPSRFSGSGSETDFTLTISSLQPEDFATYCCQQSYSTPLTFGGGTKVEIK	IGHV3-15*01	IGHJ4*02	IGHD4-17*01	IGKV1-39*01,IGKV1D-39*01	IGKJ4*01	TTISDYGDYSPVY	QQSYSTPLT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
59	Cho-C006	C2466	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTAAAGCCGGGGGGGTCCCATAGACTCTCCTGTGCAGCCTCTGGATTCACTTTCAGTTACGCTTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTGGCCGTATTAAAATGAAAACTGATGGTGGGACAGCAGACTACGCTGCACCCGTGAAAGGCAGATTCACCATCTCAAGAGATGATTCAAAAAGCACGCTGTATCTGCAAATGAACAGCCTGAAAACCGAGGACACAGCCGTGTATTACTGTACCACAACCAGTGACTACGGTGACTACTCCCCCGTGTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVKPGGSHRLSCAASGFTFSYAWMSWVRQAPGKGLEWVGRIKMKTDGGTADYAAPVKGRFTISRDDSKSTLYLQMNSLKTEDTAVYYCTTTSDYGDYSPVYWGQGTLVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTGCCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCGTCCAATTTGCAAAGTGGGGTCCCATCAAGTTTCAGTGGCAGTGGATCTGGGACACATTTCACTCTCACCATCACCAGTCTGCAACCTGCAGATTTTGCAATTTATTACTGTCAACAGAGTTACAGTTTCCCCCTCACTTTCGGCGGAGGGACCAAGGTGGAAATCAAAC	DIQLTQSPSSLSASVGDRVTITCRASQSIASYLNWYQQKPGKAPKLLIYAASNLQSGVPSSFSGSGSGTHFTLTITSLQPADFAIYYCQQSYSFPLTFGGGTKVEIK	IGHV3-15*01	IGHJ4*02	IGHD4-17*01	IGKV1-39*01,IGKV1D-39*01	IGKJ4*01	TTTSDYGDYSPVY	QQSYSFPLT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
59	COV047	C081	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTAAAGCCTGGGGGGTCCCTTAGACTCTCCTGTGCAGCCTCTGGATTCACTTTCAGTAGCGCCTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTGGCCGTATTAAAACCAAAACTGATGGTGGGACAAAAGACTACGCTGCACCCGTGAAAGGCAGATTCACCATCTCAAGAGATGATTCAAAAAACACGCTGTATCTGCAAATGAACAGCCTGAAAACCGAGGACACAGCCGTGTATTATTGTACCACAACTAACGACTACGGTGACTATTCGCCCGCCTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVKPGGSLRLSCAASGFTFSSAWMSWVRQAPGKGLEWVGRIKTKTDGGTKDYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTTNDYGDYSPAYWGQGTLVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGCTTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCCCTCACTTTCGGCGGAGGGACCAAGGTGGAAATCAAAC	DIQLTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTAFTLTISSLQPEDFATYYCQQSYSTPLTFGGGTKVEIK	IGHV3-15*01	IGHJ4*02	IGHD4-17*01	IGKV1-39*01,IGKV1D-39*01	IGKJ4*01	TTTNDYGDYSPAY	QQSYSTPLT	nan	Gaebler et al. Nature 591:639-644 (2021)	nan	nan
59	COV047	COV047_P3_IgG_54-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTAAAGCCTGGGGGGTCCCTTAGACTCTCCTGTGCAGCCTCTGGATTCACTTTCAGTAGCGCCTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTGGCCGTATTAAAACCAAAACTGATGGTGGGACAAAAGACTACGCTGCACCCGTGAAAGGCAGATTCACCATCTCAAGAGATGATTCAAAAAACACGCTGTATCTGCAAATGAACAGCCTGAAAACCGAGGACACAGCCGTGTATTATTGTACCACAACTAACGACTACGGTGACTATTCGCCCGCCTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVKPGGSLRLSCAASGFTFSSAWMSWVRQAPGKGLEWVGRIKTKTDGGTKDYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTTNDYGDYSPAYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGCTTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCCCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTAFTLTISSLQPEDFATYYCQQSYSTPLTFGGGTKVEIK	IGHV3-15*01	IGHJ4*02	IGHD4-17*01	IGKV1-39*01,IGKV1D-39*01	IGKJ4*01	TTTNDYGDYSPAY	QQSYSTPLT	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293247.1	MW293702.1
60	IML3550	ADI-57896	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTGGTGCAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATGGTATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGATGGTATAGTGGGAGCTACTACGGGAGTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVQSGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDGIVGATTGVDYWGQGTLVTVSS	nan	nan	IGHV3-33*01	IGHJ4*02	IGHD1-26*01	IGLV3-10	nan	ARDGIVGATTGVDY	YSTDSSGNLRV	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457772.1	nan
60	Li_SARS2_26	H712098+L711504	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:S2	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSENTVYLQMNSLRAEDTAVYYCARDGMVGATTGIDYWGQGTLITVSS	nan	SYELTQPPSVSVSPGQTARITCSGDALPKKYAYWYQQRSGQAPVLVIYEDSKRPSGIPERFSGSSSGTMATLTISGAQVEDEADYYCYSTDSSGNHNYVFGTGTKVTVL	IGHV3-33*01	IGHJ4	nan	IGLV3-10*01	IGLJ1	ARDGMVGATTGIDY	YSTDSSGNHNYV	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
60	CC10	CC10.3	nan	SARS-CoV-2	SARS-CoV,MERS-CoV,HKU1,OC43,NL63,229E	nan	SARS-CoV-2,SARS-CoV	S:Unk	SARS-CoV-2 spike, HKU1 spike, NL63 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATGGTATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGAGGGTATAGTGGGAGCTACTACGGGTTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREGIVGATTGFDYWGQGTLVTVSS	TCCTATGAGCTGACACAGCCACCCTCGGTGTCAGTGTCCCCAGGACAAACGGCCAGGATCACCTGCTCTGGAGATGCATTGCCAAAAAAATATGCTTATTGGTACCAGCAGAAGTCAGGCCAGGCCCCTGTGCTGGTCATCTATGAGGACAGCAAACGACCCTCCGGGATCCCTGAGAGATTCTCTGGCTCCAGCTCAGGGACAATGGCCACCTTGACTATCAGTGGGGCCCAGGTGGAGGATGAAGCTGACTACTACTGTTACTCAACAGACAGCAGTGGTAATCCCTCCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	SYELTQPPSVSVSPGQTARITCSGDALPKKYAYWYQQKSGQAPVLVIYEDSKRPSGIPERFSGSSSGTMATLTISGAQVEDEADYYCYSTDSSGNPSFGTGTKVTVL	IGHV3-33*01	IGHJ4*02	IGHD1-26*01	IGLV3-10*01	IGLJ1*01	AREGIVGATTGFDY	YSTDSSGNPS	nan	Song et al. Nat Commun. 12:2938 (2021)	MW532173.1	MW532174.1
60	Graham_P003	P003_032	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATGGTATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGATGGACAAGTGGGAGCTACTTCGGGAATAGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDGQVGATSGIDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCACCCTCGGTGTCAGTGTCCCCAGGACAAACGGCCAGGATCACCTGCTCTGGAGATGCATTGCCAAAAAAATATGCTTATTGGTACCAGCAGAAGTCAGGCCAGGCCCCTGTGCTGGTCATCTATGAGGACAGCAAACGACCCTCCGGGATCCCTGAGAGATTCTCTGGCTCCAGCTCAGGGACAATGGCCACCTTGACTATCAGTGGGGCCCAGGTGGAGGATGAAGGTGACTACTACTGTTACTCAACAGACAGCAGTGGTAATAAAAGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	NFMLTQPPSVSVSPGQTARITCSGDALPKKYAYWYQQKSGQAPVLVIYEDSKRPSGIPERFSGSSSGTMATLTISGAQVEDEGDYYCYSTDSSGNKRVFGGGTKLTVL	IGHV3-33*01	IGHJ4*02	IGHD1-26*01	IGLV3-10*01,IGLV3-10*03	IGLJ3*02	ARDGQVGATSGIDY	YSTDSSGNKRV	nan	Graham et al. Immunity 54:1276-1289.e6 (2021)	MW802394.1	MW802287.1
61	Wang-MOD3	MOD3_P2_IgG_B12-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAGGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTCCTGGAGGCACCTTTAGCAGCTATGCTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAGAGATCATCCCTCTTTTTGATACAACAAACTACGCACAGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACGAATCCACGAGCACAGCCTACATGGAGCTGAGCAGCGTGAGATCTGAAGACACGGCCGTATATTACTGTGCGAGAGGGGGGGGGAGCAGTGGCTGGAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKRPGSSVKVSCKAPGGTFSSYAISWVRQAPGQGLEWMGEIIPLFDTTNYAQKFQGRVTITADESTSTAYMELSSVRSEDTAVYYCARGGGSSGWNWFDPWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCACCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCAGCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTCCAGTACTCCTTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSISTYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLSISSLQPEDFATYYCQQSSSTPWTFGQGTKVEIK	IGHV1-69*01,IGHV1-69D*01	IGHJ5*02	IGHD6-19*01	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	ARGGGSSGWNWFDP	QQSSSTPWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
61	Wang-MOD4	C670	Mod4_P4_IgG_A9-P1369	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGGGGCACCTTCAGCAGCTATGCTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGACTTGAGTGGATGGGAGGAGTCATCCCTCTCTTTGGTACAGCAAACTACGCACAGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACAAATCCACGAACACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAAGACACGGCCGTGTATTACTGTGCGAGAGGTGGAGGTAGTAGTGGTTATAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGVIPLFGTANYAQKFQGRVTITADKSTNTAYMELSSLRSEDTAVYYCARGGGSSGYNWFDPWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAACAACTTTTTAAATTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCATCTTACTACTGTCAACAGAGTTCCAGTATCTTGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSINNFLNWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFASYYCQQSSSILYTFGQGTKLEIK	IGHV1-69*06	IGHJ5*02	IGHD3-22*01	IGKV1-39*01,IGKV1D-39*01	IGKJ2*01	ARGGGSSGYNWFDP	QQSSSILYT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
61	Wang-MOD4	Mod4_P4_IgG_B9-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATGCTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAGGGATCATCCCTATCTTTGGTACAGCAAACTACGCACAGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACAAATCCACGAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGGTGGAGGTAGTAGTGGTTATAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARGGGSSGYNWFDPWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCTTGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTLYTFGQGTKLEIK	IGHV1-69*06	IGHJ5*02	IGHD3-22*01	IGKV1-39*01,IGKV1D-39*01	IGKJ2*01	ARGGGSSGYNWFDP	QQSYSTLYT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
61	Wang-C004	C004_P2_IgG_C5-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTAGAGACACCTTCAGCAGCTATGCTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAGGGATCATCCCTATCTTTGGTACAGCAAACTACGCACAGAAGTTCCAGGGCAGAGTCACGATTATCGCGGACGAATCCACGAGCACAGCCTACATGGAGCTGCGCAGCCTGAGATCTGACGACACGGCCGTTTATTACTGTGCGAGGGGGGGAGGCAGCTATGGCTACAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGSSVKVSCKASRDTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTIIADESTSTAYMELRSLRSDDTAVYYCARGGGSYGYNWFDPWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACCACTGTCAACAGAGTAACAGTGTCCCGGACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYHCQQSNSVPDTFGQGTKLEIK	IGHV1-69*01,IGHV1-69D*01	IGHJ5*02	IGHD5-18*01,IGHD5-5*01	IGKV1-39*01,IGKV1D-39*01	IGKJ2*01	ARGGGSYGYNWFDP	QQSNSVPDT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
62	COSCA2	COVA2-34	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV,SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGATCGGCTAGTGGGAGCTACTACGGGGCTTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSASGSYYGAFDYWGQGTLVTVSS	CAGACTGTGGTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCAGCACTCTCGGCCTTTATGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	QTVVTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTLGLYVFGTGTKVTVL	IGHV3-30-3*01	IGHJ4*02	IGHD1-26*01	IGLV2-14*03	IGLJ1*01	ARSASGSYYGAFDY	SSYTSSSTLGLYV	nan	Brouwer et al. Science 369:643-650 (2020)	nan	nan
62	COSCA1	COVA1-11	nan	SARS-CoV-2	nan	nan	SARS-CoV,SARS-CoV-2	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGATCGGCTAGTGGGAGCTACTACGGGGCTTTTGGCTACTGGGGCCAGAGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSASGSYYGAFGYWGQRTLVTVSS	CAGTCTGCCCTGACTCAGCCACCCTCAGTGTCCGTGTCCCCAGGACAGACAGCCAGCATCACCTGCTCTGGAGATAAATTGGGGGATAAATATGCTTGCTGGTATCAGCAGAAGCCAGGCCAGTCCCCTGTGCTGGTCATCTATCAAGATAGCAAGCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACAGCCACTCTGACCATCAGCGGGACCCAGGCTATGGATGAGGCTGACTATTACTGTCAGGCGTGGGACAGCAGCACTGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSALTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQKPGQSPVLVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTVVFGGGTKLTVL	IGHV3-30-3*01	IGHJ4*02	IGHD1-26*01	IGLV3-1*01	IGLJ2*01,IGLJ3*01	ARSASGSYYGAFGY	QAWDSSTVV	nan	Brouwer et al. Science 369:643-650 (2020)	MT599830.1	MT599914.1
62	Jennewein_CV1	CV1-4_	CV4	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTTCAATTGGTTGAATCTGGGGGAGGGGTAGTCCAACCTGGCCGAAGCCTGCGATTGTCCTGTGCTGCAAGCGGGTTTACATTTAGTAGCTATGCAATGCATTGGGTCCGACAAGCCCCCGGGAAGGGTTTGGAGTGGGTTGCCGTGATTAGTTACGATGGGAGTAACAAATACTATGCGGACAGTGTCAAGGGTCGCTTTACGATATCTAGGGACAATTCTAAAAATACTCTTTATCTTCAAATGAATTCTCTGCGAGCCGAAGATACCGCAGTCTACTACTGCGCGCGCTCTATATCAGGCAGTTACCTTGGCGCATTCGACTATTGGGGGCAAGGTACGCTTGTAACAGTAAGCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSISGSYLGAFDYWGQG	GACATCCAGATGACCCAATCCCCGTCCACTCTTAGCGCCAGTGTTGGCGATCGCGTAACGATTACATGCAGGGCCTCACAGAGCATCAGTTCTTGGCTCGCGTGGTATCAGCAGAAGCCGGGTAAGGCACCCAAGTTGCTCATCTATAAAGCTTCTAGCTTGGAGAGTGGTGTGCCATCTAGGTTCAGTGGAAGCGGCTCAGGAACTGAGTTTACATTGACGATATCTTCACTGCAGCCTGACGACTTCGCTACTTACTATTGTCAACAGTATAACTCTTATACTTTTGGACAGGGCACCAAACTGGAAATAAAA	DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYTFGQGTKLEIK	IGHV3-33*01,IGHV3-33*06,IGHV3-33*08	IGHJ5*01	IGHD2-2*02,IGHD2-8*01,IGHD2-8*02	IGKV1-5*03	IGKJ1*01	ARSISGSYLGAFDY	nan	nan	Jennewein et al. Cell Rep. 36:109353 (2021);Seydoux et al. Immunity 53:98-105.e5 (2020)	MT462480.1	MT462546.1
62	Jennewein_CV1	CV1-7_	CV7	SARS-CoV-2	SARS-CoV	nan	SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTTCAGCTCGTGGAGTCCGGGGGTGGCGTCGTTCAGCCTGGGCGCTCTCTCAGACTTAGTTGCGCAGCTTCCGGCTTCACCTTCTCAAGCTATGCAATGCACTGGGTGAGACAGGCACCCGGAAAGGGCTTGGAGTGGGTTGCGGTAATCTCATACGATGGCAGTAATAAGTACTACGCAGACTCCGTGAAGGGGAGATTCACCATATCAAGGGACAATAGTAAAAATACTTTGTACCTTCAAATGAACTCCCTCAGGGCGGAAGACACGGCGGTGTACTATTGCGCCAGAAGTATAAGTGGTTCATACCTGGGTGCATTTGATTATTGGGGCCAGGGTACCCTGGTAACGGTAAGTTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSISGSYLGAFDYWGQGTLV	GACATTCAGATGACGCAGAGTCCCTCAACTCTGTCCGCCTCAGTTGGTGACCGGGTAACCATCACTTGTCGCGCCAGTCAGTCCATCTCTTCCTGGCTCGCCTGGTATCAACAAAAACCCGGTAAGGCCCCGAAGCTGCTCATATACAAGGCCTCCAGTTTGGAAAGTGGGGTTCCCAGCAGATTTAGTGGATCCGGAAGTGGTACAGAGTTCACATTGACGATCTCATCTCTTCAACCCGATGACTTCGCGACATATTATTGTCAACAGTATAATTCTTATACGTTCGGACAAGGGACTAAGCTCGAGATAAAA	DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYTFGQGTK	IGHV3-30*14	IGHJ4*02	IGHD1-20*01,IGHD1-7*01,IGHD1/OR15-1a*01	IGKV1-5*01	IGKJ1*01	ARSISGSYLGAFDY	QQYNSYT	nan	Jennewein et al. Cell Rep. 36:109353 (2021);Seydoux et al. Immunity 53:98-105.e5 (2020)	MT462483.1	MT462549.1
63	Wang-MOD4	C676	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTGGTGATTACTACTGGAGTTGGATCCGCCAGCCCCCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTACTACAACCCGTCCCTCCAGAGTCGAGTTACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCAGACACGGCCGTGTATTACTGTGCCAGAGATGGTTGTAGTGGTGGTAGCTGCTACTCATACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGDYYWSWIRQPPGKGLEWIGYIYYSGSTYYNPSLQSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDGCSGGSCYSYWFDPWGQGTLVTVSS	GAAATTGTGTTGACACAGTCTCCAGCCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCGGCTACTTAGCCTGGTACCAACAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGATGCATCCAACAGGGCCACTGGCATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGCCTAGAGCCTGAAGATTTTGCAGTTTATTACTGTCAGCAGCGTAGCAGCTGGAGCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	EIVLTQSPATLSLSPGERATLSCRASQSVSGYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSSWSTFGQGTRLEIK	IGHV4-30-4*01	IGHJ5*02	IGHD2-15*01	IGKV3-11*01	IGKJ5*01	ARDGCSGGSCYSYWFDP	QQRSSWST	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
63	Wang-MOD4	Mod4_P4_IgG_D7-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTGGTGATTACTACTGGAGTTGGATCCGCCAGCCCCCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTACTACAACCCGTCCCTCCAGAGTCGAGTTACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCAGACACGGCCGTGTATTACTGTGCCAGAGATGGTTGTAGTGGTGGTAGCTGCTACTCATACTGGTTCGACCCCTGGGGCCAGGGAACCCTGATCACCGTCTCCTCAG	QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGDYYWSWIRQPPGKGLEWIGYIYYSGSTYYNPSLQSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDGCSGGSCYSYWFDPWGQGTLITVSS	GAAATTGTGTTGACACAGTCTCCAGCCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCGGCTACTTAGCCTGGTACCAACAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGATGCATCCAACAGGGCCACTGGCATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGCCTAGAGCCTGAAGATTTTGCAGTTTATTACTGTCAGCAGCGTAGCAGCTGGAGCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	EIVLTQSPATLSLSPGERATLSCRASQSVSGYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSSWSTFGQGTRLEIK	IGHV4-30-4*01	IGHJ5*02	IGHD2-15*01	IGKV3-11*01	IGKJ5*01	ARDGCSGGSCYSYWFDP	QQRSSWST	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
63	Wang-MOD4	Mod4_P4_IgG_G11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTGGTGATTACTACTGGAGTTGGATCCGCCAGCCCCCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTACTACAACCCGTCCCTCCAGAGTCGAGTTACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCAGACACGGCCGTGTATTACTGTGCCAGAGATGGTTGTAGTGGTGGTAGCTGCTACTCATACTGGTTCGACCCCTGGGGCCAGGGAACCCTGATCACCGTCTCCTCAG	QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGDYYWSWIRQPPGKGLEWIGYIYYSGSTYYNPSLQSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDGCSGGSCYSYWFDPWGQGTLITVSS	GAAATTGTGTTGACACAGTCTCCAGCCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCGGCTACTTAGCCTGGTACCAACAGAAACCTGGCCAGGCTCCCAGGCTCCTCATGTATGATGCATCCAACAGGGCCACTGGCATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGCCTAGAGCCTGAAGATTTTGCAGTTTATTACTGTCAGCAGCGTAGCAGCTGGAGCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	EIVLTQSPATLSLSPGERATLSCRASQSVSGYLAWYQQKPGQAPRLLMYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSSWSTFGQGTRLEIK	IGHV4-30-4*01	IGHJ5*02	IGHD2-15*01	IGKV3-11*01	IGKJ5*01	ARDGCSGGSCYSYWFDP	QQRSSWST	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
63	IML3564	ADI-63352	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATACACCTTCACCGGCTACTATATGCACTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGATGGATCAACCCTAACAGTGGTGGCACAAACTATGCACAGAAGTTTCAGGGCAGGGTCACCATGACCAGGGACACGTCCATCAGCACAGCCTACATGGAGCTGAGCAGGCTGAGATCTGACGACACGGCCGTGTATTACTGTGCGAGAGTTTATTGTAGTGGTGGTAGCTGCTACTCTTACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARVYCSGGSCYSYWFDPWGQGTLVTVSS	nan	nan	IGHV1-2*02	IGHJ5*02	IGHD2-15*01	nan	nan	ARVYCSGGSCYSYWFDP	nan	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458858.1	nan
64	COV072	COV072_P3_HC_68-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAAAGGGTCAACCATATTGTGGTGGTGATTGCTATTTCTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKKGQPYCGGDCYFYYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTCTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCTCCGATCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	DIQMTQSPSSLSASLGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPPITFGQGTRLEIK	IGHV3-30-3*02	IGHJ4*02	IGHD2-21*01	IGKV1-33*01,IGKV1D-33*01	IGKJ5*01	AKKGQPYCGGDCYFYYFDY	QQYDNLPPIT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
64	IML3549	ADI-63066	nan	SARS-CoV-2,SARS-CoV	nan	SARS-CoV	SARS-CoV-2	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGAAGCCTCTGGATTCACCTTCAGTAATTATGGCATGAACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAATGGGTGGCAGTAATATTATATGATGGAAGTGATGAATCTTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAGTACGCTGTATCTCCAAATGAACAGCCTGAGAGTTGAGGACACTGCTGTGTATTACTGTGCGAAAAAGGGTTCGCCCTATTGTGGTGGGGACTGCTATTCGGGGTATTTCGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGGVVQPGRSLRLSCEASGFTFSNYGMNWVRQAPGKGLEWVAVILYDGSDESYADSVKGRFTISRDNSKSTLYLQMNSLRVEDTAVYYCAKKGSPYCGGDCYSGYFDYWGQGTLVTVSS	nan	nan	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-21*02	IGKV1-33	nan	AKKGSPYCGGDCYSGYFDY	QQFRNLPIT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458575.1	nan
64	VRC_SARS1	DH1064	nan	SARS-CoV,SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCTASGFTFSQYGMHWVRQAPGKGLEWVAGMSYDGNDKNYLDSVKGRFSISRDDSKSTQYLQMNSLRAEDTAVYYCAKKGSPYCGVDCYKGYFDYWGQGILVIVSS	nan	DIQMTQSPSSLSASVGDRVTITCQASHDINKYLSWYQHKPGKAPKIMTSDASNLEAGVPSRFSGGGSGTDFTLTINGLQPEDFATYYCQQYDRLPITFGQGTRLDIK	IGHV3-30*18	IGHJ4	nan	IGKV1-33*01	IGKJ5	AKKGSPYCGVDCYKGYFDY	QQYDRLPIT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
64	VRC_SARS1	ADI-55699	mAb-11	SARS-CoV,SARS-CoV-2	229E,HKU1,NL63,OC43	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAAACTCTCCTGTGTAGTCTCTGGATTCAGCTTCAGTCACTATGGCATGAACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATGTCATATGATGGAAGTGACAAGTACTATGCAGACTCCGTGAAGGGCCGATTCACCATTTCCAGAGACATTTCCAAGAACACGCTGTATCTAGAAATGAACAGCCTGAGAACTGAGGACACCGCTGTATATTACTGTGCGAAAAAGGGGTCCCCATATTGTGGTGTTGACTGCTATAAAGGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVQSGGGVVQPGRSLKLSCVVSGFSFSHYGMNWVRQAPGKGLEWVAVMSYDGSDKYYADSVKGRFTISRDISKNTLYLEMNSLRTEDTAVYYCAKKGSPYCGVDCYKGYFDYWGQGTLVTVSS	GAAATTGTGCTGACCCAGTCTCCATCCTCTCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGGAAATGTTTAAATTGGTATCAACACATACCAGGGAAAGCCCCTAAGCTCCTGATCCACGACGCTTCCAGTCTGGAATCTGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTAGTTTCACCATCAACAGCCTGCACCCTGAAGATATTGCAACATATTACTGTCAACAGTTTGAAGATCTCCCGATCACCTTCGGCCAAGGGACACGACTGGAGATTAAA	EIVLTQSPSSLSASVGDRVTITCQASQDIRKCLNWYQHIPGKAPKLLIHDASSLESGVPSRFSGSGSGTDFSFTINSLHPEDIATYYCQQFEDLPITFGQGTRLEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-21*02	IGKV1-33*01,IGKV1D-33*01	IGKJ5*01	AKKGSPYCGVDCYKGYFDY	QQFEDLPIT	nan	Wec et al. Science 369:731-736 (2020)	MT565770.1	MT565771.1
65	Wang-PFZ12	PZF12_P1_IgG_E9-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGCCTCCATCAGCAATGGTGCTTACTACTGGAGTTGGATCCGCCAGCCCCCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCAGACACGGCCGTGTATTACTGTGCCCAAACGTATTACTATGATAGTAGTGGTTCTTACTTCCAGTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSQTLSLTCTVSGASISNGAYYWSWIRQPPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCAQTYYYDSSGSYFQYYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCTGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCCCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASLSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPLTFGGGTKVEIK	IGHV4-30-4*01	IGHJ4*02	IGHD3-22*01	IGKV3-20*01	IGKJ4*01	AQTYYYDSSGSYFQYYFDY	QQYGSSPLT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
65	Wang-MOD2	Mod2_P2_IgG_E4-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAATGGTGGTTACTACTGGAGCTGGATCCGCCAGCACCCAGAGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCCCCTTCTACAACCCGTCCCTCAAGAGTCGAATTACCATGTCAGTAGACTCGTCTAAGAACCAGTTCTCCCTGAAGCTGGGCTCTGTGACTGCCGCGGACACGGCCGTGTATTACTGTGCGAGGACGTATTACTATGATAGTAGTGGTAATTACTTCCAGTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSQTLSLTCTVSGGSISNGGYYWSWIRQHPEKGLEWIGYIYYSGSPFYNPSLKSRITMSVDSSKNQFSLKLGSVTAADTAVYYCARTYYYDSSGNYFQYYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCGACTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATGTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGCTTTCTCACCGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSDYLAWYQQKPGQAPRLLMYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYAFSPLTFGGGTKVEIK	IGHV4-31*03	IGHJ4*02	IGHD3-22*01	IGKV3-20*01	IGKJ4*01	ARTYYYDSSGNYFQYYFDY	QQYAFSPLT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
65	Wang-MOD9	MOD9_P2_IgG_F6-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTGATGATTACTACTGGAGTTGGATCCGCCAGCCCCCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTCTTACATTGGGAGCACCTCCTACAACCCGTCCCTCAAGAGCCGAGTTACTGTATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGACCTCTGTGACTGCCGCAGACACGGCCGTGTATTACTGTGCCAGGACGTATTACTATGATAGTAGTGGTAATTACTTTCAATACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSQTLSLTCTVSGGSISSDDYYWSWIRQPPGKGLEWIGYISYIGSTSYNPSLKSRVTVSVDTSKNQFSLKLTSVTAADTAVYYCARTYYYDSSGNYFQYYFDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTAAGAGTGTTAGCAGCGGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASKSVSSGYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPLTFGGGTKVEIK	IGHV4-30-4*01	IGHJ4*02	IGHD3-22*01	IGKV3-20*01	IGKJ4*01	ARTYYYDSSGNYFQYYFDY	QQYGSSPLT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
65	COV072	COV072_Plate2_HC_32-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTGGTGATTACTACTGGAGTTGGATCCGCCAGCCCCCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCAGACACGGCCGTGTATTACTGTGCCAGGACGTATTACTATGATAGTAGTGGTTATTACTTCCAATACTACTTTGACTGCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGDYYWSWIRQPPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARTYYYDSSGYYFQYYFDCWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCTGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCGCCGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASLSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPLTFGGGTKVEIK	IGHV4-30-4*01	IGHJ4*02	IGHD3-22*01	IGKV3-20*01	IGKJ4*01	ARTYYYDSSGYYFQYYFDC	QQYGSSPLT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
66	COV072	COV072_P3_HC_10-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTTTCCTGCAAGGCATCTGGATACACCTTCACCAGCTACTATATACACTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAATAATCAACCCTAGTGCTGGTAGCACAAGCTACGCACAGAAGTTCCAGGGCAGAGTCACCATGACCAGGGACACGTCCACGAGCACAGTCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGATATTGCACTAGTACCAGCTGCTATGGGCCTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYIHWVRQAPGQGLEWMGIINPSAGSTSYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARDIALVPAAMGLDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCAGTAGCAGGTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGAACGCGGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSSSRYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYRTRLTFGGGTKVEIK	IGHV1-46*01	IGHJ4*02	IGHD2-2*01,IGHD2-2*03	IGKV1-39*01,IGKV1D-39*01	IGKJ4*01	ARDIALVPAAMGLDY	QQSYRTRLT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
66	Wang-PFZ10	PZF10_P2_IgG_D1-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTTTCCTGCAAGGCATCTGGATACACCTTCACCAACTACTATATACACTGGGTGCGACAGGCCCCTGGACAAGGGCCTGAGTGGATGGGAATAATCAACCCTGATGCTGGTAGCACAAGCTACGCACAGAAGTTCCAGGGCAGAGTCACCATGACCACGGACACGTCCACGAACACAGTCTACATGGACCTGAGCAGCCTGAGATCTGAGGACGCGGCCGTGTATTACTGTGCGAGAGATATTGCAGTGGTCCCAGCTGCTATGGGTCTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYYIHWVRQAPGQGPEWMGIINPDAGSTSYAQKFQGRVTMTTDTSTNTVYMDLSSLRSEDAAVYYCARDIAVVPAAMGLDYWGQGTLVTVSS	GAAATTGTGTTGACACAGTCTCCAGCCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCTACTTAGCCTGGTACCAACAGAAACCTGGCCAGGCCCCCCGGCTCCTCATCTATGATGCATCCAACAGGGCCACTGGCATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGCCTAGAGCCTGAAGATTTTGCAGTTTATTACTGTCAGCAGCGTAGCAACTGGCCTCCCTTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPFTFGPGTKVDIK	IGHV1-46*01	IGHJ4*02	IGHD2-2*01,IGHD2-2*03	IGKV3-11*01	IGKJ3*01	ARDIAVVPAAMGLDY	QQRSNWPPFT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
66	Wang-C004	C1269	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTTTCCTGCAAGGCATCTGGATACACGTTCACCAGCCAGTATATGCACTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAATAATCAACCCTAGTGCTGGTAGCACAAGCTACGCACAGAAGTTCCAGGGCAGACTCACCATGACCAGCGACACGTCCACGAGCACAGTCTACATGGACCTGAGCAGCCTGAGATCTGAGGACACGGCCGTCTATTACTGTGCGAGAGATATTGTATTTGTACCAGCTGCTATGGGCCTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGASVKVSCKASGYTFTSQYMHWVRQAPGQGLEWMGIINPSAGSTSYAQKFQGRLTMTSDTSTSTVYMDLSSLRSEDTAVYYCARDIVFVPAAMGLDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGGGCATTAGAAATGATTTAGGCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTACAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGCACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCTACAAGATTACAATTACCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCLQDYNYPWTFGQGTKVEIK	IGHV1-46*01	IGHJ4*02	IGHD2-2*01,IGHD2-2*03	IGKV1-6*01	IGKJ1*01	ARDIVFVPAAMGLDY	LQDYNYPWT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
66	Wang-C004	C004_P1_IgG_A4-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTTTCCTGCAAGGCATCTGGATACACGTTCACCAGCCAGTATATGCACTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAATAATCAACCCTAGTGCTGGTAGCACAAGCTACGCACAGAAGTTCCAGGGCAGACTCACCATGACCAGCGACACGTCCACGAGCACAGTCTACATGGACCTGAGCAGCCTGAGATCTGAGGACACGGCCGTCTATTACTGTGCGAGAGATATTGTATTTGTACCAGCTGCTATGGGCCTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCTTCAG	QVQLVQSGAEVKKPGASVKVSCKASGYTFTSQYMHWVRQAPGQGLEWMGIINPSAGSTSYAQKFQGRLTMTSDTSTSTVYMDLSSLRSEDTAVYYCARDIVFVPAAMGLDYWGQGTLVTVSS	GCCATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGGGCATTAGAAATGATTTAGGCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTACAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGCACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCTACAAGATTACAATTACCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	AIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCLQDYNYPWTFGQGTKVEIK	IGHV1-46*01	IGHJ4*02	IGHD2-2*01,IGHD2-2*03	IGKV1-6*01	IGKJ1*01	ARDIVFVPAAMGLDY	LQDYNYPWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
67	COV021	C048	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGGCTCCGTCAGCAGTGGTAATTACTACTGGAACTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATTACAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAACTCTGTGACCGCTGCGGACACGGCCGTATATCACTGTGCGAGAGAAACCTATTACTATGATAGTAGTGGTTATTATATATCCGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	VQLQESGPGLVKPSETLSLTCAVSGGSVSSGNYYWNWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLNSVTAADTAVYHCARETYYYDSSGYYISDAFDIWGQGTMVTVSS	GACATCCAGATGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTATTAGTAGCTGGTTGGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATAAGGCGTCTAGTTTAGAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACCATCAGCAGCCTGCAGCCTGATGATTTTGCAACTTATTACTGCCAACAGTATAATAGTTTTTCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSFSYTFGQGTKLEIK	IGHV4-61*01	IGHJ3*02	IGHD3-22*01	IGKV1-5*03	IGKJ2*01	ARETYYYDSSGYYISDAFDI	QQYNSFSYT	nan	Gaebler et al. Nature 591:639-644 (2021)	nan	nan
67	COV021	COVD21_P1_HC_C5-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGGCTCCGTCAGCAGTGGTAATTACTACTGGAACTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATTACAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAACTCTGTGACCGCTGCGGACACGGCCGTATATCACTGTGCGAGAGAAACCTATTACTATGATAGTAGTGGTTATTATATATCCGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QVQLQESGPGLVKPSETLSLTCAVSGGSVSSGNYYWNWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLNSVTAADTAVYHCARETYYYDSSGYYISDAFDIWGQGTMVTVSS	GACATCCAGATGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTATTAGTAGCTGGTTGGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATAAGGCGTCTAGTTTAGAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACCATCAGCAGCCTGCAGCCTGATGATTTTGCAACTTATTACTGCCAACAGTATAATAGTTTTTCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSFSYTFGQGTKLEIK	IGHV4-61*01	IGHJ3*02	IGHD3-22*01	IGKV1-5*03	IGKJ2*01	ARETYYYDSSGYYISDAFDI	QQYNSFSYT	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293153.1	MW293608.1
67	IML3564	ADI-62066	nan	SARS-CoV-2,SARS-CoV	nan	SARS-CoV,SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCGTCAGCAGTGGTAATTTCTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATTACAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGAGAAGTGTATTACTATGATAGTAGTGGTTATTACTCCGGGGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	EVQLVESGPGLVKPSETLSLTCTVSGGSVSSGNFYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCAREVYYYDSSGYYSGDAFDIWGQGTMVTVSS	nan	nan	IGHV4-61*01	IGHJ3*02	IGHD3-22*01	IGKV4-1	nan	AREVYYYDSSGYYSGDAFDI	QQYYRTPYT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458158.1	nan
67	IML3548	ADI-60714	nan	SARS-CoV-2,SARS-CoV	nan	SARS-CoV,SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTTTCCGGTAGCTCCATCAGCAGTCATAATTACTACTGGAACTGGCTCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATTACAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCACATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGTTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGAGAAGTGTATTACTATGATAATACTGGTTATTATTCATCTGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCCTCA	EVQLLESGPGLVKPSETLSLTCTVSGSSISSHNYYWNWLRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTTSVDTSKNQFSLKLSSVTAADTAVYYCAREVYYYDNTGYYSSDAFDIWGQGTMVTVSS	nan	nan	IGHV4-61*01	IGHJ3*02	IGHD3-22*01	IGKV4-1	nan	AREVYYYDNTGYYSSDAFDI	QQYYSLPRT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457983.1	nan
68	Cho-C011	C2020	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGACTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGAAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGAGACATATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARETYAFDIWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACTCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYSYTFGQGTKLEIK	IGHV3-66*01	IGHJ3*02	nan	IGKV1-9*01	IGKJ2*01	ARETYAFDI	QQLNSYSYT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
68	Wang-MOD1	Mod1_P2_IgG_C7-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTCGTCCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGAATCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTTTAGCGGTGGGAGCACATTCTACGCAGACTCCGTGAAGGGCAGATTTACCATCTCCAGAGACAATTCCAAGAACATTCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGAAGTTTACGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGFVQPGGSLRLSCAASGITVSSNYMSWVRQAPGKGLEWVSVIFSGGSTFYADSVKGRFTISRDNSKNILYLQMNSLRAEDTAVYYCAREVYAFDIWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAGTAGTTACCCTCCGGCTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLSSYPPAFGGGTKVEIK	IGHV3-66*01	IGHJ3*02	nan	IGKV1-9*01	IGKJ4*01	AREVYAFDI	QQLSSYPPA	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
68	Wang-MOD8	MOD8_P1_IgG_H4-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGTTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAGGTTTACGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREVYAFDIWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTGGCACTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTGCTGTCAACAGCTTAATAGTGACCGGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGIGTYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYCCQQLNSDRYTFGQGTKLEIK	IGHV3-53*01	IGHJ3*02	nan	IGKV1-9*01	IGKJ2*01	AREVYAFDI	QQLNSDRYT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
68	COV107	COV107_Plate1_HC_88-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGCTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGTTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAGTAGCTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREVAAFDIWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCCCCGGGGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPGFGQGTKVEIK	IGHV3-53*01	IGHJ3*02	IGHD2-15*01,IGHD2-2*01,IGHD2-2*02	IGKV1-9*01	IGKJ1*01	AREVAAFDI	QQLNSYPPG	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
69	Wang-MOD9	MOD9_P2_IgG_A12-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCGGTTATTTATCCCGGTGGTAGTACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTCTTTCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTATATTACTGTGCGAGAGATCGGGGGGGGTTCGGGGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMTWVRQAPGKGLEWVSVIYPGGSTFYADSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCARDRGGFGDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGCAGGAGACAGAGTCACCATCACTTGCCGGGCGAGTCAGGGCATTAGCAATTATTTAGCCTGGTATCAGCAGAAACCAGGGAATGCTCCTAAACTCCTGATCTATGCTGCATCCACTTTGCAATCAGGGGTCCCATCTCGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCACCAGCCTGCAGCCTGAAGATGTTGCAACTTATTACTATCAAAAGTATAACAGTGCCCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCA	DIQMTQSPSSLSASAGDRVTITCRASQGISNYLAWYQQKPGNAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTITSLQPEDVATYYYQKYNSAPPWTFGQGTKVEI	IGHV3-53*01	IGHJ4*02	IGHD3-10*01	IGKV1-27*01	IGKJ1*01	ARDRGGFGDY	QKYNSAPPWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
69	Cho-C005	C1321	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCCTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGAATCATCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAATTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTAAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACTCTGTATCTTCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTATATTACTGTGCGAGAGATAGGGGGGGGTTTATTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGIIVSSNYMSWVRQAPGKGLEWVSIIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRGGFIDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCGAGTCAGGGCATTAGCAATTATTTAGCCTGGTATCAGCAGAAACCAGGGAAAGTTCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAATCAGGGGTCCCATCTCGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATGTTGCAACTTATTACTGTCAAAAGTATAATAGTGCCCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQGISNYLAWYQQKPGKVPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCQKYNSAPPWTFGQGTKVEIK	IGHV3-66*02	IGHJ4*02	IGHD3-16*01,IGHD3-16*02	IGKV1-27*01	IGKJ1*01	ARDRGGFIDY	QKYNSAPPWT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
69	Tong_C12	C12I8	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:NTD	SARS-CoV-2 spike (and spike minus RBD)	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCACTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACTCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGATCGGGGCGGATTTATTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVALISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRGGFIDYWGQGTLVTVSS	TCCTATGAGCTGACTCAGCCACCCTCAGTGTCCGTGTCCCCAGGACAGACAGCCAGCATCACCTGCTCTGGAGATAAATTGGGGGATAAATATGCTTGCTGGTATCAGCAGAAGCCAGGCCAGTCCCCTGTGCTGGTCATCTATCAAGATAACAAGCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACAGCCACTCTGACCATCAGCGGGACCCAGGCTATGGATGAGGCTGACTATTACTGTCAGGCGTGGGACAGCAGCACTGCGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTA	SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQKPGQSPVLVIYQDNKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTAVFGGGTKLTVL	IGHV3-30-3*01	IGHJ4*02	IGHD3-10*01,IGHD3-10*02	IGLV3-1*01	IGLJ3*02	ARDRGGFIDY	QAWDSSTAV	nan	Tong et al. Cell 184:4969-4980.e15 (2021)	MW718379.1	MW718531.1
69	IML3548	ADI-60715	nan	SARS-CoV-2	nan	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTGGTGCAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGTAGCCTCTGGGATCATCGTCAGTAGAAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCATCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCGGGGAGGAGTCGGCGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVQSGGGLIQPGGSLRLSCVASGIIVSRNYMSWVRQAPGKGLEWVSLIYSGGSTFYADSVKGRFIISRDNSKNTLYLQMNSLRAEDTAVYYCARDRGGVGDYWGQGTLVTVSS	nan	nan	IGHV3-53*01	IGHJ4*02	IGHD3-10*01,IGHD3-10*02	IGKV1-33	nan	ARDRGGVGDY	QQYDHLPRT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457984.1	nan
70	IML3564	ADI-62045	nan	SARS-CoV-2	nan	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCATCGTCAGTAGAAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTTTATCTTCAAATGAACAACCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCGCGGACTGGTCGCTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFIVSRNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNNLRAEDTAVYYCARDRGLVADYWGQGTLVTVSS	nan	nan	IGHV3-53*01	IGHJ4*02	IGHD3/OR15-3a*01,IGHD3/OR15-3b*01	IGKV1-33	nan	ARDRGLVADY	QQYDNLPRT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458137.1	nan
70	Xie_mix	BD-515	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASEFIVSRNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTGVYYCARDRGLVSDYWGQGTLVTVSS	nan	DIQMTQSPSSLSASVGDRVTITCQASQDINKYLNWYQQKPGKAPKLLIFDASHLETGVPSRFSASGSGTDFTFTISSLQPEDIATYYCHQYDNLPRTFGQGTRLEIK	IGHV3-66*01	IGHJ4	IGHD3-16*01	IGKV1-33*01	IGKJ5	ARDRGLVSDY	HQYDNLPRT	7E88	Cao et al. Cell 182:73-84.e16 (2020);Cao et al. Cell Res. 31:732-741 (2021)	nan	nan
70	Cho-C016	C2024	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGATCGGGGGCTGGTATCTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRGLVSDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCTCGCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPRTFGGGTKVEIK	IGHV3-66*02	IGHJ4*02	IGHD6-19*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	ARDRGLVSDY	QQYDNLPRT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
70	Cho-C016	C2406	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGAATTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCTGAGGACACGGCTATATATTACTGTGCGAGAGATCGGGGGCTGGTATCTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASEFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAIYYCARDRGLVSDYWGQGTLVTVSS	GCCATCCGGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCTCGCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	AIRMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPRTFGGGTKVEIK	IGHV3-66*02	IGHJ4*02	IGHD6-19*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	ARDRGLVSDY	QQYDNLPRT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
71	Cho-C016	C2235	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACCATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATTTTGGGGGACTACGCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDHSKNTLYLQMNSLRAEDTAVYYCARDFGGLRFDYWGQGTLVTVSS	GCCATCCGGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAAGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCTTCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	AIRMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPSYTFGQGTKLEIK	IGHV3-53*01	IGHJ4*02	IGHD3-16*01,IGHD3-16*02	IGKV1-33*01,IGKV1D-33*01	IGKJ2*01	ARDFGGLRFDY	QQYDNLPSYT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
71	Wang-MOD1	Mod1_P1_IgG_F2-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCATCGTCAGTAGCAACTATATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGCCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGTCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGATCTCGGAGGGCTACGGTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLGGLRFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCTTCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPSYTFGQGTKLEIK	IGHV3-66*01	IGHJ4*02	IGHD5-12*01	IGKV1-33*01,IGKV1D-33*01	IGKJ2*01	ARDLGGLRFDY	QQYDNLPSYT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
71	IML3550	ADI-63149	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGAGGAGGCTTGATCCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGTAGCCTCTGAATTCATCGTCAGTAACAACTACATGAGTTGGGTCCGCCAGGCTCCAGGGAGGGGGCTGGAGTGGGTGTCAGTTATCTATAGCGGAGGTAGCACATTCTACGCAGACTCCGTCAGGGGCCGATTCACCATCTCCAGAGACAGTTCCAAGAACACACTGTATCTTCAAATGAATAACCTGAGAGTCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTCGGCGGGAGATGGTTCGACTACTGGGGCCAAGGAACCCTGGTCACCGTCTCCTCA	EVQLLESGGGLIQPGGSLRLSCVASEFIVSNNYMSWVRQAPGRGLEWVSVIYSGGSTFYADSVRGRFTISRDSSKNTLYLQMNNLRVEDTAVYYCARDLGGRWFDYWGQGTLVTVSS	nan	nan	IGHV3-53*01	IGHJ5*01	IGHD1-26*01,IGHD3-10*01,IGHD3-10*02	IGKV1-33	nan	ARDLGGRWFDY	QNYDNLPSYT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458658.1	nan
72	CV07	HK_CV07-236	nan	SARS-CoV-2	nan	nan	nan	S:S1	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	TTCTGCAACCCCGGTGTACATTCTGAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAGTATAGCAGTGGCTGGTACGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAGGGAGTGCATCCGCCCCACTTCCCCT	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREYSSGWYDYWGQGTLVTVSS	TCAATGACCCCCACAGCCCATTCTCCCTGTCTGTGTCTCCGGGGGGAGGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATAATAACTGGCCTCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAACGAACTGTGGCTGCACCATCTGTCTTCATCTTCCCGCCATCTGATGAGCAGTTGAAATCTGGAACTGCCTCTGTTGTGTGCCTGCTGAATAACTTCTATCCCAGAGAGGCCAAAGTACAGTGGAAGGTGGATAACGCCCTCCAATCGGTATCCAGAGTCTCTGAG	NDPHSPFSLSVSPGGGATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPLTFGGGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD6-19*01	IGKV3-15*01	IGKJ4*01	AREYSSGWYDY	QQYNNWPLT	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
72	COV107	COV107_Plate1_HC_45-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGCAGTCTGGAGCAGAGGTGAAAAAGCCCGGGGAGTCTCTGAGGATCTCCTGTAAGGGTTCTGCATACATCTTTACCACTTACTGGATCAGCTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATGGGGAGGATTGATCCTAGTGACTCTTATACCAACTACAGCCCGTCCTTCCAAGGCCACGTCACCATCTCAGCTGACAAGTCCATCAGCACTGCCTACCTGCAGTGGAGCAGCCTGAAGGCCTCGGACACCGCCATGTATTACTGTGCGAGACATATTAGCAGTGGCTGGTACGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVQSGAEVKKPGESLRISCKGSAYIFTTYWISWVRQMPGKGLEWMGRIDPSDSYTNYSPSFQGHVTISADKSISTAYLQWSSLKASDTAMYYCARHISSGWYDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTAAATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCGTACACTTTTGGCCAGGGGACCAAGGTGGAGATCA	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSKSGTDFTFTISSLQPEDIATYYCQQYDNLPYTFGQGTKVEI	IGHV5-10-1*01	IGHJ4*02	IGHD6-19*01	IGKV1-33*01,IGKV1D-33*01	IGKJ2*01	ARHISSGWYDY	QQYDNLPYT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
72	Wang-MOD4	Mod4_P3_IgG_G1-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAAGTGCAGCTGGTGCAGTCCGGAGCAGAGGTGAAAAAGCCCGGGGAGTCTCTGAGGATCTCCTGTAAGGCTTCTGGAAACAGCTTTTCCTTCTACTGGATCAGCTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATGGGGAGGATTGATCCCAGTGACTCTTATAGCAACTACAGCCCGTCCTTCCAAGGCCACGTCACCATCTCAGCTGACAAGTCCATCAGCACTGCCTACCTGCAGTGGAGCAGCCTGAAGGCCTCGGACACCGCCATGTATTACTGTGCGAGACATCTTAGCAGTGGCTGGTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVQSGAEVKKPGESLRISCKASGNSFSFYWISWVRQMPGKGLEWMGRIDPSDSYSNYSPSFQGHVTISADKSISTAYLQWSSLKASDTAMYYCARHLSSGWFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCANTCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGAAACTTTTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAACCTCCTGATCTACGATACATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCGTGGACGTTCGGCCCAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPXSLSASVGDRVTITCQASQDIRNFLNWYQQKPGKAPNLLIYDTSNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPWTFGPGTKVEIK	IGHV5-10-1*03	IGHJ4*02	IGHD6-19*01	IGKV1-33*01,IGKV1D-33*01	IGKJ1*01	ARHLSSGWFDY	QQYDNLPWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
73	IML3547	ADI-62880	nan	SARS-CoV-2,SARS-CoV,OV43,HKU1	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGATCACCTTGAAGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAACTATATCATATGAGGGAAGTATTAAATACTATGGAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACACTGTCTCTGCAGATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAATGGGGCAGTGGCTGGTGATGATGCTTTTGATATCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QITLKESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVATISYEGSIKYYGDSVKGRFTISRDNSKNTLSLQMNSLRAEDTAVYYCANGAVAGDDAFDIWGQGTTVTVSS	nan	nan	IGHV3-30*18,IGHV3-30-5*01	IGHJ3*02	IGHD6-19*01	IGKV2-30	nan	ANGAVAGDDAFDI	MQGTHWPLT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458388.1	nan
73	Jennewein_PCV1	PCV1-6_	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAACCTGGGAGGTCCCTGACACTCTCCTGTGCAGCCTCTGGATTCACATTCAGTTCCTATGGTGTTCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGTCACTTATATCGTATGAGGGAAGTATTACACAATACGCGGACCCCGTGAGGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACCCTGTATTTGCAAATGAACAGCCTGAAAACTGAGGACACGGCTGTGTATTACTGTGCGCGAGGGGCAGTGGCTGGGAATGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	EVQLVESGGGVVQPGRSLTLSCAASGFTFSSYGVHWVRQAPGKGLEWVSLISYEGSITQYADPVRGRFTISRDNSKNTLYLQMNSLKTEDTAVYYCARGAVAGNDAFDIWGQGTMVTVSS	GCCATCCGGATGACCCAGTCTCCACTCTCCCTGCCCGTCACCCTTGGACAGCCGGCCTCCATCTCCTGCAGGTCTAGTCAGAGCCTCGTATACAGTGATGGAAACACCTACTTGATTTGGTTTCACCAGAGGCCAGGCCAATCTCCAAGGCGCCTAATTTATAAGGTTTCTAACCGGGACTCTGGGGTCCCAGACAGATTCAGCGGCAGTGGTTCAGGCACTGATTTCACACTGAATATCAGCAGGGTGGAGGCTGAGGATGTTGGGGTTTATTACTGCATGCAAGGTACACACTGGCCTCTCACCTTCGGCCAAGGGACACGACTGGAGATTAAA	AIRMTQSPLSLPVTLGQPASISCRSSQSLVYSDGNTYLIWFHQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLNISRVEAEDVGVYYCMQGTHWPLTFGQGTRLEIK	IGHV3-30*04,IGHV3-30-3*03	IGHJ3*02	IGHD6-19*01	IGKV2-30*01	IGKJ5*01	ARGAVAGNDAFDI	MQGTHWPLT	nan	Jennewein et al. Cell Rep. 36:109353 (2021)	MW806100.1	MW806146.1
73	Wheatley-CP63	PDI_220	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAAGTGCAGCTGGTAGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGTGGTCCCTGAGACTCTCCTGTGCGGCCTCTGGATTCACCCTCAGTGATTTTGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGTTGGAGTGGGTGGCGTTTATATCATATGGAGGCAGTATTAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAACTCTACCCTGTTCCTGCTAATGGACAGCCTGCGAGATGACGACACGGCTGTGTTTTACTGTGCGAGGGGGGCGGTGGCTGGTCGTCACGCTTTTGACATCTGGGGCCGAGGGACGTTGGTCATCGTCTCTTCA	QVQLVESGGGVVQPGWSLRLSCAASGFTLSDFGMHWVRQAPGKGLEWVAFISYGGSIKYYADSVKGRFTISRDNSTLFLLMDSLRDDDTAVFYCARGAVAGRHAFDIWGRGTLVIVSS	GATGTTGTGATGACTCAGTCTCCACTCTCCCTGCCCGTCACCCTTGGACAGCCGGCCTCCATCTCCTGCAGGTTTAGTCAAAGCCTGGTATACAGTGATGGAAACACCTACGTGAATTGGTTTCAGCAGAGGCCAGGCCAATCTCCAAGGCGCCTAATTTATAAGGTTTCTAACCGGGACTCTGGGGTCCCAGACAGATTCAGCGGCAGTGGGTCCGGCACTGATTTCACACTGAAAATCAGCAGGGTGGAGGCTGAGGATGTTGGGGTTTATTACTGCATGCAAGGTACACACTGGCCTCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAA	DVVMTQSPLSLPVTLGQPASISCRFSQSLVYSDGNTYVNWFQQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQGTHWPLTFGGGTKVEIK	IGHV3-30*03	IGHJ3*02	IGHD6-19*01	IGKV2-30*01	IGKJ4*01	ARGAVAGRHAFDI	MQGTHWPLT	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
74	IML3549	ADI-63052	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTTGTACAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGCACCTATGCGATCCACTGGTTCCGCCAGGCTCCAGGCAAGGGACTGGAGTGGGTGACAGTTATATCATATGATGGATATAATAAGTACTACGCGGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAACTCCAAGAACACGGTGTTTCTGCAAATGAACAGCCTGACACCTGAGGACACGGCTGTCTATTACTGTGCGAGAGGGCGGGGGGGCTACCAGACGTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVQSGGGVVQPGRSLRLSCAASGFTFSTYAIHWFRQAPGKGLEWVTVISYDGYNKYYADSVKGRFTISRDNSKNTVFLQMNSLTPEDTAVYYCARGRGGYQTYFDYWGQGTLVTVSS	nan	nan	IGHV3-30*04,IGHV3-30-3*03	IGHJ4*02	IGHD1-26*01	IGKV3-20	nan	ARGRGGYQTYFDY	QQYGSPLIT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458561.1	nan
74	Tong_C81	C81E2	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike (and spike minus RBD)	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAAGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGGGGACGAGGGAGCTACTTTACCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGRGSYFTYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCGAGTCAGGGCATTAGCAATTATTTAGCCTGGTATCAGCAGAAACCAGGGAAAGTTCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAATCAGGGGTCCCATCTCGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATGTTGCAACTTATTACTGTCAAAAGTATAACAGTGCCTCTCCGCTCACTTTCGGCGGAGGGACCAAGGTGGAAATCAAA	DIQMTQSPSSLSASVGDRVTITCRASQGISNYLAWYQQKPGKVPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCQKYNSASPLTFGGGTKVEIK	IGHV3-30-3*01	IGHJ4*02	IGHD1-26*01	IGKV1-27*01	IGKJ4*01	ARGRGSYFTYFDY	QKYNSASPLT	nan	Tong et al. Cell 184:4969-4980.e15 (2021)	MW718451.1	MW718603.1
74	Li_SARS2_26	DH1099	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGRGSYNTYFDYWGQGTLVTVSS	nan	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPYTFGQGTKLEIK	IGHV3-30*01	IGHJ4	nan	IGKV3-20*01	IGKJ2	ARGRGSYNTYFDY	QQYGSSPYT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
75	Kaku_patientB	10-121	nan	SARS-CoV-2	nan	SARS-CoV-2	SARS-CoV;MERS-CoV	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCTTGTGCAGCCTCTGGATTGACCGTCAGTAGGAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAGGGGGCTGGAGTGGGTCTCACTTATTTATAGCGGAGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAGTTCCAAGAACACGTTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGACCTATAGTGGGAGCTAGGGCGGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGLTVSRNYMSWVRQAPGRGLEWVSLIYSGGSTYYADSVKGRFTISRDSSKNTLYLQMNSLRAEDTAVYYCARPIVGARAGMDVWGQGTTVTVSS	GATATCCGNATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCGGTCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	DIRMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPVTFGQGTRLEIK	IGHV3-53*01	IGHJ6*02	IGHD1-26*01	IGKV1-33*01,IGKV1D-33*01	IGKJ5*01	ARPIVGARAGMDV	QQYDNLPVT	nan	Kaku et al. Cell Rep. 36:109385 (2021)	MZ089617.1	MZ089622.1
75	Xie_mix	BD-602	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARPIVGARSGMDVWGQGTTVTVSS	nan	DIQMTQSPSSLSASVGDRVTITCQASQDINNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFIISSLQPEDIATYYCQQHDNLPVTFGGGTKVEIK	IGHV3-53*01	nan	nan	IGKV1-33*01	nan	ARPIVGARSGMDV	QQHDNLPVT	nan	Du et al. Cell 183:1013-1023.e13 (2020)	nan	nan
75	COV107	C583	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTATATTAACCGTCAGTAGGAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAAGTATTTATAGCGGTGGTACAACATACTACGCAGACTCAGTGAAGGGCCGATTCACCATCTCCAGAGACGATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTCTATTACTGTGCGAGACCGGTGGTGGGGGGTCGGGCGGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASILTVSRNYMSWVRQAPGKGLEWVSSIYSGGTTYYADSVKGRFTISRDDSKNTLYLQMNSLRAEDTAVYYCARPVVGGRAGMDVWGQGTTVTVSS	GACATCCAGATGACCCAGTCCCCATCCTCCCTGTCTGCATCTGTTGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAACAAGTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACAATCAGTAGCCTGCAGCCTGAAGATATTGGAACATTTTACTGTCTACACAATGATAATCCCCCTCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDINKYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIGTFYCLHNDNPPLTFGGGTKVEIK	IGHV3-53*01	IGHJ6*02	IGHD2-15*01,IGHD2-21*01,IGHD2-21*02	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	ARPVVGGRAGMDV	LHNDNPPLT	nan	Gaebler et al. Nature 591:639-644 (2021)	nan	nan
76	Wang-MOD7	MOD7_P2_IgG_H3-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAAGTGCAGCTGGTGCAGTCTGGAGCAGAGGTGAAAAAGCCCGGGGAGTCTCTGAGGATCTCCTGTAAGGGTTCTGGATACAGCTTTACCAACTACTGGATCACCTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATGGGGAGGATTGATCCTAGTGACTCTTATACCAACTACAGCCCGTCCTTCCAAGGCCACGTCACCATCTCAGCTGACAAGTCCATCAGCACTGCCTACCTGCAGTGGAGCAGCCTGAAGGCCTCGGACACCGCCATGTATTACTGTGCGAGACAGCTTTGTGGTGGTGACTGCTACCCTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVQSGAEVKKPGESLRISCKGSGYSFTNYWITWVRQMPGKGLEWMGRIDPSDSYTNYSPSFQGHVTISADKSISTAYLQWSSLKASDTAMYYCARQLCGGDCYPDYWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCACCAGTGACCTTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTTATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGCCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCAGCACTCTCGTTTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPASVSGSPGQSITISCTGTTSDLGGYNYVSWYQQHPGKAPKLMIYDVSYRPSGVSNRFSGSKSANTASLTISGLQAEDEADYYCSSYTSSSTLVFGGGTKLTVL	IGHV5-10-1*01	IGHJ4*02	IGHD2-21*02	IGLV2-14*03	IGLJ2*01,IGLJ3*01,IGLJ3*02	ARQLCGGDCYPDY	SSYTSSSTLV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
76	Wang-MOD3	MOD3_P1_IgG_E1-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAAGTGCAGCTGGTGCAGTCCGGAGCAGAGGTGAAAAAGCCCGGGGAGTCTCTGACGATCTCCTGTAAGGGTTCTGGATACAGGTTTACCAGCTACTGGATCAGCTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATGGGGAGGATTGATCCGAGTGACTCTCATACCAAGTACAGCCCGTCCTTTGAAGGCCACGTCACCATGTCAGCTGACAGGTCCATCAGCACTGCCTACCTGCAGTGGAGCAGCCTGAAGGCCTCGGACACCGCCATGTATTACTGTGCGAGACAGATGTGTGGTGGCGATTGCGACCCTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVQSGAEVKKPGESLTISCKGSGYRFTSYWISWVRQMPGKGLEWMGRIDPSDSHTKYSPSFEGHVTMSADRSISTAYLQWSSLKASDTAMYYCARQMCGGDCDPDYWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCGCTGGAACCAGCAGTGACTTTGGTGTTTATAATTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTCATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGAAGCAGCACTCTAGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPASVSGSPGQSITISCAGTSSDFGVYNYVSWYQQHPGKAPKLMIYDVSHRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTRSSTLVFGGGTKLTVL	IGHV5-10-1*03	IGHJ4*02	IGHD2-21*01	IGLV2-14*03	IGLJ2*01,IGLJ3*01	ARQMCGGDCDPDY	SSYTRSSTLV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
76	Jennewein_healthy_CN2	CN2-31	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;Healthy Donor	CAGGTGCAGCTGCAGGAGTNGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCACTGTCTNTGGTGGNTCCATCAGCAGTGGTGATTANTACTGGAGTTGGATNCGCCAGCCCCCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGNTGAGCTCTGTGACTGCCGCAGACACGGCCGTGTATTACTGTGCCAGAGTGGATTGTGGTGGTGACTGCTATCCTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLQEXGPGLVKPSQTLSLTCTVXGGSISSGDXYWSWXRQPPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKXSSVTAADTAVYYCARVDCGGDCYPDYWGQGTLVTVSS	GCCATCCGGATGACCCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATAATAACTGGCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAA	AIRMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPWTFGQGTKVEIK	IGHV4-30-4*01	IGHJ4*02	IGHD2-21*02	IGKV3-15*01	IGKJ1*01	ARVDCGGDCYPDY	QQYNNWPWT	nan	Jennewein et al. Cell Rep. 36:109353 (2021)	MZ151246.1	MZ151245.1
77	BG7	BG7-3	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCTASTFTVSSNYMSWVRQAPGKGLEWVSVIYTGGSTYYADSVKGRFTISRDNSKNTLYLQVNSLRAEDTAVYYCA	nan	QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSST	IGHV3-53*01	nan	nan	IGLV2-14*03	nan	AGSPVRGVITHFDY	SSYTSSSTQV	nan	Scheid et al. Cell 184:3205-3221.e24 (2021)	nan	nan
77	BG4	BG4-27	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASGFTILSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRHNSKNTLFLQMNSLRVEDTAVYYCAR	nan	QSALTQPASVSGSPGQSITISCTGTSSDVGGYDFVSWYQQHPGKAPKLMIYDDINRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSST	IGHV3-53*04	nan	nan	IGLV2-14*03	nan	ARGPVRGVITHFDY	SSYTSSSTSSV	nan	Scheid et al. Cell 184:3205-3221.e24 (2021)	nan	nan
77	BG7	BG7-10	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIHPGGSLRLSCAASGFTVTSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCA	nan	QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSRS	IGHV3-53*01	nan	nan	IGLV2-14*03	nan	ASSPVRGVITQFDY	SSYTSRSPWV	nan	Scheid et al. Cell 184:3205-3221.e24 (2021)	nan	nan
78	Wang-MOD6	MOD6_P2_IgG_G9-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAAGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGCAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTGATGATTATGCCATGCACTGGGTCCGGCAAGCTCCAGGGAAGGGCCTGGAGTGGGTCTCAGGTATTAGTTGGAATAGTGGTAGCAAAGGCTATGTGGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCCCTGTATCTGCAAATGAACAGTCTGAGAGCTGAGGACACGGCCTTGTATTACTGTGCAAAAGATATCGGTGGCGGGTTTGGTGACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSGSKGYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCAKDIGGGFGDYFDYWGQGTLVTVSS	TCCTATGTGCTGACTCAGCCACCCTCAGTGTCAGTGGCCCCAGGAAAGACGGCCAGGATTACCTGTGGGGGAAACAACATTGGAAGTAAAAGTGTGCACTGGTACCAGCAGAAGCCAGGCCAGGCCCCTGTGCTGGTCATCTATTATGATAGCGGCCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACGGCCACCCTGACCATCAGCAGGGTCGAAGCCGGGGATGAGGCCGACTATTACTGTCAGGTGTGGGATAGTAATAGTGATCACCCTTATGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	SYVLTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVIYYDSGRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSNSDHPYVFGTGTKVTVL	IGHV3-9*01	IGHJ4*02	IGHD6-19*01	IGLV3-21*04	IGLJ1*01	AKDIGGGFGDYFDY	QVWDSNSDHPYV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
78	Wang-MOD8	MOD8_P2_IgG_F11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAAGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGCAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTGATGATTATGCCATGCACTGGGTCCGGCAAGCTCCAGGGAAGGGCCTGGAGTGGGTCTCAGGTATTAGTTGGAATAGTGGTAGCATAGGCTATGCGGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCCCTGTATCTGCAAATGAACAGTCTGAGAACTGAGGACACGGCCTTGTATTACTGTGCAAAAGATATCGGAAGTGGCTACGGTGACTATTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSGSIGYADSVKGRFTISRDNAKNSLYLQMNSLRTEDTALYYCAKDIGSGYGDYFDYWGQGTLVTVSS	TCCTATGTGCTGACTCAGCCACCCTCAGTGTCAGTGGCCCCAGGAAAGACGGCCAGGATTACCTGTGGGGGAAACAACATTGGAAGTAAAAGTGTGCACTGGTACCAGCAGAAGCCAGGCCAGGCCCCTGTGCTGGTCATCTATTATGATAGCGACCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACGGCCACCCTGACCATCAGCAGGGTCGAAGCCGGGGATGAGGCCGACTATTACTGTCAGGTGTGGGATAGTAGTAGGGATCATTATGTCTTCGGAACTGGGACCAAGCTCAGCGTCCTAG	SYVLTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVIYYDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSRDHYVFGTGTKLSVL	IGHV3-9*01	IGHJ4*02	IGHD5-12*01	IGLV3-21*04	IGLJ1*01	AKDIGSGYGDYFDY	QVWDSSRDHYV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
78	Wang-MOD7	MOD7_P2_IgG_G9-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAACTATTAGTGGTAGTGGTGATACCACATACTACGCAGACTCCGTGAAGGGCCGGTTCACCATCTCCAGAGACACTTCCAAGAACACGCTGTATCTGCAAATGAACACCCTGAGAGCCGAGGACACGGCCGTATATTACTGTGCGAAAGATTGGTCTTCTGGCTACGGTGACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSTISGSGDTTYYADSVKGRFTISRDTSKNTLYLQMNTLRAEDTAVYYCAKDWSSGYGDYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAATTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAGCCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAATACCCCTCCGAATACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASNLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYNTPPNTFGQGTKVEIK	IGHV3-23*01,IGHV3-23D*01	IGHJ4*02	IGHD4-17*01,IGHD4-23*01,IGHD5-12*01	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	AKDWSSGYGDYFDY	QQSYNTPPNT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
79	COV072	C139	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV,SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTCTGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAGGGGGGGCCTACAGCTACTACTACTACATGGACGTCTGGGGCAAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYSADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGGAYSYYYYMDVWGKGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCGCTCACTTTCGGCGGAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ6*03	IGHD4-11*01,IGHD4-4*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	AKGGAYSYYYYMDV	QQYDNLPLT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
79	COV072	COV072_Plate2_HC_63-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTCTGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAGGGGGGGCCTACAGCTACTACTACTACATGGACGTCTGGGGCAAAGGGACCACGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYSADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGGAYSYYYYMDVWGKGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ6*03	IGHD4-11*01,IGHD4-4*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	AKGGAYSYYYYMDV	QQYDNLPLT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
79	Dejnirattisai_Cell_Patients	COVOX-45	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVLSYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGGSYAYYYYMDVWGKGTTVTVSS	nan	DIQLTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGGGSGTDFTFTITSLQPEDIATYYCQQYDNLPLTFGGGTKVDIK	IGHV3-30-3*	IGHJ6	nan	IGKV1-33*01	IGKJ4	AKGGSYAYYYYMDV	QQYDNLPLT	7BEL	Dejnirattisai et al. Cell 184:2183-2200.e22 (2021)	nan	nan
80	Jennewein_CV3	CV3-48	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCGTCAGCAGCGATAATTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGCTATATCTATTACAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATGTCAGTAGACACGTCTAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGGGGTTTTGTCGCCACCTACTACTACTACATGGACGTCTGGGGCAAAGGGACAACGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCTVSGGSVSSDNYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTMSVDTSKNQFSLKLSSVTAADTAVYYCARGFVATYYYYMDVWGKGTTVTVSS	GATATTGTGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTATAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAACAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTGAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTCCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAA	DIVMTQSPSSLSASIGDRVTITCRASQSINNYLNWYQQKPGKAPELLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSPYTFGQGTKLEIK	IGHV4-61*01	IGHJ6*03	IGHD3-3*01,IGHD3-3*02,IGHD3-9*01	IGKV1-39*01,IGKV1D-39*01	IGKJ2*01	ARGFVATYYYYMDV	QQSYSPYT	nan	Jennewein et al. Cell Rep. 36:109353 (2021)	MW681585.1	MW681613.1
80	COSCA3	COVA3-01	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV,SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATTACAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGGGGCCCCGCGGCTACCTACTACTACTACATGGACGTCTGGGGCAAAGGGACCAGGGTCACCGTCTCTTCA	EVQLVESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGPAATYYYYMDVWGKGTRVTVSS	GAAATAGTGATGACGCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATGAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAGAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACTCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	EIVMTQSPSSLSASVGDRVTITCRASQSMSSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTLTFGGGTKVEIK	IGHV4-59*01	IGHJ6*03	IGHD6-25*01	IGKV1-39*01,IGKV1D-39*01	IGKJ4*01	ARGPAATYYYYMDV	QQSYSTLT	nan	Brouwer et al. Science 369:643-650 (2020)	nan	nan
80	IML3546	ADI-62847	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTGGTAATTACTACTGGAGCTGGATCCGCCAGCACCCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTACTACCACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCGTGTATTACTGTGCGAGAGGCCCAGCTGCTATGTACTACTACTACATGGACGTCTGGGGCAAAGGGACCACGGTCACCGTCTCCTCA	EVQLLESGPGLVKPSQTLSLTCTVSGGSISSGNYYWSWIRQHPGKGLEWIGYIYYSGSTYYHPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGPAAMYYYYMDVWGKGTTVTVSS	nan	nan	IGHV4-31*03	IGHJ6*03	IGHD2-2*01,IGHD2-2*03	IGKV1-39*01	nan	ARGPAAMYYYYMDV	QQSSSTRFT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458355.1	nan
81	COV072	C516	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATGCTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAAGGATCATCCCTATGCTTGTTATAGCAACCTACGCACGGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACAAATCCACGAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGGGGTGGTAGCTGCTACTCCGGGGAATTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPMLVIATYARKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARGVVAATPGNFDIWGQGTMVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATAATAACGGGCTCACTTTCGGCGGAGGGACCAAGGTGGAAATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNGLTFGGGTKVEIK	IGHV1-69*09	IGHJ3*02	IGHD2-15*01	IGKV3-15*01	IGKJ4*01	ARGVVAATPGNFDI	QQYNNGLT	nan	Gaebler et al. Nature 591:639-644 (2021)	nan	nan
81	COV072	COV072_P3_HC_30-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATGCTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAAGGATCATCCCTATGCTTGTTATAGCAACCTACGCACGGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACAAATCCACGAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGGGGTGGTAGCTGCTACTCCGGGGAATTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPMLVIATYARKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARGVVAATPGNFDIWGQGTMVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATAATAACGGGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNGLTFGGGTKVEIK	IGHV1-69*04	IGHJ3*02	IGHD2-15*01	IGKV3-15*01	IGKJ4*01	ARGVVAATPGNFDI	QQYNNGLT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
81	Crowe_mix	COV2-2479	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTGGTTCAATCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGACTTCTGGAGACACCTCCAGCAGTTATACTGTCGGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAAGGATCATCCCTATCCTTGGTATAGCATACTCCGCACAGAAGTTCCAGGGCAGACTCACGATTACCGCGGACAAATCCACGAGCACATCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTTTATTACTGTGCGAGAGGGGTGGTAGCTGCTACTCCGGGTTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVQSGAEVKKPGSSVKVSCKTSGDTSSSYTVGWVRQAPGQGLEWMGRIIPILGIAYSAQKFQGRLTITADKSTSTSYMELSSLRSEDTAVYYCARGVVAATPGWFDPWGQGTLVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGTCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCGGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATAATAACTTCCTCACTTTCGGCGGAGGGACCAAGGTAGAGATCAAA	EIVMTQSPATLSVSPGERVTLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGGGSGTEFTLTISSLQSEDFAVYYCQQYNNFLTFGGGTKVEIK	IGHV1-69*02	IGHJ5*02	IGHD2-15*01	IGKV3-15*01	IGKJ4*01	ARGVVAATPGWFDP	QQYNNFLT	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665423.1	MT665036.1
82	Wang-MOD9	MOD9_P1_IgG_A11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGCAGTCTGGAGCAGAGGTGAAAAAGCCCGGGGAGTCTCTGAAGATCTCCTGTAAGGCTTCTGGATACAGTTTTATCAGCCACTGGATCGGCTGGGTGCGCCAGATGCCCGGGAAGGGCCTGGAATGGATGGGCATCATCTATCCTGGTGACTCTGATACCATATACAGCCCGTCCTTCCAGGGCCAGGTCACCATCTCAGCCGACAGGTCCATCACCACCGCCTACCTGCAATGGAGCAGCCTGAAGGCCTCGGACACCGCCATATACTACTGTGCGAGACGCGATAGTGGGAGCTACTCCGGATACTTTGCCTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVQSGAEVKKPGESLKISCKASGYSFISHWIGWVRQMPGKGLEWMGIIYPGDSDTIYSPSFQGQVTISADRSITTAYLQWSSLKASDTAIYYCARRDSGSYSGYFAYWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCACCCTCAGCGTCTGGGACCCCCGGGCAGAGGGTCACCATCTCTTGTTCTGGACGCAGCTCCAACATCGGAAGTAATCCTGTAAACTGGTACCAGCAGTTCCCAGGAACGGCCCCCAAACTCCTCATCTCTCATAATAATCAGCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCAGTGGGCTCCAGTCTGAGGATGAGGCTGATTATTACTGTGCAGCATGGGATGACAGCCTGAATGGTCTTTATGTCTTCGGACCTGGGACCAAGGTCACCGTCCTAG	QSVLTQPPSASGTPGQRVTISCSGRSSNIGSNPVNWYQQFPGTAPKLLISHNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGLYVFGPGTKVTVL	IGHV5-51*01	IGHJ4*02	IGHD1-26*01	IGLV1-44*01	IGLJ1*01	ARRDSGSYSGYFAY	AAWDDSLNGLYV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
82	IML3564	ADI-62024	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGCAGAGGTGAAAAAGCCCGGGGAGTCTCTGAAGATCGCCTGTAAGGGTTTTGGATTCAGCTTTACCAGCTACTGGATCGGCTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATGGGGATCATCTATCCTGGTGACTCTGATACCAGATACAGCCCGTCCTTTGAAGGCCAGGTCACCATCTCAGCCGACAAGTCCATCAGCACCGCCTACCTGCAGTGGAGCAGCCTGAAGGCCTCGGACACCGCCATATATTACTGTGCGAGACGGGATAGTGGGAGCTACTCTGGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGAEVKKPGESLKIACKGFGFSFTSYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFEGQVTISADKSISTAYLQWSSLKASDTAIYYCARRDSGSYSGYFDYWGQGTLVTVSS	nan	nan	IGHV5-51*01	IGHJ4*02	IGHD1-26*01	IGLV1-44	nan	ARRDSGSYSGYFDY	ATWDDSLNGQVV	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458116.1	nan
82	Wang-PFZ10	PZF10_P2_IgG_F3-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGCAGTCTGGAGCAGAGGTGAAAAAGCCCGGGGAGTCTCTGAAGATCTCCTGTAAGGGTTCTGGATACAGCTTCACCAGCTACTGGACCGGCTGGGTGCGCCAGAAGCCCGGGAAAGGCCTGGAGTGGATGGGGATCATCTATCCTGGTGACTCTGATACCAGATACAGCCCGTCCTTCCAAGGCCAGGTCACCATCTCAGCCGACAAGTCCATCAGCACCGCCTACCTGCAGTGGAGCAGCCTGAAGGCCTCGGACACCGCCATGTATTACTGTGCGAGACGGGATAGTGGGAGCTATTCAGGTTACTTTGACTACTGGGGCCAGGGAACCCTGGTCGCCGTCTCCTCAG	EVQLVQSGAEVKKPGESLKISCKGSGYSFTSYWTGWVRQKPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARRDSGSYSGYFDYWGQGTLVAVSS	CAGTCTGTGCTGACTCAGCCACCCTCAGCGTCTGGGACCCCCGGGCAGAGGGTCACCATCTCTTGTTCTGGAAGCAGCTCCAACATCGGAAGTAATCCTGTAAACTGGTACCAGCAGCTCCCAGGAACGGCCCCCAAACTCCTCATCTATAGTAATAATCAGCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCAGTGGGCTCCAGTCTGAGGATGAGGCTGATTATTACTGTGCAGCATGGGATGACAGCCTGAATGGTCTGGTATTCGGCGGAGGGACCAAGTTGACCGTCCTA	QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNPVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGLVFGGGTKLTVL	IGHV5-51*01,IGHV5-51*02	IGHJ4*02	IGHD1-26*01	IGLV1-44*01	IGLJ2*01,IGLJ3*01	ARRDSGSYSGYFDY	AAWDDSLNGLV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
83	Jennewein_healthy_CN1	CN1-9	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;Healthy Donor	CAGGTACAACTCTTGGAGAGCGGCGGTGGTGTAGTACAGCCTGGACGCTCACTGCGGCTTAGTTGCGCGGCGTCAGGTTTCACGTTCAGCTCATATGGAATGCACTGGGTACGCCAGGCACCCGGTAAAGGGCTGGAGTGGGTGGCCGTCATATCTTATGACGGGTCTAACAAATATTATGCCGACAGCGTAAAGGGACGGTTTACAATCTCACGAGATAATTCAAAAAATACATTGTACTTGCAAATGAATAGCCTGCGAGCTGAAGACACCGCGGTATATTATTGTGCGAAAACCATGATGGGGTATTACTATTATTATTATGGAATGGATGTTTGGGGACAGGGCACGACAGTTACCGTCTCCTCA	QVQLLESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKTMMGYYYYYYGMDVWGQGTTVTVSS	GAAATTGTGTTGACACAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAA	EIVLTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPYTFGQGTKLEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ6*01,IGHJ6*02	IGHD3-16*01,IGHD3-16*02,IGHD3-22*01	IGKV1-39*01,IGKV1D-39*01	IGKJ2*01	AKTMMGYYYYYYGMDV	QQSYSTPYT	nan	Jennewein et al. Cell Rep. 36:109353 (2021)	MZ151201.1	MZ151202.1
83	COV047	COV047_P5_IgM_40-P1348	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGAGATAAATACTATGTAGACTCCGTGAAGGGCCGATTCATAATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGGTGAGGACACGGCTGTGTATTACTGTGCGAAGACATATAGTGGCTACGGCTACTACTACTACGGTATGGACGTCTGGGGCCAGGGGACCACGGTCACCTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGRDKYYVDSVKGRFIISRDNSKNTLYLQMNSLRGEDTAVYYCAKTYSGYGYYYYGMDVWGQGTTVTSP	CAGTCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGATTATAACTATGTCTCCTGGTACCAACAGCACCCAGGCAAAGCCCCCAAACTCATGATTTATGAGGTCAGTAATCGGCCCTCAGGGGTTTCTGATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCAGCACTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPASVSGSPGQSITISCTGTSSDVGDYNYVSWYQQHPGKAPKLMIYEVSNRPSGVSDRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTWVFGGGTKLTVL	IGHV3-30*18,IGHV3-30-5*01	IGHJ6*02	IGHD5-12*01	IGLV2-14*01	IGLJ3*02	AKTYSGYGYYYYGMDV	SSYTSSSTWV	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292978.1	MW293433.1
83	COV047	Wang-C172	COV047_P4_IgM_25-P1348	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGAGATAAATACTATGTAGACTCCGTGAAGGGCCGATTCATAATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGGTGAGGACACGGCTGTGTATTACTGTGCGAAGACATATAGTGGCTACGGCTACTACTACTACGGTATGGACGTCTGGGGCCAGGGGACCACGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGRDKYYVDSVKGRFIISRDNSKNTLYLQMNSLRGEDTAVYYCAKTYSGYGYYYYGMDVWGQGTTVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGATTATAACTATGTCTCCTGGTACCAACAGCACCCAGGCAAAGCCCCCAAACTCATGATTTATGAGGTCAGTAATCGGCCCTCAGGGGTTTCTGATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCAGCACTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSALTQPASVSGSPGQSITISCTGTSSDVGDYNYVSWYQQHPGKAPKLMIYEVSNRPSGVSDRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTWVFGGGTKLTVL	IGHV3-30*18,IGHV3-30-5*01	IGHJ6*02	IGHD5-12*01	IGLV2-14*01	IGLJ3*02	AKTYSGYGYYYYGMDV	SSYTSSSTWV	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW292977.1	MW293432.1
84	Wheatley-CP8	PDI_69	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTTTGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTACTAAATACTCCGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTCCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGATTCTGAAGATTGTAGTAGTTTGAGCTGCTACCTTGACTTCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGVVQPGRSLRLSCAASGFTFSSFAMHWVRQAPGKGLEWVAVISYDGSTKYSADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDSEDCSSLSCYLDFWGQGTLVTVSS	GACATCGTGATGACCCAGTCTCCAGTCTCCCTGGCTGTGTCTCTGGGCGAGAGGGCCACCATCAACTGCAAGTCCAGCCAGAGTGTTTTATACCGCTCCAACAATAAGAACTACTTAGCTTGGTACCAGCAGAAACCAGGACAGCCTCCTAAGCTGCTCATTTACTGGGCGTCTACCCGGGGATCCGGGGTCCCTGACCGATTCAGTGGCAGCGGGTCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGGCTGAAGATGTGGCAGTTTATTACTGTCAGCAATATTATAGTACTCCATTCACTTTCGGCCCTGGGACCAAAGTGGATGTCAAA	DIVMTQSPVSLAVSLGERATINCKSSQSVLYRSNNKNYLAWYQQKPGQPPKLLIYWASTRGSGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPFTFGPGTKVDVK	IGHV3-30*04,IGHV3-30*14,IGHV3-30-3*03	IGHJ4*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV4-1*01	IGKJ3*01	ARDSEDCSSLSCYLDF	QQYYSTPFT	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
84	Wheatley-CP63	PDI_305	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTAGAGTGGGTGGCACTTATATCATATGATGGAAGTACTAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGATCACGCTGTATCTGCACATGAACAGCCTGAGAGCTGAGGACACGGCTGTCTATTACTGTGCGAGAGATTCGGAGGATTGTAGTAGTCTCAGCTGCTACTTGGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVALISYDGSTKYYADSVKGRFTISRDNSKITLYLHMNSLRAEDTAVYYCARDSEDCSSLSCYLDYWGQGTLVTVSS	GACATCGTGATGACCCAGTCTCCAGACTCCCTGGCTGTGTCTCTGGGCGAGAGGGCCACCATCAACTGCAAGTCCAGCCAGAGTGTTTTATACAGCTCCAACAATAAGAACTACTTAGGTTGGTACCAGCAGAAACCAGGACAGCCTCCTAAGCTGCTCATTTACTGGGCATCTACCCGGGAATCCGGGGTCCCTGACCGATTCAGTGGCAGCGGGTCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGGCTGAAGATGTGGCAGTTTATTACTGTCAGCAATATTATAGTACTCCATTCACTTTCGGCCCTGGGACCACAGTGGATATCAAA	DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLGWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPFTFGPGTTVDIK	IGHV3-30*01	IGHJ4*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV4-1*01	IGKJ3*01	ARDSEDCSSLSCYLDY	QQYYSTPFT	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
84	COV021	COVD21_P1_HC_B1-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGATAGCGAGGATTGTAGTAGTACCAGCTGCTACCTCGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDSEDCSSTSCYLDYWGQGTLVTVSS	GACATCGTGATGACCCAGTCTCCAGTCTCCCTGGCTGTGTCTCTGGGCGAGAGGGCCACCATCAACTGCAAGTCCAGCCAGAGTGTTTTATACAGCTCCAACAATAAGAACTACTTAGCTTGGTACCAGCAGAAACCAGGACAGCCTCCTAAGCTGCTCATTTACTGGGCATCTACCCGGGAATCCGGGGTCCCTGACCGATTCAGTGGCAGCGGGTCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGGCTGAAGATGTGGCAGTTTATTACTGTCAGCAATATTATAGTACTCCATTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIVMTQSPVSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPFTFGPGTKVDIK	IGHV3-30-3*01	IGHJ4*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV4-1*01	IGKJ3*01	ARDSEDCSSTSCYLDY	QQYYSTPFT	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293147.1	MW293602.1
85	Crowe_mix	COV2-2532	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV,SARS-CoV-2	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAGGGTTTCCTGCAAGGCACCTGGATACACCTTCACCACCTACTATATACACTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAATAATCAACCCTAGTGCTGGTAGTACAACCTACGCACAGAAGTTCCAGGGCAGAGTCACCATGACCAGGGACACGTCCACGAGCACAGTCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGGATTCCATGTACCAGCTGCTCTTCGGAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVQSGAEVKKPGASVRVSCKAPGYTFTTYYIHWVRQAPGQGLEWMGIINPSAGSTTYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARGFHVPAALRNWFDPWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCACCCTCAGCGTCTGGGACCCCCGGGCAGAGGGTCACCATCTCTTGTTCTGGAAGCAGCTCCAACATCGGAAGTAATACTGTAAACTGGTACCAGCAGCTCCCAGGAACGGCCCCCAAACTCCTCATCTATAATAATAATCAGCGGCCCTCAGGGGTCCCTGACCGACTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCAGTGGGCTCCAGTCTGAGGATGAGGCTGATTATTACTGTGTGGCATGGGATGACAGCCGGAATGGCCTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTA	QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYNNNQRPSGVPDRLSGSKSGTSASLAISGLQSEDEADYYCVAWDDSRNGLVFGGGTKLTVL	IGHV1-46*01	IGHJ5*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGLV1-44*01	IGLJ2*01,IGLJ3*01	ARGFHVPAALRNWFDP	VAWDDSRNGLV	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665483.1	MT665096.1
85	Crowe_mix	COV2-2789	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV,SARS-CoV-2	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAGGGTTTCCTGCAAGGCACCTGGATACACCTTCACCACCTACTATATACACTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAATAATCAACCCTAGTGCTGGTAGTACAACCTACGCACAGAAGTTCCAGGGCAGAGTCACCATGACCAGGGACACGTCCACGAGCACAGTCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGGATTCCATGTACCAGCTGCTCTTCGGAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVQSGAEVKKPGASVRVSCKAPGYTFTTYYIHWVRQAPGQGLEWMGIINPSAGSTTYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARGFHVPAALRNWFDPWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCACCCTCAGCGTCTGGGACCCCCGGGCAGAGGGTCACCATCTCTTGTTCTGGAAGCAGCTCCAACATCGGAAGTAATACTGTAAACTGGTACCAGCAGCTCCCAGGAACGGCCCCCAAACTCCTCATCTATAATAATAATCAGCGGCCCTCAGGGGTCCCTGACCGACTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCAGTGGGCTCCAGTCTGAGGATGAGGCTGATTATTACTGTGCAACATGGGATGACAGCCTGAATGGTCCGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTA	QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYNNNQRPSGVPDRLSGSKSGTSASLAISGLQSEDEADYYCATWDDSLNGPVFGGGTKLTVL	IGHV1-46*01	IGHJ5*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGLV1-44*01	IGLJ2*01,IGLJ3*01	ARGFHVPAALRNWFDP	ATWDDSLNGPV	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665530.1	MT665143.1
85	Wang-MOD3	MOD3_P1_IgG_G12-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGCATCTGGAAACACCTTCACCAGCTACTATATACACTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAATAATCAACCCAAGTGCTGGGAGCACAACCTACGCACAGAAGTTCCAGGGCAGAGTCACCATGACCAGGGACACGTCCACGAGCACAGTCTACATGGAGCTGAGCAGCCTGAGATCGGAGGACATGGCCGTGTATTACTGTGCGAGAGGGTTTCCGGTGCCAGCTGCTAGTTTGAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGASVKVSCKASGNTFTSYYIHWVRQAPGQGLEWMGIINPSAGSTTYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDMAVYYCARGFPVPAASLNWFDPWGQGTLVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATAATAACTGGCTTCCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWLPYTFGQGTKLEIK	IGHV1-46*01	IGHJ5*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-15*01	IGKJ2*01	ARGFPVPAASLNWFDP	QQYNNWLPYT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
86	CV07	HK_CV07-183	nan	SARS-CoV-2	nan	nan	nan	S:S1	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	CCCCTTACATTTTGAGGTGCAGCTGGTGCAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTGCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACTGTAAGTATAAGCAAATGATCAACCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAAAGAGGGGTCGAAGGGGTGGATACAAAACTCGTGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAGCCTCCATCAAGGGCCCATCGGTCTTCCCCCTGGCACCCTCCTCCAAGAGCACCTCTGCTGTACAGCAGCCAGGTTCC	EVQLVQSGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNCKYKQMINLRAEDTAVYYCAKEGSKGWIQNSCYFDYWGQGTLVTVSS	CAGGCTCCATTCTCCCTGGCTGTGTCTCTGGGCGAGAGGGCCACCATCAACTGCAAGTCCAGCCAGAGTGTTTTATACAGCTCCAACAATAAGAACTACTTAGCTTGGTACCAGCAGAAACCAGGACAGCCTCCTAAGCTGCTCATTTACTGGGCATCTACCCGGGAATCCGGGGTCCCTGACCGATTCAGTGGCAGCGGGTCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGGCTGAAGATGTGGCAGTTTATTACTGTCAGCAATATTATAGTACTCCTCCGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAACGAACTGTGGCTGCACCATCTGTCTTCATCTTCCCGCCATCTGATGAGCAGTTGAAATCTGGAACTGCCTCTGTTGTGTGCCTGCTGAATAACTTCTATCCCAGAGAGGCCAAAGTACAGTGGAAGGTGGATAACGCCCTCCAATCGGTACTGCAGAGATGCTT	QAPFSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPPTFGQGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGKV4-1*01	IGKJ1*01	AKEGSKGWIQNSCYFDY	QQYYSTPPT	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
86	CV07	HK_CV07-161	nan	SARS-CoV-2	nan	nan	nan	S:S1	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	AGACCCCGGGGTCCCGTCCCTGGCTTTTTTTGGAAACTAATTCGGGTGCAGGCCCCCCCAAATTTCAATCCGTTCTGGCAATCCCGTGTACATTCTCAGGTGCAGCTGGTGTCTTCAAGGGGGGGGTACATTCCGAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGACCCCGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAGAGGGGTCGAAGGGGTGGCTCCAAAGCTCGTGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAGCCTCCCTCAAGGGCACATCGCTAGACCCCCTGGCACCCTCCTCCAAGAGCACCTCTGCTGTACAGCAGCCAGTTGCC	EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKTPLYLQMNSLRAEDTAVYYCAKEGSKGWLQSSCYFDYWGQGTLVTVSS	TTTTTTTTTGTTTTTTGTGGCTCCCGGTTTGGCCCTTTGGGGCGGTAATGCTTTGGGGAAAAAGAAACAAAAAAGAAAAATTTTTTTTTTCCCCCCCGTTCTATCTCCCTGCCCGTCACTCCTGGAGAGTCGGCCTCCATCTCCTGCAGGTCTAATCAGAGCCTCCTCCACAGTGATGGACACAATTACCTGGATTGGTACCTGCTGCAGTCAGGCCACCCTGCACAGCTCCTGATCTATTTGGGTTCTAAGCGGGCCTCCGGGACCCCTGACAGGTTCAGTGGCAGTGGATCGGGCACAACATTTACATTTACCATAGGCAGAGTGGAGGCTGAGGATGTTGGACTTTATGTCTGCATGCAAGCTTTCGAACCTCCGGCGATCACCTTCGGCCAGGGGACACAATTGGAGATTAAGCGAACTGTGGCTGCACCATCTGTCTTCATCTTCCCGCCATCTGATGAGCAGTTGAAATCTGGAACTGCCTCTGTTGTGTGCCTGCTGAATAACTTCTATCCCAGAGAGGCCAAAGTACAGTGGAAGGTGGATAACGCCCTCCAATCGGGTAATTCCCAGAGTCGGG	NFFFPPRSISLPVTPGESASISCRSNQSLLHSDGHNYLDWYLLQSGHPAQLLIYLGSKRASGTPDRFSGSGSGTTFTFTIGRVEAEDVGLYVCMQAFEPPAITFGQGTQLEI	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD6-6*01	IGKV2-28*01,IGKV2D-28*01	IGKJ5*01	AKEGSKGWLQSSCYFDY	MQAFEPPAIT	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
86	CV05	HL_CV05-195	nan	SARS-CoV-2	nan	nan	nan	S:S1	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	TCTGCAAACCCCGGTGTACATTCCTGAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAGAGGGGTCGAAGGGGTGGCTACAAAGCTCGTGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAGCCTCCACCAAGGGCCCATCGGTCTTCCCCCTGGCACCCTCCTCCAAGAGCACCTCTGGGGCAGCCAGCGGCCGGGCGGG	EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKEGSKGWLQSSCYFDYWGQGTLVTVSS	TCTCTCTCTCCTCGAGAGTGTGAGCAGAGATCTGCTACCCCGGTTCTGTGACCCACTATGAGCTGACTCAGCCACCCTCGGTGTCAGTGTCCCCAGGACAGACGGCCAGGATCACCTGCTCTGGAGATGCATTGCCAAAGCAATATGCTTATTGGTACCAGCAGAAGCCAGGCCAGGCCCCTGTGCTGGTGATATATAAAGACAGTGAGAGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAGCTCAGGGACAACAGTCACGTTGACCATCAGTGGAGTCCAGGCAGAAGACGAGGCTGACTATTACTGTCAATCAGCAGACAGCAGTGGTACTTATCAGGTATTCGGCGGAGGGACCAAGCTGACCTCCTAAGTCAGCTCATAGCTGTCCTTTCCTGAA	HYELTQPPSVSVSPGQTARITCSGDALPKQYAYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSSGTYQVFGGGTKLT	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD5-24*01	IGLV3-25*03	IGLJ2*01,IGLJ3*01	AKEGSKGWLQSSCYFDY	QSADSSGTYQV	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
87	Chen_Vax_p1	COV2-vax-65	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGCGGACCTAGGATATTGTACTAATGGTGTATGCTATATTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARADLGYCTNGVCYIDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCGGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCAGCAATTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNWVFGGGTKLTVL	IGHV3-30-3*01	IGHJ4*02	IGHD2-8*01	IGLV6-57*02	IGLJ3*02	ARADLGYCTNGVCYIDY	QSYDSSNWV	nan	Chen et al. Cell Rep. 36:109604 (2021)	MZ555532.1	MZ555533.1
87	COV072	C141	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV,SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGTTCTGGGTCCGCCAGGCTCCGGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGGGCGGATTTAGGATATTGTACTAATGGTGTATGCTATGTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMFWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARADLGYCTNGVCYVDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCGGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCAGCAATTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNWVFGGGTKLTVL	IGHV3-30-3*01	IGHJ4*02	IGHD2-8*01	IGLV6-57*02	IGLJ3*02	ARADLGYCTNGVCYVDY	QSYDSSNWV	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
87	COV072	COV072_P3_HC_91-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGTTCTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGGGCGGATTTAGGATATTGTACTAATGGTGTATGCTATGTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMFWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARADLGYCTNGVCYVDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCGGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCAGCAATTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNWVFGGGTKLTVL	IGHV3-30-3*01	IGHJ4*02	IGHD2-8*01	IGLV6-57*02	IGLJ3*02	ARADLGYCTNGVCYVDY	QSYDSSNWV	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
88	Crowe_mix	COV2-2197	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV,SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGCAGTCTGGAGCAGAGGTGAAAAAGCCCGGGGAGTCTCTGAAGATCTCCTGTAAGGGTTCTGGATACAGCTTTACCAGCTACTGGATCGGCTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATGGGGATCATCTATCCTGGTGACTCTGATACCAGATACAGCCCGTCCTTCCAAGGCCAGGTCACCATCTCAGCCGACAAGTCCATCAGCACCGCCTACCTGCAGTGGAGCAGCCTGAAGGCCTCGGACACCGCCATGTATTACTGTGCGAGACCCGACTATAGCAGTGGCTGGTTTAGCTACTGGTACTTCGATCTCTGGGGCCGTGGCACCCTGGTCACTGTCTCCTCA	EVQLVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARPDYSSGWFSYWYFDLWGRGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTCTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGCCAGCAGTATGGTCGCTCACCGATCACCTTCGGCCAAGGGACACGACTGGAGATTAAA	EIVLTQSPGTLSLSPGERATLSCRASQSVSSNFLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGRSPITFGQGTRLEIK	IGHV5-51*01	IGHJ2*01	IGHD6-19*01	IGKV3-20*01	IGKJ5*01	ARPDYSSGWFSYWYFDL	QQYGRSPIT	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665705.1	MT665318.1
88	Crowe_mix	COV2-2602	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGCAGTCTGGAGCAGAGGTGAAAAAGCCCGGGGAGTCTCTGAAGATCTCCTGTAAGGGTTCTGGATACAGCTTTACCAGCTACTGGATCGGCTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATGGGGATCATCTATCCTGGTGACTCTGATACCAGATACAGCCCGTCCTTCCAAGGCCAGGTCACCATCTCAGCCGACAAGTCCATCAGCACCGCCTACCTGCAGTGGAGCAGCCTGAAGGCCTCGGACACCGCCATGTATTACTGTGCGAGACCCGACTATAGCAGTGGCTGGTTTAGCTACTGGTACTTCGATCTCTGGGGCCGTGGCACCCTGGTCACTGTCTCCTCA	EVQLVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARPDYSSGWFSYWYFDLWGRGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTCTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGCCAGCAGTATGGTCGCTCACCGATCACCTTCGGCCAAGGGACACGACTGGAGATTAAA	EIVLTQSPGTLSLSPGERATLSCRASQSVSSNFLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGRSPITFGQGTRLEIK	IGHV5-51*01	IGHJ2*01	IGHD6-19*01	IGKV3-20*01	IGKJ5*01	ARPDYSSGWFSYWYFDL	QQYGRSPIT	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665716.1	MT665329.1
88	IML3546	ADI-57876	nan	SARS-CoV-2	nan	SARS-CoV	SARS-CoV-2	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTACGACATGCACTGGGTCCGCCAAGCTACAGGAAAAGGTCTGGAGTGGGTCTCAGCTATTGGTACTGCTGGTGACACATACTATCCAGGCTCCGTGAAGGGCCGATTCACCATCTCCAGAGAAAATGCCAAGAACTCCTTGTATCTTCAAATGAACAGCCTGAGAGCCGGGGACACGGCTGTGTATTACTGTGCAAGAGTCATGTATAGCAGTGGCTGGCCCTCCTACTGGTACTTCGATCTCTGGGGCCGTGGCACCCTGGTCACCGTCTCCTCA	EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYDMHWVRQATGKGLEWVSAIGTAGDTYYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARVMYSSGWPSYWYFDLWGRGTLVTVSS	nan	nan	IGHV3-13*01	IGHJ2*01	IGHD6-19*01	IGKV1-39*01	nan	ARVMYSSGWPSYWYFDL	QQSYSTPPDT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457752.1	nan
89	CV07	HK_CV07-265	nan	SARS-CoV-2	nan	nan	nan	S:S1	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	GGGTACATTCTGAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGTTATGAAATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTGGTAGTATCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAATTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTTTATTACTGTGCGAGAAGGCGGTATAGCAGCAGCTGGTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAGCCTCCACCAAGGGCCCATCGGTCTTCCCCCTGGCACCCTCCTCCAAGAGCACCTCTGGGGCACAGCGCCATGGTCTTG	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYEMNWVRQAPGKGLEWVSYISSSGSIIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARRRYSSSWYYYYGMDVWGQGTTVTVSS	GCCGGCCCTTGTGTTCTTTTTTTTTTTCCCCCCCATCTCATCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAACGAACTGTGGCTGCACCATCTGTCTTCATCTTCCCGCCATCTGATGAGCAGTTGAAATCTGGAACTGCCTCTGTTGTGTGCCTGCTGAATAACTTCTATCCCAGAGAGGCCAAAGTACAGTGGAAGGTGGATAACGCCCTCCAATCGGGTCAATTCCCCGAGCTGT	LFFFPPHLISLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPLTFGGGTKVEIK	IGHV3-48*03	IGHJ6*02	IGHD6-13*01	IGKV1-9*01	IGKJ4*01	ARRRYSSSWYYYYGMDV	QQLNSYPLT	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
89	Crowe_mix	COV2-2146	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV,SARS-CoV-2	S:NTD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGAGGGTCCCTGAGACTCTCCTGTGAAGCCTCTGGATTCACCTTCAGTAGTTCTGAAATCAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCACACATTAGTAGTAGTGGTAGTATCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTTTATTACTGTGCGAGGAGATCTTATAGAAGCAGCTGGTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCEASGFTFSSSEINWVRQAPGKGLEWVSHISSSGSIIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARRSYRSSWYYYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCTTCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCCGTGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAA	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPVTFGQGTKVEIK	IGHV3-48*03	IGHJ6*02	IGHD6-13*01	IGKV1-9*01	IGKJ1*01	ARRSYRSSWYYYYGMDV	QQLNSYPVT	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665600.1	MT665213.1
89	Crowe_mix	COV2-2263	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV,SARS-CoV-2	S:NTD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGAGGGTCCCTGAGACTCTCCTGTGAAGCCTCTGGATTCACCTTCAGTAGTTCTGAAATCAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCACACATTAGTAGTAGTGGTAGTATCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTTTATTACTGTGCGAGGAGATCTTATAGAAGCAGCTGGTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCEASGFTFSSSEINWVRQAPGKGLEWVSHISSSGSIIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARRSYRSSWYYYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCTTCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCCGTGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAA	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPVTFGQGTKVEIK	IGHV3-48*03	IGHJ6*02	IGHD6-13*01	IGKV1-9*01	IGKJ1*01	ARRSYRSSWYYYYGMDV	QQLNSYPVT	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665612.1	MT665225.1
90	Wang-MOD4	Mod4_P3_IgG_H5-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTTCAGCTGGTGCAGTCTGGAGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGTTACACCTTTACCAGCTATGGTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGATGGATCAGCACTTACAATGGTAACACAAACTACGCACAGAAGCTCCAGGGCAGAGTCACCATGACCACAGACACATCCACGAGCACAGCCTACATGGAGCTGAGGAGCCTGAGATCTGACGACACGGCCGTGTATTACTGTGCGAGAGTTGATACGTATTACTATGATAGTAGTGGTTATTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISTYNGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARVDTYYYDSSGYYFDYWGQGTLVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTATTAGCAGCAACTTAGCCTGGTACCACCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATAGTAACTGGCCTCCACAGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSISSNLAWYHQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYSNWPPQWTFGQGTKVEIK	IGHV1-18*01	IGHJ4*02	IGHD3-22*01	IGKV3-15*01	IGKJ1*01	ARVDTYYYDSSGYYFDY	QQYSNWPPQWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
90	Wang-MOD4	C665	Mod4_P3_IgG_H9-P1369	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTTCAGCTGGTGCAGTCTGGACCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGTTACACCTTTACCAGCTATGGTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGATGGATCTCCACTTACAATGGTAACACAAACTATGCACAGAAGCTCCAGGGCAGAGTCACCATGACCACAGACTCATCCACGAGCACAGCCTACATGGAACTGAGGAGCCTGAGATCTGACGACACGGCCGTTTTTTACTGTGCGAGAGTGGGCACATATTACTCTGATAGTAGTGCTTATTACTTCGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGPEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISTYNGNTNYAQKLQGRVTMTTDSSTSTAYMELRSLRSDDTAVFYCARVGTYYSDSSAYYFDYWGQGTLVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATGATAACTGGCCCCCTATATTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYDNWPPIFTFGPGTKVDIK	IGHV1-18*01	IGHJ4*02	IGHD3-22*01	IGKV3-15*01	IGKJ3*01	ARVGTYYSDSSAYYFDY	QQYDNWPPIFT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
90	Tong_C53	C53F9	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike (and spike minus RBD)	B-cells;SARS-CoV-2 Human Patient	CAGGTTCAGCTGGTGCAGTCTGGAGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGTTACACCTTTACCAGCTACGGTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGATGGATCAGCGCTTACAATGGTAACACAAACTATGCACAGAAGCTCCAGGGCAGAGTCACCATGACCACAGACACATCCACGAGCACAGCCTACATGGAGCTGAGGAGCCTGAGATCTGACGACACGGCCGTGTATTACTGTGCGAGAGTCGGAACGTATTACTATGATAGTAGTGCTTATTATTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARVGTYYYDSSAYYFDYWGQGTLVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTGGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATAATAACTGGCCTCCCGAGTTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAA	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPEFTFGPGTKVDIK	IGHV1-18*04	IGHJ4*02	IGHD3-22*01	IGKV3-15*01	IGKJ3*01	ARVGTYYYDSSAYYFDY	QQYNNWPPEFT	nan	Tong et al. Cell 184:4969-4980.e15 (2021)	MW718382.1	MW718534.1
91	Ehling_bioRxiv_pool	Ehling_mAb-17	nan	SARS-CoV-2	nan	nan	nan	S:S1 non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSMHWVRQAPGKGLEWMGGFDPEDGETIYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATGVAVAGTPINYYYYYGMDVWGQGTTVTVSS	nan	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGKAFGQGTKVEIK	IGHV1-24	IGHJ6	nan	IGKV3-20	IGKJ1	ATGVAVAGTPINYYYYYGMDV	QQYGKA	nan	Ehling et al. bioRxiv. DOI: 10.1101/2021.02.12.430940	nan	nan
91	Wheatley-CP25	PDI_129	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTGGTACAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGTTTCCGGATACACCCTCACTGAATTGTCCATGCACTGGGTGCGACAGGCTCCTGGAAAAGGGCTTGAGTGGATGGGAGGTTTTGATCCTGAAGATGGTGAAACAATCTACGCACAGAAGTTCCAGGGCAGAGTCACCATGACCGAGGACACATCTACAGACACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTATATTACTGTGCAACAGGGGTAGCAGTAGCTGGTACCCCTTCCTCTTACTACTACTACTACTACATGGACGTCTGGGGCAAAGGGACCACGGTCACCGTCTCCTCA	QVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSMHWVRQAPGKGLEWMGGFDPEDGETIYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATGVAVAGTPSSYYYYYYMDVWGKGTTVTVSS	GACATCCAGTTGACCAAGTTTCCATTCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAACAGTTATTTAGCCTGGTATCAGCAAGAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCTTCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCGGACCTTCGGCCAAGGGACACGACTGGAGATTAAA	DIQLTKFPFSLSASVGDRVTITCRASQGINSYLAWYQQEPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPRTFGQGTRLEIK	IGHV1-24*01	IGHJ6*03	IGHD6-13*01,IGHD6-19*01	IGKV1-9*01	IGKJ5*01	ATGVAVAGTPSSYYYYYYMDV	QQLNSYPRT	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
91	Graham_P054	P054_021	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:NTD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTACAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGTTTCCGGATACACCCTCACTGAATTATCCATGCACTGGGTGCGACAGGCTCCTGGAAAAGGGCTTGAGTGGCTGGGAGGCTTTGATCCTGAAGATGCTGAAACAATCTACGCACAGAAGTTCCAGGGCAGAGTCACCATGACCGAGGACACATCTACAGACACCGCCTACATGGGGCTGAGCAGCCTGACATCTGAGGACACGGCCGTGTATTACTGTGCAACCGGTGTAGCAGTGGCTGGTACTCAGAAGAATTACTCCTACTACTACGGTTTGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSMHWVRQAPGKGLEWLGGFDPEDAETIYAQKFQGRVTMTEDTSTDTAYMGLSSLTSEDTAVYYCATGVAVAGTQKNYSYYYGLDVWGQGTTVTVSS	GACATCCAGATGACCCAGACTCCACTCTCCTCACCTGTCACCCTTGGACAGCCGGCCTCCATCTCCTGCAGGTCTAGTCAAAGCCTCGTACACAGTGATGGAAACACCTACTTGAGTTGGCTTCAGCAGAGGCCAGGCCAGCCTCCAAGACTCCTAATTTATAAGATTTCTAACCGGTTCTCTGGGGTCCCAGACAGATTCAGTGGCAGTGGGGCAGGGACAGATTTCACACTGAAAATCAGCAGGGTGGAAGCTGAGGATGTCGGGGTTTATTACTGCATGCAAGCTACACAATTTCCGATCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	DIQMTQTPLSSPVTLGQPASISCRSSQSLVHSDGNTYLSWLQQRPGQPPRLLIYKISNRFSGVPDRFSGSGAGTDFTLKISRVEAEDVGVYYCMQATQFPITFGQGTRLEIK	IGHV1-24*01	IGHJ6*02	IGHD6-19*01	IGKV2-24*01	IGKJ5*01	ATGVAVAGTQKNYSYYYGLDV	MQATQFPIT	nan	Graham et al. Immunity 54:1276-1289.e6 (2021)	MW802478.1	MW802371.1
92	CV38	HK_CV38-183	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGGCGATGGCTGGGACAACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGDGWDNYYYGMDVWGQGTTVTVSS	CAGTCTGTGCTGACGCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGCTCCAACATCGGGGCAGGTTATGATGTACACTGGTACCAGCACCTTCCAGGAACAGCCCCCAAACTCCTCATCTATGCTAACAGCAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAGCAGCCTGAGTGGTTCAGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAGGTCAGCCCAAGGCTGCCCCCTCGGTCACTCTGTTCCCACCC	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQHLPGTAPKLLIYANSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGSVFGGGTKLTVL	IGHV3-53*01	IGHJ6*02	IGHD5-24*01,IGHD6-19*01	IGLV1-40*01	IGLJ2*01,IGLJ3*01	ARGDGWDNYYYGMDV	QSYDSSLSGSV	nan	Kreye et al. Cell 183:1058-1069 (2020)	MW002774.1	MW002792.1
92	CV38	HL_CV38-183	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	ATCCGCCACACCCCCGGTACATTCTGAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGGCGATGGCTGGGACAACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAGCCTCCACCAAGGGCCCATCGGTCTTCCCCCTGGCACCCTCCTCCAAGAGCACCTCTTGGGGCACAGGGCCTGCGAGG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGDGWDNYYYGMDVWGQGTTVTVSS	TTTCTGCTACCCGGTCCTGGTCCCAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGCTCCAACATCGGGGCAGGTTATGATGTACACTGGTACCAGCACCTTCCAGGAACAGCCCCCAAACTCCTCATCTATGCTAACAGCAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAGCAGCCTGAGTGGTTCAGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAGGTTCAGCCCAAGGCTGCCCCCTTTTGTG	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQHLPGTAPKLLIYANSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGSVFGGGTKLTVL	IGHV3-53*01	IGHJ6*02	IGHD5-24*01,IGHD6-19*01	IGLV1-40*01	IGLJ2*01,IGLJ3*01	ARGDGWDNYYYGMDV	QSYDSSLSGSV	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
92	Wang-C003	C003_P2_IgG_D12-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGACTCACCGTCAGTAGCAACTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGTTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGGGGACAGTTACGATAACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMTWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGDSYDNYYYGMDVWGQGTTVTVSS	CAGTCTGTGCTGACGCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGCTCCAACATCGGGGCAGGTTATGATGTACACTGGTACCAGCAGCTTCCAGGAACAGCCCCCAAACTCCTCATCTATGGTAACATCAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAGGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAGCAGCCTGAGTGGTTCGGTGTTCGGCGGAGGGACCAAGCTGACCGTACTAG	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNINRPSGVPDRFSGSRSGTSASLAITGLQAEDEADYYCQSYDSSLSGSVFGGGTKLTVL	IGHV3-66*01	IGHJ6*02	IGHD3-9*01	IGLV1-40*01	IGLJ3*02	ARGDSYDNYYYGMDV	QSYDSSLSGSV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
93	Cho-C017	C2132	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:non-RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGCTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCATTGTCTCTGGTGGCTCCATCAATAGTACTACTTACTACTGGGACTGGATCCGCCAGTCCCCAGGGAAGGGGCTGGAGTGGATTGGAAGTATCTTTTATACTGGGATCACCTACTACAGTCCGTCCCTCAAGACTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAGGCTGAACTCTATGACCGCCGCAGACACGGCTGTCTATTATTGTGCGAGACGCCTGCGTCAATTATGGTTCGGACCCTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QLQLQESGPGLVKPSETLSLTCIVSGGSINSTTYYWDWIRQSPGKGLEWIGSIFYTGITYYSPSLKTRVTISVDTSKNQFSLRLNSMTAADTAVYYCARRLRQLWFGPWFDPWGQGTLVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAGCACCCAGGCAAAGCCCCCAAACTCATGATTTATGAGGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCAGCACTCCCGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYEVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTPVVFGGGTKLTVL	IGHV4-39*01	IGHJ5*02	IGHD3-10*01	IGLV2-14*01	IGLJ2*01,IGLJ3*01	ARRLRQLWFGPWFDP	SSYTSSSTPVV	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
93	COV021	C047	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTACTACTTACTACTGGGACTGGATCCGCCAGTCCCCAGGGAAGGGGCTGGAGTGGATTGGAAGTATCTTTTATACTGGGATCACCTACTACAGCCCGTCCCTCAAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAGGCTGAACTCTATGACCGCCGCAGACACGGCTGTCTATTATTGTGCGAGACGCCTGCGTCAACTATGGTTCGGACCCTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSETLSLTCTVSGGSISSTTYYWDWIRQSPGKGLEWIGSIFYTGITYYSPSLKSRVTISVDTSKNQFSLRLNSMTAADTAVYYCARRLRQLWFGPWFDPWGQGTLVTVSS	CAGTCTGCCCTGACTCAGCCTCCCTCCGCGTCCGGGTCTCCTGGACAGTCAGTCACCATCTCCTGCACTGGAACCCGCAGTGACGTTGGTGATTATAACTATGTCTCCTGGTACCAACAACACCCAGACAAGGCCCCCAAACTCATAATTTATGAGGTCACTAAGCGGCCCTCAGGGGTCCCTGATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCGTCTCTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCAGCTCATATGCAGGCAGCAACAATGTGATGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSALTQPPSASGSPGQSVTISCTGTRSDVGDYNYVSWYQQHPDKAPKLIIYEVTKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYAGSNNVMFGGGTKLTVL	IGHV4-39*01	IGHJ5*02	IGHD3-10*01	IGLV2-8*01	IGLJ3*02	ARRLRQLWFGPWFDP	SSYAGSNNVM	nan	Gaebler et al. Nature 591:639-644 (2021)	nan	nan
93	COV021	C710	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCATTGTCTCTGGTGGCTCCATCAATAGTACTACTTACTACTGGGACTGGATCCGCCAGTCCCCAGGGAAGGGGCTGGAGTGGATTGGAAGTATCTTTTATACTGGGATCACCTACTACAGTCCGTCCCTCAAGACTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAGGCTGAACTCTATGACCGCCGCAGACACGGCTGTCTATTATTGTGCGAGACGCCTGCGTCAATTATGGTTCGGACCCTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSETLSLTCIVSGGSINSTTYYWDWIRQSPGKGLEWIGSIFYTGITYYSPSLKTRVTISVDTSKNQFSLRLNSMTAADTAVYYCARRLRQLWFGPWFDPWGQGTLVTVSS	CAGTCTGCCCTGACTCAGCCTCCCTCCGCGTCCGGGTCTCCTGGACAGTCAGTCACCATCTCCTGCACTGGAACCCGCAGTGACGTTGGTGATTATAACTATGTCTCCTGGTACCAACAACACCCAGACAAGGCCCCCAAACTCATAATTTTTGAGGTCACTAAGCGGCCCTCAGGGGTCCCTGATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCGTCTCTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCAGCTCATATGCAGGCAGCAGCAATGTGATGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSALTQPPSASGSPGQSVTISCTGTRSDVGDYNYVSWYQQHPDKAPKLIIFEVTKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYAGSSNVMFGGGTKLTVL	IGHV4-39*01	IGHJ5*02	IGHD3-10*01	IGLV2-8*01	IGLJ3*02	ARRLRQLWFGPWFDP	SSYAGSSNVM	nan	Gaebler et al. Nature 591:639-644 (2021)	nan	nan
94	Tong_C81	C81A3	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:NTD	SARS-CoV-2 spike (and spike minus RBD)	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGGGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGGCTCCATCAGCAGTAGTAACTGGTGGAGTTGGGTCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGGAAATCTATCATAGTGGGAGCACCAACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCAGTGGACAAGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATTACTGTGCGAGAAGATATTGTAGTGGTGGTAGCTGCTCAGGCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSGTLSLTCAVSGGSISSSNWWSWVRQPPGKGLEWIGEIYHSGSTNYNPSLKSRVTISVDKSKNQFSLKLSSVTAADTAVYYCARRYCSGGSCSGFDYWGQGTLVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGATGTTGGGAGTTATAACCTTGTCTCCTGGTACCAACATCACCCAGGCAAAGCCCCCAAACTCATGATTTATGAGGGCAGTAAGCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACAATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCTGCTCATATGCAGGTTTTAGCACTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTA	QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQHHPGKAPKLMIYEGSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGFSTWVFGGGTKLTVL	IGHV4-4*02	IGHJ4*02	IGHD2-15*01	IGLV2-23*01,IGLV2-23*03	IGLJ3*02	ARRYCSGGSCSGFDY	CSYAGFSTWV	nan	Tong et al. Cell 184:4969-4980.e15 (2021)	MW718373.1	MW718525.1
94	Li_SARS2_26	H712057+L711468	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:NTD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLQESGPGLVKPSGTLSLTCAVSGGSISSGHWWTWVRQPPGKGLEWIGEIYHSGNTNYNTSLKSRVTISVDKSNNQFSLKLTSVTAADTAVFYCARRYCSGGTCSPFDYWGQGTLVTVSS	nan	QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEVNKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYGGSSTWVFGGGTKLTVL	IGHV4-4*02	IGHJ4	nan	IGLV2-23*02	IGLJ3	ARRYCSGGTCSPFDY	CSYGGSSTWV	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
94	Li_SARS2_26	H712218+K711809	nan	SARS-CoV-2	SARS-CoV	nan	nan	S:S2	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLQESGPGLVKPSGTLSLTCAVSGGSISSGHWWTWVRQPPGKGLEWIGEIYHSGNTNYNTSLKSRVTISVDKSNNQFSLKLTSVTAADTAVFYCARRYCSGGTCSPFDYWGQGTLVTVSS	nan	EIVLTQSPDTLSLSPGERATLSCGASQRIRSNYLAWYQQKPGQAPRLLIYATSTRATGIPDRFSGSGSGTDFTLIISRLEPEDFAVYYCQQYGSSQWTFGQGTKVEIK	IGHV4-4*02	IGHJ4	nan	IGKV3-20*01	IGKJ1	ARRYCSGGTCSPFDY	QQYGSSQWT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
95	IML3547	ADI-62202	nan	SARS-CoV-2	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCTTGGTCCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGTAGGCGCTGGATTCACCTTCAGCAACATTGCCATGAACTGGGTCCGCCAGACTCCAGGGAAGGGGCTGGAGTGGGTCTCCACTATTGGCATTCGTGATCATTGGACACACTACGCGGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAGCACGCTGTTTCTGGAGATGACTAGCCTGAGAGTCGACGACACGGCCATATATTACTGTTGCCCGGACTTGGATAGTTCTGCCTCTTGGGAGACTCTTCATGTCTGGGGTCAGGGGACCACGGTCACCGTCTCCTCA	EVQLLESGGGLVQPGGSLRLSCVGAGFTFSNIAMNWVRQTPGKGLEWVSTIGIRDHWTHYADSVKGRFTISRDNSKSTLFLEMTSLRVDDTAIYYCCPDLDSSASWETLHVWGQGTTVTVSS	nan	nan	IGHV3-23*01,IGHV3-23D*01	IGHJ6*01,IGHJ6*02	IGHD1-26*01,IGHD2-2*03,IGHD3-22*01	IGKV2-24	nan	CPDLDSSASWETLHV	MQATHFPRT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457926.1	nan
95	IML3547	ADI-62209	nan	SARS-CoV-2	nan	nan	SARS-CoV,SARS-CoV-2	S:S1	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCACCTTGAAGGAGTCTGGGGGAGGCTTGGTCCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGTAGGCGCTGGATTCACCTTCAGCAACATTGCCATGAACTGGGTCCGCCAGACTCCAGGGAAGGGGCTGGAGTGGGTCTCCACTATTGGCATTCGTGATCATTGGACACACTACGCGGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAGCACGCTGTTTCTGGAGATGACTAGCCTGAGAGTCGACGACACGGCCATATATTACTGTTGCCCGGACTTGGATAGTTCTGCCTCTTGGGAGACTCTTCATGTCTGGGGTCAGGGGACCCTGGTCACCGTCTCCTCA	QVTLKESGGGLVQPGGSLRLSCVGAGFTFSNIAMNWVRQTPGKGLEWVSTIGIRDHWTHYADSVKGRFTISRDNSKSTLFLEMTSLRVDDTAIYYCCPDLDSSASWETLHVWGQGTLVTVSS	nan	nan	IGHV3-23*01,IGHV3-23*04,IGHV3-23D*01	IGHJ1*01,IGHJ4*02,IGHJ4*03	IGHD1-26*01,IGHD2-2*03,IGHD3-22*01	IGKV2-24	nan	CPDLDSSASWETLHV	MQATHFPRT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457933.1	nan
95	IML3564	ADI-63421	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAATCTGGGGGAGGCTTGGTCCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGTAGGCGCTGGATTCACCTTCAGCAACATTGCCATGAACTGGGTCCGCCAGACTCCAGGGAAGGGGCTGGAGTGGGTCTCCACTATTGGCATTCGTGATCATTGGACACACTACGCGGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAGCACGCTGTTTCTGGAGATGACTAGCCTGAGAGTCGACGACACGGCCATATATTACTGTTGCCCGGACTTGGATAGTTCTGCCTCTTGGGAGACTCTTCATGTCTGGGGTCAGGGGACCACGGTCACCGTCTCTTCA	EVQLLESGGGLVQPGGSLRLSCVGAGFTFSNIAMNWVRQTPGKGLEWVSTIGIRDHWTHYADSVKGRFTISRDNSKSTLFLEMTSLRVDDTAIYYCCPDLDSSASWETLHVWGQGTTVTVSS	nan	nan	IGHV3-23*01,IGHV3-23D*01	IGHJ6*01,IGHJ6*02	IGHD1-26*01,IGHD2-2*03,IGHD3-22*01	nan	nan	CPDLDSSASWETLHV	nan	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458421.1	nan
96	COV021	COVD21_P1_HC_D10-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATACACCTTCACCGGCTACTATATGCACTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGATGGATCAATCCTATCAGTGGTGGCACAAACTCTGCACAGAAGTTTCAGGGCAGGGTCACCATGACCAGGGACACGTCCATCACCACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGACGACACGGCCGTGTATCACTGTGCGAAGTCCCCGTATTACTATGATAGTAGTGGTTATTTGGGTGGGTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPISGGTNSAQKFQGRVTMTRDTSITTAYMELSSLRSDDTAVYHCAKSPYYYDSSGYLGGFDYWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCTGCCTCCGAGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGATGTTGGGACTTATAACCTTGTCTCCTGGTACCAACAGCACCCAGGCAAAGCCCCCAAACTCATGATTTATGAGGGCAGTAAGCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACAATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCTGCTCATATGCAGCTAGTAGCACTTATGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	QSVLTQPASESGSPGQSITISCTGTSSDVGTYNLVSWYQQHPGKAPKLMIYEGSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAASSTYVFGTGTKVTVL	IGHV1-2*02	IGHJ4*02	IGHD3-22*01	IGLV2-23*01,IGLV2-23*03	IGLJ1*01	AKSPYYYDSSGYLGGFDY	CSYAASSTYV	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293188.1	MW293643.1
96	Li_SARS2_26	DH1184	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSRYGISWVRQAPGQGLEWMGRIIPMFGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCATKPYYYDSSGYYGGFDYWGQGTLVTVSS	nan	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	IGHV1-69*04	IGHJ4	nan	IGKV3-20*01	IGKJ1	ATKPYYYDSSGYYGGFDY	QQYGSSPWT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
96	Li_SARS2_26	DH1185	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSRYGISWVRQAPGQGLEWMGRIIPMFGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCATKPYYYDSSGYYGGFDYWGQGTLVTVSS	nan	EIVLTQSPDTLSLSPGERATLSCGASQRIRSNYLAWYQQKPGQAPRLLIYATSTRATGIPDRFSGSGSGTDFTLIISRLEPEDFAVYYCQQYGSSQWTFGQGTKVEIK	IGHV1-69*04	IGHJ4	nan	IGKV3-20*01	IGKJ1	ATKPYYYDSSGYYGGFDY	QQYGSSQWT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
97	Wang-C001	C1424	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTCACTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATTATATGATGGAAGTGATAAATACTATGCAGACTCCGTGAAAGGCCGATTCACCATCTCCAGAGACAATCCCAAGAACACGCTGTATCTCCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAACAAGCGGGCCCATATTGTAGTGGTGGTAACTGCTACGGTGGGACCCTTGACTACTGGGGCCAGGGATCCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSHYGMHWVRQAPGKGLEWVAVILYDGSDKYYADSVKGRFTISRDNPKNTLYLQMNSLRAEDTAVYYCAKQAGPYCSGGNCYGGTLDYWGQGSLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGCAGGCCCCTAAACTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGATGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCTCCGGCTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGQAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPDDIATYYCQQYDNLPPAFGPGTKVDIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ3*01	AKQAGPYCSGGNCYGGTLDY	QQYDNLPPA	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
97	Wang-C001	C001_P2_IgG_C5-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTCACTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATTATATGATGGAAGTGATAAATACTATGCAGACTCCGTGAAAGGCCGATTCACCATCTCCAGAGACAATCCCAAGAACACGCTGTATCTCCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAACAAGCGGGCCCATATTGTAGTGGTGGTAACTGCTACGGTGGGACCCTTGACTACTGGGGCCAGGGATCCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSHYGMHWVRQAPGKGLEWVAVILYDGSDKYYADSVKGRFTISRDNPKNTLYLQMNSLRAEDTAVYYCAKQAGPYCSGGNCYGGTLDYWGQGSLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGCAGGCCCCTAAACTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGATGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCTCCGGCTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGQAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPDDIATYYCQQYDNLPPAFGPGTKVDIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ3*01	AKQAGPYCSGGNCYGGTLDY	QQYDNLPPA	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
97	COV107	COV107_Plate2_HC_51-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAACAGGCTGGGCCCTATTGTAGTGGTGGTACCTGCTACCCTGGGACTCTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKQAGPYCSGGTCYPGTLDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATGTCCCTCTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNVPLTFGPGTKVDIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ3*01	AKQAGPYCSGGTCYPGTLDY	QQYDNVPLT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
98	Wang-MOD4	C671	Mod4_P3_IgG_A8-P1369	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATACACCTTCACCAGTTATGATATTAACTGGGTGCGACAGGCCACTGGACAAGGGCTTGAGTGGATGGGATGGATGAACCCTATCAGTGGTAACACAGGCTATGCACAGAAGTTCCAGGGCAGAGTCACCATGACCAGGAATACCTCCATAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGGCGGGAGATATTGTAGTGGTGATAGCTGCTACTCCAATATCTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYDINWVRQATGQGLEWMGWMNPISGNTGYAQKFQGRVTMTRNTSISTAYMELSSLRSEDTAVYYCARGGRYCSGDSCYSNIWFDPWGQGTLVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAATTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGGTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCAGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCCGGGATCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISNYLAWYQQKPGKAPKVLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPGITFGQGTRLEIK	IGHV1-8*01	IGHJ5*02	IGHD2-15*01	IGKV1-9*01	IGKJ5*01	ARGGRYCSGDSCYSNIWFDP	QQLNSYPGIT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
98	Wang-MOD4	Mod4_P3_IgG_C12-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATACACCTTCACCAGTTATGATATTAACTGGGTGCGACAGGCCACTGGACAAGGGCTTGAGTGGATGGGATGGATGAACCCTATCAGTGGTAACACAGGCTATGCACAGAAGTTCCAGGGCAGAGTCACCATGACCAGGAACACCTCCATAAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGGCGGGAGATATTGTAGTGGTGATAGCTGCTACTCCAATATCTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYDINWVRQATGQGLEWMGWMNPISGNTGYAQKFQGRVTMTRNTSISTAYMELSSLRSEDTAVYYCARGGRYCSGDSCYSNIWFDPWGQGTLVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAATTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGGTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCAGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCCGGGATCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISNYLAWYQQKPGKAPKVLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPGITFGQGTRLEIK	IGHV1-8*01	IGHJ5*02	IGHD2-15*01	IGKV1-9*01	IGKJ5*01	ARGGRYCSGDSCYSNIWFDP	QQLNSYPGIT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
98	ZhouY_P1	XG009	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV1-8	IGHJ5	IGHD2-15*01	IGKV1-9	IGKJ4	ARGGRYCSGGSCFSGIWFDP	QQLNSYPSS	nan	Zhou et al. Cell Rep. 34:108699 (2021)	nan	nan
99	CV07	HK_CV07-301	nan	SARS-CoV-2	nan	nan	nan	S:S1	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	TTCCGGCAAACCCGGGGTCATTCTCAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATACACCTTCACCGGCTACTATATGCACTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGATGGATCAACCCTAACAGTGGTGGCACAAACTATGCACAGAAGTTTCAAGGCAGGGTCACCATGACCAGGGACACGTCCATCAGCACAGCCTACATGGAGCTGAGCAGGCTGAGATCTGACGACACGGCCGTGTATTACTGTGCGAGAGTTGATACAACTGGAACTACGTTTTGGCTCTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAGCCTCCACCAAGGGCCCATCGGTCTTCCCCCTGCACCTCCTCCAAGAGCACCTCTGGGGCACAGCGCCTGGGGGG	QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARVDTTGTTFWLYYYYGMDVWGQGTTVTVSS	TTTTTTTCCCCCCCATTCAGTCTCCCTGTCCGTCACCCCTGGACAGCCGGCCTCCATCTCCTGCAAGTCTAGTCAGAGCCTCCTGCATAGTGATGGAAAGACCTATTTGTATTGGTACCTGCAGAAGCCAGGCCAGCCTCCACAGCTCCTGATCTATGAAGTTTCCAACCGGTTCTCTGGAGTGCCAGATAGGTTCAGTGGCAGCGGGTCAGGGACAGATTTCACACTGAAAATCAGCCGGGTGGAGGCTGAGGATGTTGGGGTTTATTACTGCATGCAAAGTATACAGCTTCCTCGTGGCCCTGGGACCAAAGTGGATATCAAACGAACTGTGGCTGCACCATCTGTCTTCATCTTCCCGCCATCTGATGAGCAGTTGAAATCTGGAACTGCCTCTGTTGTGTGCCTGCTGAATAACTTCTATCCCAGAGAGGCCAAAGTACAGTGGAAGGTGGATAACGCCCTCCAATCGGGACTCCCAGGGAGG	FFPPHSVSLSVTPGQPASISCKSSQSLLHSDGKTYLYWYLQKPGQPPQLLIYEVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQSIQLPRGPGTKVDIK	IGHV1-2*02	IGHJ6*02	IGHD1-1*01,IGHD1-7*01	IGKV2D-29*01	IGKJ3*01	ARVDTTGTTFWLYYYYGMDV	nan	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
99	CV05	HL_CV05-170	nan	SARS-CoV-2	nan	nan	nan	S:S1	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	TTCTGCAAACCCGGTGTACATTCTGAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATACACCTTCACCGGCTACTATATGCACTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGATGGATCAACCCTAACAGTGGTGGCACAAACTATGCACAGAAGTTTCAGGGCAGGGTCACCATGACCAGGGACACGTCCATCAGCACAGCCTACATGGAGCTGAGCAGGCTGAGATCTGACGACACGGCCGTGTATTACTGTGCGAGAGTTGATACAACTGGAACTACGTTTTGGCTCTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAGCCTCCACCAAGGGCCCATCGGTCTTCCCCCTGGCACCCTCCTCCAAGAGCACCTCTGGGGCACAGCGGCCGGGGGGG	EVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARVDTTGTTFWLYYYYGMDVWGQGTTVTVSS	TCTGCTACCCCGGTCTAGGTCCACGTCTGTGCTGACTCAGCCACCCTCAGTGTCCGTGTCCCCAGGACAGACAGCCAGCATCACCTGCTCTGGAGATAAATTGGGGGATAAATATGCTTGCTGGTATCAGCAGAAGCCAGGCCAGTCCCCTGTGCTGGTCATCTATCAAGATAGCAAGCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACAGCCACTCTGACCATCAGCGGGACCCAGGCTATGGATGAGGCTGACTATTACTGTCAGGCGTGGGACAGCAGCACTGCCCTTGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAGTCAGCCCAAGCTGCTCCTTCCGAAC	TSVLTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQKPGQSPVLVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTALVVFGGGTKLTVL	IGHV1-2*02	IGHJ6*02	IGHD1-1*01,IGHD1-7*01	IGLV3-1*01	IGLJ2*01,IGLJ3*01	ARVDTTGTTFWLYYYYGMDV	QAWDSSTALVV	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
99	CV07	HL_CV07-301	nan	SARS-CoV-2	nan	nan	nan	S:S1	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	TTCCGGCAAACCCGGGGTCATTCTCAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATACACCTTCACCGGCTACTATATGCACTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGATGGATCAACCCTAACAGTGGTGGCACAAACTATGCACAGAAGTTTCAAGGCAGGGTCACCATGACCAGGGACACGTCCATCAGCACAGCCTACATGGAGCTGAGCAGGCTGAGATCTGACGACACGGCCGTGTATTACTGTGCGAGAGTTGATACAACTGGAACTACGTTTTGGCTCTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCAGCCTCCACCAAGGGCCCATCGGTCTTCCCCCTGCACCTCCTCCAAGAGCACCTCTGGGGCACAGCGCCTGGGGGG	QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARVDTTGTTFWLYYYYGMDVWGQGTTVTVSS	AATTTTTTTTTCCTTAACTCCTCCCCCCCTCTTGTCTCCTGGGAAAAGATAGGGGACAGAGTCCCTTCCCGTCTGAGCAGGTTAGCATCACTTGAGGAATCTGCTACCCGGTCCTTGGCCCAGTCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGATGTTGGGAGTTATAACCTTGTCTCCTGGTACCAACAGCACCCAGGCAAAGCCCCCAAACTCATGATTTATGAGGGCAGTAAGCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACAATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCTGCTCATATGCAGGTAGTAGCACTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAGGTCAGCCCAAGCTGCCCTTTGCCG	QSVLTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEGSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSTWVFGGGTKLTVL	IGHV1-2*02	IGHJ6*02	IGHD1-1*01,IGHD1-7*01	IGLV2-23*01,IGLV2-23*03	IGLJ3*02	ARVDTTGTTFWLYYYYGMDV	CSYAGSSTWV	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
100	CV07	HK_CV07-104	nan	SARS-CoV-2	nan	nan	nan	S:S1	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	TAATAAGGTTATTTTTTTTTTTTTCAATTATATACAGGAAACAGGGATTGTGTGTGGGGGTGACCCCCCCAGCGACAAAAAAGAAAGATATTATTTTTTTCTGCCCCCGGGGGCGGCGGGACGAAATACACACGCCCGGTCGGCAATCTACGTCCTTCATATTAATAAAAAAAAAAAATTTCTGGTCTTACTACCACTCATTCACAGGGGGAGACAGAATTTTTTCCCCTTTTCTTATTTTTTTTTTTCCCCCCTTTCTCACAGGGTCGGGCTGATGGGCCCCCCCCCCCCATAATCATAGAAAAAAAACCCCCCCACCCCCATCCCAGGTGGAGGGGATGCGGGCTTCCCGGGGGATATCATTTTTAAACGAGTGTCCATTAGTTAGTCATCGCCGCTCAAAACCCGTTACATTCTGAGGTGCAGCTGGTGGAGTCTGCAGGAGGGTTGGTCCAGCCGGGGGGGTCCCTGAGACTCTCCTGCGCAGCCTCTGGATTCAACTTGAGCACCTTCTGGATGAGTTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTGGCCAATATTAACGAAGACGGAAGGGAGAAACACTATGTGGACTCTGTGAAGGGTCGATTCAACATCTCCAGAGACAACACCAAGAGCTCTCTGTATTTGCAAATGAAAAGCCTGAGAGCCGACGACACGGCTGTATATTTCTGTGCGAGAGATGCGGCCAGGTATTATGGTATGGACGTCTGGGGGCAAGGGACCACGCTCGCCTTCTCCTCAGCCTCCACCAAGGGCCCATCGTCTTCCACCTGGCACCCTCCTCCAAGAGCACCTCTAGTGCACAGCGACATGGTCC	EVQLVESAGGLVQPGGSLRLSCAASGFNLSTFWMSWVRQAPGKGLEWVANINEDGREKHYVDSVKGRFNISRDNTKSSLYLQMKSLRADDTAVYFCARDAARYYGMDVWGQGTTLAFSS	TTTTTTTCCCCCCCGGCTCCACTCTCCCTGTCTGCTTCTGTAGGAGACAGAGTCACCATCAGTTGCCGGGCAAATCAGAGCATTAACAGTTACTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGTTCCTGATCTATGCTGCAGCCAGTTTGCGAAGCGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCTCGGACTTTTGGCCAGGGGACCAAGCTGAAAATCGAACAACCTGTTCTCCACTCTATCTGTCTTCATCTTCCCGCCATCTGATGAGCAGTTGAAATCTGGAACTGCCTCTGTTGTGTGCCTGCTGAATAACTTCTATCCCAGAGAGGCCAAAGTACAGTGGAAGGTGGATAACGCCCTCCAATCGGGTTAACTCCCAGAGACGGG	FFSPPAPLSLSASVGDRVTISCRANQSINSYLNWYQQKPGKAPKFLIYAAASLRSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPRTFGQGTKLKIE	IGHV3-7*01	IGHJ6*01	IGHD3-16*01,IGHD3-16*02,IGHD3/OR15-3a*01	IGKV1-39*01,IGKV1D-39*01	IGKJ2*01,IGKJ2*02	ARDAARYYGMDV	QQSYSTPRT	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
100	Wang-MOD6	MOD6_P2_IgG_B8-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTAACCGTCAGTAGTAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAACAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTTTATTACTGTGCGAGAGATCGGGCCCACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSNNTLYLQMNSLRAEDTAVYYCARDRAHYYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCAGTCACCCTGTCTGCATCTGTGGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCACTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAAGAGCTTAATAGTGACCCCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPVTLSASVGDRVTITCRASQGISTYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQELNSDPTFGGGTKVEIK	IGHV3-66*01	IGHJ6*02	IGHD3-10*01,IGHD3-10*02	IGKV1-9*01	IGKJ4*01	ARDRAHYYGMDV	QELNSDPT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
100	Wang-MOD4	Mod4_P3_IgG_B2-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGGTCATCGTCAGCAGCAATTACATGACCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTTAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGTCGAGGACACGGCCGTGTATTACTGTGCGAGAGATAGGTCTCACCACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGVIVSSNYMTWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCARDRSHHYGMDVWGQGTTVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCTAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGCCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCCGGACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQLKPGKAPKLLIYAASTLQSGVPSRFSASGSGTEFTLTISSLQPEDFATYYCQQLNSYPPDTFGQGTKLEIK	IGHV3-53*01	IGHJ6*02	nan	IGKV1-9*01	IGKJ2*01	ARDRSHHYGMDV	QQLNSYPPDT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
101	505	505-3	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 S1/RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	nan	nan	nan	nan	nan	ARDFISRPRGYR	MQGTHWPPT	nan	Wan et al. Cell Rep. 32:107918 (2020)	nan	nan
101	505	505-5	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 S1/RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	nan	nan	nan	nan	nan	ARDFISRPRGYR	MQGTHWPPT	nan	Wan et al. Cell Rep. 32:107918 (2020)	nan	nan
101	515	515-1	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	SARS-CoV	S:RBD	SARS-CoV-2 S1/RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	nan	nan	nan	nan	nan	ARDFISRPRGYR	MQGTHWPPT	nan	Wan et al. Cell Rep. 32:107918 (2020)	nan	nan
102	IML3558	ADI-63234	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTGGTACAGTCTGGAGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCGCCTGCAAGGCTTCTGGTTACAACTTTACCACCTATGGTATAAGTTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGGTGGGTTGGGTCAGCCCTTTTAATGGGAATACACAGTATGCACGGAGATTCCAGGGCAGAGTCACTCTGACCACAGACACATCCACGAACACAGCCTACATGGACCTGAAGAGCCTTAGATCTGACGACACGGCCGTGTTTTACTGCGCGAGAGACGGGGAATTTCTCAACTGGTTCGACCCCTGGGGCCAGGGATCCCTGGTCACCGTCTCCTCA	QVQLVQSGAEVKKPGASVKVACKASGYNFTTYGISWVRQAPGQGLEWVGWVSPFNGNTQYARRFQGRVTLTTDTSTNTAYMDLKSLRSDDTAVFYCARDGEFLNWFDPWGQGSLVTVSS	nan	nan	IGHV1-18*01	IGHJ5*02	IGHD3-10*01,IGHD3-10*02	IGLV2-23	nan	ARDGEFLNWFDP	CSYGGDSTWI	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458743.1	nan
102	IDCnC2	CnC2t1p1_B4	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTTCAGCTGGTGCAGTCTGGAGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGTTACACCTTTACCAGCTACGGTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGATGGATCAGCGCTTACAATGGTAACACAAACTATGCACAGAAGCTCCAGGGCAGAGTCACCATGACCACAGACACATCCACGAGCACAGCCTACATGGAGCTGAGGAGCCTGAGATCTGACGACACGGCCGTGTATTACTGTGCGAGAGATGGGGAGTTATTGGGCTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDGELLGWFDPWGQGTLVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGATGTTGGGAGTTATAACCTTGTCTCCTGGTACCAACAGCACCCAGGCAAAGCCCCCAAACTCATGATTTATGAGGGCAGTAAGCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACAATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCTGCTCATATGCAGGTAGTAGCACTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEGSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSTWVFGGGTKLTVL	IGHV1-18*04	IGHJ5*02	IGHD3-10*01,IGHD3-10*02	IGLV2-23*01,IGLV2-23*03	IGLJ3*02	ARDGELLGWFDP	CSYAGSSTWV	nan	Kreer et al. Cell 182:843-854.e12 (2020)	MT658807.1	MT658835.1
102	Cho-C016	C2456	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTTCAGCTGGTGCAGTCTGGAGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGACTTCTGGTTACAACTTTAAAAGCTTTGGCATCAGCTGGGTGCGACAGGCCCCTGGACAAGGACTTGAGTGGATGGGGTGGATCAGCCCTTACAATGGTAACACAAAGTATGTACAGAAGTTTCGGGGCAGAGTCACCATGACCACAGACACATCCACGAGCACAGCCTACATGGAGCTGAGGAGCCTGAGATCTGACGACACGGCCGTGTATTACTGTGCGAGAGATGGGGAGTTAATGGGGTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGASVKVSCKTSGYNFKSFGISWVRQAPGQGLEWMGWISPYNGNTKYVQKFRGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDGELMGWFDPWGQGTLVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGAGACTGGGTCTCCTGGACAGTCGATCACCATCTCCTGTAGTGGAACCAGCAGTGATGTTGGAAGTTATAACCTTGTTTCCTGGTACCAACAGCACCCAGGCCAACCCCCCAAACTCATGATTTATAAGGACACTGAGCGGCCCTCAGGGATTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACAATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCTGCTCATATGCAGGTAGTAGCACTTGGGTGTTCGGCGGAGGGACCAAACTGACCGTCCTAG	QSALTQPASETGSPGQSITISCSGTSSDVGSYNLVSWYQQHPGQPPKLMIYKDTERPSGISNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSTWVFGGGTKLTVL	IGHV1-18*01	IGHJ5*02	IGHD3-10*01,IGHD3-10*02,IGHD3-16*01	IGLV2-23*01,IGLV2-23*02,IGLV2-23*03	IGLJ3*02	ARDGELMGWFDP	CSYAGSSTWV	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
103	IML3546	ADI-62854	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGAGGAGGCTTGATCCAGTTTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTCGCAACTACATGAGTTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGCGTCTCAGTTATTTATGCTGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATTTCTAGAGACAATTCCAAGAACACGCTGTATCTTCAGATGAACAGCCTGAGAGCCGAGGACACGGCCGTATATTACTGTGCGAGAGATTTAGGGCCGGTGGGAGGTACTGATATCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLLESGGGLIQFGGSLRLSCAASGFTVSRNYMSWVRQAPGKGLECVSVIYAGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLGPVGGTDIWGQGTTVTVSS	nan	nan	IGHV3-53*01	IGHJ6*02	IGHD1-26*01	IGKV3-20	nan	ARDLGPVGGTDI	QHSDSSPWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458362.1	nan
103	Aishun_Jin_mix	59A1	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV3-66*01	IGHJ4*02	IGHD1-26*01	IGKV1-39*01	IGKJ2*01	ARELGPVGGTDQ	QQSHSTPYT	nan	Han et al. Front Immunol. 12:653189 (2021)	nan	nan
103	Aishun_Jin_mix	CQTS135	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGACTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGATTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGAGTTGGGTCCCGTGGGAGGTACTGACCAGTGGGGCCAGGGAACCCTGGTCAGCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLDWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARELGPVGGTDQWGQGTLVSVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTCGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCTCCTATTTAAATTGGTATCAGCAGAAACAAGGGAAAGCCCCTAACCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGTGTCCCATCAAGGTTCAGTGGCAGTGGGTCTGGGACAGATTTCACTCTCACCATCACCAGTCTGCAAGTTGAAGATTTTGCAACTTATTATTGTCAACAGAGTCATAGTACCCCGTACACTTTTGGCCAGGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKQGKAPNLLIYAASSLQSGVPSRFSGSGSGTDFTLTITSLQVEDFATYYCQQSHSTPYTFGQGTKVEIK	IGHV3-66*01	IGHJ4*02	IGHD1-26*01	IGKV1-39*01,IGKV1D-39*01	IGKJ2*01	ARELGPVGGTDQ	QQSHSTPYT	nan	Patent: CN111925443A	MW587564.1	MW587565.1
104	Wang-PFZ12	PZF12_P2_IgG_G8-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGACTGGAGGAGGTTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGATCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAAGTCCAAGAACACGCTGTATCTCCAAATGAACAGCCTGAGAGTCGAGGACACGGCCGTGTATTACTGTGCGAGAGATTTTTGGGAAGGCGCTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVETGGGLIQPGGSLRLSCAASGITVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDKSKNTLYLQMNSLRVEDTAVYYCARDFWEGAMDVWGQGTTVTVSS	TCCTATGTGCTGACTCAGCCACCCTCGGTGTCAGTGGCCCCAGGACAGACGGCCAGGATTACCTGTGGGGGAAACAACATTGGAAGTAAAAATGTGCACTGGTACCAGCAGAAGCCAGGCCAGGCCCCTGTGCTGGTCGTCTATGATGATAGCGACCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACGGCCACCCTGACCATCAGCAGGGTCGAAGCCGGGGATGAGGCCGACTATTACTGTCAGGTGTGGGATAGTAGTGGTCACCCTTATGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	SYVLTQPPSVSVAPGQTARITCGGNNIGSKNVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSGHPYVFGTGTKVTVL	IGHV3-53*02	IGHJ6*02	IGHD3-3*01,IGHD3-3*02,IGHD3/OR15-3a*01	IGLV3-21*02	IGLJ1*01	ARDFWEGAMDV	QVWDSSGHPYV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
104	Kaku_patientB	8-92	nan	SARS-CoV-2	nan	SARS-CoV-2	SARS-CoV;MERS-CoV	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGAGATCACCGTCAGTCGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGAAGTAGATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATAAAAATGAAGGAGCGATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASEITVSRNYMSWVRQAPGKGLEWVSVIYSGGSRYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDKNEGAMDVWGQGTTVTVSS	GATATCGTGATGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACACCTTAATAGTTACTCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIVMTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQHLNSYSYTFGQGTKLEIK	IGHV3-53*01	IGHJ6*02	IGHD1-26*01	IGKV1-9*01	IGKJ2*01	ARDKNEGAMDV	QHLNSYSYT	nan	Kaku et al. Cell Rep. 36:109385 (2021)	MZ089620.1	MZ089623.1
105	IML3564	ADI-63292	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGGTCACCGTCAGTAGCAACTACATGAGTTGGGTCCGCCAAACTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTATTTATGCCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACTCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAAACTACGGAGGTGCTTTTGATATCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLLESGGGLIQPGGSLRLSCAASGVTVSSNYMSWVRQTPGKGLEWVSLIYAGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARENYGGAFDIWGQGTTVTVSS	nan	nan	IGHV3-53*01	IGHJ3*02	IGHD4-17*01,IGHD4-23*01	IGKV1-27	nan	ARENYGGAFDI	QKYNSAPADVGI	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458800.1	nan
105	Wang-MOD11	Mod11_P2_IgG_H3-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATGCAGCCGGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTAATCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTTTAGCGGTGGTAGCACATTCTACGGAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGTTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGGGAAGTGGCTGGGGGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLMQPGGSLRLSCAASGLIVSSNYMSWVRQAPGKGLEWVSVIFSGGSTFYGDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREVAGGAFDIWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATNTGGGACAGATTTCACTCTCACCATCAGCANCCTNCAGCCTGAAGATTTTGCAACTTATTACTGTCAACATCTTAATAGTTACCCTCCCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGXGTDFTLTISXLQPEDFATYYCQHLNSYPPTFGGGTKVEIK	IGHV3-53*01	IGHJ3*02	IGHD6-19*01	IGKV1-9*01	IGKJ4*01	AREVAGGAFDI	QHLNSYPPT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
106	IML3558	ADI-63256	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCCGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTTTCTACGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTAGAGTGGGTGGCACTTATTTCATATGACGGAAGTAATAGATATTACGCAGACTCCGTTAGGGGCCGATTCACCATCTCCAGAGACAATACCAAGAACACGCTGTATCTGCAACTGAACAGCCTGAGACCTGAGGACTCGGCTGTATTTTACTGCGCGAGAGGTCCGAATTACTCCTATATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLQESGGGVVQPGRSLRLSCAASGFTFSFYAMHWVRQAPGKGLEWVALISYDGSNRYYADSVRGRFTISRDNTKNTLYLQLNSLRPEDSAVFYCARGPNYSYMDVWGQGTTVTVSS	nan	nan	IGHV3-30*01	IGHJ6*02	IGHD2-15*01,IGHD3-10*01,IGHD3-10*02	IGKV3-20	nan	ARGPNYSYMDV	QQYGNSYT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458765.1	nan
106	Jennewein_CV3	CV3-8_	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTATCTATGCTATACACTGGGTCCGCCAGGCTCCAGGCCAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTACGCAGACTCCGTGAGGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACTCTGTATCTGCAAATGAACACCCTGAGAGCTGAGGACACGGCTGTCTATTACTGTGCGAGAGGTCCGACCTACTCCTACATGGACGTCTGGGGCAAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGVVQPGRSLRLSCAASGFTFSIYAIHWVRQAPGQGLEWVAVISYDGSNKYYADSVRGRFTISRDNSKNTLYLQMNTLRAEDTAVYYCARGPTYSYMDVWGKGTTVTVSS	GAAATTGTGTTGACACAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCACCTACTTAGCCTGGTACCAGCAGAAACCTGCCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAACAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCCCCACTGACTTTCGGCCCTGGGACCAAAGTGGATATCAAACGAACTGTGGCTGCACCATCTGTCTTCATCTTCCCGCCATCTGATGAGCAGTTGAAATCCGGAACTGCCTCTGTTGTGTGCCTGCTGAATAACTTCTATCCCAGAGAGGCCAAAGTACAGTGGAAGGTGGATAACGCCCTCCAATCGGGTAACTCCCAGGAGAGTGTCACAGAGCAGGACAGCAAGGACAGCACCTACAGCCTCAGCAGC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSTYLAWYQQKPAQAPRLLIYGASNRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPPLTFGPGTKVDIK	IGHV3-30*04,IGHV3-30-3*03	IGHJ6*03	nan	IGKV3-20*01	IGKJ3*01	ARGPTYSYMDV	QQYGSSPPLT	nan	Jennewein et al. Cell Rep. 36:109353 (2021)	MW681565.1	MW681593.1
107	COV072	COV072_P3_HC_26-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGATCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGGACACGCTGTATCTTCAAATGAACCGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGATCATTCTACTTTGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWISVIYSGGSTFYADSVKGRFTISRDNSKDTLYLQMNRLRAEDTAVYYCARSFYFDAFDIWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCTGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPLLTFGGGTKVEIK	IGHV3-53*01	IGHJ3*02	IGHD2/OR15-2a*01,IGHD2/OR15-2b*01	IGKV1-9*01	IGKJ4*01	ARSFYFDAFDI	QQLNSYPLLT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
107	Wang-MOD3	MOD3_P1_IgG_C9-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGGTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGATCCGGGTATTATGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLIQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSGYYDAFDIWGQGTMVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTATCCGGGATTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPGFTFGPGTKVDIK	IGHV3-53*01	IGHJ3*02	IGHD3-10*01,IGHD3-10*02,IGHD3-16*01	IGKV1-9*01	IGKJ3*01	ARSGYYDAFDI	QQLNSYPGFT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
108	S144	S144-466	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 spike/RBD/NP/ORF8/HCoVspike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGCAGTCTGGAGCAGAGGTGAAAAAGCCCGGGGAGTCTCTGAAGATCTCCTGTAAGGGTTCTGGATACAGGTTTACCAGATACTGGATCGGCTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATGGGGATCATCTATCTTGGTGACTCTGAAACCAGATACAGTCCGTCCTTCCAAGGCCAGGTCACCATCTCAGCCGACAACTCCATCAGCACCGCCTACCTGCAGTGGAGCAGCCTGAAGGCCTCGGACACCGCCATGTATTACTGTGCGAGAAGTTCCAATTGGAATTACGGTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVQSGAEVKKPGESLKISCKGSGYRFTRYWIGWVRQMPGKGLEWMGIIYLGDSETRYSPSFQGQVTISADNSISTAYLQWSSLKASDTAMYYCARSSNWNYGDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTGGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTATTACTAGTTGGTTGGCCTGGTATCAGCAGAAATCAGGGAAAGCCCCTAAACTCCTGATCTATGATGCCTCCAGTTTGGAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACCATCAGCAGCCTGCAGCCTGATGATTTTGCAACTTATTACTGCCAACAGTATAATAGTTATCCTTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSTLSASVGDRVTITCRASQSITSWLAWYQQKSGKAPKLLIYDASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYPWTFGQGTKVEIK	IGHV5-51*01	IGHJ4*02	IGHD1-1*01,IGHD1-7*01	IGKV1-5*01	IGKJ1*01	ARSSNWNYGDY	QQYNSYPWT	nan	Dugan et al. Immunity 54:1290-1303.e7 (2021)	nan	nan
108	Wang-MOD11	Mod11_P2_IgG_E11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGCAGTCTGGAGCAGAGGTGAAAAAGCCCGGGGAGTCTCTGAATATCTCCTGTAAGGGTTCTGGATACAGCTTTACCACCTACTGGATCGGCTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATGGGGATCATCTATCCTGGTGACTCTGAAACCAGATACAGCCCGTCCTTCCAAGGCCAGGTCACCATCTCAGCCGACAAGTCCATCAGCACCGCCTACCTGCAGTGGAGCAGCCTGAAGGCCTCGGACACCGCCATGTTTTACTGTGCGAGATCCTATAACTGGAACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVQSGAEVKKPGESLNISCKGSGYSFTTYWIGWVRQMPGKGLEWMGIIYPGDSETRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMFYCARSYNWNYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTATTAGTATCTGGTTGGCCTGGTATCAGCGGAAACCAGGGAAAGCCCCTAAGTTCCTGATCTATGATGCCTCCAATTTAGAAAGTGGGGTCTCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACCATCAGCAGCCTCCAGCCTGATGATTTTGCAACTTATTACTGCCAACAGTATAATAGTTATCCTTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSTLSASVGDRVTITCRASQSISIWLAWYQRKPGKAPKFLIYDASNLESGVSSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYPWTFGQGTKVEIK	IGHV5-51*01	IGHJ4*02	IGHD1-20*01,IGHD1-7*01,IGHD1/OR15-1a*01	IGKV1-5*01	IGKJ1*01	ARSYNWNYFDY	QQYNSYPWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
109	Cho-C012	C2398	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACGCTGTCCCTCACCTGCACTGTCTCTGGTGCCTCCATCAGCAGTGGTGGTGACTATTGGAGCTGGATCCGCCAGCACCCAGGGAAGGGCCTGGAGTGGATTGGGTACATTCATCACAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTTACCATGTCAGTCGACACGTCTAAGAACCAGTTCTCCCTGAAGCTGAACTCTGTGACTGCCGCGGACACGGCCGTGTATTACTGTGCGAGAGTTGGTGACTTCGACTGGTTCGACACCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSQTLSLTCTVSGASISSGGDYWSWIRQHPGKGLEWIGYIHHSGSTYYNPSLKSRVTMSVDTSKNQFSLKLNSVTAADTAVYYCARVGDFDWFDTWGQGTLVTVSS	GAAATTGTGTTGACACAGTCTCCAGCCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTGGCAGCTACTTAGCCTGGTATCAACAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGATGCATCCTACAGGGCCACTGGCATCCCAGCCAGGTTCAGTGGCAGCGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGCCTAGAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGCGTTTCAACTGGCCTCCGATCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	EIVLTQSPATLSLSPGERATLSCRASQSVGSYLAWYQQKPGQAPRLLIYDASYRATGIPARFSGSGSGTDFTLTISSLESEDFAVYYCQQRFNWPPITFGQGTRLEIK	IGHV4-31*03	IGHJ5*02	IGHD2-21*02	IGKV3-11*01	IGKJ5*01	ARVGDFDWFDT	QQRFNWPPIT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
109	Wheatley-CP8	PDI_98	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTGGTGGTTACTACTGGAGCTGGATCCGCCAGCACCCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTCCAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCGTGTATTACTGTGCGAGAGTTAGTGATTTTGACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGYYWSWIRQHPGKGLEWIGYIYSSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARVSDFDWFDPWGQGTLVTVSS	GAAATTGTGTTGACACAGTCTCCAGCCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCTACTTAGCCTGGTACCAACAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGATGCATCCAACAGGGCCACTGGCATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGCCTAGAGCCTGAAGATTTTGCAGTTTATTACTGTCAGCAGCGTTTCAACTGGCCTCCGATCACCTTCGGCCAAGGGACACGACTGGAGATTAAA	EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRFNWPPITFGQGTRLEIK	IGHV4-31*03	IGHJ5*02	IGHD3/OR15-3a*01,IGHD3/OR15-3b*01	IGKV3-11*01	IGKJ5*01	ARVSDFDWFDP	QQRFNWPPIT	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
110	Wang-MOD6	MOD6_P2_IgG_H11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCACCTATGCCATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCCGGAGTGGGTCTCAGGTATTAGTGGTAGTGGTGGCAGCACATACTACGCAGACTCCGTGAAGGTCCGGTTCACCATCTCCAAAGACACTTCCAAGAACATGCTGTTTCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTATATTACTGTGCGAAAGGACCTCGTGGTTCCGAGGACTACTTTGAGTCCTGGGGCCGGGGAACCCTGGTAACCGTCTCCTCAG	EVQLLESGGGLVQPGGSLRLSCAASGFTFSTYAMSWVRQAPGKGPEWVSGISGSGGSTYYADSVKVRFTISKDTSKNMLFLQMNSLRAEDTAVYYCAKGPRGSEDYFESWGRGTLVTVSS	GACATCCAGATGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTATTAGTAGCTGGATGGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGATGTCTCCAATTTGGAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGAACAGAATTCACTCTCACCATCAGCAGCCTGCAGCCTGATGATTTTGCAACTTATTACTGCCAACAGTATAATAGGTACCCGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQMTQSPSTLSASVGDRVTITCRASQSISSWMAWYQQKPGKAPKLLIYDVSNLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNRYPYTFGQGTKLEIK	IGHV3-23*01,IGHV3-23D*01	IGHJ4*02	IGHD3-10*01,IGHD3-22*01,IGHD3-3*01	IGKV1-5*01	IGKJ2*01	AKGPRGSEDYFES	QQYNRYPYT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
110	Wang-MOD11	Mod11_P2_IgG_C10-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCTTGATACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAACCTCTGGATTCATCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGGTTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTATATTACTGTGCGAAAGGGCCTCGTGGGAGCTACGACTACTTTGAGTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLLESGGGLIQPGGSLRLSCATSGFIFSSYAMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGPRGSYDYFEYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTATTAGTAGCTGGTTGGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGATGCCTCCAGTTTGGAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACCATCAGCAGCCTGCAGCCTGATGACTTTGCAACTTATTACTGCCAACAGTTTAGTAGCTATGCGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQFSSYATFGQGTKVEIK	IGHV3-23*01,IGHV3-23D*01	IGHJ4*02	IGHD1-26*01	IGKV1-5*01	IGKJ1*01	AKGPRGSYDYFEY	QQFSSYAT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
111	S210	S210-852	nan	SARS-CoV-2	nan	nan	nan	S:non-RBD	SARS-CoV-2 spike/RBD/NP/ORF8/HCoVspike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTAAGTATTTATTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTGGCCAACATAAAGCAAGATGGACGTGAGAAATACCATGTGGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAACAACTCACTGTATCTGCAAATGAACAACCTGAGAGCCGAGGACACGGCTGTGTATTTCTGTGCGAGAGATGGTATAGCAGTGGCTGGGGGGTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTLSIYWMSWVRQAPGKGLEWVANIKQDGREKYHVDSVKGRFTISRDNANNSLYLQMNNLRAEDTAVYFCARDGIAVAGGFDYWGQGTLVTVSS	TCCTATGAGCTGACTCAGCCACCCTCAGTGTCCGTGTCCCCAGGACAGACAGCCAGCATCACCTGCTCTGGAGATAAATTGGGGGATACATATGCTTGCTGGTATCAGCAGAAGCCAGGCCAGTCCCCTGTACTGGTCATCTATCAAGATAGCAAGCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACAGCCACTCTGACCATCAGCGGGACCCAGGCTATGGATGAGGCTGACTATTACTGTCAGGCGTGGGACAGCAGCACGTCTGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	SYELTQPPSVSVSPGQTASITCSGDKLGDTYACWYQQKPGQSPVLVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTSVVFGGGTKLTVL	IGHV3-7*01	IGHJ4*02	IGHD6-19*01	IGLV3-1*01	IGLJ2*01,IGLJ3*01	ARDGIAVAGGFDY	QAWDSSTSVV	nan	Dugan et al. Immunity 54:1290-1303.e7 (2021)	nan	nan
111	S166	S166-2620	nan	SARS-CoV-2	nan	nan	nan	S:non-RBD	SARS-CoV-2 spike/RBD/NP/ORF8/HCoVspike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGTAGCTATTGGATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTGGCCAACATAAAGCAAGATGGAAGTGAGAAATACTATGTGGCCTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATAGTATAGCAGTGGCTGGGGGCCTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVANIKQDGSEKYYVASVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDSIAVAGGLDYWGQGTLVTVSS	TCCTATGAGCTGACTCAGCCACCCTCAGTGTCCGTGTCCCCAGGACAGACAGCCAGCATCACCTGCTCTGGAGATAAATTGGGGGATAAATATGCTTGCTGGTATCAGCAGAAGCCAGGCCAGTCCCCTGTGCTGGTCATCTATCAAGATAGCAAGCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACAGCCACTCTGACCATCAGCGGGACCCAGGCTATGGATGAGGCTGACTATTTCTGTCAGGCGTGGGACAGCAGCACTGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTA	SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQKPGQSPVLVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYFCQAWDSSTVVFGGGTKLTVL	IGHV3-7*03	IGHJ4*02	IGHD6-19*01	IGLV3-1*01	IGLJ2*01,IGLJ3*01	ARDSIAVAGGLDY	QAWDSSTVV	nan	Dugan et al. Immunity 54:1290-1303.e7 (2021)	nan	nan
112	COV047	C146	nan	SARS-CoV-2	nan	nan	SARS-CoV,SARS-CoV-2	S:non-RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCCTGGTCAAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGACTCACCTTCACTGCCTATAGAATGAATTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGCTCTCATCAATTAGTAATACAAATGGCGACATATACTATGCAGACTCAGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAATTCTCTGTATCTGCAAATGAACAGCCTGAGGGCCGACGACACGGCTGTATATTACTGTGCGAGAGATGTTGCATCTAACTACGCTTACTTTGACCTTTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVKPGGSLRLSCAASGLTFTAYRMNWVRQAPGKGLEWLSSISNTNGDIYYADSVKGRFTISRDNAKNSLYLQMNSLRADDTAVYYCARDVASNYAYFDLWGQGTLVTVSS	CAGTCTGCCCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACATTGGTGTTTATAACTATATCTCCTGGAGCCAACAACACCCAGGCAAAGCCCCCAAAGTCATGATTTATGATGTCACTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTATTGCAGCTCATATAGAGGCAGCAGCACTCCCTATGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	QSALTQPASVSGSPGQSITISCTGTSSDIGVYNYISWSQQHPGKAPKVMIYDVTNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYRGSSTPYVFGTGTKVTVL	IGHV3-21*06	IGHJ4*02	IGHD4/OR15-4a*01,IGHD4/OR15-4b*01	IGLV2-14*03	IGLJ1*01	ARDVASNYAYFDL	SSYRGSSTPYV	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
112	COV057	COVD57_P2_HC_E11-1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCCTGGTCAAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGACTCACCTTCACTGCCTATAGAATGAATTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGCTCTCATCAATTAGTAATACAAATGGCGACATATACTATGCAGACTCAGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAATTCTCTGTATCTGCAAATGAACAGCCTGAGGGCCGACGACACGGCTGTATATTACTGTGCGAGAGATGTTGCATCTAACTACGCTTACTTTGACCTTTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVKPGGSLRLSCAASGLTFTAYRMNWVRQAPGKGLEWLSSISNTNGDIYYADSVKGRFTISRDNAKNSLYLQMNSLRADDTAVYYCARDVASNYAYFDLWGQGTLVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCACCCTGTCTCTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTTAGCCTGGTACCATCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCTACCAGGGCCACTGGTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATGATAACTGGCCACTCTTCGGCCAAGGGACACGACTGGAGATTAAAC	EIVMTQSPATLSLSPGERATLSCRASQSVSSNLAWYHQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYDNWPLFGQGTRLEIK	IGHV3-21*06	IGHJ4*02	IGHD4/OR15-4a*01,IGHD4/OR15-4b*01	IGKV3-15*01	IGKJ5*01	ARDVASNYAYFDL	QQYDNWPL	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
113	COV072	COV072_P3_HC_73-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTACAGCAGTGGGGCGCAGGACTGTTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGCTTACTCCTGGAGCTGGATCCGCCAGCCCCCAGGGAAGGGTCTGGAGTGGATTGGGGAAATCAATCATGGTGGAAGCACCAACTACAACGCGTCCCTCAAGAGTCGAGTCACCATATCAGCAGACACGTCCAAGAACCTGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCTGTGTATTACTGTGCGAGAGAAGGCGCAGTGGCTGGCGGGGATTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQQWGAGLLKPSETLSLTCAVYGGSFSAYSWSWIRQPPGKGLEWIGEINHGGSTNYNASLKSRVTISADTSKNLFSLKLSSVTAADTAVYYCAREGAVAGGDFDYWGQGTLVTVSS	TCCTATGTGCTGACTCAGCCACCCTCAGTGTCAGTGGCCCCAGGAAAGACGGCCAGGATTACCTGTGGGGGAAACAACATTGGAAGTAAAAGTGTGCACTGGTACCAGCAGAAGCCAGGCCAGGCCCCTGTGCTGGTCATCTATTATGATAGCGACCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACGGCCACCCTGACCATCAGCAGGGTCGAAGCCGGGGATGAGGCCGACTATTACTGTCAGGTGTGGGATGGTACTAGTGATCATCCGGGATGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	SYVLTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVIYYDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDGTSDHPGWVFGGGTKLTVL	IGHV4-34*01	IGHJ4*02	IGHD6-19*01	IGLV3-21*04	IGLJ3*02	AREGAVAGGDFDY	QVWDGTSDHPGWV	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
113	IML3547	ADI-62188	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTTGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATACACCTTCACCGGCTACTATATGCACTGGGCGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGATGGATCAACCCTAACAGTGGTGTCACAAACTATGCACAGAAGTTTCAGGGCAGGGTCACCATGACCAGGGACACGTCCATCAGCACAGCCTACATGGAGCTGAGCAGGCTGAGATCTGACGACACGGCCGTGTATTACTGTGCGAGAGAACGGGCAGTGGCTGGAACCGACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWARQAPGQGLEWMGWINPNSGVTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARERAVAGTDFDYWGQGTLVTVSS	nan	nan	IGHV1-2*02	IGHJ4*02	IGHD6-19*01	IGLV2-14	nan	ARERAVAGTDFDY	SSYTSRSTLV	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457912.1	nan
114	COV047	COV047_P5_IgG_21-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTTCAGCTGGTGCAGTCTGGAGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGTTACACCTTTACCAGCTACGATATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGATGGATCAACGCTTACAATGGTAACACAAACTATGCACAGAAGCTCCAGGGCAGAGTCACCATGACCACAGACACATCCACGAGCACAGCCTACATGGAGCTGAGGAGCCTGAGATCTGACGACACGGCCGTGTATTACTGTGCGAGACCCAGCAGCTCGCTGACGTCCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYDISWVRQAPGQGLEWMGWINAYNGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARPSSSLTSYFDYWGQGTLVTVSS	TCCTATGTGCTGACTCAGCCACCCTCGGTGTCAGTGGCCCCAGGACAGACGGCCAGGATTACCTGTGGGGGAAACAACATTGGAAGTAAAAATGTGCACTGGTACCAGCAGAAGCCAGGCCAGGCCCCTGTGCTGGTCGTCTATGATGATAGCGACCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACGGCCACCCTGACCATCAGCAGGGTGGAAGCCGGGGATGAGGCCGACTATTACTGTCAGGTGTGGGATAGTAGTAGTGATCGTCATTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	SYVLTQPPSVSVAPGQTARITCGGNNIGSKNVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDRHWVFGGGTKLTVL	IGHV1-18*04	IGHJ4*02	IGHD6-6*01	IGLV3-21*02	IGLJ3*02	ARPSSSLTSYFDY	QVWDSSSDRHWV	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293080.1	MW293535.1
114	Wang-MOD9	MOD9_P1_IgG_C5-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATACACCTTCACCAATTATGATATCAACTGGGTGCGACAGGCCACTGGACAAGGGCTTGAGTGGATGGGATGGATGAACCCTAACAGTGGTAACACAGGCTATGCACAGAAGTTCCAGGGCAGAGTCACCATGACCGGGGACACCTCCATAAGCATAGCCTACATGGAGCTGAACAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGTCAGTTCGTCCCTCACCTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYDINWVRQATGQGLEWMGWMNPNSGNTGYAQKFQGRVTMTGDTSISIAYMELNSLRSEDTAVYYCARVSSSLTYYFDYWGQGTLVTVSS	TCCTATGTGCTGACTCAGCCACCCTCGGTGTCAGTGGCCCCAGGACAGACGGCCAGGATTGCCTGTGGGGGAAACTACATTGGAAGTAAAAGTGTCCACTGGTACCAGCAGAGGCCAGGCCAGGCCCCTGTGCTGGTCGTCTATGATGATAGCGACCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACGGCCACCCTGACCATCAGCAGGGTCGAAGCCGGCGATGAGGCCGACTATTACTGTCAGGTGTGGGATAGTACTACTGATCATCCTCATGTGGTATTCGGCGGAGGGACCAGGCTGACCGTCCTAG	SYVLTQPPSVSVAPGQTARIACGGNYIGSKSVHWYQQRPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSTTDHPHVVFGGGTRLTVL	IGHV1-8*01	IGHJ4*02	IGHD6-6*01	IGLV3-21*02	IGLJ2*01,IGLJ3*01	ARVSSSLTYYFDY	QVWDSTTDHPHVV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
115	Wang-MOD11	Mod11_P1_IgG_B2-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAATTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGTCCTACCCCTCTACGGTGACTACGAGGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSIIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARVLPLYGDYEDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCTCGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSISNYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPRTFGQGTKVEIK	IGHV3-53*01	IGHJ4*02	IGHD4-17*01	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	ARVLPLYGDYEDY	QQSYSTPRT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
115	Shi_p1	CB6	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCATGAACACGCTGTTTCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGTGCTACCTATGTACGGTGACTACCTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAGCCAGCACCAAAGGCCCGAGCGTGTTTCCGCTGGCGCCGAGCAGCAAAAGCACCAGCGGCGGCACCGCGGCGCTGGGCTGCCTGGTGAAAGATTATTTTCCGGAACCGGTGACCGTGAGCTGGAACAGCGGCGCGCTGACCAGCGGCGTGCATACCTTTCCGGCGGTGCTGCAGAGCAGCGGCCTGTATAGCCTGAGCAGCGTGGTGACCGTGCCGAGCAGCAGCCTGGGCACCCAGACCTATATTTGCAACGTGAACCATAAACCGAGCAACACCAAAGTGGATAAACGCGTGGAGCCCAAATCTTGTGACAAAACTCACACATGCCCACCGTGCCCAGCACCTGAACTCCTGGGGGGACCGTCAGTCTTCCTCTTCCCCCCAAAACCCAAGGACACCCTCATGATCTCCCGGACCCCTGAGGTCACATGCGTGGTGGTGGACGTGAGCCACGAAGACCCTGAGGTCAAGTTCAACTGGTACGTGGACGGCGTGGAGGTGCATAATGCCAAGACAAAGCCGCGGGAGGAGCAGTACAACAGCACGTACCGTGTGGTCAGCGTCCTCACCGTCCTGCACCAGGACTGGCTGAATGGCAAGGAGTACAAGTGCAAGGTCTCCAACAAAGCCCTCCCAGCCCCCATCGAGAAAACTATCTCCAAAGCCAAAGGGCAGCCCCGAGAACCACAGGTGTACACCCTGCCCCCATCCCGGGATGAGCTGACCAAGAACCAGGTCAGCCTGACCTGCCTGGTCAAAGGCTTCTATCCCAGCGACATCGCCGTGGAGTGGGAGAGCAATGGGCAGCCGGAGAACAACTACAAGACCACGCCTCCCGTGCTGGACTCCGACGGCTCCTTCTTCCTCTACAGCAAGCTCACCGTGGACAAGAGCAGGTGGCAGCAGGGGAACGTCTTCTCATGCTCCGTGATGCATGAGGCTCTGCACAACCACTACACGCAGAAGAGCCTCTCCCTGTCTCCGGGTAAATGA	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSMNTLFLQMNSLRAEDTAVYYCARVLPMYGDYLDYWGQGTLVTVSS	GATATTGTGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGGTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCTCCGGAGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAACGAACTGTGGCTGCACCAAGCGTGTTTATCTTCCCTCCCAGCGACGAGCAGCTGAAGAGCGGCACCGCCAGCGTGGTCTGTCTCCTGAACAACTTCTATCCCAGGGAGGCCAAGGTCCAGTGGAAAGTGGACAACGCCCTGCAAAGCGGCAATAGCCAGGAGTCCGTCACAGAGCAGGACAGCAAGGACAGCACCTACAGCCTGTCCAGCACCCTGACCCTCAGCAAGGCCGACTACGAGAAGCACAAGGTGTACGCTTGCGAGGTGACCCATCAGGGCCTGTCCAGCCCCGTGACCAAGTCCTTCAACAGGGGCGAATGCAGCTAA	DIVMTQSPSSLSASVGDRVTITCRASQSISRYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPEYTFGQGTKLEIK	IGHV3-66*01	IGHJ4*02	IGHD3-10*02	IGKV1-39*01,IGKV1D-39*01	IGKJ2*01	ARVLPMYGDYLDY	QQSYSTPPEYT	7C01	Shi et al. Nature 584:120-124 (2020)	MT470197.1	MT470196.1
116	Tong_C18	C18C11	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike (and spike minus RBD)	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGCCTCATTACTATGGTTCGGGGAGTTTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCASLITMVRGVFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCAGCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCCCTCACTTTCGGCGGAGGGACCAAGGTGGAAATCAAA	DIQMTQSPATLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPLTFGGGTKVEIK	IGHV3-30-3*01	IGHJ4*02	IGHD3-10*01	IGKV1-39*01,IGKV1D-39*01	IGKJ4*01	ASLITMVRGVFDY	QQSYSTPLT	nan	Tong et al. Cell 184:4969-4980.e15 (2021)	MW718410.1	MW718562.1
116	Cho-C006	C2465	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	AGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGTACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTATATTACTGTGCGAGTCTAATTACTATGGTTCGGGGAGTCCCTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	VQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKYTLYLQMNSLRAEDTAVYYCASLITMVRGVPDYWGQGTLVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTACAACCTGAAGATTTTGCATCTTACTACTGTCAACAGAGTTACAGTACCCCGATCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	DIQLTQSPSSLSASVGDRVTITCRASQNISNYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFASYYCQQSYSTPITFGQGTRLEIK	IGHV3-30-3*01	IGHJ4*02	IGHD3-10*01	IGKV1-39*01,IGKV1D-39*01	IGKJ5*01	ASLITMVRGVPDY	QQSYSTPIT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
117	IML3546	ADI-57842	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTGGTACAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAGGGTATAGTGGGAGCTACTGGGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	QVQLVQSGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGYSGSYWDAFDIWGQGTMVTVSS	nan	nan	IGHV3-30*18,IGHV3-30-5*01	IGHJ3*02	IGHD1-26*01	IGKV4-1	nan	AKGYSGSYWDAFDI	QQYYSTPLT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457718.1	nan
117	Li_SARS2_26	H025837+K023736	nan	SARS-CoV-2	SARS-CoV,MERS-CoV	nan	nan	S:S2	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARTYSGSYWDAFDIWGQGTMVTVSS	nan	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSYSFGQGTKLEIK	IGHV3-30*01	IGHJ3	nan	IGKV3-20*01	IGKJ2	ARTYSGSYWDAFDI	QQYGSSYS	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
118	IML3546	ADI-57836	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTTGTACAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGGCTCTGGATTCACCTTCAATATCTATGGCCTGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAACCCCAGAGTGGGAGCTACCGTGATGCTTTTGATATCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLVQSGGGVVQPGRSLRLSCAGSGFTFNIYGLHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKPQSGSYRDAFDIWGQGTTVTVSS	nan	nan	IGHV3-30*18,IGHV3-30-5*01	IGHJ3*02	IGHD1-26*01	IGLV2-14	nan	AKPQSGSYRDAFDI	SSYTSSSTLVV	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457712.1	nan
118	IML3564	ADI-63366	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAATAATAAATACTATGCAGAGTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAGACTAATAGTGGGAGCTACCGTGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	EVQLLESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVAVISYDGNNKYYAESVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKTNSGSYRDAFDIWGQGTMVTVSS	nan	nan	IGHV3-30*18,IGHV3-30-5*01	IGHJ3*02	IGHD1-26*01	IGKV1-5	nan	AKTNSGSYRDAFDI	QQYNSYWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458872.1	nan
119	IML3564	ADI-63318	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGCCTCTCCTGTGCAGCCTCTGGGTTCATCTTCAATACCTTTGCCATACACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCACTAATATCCTATGATGGTATCAACAAATACTACGCCGACTCCGTGAGGGGCCGATTCACCGTCTCCAGAGACAACTCCAAGAACACGCTGTCTCTGCAAATGAAGAGCCTGAGACTTGAGGACTCGGGTACTTATTACTGTGCGAGAGCGTCTAGTGGGGGCTACTGGAGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	EVQLVESGGGVVQPGRSLSLSCAASGFIFNTFAIHWVRQAPGKGLEWVALISYDGINKYYADSVRGRFTVSRDNSKNTLSLQMKSLRLEDSGTYYCARASSGGYWSAFDIWGQGTMVTVSS	nan	nan	IGHV3-30-3*01	IGHJ3*02	IGHD1-26*01	IGKV3-20	nan	ARASSGGYWSAFDI	QHYGSSPFT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458826.1	nan
119	Wheatley-CP42	PDI_57	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GTGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCATCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAATAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAAGACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGCGAGCAGTGGGAGCTACTTCTCTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	VVQLVESGGGVVQPGRSLRLSCAASGFIFSSYAMHWVRQAPGKGLEWVAVISYDGNNKYYADSVKGRFTISRDNSKKTLYLQMNSLRAEDTAVYYCARASSGSYFSAFDIWGQGTMVTVSS	GACATCCAGATGACCCAGTCTCCAGCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTCTTAGTAGCTGGTTGGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATAAGGCATCTAGTTTAGAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACCATCAGCAGCCTGCAGCCTGATGATTTTGCAACTTATTACTGCCAACAGTATAATAGTTATTTCCTGTTCGGCCAAGGGACCAAGGTGGAAATCAAA	DIQMTQSPATLSASVGDRVTITCRASQSLSSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYFLFGQGTKVEIK	IGHV3-30*04,IGHV3-30-3*03	IGHJ3*02	IGHD1-26*01	IGKV1-5*03	IGKJ1*01	ARASSGSYFSAFDI	QQYNSYFL	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
120	IML3564	ADI-63388	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGAAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCATCTTCAGTAGCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAATCAACAAATACTACGCAGACTCCGTGAAGGGCCGGTTCACCATCTCCAGAGACAATTCCAAGAACACACTGGATCTGCTAATGACGAGCCTGAGACCTGAGGACACGGCTGTATATTACTGTGCGAGAGATAGGTCAGGAGGATACAGTTTTTCTTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGEGVVQPGRSLRLSCAASGFIFSSYAMHWVRQAPGKGLEWVAVISYDGINKYYADSVKGRFTISRDNSKNTLDLLMTSLRPEDTAVYYCARDRSGGYSFSFDYWGQGTLVTVSS	nan	nan	IGHV3-30-3*01	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGKV1-39*01	nan	ARDRSGGYSFSFDY	QQSSSAPGT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458894.1	nan
120	Wheatley-CP63	PDI_221	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGCAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTATCTATGCTATACACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTAGAGTGGGTGGCAGTTATATCCTATGATGGAATTAATAAATACTACGCAGACTCCGTGAGGGGCCGATTCACCATCTCCAGAGACAATTCCATGAACACGCTGTCTCTGCAAATGAACAGCCTGAGAACTGAGGACACGGCTGTCTATTACTGTGCGAGAGATCGAAGCGGTGGATACAGCTACAACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVQSGGGVVQPGRSLRLSCAASGFTFSIYAIHWVRQAPGKGLEWVAVISYDGINKYYADSVRGRFTISRDNSMNTLSLQMNSLRTEDTAVYYCARDRSGGYSYNFDYWGQGTLVTVSS	GAAATAGTGATGACGCAGTCTCCAGCCTCCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAAGTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCACCAGGGCCACTGCTATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGAGACAGAGTTCACTCTCACCATCAGCAGCCTGCAGTCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATAATAACTGGCCGGGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAA	EIVMTQSPASLSVSPGERATLSCRASQSVSSKLAWYQQKPGQAPRLLIYGASTRATAIPARFSGSGSETEFTLTISSLQSEDFAVYYCQQYNNWPGTFGQGTKVEIK	IGHV3-30*01	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGKV3-15*01	IGKJ1*01	ARDRSGGYSYNFDY	QQYNNWPGT	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
121	Wheatley-CP8	PDI_169	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGTCACCGTCAGTAGCAACTACATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTATTGTGCGAGAGGAGATAGCAATGGCTGGTCCTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAVTVSSNYMNWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGDSNGWSYYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCACCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCATAAGCTCATTATCTATGTTGCATCCAGTTTGCAAAGTGGGGTCCCATCACGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTGTGCATCCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCCTTGGGTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAG	DIQMTQSPSSLSASVGDRVTITCRASQSISTYLNWYQQKPGKAHKLIIYVASSLQSGVPSRFSGSGSGTDFTLTISSVHPEDFATYYCQQSYSTPWVTFGGGTKVEI	IGHV3-53*01	IGHJ4*02	IGHD6-19*01	IGKV1-39*01,IGKV1D-39*01	IGKJ4*01	ARGDSNGWSYYFDY	QQSYSTPWVT	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
121	VRC_SARS1	ADI-56034	mAb-156	229E,HKU1,SARS-CoV,SARS-CoV-2	NL63,OC43	nan	nan	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCACTGACAACTACATGAGTTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTCTTTATAGCGGTGGTAGCACGTACTACGCAGACGCCGTGCAGGGCCGATTCTCCATCTCCAGAGACAATTCCAAGAACGCTCTGTATCTTCAAATGAACAGCCTGAGGGCCGAGGACACGGCCGTCTATTACTGTGCGAGGGGATTTGGTAATGGCTGGTCGTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVTDNYMSWVRQAPGKGLEWVSVLYSGGSTYYADAVQGRFSISRDNSKNALYLQMNSLRAEDTAVYYCARGFGNGWSYYFDYWGQGTLVTVSS	GATATTGTGCTGACTCAGACTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGACCATTGCCACCTATTTAAGTTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAACTCCTGATCTATGCTGTATCCAGTTTACAAAGTGGAGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGACTTCACTCTCACCATCGGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTATCCCGTGGACGTTCGGCCAAGGGACCAAAGTGGATATCAAA	DIVLTQTPSSLSASVGDRVTITCRASQTIATYLSWYQQKPGKAPKLLIYAVSSLQSGVPSRFSGSGSGTDFTLTIGSLQPEDFATYYCQQSYSIPWTFGQGTKVDIK	IGHV3-53*01	IGHJ4*02	IGHD6-19*01	IGKV1-39*01,IGKV1D-39*01	IGKJ1*01	ARGFGNGWSYYFDY	QQSYSIPWT	nan	Wec et al. Science 369:731-736 (2020)	MT566060.1	MT566061.1
122	IML3564	ADI-63344	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGAATTCACCTTCAGTATCTATGCTATGAACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCCGTTATATCATATGATGGATTCAATAAATACTACGCAGACTCCGTGATGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAGAGGTCGAAGTGGGAACTATTTTTCCTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLLESGGGVVQPGRSLRLSCAASEFTFSIYAMNWVRQAPGKGLEWVAVISYDGFNKYYADSVMGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGRSGNYFSWFDPWGQGTLVTVSS	nan	nan	IGHV3-30-3*01	IGHJ5*02	IGHD1-26*01	IGKV3D-15	nan	ARGRSGNYFSWFDP	QQYNNWPLT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458850.1	nan
122	IML3558	ADI-63254	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCGATATCTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTAGAGTGGGTGGCAGTTATATCATATGATGGAAATAATAAATATTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCCAGAGCACACTGTATCTGCAAATGAACAGCCTGAGACTTGAGGACACGGCTGTGTATTTCTGTGCGAGACCGTCTAGTGGGAACTACTTCTCCTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACTGTCTCCTCA	EVQLVESGGGVVQPGRSLRLSCAASGFTFDIYAMHWVRQAPGKGLEWVAVISYDGNNKYYADSVKGRFTISRDNSQSTLYLQMNSLRLEDTAVYFCARPSSGNYFSWFDPWGQGTLVTVSS	nan	nan	IGHV3-30*01	IGHJ5*02	IGHD1-26*01	IGKV3-20	nan	ARPSSGNYFSWFDP	QHYGSSPFT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458763.1	nan
123	IML3549	ADI-63089	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S1	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAACAGTGATGCTTACTACTGGAGCTGGGTCCGCCAGCACCCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAACACCTACTCCAACCCGTCCCTCAAGAGTCTAATTTCCATATCAATGGACACGTCTAAGAACCAGTTCTCCCTGAAGCTCAACTCTGTGACTGCCGCGGACACGGCCGTGTATTATTGTGCGAGAGGGTCAATTGGTACCTACTACTACTACATGGACGTCTGGGGCAAGGGGACCACGGTCACCGTCTCCTCA	EVQLVESGPGLVKPSQTLSLTCTVSGGSINSDAYYWSWVRQHPGKGLEWIGYIYYSGNTYSNPSLKSLISISMDTSKNQFSLKLNSVTAADTAVYYCARGSIGTYYYYMDVWGKGTTVTVSS	nan	nan	IGHV4-31*01	IGHJ6*03	IGHD6-13*01,IGHD6-19*01	IGKV1-39*01	nan	ARGSIGTYYYYMDV	QHSYIFFPR	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458598.1	nan
123	Crowe_mix	COV2-2310	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGCCTCCATCAGCAGTGGTAGTTACTACTGGAGCTGGATCCGGCAGCCCGCCGGGAAGGGACTGGAGTGGATTGGGCGTATCTATACCAGTGGGAACACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGTTCTGTGACCGCCGCAGACACGGCCGTGTATTACTGTGCGACAGGTTATATTGGTACCTACTACTACTACATGGACGTCTGGGGCAAAGGGACCACGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSQTLSLTCAVSGASISSGSYYWSWIRQPAGKGLEWIGRIYTSGNTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCATGYIGTYYYYMDVWGKGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCACTTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACCACTGTCAACAGAGTTACAGTACCCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAA	DIQMTQSPSSLSASVGDRVTITCRASQSISTYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYHCQQSYSTLTFGGGTKVEIK	IGHV4-61*02	IGHJ6*03	IGHD2-15*01,IGHD2-2*01,IGHD2-2*02	IGKV1-39*01,IGKV1D-39*01	IGKJ4*01	ATGYIGTYYYYMDV	QQSYSTLT	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665758.1	MT665371.1
124	IML3558	ADI-63203	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTGGTGCAGTCTGGAGCAGAGGTGAAAAAGCCCGGGGAGTCTCTGAGGATCTCCTGTAAGGGTTCTGGATACAGCTTTACCAGCTACTGGATCAGCTGGGTGCGCCAGATGCCCGGGAAAGGCCTGGAGTGGATGGGGACGATTGATCCTAGTAACTCTTACACCAACTATGGCCCGTCCTTCCGAGGCCACGTCACCATCTCAGCTGACGAGTCCATCAGCACTGCCTACCTACAGTGGAGTAGTCTGAAGGCCTCGGACATCGCCATTTATTATTGTGCGAGACACCTCGGGGGGGAGCTCCTCGGTTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVQSGAEVKKPGESLRISCKGSGYSFTSYWISWVRQMPGKGLEWMGTIDPSNSYTNYGPSFRGHVTISADESISTAYLQWSSLKASDIAIYYCARHLGGELLGWFDPWGQGTLVTVSS	nan	nan	IGHV5-10-1*01	IGHJ5*02	IGHD1-26*01,IGHD3-16*01,IGHD3-16*02	IGKV3-20	nan	ARHLGGELLGWFDP	QHFGGSLWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458712.1	nan
124	Jennewein_CV2	CV2-25	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAAGTCCAACTTGTGCAATCCGGGGCCGAGGTAAAGAAGCCCGGAGAGTCTCTGCGAATCAGCTGTAAAGGTTCAGGTTACAGTTTTACGTCTTACTGGATTTCATGGGTTCGACAGATGCCTGGAAAAGGGCTTGAATGGATGGGCAAGATTGACCCCAGTGATTCATATACGAATTACTCTCCAAGTTTCCAAGGGCATGTTACTATTTCAGCAGATAAGTCAATAAGTACCGCCTACCTCCAGTGGTCTTCTCTCAAGGCGAGTGATACCGCAATGTATTACTGTGCTCGGCAATTCGGTGGTGAGTTGTTGGGTTGGTTTGACCCGTGGGGGCAAGGTACGCTCGTAACAGTTTCCTCAG	EVQLVQSGAEVKKPGESLRISCKGSGYSFTSYWISWVRQMPGKGLEWMGKIDPSDSYTNYSPSFQGHVTISADKSISTAYLQWSSLKASDTAMYYCARQFGGELLGWFDPWGQGTLVTVSS	GACATTCAAATGACGCAGAGCCCCAGCAGCTTGTCTGCCTCCGTGGGGGACAGGGTAACAATCACGTGCCGAGCTAGTCAAGGGATAAGTAACTATCTCGCGTGGTATCAACAAAAACCCGGCAAAGTGCCAAAATTGTTGATCTACGCTGCATCAACTCTCCAATCCGGCGTACCCAGTCGGTTCTCTGGCAGTGGTAGCGGCACAGACTTCACATTGACGATCAGCAGTTTGCAGCCAGAGGATGTTGCTACATATTATTGTCAGAAATATAATTCAGCACCATTTACTTTTGGTCCGGGGACTAAAGTTGACATCAAA	DIQMTQSPSSLSASVGDRVTITCRASQGISNYLAWYQQKPGKVPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCQKYNSAPFTFGPGTKVDIK	IGHV5-10-1*03	IGHJ5*01,IGHJ5*02	IGHD2-21*01,IGHD2-21*02	IGKV1-27*01	IGKJ2*01,IGKJ2*02	ARQFGGELLGWFDP	QKYNSAPFT	nan	Jennewein et al. Cell Rep. 36:109353 (2021)	MW681662.1	MW681663.1
125	IML3549	ADI-61226	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCCGGGGCTGAGGTGAAGCCGCCTGGGTCGTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTCCACCAGCAACGCTCTCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAGGGGTCATCCCTATCTTTGGTACAACAAACTATGCACAGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACGAATCCACGAGCACAGCCTACATGGAGTTGAGCAGCCTGACATCTGAGGACACGGCCGTGTATTACTGTGCGAGATTATATTGTAGTGATGGTAGCTGCCCTTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGAEVKPPGSSVKVSCKASGGTSTSNALSWVRQAPGQGLEWMGGVIPIFGTTNYAQKFQGRVTITADESTSTAYMELSSLTSEDTAVYYCARLYCSDGSCPFDYWGQGTLVTVSS	nan	nan	IGHV1-69*01,IGHV1-69D*01	IGHJ4*02	IGHD2-15*01	IGKV3-11	nan	ARLYCSDGSCPFDY	QRRSNWPPRLT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458083.1	nan
125	IML3547	ADI-62921	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTTGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGACTCCTCCAGCGCCAATAGTATCAACTGGGTGCGACAGGCCCCCGGACAAGGGCTTGAGTGGCTGGGAGGGATCATCCCTATCTTTCATACAACAAACTACGCACAGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACGAATCCACGAGCACAGCCTACATGGAGCTGAGTAGCCTGAGATCTGAGGACACGGCCATATATTACTGTGCGAGGCTATATTGTAGTGGAGGTAGCTGCCCCTATGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVQSGAEVKKPGSSVKVSCKASGDSSSANSINWVRQAPGQGLEWLGGIIPIFHTTNYAQKFQGRVTITADESTSTAYMELSSLRSEDTAIYYCARLYCSGGSCPYDYWGQGTLVTVSS	nan	nan	IGHV1-69*12	IGHJ4*02	IGHD2-15*01	IGKV3-11	nan	ARLYCSGGSCPYDY	QHRRNWPPALT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458430.1	nan
126	IML3547	ADI-62920	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTTGTGCAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGTCTCTGGATTCATCTTCAGTAGCTATGCTATGTACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAATCATATCATATGATGGAAGTAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGCGCTGAAGACACGGCTGTGTATTACTGTGCGAGACCTTATAGTGGGAACTACTTTTCCGCTTTTGATGTCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	QVQLVQSGGGVVQPGRSLRLSCAVSGFIFSSYAMYWVRQAPGKGLEWVAIISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLSAEDTAVYYCARPYSGNYFSAFDVWGQGTMVTVSS	nan	nan	IGHV3-30*04,IGHV3-30-3*03	IGHJ3*01	IGHD1-26*01	IGKV3-20	nan	ARPYSGNYFSAFDV	QQYGTSPT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458429.1	nan
126	Jennewein_CV2	CV2-8_	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTTCAACTGGTGGAAAGCGGCGGCGGTGTAGTTCAGCCCGGTCGATCTTTGAGGCTCTCTTGTGGAGCGAGCGGATTTATCTTTTCATCCTACGCTATGCACTGGGTGCGGCAAGCACCCGGAAAAGGACTGGAATGGGTGGCAGTTATATCATACGACGGGAATAACAAATACTATGCCGATTCTGTTAAAGGGAGGTTTACCATCTCAAGAGACAATTCCAAAAACACGTTGTACCTTCAAATGAATTCATTGAGAGCGGAAGACACAGCTGTCTATTACTGCGCGAGACCGTATTCAGGGACGTACTTTAGTGCATTCGACATTTGGGGACAGGGCACGATGGTCACTGTAAGTTCAG	QVQLVESGGGVVQPGRSLRLSCGASGFIFSSYAMHWVRQAPGKGLEWVAVISYDGNNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARPYSGTYFSAFDIWGQGTMVT	GACATAGTGATGACTCAAAGTCCTGACTCACTCGCCGTCTCACTGGGTGAAAGAGCGACAATTAACTGCAAAAGTTCTCAGAGCGTGCTCTACAGCTCTAACAACAAAAATTACCTGGCCTGGTACCAGTTGCAACCCGGCCAGCCTCCTAAACTCCTGATCTACTGGGCTAGCACCAGAGAAAGTGGCGTTCCTGACCGCTTTTCCGGGAGCGGAAGCGGTACGGACTTTACTCTGACGATTTCCTCATTGCAGGCGGAAGACGTAGCAGTGTATTATTGTCAGCAATACTACTCTATCCCTACCTTTGGTCAGGGAACAAAGGTCGAGATAAAA	DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQLQPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQY	IGHV3-30*14	IGHJ1*01	IGHD2/OR15-2a*01,IGHD2/OR15-2b*01	IGKV4-1*01	nan	ARPYSGTYFSAFDI	nan	nan	Jennewein et al. Cell Rep. 36:109353 (2021)	MW681628.1	MW681629.1
127	Jennewein_CV1	CV1-41	CV41	SARS-CoV-2	SARS-CoV	nan	SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTACAACTCGTCGAGAGCGGCGGTGGGGTAGTTCAACCAGGACGGTCACTGCGACTTTCATGCGCGGCAAGCGGGTTCACTTTTAGTAGTTACGCTATGCATTGGGTCCGACAAGCTCCTGGCAAAGGTTTGGAATGGGTCGCCGTGATCTCATACGACGGTTCTAACAAATACTATGCAGACTCCGTGAAAGGACGGTTCACTATTAGCCGAGATAATTCTAAGAACACGCTGTACTTGCAAATGAATAGTCTCAGGGCCGAAGATACTGCTGTCTATTATTGTGCGCGAACCAAGGGCGGTTCATATTTTGCCCCGTTTGATTACTGGGGACAAGGTACCTTGGTAACTGTGTCTTCA	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARTKGGSYFAPFDYWGQGTLVTVSS	GAAATTGTTATGACGCAGAGCCCTGCCACGCTTTCCGTAAGCCCAGGTGAGCGCGCGACGCTCAGTTGTCGAGCCTCCCAATCCGTCTCCTCAAACCTGGCATGGTACCAGCAAAAACCTGGTCAGGCTCCTCGGCTCCTCATTTACGGAGCATCAACCCGCGCTACCGGGATTCCCGCACGGTTTAGTGGGAGCGGGAGCGGAACCGAGTTTACTCTGACTATATCCTCTCTCCAGTCAGAAGACTTTGCGGTTTACTACTGCCAGCAGTATAATAATTGGCCACTTACATTTGGCGGTGGCACCAAAGTGGAAATCAAA	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPLTFGGGTKVEIK	IGHV3-30*04,IGHV3-30*07,IGHV3-30-3*03	IGHJ4*01,IGHJ4*03	IGHD3-9*01	IGKV3-15*01,IGKV3D-15*01	IGKJ3*01	ARTKGGSYFAPFDY	nan	nan	Jennewein et al. Cell Rep. 36:109353 (2021);Seydoux et al. Immunity 53:98-105.e5 (2020)	MT462515.1	MT462566.1
127	IML3549	ADI-63059	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAATACTTATGCTATGTACTGGGTCCGCCAGGCTCCAGGCAGGGGGCTGGAGTGGGTGTCACTTATATCATATGATGGAATCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAGCACCCTGAGAGCTGAGGACGCGGCTGTCTATTACTGTGCGAGAACTTATGGTGGAAGCTATTATGCCCCCTTTGACTACTGGGGCCAGGGAGCCCTGGTCACCGTCTCCTCA	EVQLVESGGGVVQPGRSLRLSCAASGFTFNTYAMYWVRQAPGRGLEWVSLISYDGINKYYADSVKGRFTISRDNSKNTLYLQMSTLRAEDAAVYYCARTYGGSYYAPFDYWGQGALVTVSS	nan	nan	IGHV3-30-3*01	IGHJ4*02	IGHD2-8*01	IGKV3-20	nan	ARTYGGSYYAPFDY	QQYGSSYT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458568.1	nan
128	Wang-PFZ12	PZF12_P1_IgG_D3-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCTCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTGGTGATTACTACTGGAATTGGATCCGCCAGCCCCCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGGTCACCTACTACAACCCGTCCCTCAAGAGTCGAGTTACCGTTTCACTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCACAGACACGGCCGTGTATTACTGTGCCACCGCCCCTCCTACGGTGACTACCGAACAGTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGDYYWNWIRQPPGKGLEWIGYIYYSGVTYYNPSLKSRVTVSLDTSKNQFSLKLSSVTATDTAVYYCATAPPTVTTEQFDYWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGCGGCCCCAGGACAGAAGGTCAGCATCTCCTGCTCTGGAAGCAGCTCCAACATTGGGAATAATTATGTATCCTGGTACCAGCAGCTCCCAGGAACAGCCCCCAAACTCCTCATTTATGACAATAATAAGCGACCCTCAGGGATTCCTGACCGATTCTCTGGCTCCAAGTCTGGCACGTCAGCCACCCTGGGCATCACCGGACTCCAGACTGGGGACGAGGCCGATTATTACTGCGGAACATGGGATAGTAGCCTGAGTGCTGGGGTGTTCGGCGGAGGGACCAAGCTGACCNTC	QSVLTQPPSVSAAPGQKVSISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSAGVFGGGTKLTX	IGHV4-30-4*01	IGHJ4*02	IGHD4-17*01	IGLV1-51*01	IGLJ3*02	ATAPPTVTTEQFDY	GTWDSSLSAGV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
128	Wang-MOD4	Mod4_P3_IgG_B1-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTGGTGATTACTACTGGAACTGGATCCGCCAGCACCCAGGGAAGGGCCTGGAGTGGATTGGGTACATTTATTACAGTGGGACCACCTACTACAACCCGTCCCTCAAGAGTCGAGTTACCATATCACTAGACACGTCTAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCGGACACGGCCGTGTATTTCTGTGCGACAGGCCCCCCTACAGTAACTACCGAAACCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGDYYWNWIRQHPGKGLEWIGYIYYSGTTYYNPSLKSRVTISLDTSKNQFSLKLSSVTAADTAVYFCATGPPTVTTETFDYWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGCGGCCCCAGGACAGAAGGTCACCATCTCCTGCTCTGGAAGCAGCTCCAACATTGGGAATAATTATGTATCCTGGTACCAGCACCTCCCAGGAACAGCCCCCAAACTCCTCATTTATGACAATAATAAGCGACCCTCAGGGATTCCTGACCGATTCTCTGGCTCCAAGTCTGGCACGTCAGCCACCCTGGGCATCACCGGACTCCAGACTGGGGACGAGGCCGATTATTACTGCGGAACATGGGATAGCAGCTCGAGTGCTGGAGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQHLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSSSAGVFGGGTKLTVL	IGHV4-31*03	IGHJ4*02	IGHD4-11*01,IGHD4-4*01	IGLV1-51*01	IGLJ3*02	ATGPPTVTTETFDY	GTWDSSSSAGV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
129	Wang-MOD3	C651	MOD3_P1_IgG_H6-P1369	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACTTTCAGTAATTATGGCATGTACTGGGTCCGCCAGGCTCCAGGAAAGGGGCTGGAGTGGGTGGCACTTATATCATATGATGGAAGTGATAAATACTATGCAGACTCCGTGAAGGGCCGAATCACCATCTCCAGAGACAATTCCAAGAACACCCTATATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATAACTGTGCGAAATGTTTCTACAGCTATGGTTACCCTTGTTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGMYWVRQAPGKGLEWVALISYDGSDKYYADSVKGRITISRDNSKNTLYLQMNSLRAEDTAVYNCAKCFYSYGYPCYYFDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCGCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCCGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCACCAATGTGATCTATGAGGATAACCAAAGACCCTATGGGGTCCCTGATCGGTTCTCTGGCTCCATTGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTGTGATAGCAACAACCTCTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSAPTNVIYEDNQRPYGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSCDSNNLWVFGGGTKLTVL	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGLV6-57*04	IGLJ3*02	AKCFYSYGYPCYYFDY	QSCDSNNLWV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
129	Cho-C016	C2230	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	AGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAAATTTCTACAGCTATGGTTACCAGGGTTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	VQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKNFYSYGYQGYYFDYWGQGTLVTVSS	CATCCGGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCGTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	IRMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLVTFGGGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	AKNFYSYGYQGYYFDY	QQYDNLVT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
130	Graham_P008	P008_100	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCGTCCGGACTCATCTTCAGTCACTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCATTTATACGGAATGATGGAACTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTCTATTACTGTGCGAAAGATGGGGGGTATTACTATGAAAGTAGTGGGTGGTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCTTCAG	EVQLLESGGGVVQPGGSLRLSCAASGLIFSHYGMHWVRQAPGKGLEWVAFIRNDGTNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDGGYYYESSGWFDYWGQGTLVTVSS	GAAATTGTGTTGACACAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAATCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACGGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATAAGCAGACTGCAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCCATGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKSGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLQPEDFAVYYCQQYGSSPMYTFGQGTKLEIK	IGHV3-30*02,IGHV3-30-5*02	IGHJ4*02	IGHD3-22*01	IGKV3-20*01	IGKJ2*01	AKDGGYYYESSGWFDY	QQYGSSPMYT	nan	Graham et al. Immunity 54:1276-1289.e6 (2021)	MW802465.1	MW802358.1
130	Cho-C016	C2234	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	AGGTGCAGCTGGTGGAGTCTGGGGGAGGCGAGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTAACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCATTTATACGGAATGATGGAAGTAACAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAGATGGAGGGTATTACTATGAGAGTAGTGGCTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	VQLVESGGGEVQPGGSLRLSCAASGLTFSSYGMHWVRQAPGKGLEWVAFIRNDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDGGYYYESSGYFDYWGQGTLVTVSS	CATCCGGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCTCCACAATTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	IRMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPPQFTFGPGTKVDIK	IGHV3-30*02,IGHV3-30-5*02	IGHJ4*02	IGHD3-22*01	IGKV1-33*01,IGKV1D-33*01	IGKJ3*01	AKDGGYYYESSGYFDY	QQYDNLPPQFT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
131	Wang-MOD8	MOD8_P2_IgG_E3-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCACCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTATGGCATACACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCACTTATATCATATGATGGAAGTAATGAATACTATACAGGCTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAAAGATTTGTATTACTATGGTTCGGGGAGTTATGTCTTTGACTTCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVHPGRSLRLSCAASGFTFSNYGIHWVRQAPGKGLEWVALISYDGSNEYYTGSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDLYYYGSGSYVFDFWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGGAACTTTTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCTCCGATCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDIRNFLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPPITFGQGTRLEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD3-10*01	IGKV1-33*01,IGKV1D-33*01	IGKJ5*01	AKDLYYYGSGSYVFDF	QQYDNLPPIT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
131	COV096	COV096_HC_43-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTATATTTCTGTGCGAAACAGTTATATTACTATGGTTCGGGGAGTTATGTCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYFCAKQLYYYGSGSYVFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTCGCAACTTTTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCTCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDIRNFLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD3-10*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	AKQLYYYGSGSYVFDY	QQYDNLPLT	nan	Robbiani et al. Nature 584:437-442 (2020);Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW293175.1	MW293630.1
132	Wheatley-CP63	PDI_223	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGGAGTCTGGGGGAGGCGCGGTCCAGCCTGGGAGGTCCCTGAGACTCTCTTGTGCAGCCTCTGGATTCACCTTCAGGAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAATGATATCATTTGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGTTGAGGACACGGCTGTGTATTACTGTGCGAAAGACTGGGACGACGCATACTACTTCTACTACTACATGGACATCTGGGGCAAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGAVQPGRSLRLSCAASGFTFRSYGMHWVRQAPGKGLEWVAMISFDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCAKDWDDAYYFYYYMDIWGKGTTVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCTCCCTGTCTGTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTCAGCAGTAATTACCTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTGGCTCATCCGTTTTCGGCGGAGGGACCAAGGTTGAGATCAAA	EIVLTQSPGSLSVSPGERATLSCRASQSVSSNYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGGSSVFGGGTKVEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ6*03	IGHD1-1*01,IGHD1-20*01	IGKV3-20*01	IGKJ4*01	AKDWDDAYYFYYYMDI	QQYGGSSV	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
132	IML3545	ADI-60525	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:NTD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAATAATAAATACTCTGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAATTGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAGACTGGGACGACTCCTTCTACTTCTACTACTACATGGACGTCTGGGGCAAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGNNKYSADSVKGRFTISRDNSKNTLYLQLNSLRAEDTAVYYCAKDWDDSFYFYYYMDVWGKGTTVTVSS	nan	nan	IGHV3-30*18,IGHV3-30-5*01	IGHJ6*03	IGHD1-1*01,IGHD1-20*01	IGKV3-20	nan	AKDWDDSFYFYYYMDV	QQYGSSLT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457856.1	nan
133	Graham_P008	P008_070	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAAGTCCCTGAGACTCTCCTGTGCAGCCTCGGGACTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAGAGGGATGGGGATACAGTTATGGTTCCTATTACTTCGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCTTCAG	QVQLVESGGGVVQPGKSLRLSCAASGLTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKEGWGYSYGSYYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCACCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCGCTCACTTTCGGCGGAGGGACCAAAGTGGATATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYHQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVDIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	AKEGWGYSYGSYYFDY	QQYDNLPLT	nan	Graham et al. Immunity 54:1276-1289.e6 (2021)	MW802443.1	MW802336.1
133	Wang-PFZ12	PZF12_P2_IgG_E4-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGCGGCGTGGTCCAGCCTGGGAGGTCTCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTCGCTATGGCATACACTGGGTCCGCCAGGCTCCGGGCAAGGGGCTGGAGTGGGTGGCAGTTGTATCATATGATGGAAGTGATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTCTATTACTGTGCGAAGTCGGGTTTTGGATACAGCTATGGCTACTACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFSRYGIHWVRQAPGKGLEWVAVVSYDGSDKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKSGFGYSYGYYYFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGTAACTATTTAAATTGGTATCAACAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCATCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTCTGATTATCTCCCGATCACCTTCGGCCAAGGGACACGACTGGAGATTAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTIISLQPEDIATYYCQQSDYLPITFGQGTRLEIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGKV1-33*01,IGKV1D-33*01	IGKJ5*01	AKSGFGYSYGYYYFDY	QQSDYLPIT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
134	Wang-C001	C001_P2_IgG_C11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGAAGCCTCTGGATTCACCTTCAGTAACTACGACATGCACTGGGTCCGCCAATCTACAGTAAAAGGGCTGGAGTGGGTCTCAGTTATTGGTACTGCTGGTGACACATACTATCCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGAGAATGCCAAGAACTCCTTGTATCTTCAAATGAACAGCCTGAGAGCCGGGGACACGGCTGTATATTACTGTGCAAGAGGGAACTTTGATAGTAGTGGTTATTACTCCAACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCEASGFTFSNYDMHWVRQSTVKGLEWVSVIGTAGDTYYPDSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARGNFDSSGYYSNFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGGAGTTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAACTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTATTACTGTCAACAGAGTTACAGTATCCCTCCGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQSIRSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSIPPLTFGGGTKVEIK	IGHV3-13*01	IGHJ4*02	IGHD3-22*01	IGKV1-39*01,IGKV1D-39*01	IGKJ4*01	ARGNFDSSGYYSNFDY	QQSYSIPPLT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
134	Wang-C003	C1227	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTACGACATGCACTGGGTCCGCCAAAGTACAGTAAAAGGTCTGGAGTGGGTCTCAGTTATTGGTACTGCTGATGATACATACTATCCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGAAAATGCCAAGAACTCCTTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCAAGAGGCGTCTTTGATAGTAGTGGTTTTTACTCCTCCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDMHWVRQSTVKGLEWVSVIGTADDTYYPDSVKGRFTISRENAKNSLYLQMNSLRAEDTAVYYCARGVFDSSGFYSSFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTATAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGGTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAACTCCTGATCTTTGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCGAGGTTCAGTGGCAGTGGCTCTGGGACAGATTTCACTCTCACCATCAGCGGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACATTACTCCCGGGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQMTQSPSSLSASIGDRVTITCRASQSISRYLNWYQQKPGKAPKLLIFAASSLQSGVPSRFSGSGSGTDFTLTISGLQPEDFATYYCQQSYITPGYTFGQGTKLEIK	IGHV3-13*01	IGHJ4*02	IGHD3-22*01	IGKV1-39*01,IGKV1D-39*01	IGKJ2*01	ARGVFDSSGFYSSFDY	QQSYITPGYT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
135	BG1	BG1-24	nan	SARS-CoV-2	SARS-CoV,MERS-CoV	SARS-CoV-2	SARS-CoV;MERS-CoV	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIISMFGIANNAQKFQGRLTITADTSTSTAYMELSSLRSEDTAVYYCAR	nan	EIVLTQSPGTLSLSPGERATLSCRASQSVGSGYLAWYQQRPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYAGSP	IGHV1-69*15	IGHJ4	nan	IGKV3-20*01	IGKJ5	ARGPYYYDSGGYYLDY	QQYAGSPRT	7M6I	Scheid et al. Cell 184:3205-3221.e24 (2021)	nan	nan
135	REGN_donor1	REGN10977	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATGCTATCACCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAAGGATCATCCCTATGTTTGGTATAGCAAACTACGCACAGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACAAATCCACGAGCACAGCCTACATGGAGGTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAACACCGTTTTACTATGATAGTAGTGGTTATTACCTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAITWVRQAPGQGLEWMGRIIPMFGIANYAQKFQGRVTITADKSTSTAYMEVSSLRSEDTAVYYCARTPFYYDSSGYYLDYWGQGTLVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCTTGCAGGGCCAGTCAGAGTGTTAGCAGCAACTACTTAGCCTGGTACCAGCAGAGTCCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTTTATTACTGTCAGCAGTATGTTAGGTCACCCCGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAA	EIVLTQSPGTLSLSPGERATLSCRASQSVSSNYLAWYQQSPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYVRSPRTFGQGTKVEIK	IGHV1-69*09,IGHV1-69*17	IGHJ4*02	IGHD3-22*01	IGKV3-20*01	IGKJ1*01	ARTPFYYDSSGYYLDY	QQYVRSPRT	nan	Hansen et al. Science 369:1010-1014 (2020)	nan	nan
136	Cho-C030	C1414	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCAATGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATTACAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCATCATATCAGTAGACACGTCCAAGAAGCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCCGTGTATTACTGTGCGAGACACTATGATAGTAGTGGTTATACGTACAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSETLSLTCNVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVIISVDTSKKQFSLKLSSVTAADTAVYYCARHYDSSGYTYNWFDPWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGCTCCAACATCGGGGCAGGTTTTGATGTACACTGGTACCAGCAGCTTCCAGGAACAGCCCCCAAACTCCTCATCTATGGTAACAGTAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAGCAGCCTGAGTAGTTTGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGFDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSSLVFGGGTKLTVL	IGHV4-59*08	IGHJ5*02	IGHD3-22*01	IGLV1-40*01	IGLJ3*02	ARHYDSSGYTYNWFDP	QSYDSSLSSLV	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
136	COV021	COVD21_P3_HC_C4-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATTACAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGAAGCTATGATAGTAGTGGTCTGAGTTACAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARSYDSSGLSYNWFDPWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGCTCCAACATCGGGGCAGGTTATGATGTACACTGGTACCAGCAGCTTCCAGGAACAGCCCCCAAACTCCTCATCTATGGTAACAGCAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAGCAGCCTGAGTGGTTATGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGYVVFGGGTKLTVL	IGHV4-59*01	IGHJ5*02	IGHD3-22*01	IGLV1-40*01	IGLJ2*01,IGLJ3*01	ARSYDSSGLSYNWFDP	QSYDSSLSGYVV	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293130.1	MW293585.1
137	CV05	HK_CV05-172	nan	SARS-CoV-2	nan	nan	nan	S:S1	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	CTGCAAACCCCGTGACATTCTCAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTGGTGATTACTACTGGAGTTGGATCCGCCAGCCCCCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCAGACACGGCCGTGTATTACTGTGCCAGACTGAGCATGACTACGGTGACTAGGGGCAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAGGGAGTCCATCCGCCCCACTTCCCCT	QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGDYYWSWIRQPPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARLSMTTVTRGNWFDPWGQGTLVTVSS	GCGTTTTATGACCCCCAGTCTCCATTCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGAGCATTAGCAGCTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCAGTTTGCAAAGTGGGGTCCCATCAAGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGTCTGCAACCTGAAGATTTTGCAACTTACTACTGTCAACAGAGTTACAGTACCCACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAACGAACTGTGGCTGCACCATCTGTCTTCATCTTCCCGCCATCTGATGAGCAGTTGAAATCTGGAACTGCCTCTGTTGTGTGCCTGCTGAATAACTTCTATCCCAGAGAGGCCAAAGTACAGTGGAAGGTGGATAACGCCCTCCAATCGGGTAATTCCCCGAGAGGCGGG	AFYDPQSPFSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTHTFGQGTKLEIK	IGHV4-30-4*01	IGHJ5*02	IGHD4-17*01	IGKV1-39*01,IGKV1D-39*01	IGKJ2*01	ARLSMTTVTRGNWFDP	QQSYSTHT	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
137	CV07	HL_CV07-137	nan	SARS-CoV-2	nan	nan	nan	S:S1	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	CTCCGCCAACCCCGGGTACATTCTGAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTGGTGATTACTACTGGAGTTGGATCCGCCAGCCCCCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCAGACACGGCCGTGTATTACTGTGCCAGACTGAGCATGACTACGGTGACTAGGGGCAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTTCCTCAGGGAGTTCTTCCGCCCCACTTCCCCCC	EVQLQESGPGLVKPSQTLSLTCTVSGGSISSGDYYWSWIRQPPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARLSMTTVTRGNWFDPWGQGTLVTV	CACTTATTAGTCCCAATTTCATTCTCCCTGGCTGTGTCTCTGGGCGAGAGGGCCAGCATCAACTGCAAGTCCAGCCAGAGTGTCCTATACAGCTCAAACAATAAGAAATAAAAGTCTGCTACCCGGGTCCTGGTCCCAGTCTGTGCTGACTCAGCCACCCTCAGCGTCTGGGACCCCCGGGCAGAGGGTCACCATCTCTTGTTCTGGAAGCAGCTCCAACATCGGAAGTAATTATGTATACTGGTACCAGCAGCTCCCAGGAACGGCCCCCAAACTCCTCATCTATAGGAATAATCAGCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCAGTGGGCTCCGGTCCGAGGATGAGGCTGATTATTACTGTGCAGCATGGGATGACAGCCTGAGTGGTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAGTCAGCCAAGGCTGCCACTCGGGCA	QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNYVYWYQQLPGTAPKLLIYRNNQRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDDSLSGWVFGGGTKLTVL	IGHV4-30-4*01	IGHJ5*02	IGHD4-17*01	IGLV1-47*01	IGLJ3*02	ARLSMTTVTRGNWFDP	AAWDDSLSGWV	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
138	Xie_mix	N12-11	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:NTD	SARS-CoV-2 RBD/NTD/S1/S2/N	B-cells;SARS-CoV-2 Human Patient	nan	QVQVVQSGAEVKKPGASVKVSCKVSGYTLIEISIHWVRQAPGKGLEWMGGFDPEAGETIYAQKFQGRVTMTEDTSTDTAYMEVSSLRSEDTAVYYCATGPAIAAAETNWFDLWGQGTLVTVSS	nan	QSALTQPASVSGSPGQSITISCTGTSSDVGSYNYVSWYQQHPGKAPKLMIYDVTKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTWVFGGGTKLTVL	IGHV1-24*01	IGHJ4	nan	IGLV2-14*05	IGLJ3	ATGPAIAAAETNWFDL	SSYTSSSTWV	7E7X	Cao et al. Cell Res. 31:732-741 (2021)	nan	nan
138	COSCA2	COVA2-25	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV,SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAAGTGCAGCTGGTGGAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGTTTCCGGATACACCCTCCCTGAATTATCCATGCACTGGGTGCGACAGACTCCTGGAAAAGGACTTGAGTGGATGGGAGGTTTTGATCCTGAAGATGGTGAAACAATCTACGCACAGAAGTTCCAGGGCAGAGTCACCATGACCGAGGACACATCTACAGACACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCAACAGGTCCAACCATAGCAGCAGCTGCCACGAACTGGTTCGACCCCGGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGAEVKKPGASVKVSCKVSGYTLPELSMHWVRQTPGKGLEWMGGFDPEDGETIYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATGPTIAAAATNWFDPGGQGTLVTVSS	CAGCCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAACACCCAGGCAAAGCCCCCAAACTCATGATTTATGATGTCAGTAATCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAGGTCTGGCGACACGGCCTCCCTGACCATCTCTGGGCTCCAGGCTGAGGACGAGGCTGATTATTACTGCAGCTCATATACAAGCAGCAGCACTTGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QPVLTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSRSGDTASLTISGLQAEDEADYYCSSYTSSSTWVFGGGTKLTVL	IGHV1-24*01	IGHJ5*02	IGHD6-13*01	IGLV2-14*03	IGLJ3*02	ATGPTIAAAATNWFDP	SSYTSSSTWV	nan	Brouwer et al. Science 369:643-650 (2020)	nan	nan
139	Tong_G32	G32L7	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:NTD	SARS-CoV-2 spike (and spike minus RBD)	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCTCGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCAGCTATGCCATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTAGTGGTAGTGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGGTTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTATATTACTGTGCGAAGGCCGAACGTATTACTATGTTAGTAGTGGTTACCTTGATTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLLESGGGSVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSVISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKAERITMLVVVTLIDYWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGCGGCCCCAGGACAGAAGGTCACCATCTCCTGCTCTGGAAGCAGCTCCAACATTGGGAATAATTATGTATCCTGGTACCAGCAGCTCCCAGGAACAGCCCCCAAACTCCTCATTTATGACAATAATAAGCGACCCTCAGGGATTCCTGACCGATTCTCTGGCTCCAAGTCTGGCACGTCAGCCACCCTGGGCATCACCGGACTCCAGACTGGGGACGAGGCCGATTATTACTGTGGAACATGGGATAGCAGCCTGAGTGCTGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTA	QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSAVVFGGGTKLTVL	IGHV3-23*01,IGHV3-23D*01	IGHJ4*02	IGHD3-22*01	IGLV1-51*01	IGLJ2*01,IGLJ3*01	AKAERITMLVVVTLIDY	GTWDSSLSAVV	nan	Tong et al. Cell 184:4969-4980.e15 (2021)	MW718375.1	MW718527.1
139	Crowe_mix	COV2-2293	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV,SARS-CoV-2	S:NTD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGCAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGGAACTATGCCATGAGTTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTACCACATACTACGCAGACTCCGTGAAGGGCCGGTTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTATATTACTGCGCGAAAAACGAGCGGATTACTATGCTAGTAGTAGTTACCCTCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCC	EVQLLQSGGGLVQPGGSLRLSCAASGFTFRNYAMSWVRQAPGKGLEWVSAISGSGGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKNERITMLVVVTLFDYWGQGTLVTVSS	CAGTCTGTGTTGACGCAGCCGCCCTCAGTGTCTGCGGCCCCAGGACAGAAGGTCACCATCTCCTGCTCTGGAAGCAGCTCCAACATTGGAAATAATTATATATCCTGGTACCAGCAACTCCCAGGAACAGCCCCCAAACTCCTCATTTATGACAATAATAAGCGACCCTCAGGGATTCCTGACCGATTCTCTGGCTCCAAGTCTGGCACGTCAGCCACCCTGGGCATCACCGGACTCCAGACTGGGGACGAGGCCGATTATTACTGCGGAACATGGGATAGCAGCCTGAGTGCTGTGGTTTTCGGCGGAGGGACCAAGCTGACCGTCCTA	QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYISWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSAVVFGGGTKLTVL	IGHV3-23*01,IGHV3-23D*01	IGHJ4*02	IGHD3-22*01	IGLV1-51*01	IGLJ2*01,IGLJ3*01	AKNERITMLVVVTLFDY	GTWDSSLSAVV	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665613.1	MT665226.1
140	Wang-C004	C004_P2_IgG_G9-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACAAACTACGCAGACTCCGTGAAGGGCCGATTCACCGTCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCGACGTATTGGGATACCCTTCTACTACTACTATATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTNYADSVKGRFTVSRDNSKNTLYLQMNSLRAEDTAVYYCARDRRIGIPFYYYYMDVWGQGTTVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCAGCTACTTAGCCTGGTACCAGCAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTAGCTCACCGGGACTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPGLTFGGGTKVEIK	IGHV3-53*01	IGHJ6*02,IGHJ6*03	IGHD5-18*01,IGHD5-5*01	IGKV3-20*01	IGKJ4*01	ARDRRIGIPFYYYYMDV	QQYGSSPGLT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
140	IML3548	ADI-63032	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGACTGGAGGAGGCTTGATCCAGCCGGGGGGGTCCCTGAGACTCTCTTGTGCAGCCTCTGGGTTCAACGTCAATGATAACTACATGAGTTGGGTCCGTCAGGCGCCAGGGAAGCGGCTGCAGTGGGTCTCAGTAATGTTTGCCGGTGGTAGCACAGACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCTAGAGACAATTCCAAGAACACGGTGTATCTTCAAATGAACAGCCTGAGAGTCGACGACACGGCCGTGTATTATTGTGTGAGAGATCGGCGGATCGGCAACCCGTTCCACTACTACTACATGGACGTCTGGGGCAAAGGGACCACGGTCACCGTCTCCTCA	EVQLVETGGGLIQPGGSLRLSCAASGFNVNDNYMSWVRQAPGKRLQWVSVMFAGGSTDYADSVKGRFTISRDNSKNTVYLQMNSLRVDDTAVYYCVRDRRIGNPFHYYYMDVWGKGTTVTVSS	nan	nan	IGHV3-53*02	IGHJ6*03	nan	IGKV3-20	nan	VRDRRIGNPFHYYYMDV	QRHGSSPT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458541.1	nan
141	IML3558	ADI-63198	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCGTGTCCCTCACCTGTACTGTCTCTGGTGGCTCCATCACTGATTACTACTGGAGCTGGATCCGGCAGGCCCCAGGGAAGGGACTGGAGTGGATTGGCTATATCTATTACAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCACATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGCGCCATCTGTATGATAGTAGTGGTTATTACTACGATGCTTTTGATATGTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	EVQLQESGPGLVKPSETVSLTCTVSGGSITDYYWSWIRQAPGKGLEWIGYIYYSGSTNYNPSLKSRVTTSVDTSKNQFSLKLSSVTAADTAVYYCARHLYDSSGYYYDAFDMWGQGTMVTVSS	nan	nan	IGHV4-59*01	IGHJ3*02	IGHD3-22*01	IGKV3-20	nan	ARHLYDSSGYYYDAFDM	QQYGSSSWT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458707.1	nan
141	IML3546	ADI-62840	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGCAGGGACTGGAGTGGATTGGGTATGTCTATTACAGTGGGAGCACCAACTCCAACCCCTCCCTCAAGAGTCGAGTCACCATTTCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGACACTACTATGATAGTAGTGGTTATTACTATGATGCTTTTGATATCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGQGLEWIGYVYYSGSTNSNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARHYYDSSGYYYDAFDIWGQGTTVTVSS	nan	nan	IGHV4-59*01	IGHJ3*02	IGHD3-22*01	IGKV3-20	nan	ARHYYDSSGYYYDAFDI	QQYGSSLLT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458348.1	nan
142	CV05	HK_CV05-148	nan	SARS-CoV-2	nan	nan	nan	S:S1	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	TTCTGCAAACCCGGTGTACATTCCTGAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGGCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCTGTGTATTACTGTGCGAGACAGAGGACCCATACGATTTTTGGAGTGGTTGTACACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAGCCTCCACCAAGGGCCCATCGGTCTTCCCCCTGGCACCCTCCTCCAAGAGCACCTCTGGGGCACAAGCGGCCGGCGGA	EVQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARQRTHTIFGVVVHFDYWGQGTLVTVSS	AGGCCCATTCTCCCTGGCTGTGTCTCTGGGCGAGAGGGCCACCATCAACTGCAAGTCCAGCCAGAGTGTTTTATACAGCTCCAACAATAAGAACTACTTAGCTTGGTACCAGCAGAAACCAGGACAGCCTCCTAAGCTGCTCATTTACTGGGCATCTACCCGGGAATCCGGGGTCCCTGACCGATTCAGTGGCAGCGGGTCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGGCTGAAGATGTGGCAGTTTATTACTGTCAGCAATATTATAGTACTCCCTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAACGAACTGTGGCTGCACCATCTGTCTTCATCTTCCCGCCATCTGATGAGCAGTTGAAATCTGGAACTGCCTCTGTTGTGTGCCTGCTGAATAACTTCTATCCCAGAGAGGCCAAAGTACAGTGGAAGGTGGATAACGCCCTCCAATCGGTATGCAGAGATCCCA	GPFSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPWTFGQGTKVEIK	IGHV4-39*01	IGHJ4*02	IGHD3-3*01	IGKV4-1*01	IGKJ1*01	ARQRTHTIFGVVVHFDY	QQYYSTPWT	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
142	CV24	HL_CV24-322	nan	SARS-CoV-2	nan	nan	nan	S:S1	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	CTTCCCCCAAACCCCCGGTTCATTCTGAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGGCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCTGTGTATTACTGTGCGAGACAGAGGACCCATACGATTTTTGGAGTGGTTGTACACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAGCCTCCACCAAGGGCCCATCGGTCTTCCCCCTGCACCTCCTCCAAGAGCACTCTGGGGCACAGCGCCTGCGGTA	EVQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARQRTHTIFGVVVHFDYWGQGTLVTVSS	CCACCATCCTCCCGTCCTTTTCAGGAGGAAAAGGCAACGATACCCTGCAGGTTCACTCGGAGTGCAGGCACCAGCATAACCTAGTATCAGCATCTGCTACCCCGATCCTGGGCCCAGTCTGTGCTGACTCAGCCACCCTCGGTGTCAGTGTCCCCAGGACAGACGGCCAGGATCACCTGCTCTGGAGATGCATTGCCAAAGCAATATGCTTATTGGTACCAGCAGAAGCCAGGCCAGGCCCCTGTGCTGGTGATATATAAAGACAGTGAGAGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAGCTCAGGGACAACAGTCACGTTGACCATCAGTGGAGTCCAGGCAGAAGACGAGGCTGACTATTACTGTCAATCAGCAGACAGCAGTGGTACTTATGACGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAGGTCAGCCCAAGCCACCCCCATCCT	QSVLTQPPSVSVSPGQTARITCSGDALPKQYAYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSSGTYDVFGTGTKVTVL	IGHV4-39*01	IGHJ4*02	IGHD3-3*01	IGLV3-25*03	IGLJ1*01	ARQRTHTIFGVVVHFDY	QSADSSGTYDV	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
143	Wang-C001	C001_P2_IgG_C10-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCAGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGATTTGCGGGACGAGGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLRDEVWGQGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAAGTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCTCGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISKYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPRTFGQGTKVEIK	IGHV3-66*01	IGHJ6*02	nan	IGKV1-33*01,IGKV1D-33*01	IGKJ1*01	ARDLRDEV	QQYDNLPRT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
143	PT28	282E5	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	nan	nan	nan	IGHV3-66	nan	nan	IGKV1-33	nan	ARDLRDWV	HQYDNLPRT	nan	Zhou et al. Cell Rep. 35:109109 (2021)	nan	nan
144	Wheatley-CP63	PDI_283	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTTCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTATTGCTGGAACTGGATCCGGCAGATCCCAGGGAAGGGACTGGAGTGGATTGGATATATCTACTCCAGTGGGACCACCAAGTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGCAGACACGTCCAAGAACCAATTCTCCCTGGAACTGAGCTCTGTGACCGCTGCGGACACGGCCGTCTATTACTGTGCGAGAGCTCCGGGCGCATCGTATAGCAGTGGCTGGTACCACTATTATTATTACATGGACGTCTGGGGCAAAGGGACCACGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCTVSGGSISSYCWNWIRQIPGKGLEWIGYIYSSGTTKYNPSLKSRVTISADTSKNQFSLELSSVTAADTAVYYCARAPGASYSSGWYHYYYYMDVWGKGTTVTVSS	GAAATTGTGTTGACGCAGTCTCCAGGCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCATGCAGGGCCAGTCAGAGTGTTGCCAGCAGGTATTTAGCGTGGTACCAGCAGAAACCAGGCCAGGCTCCCAGGCTCTTCATGTATGGTGCATCCAGCAGGGCCACGGGCATCCCAGACAGGTTCACGGGCAGTGGGTTTGGGACAGATTTCACTCTCACCATCAGCAGCCTGGAGCCTGAAGATATTGCAGTTTATTACTGTCAGCAATATGGTAACTCCCCCACGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAA	EIVLTQSPGTLSLSPGERATLSCRASQSVASRYLAWYQQKPGQAPRLFMYGASSRATGIPDRFTGSGFGTDFTLTISSLEPEDIAVYYCQQYGNSPTWTFGQGTKVEIK	IGHV4-59*01	IGHJ6*03	IGHD6-19*01	IGKV3-20*01	IGKJ1*01	ARAPGASYSSGWYHYYYYMDV	QQYGNSPTWT	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
144	Jennewein_CV3	CV3-37	nan	SARS-CoV-2	nan	nan	nan	S:Unk	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGCTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATTACAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACTATATCAGCAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGAGCTCCTGGGGCTACGTATAGCAGTGGCTGGTACTACTACTACTACTACATGGACGTCTGGGGCAAAGGGACCACGGTCACCGTCTCCTCA	QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISADTSKNQFSLKLSSVTAADTAVYYCARAPGATYSSGWYYYYYYMDVWGKGTTVTVSS	GATATTGTGATGACTCAGTCTCCACTCTCCCTGCCCGTCACCCCCGGAGAGCCGGCCTCCATCTCCTGCAGGTCTAGTCAGAGCCTCCTGCATAGTAATGGATACAACTATTTGGATTGGTACCTGCAGAAGCCAGGGCAGTCTCCACAGCTCCTGATCTATTTGGGTTCTAATCGGGCCTCCGGGGTCCCTGACAGGTTCAGTGGCAGTGGATCAGGCACAGATTTTACACTGAAAATCAGCAGAGTGGAGGCTGAGGATGTTGGGGTTTATTACTGCATGCAAGCTCTACAAACTCCTTTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAA	DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPFTFGPGTKVDIK	IGHV4-59*01	IGHJ6*03	IGHD6-19*01	IGKV2-28*01,IGKV2D-28*01	IGKJ3*01	ARAPGATYSSGWYYYYYYMDV	MQALQTPFT	nan	Jennewein et al. Cell Rep. 36:109353 (2021)	MW681576.1	MW681604.1
145	COV021	COVD21_P1_HC_G6-p1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATGCTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAGGGATCATCCCTATCTTTTATACAGCAAACTACGCACAGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACAAATCCACGAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGATGAAGGATATTGTAGTGGTGGTAGCTGCTACGGCTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFYTANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARDEGYCSGGSCYGYYYGMDVWGQGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCCATGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPMYTFGQGTKLEIK	IGHV1-69*06	IGHJ6*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ2*01	ARDEGYCSGGSCYGYYYGMDV	QQYDNLPMYT	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293235.1	MW293690.1
145	IML3548	ADI-60717	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGTAAGGCTTCTGGAAACACTTTCAGCAACTACGCAATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAGGGATCATCCCTATCTTTGGTACAACAAACTACGCACAGAAGTTACAGGGCAGAGTCACGATTACCGCGGACGAACCCACGAGCACAACCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTAGGATATTGTAGTGGTGATAGCTGCTTCGACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLVQSGAEVKKPGSSVKVSCKASGNTFSNYAISWVRQAPGQGLEWMGGIIPIFGTTNYAQKLQGRVTITADEPTSTTYMELSSLRSEDTAVYYCARDLGYCSGDSCFDYYYGMDVWGQGTTVTVSS	nan	nan	IGHV1-69*01,IGHV1-69D*01	IGHJ6*02	IGHD2-15*01	IGKV3-11	nan	ARDLGYCSGDSCFDYYYGMDV	QQRSNWPPALT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457986.1	nan
146	VRC_SARS1	DH1061-1	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV-2	S:NTD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV Human Patient	nan	QVQLVQSGAEVKKPGSSVKVSCKASGGTFRTYAINWVRQAPGQGLEWMGGIIPLFGTPSYPRSYQGRVTITADESTSTAFLTLNSLRSDDTAVYYCARDDGKMNFGSAPWDFFHSWGQGTLVTVSS	nan	EIVLTQSPGTLSLSPGQRATLSCRASQSVSSNYLAWFQQKPGQAPRLLIYGASSRATGIPARFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPGITFGQGTRLEIK	IGHV1-69*01	IGHJ4	nan	IGKV3-20*01	IGKJ5	ARDDGKMNFGSAPWDFFHS	QQYGSSPGIT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
146	Li_SARS2_26	H026164+K023917	nan	SARS-CoV	SARS-CoV-2,MERS-CoV	nan	nan	S:non-RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV Human Patient	nan	QVQLVQSGAEVKKPGSSVKVSCKASGGTFRTYAINWVRQAPGQGLEWMGGIIPLFGTPSYPRSYQGRVTITADESTSTAFLTLNSLRSDDTAVYYCARDDGKMNFGSAPWDFFHSWGQGTLVTVSS	nan	EIVLTQSPGTLSLSPGQRATLSCRASQSVSSNYLAWFQQKPGQAPRLLIYGASSRATGIPARFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPGITFGQGTRLEIK	IGHV1-69*01	IGHJ5	nan	IGKV3-20*01	IGKJ5	ARDDGKMNFGSAPWDFFHS	QQYGSSPGIT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
147	Yu_Patient	4B7	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASGFPFSSYAMSWVRQAPGKGLEWVSAITGSGGSTYYADSVKGRFTISRDNSKNTLYLHMNSLRAEDTAVYYCAKDDYGDYVLGAFDIWGQGTTVTVSS	nan	QSALTQPASVSGSPGQSITISCTGTSSDVGTYKFVSWYQQHPGKAPKLMIYEGSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSTLVFGGGTKLTVL	IGHV3-23*04	IGHJ3	nan	IGLV2-23*01	IGLJ3	AKDDYGDYVLGAFDI	CSYAGSSTLV	nan	Patent: CN111732655A	nan	nan
147	Wang-MOD11	Mod11_P1_IgG_D8-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTTAGCACCTATGCCATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGCTATTAGTGGTAGTGGTGGTAGCACAAACTACGCAGACTCCGTGAAGGGCCGGTTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTATATTACTGTGCGAAAGACGACTACGGTGACTACGTTTTGGGCGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLLESGGGLVQPGGSLRLSCAASGFTFSTYAMSWVRQAPGKGLEWVSAISGSGGSTNYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDDYGDYVLGAFDIWGQGTMVTVSS	CAGTCTGTGCTGACTCAGCCTCCCTCCGCGTCCGGGTCTCCTGGACAGTCAGTCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAGCACCCCGGCAAAGCCCCCAAACTCATGATTTATGAGGTCAGTAAGCGGCCCTCAGGGGTCCCTGATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCGTCTCTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCAGCTCATATGCAGGCAGCAACAATTTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPPSASGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYAGSNNLVFGGGTKLTVL	IGHV3-23*01,IGHV3-23D*01	IGHJ3*02	IGHD4-17*01	IGLV2-8*01	IGLJ2*01,IGLJ3*01	AKDDYGDYVLGAFDI	SSYAGSNNLV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
148	Wheatley-CP63	PDI_227	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAAGTTTCCTGCAAGGCATCTGGATACACCTTCACCAGCTACTATATGCACTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAGTAATCAACCCTAGTGCTGGTAGCACAAGCTCCGCACAGAAGTTCCAGGGCAGAGTCACCATGACCACGGACACGTCCACGAGCACAGTCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGATGAGGTACTAATACCAGCTGCTAGGGCCTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGVINPSAGSTSSAQKFQGRVTMTTDTSTSTVYMELSSLRSEDTAVYYCARDEVLIPAARAFDIWGQGTMVTVSS	GAAATTGTGTTGACACAGTCTCCAGCCTCCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCACCTACTTGGCCTGGTACCAACAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGATGCATCCAACAGGGCCACTGGCATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGCCTAGAGCCTGAAGATTTCGCAGTTTATTACTGTCAGCACCGTAGCAACTGGCCTCCGTTCACCTTCGGCCAAGGGACGCGACTGGAGATTAAA	EIVLTQSPASLSLSPGERATLSCRASQSVSTYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQHRSNWPPFTFGQGTRLEIK	IGHV1-46*01	IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-11*01	IGKJ5*01	ARDEVLIPAARAFDI	QHRSNWPPFT	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
148	Wang-C001	C1257	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTTTCCTGCAAGGCATCTGGATACACCTTCACCACCTACTACATCCACTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGATTGATCAACCCTGATGCTGCTAGCACAACCTACGCACAGAAGTTCCAGGGCAGAGTCACCATGACCACAGACACGTCCACGAGCACAGTCTACATGGAACTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTTCTGTGCGAGAGATGAAGTCCTAATACCAGCTGCTAGAGCCCTTGACTACTGGGGCCAGGGATCCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGASVKVSCKASGYTFTTYYIHWVRQAPGQGLEWMGLINPDAASTTYAQKFQGRVTMTTDTSTSTVYMELSSLRSEDTAVYFCARDEVLIPAARALDYWGQGSLVTVSS	GAAATTGTGTTGACACAGTCTCCAGCCACCCTGTCTTTGTCCCCAGGGGAAAGGGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCTACTTAGCCTGGTACCAACAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGATGCATCCAACAGGGCCACTGGCATCCCAGGCAGGTTCAGTGGCAGTGGGTCTGGGACAGAGTTCACTCTCACCATCAGCAGCCTAGAGCCGGAAGATTTTGCAGTCTATTACTGTCAGCAGCGTAGCAACTGGCCTCGGATATTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPGRFSGSGSGTEFTLTISSLEPEDFAVYYCQQRSNWPRIFTFGPGTKVDIK	IGHV1-46*01	IGHJ4*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV3-11*01	IGKJ3*01	ARDEVLIPAARALDY	QQRSNWPRIFT	nan	Cho et al. Nature (2021) DOI: 10.1038/s41586-021-04060-7	nan	nan
149	Li_SARS2_26	H026349+K024023	nan	SARS-CoV-2	SARS-CoV,MERS-CoV,OC43,HKU1,NL63	nan	nan	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPKKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREGAAANTHGWFDPWGQGTLVTVSS	nan	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPITFGQGTRLEIK	IGHV3-53*01	IGHJ5	nan	IGKV1-9*01	IGKJ5	AREGAAANTHGWFDP	QQLNSYPPIT	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
149	Wang-MOD3	MOD3_P2_IgG_C12-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGCTATGTCTGGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGAAGGGGCAGCAGCTAATACATGGGGCTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSAMSGGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREGAAANTWGWFDPWGQGTLVTVSS	GACATCCAGTTGACCCAGTCTCCATCCTTCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGGGCATTAGCAGTTATTTAGCCTGGTATCAGCAAAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATGCTGCATCCACTTTGCAAAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACAATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGCTTAATAGTTACCCTCGAGGGTGTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPRGCFGPGTKVDIK	IGHV3-53*01	IGHJ5*02	IGHD6-13*01	IGKV1-9*01	IGKJ3*01	AREGAAANTWGWFDP	QQLNSYPRGC	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
150	IML3549	ADI-63053	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTCCAGCTGGTACAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTATCCTGCAAGGCATCTGGATACACCTTCACCAACTACTATATGCAGTGGGTGCGGCAGGCCCCTGGACAAGGGCTTCAGTGGATGGGAATACTCAACCCTGATGGTGGTAGCACGACCTACGCACAGAAGTTCCAGGGCAGAGTCACCATGACCAGCGACACGTCCACGAGCACAGTCTACATGGAGCTGAGCAGCCTGACATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGGCGGGATAGTGCCATCTGCCAGTGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYYMQWVRQAPGQGLQWMGILNPDGGSTTYAQKFQGRVTMTSDTSTSTVYMELSSLTSEDTAVYYCARGGIVPSASDAFDIWGQGTMVTVSS	nan	nan	IGHV1-46*01	IGHJ3*02	IGHD1-26*01,IGHD3-22*01,IGHD5-12*01	IGKV3-20	nan	ARGGIVPSASDAFDI	QQYGYSSGYT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458562.1	nan
150	Wang-C004	C004_P2_IgG_C4-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCATCAGTGAAGGTTTCTTGTAAGGCTTCTGGAAACACCTTCACCCACTACTATATGCACTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAATAATCAACCCTAGTGGTGGTAGCACAAGCTACGCACAGAAATTCCAGGGCAGAGTCACCATGACCAGTGACACGTCCACGAGCACAGTCTACATGGAACTGAGCAGCCTGAGATTTGAGGACACGGCCGTGTATTACTGTGCGAGAGGGGGGATAGTACCCTCTGCCAGTGATGCTTTTGATATCTGGGGCCAAGGGACAATGGTCTCCGTCTCTTCAG	QVQLVQSGAEVKKPGASVKVSCKASGNTFTHYYMHWVRQAPGQGLEWMGIINPSGGSTSYAQKFQGRVTMTSDTSTSTVYMELSSLRFEDTAVYYCARGGIVPSASDAFDIWGQGTMVSVSS	GACATCCAGATGACCCAGTCTCCTTCCACCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCCAGTCAGAGTATTAGTAACTGGTTGGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTATAAGGCATCTAGTTTAGAGAGTGGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACCATCAGCAGCCTGCAGCCTGATGATTTTGGAACTTTTTACTGCCAACAGTGTAACAGTTTTGCAGGGTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	DIQMTQSPSTLSASVGDRVTITCRASQSISNWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFGTFYCQQCNSFAGYTFGQGTKLEIK	IGHV1-46*01	IGHJ3*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV1-5*03	IGKJ2*01	ARGGIVPSASDAFDI	QQCNSFAGYT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
151	IML3550	ADI-63142	nan	SARS-CoV-2,SARS-CoV	nan	SARS-CoV	SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGCAATCTGGGGCTGAGGTGAAGAATCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATGCTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAGGGATCATCCCTATCTTTGGTACAGCAAACTACGCACAGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACGAATCCACGAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTTCTGTGCGCGAGTTGACGCTTATGATAGTAGTGGTTATTACAATGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVQSGAEVKNPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYFCARVDAYDSSGYYNDYWGQGTLVTVSS	nan	nan	IGHV1-69*01,IGHV1-69D*01	IGHJ4*02	IGHD3-22*01	IGKV3-11	nan	ARVDAYDSSGYYNDY	QQRSNWPPRLT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458651.1	nan
151	COSCA1	COVA1-07	nan	SARS-CoV,SARS-CoV-2	nan	nan	SARS-CoV,SARS-CoV-2	S:non-RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGGTGGAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCTTGCAAGGCTTCTGGAGGCACCCTCAGCAGCTATGCTATCACCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGGTGGGAGGGATCATCCCTATCTTTGGTACAGCAAACTACGCACAGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACGAATCCACGAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGTAGGGGCCTATGATAGTAGTGGTTATTCCAATGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGAEVKKPGSSVKVSCKASGGTLSSYAITWVRQAPGQGLEWVGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARVGAYDSSGYSNDYWGQGTLVTVSS	GACATCCAGTTGACCCAGTCTCCAGCCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGCTACTTAGCCTGGTACCAACAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGATGCATCCAACAGGGCCACTGGCATCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGCCTAGAGCCTGAAGATTTTGCAGTTTATTACTGTCAGCAGCGTAGCAATTGGCCTCCGAGGGTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAAC	DIQLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPRVTFGGGTKVEIK	IGHV1-69*01,IGHV1-69D*01	IGHJ4*02	IGHD3-22*01	IGKV3-11*01	IGKJ4*01	ARVGAYDSSGYSNDY	QQRSNWPPRVT	nan	Brouwer et al. Science 369:643-650 (2020)	MT599826.1	MT599910.1
152	Graham_P008	P008_064	nan	SARS-CoV-2	SARS-CoV	nan	SARS-CoV-2	S:NTD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAATCTGGGGGAGGCCTGGTCAAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAGCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGCCTCATCCATTAGTAGTAATAGTAGTTGCATATACTACGCAGACTCAGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCCCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTCTATTACTGTGCGAGTGGGGAGCACAATTACTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCATCTCCTCA	EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWASSISSNSSCIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCASGEHNYYYYYGMDVWGQGTTVTISS	GATATTGTGATGACCCAGTCTCCACTCTCCCTGGCCGTCACCCCTGGAGAGCCGGCCTCCATCTCCTGCAGGTCTAGTCAGAGCCTCCTGCATAGTGATGGATACAACTATTTGGATTGGTACCTGCAGAAGCCAGGGCAGTCTCCACAGCTCCTGACCTATTTGGGTTCTAATCGGGCCTCCGGGGTCCCTGACAGGTTCAGTGGCAGTGGATCAGGCACAGATTTTACACTGAAAATCAGCAGAGTGGAGGCTGAAGATGTTGGGGTTTATTACTGCATGCAAGCTCTACAAACTTCGATCACCTTCGGCCAAGGGACACGACTGGAGATCAAAC	DIVMTQSPLSLAVTPGEPASISCRSSQSLLHSDGYNYLDWYLQKPGQSPQLLTYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTSITFGQGTRLEIK	IGHV3-21*01	IGHJ6*02	IGHD1-26*01,IGHD3-10*01,IGHD3-10*02	IGKV2-28*01,IGKV2D-28*01	IGKJ5*01	ASGEHNYYYYYGMDV	MQALQTSIT	nan	Graham et al. Immunity 54:1276-1289.e6 (2021)	MW802439.1	MW802332.1
152	IML3549	ADI-57820	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:NTD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAACCTCTGGATTCATCTTCAGTGACTATGCTATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGCAATAAATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCTGAGGACACGGCTGTCTATTACTGTGCGAGTGGTGGTCACTATTACTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGVVQPGRSLRLSCATSGFIFSDYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCASGGHYYYYYYGMDVWGQGTTVTVSS	nan	nan	IGHV3-30-3*01	IGHJ6*02	IGHD2-21*02	IGKV2D-28	nan	ASGGHYYYYYYGMDV	MQALQTPRT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457696.1	nan
153	CV07	HL_CV07-222	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	TCTGCAAACCCCGGGTACATTCCGAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATACACCTTCACCGACTACTATGTCCACTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGATGGATCAACCCTATTAGTGGTGGCACAAACTATGCACAGAAGTTTCAGGGCAGGGTCACCATGACCAGGGACACGTCCATCAGCACAGCCTACATGGAGCTGAGCAGGCTGAGATCTGACGACACGGCCGTGTATTACTGTGCGAGAGGGCCGTATTACTATGATAGTAGTGGTTCCTTGGGTGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAGCCTCCACCAAGGGCCCATCGGTCTTCCCCCTGGCACCCTCCTCCAAGAGCACCTCTGGGCACAGCGACATTGTCTTG	EVQLVQSGAEVKKPGASVKVSCKASGYTFTDYYVHWVRQAPGQGLEWMGWINPISGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGPYYYDSSGSLGAFDIWGQGTMVTVSS	TCTGCTACCCCGTGTCCTGGTCCCAGTCTGTGCTGACTCAGCCTGCCTCCGTGTCTGGGTCTCCTGGACAGTCGATCACCATCTCCTGCACTGGAACCAGCAGTGATGTTGGGAGTTATAACCTTGTCTCCTGGTACCAACAGCACCCAGGCAAAGCCCCCAAACTCATGATTTATGAGGGCAGTAAGCGGCCCTCAGGGGTTTCTAATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACAATCTCTGGGCTCCAGGCTGAGGACGAGGCTCATTATTACTGCTGCTCATATGCAGGTGGTAGCACTTCGTATGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAGGTCAGCCAAGCACCCTACTGAAAAA	QSVLTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEGSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEAHYYCCSYAGGSTSYVFGTGTKVTVL	IGHV1-2*02	IGHJ3*02	IGHD3-22*01	IGLV2-23*01,IGLV2-23*03	IGLJ1*01	ARGPYYYDSSGSLGAFDI	CSYAGGSTSYV	nan	Kreye et al. Cell 183:1058-1069 (2020)	MW002771.1	MW002789.1
153	IML3547	ADI-62196	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATACACCTTCACCGGCTACTATATGCACTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGATGGATCAACCCTAACAGTGGTGGCACAAACTATGCACAGAAGTTTCAGGGCAGGGTCACCATGACCAGGGACACGTCCATCAGCACAGCCTACATGGAGCTGAGCAGGCTGAGATCTGACGACACGGCCGTGTATTACTGTGCGAGAGGGCCGTATTACTATGATAGTAGTGGTTCCCGTGGCGCTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	EVQLLESGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGPYYYDSSGSRGAFDIWGQGTMVTVSS	nan	nan	IGHV1-2*02	IGHJ3*02	IGHD3-22*01	IGLV2-14	nan	ARGPYYYDSSGSRGAFDI	SSYTSSSTYV	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457920.1	nan
154	Wang-MOD4	Mod4_P3_IgG_D8-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGGACCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAATGGGTGGCAGTTATATCATATGATGGAAGTAATAGATACTATGCAGACTCCGTGAAGGGCCGAATCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAGCAGCCTGAGAGCTGAGGACACGGCTGTGTATTACTGTGCGAAAGCGTTGGGTCCGTATTGTGGTGGTGGTAGCTGCTACTCGGGTCCCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVISYDGSNRYYADSVKGRITISRDNSKNTLYLQMSSLRAEDTAVYYCAKALGPYCGGGSCYSGPFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTTTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTACCAATAATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAACCTCCTCATCTTCGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCTATCACCTTCGGCCAAGGGACACGACTGGACATTAAAC	DIQMTQSPSSLSASLGDRVTITCQASQDITNNLNWYQQKPGKAPNLLIFDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPITFGQGTRLDIK	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33*01,IGKV1D-33*01	IGKJ5*01	AKALGPYCGGGSCYSGPFDY	QQYDNLPIT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
154	IML3558	ADI-63257	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGTTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTAACTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATCATATGATGGAAGTAATAAATACTATGGAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAGGAACACGCTTTATCTGCAAATGAACAGCCTGAGACCTGAGGACACGGCTGTGTATTACTGTGCGAAAGCCCTAAGCCCCTATTGTGGTGGTGGTAGCTGCTACTCCGGGAGCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLLESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVAVISYDGSNKYYGDSVKGRFTISRDNSRNTLYLQMNSLRPEDTAVYYCAKALSPYCGGGSCYSGSFDYWGQGTLVTVSS	nan	nan	IGHV3-30*18,IGHV3-30-5*01	IGHJ4*02	IGHD2-15*01	IGKV1-33	nan	AKALSPYCGGGSCYSGSFDY	QQYDNFPLT	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW458766.1	nan
155	Li_SARS2_26	H026348+L024151	nan	SARS-CoV-2	SARS-CoV,MERS-CoV,OC43,HKU1,NL63	nan	nan	S:RBD	SARS-CoV-2 spike/NTD/RBD	B-cells;SARS-CoV-2 Human Patient	nan	QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYGMHWVRQAPGKGLEWVALIWYDGSNKYYVDSVKGRLTISRDNSKNTLYLQMNSLRAEDTAVYYCARGADILTGYYNYYYYGMDVWGQGTTVTVSS	nan	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNNNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSFDSSLSDHVVFGGGTKLTVL	IGHV3-33*01	IGHJ6	nan	IGLV1-40*01	IGLJ3	ARGADILTGYYNYYYYGMDV	QSFDSSLSDHVV	nan	Li et al. Cell 184:4203-4219.e32 (2021)	nan	nan
155	IML3558	ADI-60577	nan	SARS-CoV-2	nan	nan	SARS-CoV,SARS-CoV-2	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGCAGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAACTATGGCATCCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATGGTATGATGGAAGTAATAAATATTATGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCCAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGATGGGGCGATCTTTTGACTGGTTATTATAACTACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	EVQLQESGGGVVQPGRSLRLSCAASGFTFSNYGIHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSQNTLYLQMNSLRAEDTAVYYCARWGDLLTGYYNYYYYGMDVWGQGTTVTVSS	nan	nan	IGHV3-33*01	IGHJ6*02	IGHD3-9*01	IGLV1-40	nan	ARWGDLLTGYYNYYYYGMDV	QSYDSSLSGSYVV	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457908.1	nan
156	Xie_mix	BD-611	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLDYMDVWGKGTTVTVSS	nan	AIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSYPPMYTFGQGTKLEIK	IGHV3-66*01	nan	nan	IGKV1-9*01	nan	ARDLDYMDV	QQLNSYPPMYT	nan	Du et al. Cell 183:1013-1023.e13 (2020)	nan	nan
156	Wang-MOD1	Mod1_P2_IgG_D1-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGATCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATCCCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATTTGGGCTACATGGACGTCTGGGGCAAAGGGACCACGGTCACCGTCTCCTCA	EVQLVESGGGLIQPGGSLRLSCAASGITVSSNYMSWVRQAPGKGLEWVSVIYPGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLGYMDVWGKGTTVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTTGGAGACAGAGTCACCATCACTTGCCGGGCGAGTCAGGGCATTAGCAATTATTTAGCCTGGTATCAGCAGAAACCAGGGAAAGTTCTTAAGCTCCTGATCTATGATGCAACCACTTTGCAATCAGGGGTCCCATCTCGGTTCAGTGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATGTTGCAACTTATTACTGTCAAAAGTATAACAGTGCCCCTCCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQGISNYLAWYQQKPGKVLKLLIYDATTLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCQKYNSAPPWTFGQGTKVEIK	IGHV3-53*01	IGHJ6*03	IGHD3-16*01,IGHD3-16*02	IGKV1-27*01	IGKJ1*01	ARDLGYMDV	QKYNSAPPWT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
157	CV38	HK_CV38-184	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	CTTCTGGCAAACCGGGGTCATTCTGAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTAGTAGTTACTACTGGGGCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGAGTATCTATTATAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCCGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCAGACACGGCTGTGTATTACTGTGCGAGAGGGTTGGGTTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAGCCTCCACCAAGGGCCCATCGGTCTTCCCCCTGGCACCCTCCTCCAAGAGCACCTCTGGGGCACAGGGCCCGGCGAGG	EVQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGLGWFDPWGQGTLVTVSS	TATGACCCCCCAAGTTCCACTCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCGAGTCAGGGCATTAGCAATTCTTTAGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGCTCTATGCTGCATCCAGATTGGAAAGTGGGGTCCCATCCAGGTTCAGTGGCAGTGGATCTGGGACGGATTACACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGTATTATAGTACCCCTCCGAGGACTTTTGGCCAGGGGACCAAGCTGGAGATCAAACGAACTGTGGCTGCACCATCTGTCTTCATCTTCCCGCCATCTGATGAGCAGTTGAAATCTGGAACTGCCTCTGTTGTGTGCCTGCTGAATAACTTCTATCCCAGAGAGGCCAAAGTACAGTGGAAGGTGGATAACGCCCTCCAATCGGTACGCCAGAGATCCC	MTPQVPLSLSASVGDRVTITCRASQGISNSLAWYQQKPGKAPKLLLYAASRLESGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCQQYYSTPPRTFGQGTKLEIK	IGHV4-39*01	IGHJ5*02	IGHD3-16*01,IGHD3-16*02	IGKV1-NL1*01	IGKJ2*01,IGKJ2*02	ARGLGWFDP	QQYYSTPPRT	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
157	IML3547	ADI-62191	nan	SARS-CoV-2,SARS-CoV	nan	nan	SARS-CoV,SARS-CoV-2	S:S2	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTGGTGATTACTACTGGAGTTGGATCCGCCAGCCCCCAGGGAAGGGCCTGGAGTGGATTGGGTACATCTATTACAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACTGCCGCAGACACGGCCGTGTATTACTGTGCCAGAGTTCTCGGGTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCA	EVQLVESGPGLVKPSQTLSLTCTVSGGSISSGDYYWSWIRQPPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARVLGWFDPWGQGTLVTVSS	nan	nan	IGHV4-30-4*01	IGHJ5*02	IGHD3-10*01,IGHD3-10*02	IGLV2-14	nan	ARVLGWFDP	SSYTSSSTLYV	nan	Sakharkar et al. Sci. Immunol. 6:eabg6916 (2021)	MW457915.1	nan
158	COV047	COV047_P5_IgM_47-P1348	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGGGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGGCTCCATCAGCAGTAGTAACTGGTGGAGTTGGGTCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGGAAATCTATCATAGTGGGAGCACCAACTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCAGTAGACAAGTCCAAGAACCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATTACTGTGCGCGGGTCTCAGGCCTGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACGTCTCCTCAG	QVQLQESGPGLVKPSGTLSLTCAVSGGSISSSNWWSWVRQPPGKGLEWIGEIYHSGSTNYNPSLKSRVTISVDKSKNQFSLKLSSVTAADTAVYYCARVSGLFDPWGQGTLVTSPQ	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCGAGTCAGGGCATTAGCAATTCTTTAGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGCTCTATGCTGCATCCAGATTGGAAAGTGGGGTCCCATCCAGGTTCAGTGGCAGTGGATCTGGGACGGATTACACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGTATTATAGTACGCGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQGISNSLAWYQQKPGKAPKLLLYAASRLESGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCQQYYSTRTFGQGTKVEIK	IGHV4-4*02	IGHJ5*02	nan	IGKV1-NL1*01	IGKJ1*01	ARVSGLFDP	QQYYSTRT	nan	Wang et al. Sci. Transl. Med. 13:eabf1555 (2021)	MW293046.1	MW293501.1
158	Wang-C004	C004_P2_IgG_B7-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGGGACCCTGTCCCTCACCTGCGCTGTCTCTGGTGGCTCCATCAGCAGTACTAACTGGTGGAGTTGGGTCCGCCAGCCCCCAGGGAAGGGGCTGGAATGGATTGGGGAAATCTTTCATAGTGGGAGCACCAAGTACAACCCGTCCCTCAAGAGTCGAGTCACCATATCAGTAGACAAGTCCAAGAAGCAGTTCTCCCTGAAGCTGAGCTCTGTGACCGCCGCGGACACGGCCGTGTATTACTGTGCGAGAGTCAGTGGCCTTTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSGTLSLTCAVSGGSISSTNWWSWVRQPPGKGLEWIGEIFHSGSTKYNPSLKSRVTISVDKSKKQFSLKLSSVTAADTAVYYCARVSGLFDYWGQGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCGAGTCAGGGCATTAGCAATTCTTTAGCCTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGCTCTATGCTGCATCCACATTGGAAAGTGGGGTCCCATCCAGGTTCGGTGGCAGAGGATCTGGGACGGATTACACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGTCAACAGTATTATGGTACCGTCCGGACGTTCGGCCACGGGACCAAGGTGGACATCAAAC	DIQMTQSPSSLSASVGDRVTITCRASQGISNSLAWYQQKPGKAPKLLLYAASTLESGVPSRFGGRGSGTDYTLTISSLQPEDFATYYCQQYYGTVRTFGHGTKVDIK	IGHV4-4*02	IGHJ4*02	IGHD6-19*01	IGKV1-NL1*01	IGKJ1*01	ARVSGLFDY	QQYYGTVRT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
159	Wang-MOD4	Mod4_P4_IgG_A1-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGAATTCACCGTCAGCAGCAATTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTATTTATAGCGGTGGTACCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACTCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCCAGATGCTTACCCTTCGGGGACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLIQPGGSLRLSCAASEFTVSSNYMSWVRQAPGKGLEWVSLIYSGGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARCLPFGDYFDYWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGCGGCCCCAGGACAGAAGGTCACCATCTCCTGCTCTGGAAGCAGCTCCAACATTGGGAATAATTATGTATCCTGGTACCAGCAGCTCCCAGGAACAGCCCCCAAACTCCTCATTTATGACAATAATAAGCGACCCTCAGGGATTCCTGACCGATTCTCTGGCTCCAAGTCTGGCACGTCAGCCACCCTGGGCATCACCGGACTCCAGACTGGGGACGAGGCCGATTATTACTGCGGGACATGGGATAGCAGCCTGAGTGCTTGGATGTTCGGCGGAGGGACCCAGCTGACCGTCCTAG	QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSAWMFGGGTQLTVL	IGHV3-53*01	IGHJ4*02	IGHD3-10*01,IGHD3-10*02	IGLV1-51*01	IGLJ3*02	ARCLPFGDYFDY	GTWDSSLSAWM	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
159	COV047	COV047_P3_IgG_14-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGACTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGAATTCACCGTCAGTAGCAACTACATGAGTTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCACTTATTTATAGCGGTGGTAGCACATACTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTATATTACTGTGCGAGAGTCCTTCCTTTTGGGGACTACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVETGGGLIQPGGSLRLSCAASEFTVSSNYMSWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARVLPFGDYFDYWGQGTLVTVSS	CAGTCTGTGCTGACTCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGCTCCAACATCGGGGCAGGTTATGATGTACACTGGTGCCAGCAGCTTCCAGGAACAGCCCCCAAACTCCTCATCTATGGTTACAGCAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACATCAACCTGAGTGCCTGGGTGTTCGGCGGAGGGACCAGGCTGACCGTCCTAG	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWCQQLPGTAPKLLIYGYSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDINLSAWVFGGGTRLTVL	IGHV3-53*02	IGHJ4*02	IGHD3-16*01,IGHD3-16*02	IGLV1-40*01	IGLJ3*02	ARVLPFGDYFDY	QSYDINLSAWV	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293021.1	MW293476.1
160	Wang-C004	C004_P1_IgG_C11-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCACAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTGGTGGTTACTACTGGAGCTGGATCCGCCAGCACCCAGGGAAGGGCCTGGAGTGGATTGGGTACATCCATTACAGTGGGAACTCCTACTACAACCCCTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAACCAGTTCTCCCTGAAGGTGAAGTCTGTGACTGCCGCGGACACGGCCGTGTATTACTGTGCGAGAGATGGGGACGTGGCTGGCAACTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGYYWSWIRQHPGKGLEWIGYIHYSGNSYYNPSLKSRVTISVDTSKNQFSLKVKSVTAADTAVYYCARDGDVAGNFDYWGQGTLVTVSS	GAAATTGTGTTGACACAGTCTCCAGCCACCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGCAGGGCCAGTCAGAGTGTTAGCAGGTACTTAGCCTGGTACCAACAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGATGCATCCAACAGGGCCACTGGCGTCCCAGCCAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCGACAGCCTAGAGCCTGAAGATTTTGCAGTTTATTACTGTCAGCAGCGTTACAACTGGCCTCCTTACACTTTTGGCCAGGGGACCAAGCTGGAGATCAAAC	EIVLTQSPATLSLSPGERATLSCRASQSVSRYLAWYQQKPGQAPRLLIYDASNRATGVPARFSGSGSGTDFTLTIDSLEPEDFAVYYCQQRYNWPPYTFGQGTKLEIK	IGHV4-31*03	IGHJ4*02	IGHD6-19*01	IGKV3-11*01	IGKJ2*01	ARDGDVAGNFDY	QQRYNWPPYT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
160	CV07	HK_CV07-163	nan	SARS-CoV-2	nan	nan	nan	S:S1	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	GCGGTTCCATTTCACCCTACAGATGAGAGGAGTGTGGGGTCCAGTTTGGGGCGACCCCTGCCCCCTGACTGGGACGTCTGCAAACCCCGGGTACATTCTGAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCAGCTTCAATACCTATGACATGCATTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATGGCATGATGGAAATAATAAATACTATGCAGAATCTGTGGAGGGCCGATTCACCATTTCCAGAGACAATTCCAAGAAAACGCTGTATTTGCAAATGAACAGCCTGAGAGTCGAGGACACGGCTGTGTATTACTGTGCGAGAGATTGGGCAGTGGCTGGTAATTTTGACTACTGGGGCCAGGGAACCCTGGTCACCTCTCCTCAGGGAGTCACCGCGCACCCTACC	EVQLVESGGGVVQPGRSLRLSCAASGFSFNTYDMHWVRQAPGKGLEWVAVIWHDGNNKYYAESVEGRFTISRDNSKKTLYLQMNSLRVEDTAVYYCARDWAVAGNFDYWGQGTLVTSPQ	AATTTTTTTTTGCCCCCCCGTGGCTCAGTCTCCCTGTCTTTGTCTCCAGGGGAAAGAGCCACCCTCTCCTGTCGGGCCAGTCAGAGTGTTAGCAGCACCTACTTAGCCTGGTACCAGCATAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGGTGCATCCAGCAGGGCCACTGGCATCCCAGACAGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCAGCATCAGCAGACTGGAGCCTGAAGATTTTGCAGTGTATTACTGTCAGCAGTATGGTGCCTCACCTCCGACCACCTTCGGCCAAGGGACACGACTGGAGATTAAACGAACTGTGGCTGCACCATCTGTCTTCATCTTCCCGCCATCTGATGAGCAGTTGAAATCTGGAACTGCCTCTGTTGTGTGCCTGCTGAATAACTTCTATCCCAGAGAGGCCAAAGTACAGTGGAAGGTGGATAACGCCCTCCAATCGGGTACTCCCAGAGACGGGG	FFLPPRGSVSLSLSPGERATLSCRASQSVSSTYLAWYQHKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLSISRLEPEDFAVYYCQQYGASPPTTFGQGTRLEIK	IGHV3-33*01	IGHJ4*02	IGHD6-19*01	IGKV3-20*01	IGKJ5*01	ARDWAVAGNFDY	QQYGASPPTT	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
161	CV07	HK_CV07-209	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	TCTGCAACCCCGGGTACATTCTGAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCTCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTGTTAGTACCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGGGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATGGGGTTATCCCACCACGATTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAGCCTCCACCAAGGGCCCATCGGTCTTCCCCCTGGCACCCTCCTCCAAGAGCACCTCTGGGGCACAGCGGCCTGGTTTTC	EVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMSWIRQAPGKGLEWVSYISSSVSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDGVIPPRFDYWGQGTLVTVSS	AATGACCCCAGGCTCCATTCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAACTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAACGAACTGTGGCTGCACCATCTGTCTTCATCTTCCCGCCATCTGATGAGCAGTTGAAATCTGGAACTGCCTCTGTTGTGTGCCTGCTGAATAACTTCTATCCCAGAGAGGCCAAAGTACAGTGGAAGGTGGATAACGCCCTCCAATCGGTATCCCAGAGACCTGTACG	SASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK	IGHV3-11*01	IGHJ4*02	IGHD3-16*02,IGHD3-22*01,IGHD3-3*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	ARDGVIPPRFDY	QQYDNLPLT	nan	Kreye et al. Cell 183:1058-1069 (2020)	MW002770.1	MW002788.1
161	Graham_P008	P008_108	nan	SARS-CoV-2	SARS-CoV	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTATTACATGAGTTGGATCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTACTAGTCCTGGTAGTGCCATATACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGGGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCCTGTATTACTGTACGAGAGACGGAGTAATTCCGCCCAGATTTGACTACTGGGGCCAGGGAACCATGGTCACCGTCTCTTCAG	EVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMSWIRQAPGKGLEWVSYITSPGSAIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCTRDGVIPPRFDYWGQGTMVTVSS	GACATCGTGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAAGTATTTAAATTGGTATCAGCGGAAACCAGGGACAGCCCCTACGCTCCTGATCTATGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCAGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGGAACATATTACTGTCAACAGTATGATAATCTCCCCACTTTCGGCGGCGGGACCAAGGTGGAAATCAAAC	DIVMTQSPSSLSASVGDRVTITCQASQDISKYLNWYQRKPGTAPTLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIGTYYCQQYDNLPTFGGGTKVEIK	IGHV3-11*01	IGHJ4*02	IGHD3-10*01,IGHD3-10*02	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	TRDGVIPPRFDY	QQYDNLPT	nan	Graham et al. Immunity 54:1276-1289.e6 (2021)	MW802468.1	MW802361.1
162	CV03	HK_CV03-191	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	TTCTGCAACCCCGGTGTACATTCTGAGGTGCAGCTGGTGGAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGATCTAGGCTACAATAGACGGTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAGGGAGTGCTTCCGCCCCACTTCCTCT	EVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMSWIRQAPGKGLEWVSYISSSSSYTNYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDLGYNRRFDYWGQGTLVTVSS	TTATGAACCCCCAAGCTCAGTCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAACGAACTGTGGCTGCACCATCTGTCTTCATCTTCCCGCCATCTGATGAGCAGTTGAAATCTGGAACTGCCTCTGTTGTGTGCCTGCTGAATAACTTCTATCCCAGAGAGGCCAAAGTACAGTGGAAGGTGGATAACGCCCTCCAATCGGGTAATTCCCCGGGAGCGGGG	YEPPSSVSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK	IGHV3-11*06	IGHJ4*02	IGHD5-24*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	ARDLGYNRRFDY	QQYDNLPLT	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
162	CV-X1	HK_CV-X1-143	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	TCCGCAAACCCGGTGTACATTCTGAGGTGCAGCTGGTGCAGTCTGGGGGAGGCTTGGTCAAGCCTGGAGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTGACTACTACATGAGCTGGATCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTTACACAAACTACGCAGACTCTGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTAGGGTATAGCACTCGCTTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAGCCTCCACCAAGGGCCCATCGGTCTTCCCCCTGGCACCCTCCTCCAAGAGCACCTCTGGGGCACAGCCGGCCGGCGGGA	EVQLVQSGGGLVKPGGSLRLSCAASGFTFSDYYMSWIRQAPGKGLEWVSYISSSSSYTNYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDLGYSTRFDYWGQGTLVTVSS	TTTTAGGACCCCCCAGTCCCTCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCGCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAACGAACTGTGGCTGCACCATCTGTCTTCATCTTCCCGCCATCTGATGAGCAGTTGAAATCTGGAACTGCCTCTGTTGTGTGCCTGCTGAATAACTTCTATCCCAGAGAGGCCAAAGTACAGTGGAAGGTGGATAACGCCCTCCAATCGGTACTCCAGAGAAAGC	FRTPQSLSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK	IGHV3-11*05	IGHJ4*02	IGHD6-13*01,IGHD6-19*01,IGHD6-25*01	IGKV1-33*01,IGKV1D-33*01	IGKJ4*01	ARDLGYSTRFDY	QQYDNLPLT	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
163	Wang-PFZ10	PZF10_P1_IgG_D4-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	GAGGTGCAGCTGGTGGAGACTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGGTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGTACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTTTCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATCTCCGCGGGCCAGGTTTATTCGATCTCTGGGGCCGTGGCACTCTGGTCACTGTCTCCTCAG	EVQLVETGGGLIQPGGSLRLSCAASGVTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCARDLRGPGLFDLWGRGTLVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCTCATCAAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCTGGGGTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVSSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPGVTFGPGTKVDIK	IGHV3-53*02	IGHJ2*01	nan	IGKV1-33*01,IGKV1D-33*01	IGKJ3*01	ARDLRGPGLFDL	QQYDNLPGVT	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
163	COV107	COV107_Plate1_HC_44-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTACATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAGTTATTTATAGCGGTGGTAGCACATTCTACGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGCGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAGCCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGAGATTTGCGGGGCCCCGGCACTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCAG	EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISSDNSKNTLYLQMNSLRAEDTAVYYCARDLRGPGTFDIWGQGTMVTVSS	GACATCCAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCAGGCGAGTCAGGACATTAGCAACTATTTAAATTGGTATCAGCAGAAACCAGGGAAAGCCCCTAAGCTCCTGATCTACGATGCATCCAATTTGGAAACAGGGGTCCCATCCAGGTTCAGTGGAAGTGGATCTGGGACAGATTTTACTTTCACCATCAGCAGCCTGCAGCCTGAAGATATTGCAACATATTACTGTCAACAGTATGATAATCTCCCCCGGGTCACTTTCGGCCCTGGGACCAAAGTGGATATCAAAC	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPRVTFGPGTKVDIK	IGHV3-53*01	IGHJ3*02	IGHD3-10*01,IGHD3-10*02	IGKV1-33*01,IGKV1D-33*01	IGKJ3*01	ARDLRGPGTFDI	QQYDNLPRVT	nan	Robbiani et al. Nature 584:437-442 (2020)	nan	nan
164	Wang-MOD9	MOD9_P2_IgG_B2-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAAGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATACACCTTCACCAATTATGATATCAACTGGGTGCGACAGGCCGCTGGACAAGGGCTTGAGTGGATGGGATGGATGAACCCTAACAGTGGTAGCACAGGCTATGCACAGAAGTTCCAGGGCAGAGTCACCATGACCAGGAACACCTCCATAAGCACAGCCTACATGGAACTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGGCGGGGCTTTGACTGGTTATGTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYDINWVRQAAGQGLEWMGWMNPNSGSTGYAQKFQGRVTMTRNTSISTAYMELSSLRSEDTAVYYCARGGALTGYVDYWGQGTLVTVSS	TCCTATGTGCTGACTCAGCCACCCTCGGTGTCAGTGGCCCCAGGACAGACGGCCAGGATTACCTGTGGGGGAAACAACATTGGAAGTAAAAATGTGCACTGGTACCAGCAGAAGCCAGGCCAGGCCCCTGTGCTGGTCGTCTTTGATGATAGCGACCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACGGCCACCCTGACCATCAGCAGGGTCGAAGCCGGGGATGAGGCCGACTATTACTGTCAGCTGTGGGATAGTACTGGTGATCCCCTTTATGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	SYVLTQPPSVSVAPGQTARITCGGNNIGSKNVHWYQQKPGQAPVLVVFDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQLWDSTGDPLYVFGTGTKVTVL	IGHV1-8*01	IGHJ4*02	IGHD3-9*01	IGLV3-21*02	IGLJ1*01	ARGGALTGYVDY	QLWDSTGDPLYV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
164	Wang-MOD6	MOD6_P2_IgG_E5-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATACACCTTCACCAGTTATGATATCAACTGGGTGCGACAGGCCACTGGACAAGGGCTTGAGTGGATGGGATGGATGAACCCTAACAGTGGTAGCAGAGGCTATGCACAGAAGTTCCAGGGCAGAGTCACCATGACCAGGAACACCTCCATAAGTACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGGAGGGGGCTTAACTGGGGACGTTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYDINWVRQATGQGLEWMGWMNPNSGSRGYAQKFQGRVTMTRNTSISTAYMELSSLRSEDTAVYYCARGGGLTGDVDYWGQGTLVTVSS	TCCTATGTGCTGACTCAGCCACCCTCGGTGTCAGTGGCCCCAGGACAGACGGCCAGGATTACCTGTGGGGGAAACAACATTGGAAGTAAAAATGTTCACTGGTACCAGCAGAAGCCAGGCCAGGCCCCTGTGCTGGTCGTCTTTGATGATAGCGACCGGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCTGGGAACACGGCCACCCTGACCATCAGCAGGGTCGAAGCCGGGGATGAGGCCGACTACTACTGTCAGGTGTGGGAAAGTAGTGGTGATCATGTGGTCTTCGGCGGAGGGACCAAGCTGACCGTCCTAG	SYVLTQPPSVSVAPGQTARITCGGNNIGSKNVHWYQQKPGQAPVLVVFDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWESSGDHVVFGGGTKLTVL	IGHV1-8*01	IGHJ4*02	IGHD7-27*01	IGLV3-21*02	IGLJ2*01,IGLJ3*01	ARGGGLTGDVDY	QVWESSGDHVV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
165	BG7	BG7-19	nan	SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGLVQPGGGSLRLSCAASGFTFSTYWMSWVRQAPGKGLEWVANIKEDGSEKYYVDSVKGRVTISRDNAKNSLYLQMNSLRVEDTAVYYCAR	nan	NFMLTQPRSVSESPGKTVTISCTRTSGSIAINYVQWYQQRPGSSPTTVIYEDSQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSGS	IGHV3-7*01	nan	nan	IGLV6-57*01	nan	ARVRWLQGGIDY	QSYDSGSWV	nan	Scheid et al. Cell 184:3205-3221.e24 (2021)	nan	nan
165	Wang-C001	C001_P2_IgG_C8-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTGCAGCTACAGCAGTGGGGCGCAGGACTGTTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCGCTGTCTATGGTGGGTCCTTCAGTGATTACTACTGGACCTGGATCCGCCAGCCCCCAGGGAAGGGGCTGGAGTGGATTGGGGAAATCAATCATAGTGGAGGCACCAACTTCAACCCGTCCCTCAGGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAGCCAGTTCTCCCTGAACCTGAGCTCTGTGACCGCCGCGGACACGGCTGTGTATTACTGTGCGAGAGTCGTATGGTTACAAGGGGAGATTGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLQQWGAGLLKPSETLSLTCAVYGGSFSDYYWTWIRQPPGKGLEWIGEINHSGGTNFNPSLRSRVTISVDTSKSQFSLNLSSVTAADTAVYYCARVVWLQGEIDYWGQGTLVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACTCTAAGCAGNNNCACCANCGGCTGCAAGTACCAGCAGGGGTNGCATCAGCCCCAGTGCGGGTCGGANTCTCCGGGGAAGNCGGTAACCATCTCAAGCACCTGCAGCAGCCGCAGCATTGTCAGCAGNNATGTGCAGNGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTATTTCTGTCAGTCTTATGATACCACCATTCCGAGGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	NFMLTQPHSVSESPGKTVTISCTLSXXTXGCKYQQGXHQPQCGSXSPGKXVTISSTCSSRSIVSXXVQXSSNSASLTISGLKTEDEADYFCQSYDTTIPRVFGGGTKLTVL	IGHV4-34*01	IGHJ4*02	IGHD5-18*01,IGHD5-5*01	IGLV6-57*01	IGLJ2*01,IGLJ3*01	ARVVWLQGEIDY	QSYDTTIPRV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
166	Wheatley-CP13	PDI_103	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	CAGGTGCAGCTGCAGGAGTCGGGCCCAGGACTGGTGAAGCCTTCGGAGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGTAGTTACTACTGGAGTTGGATCCGGCAGCCCCCAGGGAAGGGACTGGAGTGGATTGGGTATATCTATAACAGTGGGAGCACCAACTACAACCCCTCCCTCAAGAGTCGAGTCACCATATCAGTAGACACGTCCAAGAACCAGATCTCCCTGAAGCTGAGCTCTGTGACCGCTGCGGACACGGCCGTGTATTACTGTGCGAGCAGTCTATGGTTACGGGGTGGTTTTGATATCTGGGGCCAAGGGACAATGGTCACCGTCTCTTCA	QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYNSGSTNYNPSLKSRVTISVDTSKNQISLKLSSVTAADTAVYYCASSLWLRGGFDIWGQGTMVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGTTAATCATGTCGAGCACCGGCAGCAGTGGCAGCATTGCCAGCAAGTATTTGCAGTGGTACCAGCAGGGCCCCGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTGTCCGGATCCATTGACAGCTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGAATACTACTGTCAGTCTTATGATAACAACAATCGGGTGTTCGGCGGAGGGACCAAGCTGACCGTCCTA	NFMLTQPHSVSESPGKTLIMSSTGSSGSIASKYLQWYQQGPGSAPTTVIYEDNQRPSGVPDRLSGSIDSSSNSASLTISGLKTEDEAEYYCQSYDNNNRVFGGGTKLTVL	IGHV4-59*01	IGHJ3*02	IGHD5-18*01,IGHD5-5*01	IGLV6-57*02	IGLJ3*02	ASSLWLRGGFDI	QSYDNNNRV	nan	Wheatley et al. Cell Rep. 37:109822 (2021)	nan	nan
166	Crowe_mix	COV2-2354	nan	SARS-CoV,SARS-CoV-2	nan	SARS-CoV-2	nan	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCACCTGGTGGGGTCTGGAGGAGGCTTGATCCAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGGTTCACCGTCAGTAGCAACTTCATGAGCTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCAATTATTCATAACGGTGGCGACTCATACTACACAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTTCAAATGAACAACCTGAGAGCCGAGGACACGGCCGTGTATTACTGTGCGAGCAGCAGCTGGTTACGAGGTGCTTTTGATATCTGGGGTCAAGGGACAATGGTCACCGTCTCTTCA	EVHLVGSGGGLIQPGGSLRLSCAASGFTVSSNFMSWVRQAPGKGLEWVSIIHNGGDSYYTDSVKGRFTISRDNSKNTLYLQMNNLRAEDTAVYYCASSSWLRGAFDIWGQGTMVTVSS	AATTTTATGCTGACTCAGCCCCACTCTGTGTCGGAGTCTCCGGGGAAGACGGTAACCATCTCCTGCACCGGCAGCAGTGGCAGCATTGCCAGCAACTATGTGCAGTGGTACCAGCAGCGCCCGGGCAGTGCCCCCACCACTGTGATCTATGAGGATAACCAAAGACCCTCTGGGGTCCCTGATCGGTTCTCTGGCTCCATCGACAGTTCCTCCAACTCTGCCTCCCTCACCATCTCTGGACTGAAGACTGAGGACGAGGCTGACTACTACTGTCAGTCTTATGATAGCAGCAAATATGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTA	NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSKYVVFGGGTKLTVL	IGHV3-53*01	IGHJ3*02	IGHD6-13*01	IGLV6-57*02	IGLJ2*01,IGLJ3*01	ASSSWLRGAFDI	QSYDSSKYVV	nan	Zost et al. Nat. Med. 26:1422-1427 (2020)	MT665451.1	MT665064.1
167	CV38	HL_CV38-231	nan	SARS-CoV-2	nan	nan	nan	S:S1	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	ATTCCGCCAACCCCGGTGTACATTCTGAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATGGTATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCGTCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGATGGGCTCGATGATGATTACATTTGGGGGAGTTTCAAGATTAGGTACTACTACATGGACGTCTGGGGCAAAGGGACCACGGTCACCGTCTCCTCAGCCTCCACCAAGGGCCCATCGGTCTTCCCCCTGGCACCCTCCTCCAAGAGCACCTCTGGGGCACAGCGGCCTGGCGGGG	EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTVSRDNSKNTLYLQMNSLRAEDTAVYYCARDGLDDDYIWGSFKIRYYYMDVWGKGTTVTVSS	TTTTTTTTTTTACACCCCCCTCCTCCCCTCGATCGTCAGGATACGAGAGAGACACACACCCCAGTGCGCGGCGCCGACACTGTCAATAAAACCCGTGGTTTTCTTCGTATCAGCATCTCTGCTACCCCCGGGCCTGGTGCCAAGTCTGTGCTGACTCAGCCTCCCTCCGCGTCCGGGTCTCCTGGACAGTCAGTCACCATCTCCTGCACTGGGACCAGCAGTGACATTGGTGCTTATAATTATGTCTCCTGGTACCAACAGCACCCAGGCAAAGCCCCCAAACTCATGATTTTTGAAGTCTCTAAGCGGCCCTCAGGGGTCCCTGATCGCTTCTCTGCCTCCAAGTCTGGCAACACGGCCTCCCTGACCGTCTCTGGGCTCCAACCTGAGGATGAGGCTCATTACTACTGCAGCTCATATTCAGGCACCACCAACTTCGCCCAGTTCGGCGGGGGGACCAAGCTGACCTCCTTGGTCAGCCAAGCTCTCCCTCGG	KSVLTQPPSASGSPGQSVTISCTGTSSDIGAYNYVSWYQQHPGKAPKLMIFEVSKRPSGVPDRFSASKSGNTASLTVSGLQPEDEAHYYCSSYSGTTNFAQFGGGTKLT	IGHV3-33*01	IGHJ6*03	IGHD3-16*01,IGHD3-16*02	IGLV2-8*01	IGLJ3*02	ARDGLDDDYIWGSFKIRYYYMDV	SSYSGTTNFAQ	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
167	CV48	HL_CV48-113	nan	SARS-CoV-2	nan	nan	nan	S:S1	SARS-CoV-2 S1	B-cells;SARS-CoV-2 Human Patient	TTCTGCAAACCCCGGTGTACATTCTGAGGTGCAGCTGGTGGAGTCTGGGGGAGGCGTGGTCCAGCCTGGGAGGTCCCTGAGACTCTCCTGTGCAGCGTCTGGATTCACCTTCAGTAGCTATGGCATGCACTGGGTCCGCCAGGCTCCAGGCAAGGGGCTGGAGTGGGTGGCAGTTATATGGTATGATGGAAGTAATAAATACTATGCAGACTCCGTGAAGGGCCGATTCACCATCTCCAGAGACAATTCCAAGAACACGCTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGATGGGCTCGATGATGATTACATTTGGGGGAGTTTCAAGATTAGGTACTACTACATGGACGTCTGGGGCAAAGGGACCACGGTCACCGTCTCCTCAGCCTCCACCAAGGGCCCATCGGTCTTCCCCCTGGCACCCTCCTCCAAGAGCACCTCTTGGGGCACCAAGGGCCTGCGGGG	EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDGLDDDYIWGSFKIRYYYMDVWGKGTTVTVSS	TTCTTTCGCTAAGTCTCCCCTACGAGGGGAAAGCTGTCCACATCAACAGGGGAAGTATTCAACGCAACTCTTGCGGGGACACGGGGGAATTCTGAAGACATCTGCTACCCGGGTCCTGGTCCCAGTCTGTGCTGACTCAGTCGCCCTCTGCCTCTGCCTCCCTGGGAGCCTCGGTCAAGCTCACCTGCACTCTGAGCAGTGGGCACAGCAGCTACGCCATCGCATGGCATCAGCAGCAGCCAGAGAAGGGCCCTCGGTACTTGATGAAGCTTAACAGTGATGGCAGCCACAGCAAGGGGGACGGGATCCCTGATCGCTTCTCAGGCTCCAGCTCTGGGGCTGAGCGCTACCTCACCATCTCCAGCCTCCAGTCTGAGGATGAGGCTGACTATTACTGTCAGACCTGGGGCACTGGCATCAATGTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAGTCAGCCCAAGCTGCTCACTCGG	QSVLTQSPSASASLGASVKLTCTLSSGHSSYAIAWHQQQPEKGPRYLMKLNSDGSHSKGDGIPDRFSGSSSGAERYLTISSLQSEDEADYYCQTWGTGINVVFGGGTKLTVL	IGHV3-33*01	IGHJ6*03	IGHD3-16*01,IGHD3-16*02	IGLV4-69*01	IGLJ2*01,IGLJ3*01	ARDGLDDDYIWGSFKIRYYYMDV	QTWGTGINVV	nan	Kreye et al. Cell 183:1058-1069 (2020)	nan	nan
168	Wang-MOD3	MOD3_P2_IgG_B4-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTTCAGCTGGTGCAGTCTGGAGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGTTACACCTTTACCAGCTACGGTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGCATGGATCAGCCCTTACAATGGTAACACAGACTATGCACAGAAGCTCCAGGGCAGAGTCATCATGACCACAGACACAGCCACGAGCACAGCCTACATGGAGCTGAGGAGCCTGAGATCTGACGACACGGCCGTGTATTACTGTGCGAGAGATCTTGGTAAAAAGTATGATAGTAGTGGTTATTCTTATTACTACTACTACAACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMAWISPYNGNTDYAQKLQGRVIMTTDTATSTAYMELRSLRSDDTAVYYCARDLGKKYDSSGYSYYYYYNGMDVWGQGTTVTVSS	CAGTCTGTGCTGACTCAGCCTCCCTCCGCGTCCGGGTCTCCTGGACAGTCAGTCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGATTATAACTATGTCTCCTGGTACCAACAGCACCCAGGCAAAGCCCCCAAACTCATGATTTATGAGGTCACTAAGCGGCCCTCAGGGGTCCCTGATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCGTCTCTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCAGCTCATATGCAGGCAGCAACAATTTGGTATTCGGCGGAGGGACCTACCTGACCGTCCTAG	QSVLTQPPSASGSPGQSVTISCTGTSSDVGDYNYVSWYQQHPGKAPKLMIYEVTKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYAGSNNLVFGGGTYLTVL	IGHV1-18*04	IGHJ6*02	IGHD3-22*01	IGLV2-8*01	IGLJ2*01,IGLJ3*01	ARDLGKKYDSSGYSYYYYYNGMDV	SSYAGSNNLV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
168	Wang-MOD8	MOD8_P2_IgG_A12-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human mRNA Vaccinee	CAGGTTCAGCTGGTGCAGTCTGGAGCTGAGGTGAAGAAGCCTGGGGCCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGTTACACCTTTACCAGCTATGGTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGATGGATCACCGCTTACAATGGTAACACAAACTATGCACAGAACCTCCAGGGCAGAGTCACCATGACCACAGACACATCCACGAGCACAGCCTACATGGAGCTGAGGAGCCTGAGATCTGACGACACGGCCGTGTATTACTGTGCGAGAGATTTGGGTCGGGAATATGATAGTAGTGGTTATTCCTACAAATACTACTACTACGGTATGGACGTCTGGGGCCAAGGGACCACGGTCACCGTCTCCTCA	QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWITAYNGNTNYAQNLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDLGREYDSSGYSYKYYYYGMDVWGQGTTVTVSS	CAGTCTGTGCTGACTCAGCCTCCCTCCGCGTCCGGGTCTCCTGGACAGTCAGTCACCATCTCCTGCACTGGAACCAGCAGTGACGTTGGTGGTTATAACTATGTCTCCTGGTACCAACAGCACCCAGGCAAAGCCCCCAAGCTCATGATTTATGAGGTCACTAAGCGGCCCTCAGGGGTCCCTGATCGCTTCTCTGGCTCCAAGTCTGGCAACACGGCCTCCCTGACCGTCTCTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCAGCTCATATGCAGGCAGCAACAATTTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAG	QSVLTQPPSASGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYEVTKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYAGSNNLVFGGGTKLTVL	IGHV1-18*01	IGHJ6*02	IGHD3-22*01	IGLV2-8*01	IGLJ2*01,IGLJ3*01	ARDLGREYDSSGYSYKYYYYGMDV	SSYAGSNNLV	nan	Wang et al. Nature 592:616-622 (2021)	nan	nan
169	A VelocImmune mouse	REGN10932	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 spike	B-cells;Humanized Mouse	nan	EVQLVESGGGLVQSGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYSDSVKGRFTISRHNSKNTLYLQMNSLRAEDTAVYYCARARGDAFDIWGQGTMVTVSS	nan	DRVTITCQASQGISNYLNWYQQKPGKAPKLLISDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLRFFTFGPGTKVDIK	IGHV3-53*04	IGHJ3	nan	IGKV1-33*01	IGKJ3	ARARGDAFDI	QQYDNLRFFT	nan	Patent: US10787501	nan	nan
169	BG10	BG10-15	nan	SARS-CoV-2	nan	nan	SARS-CoV-2	S:RBD	SARS-CoV-2 spike/RBD	B-cells;SARS-CoV-2 Human Patient	nan	EVQLVESGGGSVQPGGSLRLSCAASGFTFSPYSMTWVRQAPGKGLEWVSYISSSSSTIHYAESVKGRFTISRDNARDSLYLQMNSLKDEDTAVYYCAR	nan	QSVLTQPPSVSAAPGQKVTISCSGNSSNIGNNYVSWYHQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDNSLS	IGHV3-48*02	nan	nan	IGLV1-51*01	nan	ARARGDAFDI	GTWDNSLSVGV	nan	Scheid et al. Cell 184:3205-3221.e24 (2021)	nan	nan
170	COV047	COV047_P3_IgG_84-P1369	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 RBD	B-cells;SARS-CoV-2 Human Patient	GAGGTGCAGCTGGTGGAGTCTGGGGGAGGCCTGGTCAAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGTACCTATAGCATGAACTGGGTCCGCCAGGCTCCAGGGAAGGGGCTGGAGTGGGTCTCATCCATTAGTAGTAGTAGTAGTTACATATACTACGCAGACTCAGTGAAGGGCCGATTCACCATCTCCAGAGACAACGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGACACGGCTGTGTATTACTGTGCGAGAGTAGTAGCCAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	EVQLVESGGGLVKPGGSLRLSCAASGFTFSTYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVVANWFDPWGQGTLVTVSS	GACATCGTGATGACCCAGTCTCCAGACTCCCTGGCTGTGTCTCTGGGCGAGAGGGCCACCATCAACTGCAAGTCCAGCCAGAGTGTTTTATACAGCTCCAACAATAAGAACTACTTGGCTTGGTACCAGCAGAAACCAGGACAGCCTCCTAAGCTGCTCATTTACTGGGCATCTACCCGGGAATCCGGGGTCCCTGACCGATTCAGTGGCAGCGGGTCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGGCTGAAGATGTGGCAGTTTATTACTGTCAGCAATATTATAGTACTCCTCAGCCGTCGTGGACGTTCGGCCAAGGGACCAAGGTGGAAATCAAAC	DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPQPSWTFGQGTKVEIK	IGHV3-21*01	IGHJ5*02	IGHD2-2*01,IGHD2-2*02,IGHD2-2*03	IGKV4-1*01	IGKJ1*01	ARVVANWFDP	QQYYSTPQPSWT	nan	Robbiani et al. Nature 584:437-442 (2020)	MW293075.1	MW293530.1
170	Donor5	ab166	nan	SARS-CoV-2	nan	nan	nan	S:RBD	SARS-CoV-2 spike/RBDdeltaRBM	B-cells;Healthy Donor	CAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGTCCTCGGTGAAGGTCTCCTGCAAGGCTTCTGGAGGCACCTTCAGCAGCTATGCTATCAGCTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATGGGAAGGATCATCCCTATCCTTGGTATAGCAAACTACGCACAGAAGTTCCAGGGCAGAGTCACGATTACCGCGGACAAATCCACGAGCACAGCCTACATGGAGCTGAGCAGCCTGAGATCTGAGGACACGGCCGTGTATTACTGTGCGAGAGTGGTCTCTAACTGGTTCGACCCCTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAG	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARVVSNWFDPWGQGTLVTVSS	CAGTCTGAGCTGACTCAGCCGCCCTCAGTGTCTGGGGCCCCAGGGCAGAGGGTCACCATCTCCTGCACTGGGAGCAGCTCCAACATCGGGGCAGGTTATGATGTACACTGGTACCAGCAGCTTCCAGGAACAGCCCCCAAACTCCTCATCTATGGTAACAGCAATCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCACTGGGCTCCAGGCTGAGGATGAGGCTGATTATTACTGCCAGTCCTATGACAGCAGCCTGAGTGGTCCCGTCTTCGGAACTGGGACCAAGGTCACCGTCCTAG	QSELTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGPVFGTGTKVTVL	IGHV1-69*09	IGHJ5*02	nan	IGLV1-40*01	IGLJ1*01	ARVVSNWFDP	QSYDSSLSGPV	nan	Feldman et al. Science Immunology (2021): eabl5842.	OK094379.1	OK094380.1
